technical/biomed/1468-6708-3-1.txt:          used an alternative approach, which assigns a different
technical/biomed/1468-6708-3-1.txt:          maximum thickness of the internal carotid artery,
technical/biomed/1468-6708-3-10.txt:        each of three alternative antihypertensive drugs: a
technical/biomed/1468-6708-3-10.txt:          nocturnal dyspnea, dyspnea at rest, New York Heart
technical/biomed/1468-6708-3-4.txt:        journal articles. This needs to be corrected.
technical/biomed/1468-6708-3-4.txt:          International Conference on Harmonization (ICH)-E9
technical/biomed/1468-6708-3-4.txt:        the study's duration should be shortened. Alternatively,
technical/biomed/1468-6708-3-4.txt:        missing completely at random; ICH = International
technical/biomed/1471-2091-2-11.txt:        operates entirely in the liver [ 1 ] . The "alternative"
technical/biomed/1471-2091-2-11.txt:          of total RNA from the selected clones (CHO.asbt) readily
technical/biomed/1471-2091-2-11.txt:          showed the presence of the recombinant asbt mRNA (Figure
technical/biomed/1471-2091-2-11.txt:          the recombinant asbt mRNA encoded by the transgene. The
technical/biomed/1471-2091-2-11.txt:          of the recombinant mRNA encoding the recombinant HBAB in
technical/biomed/1471-2091-2-11.txt:          abundance of the HBAB mRNA (Figure 9A). Analysis of
technical/biomed/1471-2091-2-11.txt:        these cells internalize bile acids via ntcp or asbt.
technical/biomed/1471-2091-2-11.txt:          region of the encoded recombinant eukaryotic mRNA was
technical/biomed/1471-2091-2-11.txt:          RNA and immunoblot analyses
technical/biomed/1471-2091-2-11.txt:          Total RNA from CHO.asbt and BN cells was prepared and
technical/biomed/1471-2091-2-11.txt:          analyzed by RNA blotting as previously described [ 17 ] .
technical/biomed/1471-2091-2-11.txt:          The isolated DNA was treated with RNase A and then
technical/biomed/1471-2091-2-11.txt:          supernatant was assayed for caspase activity in 20 mM
technical/biomed/1471-2091-2-12.txt:        glycosylated isoforms). Alternatively, it may reflect
technical/biomed/1471-2091-2-12.txt:          and supernatant was concentrated to 2 ml by Amicon YM30
technical/biomed/1471-2091-2-13.txt:        for internal protein); the portions of the host protein are
technical/biomed/1471-2091-2-13.txt:        termed exteins (external protein) [ 3 4 5 ] .
technical/biomed/1471-2091-2-13.txt:        metabolic enzymes, DNA and RNA polymerases, gyrases,
technical/biomed/1471-2091-2-13.txt:        59°C and at an external pH between 1-2 [ 20 ] . A
technical/biomed/1471-2091-2-13.txt:          rRNA phylogeny
technical/biomed/1471-2091-2-13.txt:          and small subunit ribosomal RNAs are shown in Figure 3.
technical/biomed/1471-2091-2-13.txt:          tRNAs corresponds to the frequencies with which the
technical/biomed/1471-2091-2-13.txt:          genes. The exact causes for tRNA regulation and codon
technical/biomed/1471-2091-2-13.txt:          Archaea have codon usage frequencies and tRNA
technical/biomed/1471-2091-2-13.txt:          did not express additional rare tRNAs, was transformed
technical/biomed/1471-2091-2-13.txt:        closely related Archaea. Based on their 16S rRNA they are
technical/biomed/1471-2091-2-13.txt:        agreement with the ribosomal rRNA phylogeny, the main
technical/biomed/1471-2091-2-13.txt:        rRNA this organisms is clearly classified as a
technical/biomed/1471-2091-2-13.txt:        subunit) and with 16S rRNA do not group these two organisms
technical/biomed/1471-2091-2-13.txt:          500 μL of fresh TEP buffer. Both the supernatant and the
technical/biomed/1471-2091-2-13.txt:          subunit ribosomal RNA sequences were retrieved from the
technical/biomed/1471-2091-2-13.txt:          sequences were used for the 16S rRNA phylogeny (the
technical/biomed/1471-2091-2-13.txt:          Mc.janrrnA, Mb.tautot2, Pc.furios2, Pc.abyssi, AP000001,
technical/biomed/1471-2091-2-16.txt:        biopesticides as a safer alternative to broad spectrum
technical/biomed/1471-2091-2-16.txt:          supernatant was collected. The above procedure was
technical/biomed/1471-2091-2-16.txt:          toxins from the crude venom. The supernatant fractions
technical/biomed/1471-2091-2-5.txt:        tryptophan, induced maternal rejection of allogeneic but
technical/biomed/1471-2091-2-5.txt:        expressed at the maternal-fetal interface in pregnant mice
technical/biomed/1471-2091-2-5.txt:        defense against the maternal immune system and could
technical/biomed/1471-2091-2-5.txt:          antisense transcripts, we isolated total RNA from G418
technical/biomed/1471-2091-2-5.txt:          progressively greater amounts of IDO antisense RNA were
technical/biomed/1471-2091-2-5.txt:          1%. DMSO for 24 hours, before harvesting total RNA and
technical/biomed/1471-2091-2-5.txt:          effects described here. An alternative possibility was
technical/biomed/1471-2091-2-5.txt:          controls or RAW clones 6, 8 and 22 but COX-2 mRNA and
technical/biomed/1471-2091-2-5.txt:          later. COX-2 mRNA was most strongly induced in vector
technical/biomed/1471-2091-2-5.txt:          showed lower levels of COX-2 mRNA induction. In contrast,
technical/biomed/1471-2091-2-5.txt:          lower amounts of IDO mRNA and lower in vector only
technical/biomed/1471-2091-2-5.txt:        environment could alter COX activity. Alternatively, IDO
technical/biomed/1471-2091-2-5.txt:        (LPS), revealed a lack of correlation between COX-2 RNA and
technical/biomed/1471-2091-2-5.txt:        This suggests that COX-2 RNA and/or protein turnover may be
technical/biomed/1471-2091-2-5.txt:        showed down regulation of COX-2 mRNA when subjected to a
technical/biomed/1471-2091-2-5.txt:          performed using semi-quantitative RT-PCR. Total RNA was
technical/biomed/1471-2091-2-5.txt:          isolated from cells using RNA STAT-60 (Tel-Test Inc.) and
technical/biomed/1471-2091-2-5.txt:          IDO RNA were produced by cloning a 740 bp RT-PCR fragment
technical/biomed/1471-2091-2-5.txt:          antisense RNA was obtained by isolating total RNA from
technical/biomed/1471-2091-2-5.txt:          DNase RQ1 (Promega) and reverse transcribing RNA into
technical/biomed/1471-2091-2-5.txt:          Supernatants from cell cultures were extracted with
technical/biomed/1471-2091-2-7.txt:          hybridoma supernatants.
technical/biomed/1471-2091-2-9.txt:        converted CD39 into an ADPase in a quaternary structure
technical/biomed/1471-2091-3-14.txt:        internalization of MHC-I molecules from the plasma
technical/biomed/1471-2091-3-14.txt:        upon injection of synthetic Tat mRNA into zygotes, a marked
technical/biomed/1471-2091-3-14.txt:        translational inhibitory effects of the TAR RNA region is
technical/biomed/1471-2091-3-14.txt:        levels of doubly spliced viral mRNAs, including Tat, Rev,
technical/biomed/1471-2091-3-14.txt:        subsequent translation of viral mRNA in the cytoplasm.
technical/biomed/1471-2091-3-14.txt:          mRNA for the neuropeptide Y-like receptor (Acc# X71635),
technical/biomed/1471-2091-3-14.txt:          HIV-infected brain has a decrease of mRNA and protein of
technical/biomed/1471-2091-3-14.txt:          apparatus with the aim of optimizing viral mRNA
technical/biomed/1471-2091-3-14.txt:          RNA into fully packaged virions in a timely fashion.
technical/biomed/1471-2091-3-14.txt:          functional ribosomes needed for viral mRNA translation.
technical/biomed/1471-2091-3-14.txt:          puromycin because of its competing ability with tRNAs for
technical/biomed/1471-2091-3-14.txt:          ribosomal movement along the mRNA, were used in active
technical/biomed/1471-2091-3-14.txt:          Translation of HIV-1 RNAs pose a challenge since they
technical/biomed/1471-2091-3-14.txt:          potential translational inhibitory effects of the TAR RNA
technical/biomed/1471-2091-3-14.txt:          antagonist, which bound specifically to TAR RNA and
technical/biomed/1471-2091-3-14.txt:          recent discovery of internal ribosome entry sites (IRESs)
technical/biomed/1471-2091-3-14.txt:          ribosomes, in a manner independent of the mRNA cap or of
technical/biomed/1471-2091-3-14.txt:          located at the 5' end of all HIV-1 RNA transcripts and
technical/biomed/1471-2091-3-14.txt:          of RNAs reduces the accessibility of the 5' cap to eIF4F,
technical/biomed/1471-2091-3-14.txt:          it is thought that this feature of HIV-1 mRNAs can
technical/biomed/1471-2091-3-14.txt:          in the MMLV gag [ 47 ] , and host mRNA encoding p110
technical/biomed/1471-2091-3-14.txt:          cellular host cell mRNAs is inhibited [ 49 50 51 ] .
technical/biomed/1471-2091-3-14.txt:          RNA) and not the whole virus (all three classes of the
technical/biomed/1471-2091-3-14.txt:          RNA), can control signal transduction related to membrane
technical/biomed/1471-2091-3-14.txt:          supernatants from HAART-treated subjects, which
technical/biomed/1471-2091-3-14.txt:          [ 66 ] . There are two mRNA transcripts, which arise in a
technical/biomed/1471-2091-3-14.txt:          fibroblastic cell lines has shown that ProTα mRNA
technical/biomed/1471-2091-3-14.txt:          monocytic cell line, ProTα mRNA peaked at the end of S/G2
technical/biomed/1471-2091-3-14.txt:          More prominent mRNA regulation was found in the
technical/biomed/1471-2091-3-14.txt:          fibroblastic cell lines CV1 and NIH3T3, with peak mRNA
technical/biomed/1471-2091-3-14.txt:          Caks function as RNA polymerase II CTD kinase, Cdk
technical/biomed/1471-2091-3-14.txt:          limiting the access of transcription factors and RNA
technical/biomed/1471-2091-3-14.txt:          function as molecular switches, alternating between
technical/biomed/1471-2091-3-14.txt:          mRNA, Kawasaki et al [ 92 ] reported that reduced
technical/biomed/1471-2091-3-14.txt:          mRNA induction was seen less then 1 h after Tat (72aa)
technical/biomed/1471-2091-3-14.txt:          Tat showed an up-regulation of IL-8 in the supernatant
technical/biomed/1471-2091-3-14.txt:          their cell cycle stage, 5' stem and loop RNA structures,
technical/biomed/1471-2091-3-14.txt:          varying half-lives of proteins and mRNAs, and a host of
technical/biomed/1471-2091-3-14.txt:        viral mRNA translation prior to viral maturation and
technical/biomed/1471-2091-3-14.txt:          addition of Hu. Supernatants were collected and analyzed
technical/biomed/1471-2091-3-14.txt:          instructions (Biosource International). For controls,
technical/biomed/1471-2091-3-14.txt:          (PI) buffer (PBS with Ca2+ and Mg2+, RNase A [10 μg/ml],
technical/biomed/1471-2091-3-14.txt:          Total RNA purification
technical/biomed/1471-2091-3-14.txt:          2+/Mg 2+. Total RNA was extracted on ice using Trizol
technical/biomed/1471-2091-3-14.txt:          Reagent (Life Technologies, Inc.). Purified RNA was then
technical/biomed/1471-2091-3-14.txt:          (test sample) mRNAs were reverse transcribed into Biotin
technical/biomed/1471-2091-3-14.txt:          directions. One μg of poly A +RNA each was DNase I
technical/biomed/1471-2091-3-14.txt:          Total cellular RNA was extracted using the RNAzol
technical/biomed/1471-2091-3-14.txt:          reagent (Gibco/BRL). Total RNA (20 μg) was isolated from
technical/biomed/1471-2091-3-14.txt:          were centrifuged to pellet the cells and supernatants
technical/biomed/1471-2091-3-15.txt:          International. Lerisetron was provided by Dr. Karen
technical/biomed/1471-2091-3-16.txt:        (LGIC) is comprised of receptors with pentameric quaternary
technical/biomed/1471-2091-3-16.txt:        be consistent with this hypothesis. An alternate hypothesis
technical/biomed/1471-2091-3-17.txt:          Residual UCB in the supernatants after
technical/biomed/1471-2091-3-17.txt:          supernatant + UCB in redissolved precipitate) were
technical/biomed/1471-2091-3-17.txt:          between 90 and 100%. Only residual [UCB] in supernatants
technical/biomed/1471-2091-3-17.txt:          supernatant vs. the initial [UCB] at N 
technical/biomed/1471-2091-3-17.txt:          The supernatant from the original supersaturated
technical/biomed/1471-2091-3-17.txt:          DMSO to decrease UCB saturation, the supernatants
technical/biomed/1471-2091-3-17.txt:          insolubility [ 8 ] and only the supernatant was used.
technical/biomed/1471-2091-3-17.txt:          supernatants
technical/biomed/1471-2091-3-17.txt:          Tuttlingen, Germany). The supernatants were assayed
technical/biomed/1471-2091-3-17.txt:          Three aliquots of the clear supernatant were diluted with
technical/biomed/1471-2091-3-18.txt:        RNA genome into double stranded proviral DNA [ 3 4 ] .
technical/biomed/1471-2091-3-18.txt:        The larger subunit (p66) contains both polymerase and RNase
technical/biomed/1471-2091-3-18.txt:        thumb subdomain of p51 and RNase H subdomain of p66 are
technical/biomed/1471-2091-3-18.txt:        t-RNA primer binding for the initiation of reverse
technical/biomed/1471-2091-3-18.txt:        been shown to alter the RNase H activity of the
technical/biomed/1471-2091-3-18.txt:        of the RNase H activity of p66 [ 22 ] . The emergence of a
technical/biomed/1471-2091-3-18.txt:        polymerase and RNase H activities.
technical/biomed/1471-2091-3-18.txt:          both heteropolymeric RNA (U5-PBS RNA) and DNA (49-mer)
technical/biomed/1471-2091-3-18.txt:          On an RNA template, both these enzymes exhibited total
technical/biomed/1471-2091-3-18.txt:          polymerase activity on both RNA and DNA templates. Thus,
technical/biomed/1471-2091-3-18.txt:          Ternary complex formation by the wild type and
technical/biomed/1471-2091-3-18.txt:          In the crystal structures of the ternary complex of
technical/biomed/1471-2091-3-18.txt:          ternary complex poised for catalysis. An 
technical/biomed/1471-2091-3-18.txt:          the next correct dNTP to bind in the ternary complex
technical/biomed/1471-2091-3-18.txt:          ability of the insertion mutants to form the ternary
technical/biomed/1471-2091-3-18.txt:          ternary complex formed. The E-TP binary complex was
technical/biomed/1471-2091-3-18.txt:          complex converted to E-TP-dNTP ternary complex was
technical/biomed/1471-2091-3-18.txt:          suggesting the stability of the ternary complex. Table
technical/biomed/1471-2091-3-18.txt:          the ternary complex did not change with respect to the
technical/biomed/1471-2091-3-18.txt:          unable to form a ternary complex. These data suggest that
technical/biomed/1471-2091-3-18.txt:          mode of interaction in the ternary complex. It is
technical/biomed/1471-2091-3-18.txt:          dNTP binding in the ternary complex.
technical/biomed/1471-2091-3-18.txt:          the ternary complex, where p66 INS/p66 INSmutant was
technical/biomed/1471-2091-3-18.txt:          found to be defective in forming a productive ternary
technical/biomed/1471-2091-3-18.txt:          TP that may influence the formation of ternary complexes.
technical/biomed/1471-2091-3-18.txt:          RNase H activity of the insertion mutants
technical/biomed/1471-2091-3-18.txt:          examine how this insertion affects their RNase H
technical/biomed/1471-2091-3-18.txt:          activity. To evaluate this, we employed a 30-mer RNA-DNA
technical/biomed/1471-2091-3-18.txt:          hybrid, and examined the cleavage of the 5'- 32P-RNA
technical/biomed/1471-2091-3-18.txt:          activities, the RNase H activities of the p66 INS/p66
technical/biomed/1471-2091-3-18.txt:          is expected to affect both the polymerase and RNase H
technical/biomed/1471-2091-3-18.txt:          loop resulted in substantial recovery of the RNase H
technical/biomed/1471-2091-3-18.txt:          activity. The RNase H activity seen in case of the p66
technical/biomed/1471-2091-3-18.txt:        and RNase H activities. Earlier, we have shown that p51
technical/biomed/1471-2091-3-18.txt:        p51 and RNase H domain of p66. These contacts account for
technical/biomed/1471-2091-3-18.txt:          in the p66 and p51 subunits of HIV-1 RT. An HIV-RNA
technical/biomed/1471-2091-3-18.txt:          template-primers: U-5PBS HIV-1 RNA and synthetic 49-mer
technical/biomed/1471-2091-3-18.txt:          Gel analysis of RNA and DNA dependent polymerase
technical/biomed/1471-2091-3-18.txt:          The U5-PBS HIV-1 RNA and heteropolymeric synthetic
technical/biomed/1471-2091-3-18.txt:          Ternary complex formation assay
technical/biomed/1471-2091-3-18.txt:          The ternary complex (E-DNA-dNTP) formation was
technical/biomed/1471-2091-3-18.txt:          complex formation. The E-TP-dNTP ternary complex
technical/biomed/1471-2091-3-18.txt:          binary and ternary complexes formed by the enzyme. The
technical/biomed/1471-2091-3-18.txt:          ternary complexes formed was quantified using ImageQuant
technical/biomed/1471-2091-3-18.txt:          RNase H activity assay
technical/biomed/1471-2091-3-18.txt:          We used a 5'- 32P labeled 30-mer synthetic U5-PBS RNA
technical/biomed/1471-2091-3-18.txt:          determine the RNase H activity of the enzymes [ 31 ] .
technical/biomed/1471-2091-3-18.txt:          The reaction mixture contained labeled RNA-DNA hybrid (10
technical/biomed/1471-2091-3-22.txt:          control of the RNA levels of the cyclin Cig2p [ 33 ] .
technical/biomed/1471-2091-3-22.txt:          the level of transcription or mRNA stability, the budding
technical/biomed/1471-2091-3-22.txt:          purified from 9E10 and 12CA5 tissue culture supernatants
technical/biomed/1471-2091-3-23.txt:        RNA Polymerase II for instance, contain the conserved TATA
technical/biomed/1471-2091-3-23.txt:        less accessible to RNA polymerase. Biochemical assays have
technical/biomed/1471-2091-3-30.txt:          maintained, suggesting an alternative role for the
technical/biomed/1471-2091-3-30.txt:        macrophages [ 13 ] by demonstrating that this alternative
technical/biomed/1471-2091-3-30.txt:        Although the alternative mechanism whereby the MEK1/ERK
technical/biomed/1471-2091-3-30.txt:        alternative mechanism is due to phosphorylation of cPLA 
technical/biomed/1471-2091-3-30.txt:          concentration of the supernatant was determined by the
technical/biomed/1471-2091-3-30.txt:          of radioactivity in the supernatant was determined by
technical/biomed/1471-2091-3-31.txt:        to other proteins occurs through alternative binding motifs
technical/biomed/1471-2091-3-31.txt:          domain. To interact with an alternate set of residues, Ca
technical/biomed/1471-2091-3-31.txt:          large motor step. In the presence of an external force,
technical/biomed/1471-2091-3-31.txt:          bovine adrenal Myo1c does not appear to have alternative
technical/biomed/1471-2091-3-31.txt:          RNase A, 1.64 nm; all obtained from Amersham Pharmacia
technical/biomed/1471-2091-3-31.txt:          2-20 μg internal standards of known sedimentation
technical/biomed/1471-2091-4-1.txt:          ICN Biomedicals, Inc. and alternatively from Seikagaku.
technical/biomed/1471-2091-4-1.txt:          Alternatively, a DEAE-Sephacel column was used.
technical/biomed/1471-2091-4-1.txt:          obtained from 100 ml of CM. Alternatively, concentrated
technical/biomed/1471-2091-4-1.txt:          scintillation solution (Research Products International)
technical/biomed/1471-2091-4-1.txt:          g , 10 min) and the supernatant
technical/biomed/1471-2091-4-5.txt:          The supernatents (50 ml) were collected and sodium
technical/biomed/1471-2091-4-5.txt:          international units of PAs inhibited by PAI-1. Specific
technical/biomed/1471-2105-1-1.txt:          metabolic network, including the internal fluxes,
technical/biomed/1471-2105-1-1.txt:          maximal internal fluxes and gene regulation). The
technical/biomed/1471-2105-1-1.txt:        During the growth simulations with external parameters
technical/biomed/1471-2105-1-1.txt:        'routes' were equivalent (alternate optimal solutions), (1)
technical/biomed/1471-2105-2-1.txt:          Some RNA viruses form a quasispecies--a set of related
technical/biomed/1471-2105-2-1.txt:          this codon. Alternatively, the lysine at codon 219 may be
technical/biomed/1471-2105-2-8.txt:        Some genes produce functional noncoding RNAs (ncRNAs)
technical/biomed/1471-2105-2-8.txt:        efficiency [ 4 ] . For ncRNA genes, there are as yet no
technical/biomed/1471-2105-2-8.txt:        ncRNA genes remains poorly understood, despite the
technical/biomed/1471-2105-2-8.txt:        that produces a messenger RNA.
technical/biomed/1471-2105-2-8.txt:        New noncoding RNA genes continue to be discovered by
technical/biomed/1471-2105-2-8.txt:        systematic RNA genefinding algorithm would be of use.
technical/biomed/1471-2105-2-8.txt:        Recent discoveries have included RNAs involved in dosage
technical/biomed/1471-2105-2-8.txt:        nucleolar RNAs involved in RNA modification and processing
technical/biomed/1471-2105-2-8.txt:        [ 6 7 8 ] , and small riboregulatory RNAs controlling
technical/biomed/1471-2105-2-8.txt:        translation and/or stability of target mRNAs [ 9 10 ] .
technical/biomed/1471-2105-2-8.txt:        Mutations in the gene for RNase MRP are associated with
technical/biomed/1471-2105-2-8.txt:        positional cloning for some time; the RNase MRP gene was
technical/biomed/1471-2105-2-8.txt:        region because the RNase MRP sequence was already in the
technical/biomed/1471-2105-2-8.txt:        We have previously explored one RNA genefinding approach
technical/biomed/1471-2105-2-8.txt:        RNA structures may have more stable predicted secondary
technical/biomed/1471-2105-2-8.txt:        structural RNAs is not sufficiently distinguishable from
technical/biomed/1471-2105-2-8.txt:        basis for a reliable ncRNA genefinding algorithm.
technical/biomed/1471-2105-2-8.txt:        Nonetheless, conserved RNA secondary structure remained our
technical/biomed/1471-2105-2-8.txt:        best hope for an exploitable statistical signal in ncRNA
technical/biomed/1471-2105-2-8.txt:        Olsen approach to identify structural RNA regions. Our
technical/biomed/1471-2105-2-8.txt:        by structural RNA evolution; (3) allowing gapped
technical/biomed/1471-2105-2-8.txt:        region or structural RNA, because a primary sequence
technical/biomed/1471-2105-2-8.txt:        RNA structure) to produce three evolutionary models for
technical/biomed/1471-2105-2-8.txt:        "coding", "structural RNA", or "something else" (a null
technical/biomed/1471-2105-2-8.txt:        be classified as "coding", "structural RNA", or "something
technical/biomed/1471-2105-2-8.txt:        structural RNAs. Some ncRNA genes do
technical/biomed/1471-2105-2-8.txt:        structures, and some conserved RNA secondary structures
technical/biomed/1471-2105-2-8.txt:        function as cis-regulatory regions in mRNAs rather than as
technical/biomed/1471-2105-2-8.txt:        independent RNA genes. We will be using the term "ncRNA
technical/biomed/1471-2105-2-8.txt:        understood that this really means a conserved RNA secondary
technical/biomed/1471-2105-2-8.txt:        functional ncRNA gene upon further analysis.
technical/biomed/1471-2105-2-8.txt:          (RNA, COD, and OTH) describing different evolutionary
technical/biomed/1471-2105-2-8.txt:          The RNA model assumes that the pattern of mutation
technical/biomed/1471-2105-2-8.txt:          significantly conserves a homologous RNA secondary
technical/biomed/1471-2105-2-8.txt:          structure. To capture this, the core parameters in RNA
technical/biomed/1471-2105-2-8.txt:          P RNA( 
technical/biomed/1471-2105-2-8.txt:          P RNA( 
technical/biomed/1471-2105-2-8.txt:          s , RNA) is a product of terms 
technical/biomed/1471-2105-2-8.txt:          P RNA( 
technical/biomed/1471-2105-2-8.txt:          P RNA( 
technical/biomed/1471-2105-2-8.txt:          of an alignment given by the RNA model is a sum over all
technical/biomed/1471-2105-2-8.txt:          s |RNA) implies a full
technical/biomed/1471-2105-2-8.txt:          RNA secondary structures. The necessary machinery for
technical/biomed/1471-2105-2-8.txt:          bulges, and internal loops, including stacking and
technical/biomed/1471-2105-2-8.txt:          counterpart for the widely used MFOLD program for RNA
technical/biomed/1471-2105-2-8.txt:          RNA, COD, or OTH, we use the three likelihoods to
technical/biomed/1471-2105-2-8.txt:          with high RNA posterior probabilities are interpreted as
technical/biomed/1471-2105-2-8.txt:          candidate ncRNA genes.
technical/biomed/1471-2105-2-8.txt:          alignments culled from real RNAs, coding regions, and
technical/biomed/1471-2105-2-8.txt:          frequencies to obtain the parameters of the RNA model.
technical/biomed/1471-2105-2-8.txt:          The 16 × 16 core parameters of the RNA model are
technical/biomed/1471-2105-2-8.txt:          Alternatively, we can symmetrically derive a equation
technical/biomed/1471-2105-2-8.txt:          RNA structure.
technical/biomed/1471-2105-2-8.txt:            The RNA Model
technical/biomed/1471-2105-2-8.txt:            The complete RNA model, a pair stochastic context
technical/biomed/1471-2105-2-8.txt:            encapsulated in the RNA state of the diagram. This
technical/biomed/1471-2105-2-8.txt:            To extend these more or less standard RNA folding
technical/biomed/1471-2105-2-8.txt:            transition corresponds to stems, bulges, and internal
technical/biomed/1471-2105-2-8.txt:            bulges and internal loops is variable and depends on
technical/biomed/1471-2105-2-8.txt:            RNA model. In this paper, though, we will only be
technical/biomed/1471-2105-2-8.txt:            with the RNA model; in this case, for any given vector
technical/biomed/1471-2105-2-8.txt:          model, and 20 for the COD model and RNA models. These
technical/biomed/1471-2105-2-8.txt:          plausible alternative.
technical/biomed/1471-2105-2-8.txt:          The RNA model also has additional SCFG-related
technical/biomed/1471-2105-2-8.txt:          distributions of hairpin loops, bulges, and internal
technical/biomed/1471-2105-2-8.txt:          training set of aligned tRNAs and ribosomal RNAs as
technical/biomed/1471-2105-2-8.txt:          L ) in storage and time; the RNA
technical/biomed/1471-2105-2-8.txt:          standard algorithms. Consider the RNA model. Recall that
technical/biomed/1471-2105-2-8.txt:          P ( |RNA) by a summation over all
technical/biomed/1471-2105-2-8.txt:          RNA within the input alignment - that is, we would like
technical/biomed/1471-2105-2-8.txt:          states in the core of the RNA model, as opposed to
technical/biomed/1471-2105-2-8.txt:          nonconserved (IID) and conserved but non-RNA (OTH)
technical/biomed/1471-2105-2-8.txt:          the CYK (maximum likelihood parse) algorithm for the RNA
technical/biomed/1471-2105-2-8.txt:          model, outside of the core RNA pair-SCFG state.
technical/biomed/1471-2105-2-8.txt:           , and RNA states of the RNA model in Figure 7). Each
technical/biomed/1471-2105-2-8.txt:          represented by the RNA state). The meta-states are
technical/biomed/1471-2105-2-8.txt:           for the core RNA metastate of the RNA model
technical/biomed/1471-2105-2-8.txt:          assigned as structural RNA, versus assigning flanking
technical/biomed/1471-2105-2-8.txt:           meta-states describing non-RNA conserved residues
technical/biomed/1471-2105-2-8.txt:          Inside algorithm for scoring the core RNA state of the
technical/biomed/1471-2105-2-8.txt:          RNA model. (See Additional filefor more details.)
technical/biomed/1471-2105-2-8.txt:          is dangerous, for example, to rely on the external
technical/biomed/1471-2105-2-8.txt:          RNAs, whereas the RNA pair-SCFG, which models
technical/biomed/1471-2105-2-8.txt:          n respectively, scoring the RNA
technical/biomed/1471-2105-2-8.txt:          the external pairwise alignment algorithm will produce
technical/biomed/1471-2105-2-8.txt:          coding regions and structural RNAs, even though the
technical/biomed/1471-2105-2-8.txt:          external alignment program has no notion of these
technical/biomed/1471-2105-2-8.txt:          probabilities. We plot log-odds scores of the COD and RNA
technical/biomed/1471-2105-2-8.txt:          called QRNA. The source code and the full set of
technical/biomed/1471-2105-2-8.txt:          probability parameters used in QRNA are freely available
technical/biomed/1471-2105-2-8.txt:          the terms of the GNU General Public License. QRNA has
technical/biomed/1471-2105-2-8.txt:          qrna fastafile
technical/biomed/1471-2105-2-8.txt:          winner = RNA
technical/biomed/1471-2105-2-8.txt:          OTH = 152.817 COD = 129.240 RNA = 182.522
technical/biomed/1471-2105-2-8.txt:          logoddspostRNA = 29.705
technical/biomed/1471-2105-2-8.txt:          The line winner = RNA indicates that the 281 nt
technical/biomed/1471-2105-2-8.txt:          alignment has been classified as a structural RNA. The
technical/biomed/1471-2105-2-8.txt:          row ("logoddspostCOD"and "logoddspostRNA") correspond to
technical/biomed/1471-2105-2-8.txt:          this alignment, the RNA model is favored over COD and OTH
technical/biomed/1471-2105-2-8.txt:          of our comparative method QRNA. We give the most general
technical/biomed/1471-2105-2-8.txt:          We used these simulation results from RNA-generated
technical/biomed/1471-2105-2-8.txt:          thresholds for classification of alignments as RNA. A
technical/biomed/1471-2105-2-8.txt:          threshold of 1.4 bits for the RNA posterior log-odds
technical/biomed/1471-2105-2-8.txt:          false positive RNA classifications of COD or
technical/biomed/1471-2105-2-8.txt:          shuffled RNA-generated alignments.
technical/biomed/1471-2105-2-8.txt:          by sequences other than RNAs, we used the COD and OTH
technical/biomed/1471-2105-2-8.txt:          genomes with no structural RNA genes present. The aligned
technical/biomed/1471-2105-2-8.txt:          RNAs. We therefore devised a crude way of modifying the
technical/biomed/1471-2105-2-8.txt:          overall GC contents of 57.7% and 38.9%. We then ran QRNA
technical/biomed/1471-2105-2-8.txt:          of times a window was called RNA with a score of ≥ 5
technical/biomed/1471-2105-2-8.txt:          simulated genomes have no RNA component.
technical/biomed/1471-2105-2-8.txt:          Tests on known RNAs
technical/biomed/1471-2105-2-8.txt:          on real RNAs, we analyzed pairwise alignments taken from
technical/biomed/1471-2105-2-8.txt:          a multiple alignment of 63 eukaryotic SRP-RNAs [ 32 ]
technical/biomed/1471-2105-2-8.txt:          (also known as 7SL RNA), and a multiple alignment of 51
technical/biomed/1471-2105-2-8.txt:          eukaryotic RNaseP RNAs [ 33 ] . These RNA genes were
technical/biomed/1471-2105-2-8.txt:          chosen because they are independent from the set of tRNAs
technical/biomed/1471-2105-2-8.txt:          and rRNAs used to train the RNA model.
technical/biomed/1471-2105-2-8.txt:          alignments are an ideal case for QRNA, because they are
technical/biomed/1471-2105-2-8.txt:          we took each known RNA in turn and used it as a BLASTN
technical/biomed/1471-2105-2-8.txt:          query against the rest of the RNAs, then classified all
technical/biomed/1471-2105-2-8.txt:          significant alignments with QRNA. This is a more
technical/biomed/1471-2105-2-8.txt:          realistic scenario for QRNA; a BLASTN primary sequence
technical/biomed/1471-2105-2-8.txt:          QRNA using default parameters.
technical/biomed/1471-2105-2-8.txt:          For the first experiment, we used QRNA to score in
technical/biomed/1471-2105-2-8.txt:          different structural pairwise alignments for SRP-RNAs,
technical/biomed/1471-2105-2-8.txt:          and the 1, 325 structural pairwise alignments for RNaseP
technical/biomed/1471-2105-2-8.txt:          RNAs. The manually curated RNA structural alignments have
technical/biomed/1471-2105-2-8.txt:          alignments that were classified as RNA with a score of
technical/biomed/1471-2105-2-8.txt:          classified as RNA is a measure of the sensitivity of
technical/biomed/1471-2105-2-8.txt:          QRNA. To measure specificity, we randomly shuffled each
technical/biomed/1471-2105-2-8.txt:          RNA structure correlations but retains the percentage
technical/biomed/1471-2105-2-8.txt:          classified by QRNA as RNA are false positives. The
technical/biomed/1471-2105-2-8.txt:          results in Table 2show that QRNA can detect about half of
technical/biomed/1471-2105-2-8.txt:          the alignments as RNAs at a wide range of percent
technical/biomed/1471-2105-2-8.txt:          single RNA gene in a given family (both for the SRP-RNA
technical/biomed/1471-2105-2-8.txt:          and the RNaseP RNA families) and used it as a BLASTN
technical/biomed/1471-2105-2-8.txt:          RNAs, and 417 for RNaseP RNAs). These were then scored by
technical/biomed/1471-2105-2-8.txt:          QRNA to measure sensitivity, and then shuffled by columns
technical/biomed/1471-2105-2-8.txt:          order to be detected by QRNA, two RNA sequences must be
technical/biomed/1471-2105-2-8.txt:          base-paired positions of the RNA secondary structure.
technical/biomed/1471-2105-2-8.txt:          which QRNA performance is optimal. Based on these
technical/biomed/1471-2105-2-8.txt:          with QRNA. However, we do not fully understand the
technical/biomed/1471-2105-2-8.txt:          To test QRNA performance in a realistic whole genome
technical/biomed/1471-2105-2-8.txt:          Salmonella typhi . We compared QRNA
technical/biomed/1471-2105-2-8.txt:          genes, ncRNAs, and intergenic regions [ 34 ] . The
technical/biomed/1471-2105-2-8.txt:          RNA genes and 4, 290 known coding genes (ORFs). The known
technical/biomed/1471-2105-2-8.txt:          RNA genes include 22 rRNAs, 86 tRNAs, and 7 miscellaneous
technical/biomed/1471-2105-2-8.txt:          RNAs (RNase P, for example). At least 4 other known RNA
technical/biomed/1471-2105-2-8.txt:          components: 115 RNA features (a total of 40 kb, 1% of the
technical/biomed/1471-2105-2-8.txt:          resulted in 354 alignments to RNAs, 4, 946 alignments to
technical/biomed/1471-2105-2-8.txt:          then classified by QRNA in scanning mode, scoring
technical/biomed/1471-2105-2-8.txt:          bits for one of the three models were annotated as RNA,
technical/biomed/1471-2105-2-8.txt:          many of the known features (ncRNAs and ORFs) were
technical/biomed/1471-2105-2-8.txt:          "detected" as RNA or COD if it had one or more
technical/biomed/1471-2105-2-8.txt:          overlapping QRNA annotations of that type. It is possible
technical/biomed/1471-2105-2-8.txt:          115 known ncRNAs, 33 have one or more BLASTN alignments
technical/biomed/1471-2105-2-8.txt:          all 33 were annotated as RNA by QRNA; none were called
technical/biomed/1471-2105-2-8.txt:          RNA, and 184 were called both COD and RNA.
technical/biomed/1471-2105-2-8.txt:          115 known RNAs were detected, but invariably (in this
technical/biomed/1471-2105-2-8.txt:          case), a failure to detect an RNA resulted from the lack
technical/biomed/1471-2105-2-8.txt:          perspective of how many of QRNA's annotations are
technical/biomed/1471-2105-2-8.txt:          windows with the same QRNA annotation were merged into a
technical/biomed/1471-2105-2-8.txt:          annotated in the ncRNA sequence fraction: 33 as RNA, none
technical/biomed/1471-2105-2-8.txt:          ORF sequence fraction: 88 as RNA, 3397 as COD, and 3937
technical/biomed/1471-2105-2-8.txt:          sequence fraction: 351 as RNA, 61 as COD, and 1562 as
technical/biomed/1471-2105-2-8.txt:          OTH. Therefore QRNA annotated a total of 5614 sequence
technical/biomed/1471-2105-2-8.txt:          conserved noncoding sequence of potential interest. QRNA
technical/biomed/1471-2105-2-8.txt:          Most interestingly, QRNA annotated a total of 472
technical/biomed/1471-2105-2-8.txt:          E. coli as RNA, of which only 33
technical/biomed/1471-2105-2-8.txt:          (7%) are in known RNAs. It is not possible to
technical/biomed/1471-2105-2-8.txt:          RNA annotations that overlap known ORFs may be false
technical/biomed/1471-2105-2-8.txt:          positives, or may indicate cis-regulatory RNA structures
technical/biomed/1471-2105-2-8.txt:          disproportionate number of QRNA's RNA annotations (74%,
technical/biomed/1471-2105-2-8.txt:          see if there were a fair number of undetected RNA
technical/biomed/1471-2105-2-8.txt:          them are the four ncRNA genes (csrB, oxyS, micF, and
technical/biomed/1471-2105-2-8.txt:          cis-regulatory RNA structures such as ρ-independent
technical/biomed/1471-2105-2-8.txt:          terminators (which have an RNA stem loop structure) and
technical/biomed/1471-2105-2-8.txt:          correspond to novel RNAs, and we cannot assign a known
technical/biomed/1471-2105-2-8.txt:          or experimental evidence. A more in-depth QRNA screen of 
technical/biomed/1471-2105-2-8.txt:          E. coli for novel ncRNAs using
technical/biomed/1471-2105-2-8.txt:          predicted RNAs are indeed novel ncRNA genes, is presented
technical/biomed/1471-2105-2-8.txt:        QRNA. The three probabilistic models are calibrated to a
technical/biomed/1471-2105-2-8.txt:        BLASTN cannot detect RNA sequences that are this diverged.
technical/biomed/1471-2105-2-8.txt:        for QRNA to work best in its current formulation. We
technical/biomed/1471-2105-2-8.txt:        In principle QRNA may also be useful as a coding-region
technical/biomed/1471-2105-2-8.txt:        sensitivity and specificity of QRNA coding annotations seem
technical/biomed/1471-2105-2-8.txt:        performance of QRNA for this purpose.
technical/biomed/1471-2105-2-8.txt:        In terms of other QRNA improvements, it should be
technical/biomed/1471-2105-2-8.txt:        window that QRNA works best in - in particular, by
technical/biomed/1471-2105-2-8.txt:        RNA model to be favored artifactually in certain cases
technical/biomed/1471-2105-2-8.txt:        assumptions in trying to calculate QRNA's parameters all
technical/biomed/1471-2105-2-8.txt:        correct pairwise alignments of coding regions or RNA
technical/biomed/1471-2105-2-8.txt:        performance of QRNA, particularly for more dissimilar
technical/biomed/1471-2105-2-8.txt:        dynamic programming (if, indeed, dynamic programming RNA
technical/biomed/1471-2105-2-8.txt:        Because QRNA detects conserved RNA secondary structure,
technical/biomed/1471-2105-2-8.txt:        it is not expected to detect ncRNAs that apparently lack
technical/biomed/1471-2105-2-8.txt:        box small nucleolar RNAs [ 6 ] . Identifying novel
technical/biomed/1471-2105-2-8.txt:        unstructured ncRNAs remains an entirely open problem. A
technical/biomed/1471-2105-2-8.txt:        novel ncRNAs may prove more fruitful for unstructured
technical/biomed/1471-2105-2-8.txt:        ncRNAs. Expression arrays that pave the entire target
technical/biomed/1471-2105-2-8.txt:        RNAs can be constructed and EST sequenced [ 42 ] .
technical/biomed/1471-2105-2-8.txt:        QRNA is also expected to identify 
technical/biomed/1471-2105-2-8.txt:        cis -regulatory RNA structures in
technical/biomed/1471-2105-2-8.txt:        mRNAs, in addition to structured ncRNA genes.
technical/biomed/1471-2105-2-8.txt:        Distinguishing an ncRNA gene from a 
technical/biomed/1471-2105-2-8.txt:        cis -regulatory RNA structure in an
technical/biomed/1471-2105-2-8.txt:        mRNA is nontrivial in absence of experimental evidence.
technical/biomed/1471-2105-2-8.txt:        This cautions against using QRNA for fully automated genome
technical/biomed/1471-2105-2-8.txt:        Instead, QRNA is best used as a computational screen for
technical/biomed/1471-2105-2-8.txt:        candidate ncRNA genes, after which candidate loci are
technical/biomed/1471-2105-2-8.txt:        experimental verification of many novel ncRNA genes (E.R.,
technical/biomed/1471-2105-2-8.txt:        indicate that QRNA can be successfully used in this role.
technical/biomed/1471-2105-2-8.txt:        we believe QRNA is the first example of a generally
technical/biomed/1471-2105-2-8.txt:        applicable computational genefinder for noncoding RNA
technical/biomed/1471-2105-2-8.txt:        genes. We expect to be able to apply QRNA - based screens
technical/biomed/1471-2105-2-8.txt:        for ncRNAs to a number of organisms as comparative sequence
technical/biomed/1471-2105-2-8.txt:        probabilistic models (for RNA-structure-constrained,
technical/biomed/1471-2105-2-8.txt:        alignment. The alignment is classified as RNA, coding, or
technical/biomed/1471-2105-2-8.txt:        program, QRNA, which we consider to be a prototype
technical/biomed/1471-2105-2-8.txt:        structural ncRNA genefinding program.
technical/biomed/1471-2105-2-9.txt:          money than alternative methods. High-throughput
technical/biomed/1471-2105-3-12.txt:            prematurely. An error message "An internal error has
technical/biomed/1471-2105-3-12.txt:            Alternatively, CoreGenes has been run successfully on
technical/biomed/1471-2105-3-14.txt:        masking of low complexity regions; and alternative splicing
technical/biomed/1471-2105-3-14.txt:          its internal nodes, two sequences are super-orthologous
technical/biomed/1471-2105-3-14.txt:          if and only if each internal node on their connecting
technical/biomed/1471-2105-3-14.txt:          its internal nodes, two sequences are ultra-paralogous if
technical/biomed/1471-2105-3-14.txt:          contains only internal nodes representing
technical/biomed/1471-2105-3-14.txt:          external nodes descendant from 
technical/biomed/1471-2105-3-14.txt:          internal node 
technical/biomed/1471-2105-3-14.txt:          "speciation" assigned to each internal node and rooted in
technical/biomed/1471-2105-3-14.txt:          n != external):
technical/biomed/1471-2105-3-14.txt:          n != external && indicator
technical/biomed/1471-2105-3-14.txt:          n != external):
technical/biomed/1471-2105-3-14.txt:        annotation of internal nodes of a gene tree with a
technical/biomed/1471-2105-3-17.txt:        differences in thousands of mRNA levels between
technical/biomed/1471-2105-3-17.txt:        etc . Although mRNA is not the end
technical/biomed/1471-2105-3-17.txt:        to the tags on the chip, scanned, and differences in mRNA
technical/biomed/1471-2105-3-17.txt:        labeled cRNA, hybridization to a microarray, and
technical/biomed/1471-2105-3-17.txt:            section). A pooled RNA sample from mice ( 
technical/biomed/1471-2105-3-17.txt:            The preparation of the cRNA sample is highly correlated
technical/biomed/1471-2105-3-17.txt:            representation of transcripts in the cRNA sample,
technical/biomed/1471-2105-3-17.txt:            techniques. Analyses by northern blot and RNAse
technical/biomed/1471-2105-3-17.txt:            pooled stocks of liver RNA (5 mice per experiment).
technical/biomed/1471-2105-3-17.txt:        2-fold change in mRNA levels and that lowly expressed genes
technical/biomed/1471-2105-3-17.txt:        biological changes in sample concentration of mRNA, even at
technical/biomed/1471-2105-3-17.txt:          amounts of material were pooled to obtain 10 μg total RNA
technical/biomed/1471-2105-3-17.txt:          per dietary group. RNA samples were quantified with the
technical/biomed/1471-2105-3-17.txt:          RiboGreen RNA Quantification Kit according to
technical/biomed/1471-2105-3-17.txt:          electrophoresis for intact 18 and 28s rRNA. All samples
technical/biomed/1471-2105-3-17.txt:          RNA in sufficient amounts for hybridization.
technical/biomed/1471-2105-3-17.txt:            cRNA preparation
technical/biomed/1471-2105-3-17.txt:            Total RNA (15 μg) was used as starting material for
technical/biomed/1471-2105-3-17.txt:            high quality RNA was present to detect gene expression
technical/biomed/1471-2105-3-17.txt:            primer containing a T7 RNA polymerase binding site.
technical/biomed/1471-2105-3-17.txt:            Labeled cRNA was prepared using the MEGAscript, 
technical/biomed/1471-2105-3-17.txt:            cRNA (10 μg) was fragmented at 94°C for 35 min in
technical/biomed/1471-2105-3-17.txt:            cRNA in a 6×SSPE-T hybridization buffer (1 M/L NaCl, 10
technical/biomed/1471-2105-3-17.txt:            in 0.5×SSPE-T at 50°C. The biotinylated cRNA was
technical/biomed/1471-2105-3-17.txt:            pooled RNA samples ( 
technical/biomed/1471-2105-3-18.txt:        There are a growing number of RNA gene families and RNA
technical/biomed/1471-2105-3-18.txt:        motifs [ 1 2 ] . Many (though not all) RNAs conserve a
technical/biomed/1471-2105-3-18.txt:        base-paired RNA secondary structure. Computational analyses
technical/biomed/1471-2105-3-18.txt:        of RNA sequence families are more powerful if they take
technical/biomed/1471-2105-3-18.txt:        database searching with RNA secondary structure consensus
technical/biomed/1471-2105-3-18.txt:        programs have been developed to recognize specific RNA
technical/biomed/1471-2105-3-18.txt:        detecting transfer RNA genes [ 7 8 9 ] , group I catalytic
technical/biomed/1471-2105-3-18.txt:        introns [ 10 ] , and small nucleolar RNAs [ 11 12 ] . All
technical/biomed/1471-2105-3-18.txt:        they require expert knowledge about each particular RNA
technical/biomed/1471-2105-3-18.txt:        for RNA secondary structures.
technical/biomed/1471-2105-3-18.txt:        multiple alignment of an RNA sequence family for which I
technical/biomed/1471-2105-3-18.txt:        if we had an RNA structure equivalent of the HMMER profile
technical/biomed/1471-2105-3-18.txt:        conserved RNA structures and multiple alignments, analogous
technical/biomed/1471-2105-3-18.txt:        provide a general approach to RNA structure alignment [ 22
technical/biomed/1471-2105-3-18.txt:        correlations in non-pseudoknotted RNA secondary structure
technical/biomed/1471-2105-3-18.txt:        to be taken into account in RNA alignments. SCFGs can be
technical/biomed/1471-2105-3-18.txt:        to deal with 2D RNA secondary structure.
technical/biomed/1471-2105-3-18.txt:        RNA secondary structure alignment problems, SCFG algorithms
technical/biomed/1471-2105-3-18.txt:        alignment of an RNA structure to a sequence costs 
technical/biomed/1471-2105-3-18.txt:        programming algorithm for RNA alignment; their algorithm
technical/biomed/1471-2105-3-18.txt:        alignments of small structural RNAs are feasible. Using my
technical/biomed/1471-2105-3-18.txt:        RNA alignments (~75 nucleotides) take about 0.2 cpu second
technical/biomed/1471-2105-3-18.txt:        COVE-based search program, tRNAscan-SE, for annotating
technical/biomed/1471-2105-3-18.txt:        transfer RNA genes [ 9 ] . However, many larger RNAs of
technical/biomed/1471-2105-3-18.txt:        ribosomal RNA sequence to the SSU rRNA consensus structure
technical/biomed/1471-2105-3-18.txt:        Applying SCFG methods to RNAs this large has required
technical/biomed/1471-2105-3-18.txt:        genetic algorithm (GA) to optimize a pairwise RNA alignment
technical/biomed/1471-2105-3-18.txt:        reasonable solutions for large RNA alignment problems,
technical/biomed/1471-2105-3-18.txt:        including ribosomal RNA alignments. A different
technical/biomed/1471-2105-3-18.txt:        problem of structural alignment of large RNAs. The central
technical/biomed/1471-2105-3-18.txt:        and conquer strategy can also be applied to the RNA
technical/biomed/1471-2105-3-18.txt:        structural alignment of large RNAs possible.
technical/biomed/1471-2105-3-18.txt:        of known RNA structure. By "secondary structure" I mean
technical/biomed/1471-2105-3-18.txt:        nested (nonpseudoknotted) pairwise RNA secondary structure
technical/biomed/1471-2105-3-18.txt:        permitting noncanonical base pairs. This RNA structural
technical/biomed/1471-2105-3-18.txt:        two known RNA secondary structures together [ 32 ] , and
technical/biomed/1471-2105-3-18.txt:        from the problem of aligning two RNA sequences of unknown
technical/biomed/1471-2105-3-18.txt:          for SCFG-based RNA alignment is not as obvious.
technical/biomed/1471-2105-3-18.txt:            (e.g. the observable alphabet, a,c,g,u for RNA). I will
technical/biomed/1471-2105-3-18.txt:            positions in an RNA secondary structure consensus. A
technical/biomed/1471-2105-3-18.txt:            by D states, and the branching topology of the RNA
technical/biomed/1471-2105-3-18.txt:            sequence alignment of homologous RNAs, with a line
technical/biomed/1471-2105-3-18.txt:            describing the consensus RNA secondary structure. The
technical/biomed/1471-2105-3-18.txt:            Figure 1. Alternatively, automatic methods might be
technical/biomed/1471-2105-3-18.txt:            unstructured RNA multiple alignment would be modeled by
technical/biomed/1471-2105-3-18.txt:            extend profile HMMs to deal with RNA secondary
technical/biomed/1471-2105-3-18.txt:            internal bifurcations that lead to branches in the
technical/biomed/1471-2105-3-18.txt:            http://www.genetics.wustl.edu/eddy/infernal/under a GNU
technical/biomed/1471-2105-3-18.txt:          M , we can alternatively state the
technical/biomed/1471-2105-3-18.txt:          An example of a pathological case is an RNA structure
technical/biomed/1471-2105-3-18.txt:          RNAs (see below) indicate that the extra time required to
technical/biomed/1471-2105-3-18.txt:          Six structural RNA families were chosen for empirical
technical/biomed/1471-2105-3-18.txt:          evaluations of the algorithm, using available RNA
technical/biomed/1471-2105-3-18.txt:          database resources - tRNA [ 49 ] , 5S ribosomal RNA [ 50
technical/biomed/1471-2105-3-18.txt:          ] , signal recognition particle (SRP) RNA [ 51 ] , RNase
technical/biomed/1471-2105-3-18.txt:          P [ 52 ] , small subunit (SSU) ribosomal RNA [ 53 ] , and
technical/biomed/1471-2105-3-18.txt:          large subunit (LSU) ribosomal RNA [ 54 ] . For each
technical/biomed/1471-2105-3-18.txt:          the alignments ranges from 72 (tRNA) to 2898 (LSU rRNA);
technical/biomed/1471-2105-3-18.txt:          states (tRNA) to 9023 (LSU). About 1/150 of the states in
technical/biomed/1471-2105-3-18.txt:          and 5 for LSU rRNA. Therefore the minimum constant of 10
technical/biomed/1471-2105-3-18.txt:          for the largest structural RNAs. (Even without optimal
technical/biomed/1471-2105-3-18.txt:          rRNA (because of the steep memory requirement). In all
technical/biomed/1471-2105-3-18.txt:          conquer alignment ranges up to 271 MB for LSU rRNA,
technical/biomed/1471-2105-3-18.txt:          of about two-fold more for SRP-RNA.
technical/biomed/1471-2105-3-18.txt:          wide range of RNAs. The difference shown in Figure 6is
technical/biomed/1471-2105-3-18.txt:          for SSU and LSU rRNA. Because score-only CYK does not
technical/biomed/1471-2105-3-18.txt:        possible to align even the largest structural RNAs to
technical/biomed/1471-2105-3-18.txt:        SSU and LSU rRNA structural alignments can be performed in
technical/biomed/1471-2105-3-18.txt:        mathematical optimality to achieve ribosomal RNA
technical/biomed/1471-2105-3-18.txt:        therefore, to unprofiled SCFG applications in RNA secondary
technical/biomed/1471-2105-3-18.txt:        from known RNA structures [ 57 ] . At this stage it would
technical/biomed/1471-2105-3-2.txt:        single molecular chronometer, the ribosomal RNA (rRNA), and
technical/biomed/1471-2105-3-2.txt:        to predict the correct structure for an RNA molecule, given
technical/biomed/1471-2105-3-2.txt:        organism's rRNA, a molecule that encompasses two-thirds of
technical/biomed/1471-2105-3-2.txt:        ] . Subsequently, the analysis of ribosomal RNA produced
technical/biomed/1471-2105-3-2.txt:        rRNA-based phylogenetic analysis, which has resulted in the
technical/biomed/1471-2105-3-2.txt:        sequencing of more than 10,000 16S and 16S-like rRNA and
technical/biomed/1471-2105-3-2.txt:        1,000 23S and 23S-like rRNA genes, from laboratories trying
technical/biomed/1471-2105-3-2.txt:        The prediction of tRNA structure with a comparative
technical/biomed/1471-2105-3-2.txt:        validation with tRNA crystal structures [ 10 11 ]
technical/biomed/1471-2105-3-2.txt:        to begin predicting 5S rRNA structure from the analysis of
technical/biomed/1471-2105-3-2.txt:        the same functional RNA class (in this case, 5S rRNA) will
technical/biomed/1471-2105-3-2.txt:        all of the possible RNA secondary and tertiary structures
technical/biomed/1471-2105-3-2.txt:        for any one RNA sequence, such as for 
technical/biomed/1471-2105-3-2.txt:        Escherichia coli 5S rRNA, the correct
technical/biomed/1471-2105-3-2.txt:        secondary structure for every other 5S rRNA sequence [ 12
technical/biomed/1471-2105-3-2.txt:        While the first complete 16S rRNA sequence was
technical/biomed/1471-2105-3-2.txt:        more 16S rRNA sequences were determined [ 15 16 17 ] . The
technical/biomed/1471-2105-3-2.txt:        first 23S rRNA sequence was determined for 
technical/biomed/1471-2105-3-2.txt:        following year, once a few more complete 23S rRNA sequences
technical/biomed/1471-2105-3-2.txt:        alignments of 16S and 23S rRNA sequences were analyzed for
technical/biomed/1471-2105-3-2.txt:        ] rRNAs. The 16S and 23S rRNA covariation-based structure
technical/biomed/1471-2105-3-2.txt:        structure model for 16S and 23S rRNA. While the majority of
technical/biomed/1471-2105-3-2.txt:        comparative analysis of the rRNA sequences and structures
technical/biomed/1471-2105-3-2.txt:        ribosomal RNAs and transfer RNA, several other RNAs have
technical/biomed/1471-2105-3-2.txt:        I [ 30 31 32 33 ] and II [ 34 35 ] introns, RNase P [ 36 37
technical/biomed/1471-2105-3-2.txt:        38 ] , telomerase RNA [ 39 40 ] , tmRNA [ 41 ] , U RNA [ 42
technical/biomed/1471-2105-3-2.txt:        ] , and the SRP RNA [ 43 ] . The comparative sequence
technical/biomed/1471-2105-3-2.txt:        structure over this wide range of RNA molecules.
technical/biomed/1471-2105-3-2.txt:        Very recently, the authenticities of the ribosomal RNA
technical/biomed/1471-2105-3-2.txt:        RNA molecules ( 
technical/biomed/1471-2105-3-2.txt:        e.g., 16S and 23S rRNAs) have been
technical/biomed/1471-2105-3-2.txt:        relationships and RNA structure with comparative analysis
technical/biomed/1471-2105-3-2.txt:        [ 46 47 ] and 23S (and 23S-like) ribosomal RNAs [ 48 49 50
technical/biomed/1471-2105-3-2.txt:        RNA sequence and structure data (the RDP/RDP II [ 53 54 ]
technical/biomed/1471-2105-3-2.txt:        increases in the amount of sequences available for the RNAs
technical/biomed/1471-2105-3-2.txt:        established a new "Comparative RNA Web" (CRW) Site
technical/biomed/1471-2105-3-2.txt:        http://www.rna.icmb.utexas.edu/. This resource has been
technical/biomed/1471-2105-3-2.txt:            Models http://www.rna.icmb.utexas.edu/CSI/2STR/contains
technical/biomed/1471-2105-3-2.txt:            our most recent 16S and 23S rRNA covariation-based
technical/biomed/1471-2105-3-2.txt:            rRNA), and the structure models for 5S rRNA [ 12 ] ,
technical/biomed/1471-2105-3-2.txt:            tRNA [ 5 6 7 8 9 ] , and the group I [ 32 ] and group
technical/biomed/1471-2105-3-2.txt:            collection of RNA structure models was predicted with
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.edu/METHODS/and in several
technical/biomed/1471-2105-3-2.txt:            e.g., tRNA sequences). It was
technical/biomed/1471-2105-3-2.txt:            details). One exception to this is the tRNA analysis,
technical/biomed/1471-2105-3-2.txt:            predict RNA structure with extreme accuracy. All of the
technical/biomed/1471-2105-3-2.txt:            present in the tRNA crystal structure [ 10 11 ] . The
technical/biomed/1471-2105-3-2.txt:            analysis of fragments of 5S rRNA [ 75 ] and the group I
technical/biomed/1471-2105-3-2.txt:            have given us the opportunity to evaluate our rRNA
technical/biomed/1471-2105-3-2.txt:            23S rRNA base pairs predicted with covariation analysis
technical/biomed/1471-2105-3-2.txt:            23S and 5S rRNAs, group I and II introns, and tRNA are
technical/biomed/1471-2105-3-2.txt:            on the 16S and 23S rRNAs. Thus, some of our subsequent
technical/biomed/1471-2105-3-2.txt:            two RNAs.
technical/biomed/1471-2105-3-2.txt:            Each RNA structure model presented here is based
technical/biomed/1471-2105-3-2.txt:            as the reference sequence for rRNA (5S, 16S, and 23S),
technical/biomed/1471-2105-3-2.txt:            Each of the six structure models (5S, 16S and 23S rRNA,
technical/biomed/1471-2105-3-2.txt:            group I and II introns, and tRNA) in the "Current
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.edu/CSI/2STR/contains six or
technical/biomed/1471-2105-3-2.txt:            E. coli 16S and 23S rRNA
technical/biomed/1471-2105-3-2.txt:            16S and 23S rRNA have a red base pair symbol, our
technical/biomed/1471-2105-3-2.txt:            8500 16S and 16S-like rRNA sequences and 1050 23S and
technical/biomed/1471-2105-3-2.txt:            23S-like rRNA sequences were collected from all
technical/biomed/1471-2105-3-2.txt:            described in more detail in the "Predicting RNA
technical/biomed/1471-2105-3-2.txt:            Site http://www.rna.icmb.utexas.edu/METHODS/and in
technical/biomed/1471-2105-3-2.txt:            and 23S rRNA structure models, we have also identified
technical/biomed/1471-2105-3-2.txt:            some base pairs in the 16S and 23S rRNAs that have a
technical/biomed/1471-2105-3-2.txt:            separate 16S and 23S rRNA secondary structure diagrams
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.edu/CSI/2STR/. These base
technical/biomed/1471-2105-3-2.txt:            unambiguously numbering each helix in a RNA molecule.
technical/biomed/1471-2105-3-2.txt:            16S rRNA helix, which spans 
technical/biomed/1471-2105-3-2.txt:            traversing the RNA backbone.
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.edu/CSI/2STR/both abstract
technical/biomed/1471-2105-3-2.txt:            between the two interacting positions within the RNA
technical/biomed/1471-2105-3-2.txt:            two alternative formats. The majority of the base pairs
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.edu/CSI/2STR/, the same RNA
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.edu/METHODS/). For example,
technical/biomed/1471-2105-3-2.txt:            S. cerevisiae phenylalanine tRNA
technical/biomed/1471-2105-3-2.txt:            E. coli 16S rRNA, with 1542
technical/biomed/1471-2105-3-2.txt:            E. coli 23S rRNA (2904 nt), there
technical/biomed/1471-2105-3-2.txt:            tRNA secondary structure models is approximately 2.5 ×
technical/biomed/1471-2105-3-2.txt:            structure models for 16S and 23S rRNA, respectively
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.edu/METHODS/). Covariation
technical/biomed/1471-2105-3-2.txt:            and 23S rRNAs (see above) from this very large number
technical/biomed/1471-2105-3-2.txt:            1B. Evolution of the 16S and 23S rRNA comparative
technical/biomed/1471-2105-3-2.txt:            the 16S and 23S rRNAs is presented here
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.edu/CSI/EVOLUTION/(H-1B.1).
technical/biomed/1471-2105-3-2.txt:            base pair in each version of the 16S and 23S rRNA
technical/biomed/1471-2105-3-2.txt:            and 23S [ 19 ] rRNA models. Every base pair in each of
technical/biomed/1471-2105-3-2.txt:            number and diversity of new rRNA sequences. Proposed
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.edu/METHODS/for more
technical/biomed/1471-2105-3-2.txt:            for 16S and 23S rRNA are very similar to one another.
technical/biomed/1471-2105-3-2.txt:            579 proposed 16S rRNA base pairs evaluated against six
technical/biomed/1471-2105-3-2.txt:            versions of the structure model and 1001 23S rRNA base
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.edu/CSI/EVOLUTION/) that
technical/biomed/1471-2105-3-2.txt:            major versions of the 16S and 23S rRNA structure
technical/biomed/1471-2105-3-2.txt:            16S rRNA, and 870 base pairs and approximately 1050
technical/biomed/1471-2105-3-2.txt:            sequences for 23S rRNA). Three sets of 16S and 23S rRNA
technical/biomed/1471-2105-3-2.txt:            models; 2) changes since 1983 (16S rRNA) or 1984 (23S
technical/biomed/1471-2105-3-2.txt:            rRNA); and 3) all previously proposed base pairs that
technical/biomed/1471-2105-3-2.txt:            conclusions from the evolution of the 16S and 23S rRNA
technical/biomed/1471-2105-3-2.txt:            rRNA base pairs predicted in the initial structure
technical/biomed/1471-2105-3-2.txt:            1C. RNA structure definitions
technical/biomed/1471-2105-3-2.txt:            The RNA structure models presented here are composed
technical/biomed/1471-2105-3-2.txt:            that are described and illustrated at our RNA Structure
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.edu/CSI/DEFS/(H-1C.1-2). The
technical/biomed/1471-2105-3-2.txt:            unique color code in the illustrations on the "RNA
technical/biomed/1471-2105-3-2.txt:            examples of each category from the 16S and 23S rRNA
technical/biomed/1471-2105-3-2.txt:            the end of a helix), internal loop (nucleotides within
technical/biomed/1471-2105-3-2.txt:            a subset of the RNAs in the CRW Site collection
technical/biomed/1471-2105-3-2.txt:            the reference sequence, for every RNA in this
technical/biomed/1471-2105-3-2.txt:            organized into the same alignment. For the three rRNAs,
technical/biomed/1471-2105-3-2.txt:            nuclear-encoded rRNA for each of the three primary
technical/biomed/1471-2105-3-2.txt:            (no alignments yet for the 5S rRNA; (4) Chloroplasts
technical/biomed/1471-2105-3-2.txt:            include all of the (6) nuclear-encoded rRNA sequences
technical/biomed/1471-2105-3-2.txt:            For the tRNA and group I and II intron sequences,
technical/biomed/1471-2105-3-2.txt:            the same functional and/or structural class. The tRNA
technical/biomed/1471-2105-3-2.txt:            are bound to the tRNA. Currently, only the type I tRNAs
technical/biomed/1471-2105-3-2.txt:            [ 81 ] are included here; the tRNAs are collected in 19
technical/biomed/1471-2105-3-2.txt:            CRW Site http://www.rna.icmb.utexas.edu/METHODS/. The
technical/biomed/1471-2105-3-2.txt:            during the evolution of that RNA (for the rRNAs, the
technical/biomed/1471-2105-3-2.txt:            927:1390 base pair in 16S rRNA (Figure 2C; H-2A). Note
technical/biomed/1471-2105-3-2.txt:            1.00, greater than the minimum value for this RNA and
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.edu/METHODS/). Note that the
technical/biomed/1471-2105-3-2.txt:            Currently, only the 16S and 23S rRNA nucleotide
technical/biomed/1471-2105-3-2.txt:            the tree (H-2B.2). For example, for the 16S rRNA base
technical/biomed/1471-2105-3-2.txt:            5S, 16S, and 23S rRNA for the broadest phylogenetic
technical/biomed/1471-2105-3-2.txt:            mitochondria. Longer term, our goal is to generate rRNA
technical/biomed/1471-2105-3-2.txt:            and 23S rRNA conservation diagrams for many of the
technical/biomed/1471-2105-3-2.txt:            information for the rRNA sequences in that phylogenetic
technical/biomed/1471-2105-3-2.txt:            group. For each of the three rRNA molecules (5S, 16S,
technical/biomed/1471-2105-3-2.txt:            location; 4) RNA Type; 5) RNA Class; and 6) NCBI
technical/biomed/1471-2105-3-2.txt:            analysis of RNA structure
technical/biomed/1471-2105-3-2.txt:            and variation present in RNA sequence alignments can
technical/biomed/1471-2105-3-2.txt:            predict RNA structure. The accuracy of the phylogenetic
technical/biomed/1471-2105-3-2.txt:            tree and the predicted RNA structure is directly
technical/biomed/1471-2105-3-2.txt:            prediction of the 16S and 23S rRNA secondary structures
technical/biomed/1471-2105-3-2.txt:            that are conserved in all of the rRNA sequences that
technical/biomed/1471-2105-3-2.txt:            mitochondria. Other regions of the rRNA are conserved
technical/biomed/1471-2105-3-2.txt:            example, Bacterial rRNAs have positions that are
technical/biomed/1471-2105-3-2.txt:            phylogenetic tree and result in features in the rRNA
technical/biomed/1471-2105-3-2.txt:            of evolution at the positions in the rRNA to the hands
technical/biomed/1471-2105-3-2.txt:            change in the hour hand regions of the rRNAs. In
technical/biomed/1471-2105-3-2.txt:            the positions in the rRNA are dependent on one another.
technical/biomed/1471-2105-3-2.txt:            same RNA structure from similar RNA sequences (see
technical/biomed/1471-2105-3-2.txt:            evolution and positional dependency of the RNA to
technical/biomed/1471-2105-3-2.txt:            RNA sequences. Our current RNA data sets contain a very
technical/biomed/1471-2105-3-2.txt:            RNA sequences are very similar to at least one sequence
technical/biomed/1471-2105-3-2.txt:            nuclear-encoded 23S-like rRNAs. These two regions could
technical/biomed/1471-2105-3-2.txt:            23S-like rRNA sequences was determined, we reanalyzed
technical/biomed/1471-2105-3-2.txt:            rRNAs (see Figures 3and 6 in [ 52 ] ). While the
technical/biomed/1471-2105-3-2.txt:            secondary structures for the fungal 23S-like rRNAs are
technical/biomed/1471-2105-3-2.txt:            determined in these regions, the animal rRNAs were only
technical/biomed/1471-2105-3-2.txt:            insertions in the animal rRNAs, and this will require
technical/biomed/1471-2105-3-2.txt:            even more animal 23S-like rRNA sequences from organisms
technical/biomed/1471-2105-3-2.txt:            structure diagram with the program XRNA (Weiser &
technical/biomed/1471-2105-3-2.txt:            conservation and variation for any one RNA type.
technical/biomed/1471-2105-3-2.txt:            A) Align all rRNA, group I and II intron sequences
technical/biomed/1471-2105-3-2.txt:            B) Generate rRNA and group I/II intron secondary
technical/biomed/1471-2105-3-2.txt:            representative of a type of RNA structural element. The
technical/biomed/1471-2105-3-2.txt:            generation of 5S, 16S, and 23S rRNAs secondary
technical/biomed/1471-2105-3-2.txt:            priority over other rRNA sequences.
technical/biomed/1471-2105-3-2.txt:            system. This computer system organizes all of our RNA
technical/biomed/1471-2105-3-2.txt:            number of ribosomal RNA and group I and II intron
technical/biomed/1471-2105-3-2.txt:            structure diagrams for each of these RNAs for the major
technical/biomed/1471-2105-3-2.txt:            for the 5S, 16S, and 23S rRNAs and group I and group II
technical/biomed/1471-2105-3-2.txt:            11,464 rRNA (5S, 16S, and 23S) and intron (group I, II,
technical/biomed/1471-2105-3-2.txt:            and other) sequences. The ribosomal RNAs comprise 80%
technical/biomed/1471-2105-3-2.txt:            of this total, and 16S rRNA represents 82% of the rRNA
technical/biomed/1471-2105-3-2.txt:            rRNAs. Intron sequences comprise 20% of our total
technical/biomed/1471-2105-3-2.txt:            and 23S (20%) rRNAs. At this time, tRNA records are not
technical/biomed/1471-2105-3-2.txt:            The display also indicates the cell location and RNA
technical/biomed/1471-2105-3-2.txt:            Bacteria, Eukaryota, and Virus), RNA Class (see Table
technical/biomed/1471-2105-3-2.txt:            rRNA diagrams (which appear in two halves) are
technical/biomed/1471-2105-3-2.txt:            only the rRNA alignments are available; the group I and
technical/biomed/1471-2105-3-2.txt:            3E. rRNA Introns
technical/biomed/1471-2105-3-2.txt:            The introns that occur in 16S and 23S rRNAs are
technical/biomed/1471-2105-3-2.txt:            position in the rRNA, 2) intron type, 3) phylogenetic
technical/biomed/1471-2105-3-2.txt:            3E. rRNA Introns Table 1: Intron Position
technical/biomed/1471-2105-3-2.txt:            The introns in rRNA Introns Table 1 are organized by
technical/biomed/1471-2105-3-2.txt:            their position numbers in the 16S and 23S rRNAs. The
technical/biomed/1471-2105-3-2.txt:            16S and 23S rRNA position numbers are based on the 
technical/biomed/1471-2105-3-2.txt:            E. coli rRNA reference sequence
technical/biomed/1471-2105-3-2.txt:            position 516 and 517 are listed as 516). rRNA Introns
technical/biomed/1471-2105-3-2.txt:            positions with at least one intron in 16S and 23S rRNA
technical/biomed/1471-2105-3-2.txt:            are shown in rRNA Introns Table 1A (see highlights
technical/biomed/1471-2105-3-2.txt:            rRNA introns, sorted by the numeric order of the intron
technical/biomed/1471-2105-3-2.txt:            positions, is contained in rRNA Introns Table 1B. This
technical/biomed/1471-2105-3-2.txt:            table has nine fields: 1) rRNA type (16S or 23S); 2)
technical/biomed/1471-2105-3-2.txt:            (RNA classes) for each rRNA intron position; 5) the
technical/biomed/1471-2105-3-2.txt:            number of introns for each intron type for each rRNA
technical/biomed/1471-2105-3-2.txt:            defined using the third column from rRNA Introns Table
technical/biomed/1471-2105-3-2.txt:            These fields in rRNA Introns Table 1B (H-3E.1) allow
technical/biomed/1471-2105-3-2.txt:            at each rRNA site. For example, of the 116 introns (as
technical/biomed/1471-2105-3-2.txt:            of December 2001) at position 516 in 16S rRNA, 55 of
technical/biomed/1471-2105-3-2.txt:            for each of the values in rRNA Introns Table 1B
technical/biomed/1471-2105-3-2.txt:            are: 1) exon (16S or 23S rRNA); 2) intron position in
technical/biomed/1471-2105-3-2.txt:            the rRNA; 3) intron type (RNA class); 4) length of
technical/biomed/1471-2105-3-2.txt:            tabulated in rRNA Introns Table 1C (H-3E.4), while the
technical/biomed/1471-2105-3-2.txt:            number of introns at each rRNA position are ranked in
technical/biomed/1471-2105-3-2.txt:            rRNA Introns Table 1D (H-3E.5). This latter table
technical/biomed/1471-2105-3-2.txt:            contains six fields of information for each rRNA: 1)
technical/biomed/1471-2105-3-2.txt:            number of introns per rRNA position; 2) number of
technical/biomed/1471-2105-3-2.txt:            positions with that number of introns; 3) the rRNA
technical/biomed/1471-2105-3-2.txt:            × field #2); 5) the Poisson probability (see rRNA
technical/biomed/1471-2105-3-2.txt:            introns per rRNA site.
technical/biomed/1471-2105-3-2.txt:            The highlights from rRNA Introns Table 1 are: 1) As
technical/biomed/1471-2105-3-2.txt:            introns that occur in the rRNAs, with 900 in the 16S
technical/biomed/1471-2105-3-2.txt:            rRNA, and 284 in 23S rRNA. These introns are
technical/biomed/1471-2105-3-2.txt:            rRNA and 68 in 23S rRNA. 2) Although 16S rRNA is
technical/biomed/1471-2105-3-2.txt:            approximately half the length of 23S rRNA, there are
technical/biomed/1471-2105-3-2.txt:            more than three times as many introns in 16S rRNA.
technical/biomed/1471-2105-3-2.txt:            more prevalent sampling of 16S and 16S-like rRNAs for
technical/biomed/1471-2105-3-2.txt:            the most introns (943, 516, and 1516 in 16S rRNA)
technical/biomed/1471-2105-3-2.txt:            contain 361, or 31% (361/1163), of the rRNA introns. 4)
technical/biomed/1471-2105-3-2.txt:            rRNA Introns Table 1D compares the observed
technical/biomed/1471-2105-3-2.txt:            distribution of rRNA introns with the Poisson
technical/biomed/1471-2105-3-2.txt:            raw numbers of introns in the 16S and 23S rRNAs, we
technical/biomed/1471-2105-3-2.txt:            expect to see no positions in 16S rRNA containing more
technical/biomed/1471-2105-3-2.txt:            than five introns and no positions in 23S rRNA
technical/biomed/1471-2105-3-2.txt:            thirty-five rRNA positions fall into one of those two
technical/biomed/1471-2105-3-2.txt:            rRNA introns among the available insertion positions is
technical/biomed/1471-2105-3-2.txt:            (16S rRNA positions 516 and 1199, and 23S rRNA position
technical/biomed/1471-2105-3-2.txt:            2563). The 16S rRNA position 788 has several examples
technical/biomed/1471-2105-3-2.txt:            3E. rRNA Introns Table 2: Intron Type
technical/biomed/1471-2105-3-2.txt:            above, in rRNA Introns Table 2 (H-3E.6). The frequency
technical/biomed/1471-2105-3-2.txt:            of 16S and 23S rRNA exons, non-rRNA exons, number of
technical/biomed/1471-2105-3-2.txt:            intron positions in the 16S and 23S rRNA, cell
technical/biomed/1471-2105-3-2.txt:            are: 1) Of the 1184 known rRNA introns, 980 (83%) are
technical/biomed/1471-2105-3-2.txt:            only 2% of the rRNA introns are group II, 62%
technical/biomed/1471-2105-3-2.txt:            (728/1180) of the non-rRNA introns are group II. In
technical/biomed/1471-2105-3-2.txt:            introns do not occur in rRNAs. 2) The majority of the
technical/biomed/1471-2105-3-2.txt:            rRNA group I introns (851/980 = 87%) fall into one of
technical/biomed/1471-2105-3-2.txt:            three times as many 16S rRNA group I introns than 23S
technical/biomed/1471-2105-3-2.txt:            rRNA group I introns (753 vs. 227). 4) Among the three
technical/biomed/1471-2105-3-2.txt:            The 183 introns described in rRNA Introns Table 2 as
technical/biomed/1471-2105-3-2.txt:            rRNAs (the Archaeal introns). Thirty-one of the known
technical/biomed/1471-2105-3-2.txt:            Archaeal introns are found in 16S rRNA and the
technical/biomed/1471-2105-3-2.txt:            remaining twelve are from 23S rRNA exons. The Archaeal
technical/biomed/1471-2105-3-2.txt:            rRNAs. 92 spliceosomal introns are from 16S rRNA and 29
technical/biomed/1471-2105-3-2.txt:            are from 23S rRNA; the lengths of these introns range
technical/biomed/1471-2105-3-2.txt:            introns occur only in nuclear rRNA genes and tend to
technical/biomed/1471-2105-3-2.txt:            rRNA position 787, a position where a group IIB intron
technical/biomed/1471-2105-3-2.txt:            Marchantia polymorpha rRNA. The
technical/biomed/1471-2105-3-2.txt:            rRNA Introns Table 2 expands the presentation by
technical/biomed/1471-2105-3-2.txt:            3E. rRNA Introns Table 3: Phylogenetic
technical/biomed/1471-2105-3-2.txt:            is tabulated in rRNA Introns Table 3A (H-3E.8) and 3B
technical/biomed/1471-2105-3-2.txt:            (H-3E.9). rRNA Introns Table 3A reveals the ratio of
technical/biomed/1471-2105-3-2.txt:            the number of rRNA introns per rRNA gene for the
technical/biomed/1471-2105-3-2.txt:            nuclear, chloroplast, and mitochondrial encoded RNAs
technical/biomed/1471-2105-3-2.txt:            distributions are: 1) The majority (96%) of the rRNA
technical/biomed/1471-2105-3-2.txt:            the Bacteria. 2) Only one rRNA intron has been
technical/biomed/1471-2105-3-2.txt:            rRNA gene sequences that have been determined, the
technical/biomed/1471-2105-3-2.txt:            ratio of rRNA introns per rRNA gene is essentially zero
technical/biomed/1471-2105-3-2.txt:            Archaea rRNAs is higher, with 43 examples documented as
technical/biomed/1471-2105-3-2.txt:            ratio of rRNA introns in the Desulfurococcales and
technical/biomed/1471-2105-3-2.txt:            the highest ratio of rRNA introns per rRNA gene is for
technical/biomed/1471-2105-3-2.txt:            Eucarya that have significant numbers of rRNA
technical/biomed/1471-2105-3-2.txt:            ratios of rRNA introns per rRNA gene are similar
technical/biomed/1471-2105-3-2.txt:            number of rRNA introns occurs in the plants, with
technical/biomed/1471-2105-3-2.txt:            similar ratios of rRNA intron/rRNA gene for the
technical/biomed/1471-2105-3-2.txt:            animal rRNA, occurring within the 
technical/biomed/1471-2105-3-2.txt:            23S-like rRNA (GenBank accession number K02309).
technical/biomed/1471-2105-3-2.txt:            Each of the two special "Unclassified" rRNA intron
technical/biomed/1471-2105-3-2.txt:            groups has a specific phylogenetic bias. Archaeal rRNA
technical/biomed/1471-2105-3-2.txt:            non-Archaeal introns have been found in Archaea rRNAs
technical/biomed/1471-2105-3-2.txt:            to date. Splicesomal rRNA introns have only been
technical/biomed/1471-2105-3-2.txt:            ] . rRNA Introns Table 3A also presents the numbers of
technical/biomed/1471-2105-3-2.txt:            (complete or nearly so) rRNA sequences in the same
technical/biomed/1471-2105-3-2.txt:            be considered. First, the numbers of rRNA sequences are
technical/biomed/1471-2105-3-2.txt:            an underestimate, since many rRNA introns are published
technical/biomed/1471-2105-3-2.txt:            rRNA sequence count. The second caveat is that many
technical/biomed/1471-2105-3-2.txt:            rRNA sequences contain multiple introns (see rRNA
technical/biomed/1471-2105-3-2.txt:            location combinations shown in rRNA Introns Table 3
technical/biomed/1471-2105-3-2.txt:            that may contain rRNA introns, 15 (29%) have a
technical/biomed/1471-2105-3-2.txt:            intron:rRNA sequence ratio greater than 1.0, indicating
technical/biomed/1471-2105-3-2.txt:            known rRNA introns. Ten (20%) of the groups have
technical/biomed/1471-2105-3-2.txt:            available in rRNA Introns Table 3B (H-3E.10). The first
technical/biomed/1471-2105-3-2.txt:            organism, cell location, exon (16S or 23S rRNA), and
technical/biomed/1471-2105-3-2.txt:            3E. rRNA Introns Table 4: Number of Introns per
technical/biomed/1471-2105-3-2.txt:            rRNA Introns Table 4 presents the number of introns
technical/biomed/1471-2105-3-2.txt:            per rRNA gene (H-3E.11). While more than 80% of the
technical/biomed/1471-2105-3-2.txt:            documented rRNA genes do not have an intron, 646 16S
technical/biomed/1471-2105-3-2.txt:            and 182 23S rRNAs have at least one intron.
technical/biomed/1471-2105-3-2.txt:            rRNA genes have 6, 7 or 8 introns, and one rRNA gene
technical/biomed/1471-2105-3-2.txt:            per rRNA gene) has been used to calculate the number of
technical/biomed/1471-2105-3-2.txt:            rRNA sequences expected to contain a given number of
technical/biomed/1471-2105-3-2.txt:            introns (rRNA Introns Table 4). Based upon this data,
technical/biomed/1471-2105-3-2.txt:            no rRNA sequences are expected to contain four or more
technical/biomed/1471-2105-3-2.txt:            category: fewer rRNAs contain only one intron than
technical/biomed/1471-2105-3-2.txt:            The two molecules (16S and 23S rRNA) show a
technical/biomed/1471-2105-3-2.txt:            rRNA, only nuclear genes (ten) have been observed to
technical/biomed/1471-2105-3-2.txt:            nuclear (both of these are mitochondrial). In 23S rRNA,
technical/biomed/1471-2105-3-2.txt:            rRNA sequences containing four or more introns, five
technical/biomed/1471-2105-3-2.txt:            rRNA Introns Table 4 provides access to seventeen
technical/biomed/1471-2105-3-2.txt:            e.g., 16S rRNA genes containing
technical/biomed/1471-2105-3-2.txt:            The final components of the "rRNA Introns" page are
technical/biomed/1471-2105-3-2.txt:            16S and 23S rRNA secondary structure diagrams that show
technical/biomed/1471-2105-3-2.txt:            the locations for all of the known rRNA introns
technical/biomed/1471-2105-3-2.txt:            (H-3E.13). The information collected here on the "rRNA
technical/biomed/1471-2105-3-2.txt:            structure of the 16S and 23S rRNA (Jackson 
technical/biomed/1471-2105-3-2.txt:            distribution of introns on the rRNA (Bhattacharya 
technical/biomed/1471-2105-3-2.txt:            ribosomal RNA. The "Intron Distribution Data" page
technical/biomed/1471-2105-3-2.txt:            exons with the most Group I introns are 16S rRNA (900),
technical/biomed/1471-2105-3-2.txt:            leucine tRNA (337), 23S rRNA (284), ribosomal protein
technical/biomed/1471-2105-3-2.txt:            for most applications the "QrRNA" (query rRNA),
technical/biomed/1471-2105-3-2.txt:            most important for searching for ribosomal RNA or group
technical/biomed/1471-2105-3-2.txt:            • The values for the attributes RNA Type, ORF (open
technical/biomed/1471-2105-3-2.txt:            The values for other attributes such as RNA Class,
technical/biomed/1471-2105-3-2.txt:            example, when only rRNA is selected for the "RNA Type,"
technical/biomed/1471-2105-3-2.txt:            selected "RNA Type," while only a subset of the
technical/biomed/1471-2105-3-2.txt:            a search for all Eucarya rRNA entries. By default, the
technical/biomed/1471-2105-3-2.txt:            cell location, and last by their RNA class. In
technical/biomed/1471-2105-3-2.txt:            cell location, and RNA class> and <organism name,
technical/biomed/1471-2105-3-2.txt:            RNA class, phylogeny, and cell location> produce
technical/biomed/1471-2105-3-2.txt:            the left of each attribute's S button; alternatively,
technical/biomed/1471-2105-3-2.txt:            (pink and white) alternate for changes in the organism
technical/biomed/1471-2105-3-2.txt:            • RNA Type/Class: currently, we do not have data
technical/biomed/1471-2105-3-2.txt:            entries for the following RNA Types and Classes: mRNA,
technical/biomed/1471-2105-3-2.txt:            tRNA, SnRNA, and Other.
technical/biomed/1471-2105-3-2.txt:            through the phylogenetic data, and how to retrieve RNA
technical/biomed/1471-2105-3-2.txt:            of the phylogenetic tree and any RNA information. In
technical/biomed/1471-2105-3-2.txt:            and RNA information shown in the Results Frame. Help is
technical/biomed/1471-2105-3-2.txt:            RNA information can be mapped onto the phylogenetic
technical/biomed/1471-2105-3-2.txt:            view six RNA types (5S, 16S, and 23S rRNA; group I, II
technical/biomed/1471-2105-3-2.txt:            all entries that satisfy the RNA type and cell location
technical/biomed/1471-2105-3-2.txt:            individual RNA type is: [cell location, # sequences/#
technical/biomed/1471-2105-3-2.txt:            ...]. The RNA types are indicated in different colors
technical/biomed/1471-2105-3-2.txt:            (rRNA: 5S, green; 16S, red; 23S, blue; introns: group
technical/biomed/1471-2105-3-2.txt:            in our CRW RDBMS for RNA types ( 
technical/biomed/1471-2105-3-2.txt:            4C. RNA Structure Query System
technical/biomed/1471-2105-3-2.txt:            predict an RNA structure from its underlying sequence
technical/biomed/1471-2105-3-2.txt:            due in part to the lack of more fundamental RNA
technical/biomed/1471-2105-3-2.txt:            structure rules that relate families of RNA sequences
technical/biomed/1471-2105-3-2.txt:            with specific RNA structural elements. Given this
technical/biomed/1471-2105-3-2.txt:            determine that RNA structure that is common to a set of
technical/biomed/1471-2105-3-2.txt:            nearly 98% of the basepairings in our 16S and 23S rRNA
technical/biomed/1471-2105-3-2.txt:            determined a large number of 5S, 16S, and 23S rRNA and
technical/biomed/1471-2105-3-2.txt:            correct rRNA structure models and a large sampling of
technical/biomed/1471-2105-3-2.txt:            decipher more relationships between RNA sequences and
technical/biomed/1471-2105-3-2.txt:            RNA structural elements. Toward this end, we developed
technical/biomed/1471-2105-3-2.txt:            adenosines in the Bacterial 16S and 23S rRNA
technical/biomed/1471-2105-3-2.txt:            23S rRNA have an A; 3) there is a bias for adenosines
technical/biomed/1471-2105-3-2.txt:            This RNA sequence/structure query system has three
technical/biomed/1471-2105-3-2.txt:            RNA type, phylogenetic group/cell location, and the
technical/biomed/1471-2105-3-2.txt:            currently supports four RNA types (5S, 16S, and 23S
technical/biomed/1471-2105-3-2.txt:            rRNAs, and group I introns) and five phylogenetic
technical/biomed/1471-2105-3-2.txt:            combination and number of RNA types and
technical/biomed/1471-2105-3-2.txt:            although at least one RNA type and one
technical/biomed/1471-2105-3-2.txt:            bacterial 16S and 23S rRNAs were selected for the
technical/biomed/1471-2105-3-2.txt:            rRNAs are GG (9.86%; H-4C.2), while in loops the most
technical/biomed/1471-2105-3-2.txt:            H-4C.1) displays the types of data (RNA molecules and
technical/biomed/1471-2105-3-2.txt:            rRNA structure models were analyzed in Figure 5and
technical/biomed/1471-2105-3-2.txt:        presently contains three RNA motif projects ("U-Tum" [ 62 ]
technical/biomed/1471-2105-3-2.txt:        two RNA folding projects ("16S rRNA Folding" [ 65 ] and
technical/biomed/1471-2105-3-2.txt:        "23S rRNA Folding" [ 66 ] ). In the "Phylogenetic Structure
technical/biomed/1471-2105-3-2.txt:        Nearly 10 years ago, our initial goals for our RNA web
technical/biomed/1471-2105-3-2.txt:        rRNA structure with comparative analysis. With dramatic
technical/biomed/1471-2105-3-2.txt:        increases in the number of ribosomal RNA sequences, we
technical/biomed/1471-2105-3-2.txt:        information for each RNA molecule under study, and our
technical/biomed/1471-2105-3-2.txt:        interest in studying more RNA molecules beyond 16S and 23S
technical/biomed/1471-2105-3-2.txt:        rRNA, we have greatly expanded our web site, and named it
technical/biomed/1471-2105-3-2.txt:        the "Comparative RNA Web" (CRW) Site.
technical/biomed/1471-2105-3-2.txt:        The major types of information available for each RNA
technical/biomed/1471-2105-3-2.txt:        1) the current comparative RNA structure model;
technical/biomed/1471-2105-3-2.txt:        the extent of conservation in the RNA sequence and
technical/biomed/1471-2105-3-2.txt:        rRNA. The other RNA molecules we maintain (5S rRNA, tRNA,
technical/biomed/1471-2105-3-2.txt:        system for each of the RNAs under study; 2) once or twice a
technical/biomed/1471-2105-3-2.txt:        (see "4)" above); 7) add new types of comparative RNA
technical/biomed/1471-2105-3-2.txt:        the data; and 8) analyze more types of RNA molecules from a
technical/biomed/1471-2105-3-2.txt:        formats utilized for the RNA molecules currently
technical/biomed/1471-2105-3-2.txt:          alignments for 16S rRNA [ 85 ] ; 2) the 5S rRNA
technical/biomed/1471-2105-3-2.txt:          alignments [ 55 ] ; and 3) the tRNA alignments [ 81 ] .
technical/biomed/1471-2105-3-2.txt:          New rRNA and intron sequences were found by searching
technical/biomed/1471-2105-3-2.txt:          e.g., "rrna" [Feature key] and
technical/biomed/1471-2105-3-2.txt:          rRNA). While the majority of the RNA sequences of
technical/biomed/1471-2105-3-2.txt:          annotations of the RNAs. However, some GenBank entries
technical/biomed/1471-2105-3-2.txt:          entries, the presence of the rRNA was not annotated and
technical/biomed/1471-2105-3-2.txt:          the rRNA was found by searching for short sequences that
technical/biomed/1471-2105-3-2.txt:          are characteristic of that rRNA (a few examples).
technical/biomed/1471-2105-3-2.txt:          discovered during the alignment of the corresponding rRNA
technical/biomed/1471-2105-3-2.txt:          uncultured archaeon SAGMA-B 16S rRNA (AB050206) and many
technical/biomed/1471-2105-3-2.txt:          contain incorrect annotations for the RNAs; the
technical/biomed/1471-2105-3-2.txt:          RNA sequence alignment and classification of intron
technical/biomed/1471-2105-3-2.txt:            CRW Site http://www.rna.icmb.utexas.edu(Table 2). rRNA,
technical/biomed/1471-2105-3-2.txt:            Type 1 tRNA, and intron sequences were manually aligned
technical/biomed/1471-2105-3-2.txt:            Diego, CA). The rRNA alignments are sorted by phylogeny
technical/biomed/1471-2105-3-2.txt:            subgroup, exon, insertion point (for rRNA introns), and
technical/biomed/1471-2105-3-2.txt:            phylogeny, and the tRNA alignments are sorted by
technical/biomed/1471-2105-3-2.txt:            aminoacyl type and phylogeny. Alignment of the rRNA
technical/biomed/1471-2105-3-2.txt:            intron-exon borders for each intron-containing rRNA
technical/biomed/1471-2105-3-2.txt:            sequence; the large number of rRNA sequences in our
technical/biomed/1471-2105-3-2.txt:            introns are referred to in rRNA GenBank entries without
technical/biomed/1471-2105-3-2.txt:            II are generally classified as "Unknown" in the "RNA
technical/biomed/1471-2105-3-2.txt:            positions toward the 5' end of the rRNA sequence).
technical/biomed/1471-2105-3-2.txt:            (for example, when an intron is inferred from a rRNA
technical/biomed/1471-2105-3-2.txt:            available from the Comparative RNA Web Site
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.edudescribed in this work
technical/biomed/1471-2105-3-2.txt:            complete phylogeny; 3) cell location; 4) RNA type
technical/biomed/1471-2105-3-2.txt:            e.g., rRNA or intron); 5) RNA
technical/biomed/1471-2105-3-2.txt:            exon), intron position (for rRNA introns only: the 
technical/biomed/1471-2105-3-2.txt:            graphics program XRNA (Weiser & Noller, University
technical/biomed/1471-2105-3-2.txt:            by XRNA were converted into PDF using ghostscript
technical/biomed/1471-2105-3-2.txt:            The Comparative RNA Web Site
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.eduis hosted on a Sun
technical/biomed/1471-2105-3-2.txt:            The Comparative RNA Web Site has instituted an
technical/biomed/1471-2105-3-2.txt:            select a username, provide a current email address (for
technical/biomed/1471-2105-3-2.txt:            pieces of information (username and password) necessary
technical/biomed/1471-2105-3-2.txt:            Comparative RNA Web Site
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.eduusing its main address,
technical/biomed/1471-2105-3-2.txt:            http://www.rna.icmb.utexas.edu/, rather than through
technical/biomed/1471-2105-3-2.txt:        CRW = Comparative RNA Web
technical/biomed/1471-2105-3-22.txt:        and RNase protection assay. Raw microarray data obtained
technical/biomed/1471-2105-3-22.txt:        and subsequently reported in scientific journals. In
technical/biomed/1471-2105-3-22.txt:        that gene will not be identified if the alternative
technical/biomed/1471-2105-3-22.txt:          UniGEM-V chip (IncyteGenomics, Palo Alto, CA) with mRNA
technical/biomed/1471-2105-3-22.txt:          using gene-specific probes in an RNase protection assay,
technical/biomed/1471-2105-3-22.txt:          RNase protection assays prior to reporting the fold
technical/biomed/1471-2105-3-22.txt:          (Fig. 3c). RT-PCR was performed using total RNA from
technical/biomed/1471-2105-3-22.txt:          represents a perfect match (PM)to the mRNA of interest,
technical/biomed/1471-2105-3-22.txt:        Northern blot and RNase protection assay. To our surprise,
technical/biomed/1471-2105-3-22.txt:        gene-specific probes in an RNase protection assay, we were
technical/biomed/1471-2105-3-22.txt:        pitfalls and alternatives will allow better utilization of
technical/biomed/1471-2105-3-22.txt:          Isolation of PBMC and RNA
technical/biomed/1471-2105-3-22.txt:          Rockville, MD) and total RNA was isolated immediately
technical/biomed/1471-2105-3-22.txt:          according to the manufacturer's instructions. Poly A+ RNA
technical/biomed/1471-2105-3-22.txt:          was isolated from total RNA by using Oligo-Tex mini mRNA
technical/biomed/1471-2105-3-22.txt:          Interleukin-2 (IL-2) (100 U/ml, 10 days), then total RNA
technical/biomed/1471-2105-3-22.txt:          IncyteGenomics. Briefly, one μg of Poly (A) + RNA
technical/biomed/1471-2105-3-22.txt:          (Santa Clara, CA). Briefly, total RNA isolated from
technical/biomed/1471-2105-3-22.txt:          10 μg of purified RNA was used to prepare double-stranded
technical/biomed/1471-2105-3-22.txt:          (dT)24 primer containing a T7 RNA polymerase promoter
technical/biomed/1471-2105-3-22.txt:          binding site. Biotinylated complementary RNA was prepared
technical/biomed/1471-2105-3-22.txt:          10 μg of total RNA from each sample was denatured at 65°C
technical/biomed/1471-2105-3-22.txt:          in RNA loading buffer, electrophoresed in a 1% agarose
technical/biomed/1471-2105-3-22.txt:          N.H). The RNA was fixed to the membrane by UV
technical/biomed/1471-2105-3-22.txt:          RNase protection assay (RPA)
technical/biomed/1471-2105-3-22.txt:          RPAs were performed using the RNA isolated from
technical/biomed/1471-2105-3-22.txt:          IL-2 and PHA. Five μg of total RNA was hybridized to the 
technical/biomed/1471-2105-3-22.txt:        purified RNA from the samples for microarray and performed
technical/biomed/1471-2105-3-23.txt:        are multiple probe pairs for each mRNA (8-20 for the arrays
technical/biomed/1471-2105-3-23.txt:        base oligonucleotide that matches an mRNA sequence (perfect
technical/biomed/1471-2105-3-23.txt:        relative expression level assigned to each mRNA on
technical/biomed/1471-2105-3-23.txt:        to generate a composite gene expression score for each mRNA
technical/biomed/1471-2105-3-23.txt:          for a labeled cRNA that hybridizes with a probe),
technical/biomed/1471-2105-3-23.txt:          arrays probing RNA from young muscle, and 643 ± 18 for
technical/biomed/1471-2105-3-23.txt:          the 6 arrays probing RNA from older muscle. These data
technical/biomed/1471-2105-3-23.txt:          declines in older muscle of several mRNAs encoding
technical/biomed/1471-2105-3-23.txt:          mRNAs, both the signal and ratio methods detected the
technical/biomed/1471-2105-3-23.txt:          research [ 12 ] . A useful alternative to P in studies
technical/biomed/1471-2105-3-23.txt:          P < 0.01) among the "absent" mRNAs than expected by
technical/biomed/1471-2105-3-23.txt:          mRNAs that warrant further study, use of both parametric
technical/biomed/1471-2105-3-23.txt:        alternative computation to take advantage of the MM data [
technical/biomed/1471-2105-3-23.txt:        whether alternative algorithms for using the MM signals, or
technical/biomed/1471-2105-3-23.txt:        definitive evidence that alternative methods are
technical/biomed/1471-2105-3-23.txt:        SAM [ 8 ] is an alternative to t-tests or rank sum
technical/biomed/1471-2105-3-23.txt:        RNA pooled from multiple subjects, whereas others (n = 8)
technical/biomed/1471-2105-3-23.txt:        probed RNA from individual subjects. The heterogeneous
technical/biomed/1471-2105-3-23.txt:        Source of RNA, scaling factors, and percentage of probe
technical/biomed/1471-2105-3-23.txt:          RNA was extracted from the muscle samples as described
technical/biomed/1471-2105-3-23.txt:          previously [ 11 ] . All RNA samples were of high quality
technical/biomed/1471-2105-3-23.txt:          separation. RNA was probed with Affymetrix HG-U95A high
technical/biomed/1471-2105-3-23.txt:          group) that probed RNA pooled from 4-8 subjects and eight
technical/biomed/1471-2105-3-23.txt:          (four for each age group) that probed RNA from a single
technical/biomed/1471-2105-3-23.txt:          subject. Pooling of RNA was necessary in some cases
technical/biomed/1471-2105-3-23.txt:          because most of the RNA from some samples had been used
technical/biomed/1471-2105-3-23.txt:          RNA, scaling factors, and percentage of transcripts
technical/biomed/1471-2105-3-23.txt:          biotinylated cRNAs hybridized with the probes. The
technical/biomed/1471-2105-3-26.txt:        We evaluated the RNA expression profiles of renal cell
technical/biomed/1471-2105-3-26.txt:        comparing mRNA expression profiles from a total of 21 human
technical/biomed/1471-2105-3-26.txt:          immunohistochemistry. The data sets revealed that mRNA
technical/biomed/1471-2105-3-26.txt:          results indicated concordance between the mRNA expression
technical/biomed/1471-2105-3-26.txt:          RNA isolation
technical/biomed/1471-2105-3-26.txt:          Total RNA was prepared from each sample (eight normal
technical/biomed/1471-2105-3-26.txt:          made by mixing equal quantities of RNA from the kidney
technical/biomed/1471-2105-3-26.txt:          quantities of RNA from the four RCCa samples also from
technical/biomed/1471-2105-3-26.txt:          steel block and hammer. RNA was extracted using Trizol
technical/biomed/1471-2105-3-26.txt:          RNA labeling and GeneChip hybridization
technical/biomed/1471-2105-3-26.txt:          Biotinylated target RNA was prepared from 15 μg of
technical/biomed/1471-2105-3-26.txt:          total RNA using the Affymetrix protocol. Labeled cRNA was
technical/biomed/1471-2105-3-26.txt:          ®containing probes for approximately 5600 mRNAs
technical/biomed/1471-2105-3-26.txt:          hybridization included control RNA transcripts. The
technical/biomed/1471-2105-3-26.txt:        Author 1, MAG, carried out sample preparation, RNA
technical/biomed/1471-2105-3-3.txt:        uses empirical rules derived from its internal research
technical/biomed/1471-2105-3-3.txt:          where mRNA prepared from the same tissue sample was
technical/biomed/1471-2105-3-3.txt:          brain or human lung replicate samples (same mRNA,
technical/biomed/1471-2105-3-3.txt:          mRNA experiment, we will use the match cell signals from
technical/biomed/1471-2105-3-3.txt:          respond very differently to mRNA sample fragments. We
technical/biomed/1471-2105-3-3.txt:          may be further complicated by alternative splicing and
technical/biomed/1471-2105-3-3.txt:          of mRNA per cell is a conserved number among
technical/biomed/1471-2105-3-30.txt:        distributed maternal factors trigger zygotic gap gene
technical/biomed/1471-2105-3-30.txt:        axis of the embryo. Maternal and gap gene factors together
technical/biomed/1471-2105-3-30.txt:        trigger pair rule gene expression in 7 alternating stripes,
technical/biomed/1471-2105-3-30.txt:          construct frequency weight matrices for the maternal
technical/biomed/1471-2105-3-30.txt:          these are all the maternal/gap genes at the top of the
technical/biomed/1471-2105-3-30.txt:          maternal/gap gene input. Thus, 17 out of 27 known modules
technical/biomed/1471-2105-3-30.txt:          maternal/gap gene binding sites.
technical/biomed/1471-2105-3-30.txt:          We therefore devised an alternative strategy that uses
technical/biomed/1471-2105-3-37.txt:        have RNase H, 3'-exonuclease, and 3'-phosphodiester
technical/biomed/1471-2105-3-38.txt:          5 = [Internal cAMP], 
technical/biomed/1471-2105-3-38.txt:          6 = [External cAMP] and 
technical/biomed/1471-2105-3-38.txt:          Fig. 5. The activity of internal cAMP ( 
technical/biomed/1471-2105-3-38.txt:          variation of each parameter. We use internal cAMP in the
technical/biomed/1471-2105-3-4.txt:        whereby RNA accumulation in cells and tissues can be
technical/biomed/1471-2105-3-4.txt:        using mixed murine tissue RNA on Affymetrix Mu11K GeneChips
technical/biomed/1471-2105-3-4.txt:        [ 20 ] . In their study, the same RNA preparation was used
technical/biomed/1471-2105-3-4.txt:        as a template for distinct cDNA/cRNA amplifications and
technical/biomed/1471-2105-3-4.txt:        effect of different laboratories processing the same RNAs.
technical/biomed/1471-2105-3-4.txt:        calls between the same RNA processed in parallel and
technical/biomed/1471-2105-3-4.txt:        of a single human patient, where RNA was prepared from two
technical/biomed/1471-2105-3-4.txt:        due to more consistent processing of RNA, cDNA, and cRNA in
technical/biomed/1471-2105-3-4.txt:        biotinylated cRNA on two different microarrays). In
technical/biomed/1471-2105-3-4.txt:        (same RNA); 2. variation due to the microarray itself (same
technical/biomed/1471-2105-3-4.txt:        cRNA on different GeneChips); 3. tissue heterogeneity
technical/biomed/1471-2105-3-4.txt:        hypothesis was that mixing of RNA samples from multiple
technical/biomed/1471-2105-3-4.txt:        Fifty six (56) different RNA samples were prepared from
technical/biomed/1471-2105-3-4.txt:        other patients here. All RNAs were converted to
technical/biomed/1471-2105-3-4.txt:        double-stranded cDNA, and then to biotinylated cRNA. The
technical/biomed/1471-2105-3-4.txt:        cRNAs were then hybridized to the MuscleChip either singly,
technical/biomed/1471-2105-3-4.txt:        sufficient cRNA amplification, and adequate
technical/biomed/1471-2105-3-4.txt:        "present" calls for each of the 34 cRNA samples tested
technical/biomed/1471-2105-3-4.txt:        of RNA to biotinylated cRNA probe was a major source of
technical/biomed/1471-2105-3-4.txt:        a series of murine RNA from different sources, using the
technical/biomed/1471-2105-3-4.txt:        animals for each variable under study were mixed, RNA
technical/biomed/1471-2105-3-4.txt:        isolated, RNA samples split, and duplicate cDNA, cRNA, and
technical/biomed/1471-2105-3-4.txt:        hybridizations processed in parallel for each RNA (Fig. 1,
technical/biomed/1471-2105-3-4.txt:        "KNagaraju" samples). We also compared RNAs processed from
technical/biomed/1471-2105-3-4.txt:        analysis shows that the different sources of RNA cluster
technical/biomed/1471-2105-3-4.txt:        together, as expected. Importantly, the same RNA used as a
technical/biomed/1471-2105-3-4.txt:        template for two distinct cDNA/cRNA preparations and
technical/biomed/1471-2105-3-4.txt:        data shows that variability from different cDNA-cRNA
technical/biomed/1471-2105-3-4.txt:        two parts, and RNA isolated independently from each of the
technical/biomed/1471-2105-3-4.txt:        RNA samples (Table 1). The resulting profiles were also
technical/biomed/1471-2105-3-4.txt:        patient cRNAs, and mixed 6-9 yr old control cRNAs [ 23 ] ,
technical/biomed/1471-2105-3-4.txt:        the same cRNA hybridization solution are the most highly
technical/biomed/1471-2105-3-4.txt:        laboratory processing of RNA, cDNA, cRNA and
technical/biomed/1471-2105-3-4.txt:        duplicate arrays on the same cRNA (Fig. 2; profiles 6a, 6b;
technical/biomed/1471-2105-3-4.txt:        alternative method is to experimentally normalize these
technical/biomed/1471-2105-3-4.txt:        together the 10 cRNAs for the two different age groups of
technical/biomed/1471-2105-3-4.txt:        processed independently through the biotinylated cRNA step,
technical/biomed/1471-2105-3-4.txt:        and then equimolar amounts of cRNA mixed for hybridization
technical/biomed/1471-2105-3-4.txt:        As above, duplicate profiles using the same cRNA
technical/biomed/1471-2105-3-4.txt:          airtight, humidified tubes at -80°C until RNA isolation.
technical/biomed/1471-2105-3-4.txt:          2 grams, with approximately 20-30 mg used for RNA
technical/biomed/1471-2105-3-4.txt:          isolation (~10-15 micrograms of total RNA). As described
technical/biomed/1471-2105-3-4.txt:          RNA isolation (Trizol, Gibco BRL), RNA purification
technical/biomed/1471-2105-3-4.txt:          (RNAeasy, Qiagen), cDNA synthesis and biotinylated cRNA
technical/biomed/1471-2105-3-4.txt:          http://microarray.cnmcresearch.org/pga.htm), with cRNA
technical/biomed/1471-2105-3-4.txt:          biotinylated cRNA were hybridized to each MuscleChip or
technical/biomed/1471-2105-3-6.txt:          observing two stipulations: A-alternative units in the
technical/biomed/1471-2105-4-13.txt:        the end of the long-term study. The International
technical/biomed/1471-2105-4-13.txt:        internal weighted connections to reduce the observed error
technical/biomed/1471-2105-4-24.txt:        Alternatively, in the above setting the chance that at
technical/biomed/1471-2105-4-24.txt:        Alternatively, there maybe some unexpected experimental
technical/biomed/1471-2105-4-24.txt:        M/Z region. The use of internal standards to normalize this
technical/biomed/1471-2105-4-26.txt:        from which RNA is extracted can often be of such small
technical/biomed/1471-2105-4-26.txt:        enough RNA sample from one subject for hybridization to one
technical/biomed/1471-2105-4-26.txt:        motivated biologists to pool RNA samples together before
technical/biomed/1471-2105-4-26.txt:          means that RNA samples from 25 subjects are randomly
technical/biomed/1471-2105-4-26.txt:          (n20c20), which suggests that by randomly pooling RNA
technical/biomed/1471-2105-4-26.txt:        treatment group, each measuring an RNA sample from a
technical/biomed/1471-2105-4-26.txt:        difficulties. To address these issues, we tested RNA sample
technical/biomed/1471-2105-4-26.txt:        alternative solution. Because arrays are usually more
technical/biomed/1471-2105-4-26.txt:        in experiments using appropriate RNA pooling strategies
technical/biomed/1471-2105-4-26.txt:        RNA pooling may also have adverse consequences, and can
technical/biomed/1471-2105-4-26.txt:        we recommend pooling RNA samples instead of tissue or cell
technical/biomed/1471-2105-4-26.txt:        usually larger than at the RNA level. However, as long as
technical/biomed/1471-2105-4-26.txt:        Appropriately designed RNA sample pooling can provide
technical/biomed/1471-2105-4-26.txt:          n . If the RNA samples from 
technical/biomed/1471-2105-4-26.txt:          uniform mixing. This shows that RNA pooling reduces
technical/biomed/1471-2105-4-26.txt:          Although pooling RNA samples with uniform mixing
technical/biomed/1471-2105-4-26.txt:          0 under the alternative non-central t
technical/biomed/1471-2105-4-26.txt:          larger than . This shifts the alternative distribution
technical/biomed/1471-2105-4-27.txt:        (RNA isolation, labeling, hybridization, staining, washing
technical/biomed/1471-2105-4-27.txt:        following types of comparisons. The labeled cRNA from a
technical/biomed/1471-2105-4-27.txt:        tube (PMT) settings (Exp 1). The labeled cRNA from a sample
technical/biomed/1471-2105-4-27.txt:        settings (Exp 2). The labeled cRNA from a sample was split,
technical/biomed/1471-2105-4-27.txt:        gain", the other at "high gain" (Exp 3). The labeled cRNA
technical/biomed/1471-2105-4-27.txt:          RNA extraction and hybridization
technical/biomed/1471-2105-4-27.txt:          Total RNA was extracted from normal human skeletal
technical/biomed/1471-2105-4-27.txt:          muscle tissue samples and used for cDNA and labeled cRNA
technical/biomed/1471-2105-4-27.txt:          fragmented cRNA together with control targets recommended
technical/biomed/1471-2105-4-31.txt:        Alternative statistics with less bias are the median and
technical/biomed/1471-2121-1-2.txt:        The ternary complex factors (TCFs) are members of the
technical/biomed/1471-2121-1-2.txt:        C/EBPβ mRNA contains three in-frame methionines which give
technical/biomed/1471-2121-1-2.txt:        SRF and TCF have been shown to form a ternary complex at
technical/biomed/1471-2121-1-2.txt:        able to observe a ternary complex between SRF and
technical/biomed/1471-2121-1-2.txt:        sufficient to form a ternary complex with the SRE 
technical/biomed/1471-2121-1-2.txt:          as previously described [ 33]. An internal control
technical/biomed/1471-2121-1-2.txt:          control plasmid, and thus makes the internal control
technical/biomed/1471-2121-1-2.txt:          at 12,000 × g for 10 min at 4°C. The supernatant was
technical/biomed/1471-2121-1-2.txt:        SRF, serum response factor; TCF, ternary complex
technical/biomed/1471-2121-2-10.txt:          alternative method, we extracted cells also with DOTMAC
technical/biomed/1471-2121-2-10.txt:          obtained from Chemicon International (Temecula, CA).
technical/biomed/1471-2121-2-10.txt:          The supernatant was discarded and the pellet was washed
technical/biomed/1471-2121-2-10.txt:          g for 5 min, the supernatant was
technical/biomed/1471-2121-2-10.txt:          from the supernatant as described above.
technical/biomed/1471-2121-2-11.txt:          increase in BLM mRNA and protein expression coincides
technical/biomed/1471-2121-2-11.txt:          34]. Alternatively TOPIIIα could regulate BLM activity by
technical/biomed/1471-2121-2-11.txt:          Alternatively the flanking regions may bind to
technical/biomed/1471-2121-2-15.txt:          RNA analysis
technical/biomed/1471-2121-2-15.txt:          immediately in liquid nitrogen. Total RNA was isolated
technical/biomed/1471-2121-2-15.txt:          total RNA was analyzed by Northern hybridization as
technical/biomed/1471-2121-2-15.txt:          supernatant was carefully removed, and cells were
technical/biomed/1471-2121-2-18.txt:          spun at 14,000 × g for 15 min at 4°C, and the supernatant
technical/biomed/1471-2121-2-18.txt:          MAPK antibody as described above. Alternatively, after
technical/biomed/1471-2121-2-18.txt:          in 2 column volumes of SDS sample buffer. Alternatively,
technical/biomed/1471-2121-2-21.txt:          any detached cells. The supernatant solution was either
technical/biomed/1471-2121-2-21.txt:          twice. After centrifugation, the supernatant was removed
technical/biomed/1471-2121-2-3.txt:        OPG mRNA and protein levels were increased compared to
technical/biomed/1471-2121-2-3.txt:        IL-1-mediated cytokine (IL-8) mRNA induction and caused
technical/biomed/1471-2121-2-6.txt:        compound targeting PP5 (ISIS 15534) acts via RNAase H
technical/biomed/1471-2121-2-6.txt:        takes ~ 6 for the mRNA degradation to occur and, due to the
technical/biomed/1471-2121-2-6.txt:          Alternatively, PP5 could have a more global role,
technical/biomed/1471-2121-2-6.txt:        of GRs. Alternatively, the data is also consistent with PP5
technical/biomed/1471-2121-2-6.txt:          were then harvested, and total RNA was extracted with
technical/biomed/1471-2121-2-6.txt:          the manufacturer. Total RNA (20 μg) was fractionated on
technical/biomed/1471-2121-2-6.txt:          centrifugation at 3000 × g for 5 min. The supernatant was
technical/biomed/1471-2121-2-6.txt:          supernatant. The pellets from the ammonium sulfate
technical/biomed/1471-2121-2-6.txt:          contaminating RNA or low molecular weight
technical/biomed/1471-2121-3-10.txt:          expressing Tag from an internal herpes thymidine kinase
technical/biomed/1471-2121-3-10.txt:        internal to the viral LTR [ 1 ] . In our established NIH
technical/biomed/1471-2121-3-10.txt:        than that of wild type. Alternatively, the cell line used
technical/biomed/1471-2121-3-10.txt:          followed by RNase treatment and propidium staining at 50
technical/biomed/1471-2121-3-11.txt:        in blood and in cell supernatants [ 1 ] . Since very little
technical/biomed/1471-2121-3-11.txt:          Flow cytometry analysis of HUVEC culture supernatant
technical/biomed/1471-2121-3-11.txt:          supernatant from cell culture was harvested and annexin
technical/biomed/1471-2121-3-11.txt:          medium. After treatment the cell culture supernatant was
technical/biomed/1471-2121-3-11.txt:          and pooled with culture supernatant. This mixture of
technical/biomed/1471-2121-3-11.txt:          microscopy and cell supernatants were collected for MP
technical/biomed/1471-2121-3-11.txt:          One hundred μL of medium or cell culture supernatant
technical/biomed/1471-2121-3-11.txt:          Medium or cell supernatant containing MP were
technical/biomed/1471-2121-3-11.txt:          discarded. Supernatant was further centrifuged at 19,800
technical/biomed/1471-2121-3-11.txt:          sample as an internal standard. TruCount beads were gated
technical/biomed/1471-2121-3-12.txt:        novel alternative spliced form of the G protein α subunit
technical/biomed/1471-2121-3-12.txt:        C-termini. Alternative splicing results in a novel 35 amino
technical/biomed/1471-2121-3-12.txt:        i2 contain an internal EE epitope, as
technical/biomed/1471-2121-3-12.txt:        consistent with the alternative hypothesis that a
technical/biomed/1471-2121-3-12.txt:        experiments concentrated on addressing the alternative
technical/biomed/1471-2121-3-12.txt:        site of palmitoylation. Alternatively, the novel C-terminal
technical/biomed/1471-2121-3-12.txt:        speculate that alternative splicing may be a mechanism to
technical/biomed/1471-2121-3-12.txt:        i2 . A precedent for such alternative
technical/biomed/1471-2121-3-12.txt:        described for H-ras [ 34 ] . Alternative splicing occurs in
technical/biomed/1471-2121-3-12.txt:        H-ras, and the alternative spliced form is predicted to
technical/biomed/1471-2121-3-12.txt:        mutation was identified that abolishes the alternatively
technical/biomed/1471-2121-3-12.txt:        demonstrated that alternative splicing is a mechanism that
technical/biomed/1471-2121-3-12.txt:        Alternative splicing may similarly play an important role
technical/biomed/1471-2121-3-12.txt:          intact cells, and the supernatant was then centrifuged at
technical/biomed/1471-2121-3-12.txt:          for 30 s at 200 × g to pellet the beads. The supernatant
technical/biomed/1471-2121-3-13.txt:          expression we examined the levels of mRNA for this ECM
technical/biomed/1471-2121-3-13.txt:          levels of mRNA for TN after treatment with either cCAF or
technical/biomed/1471-2121-3-13.txt:          affect FN mRNA levels (Fig. 3F). 
technical/biomed/1471-2121-3-13.txt:          substrate at specific sites in the gel, the supernatants
technical/biomed/1471-2121-3-13.txt:        a result of a corresponding increase in mRNA, or increase
technical/biomed/1471-2121-3-13.txt:        in TN is due to an increase in mRNA levels. The increase is
technical/biomed/1471-2121-3-13.txt:        small increase seen in mRNA. In addition, in wounds treated
technical/biomed/1471-2121-3-13.txt:        that of TN. The FN mRNA levels are not affected by cCAF
technical/biomed/1471-2121-3-13.txt:          responses between sets of cells. Therefore, internal
technical/biomed/1471-2121-3-13.txt:          read at 405 nm. Positive control: Supernatant from Rous
technical/biomed/1471-2121-3-13.txt:          Total RNA was extracted using TRIzol reagent from
technical/biomed/1471-2121-3-13.txt:          ng/ml cCAF for 4-48 hrs. Transfer of RNA to membrane was
technical/biomed/1471-2121-3-13.txt:          performed as previously described [ 51 ] . RNA probes
technical/biomed/1471-2121-3-13.txt:          Total RNA was extracted as above. RT-PCR was performed
technical/biomed/1471-2121-3-13.txt:          68°C 1.5 min for 40 cycles. 3 μl Quantum mRNA classic 18S
technical/biomed/1471-2121-3-13.txt:          primers from Ambion were used to quantify total RNA
technical/biomed/1471-2121-3-13.txt:          supernatant was used in immunoblots.
technical/biomed/1471-2121-3-13.txt:          E. coli tRNA (Sigma, St. Louis, MO)
technical/biomed/1471-2121-3-15.txt:          form a ternary complex. Since we again only detected the
technical/biomed/1471-2121-3-15.txt:          ternary complex is likely formed along the assembly
technical/biomed/1471-2121-3-15.txt:          thawed and 70 μl of supernatant was transferred to
technical/biomed/1471-2121-3-16.txt:          stayed in the supernatant was greater when using vesicles
technical/biomed/1471-2121-3-16.txt:          ability to associate with Cdc42. Alternatively,
technical/biomed/1471-2121-3-16.txt:          (supernatants), glycerol was added to a final
technical/biomed/1471-2121-3-16.txt:          TLA100 rotor. Supernatants were combined 1:1 with 2× SDS
technical/biomed/1471-2121-3-18.txt:        by v-Src, while expression of Cas anti-sense RNA in cells
technical/biomed/1471-2121-3-18.txt:          SH2 domain, or alternatively, that v-crk induces their
technical/biomed/1471-2121-3-19.txt:          . This dimension makes total internal reflection
technical/biomed/1471-2121-3-19.txt:          cell-surface contacts. Total internal reflection occurs
technical/biomed/1471-2121-3-19.txt:          g for 20 min. The resulting cleared supernatant was
technical/biomed/1471-2121-3-19.txt:          Total internal reflection fluorescence
technical/biomed/1471-2121-3-2.txt:          Barnard [ 16 ] showed that TGF-β treatment of R1E cells
technical/biomed/1471-2121-3-21.txt:        diseases [ 2 ] . Alternatively, modulation of lysosomal
technical/biomed/1471-2121-3-21.txt:        internalized into cells through the endocytic pathway, and
technical/biomed/1471-2121-3-21.txt:          with macrophages, the reduced compound was internalized
technical/biomed/1471-2121-3-21.txt:          is not due to the internalization of oxidized dye since
technical/biomed/1471-2121-3-21.txt:          -generation. Alternatively, the reactive OH •radical may
technical/biomed/1471-2121-3-22.txt:        9 ] , a finding that points towards alternative mechanisms
technical/biomed/1471-2121-3-22.txt:        not reflected by similar changes in p27 mRNA [ 13 ] . Many
technical/biomed/1471-2121-3-22.txt:        levels in the presence of high p27 mRNA [ 14 ] , suggesting
technical/biomed/1471-2121-3-22.txt:          quantitatively similar changes in steady state RNA levels
technical/biomed/1471-2121-3-22.txt:          (Fig 3A). In contrast, p27 mRNA levels were upregulated
technical/biomed/1471-2121-3-22.txt:          effect of MIB on p27 RNA levels can not fully account for
technical/biomed/1471-2121-3-22.txt:          m RNA.
technical/biomed/1471-2121-3-22.txt:          centrifugation and the supernatant was incubated with
technical/biomed/1471-2121-3-22.txt:          Isolation of total cellular RNA using a urea/LiCl
technical/biomed/1471-2121-3-25.txt:          possibilities by using an alternative strategy to make a
technical/biomed/1471-2121-3-25.txt:        investigation, we cannot rule out the alternative
technical/biomed/1471-2121-3-25.txt:        An alternative mechanism for the formation of inclusion
technical/biomed/1471-2121-3-25.txt:          reverse-transcribed from mouse brain mRNA, using 
technical/biomed/1471-2121-3-25.txt:          reverse-transcribed from Hela cell mRNA. This sequence
technical/biomed/1471-2121-3-25.txt:          100,000 × g for 30 min. The supernatant fraction was
technical/biomed/1471-2121-3-30.txt:          MmCOP1 mRNA (GenBank accession
technical/biomed/1471-2121-3-30.txt:          comparable sizes with mRNA on northern blots (data not
technical/biomed/1471-2121-3-30.txt:          same molecular weight band (Fig 3A) and RNAi against COP1
technical/biomed/1471-2121-3-30.txt:          import machinery. Alternatively, recruitment of another
technical/biomed/1471-2121-3-30.txt:          Genomic DNA and mRNA predications
technical/biomed/1471-2121-3-30.txt:          The mRNA sequences of FrCOP1 and AgCOP1 are predicted
technical/biomed/1471-2121-3-30.txt:          maximum speed for 15 minutes, the supernatant was
technical/biomed/1471-2121-3-30.txt:          supernatant was centrifuged at 300 g for 5 minutes at 4
technical/biomed/1471-2121-3-30.txt:          mitochondria fraction. The supernatant was diluted with 1
technical/biomed/1471-2121-3-30.txt:          supernatant and pellet yielded the cytosolic fraction and
technical/biomed/1471-2121-3-6.txt:        p21 interacted directly with a large internal segment of
technical/biomed/1471-2121-3-6.txt:          The "No C/EBP" cells represent an internal control for
technical/biomed/1471-2121-3-6.txt:          levels of p21 mRNA in the livers of wild-type and
technical/biomed/1471-2121-3-6.txt:          and 10 μg/ml RNAse A, then incubated at room temperature
technical/biomed/1471-2121-3-8.txt:        Blocking WOX1 expression with antisense mRNA abolishes
technical/biomed/1471-2121-4-1.txt:        after binding to cellular DNA or double stranded RNA. A
technical/biomed/1471-2121-4-1.txt:          reproduced with an alternative assay for cell viability,
technical/biomed/1471-2121-4-1.txt:          0.07). The ternary mixture of LPS (25 ng/ml), IL-1beta
technical/biomed/1471-2121-4-1.txt:          secretion and mRNA accumulation by monocytes following
technical/biomed/1471-2121-4-1.txt:        in IL-1beta mRNA levels after 3 hours that dramatically
technical/biomed/1471-2121-4-1.txt:          DNA or double stranded RNA. After each experiment, cells
technical/biomed/1471-2121-4-3.txt:        analyzed its expression at the level of protein and mRNA,
technical/biomed/1471-2121-4-3.txt:          Alternatively, an inhibitory element in the linker region
technical/biomed/1471-2121-4-3.txt:          PPT1 mRNA levels also increased in
technical/biomed/1471-2121-4-3.txt:        that Ppt1p levels rose and fell in parallel with mRNA
technical/biomed/1471-2121-4-3.txt:          Northern blot analysis of PPT1mRNA
technical/biomed/1471-2121-4-3.txt:          Total RNA was prepared from W303 and WHT4-1 yeast
technical/biomed/1471-2121-4-3.txt:          electrophoresis, 20 μg of RNA per sample was resolved on
technical/biomed/1471-2121-4-3.txt:          2 O and the RNA was transferred to a
technical/biomed/1471-2121-4-3.txt:          PPT1 mRNA to that of actin mRNA
technical/biomed/1471-2121-4-4.txt:        Alternatively, however, it is possible that Wnt/Wg can
technical/biomed/1471-2121-4-4.txt:        signaling pathway. Using a double-strand RNA interference
technical/biomed/1471-2121-4-4.txt:        (dsRNAi) technique designed to eliminate specific proteins
technical/biomed/1471-2121-4-4.txt:          DFz2, DFz3, and Arr mRNAs, but not DFz1 and DFz4 mRNAs
technical/biomed/1471-2121-4-4.txt:          cells all 4 DFzs mRNAs were detected by this procedure.
technical/biomed/1471-2121-4-4.txt:          sequences (data not shown). Thus S2 cells express mRNAs
technical/biomed/1471-2121-4-4.txt:          for Arr, DFz2 and DFz3, but mRNAs for DFz1 and DFz4 are
technical/biomed/1471-2121-4-4.txt:          To explore these issues, we used dsRNAi to reduce the
technical/biomed/1471-2121-4-4.txt:          levels of Arr and DFz2 RNAs in S2 cells in which Wg
technical/biomed/1471-2121-4-4.txt:          T7-transcribed dsRNAs [ 15 16 ] . Using this approach
technical/biomed/1471-2121-4-4.txt:          when S2 cells were co-transfected with inhibitory RNAs
technical/biomed/1471-2121-4-4.txt:          with either RNA species favors the idea that Wg signaling
technical/biomed/1471-2121-4-4.txt:          to eliminate signaling entirely with inhibitory RNAs
technical/biomed/1471-2121-4-4.txt:          dramatically reduced by addition of inhibitory RNA
technical/biomed/1471-2121-4-4.txt:          inhibitory RNA against Dsh, a cytoplasmic phosphoprotein
technical/biomed/1471-2121-4-4.txt:          treated with dsRNAi against both Arr and Dsh further
technical/biomed/1471-2121-4-4.txt:          (Figure 2B). As expected, inhibitory RNAs against Arr and
technical/biomed/1471-2121-4-4.txt:          blocked by Dsh dsRNAi (data not shown), implying that Dsh
technical/biomed/1471-2121-4-4.txt:          dependent on Dsh or DFz2, as judged by the use of dsRNAi
technical/biomed/1471-2121-4-4.txt:          dsRNAi to try to block the strong activation of signaling
technical/biomed/1471-2121-4-4.txt:          constructs (Figure 5C). Again, Arr dsRNAi markedly
technical/biomed/1471-2121-4-4.txt:        mutant proteins and/or with dsRNAi that can block
technical/biomed/1471-2121-4-4.txt:        Arr dsRNAi clearly establish a requirement for endogenous
technical/biomed/1471-2121-4-4.txt:        dsRNAi helps to refine the nature of such interactions and
technical/biomed/1471-2121-4-4.txt:          RNA from S2 cells and mbn-2 cells was prepared using
technical/biomed/1471-2121-4-4.txt:          Qiagen RNA miniprep columns and was treated with RQ1
technical/biomed/1471-2121-4-4.txt:          RNase-Free DNase (Promega). 0.1 μg RNA from each cell
technical/biomed/1471-2121-4-4.txt:          RNAi in S2 cells
technical/biomed/1471-2121-4-4.txt:          We used dsRNA against a gene unrelated to the Wg
technical/biomed/1471-2121-4-4.txt:          generate both sense and antisense strand RNA. The RNA was
technical/biomed/1471-2121-4-4.txt:          annealed to form double strand RNA. 15 μg of each dsRNA
technical/biomed/1471-2121-4-4.txt:          6cells per well. 8 to 16 hours after dsRNAi treatment,
technical/biomed/1471-2121-4-5.txt:        observation of BDM activity suggests an alternative
technical/biomed/1471-2121-4-5.txt:        Aplysia system or alternative
technical/biomed/1471-2121-4-6.txt:        Subcellular localization of mRNAs represents a
technical/biomed/1471-2121-4-6.txt:        localization of oocyte mRNAs which is crucial for the
technical/biomed/1471-2121-4-6.txt:        targeting of specific mRNAs to the synapses of nerve cells
technical/biomed/1471-2121-4-6.txt:        [ 4 5 ] , centrosomal segregation of mRNAs in the mollusk
technical/biomed/1471-2121-4-6.txt:        the localization of β-actin mRNA to sites of active actin
technical/biomed/1471-2121-4-6.txt:        7 8 ] . In each of these cases, mRNA targeting is mediated
technical/biomed/1471-2121-4-6.txt:        localization of actin mRNA to the leading edge of
technical/biomed/1471-2121-4-6.txt:        the association of β-actin mRNA with microfilaments and
technical/biomed/1471-2121-4-6.txt:        changes in the localization of poly(A) mRNA and ribosomal
technical/biomed/1471-2121-4-6.txt:        step in gene expression as inhibition of mRNA targeting can
technical/biomed/1471-2121-4-6.txt:        the 3' UTR of the mRNA for the intermediate filament
technical/biomed/1471-2121-4-6.txt:        and microinjection of fluorescently labeled RNAs have
technical/biomed/1471-2121-4-6.txt:        greatly enhanced our ability to observe intracellular RNA
technical/biomed/1471-2121-4-6.txt:        number of RNA species that may be simultaneously observed
technical/biomed/1471-2121-4-6.txt:        mRNAs with the cytoskeleton may be a more widespread
technical/biomed/1471-2121-4-6.txt:        cytosolic and cytoskeleton-associated mRNAs isolated from
technical/biomed/1471-2121-4-6.txt:        to ask the question: how many different eukaryotic mRNAs
technical/biomed/1471-2121-4-6.txt:        To investigate whether multiple mRNAs associate with the
technical/biomed/1471-2121-4-6.txt:        cytoskeleton-associated components. RNA was isolated from
technical/biomed/1471-2121-4-6.txt:        enriched in the cytoskeleton fraction were several mRNA
technical/biomed/1471-2121-4-6.txt:        species, such as those encoding β-actin mRNA and ribosomal
technical/biomed/1471-2121-4-6.txt:        Interestingly, mRNAs for multiple proteins involved in
technical/biomed/1471-2121-4-6.txt:        filaments is required for the localization of these mRNAs,
technical/biomed/1471-2121-4-6.txt:        biochemical fractions prior to RNA isolation confirmed that
technical/biomed/1471-2121-4-6.txt:        cytoskeleton fraction. RT-PCR of RNA isolated from these
technical/biomed/1471-2121-4-6.txt:        reorganization of the cytoskeleton produces changes in mRNA
technical/biomed/1471-2121-4-6.txt:        above was used to separate cytosolic and cytoskeleton mRNA
technical/biomed/1471-2121-4-6.txt:        profiles of mRNAs in differentiated HL-60 cells were
technical/biomed/1471-2121-4-6.txt:        organizing RNAs in adherent cells (Table 1bottom versus
technical/biomed/1471-2121-4-6.txt:        top, and Fig. 4). Approximately 22 unique mRNAs exhibited
technical/biomed/1471-2121-4-6.txt:        cytosolic RNAs in the precursor and macrophage cells
technical/biomed/1471-2121-4-6.txt:        distribution pattern of mRNAs upon differentiation, we
technical/biomed/1471-2121-4-6.txt:        different RNA profiles representing the two spatial pools
technical/biomed/1471-2121-4-6.txt:        words, mRNAs within each distinct subcellular compartment
technical/biomed/1471-2121-4-6.txt:        type. Thus, the overall subcellular distribution of mRNAs
technical/biomed/1471-2121-4-6.txt:        Interactions between mRNA and cytoskeleton filaments are
technical/biomed/1471-2121-4-6.txt:        ] . However, since only a small number of localized mRNAs
technical/biomed/1471-2121-4-6.txt:        extent the association of RNAs with the cytoskeleton might
technical/biomed/1471-2121-4-6.txt:        suggest that while many mRNAs distribute equally between
technical/biomed/1471-2121-4-6.txt:        that the mRNAs of these proteins are all positioned in
technical/biomed/1471-2121-4-6.txt:        described here. Abundant mRNA species may target only a
technical/biomed/1471-2121-4-6.txt:        miniscule fraction of mRNA molecules to the cytoskeleton;
technical/biomed/1471-2121-4-6.txt:        other hand, mRNAs of lowly expressed genes may be entirely
technical/biomed/1471-2121-4-6.txt:        transcripts, the relationship between mRNA localization and
technical/biomed/1471-2121-4-6.txt:        including orienting mRNA transcripts and facilitating their
technical/biomed/1471-2121-4-6.txt:        mRNA species, in addition to knowledge of its temporal
technical/biomed/1471-2121-4-6.txt:          Subcellular fractionation of RNA into
technical/biomed/1471-2121-4-6.txt:          by centrifugation (1000 g) and the supernatant containing
technical/biomed/1471-2121-4-6.txt:          components. Nuclei and internal membranes were removed by
technical/biomed/1471-2121-4-6.txt:          centrifugation (1500 g) and the supernatant containing
technical/biomed/1471-2121-4-6.txt:          "cytoskeleton-associated" components was collected. RNA
technical/biomed/1471-2121-4-6.txt:          column and reagents (Qiagen). As an internal control for
technical/biomed/1471-2121-4-6.txt:          the RNA isolation procedure, an exogenous RNA that was
technical/biomed/1471-2121-4-6.txt:          RNA isolation. RT-PCR analysis confirmed that the
technical/biomed/1471-2121-4-6.txt:          exogenous pBluII RNA was equally distributed between the
technical/biomed/1471-2121-4-6.txt:          Small samples (2 μg) from each RNA fraction were
technical/biomed/1471-2121-4-6.txt:          used to confirm the relative abundance of specific mRNA
technical/biomed/1471-2121-4-6.txt:          incubating 1 ug RNA sample with 0.5 mM each dNTP, 0.25
technical/biomed/1471-2121-4-6.txt:          μg/ml random hexamer (Boehringer Mannheim), 10 U RNase
technical/biomed/1471-213X-1-1.txt:        Gad1 RNA was detected in and around
technical/biomed/1471-213X-1-1.txt:        Gad1 RNA was detected from E9.0 to
technical/biomed/1471-213X-1-1.txt:        Gad1 RNA was not detected in the
technical/biomed/1471-213X-1-1.txt:        Gad1 RNA was also detected in some of
technical/biomed/1471-213X-1-1.txt:        Gad1 mRNA translation or protein
technical/biomed/1471-213X-1-1.txt:        post-transcriptional regulation occurs by alternative
technical/biomed/1471-213X-1-1.txt:        32, 33]. This alternate embryonic transcript inserts a stop
technical/biomed/1471-213X-1-1.txt:        Gad1 mRNA and can produce the
technical/biomed/1471-213X-1-1.txt:        Gad1 mRNA that encodes GAD67 as well
technical/biomed/1471-213X-1-1.txt:        as the embryonic alternatively spliced mRNA that can encode
technical/biomed/1471-213X-1-1.txt:        sense and antisense RNA probes were generated by labeling
technical/biomed/1471-213X-1-1.txt:        50 μg/ml torula RNA, 50 μg/ml heparin at 70°C. The final
technical/biomed/1471-213X-1-1.txt:        100 μg/ml RNase A, 100 units/ml RNase T1 in wash II for 1
technical/biomed/1471-213X-1-1.txt:        hour at 37°C. Following the RNase treatment the embryos
technical/biomed/1471-213X-1-1.txt:        hybridized RNA probe was as described previously [ 41]. The
technical/biomed/1471-213X-1-10.txt:        in situ hybridization and RNA
technical/biomed/1471-213X-1-10.txt:        Hnf3 α mRNA [ 17]. These sequences
technical/biomed/1471-213X-1-10.txt:        post-transcriptional processing of transgenic RNA. The 5'
technical/biomed/1471-213X-1-10.txt:        Hnf3 α mRNA (Fig 2) [ 17]. The 3' arm
technical/biomed/1471-213X-1-10.txt:        translation of the transgene was facilitated by an internal
technical/biomed/1471-213X-1-10.txt:            Hnf3 α mRNA. This cloning
technical/biomed/1471-213X-1-11.txt:        growth and die at a relatively rapid rate. Alternatively,
technical/biomed/1471-213X-1-12.txt:        develop to adults [ 42]. An alternative cause is the effect
technical/biomed/1471-213X-1-12.txt:          alternating current field of 5 V, 1 MHz for 2 sec using
technical/biomed/1471-213X-1-12.txt:            RNase A (200 μg/ml; Sigma) was added and samples were
technical/biomed/1471-213X-1-12.txt:            sealed with fingernail polish. The numbers of nuclei
technical/biomed/1471-213X-1-13.txt:        secondary or alternative fate. Cell ablation experiments
technical/biomed/1471-213X-1-13.txt:        neighboring cells directing them into alternative
technical/biomed/1471-213X-1-13.txt:        signals or by promoting alternative developmental pathways.
technical/biomed/1471-213X-1-13.txt:        formation of excess early-born neurons. Antisense Notch RNA
technical/biomed/1471-213X-1-13.txt:          differentiating neurons. We examined the RNA expression
technical/biomed/1471-213X-1-13.txt:          dlD RNA in all or some presumptive
technical/biomed/1471-213X-1-13.txt:          distinguish between the possibilities that alternating
technical/biomed/1471-213X-1-13.txt:          ngn1 uniformly; rather, in situ RNA
technical/biomed/1471-213X-1-13.txt:          signaling, by injection of RNA encoding a dominant
technical/biomed/1471-213X-1-13.txt:          BrdU Labeling, in situ RNA Hybridization and
technical/biomed/1471-213X-1-13.txt:          and fixed in 4% paraformaldehyde. in situ RNA
technical/biomed/1471-213X-1-13.txt:          For fluorescent detection of RNA hybridization and
technical/biomed/1471-213X-1-13.txt:          antibody labeling, embryos were first treated for RNA
technical/biomed/1471-213X-1-13.txt:          Additional in situ RNA hybridizations were performed
technical/biomed/1471-213X-1-15.txt:          However, one cannot extrapolate from mRNA abundance to
technical/biomed/1471-213X-1-15.txt:          and mRNA abundance clearly showed that mRNA transcript
technical/biomed/1471-213X-1-15.txt:          comparable mRNA levels exhibited a 20-fold difference in
technical/biomed/1471-213X-1-15.txt:          their protein expression while mRNA levels of comparable
technical/biomed/1471-213X-1-15.txt:          nylon membrane www.clontech.com. Briefly, total RNA was
technical/biomed/1471-213X-1-15.txt:          Pure Total RNA Labeling System and 32P. The labeled cDNA
technical/biomed/1471-213X-1-15.txt:          the specific mRNA it represents and was calculated by
technical/biomed/1471-213X-1-2.txt:        result from RNA interference (RNAi), the heavy genetic load
technical/biomed/1471-213X-1-2.txt:          The ALM migration defect was not due to RNAi
technical/biomed/1471-213X-1-2.txt:          stranded RNA that corresponds in sequence to a gene will
technical/biomed/1471-213X-1-2.txt:          effect is referred to as RNA interference or RNAi. In
technical/biomed/1471-213X-1-2.txt:          phenotypes, the authors attribute this to RNAi effects
technical/biomed/1471-213X-1-2.txt:          seemed unlikely that RNAi was inducing the ALM migration
technical/biomed/1471-213X-1-2.txt:          this possibility, we generated double stranded RNA that
technical/biomed/1471-213X-1-2.txt:          stranded RNA containing the 
technical/biomed/1471-213X-1-2.txt:          average ALM positions of 8.6 (n=190 and n=167). These RNA
technical/biomed/1471-213X-1-2.txt:          morphology defects were not due to RNAi.
technical/biomed/1471-213X-1-2.txt:        were not due to RNAi, nonspecific effects of carrying a
technical/biomed/1471-213X-1-2.txt:        heterodimer. Alternatively, this element might help sustain
technical/biomed/1471-213X-1-2.txt:          RNAi
technical/biomed/1471-213X-1-2.txt:          To make double stranded RNA for RNAi, we placed the 
technical/biomed/1471-213X-1-2.txt:          pBluescript II KS+. RNA was made from the T3 and T7
technical/biomed/1471-213X-1-2.txt:          The dsRNA was injected at a concentration of 25
technical/biomed/1471-213X-1-2.txt:          To identify long-range palindromic structures, an RNA
technical/biomed/1471-213X-1-4.txt:          plasmid pROSA26-1 [ 4], and the template for the external
technical/biomed/1471-213X-1-6.txt:          the medaka's characteristic filamentous ornamentation. A
technical/biomed/1471-213X-1-6.txt:          The bulge is the first external expression of the
technical/biomed/1471-213X-1-6.txt:          embryonic shield. The germ ring appears internally at
technical/biomed/1471-213X-1-6.txt:          surface beneath the dorsal lip is the first external
technical/biomed/1471-213X-1-6.txt:          The external 
technical/biomed/1471-213X-1-6.txt:          overhangs a pit floored by the external 
technical/biomed/1471-213X-1-6.txt:          Internally, the posterior part of the notochord
technical/biomed/1471-213X-1-6.txt:          are visible externally, but they are best seen from below
technical/biomed/1471-213X-1-6.txt:          a bulging liver, although this is not visible externally.
technical/biomed/1471-213X-1-6.txt:        Paraffin sections provided an internal view of specimens
technical/biomed/1471-213X-1-6.txt:        Alternately, specimens for electron microscopy were passed
technical/biomed/1471-213X-1-6.txt:        confirmed the identification of internal structures.
technical/biomed/1471-213X-1-9.txt:        Circadian rhythms, synchronized to external
technical/biomed/1471-213X-1-9.txt:        the absence of external cues [ 1, 2]. Molecular-genetic
technical/biomed/1471-213X-1-9.txt:        nighttime increase in mRNA could be accounted for as
technical/biomed/1471-213X-1-9.txt:          represents a possible alternative site of translation
technical/biomed/1471-213X-1-9.txt:          mNoc mRNA expression. We used
technical/biomed/1471-213X-1-9.txt:          single mRNA of about 3 kb (Fig. 2). The only variations
technical/biomed/1471-213X-1-9.txt:          mNoc mRNA (Fig. 2, liver and
technical/biomed/1471-213X-1-9.txt:          the latter may reflect RNA degradation.
technical/biomed/1471-213X-1-9.txt:          mNoc mRNA is expressed at early
technical/biomed/1471-213X-1-9.txt:          Northern analysis of retinal RNA shows that, as was
technical/biomed/1471-213X-1-9.txt:          mRNA abundance. Peak expression occurs at the time of
technical/biomed/1471-213X-1-9.txt:          Rhythms of mNocmRNA Abundance are Circadian in
technical/biomed/1471-213X-1-9.txt:          rhythmic changes in mRNA abundance (Figs. 4and 5).
technical/biomed/1471-213X-1-9.txt:          rhythm with virtually no mRNA detectable in the day-time
technical/biomed/1471-213X-1-9.txt:          LD (Fig. 5). Unlike other tissues, spleen RNA exhibits a
technical/biomed/1471-213X-1-9.txt:          which may reflect RNA degradation.
technical/biomed/1471-213X-1-9.txt:          mNoc mRNA appeared to reach higher
technical/biomed/1471-213X-1-9.txt:          mNoc mRNA level. This was
technical/biomed/1471-213X-1-9.txt:          presence of a transposable intracisternal A-particle
technical/biomed/1471-213X-1-9.txt:          in C3H/He mice with a prominent mRNA band at
technical/biomed/1471-213X-1-9.txt:          Although larger mRNA bands have been reported to reflect
technical/biomed/1471-213X-1-9.txt:          mNoc mRNA is expressed in tissue
technical/biomed/1471-213X-1-9.txt:          mNoc mRNA further using in situ
technical/biomed/1471-213X-1-9.txt:          cerebellum, the subiculum, the internal granule layer of
technical/biomed/1471-213X-1-9.txt:        its mRNA are conserved in the mouse. In addition, partial
technical/biomed/1471-213X-1-9.txt:        xNoc mRNA with peak abundance at
technical/biomed/1471-213X-1-9.txt:        xNoc mRNA by Northern analysis. A
technical/biomed/1471-213X-1-9.txt:        mNoc mRNA is detected in most, if not
technical/biomed/1471-213X-1-9.txt:        mouse embryo RNA indicate that mNoc is expressed early in
technical/biomed/1471-213X-1-9.txt:        unpublished). Furthermore, rhythmic increases of mRNA
technical/biomed/1471-213X-1-9.txt:        mNoc mRNA are controlled by one or
technical/biomed/1471-213X-1-9.txt:        mNoc mRNA in brain and pineal tissue.
technical/biomed/1471-213X-1-9.txt:        mNoc mRNA in multiple tissues of the
technical/biomed/1471-213X-1-9.txt:        a transposable intracisternal A-particle (IAP) element of
technical/biomed/1471-213X-1-9.txt:        resulted in hybrid mRNA transcripts whose abundance
technical/biomed/1471-213X-1-9.txt:        mNoc as a single mRNA species in
technical/biomed/1471-213X-1-9.txt:        mNoc mRNA in aging mice. The multiple
technical/biomed/1471-213X-1-9.txt:        mNoc mRNA [ 38] along with the recent
technical/biomed/1471-213X-1-9.txt:        mNoc mRNA in mice containing the IAP
technical/biomed/1471-213X-1-9.txt:          halothane anesthesia. Tissues for RNA extraction in LD
technical/biomed/1471-213X-1-9.txt:          Total RNA and Genomic DNA isolation
technical/biomed/1471-213X-1-9.txt:          Total RNA was extracted by the TRIZOL reagent protocol
technical/biomed/1471-213X-1-9.txt:          of an intracisternal A-particle (IAP) element (reference
technical/biomed/1471-213X-1-9.txt:          Ten μg (or less as specified) of each RNA sample was
technical/biomed/1471-213X-1-9.txt:          Total RNA used as a template in 5'-RACE and RT-PCR was
technical/biomed/1471-213X-1-9.txt:          treated with RNase-free DNase I (Promega, Madison, WI)
technical/biomed/1471-213X-1-9.txt:          and subsequently phenol-chloroform extracted. RNasin
technical/biomed/1471-213X-1-9.txt:          probes, and radiolabeled using T7 or T3 RNA polymerase
technical/biomed/1471-213X-2-1.txt:        external to internal layers in postnatal mouse cerebellar
technical/biomed/1471-213X-2-1.txt:          an internal control. Therefore, statistical analysis was
technical/biomed/1471-213X-2-1.txt:        ineffective in other systems [ 34 35 36 ] . Alternatively,
technical/biomed/1471-213X-2-1.txt:        mRNA is known to be expressed [ 39 ] . At E15, PN-1 protein
technical/biomed/1471-213X-2-1.txt:        two populations. Alternatively, the timing of exit of GnRH
technical/biomed/1471-213X-2-1.txt:            alternate sections.
technical/biomed/1471-213X-2-7.txt:        place at alternative locations on the cell periphery, it
technical/biomed/1471-213X-2-8.txt:          population. The tissue culture supernatant was added to
technical/biomed/1471-213X-2-8.txt:          mRNA isolated from Wnt-3A exposed cells was reverse
technical/biomed/1471-213X-3-2.txt:        RNA isolated from wt C57mg cells, C57mg cells stably
technical/biomed/1471-213X-3-2.txt:        DNA microarray analysis. Biotinylated cRNA probes
technical/biomed/1471-213X-3-2.txt:        synthesized from the RNA were hybridized to Affymetrix
technical/biomed/1471-213X-3-2.txt:        were regulated in a similar manner if we used alternative
technical/biomed/1471-213X-3-2.txt:        293T cells for 24 hours. RNA was isolated and quantitative
technical/biomed/1471-213X-3-2.txt:        RNA (data not shown). One gene, mesothelin, exhibited a
technical/biomed/1471-213X-3-2.txt:        8 hours at which point RNA was isolated and quantitative
technical/biomed/1471-213X-3-2.txt:          for RNA isolation. Total RNA was extracted using the
technical/biomed/1471-213X-3-2.txt:          hours and RNA was isolated. For induction of the Rfz-2/β 
technical/biomed/1471-213X-3-2.txt:          treatments were followed by RNA extraction.
technical/biomed/1471-213X-3-2.txt:          Total RNA was extracted using the RNeasy kit (Qiagen)
technical/biomed/1471-213X-3-2.txt:          total RNA were reverse-transcribed with an oligo(dT)
technical/biomed/1471-213X-3-2.txt:          primer coupled to a T7 RNA polymerase binding site.
technical/biomed/1471-213X-3-2.txt:          Biotinylated complementary RNA (cRNA) was then
technical/biomed/1471-213X-3-2.txt:          with the use of T7 polymerase. 30 μg of biotinylated cRNA
technical/biomed/1471-213X-3-2.txt:          quantitative RT-PCR. cDNA was created from total RNA
technical/biomed/1471-213X-3-2.txt:          prepared similarly. 2 μg RNA were included in each
technical/biomed/1471-213X-3-3.txt:        and does not require new mRNA synthesis [ 22 ] .
technical/biomed/1471-213X-3-3.txt:        that shares significant similarity to histidyl-tRNA
technical/biomed/1471-213X-3-3.txt:        revealed that the HisRS domain binds uncharged tRNAs that
technical/biomed/1471-213X-3-3.txt:        During initiation of protein synthesis, the ternary
technical/biomed/1471-213X-3-3.txt:        complex, eIF2/GTP/methionyl-tRNA 
technical/biomed/1471-213X-3-3.txt:        binding of the initiator methionyl-tRNA 
technical/biomed/1471-213X-3-3.txt:        phosphorylation, the translation of some specific mRNAs is
technical/biomed/1471-213X-3-3.txt:        characteristic feature of mRNAs whose translation is
technical/biomed/1471-213X-3-3.txt:        region (5'UTR) of the mRNAs. The uORFs are involved
technical/biomed/1471-213X-3-3.txt:        mechanistically in the enhanced initiation of these mRNAs [
technical/biomed/1471-213X-3-3.txt:        countin mRNA required increased
technical/biomed/1471-213X-3-3.txt:        shift from polysomes to free ribosomes for bulk mRNA.
technical/biomed/1471-213X-3-3.txt:          class II aminoacyl-tRNA synthetases [ 37 ] . The
technical/biomed/1471-213X-3-3.txt:          Expression of ifkAand ifkBmRNA during growth and
technical/biomed/1471-213X-3-3.txt:          ifkA gene. RNA was isolated from
technical/biomed/1471-213X-3-3.txt:          mRNA levels from both genes in Ax4 during growth and
technical/biomed/1471-213X-3-3.txt:          ifkB mRNA levels and panel C
technical/biomed/1471-213X-3-3.txt:          ifkA mRNA levels. The results
technical/biomed/1471-213X-3-3.txt:          IfkB mRNA expression remains
technical/biomed/1471-213X-3-3.txt:          ifkA mRNA dramatically drop soon
technical/biomed/1471-213X-3-3.txt:          ifkA mRNA was detected in BS153,
technical/biomed/1471-213X-3-3.txt:          ifkA mRNA in these strains (not
technical/biomed/1471-213X-3-3.txt:          is CMF [ 2 3 ] . CMF mRNA levels were normal in BS153
technical/biomed/1471-213X-3-3.txt:          ifkA null cells, the mRNA levels
technical/biomed/1471-213X-3-3.txt:          RT-PCR was carried out on RNA isolated from growing
technical/biomed/1471-213X-3-3.txt:          acaA mRNA were detected at least 2
technical/biomed/1471-213X-3-3.txt:          Additionally, higher levels for both mRNAs were found in
technical/biomed/1471-213X-3-3.txt:          carA mRNA that is normally not seen
technical/biomed/1471-213X-3-3.txt:          are established. In BS153 cells, discoidin mRNA was
technical/biomed/1471-213X-3-3.txt:          mRNA associated with polysomes drops from about 80-90% in
technical/biomed/1471-213X-3-3.txt:          countin mRNA gradually decreased
technical/biomed/1471-213X-3-3.txt:          countin mRNA was much more dramatic
technical/biomed/1471-213X-3-3.txt:          in BS153, with little detectable mRNA present by 8 hours.
technical/biomed/1471-213X-3-3.txt:          efficiency and stability of countinmRNA
technical/biomed/1471-213X-3-3.txt:          countin mRNA revealed 5 short
technical/biomed/1471-213X-3-3.txt:          mRNAs, including the yeast GCN4 mRNA, that are
technical/biomed/1471-213X-3-3.txt:          countin mRNA, along with those of
technical/biomed/1471-213X-3-3.txt:          yeast GCN2 mRNA, are shown schematically in fig. 9A. The
technical/biomed/1471-213X-3-3.txt:          countin mRNA within the polysome
technical/biomed/1471-213X-3-3.txt:          RNA was extracted from the fractions collected after
technical/biomed/1471-213X-3-3.txt:          countin mRNA was determined by
technical/biomed/1471-213X-3-3.txt:          countin mRNA was found mostly in
technical/biomed/1471-213X-3-3.txt:          countin mRNA was reproducibly less
technical/biomed/1471-213X-3-3.txt:          countin mRNA within the polysome
technical/biomed/1471-213X-3-3.txt:          shift identified above for bulk mRNA and for the shift
technical/biomed/1471-213X-3-3.txt:          seen for H7 mRNA (fig. 9B). No difference in the
technical/biomed/1471-213X-3-3.txt:          countin mRNA was found between the
technical/biomed/1471-213X-3-3.txt:          countin mRNA is retained less well
technical/biomed/1471-213X-3-3.txt:          countin mRNA occurs as a result of
technical/biomed/1471-213X-3-3.txt:          countin mRNA in developing BS153
technical/biomed/1471-213X-3-3.txt:          countin mRNA and probably accounts
technical/biomed/1471-213X-3-3.txt:          countin mRNA, and this might
technical/biomed/1471-213X-3-3.txt:          countin mRNA found in BS153 cells
technical/biomed/1471-213X-3-3.txt:          countin mRNA levels were examined
technical/biomed/1471-213X-3-3.txt:          countin mRNA was lost earlier in
technical/biomed/1471-213X-3-3.txt:          countin mRNA remained in BS153
technical/biomed/1471-213X-3-3.txt:          inhibits dissociation of ribosomes from mRNA [ 23 ] ,
technical/biomed/1471-213X-3-3.txt:          countin mRNA. Addition of
technical/biomed/1471-213X-3-3.txt:          Dictyostelium and can cause mRNAs
technical/biomed/1471-213X-3-3.txt:          countin mRNA is destabilized in
technical/biomed/1471-213X-3-3.txt:          countin mRNA in these cells.
technical/biomed/1471-213X-3-3.txt:          Countin2 mRNA levels were found to
technical/biomed/1471-213X-3-3.txt:        mRNA-associated ribosomes (polysomes) to free ribosomes [
technical/biomed/1471-213X-3-3.txt:        22 23 ] . The percentage of mRNA associated with polysomes
technical/biomed/1471-213X-3-3.txt:        the pulsing system. mRNA for both Carl, the cell surface
technical/biomed/1471-213X-3-3.txt:        mRNAs were also greater in developing BS153 cells. Thus,
technical/biomed/1471-213X-3-3.txt:        39 ] . The early and more abundant induction of their mRNAs
technical/biomed/1471-213X-3-3.txt:        loss of discoidin mRNA reinforces this conclusion as
technical/biomed/1471-213X-3-3.txt:        suggest that uncharged tRNAs are more prevalent within the
technical/biomed/1471-213X-3-3.txt:        Countin mRNA was found to be lost
technical/biomed/1471-213X-3-3.txt:        countin mRNA indicated that it was
technical/biomed/1471-213X-3-3.txt:        countin mRNA is destabilized in
technical/biomed/1471-213X-3-3.txt:        countin mRNA synthesis is not
technical/biomed/1471-213X-3-3.txt:        countin mRNA may be a result of the
technical/biomed/1471-213X-3-3.txt:        from degradation, from this mRNA in BS153 cells.
technical/biomed/1471-213X-3-3.txt:        countin mRNA within the polysome
technical/biomed/1471-213X-3-3.txt:        above, bulk mRNA undergoes a secondary shift from polysomes
technical/biomed/1471-213X-3-3.txt:        countin mRNA in early developing Ax4
technical/biomed/1471-213X-3-3.txt:        ribosome association with bulk mRNA in the two strains.
technical/biomed/1471-213X-3-3.txt:        countin mRNA is translated more
technical/biomed/1471-213X-3-3.txt:        mammalian mRNAs (GCN4, ATF4, both transcription factors
technical/biomed/1471-213X-3-3.txt:        activated by amino acid starvation, even though bulk mRNA
technical/biomed/1471-213X-3-3.txt:        The hallmark of mRNAs that are upregulated by GCN2 and
technical/biomed/1471-213X-3-3.txt:        countin mRNA, we find uORFs similar
technical/biomed/1471-213X-3-3.txt:        in number and in arrangement to those of GCN4 mRNA, the
technical/biomed/1471-213X-3-3.txt:        major mRNA regulated by yeast GCN2 [ 25 ] . Thus, we
technical/biomed/1471-213X-3-3.txt:        countin mRNA, and probably other as
technical/biomed/1471-213X-3-3.txt:        yet identified mRNAs, are translationally upregulated when
technical/biomed/1471-213X-3-3.txt:        countin mRNA in developing 
technical/biomed/1471-213X-3-3.txt:        countin mRNA be maintained and not
technical/biomed/1471-213X-3-3.txt:        reduced as is bulk mRNA during the secondary shift of
technical/biomed/1471-213X-3-3.txt:        polysomal RNA? Since the extracellular concentrations of
technical/biomed/1471-213X-3-3.txt:        mRNAs (the secondary polysome shift). For some mRNAs,
technical/biomed/1471-213X-3-3.txt:        countin mRNA. As a result,
technical/biomed/1471-213X-3-3.txt:        countin and perhaps other mRNAs.
technical/biomed/1471-213X-3-3.txt:          mRNA and polysome analysis
technical/biomed/1471-213X-3-3.txt:          RNA was isolated, processed, and used for RT-PCR as
technical/biomed/1471-213X-3-3.txt:          samples). The concentration of RNA in the supernatants
technical/biomed/1471-213X-3-3.txt:          was determined spectrophotometrically. 0.5 mg of RNA were
technical/biomed/1471-213X-3-3.txt:          continuous monitoring at 254 nm. RNA from each fraction
technical/biomed/1471-213X-3-3.txt:          followed by ethanol precipitation. RNA from an equivalent
technical/biomed/1471-213X-3-3.txt:          RNA samples used in RT-PCR reactions, H7 specific
technical/biomed/1471-213X-3-3.txt:          oligonucleotides were used as a control; H7 mRNA is
technical/biomed/1471-213X-3-3.txt:          RNA used in the reactions.
technical/biomed/1471-213X-3-3.txt:        manuscript. YX carried out RT-PCR reactions and RNA
technical/biomed/1471-213X-3-4.txt:        discernable difference in the ability of Hoxc-8 transgenic
technical/biomed/1471-213X-3-4.txt:        form A) is increased, as is Ihh mRNA, and Bmp-4 and p107
technical/biomed/1471-213X-3-4.txt:        expression of Collagen II splice form A mRNA [ 24 ] . This
technical/biomed/1471-213X-3-4.txt:        increased Collagen II mRNA expression by in situ
technical/biomed/1471-213X-3-4.txt:        Unexpected was the elevated expression of Collagen X mRNA,
technical/biomed/1471-213X-3-4.txt:        one would expect to see decreased Collagen X mRNA levels [
technical/biomed/1471-213X-3-4.txt:        27 ] . Yet, the data clearly indicate that mRNA expression
technical/biomed/1471-213X-3-4.txt:        either from increased Collagen X mRNA transcription within
technical/biomed/1471-213X-3-4.txt:        expression in responsive cells [ 30 ] . We find Ihh mRNA
technical/biomed/1471-213X-3-4.txt:        our transgenic animals. Whether the elevated Ihh mRNA
technical/biomed/1471-213X-3-4.txt:        prehypertrophic cells [ 1 ] , and PTHrP receptor mRNA
technical/biomed/1471-213X-3-4.txt:        Hoxc-8. We found the expression of p107 mRNA and Bmp-4 mRNA
technical/biomed/1471-213X-3-4.txt:        elevated Fgf receptor 3 mRNA levels in Hoxc-8 transgenic
technical/biomed/1471-213X-3-4.txt:        Alternatively, it is conceivable that the Hoxc-8 transgene
technical/biomed/1471-213X-3-4.txt:        chondrocytes can be modulated by external factors, and this
technical/biomed/1471-213X-3-4.txt:          concentration in the supernatant was assessed by Micro
technical/biomed/1471-213X-3-4.txt:          activity in the supernatant was determined
technical/biomed/1471-213X-3-4.txt:          at 400 g for five minutes without brakes, the supernatant
technical/biomed/1471-213X-3-4.txt:          supernatant, nuclei were resuspended in 1 ml 0.1 M Na 
technical/biomed/1471-213X-3-4.txt:          To measure gene expression quantitatively, RNA was
technical/biomed/1471-213X-3-4.txt:          2000 rpm for 30 seconds. The supernatant was transferred
technical/biomed/1471-213X-3-4.txt:          for 10 minutes at 4°C. The supernatant was removed and
technical/biomed/1471-213X-3-4.txt:          final removal of supernatant, the pellet was air dried
technical/biomed/1471-213X-3-4.txt:          necessary, by incubation at 37°C for 10 minutes. RNA
technical/biomed/1471-213X-3-4.txt:          transcription of RNA was performed using the Superscript
technical/biomed/1471-213X-3-4.txt:          coordinates on the mRNA sequence given in brackets) were
technical/biomed/1471-213X-3-7.txt:        Alternatively, diapause in many other insects may also
technical/biomed/1471-213X-3-7.txt:        Alternatively, the malformed phenotypes seen at 16°C may
technical/biomed/1471-2148-1-1.txt:        transcription of the TED genome by the viral RNA polymerase
technical/biomed/1471-2148-1-4.txt:        distinguish between these two alternatives but agree with
technical/biomed/1471-2148-1-6.txt:          alternative relationship, the PBS value will be negative.
technical/biomed/1471-2148-1-8.txt:        for example, rRNAs, as in traditional molecular
technical/biomed/1471-2148-1-8.txt:        natural to seek for alternatives to traditional,
technical/biomed/1471-2148-1-8.txt:        alternative way to construct a genome tree involves using
technical/biomed/1471-2148-1-8.txt:        or RNA-polymerase subunits, are conserved across a wide
technical/biomed/1471-2148-1-8.txt:            proteins and RNA polymerase subunits. The remaining
technical/biomed/1471-2148-1-8.txt:              tested, trees with alternative topologies were
technical/biomed/1471-2148-1-8.txt:              alternatives were tested for chlamydia. Alternative
technical/biomed/1471-2148-1-8.txt:              an alternative topology, with this cluster joining
technical/biomed/1471-2148-1-8.txt:              alternatively, moving spirochetes with
technical/biomed/1471-2148-1-8.txt:              alternative to the topology in Fig. 8(euryarchaeal
technical/biomed/1471-2148-1-8.txt:        testing of alternative topologies using the
technical/biomed/1471-2148-1-8.txt:        rRNA-based trees [ 2 29 ] and those built using alignments
technical/biomed/1471-2148-1-8.txt:        of RNA polymerase subunits [ 30 ] and translation
technical/biomed/1471-2148-1-8.txt:        16S RNA phylogenetic analysis, bacterial lineages that are
technical/biomed/1471-2148-1-8.txt:        trees for 16S RNA, 23 S RNA and translation factor EF-Tu [
technical/biomed/1471-2148-1-8.txt:        existence of a statistically supported alternative
technical/biomed/1471-2148-1-8.txt:            local rearrangements. Alternative topologies were
technical/biomed/1471-2148-1-8.txt:            is divided by each internal branch into two partitions.
technical/biomed/1471-2148-2-12.txt:        on alternative sugars, and the reductions in maximum growth
technical/biomed/1471-2148-2-12.txt:        real biological alternatives. Genetic variation need not
technical/biomed/1471-2148-2-14.txt:        substrates, perhaps indicating alternative pathways (see
technical/biomed/1471-2148-2-14.txt:        substrates, perhaps indicating alternative pathways (see
technical/biomed/1471-2148-2-14.txt:          supernatant was decanted and inoculating fluid from
technical/biomed/1471-2148-2-15.txt:        alternative model of cooperative behaviour to the iterated
technical/biomed/1471-2148-2-15.txt:        interactions of bacteriophages [ 36 37 ] , simple RNA
technical/biomed/1471-2148-2-15.txt:        good alternative framework for modelling variable games [ 1
technical/biomed/1471-2148-2-17.txt:        the internal transcribed spacers (ITS) of nuclear ribosomal
technical/biomed/1471-2148-2-17.txt:        Therefore as an alternative, we conducted a Bayesian
technical/biomed/1471-2148-2-17.txt:          and Quaternary periods - forced southward by the
technical/biomed/1471-2148-2-17.txt:          further south into Asia primarily during the Quaternary. 
technical/biomed/1471-2148-2-17.txt:          Absinthium (Fig. 2). Alternatively,
technical/biomed/1471-2148-2-17.txt:        alternative to MP since comparative studies have shown that
technical/biomed/1471-2148-2-17.txt:        conducted a Bayesian analysis as an alternative employing
technical/biomed/1471-2148-2-2.txt:          maturity. Alternatively, the 
technical/biomed/1471-2148-2-2.txt:        28 29 ] . An alternative hypothesis is that as a result of
technical/biomed/1471-2148-2-7.txt:        small subunit ribosomal RNA (18S rRNA) sequences challenged
technical/biomed/1471-2148-2-7.txt:        alternative hypotheses of Ecdysozoa ( 
technical/biomed/1471-2148-2-7.txt:        probability = 1.0) and the alternative hypotheses were both
technical/biomed/1471-2148-2-7.txt:        in the 18S rRNA tree [ 3 ] . To test this, phylogenies were
technical/biomed/1471-2148-2-7.txt:        phylogenetic position of nematodes. In the 18S rRNA gene,
technical/biomed/1471-2148-2-7.txt:        position in the tree. In analyses of the 18S rRNA gene,
technical/biomed/1471-2148-2-7.txt:        alternative hypothesis.
technical/biomed/1471-2148-2-7.txt:        initial analysis of 18S rRNA sequences [ 3 ] , Ecdysozoa
technical/biomed/1471-2148-2-7.txt:        of the 18S rRNA gene have been interpreted differently [ 24
technical/biomed/1471-2148-2-7.txt:        Besides the 18S rRNA evidence, other genetic evidence
technical/biomed/1471-2148-2-7.txt:        arose from the analysis of a single gene, 18S rRNA. The
technical/biomed/1471-2148-2-8.txt:          mRNA structure did not reveal any conserved stems or
technical/biomed/1471-2148-2-8.txt:          belonging to rRNA homology group I [ 37 ] , so they may
technical/biomed/1471-2148-2-8.txt:          strain KC. Alternatively, a pseudomonad ancestor could
technical/biomed/1471-2148-2-8.txt:        RNA secondary structure of the ThiF domain coding
technical/biomed/1471-2148-3-1.txt:          two bacteria showed no discernable correlation between
technical/biomed/1471-2148-3-18.txt:        alternative view suggested by Mukhopadhyay et al. [ 30 ] is
technical/biomed/1471-2148-3-18.txt:        derived from 16S rRNA, and suggest possible implications
technical/biomed/1471-2148-3-18.txt:        The 16S rRNA based phylogenetic tree (Figure 1)
technical/biomed/1471-2148-3-18.txt:        generally matched the accepted 16S rRNA model with clear
technical/biomed/1471-2148-3-18.txt:        16S rRNA tree does not suggest a relationship between these
technical/biomed/1471-2148-3-18.txt:        similarities to the 16S rRNA tree. There was clear
technical/biomed/1471-2148-3-18.txt:        to the accepted 16S rRNA phylogeny, but deep bacterial
technical/biomed/1471-2148-3-18.txt:        common origin. Given the alternate hypotheses of (1) Common
technical/biomed/1471-2148-3-18.txt:        inconsistent with the established 16S rRNA evolutionary
technical/biomed/1471-2148-3-18.txt:        arsC and 16s rRNA trees is the tight
technical/biomed/1471-2148-3-18.txt:        rRNA-defined bacterial clade) and 
technical/biomed/1471-2148-3-18.txt:        some of the 16S rRNA tree branches, might represent the
technical/biomed/1471-2148-3-18.txt:        rRNA tree reflects true phylogeny. One explanation for
technical/biomed/1471-2148-3-18.txt:        rRNA-based and 
technical/biomed/1471-2148-3-18.txt:        based on 16S rRNA, and significant genetic exchange within
technical/biomed/1471-2148-3-18.txt:          in both arsC and 16S rRNA phylogenetic analyses. Each 
technical/biomed/1471-2148-3-18.txt:          2]. Aligned 16S rRNA sequences of all organisms used in
technical/biomed/1471-2148-3-18.txt:          1]) only one 16S rRNA sequence was used for each to avoid
technical/biomed/1471-2148-3-18.txt:          arsC and 16S rRNA sequences used in
technical/biomed/1471-2148-3-18.txt:          The aligned 16S rRNA sequences (55) were used to
technical/biomed/1471-2148-3-18.txt:          tree was constructed in ARB for the 56 16S rRNA sequences
technical/biomed/1471-2148-3-3.txt:        distances. This prediction was confirmed in RNA secondary
technical/biomed/1471-2148-3-3.txt:        RNA secondary structure folding [ 11 ] , both exhibited a
technical/biomed/1471-2148-3-3.txt:        In this paper, we focus on a fairly simple system (RNA
technical/biomed/1471-2148-3-3.txt:        the frequency of other genotypes in the population. RNA
technical/biomed/1471-2148-3-3.txt:        In this system, the secondary structure of an RNA molecule
technical/biomed/1471-2148-3-3.txt:        sequence [ 31 32 33 34 35 36 ] . RNA folding has the
technical/biomed/1471-2148-3-3.txt:        RNA). Thus, we can write 
technical/biomed/1471-2148-3-3.txt:        For 100 randomly chosen RNA sequences of length 
technical/biomed/1471-2148-3-3.txt:        parameter for RNA secondary structure folding (Fig. 4), 98
technical/biomed/1471-2148-3-3.txt:        genotype space. For the case of RNA secondary structure
technical/biomed/1471-2148-3-3.txt:        [ 42 43 ] . Random graph theory predicts that RNA secondary
technical/biomed/1471-2148-3-3.txt:        Fontana [ 44 ] or, alternatively, using digital organisms [
technical/biomed/1471-2148-3-3.txt:        mutations that re-created exactly the same RNA folding as
technical/biomed/1471-2148-3-3.txt:        compensatory mutations in natural RNA structures may be
technical/biomed/1471-2148-3-3.txt:        Compensatory mutations have been reported for rRNA [ 46 ] ,
technical/biomed/1471-2148-3-3.txt:        tRNA [ 47 ] , and mRNA [ 48 ] structures, and it is
technical/biomed/1471-2148-3-3.txt:        our results can be applied to systems other than RNA
technical/biomed/1471-2148-3-3.txt:        neutral networks exist, comparable to the situation for RNA
technical/biomed/1471-2148-3-3.txt:        mutations or, alternatively, indicate that the reference
technical/biomed/1471-2148-3-3.txt:        merely reflect the robustness of individual RNA and protein
technical/biomed/1471-2148-3-3.txt:        We predicted RNA secondary structure using the Vienna
technical/biomed/1471-2148-3-3.txt:        RNA package, version 1.3.1, with the default set-up [ 31 ]
technical/biomed/1471-2148-3-3.txt:        . We used 100 randomly chosen RNA sequences of length 
technical/biomed/1471-2148-3-3.txt:        COW was responsible for the RNA folding simulations and
technical/biomed/1471-2148-3-4.txt:          in a large variety of alternatively spliced transcripts
technical/biomed/1471-2148-3-4.txt:          Alternative promoter usage among vertebrate runx
technical/biomed/1471-2148-3-4.txt:          two alternative promoters, P1 (distal) and P2 (proximal).
technical/biomed/1471-2148-3-4.txt:          clones or ESTs) in the database for alternative promoter
technical/biomed/1471-2148-3-4.txt:          suggesting that alternative promoters may have evolved in
technical/biomed/1471-2148-3-4.txt:          alternative promoter usage and splicing in the vertebrate
technical/biomed/1471-2148-3-4.txt:          these data that the usage of alternative promoters
technical/biomed/1471-2148-3-4.txt:          Takifugu utilize alternative
technical/biomed/1471-2148-3-4.txt:          promoters that give rise to similar alternative N-termini
technical/biomed/1471-2148-3-4.txt:        utilized two alternative promoters that generate
technical/biomed/1471-2148-3-4.txt:        alternative N-terminal sequences.
technical/biomed/1471-2148-3-7.txt:        Transcription of these genes is followed by RNA-splicing
technical/biomed/1471-2148-3-7.txt:        pre-mRNA in the nucleus and are removed by a
technical/biomed/1471-2148-3-7.txt:        alternate view, "introns-late", suggests that the last
technical/biomed/1471-2148-3-7.txt:        by autocatalytic RNAs (e.g., group II introns) or
technical/biomed/1471-2148-3-7.txt:        and large subunit (LSU) ribosomal (r)RNA genes [ 11 12 ] to
technical/biomed/1471-2148-3-7.txt:        in Euascomycetes rRNA and show that the introns interrupt
technical/biomed/1471-2148-3-7.txt:        - R in pre-mRNA genes [ 13 ] ) need not be perfectly
technical/biomed/1471-2148-3-7.txt:        the significant information is found in exons flanking rRNA
technical/biomed/1471-2148-3-7.txt:        of the SSU and LSU rRNA and that the group I introns are
technical/biomed/1471-2148-3-7.txt:        introns tend to occur in regions of the rRNA that are not
technical/biomed/1471-2148-3-7.txt:          Analysis of Euascomycetes rRNA Spliceosomal
technical/biomed/1471-2148-3-7.txt:          intron sites in the SSU and LSU rRNAs of Euascomycetes
technical/biomed/1471-2148-3-7.txt:          http://www.rna.icmb.utexas.edu/ANALYSIS/FUNGINT/(for
technical/biomed/1471-2148-3-7.txt:          SSU and LSU rRNA sequences in general. Previously, we
technical/biomed/1471-2148-3-7.txt:          Euascomycetes rRNA with the greatest support for the G
technical/biomed/1471-2148-3-7.txt:          new Euascomycetes SSU and LSU rRNA insertion sites in the
technical/biomed/1471-2148-3-7.txt:          Euascomycetes rRNAs.
technical/biomed/1471-2148-3-7.txt:          the Euascomycetes rRNA introns and exon flanking
technical/biomed/1471-2148-3-7.txt:          Euascomycetes rRNA exons encode significant information
technical/biomed/1471-2148-3-7.txt:          fungal SSU rRNAs and 880 fungal LSU rRNAs with all
technical/biomed/1471-2148-3-7.txt:          G-frequencies were calculated at each rRNA site and are
technical/biomed/1471-2148-3-7.txt:          [GenBank U53879]) and LSU (3554 nt [U53879]) rRNAs from
technical/biomed/1471-2148-3-7.txt:          association. The positions of rRNA spliceosomal intron
technical/biomed/1471-2148-3-7.txt:          SSU and LSU rRNA. The association is stronger in the 50
technical/biomed/1471-2148-3-7.txt:          in the 100 nt window, in particular for the SSU rRNA.
technical/biomed/1471-2148-3-7.txt:          25 intron sites using the fitted curve in the SSU rRNA is
technical/biomed/1471-2148-3-7.txt:          sites using the fitted curve in the LSU rRNA is 0.32. To
technical/biomed/1471-2148-3-7.txt:          sites and the G-contents in the LSU rRNA, we randomly
technical/biomed/1471-2148-3-7.txt:          selected 25 sites from the 3554 nt of rRNA and computed
technical/biomed/1471-2148-3-7.txt:          test for the SSU rRNA intron sites. In these 10,000
technical/biomed/1471-2148-3-7.txt:          SSU rRNA introns and G-rich regions apparent in Fig. 2.
technical/biomed/1471-2148-3-7.txt:          rRNA spliceosomal introns are fixed at the G - G or AG -
technical/biomed/1471-2148-3-7.txt:          Intron Positions on rRNA Conservation
technical/biomed/1471-2148-3-7.txt:          conserved regions in the rRNAs, we mapped the intron
technical/biomed/1471-2148-3-7.txt:          positions on SSU and LSU rRNA conservation diagrams of
technical/biomed/1471-2148-3-7.txt:          rRNA genes in the three phylogenetic domains (3Dom). This
technical/biomed/1471-2148-3-7.txt:          intron sites with rRNA sites that are 98-100% conserved
technical/biomed/1471-2148-3-7.txt:          within both 3Dom2O and 3Dom LSU rRNA analyses (see Table
technical/biomed/1471-2148-3-7.txt:          1). Only in the 3Dom analysis for SSU rRNA was the
technical/biomed/1471-2148-3-7.txt:          observed association of highly conserved rRNA and group I
technical/biomed/1471-2148-3-7.txt:          chance alone. For rRNA spliceosomal introns, however, the
technical/biomed/1471-2148-3-7.txt:          association of conserved rRNA and introns sites is less
technical/biomed/1471-2148-3-7.txt:          clear. Within the 3Dom2O analysis of SSU rRNA,
technical/biomed/1471-2148-3-7.txt:          within the 3Dom analysis of LSU rRNA no significant
technical/biomed/1471-2148-3-7.txt:          difference is found (p = 0.0969). The 3Dom2O LSU rRNA and
technical/biomed/1471-2148-3-7.txt:          3Dom SSU rRNA analyses both show an enrichment of
technical/biomed/1471-2148-3-7.txt:          fixed primarily in the most highly conserved rRNA sites
technical/biomed/1471-2148-3-7.txt:          highly conserved rRNA sites.
technical/biomed/1471-2148-3-7.txt:          Euascomycetes spliceosomal introns and rRNA conservation
technical/biomed/1471-2148-3-7.txt:          diagram generated from 1042 fungal SSU rRNA sequences
technical/biomed/1471-2148-3-7.txt:          SSU rRNA spliceosomal introns follow sites that are
technical/biomed/1471-2148-3-7.txt:          inspection of the 1800 nt alignment of SSU rRNAs and 3554
technical/biomed/1471-2148-3-7.txt:          nt of LSU rRNAs of all fungi, of fungi containing
technical/biomed/1471-2148-3-7.txt:          sites that are >95% conserved in all fungal SSU rRNAs,
technical/biomed/1471-2148-3-7.txt:          SSU rRNA 297 site (369 in the 
technical/biomed/1471-2148-3-7.txt:          towards a high frequency of Us. Analysis of the SSU rRNA
technical/biomed/1471-2148-3-7.txt:          Intron Positions on the rRNA Primary
technical/biomed/1471-2148-3-7.txt:          primary structures of E. coli SSU and LSU rRNA (Fig. 4A).
technical/biomed/1471-2148-3-7.txt:          ] . In our analyses, the rRNA genes were the sticks and
technical/biomed/1471-2148-3-7.txt:          intron distribution in both SSU and LSU rRNAs is
technical/biomed/1471-2148-3-7.txt:          significantly clustered (in particular, the LSU rRNA) and
technical/biomed/1471-2148-3-7.txt:          rRNA, suggesting that the introns in this gene are more
technical/biomed/1471-2148-3-7.txt:          strongly clustered than in the SSU rRNA (see Fig.
technical/biomed/1471-2148-3-7.txt:          The proto-splice site bounding rRNA introns
technical/biomed/1471-2148-3-7.txt:          spliceosomal introns in Euascomycetes rRNA shows
technical/biomed/1471-2148-3-7.txt:          Euascomycetes rRNAs in both intron-containing and
technical/biomed/1471-2148-3-7.txt:          S. cerevisiae pre-mRNA genes shows
technical/biomed/1471-2148-3-7.txt:          with present understanding of yeast pre-mRNA splicing.
technical/biomed/1471-2148-3-7.txt:          respectively. The finding of a similar motif in rRNA
technical/biomed/1471-2148-3-7.txt:          Euascomycetes rRNA but also may exist in pre-mRNA genes.
technical/biomed/1471-2148-3-7.txt:          conserved regions of Euascomycetes SSU rRNA, as evident
technical/biomed/1471-2148-3-7.txt:          positions in the 3Dom or 3Dom2O rRNA datasets (Table
technical/biomed/1471-2148-3-7.txt:          rRNA analyses suggest that G-rich regions in the
technical/biomed/1471-2148-3-7.txt:          rRNA spliceosomal introns map primarily to regions in the
technical/biomed/1471-2148-3-7.txt:          in rRNA, group I intron insertion sites show a stronger
technical/biomed/1471-2148-3-7.txt:          positive association with highly conserved rRNA regions
technical/biomed/1471-2148-3-7.txt:          (Fig. 3, Table 2), including those that bind tRNA [ 28 ]
technical/biomed/1471-2148-3-7.txt:          the rRNA primary structure (Fig. 4). This suggests that
technical/biomed/1471-2148-3-7.txt:          of rRNA sites at which group I introns can be fixed in
technical/biomed/1471-2148-3-7.txt:        Our findings provide concrete insights into rRNA intron
technical/biomed/1471-2148-3-7.txt:        spliceosomal and group I introns in their nuclear rRNA, are
technical/biomed/1471-2148-3-7.txt:          6 new sites that we have found in the LSU rRNA genes of 
technical/biomed/1471-2148-3-7.txt:          comparison between all rRNAs, the numbering of introns
technical/biomed/1471-2148-3-7.txt:          refer to their position relative to the LSU rRNA of 
technical/biomed/1471-2148-3-7.txt:          are also shown): SSU rRNA - 265 ( 
technical/biomed/1471-2148-3-7.txt:          LSU rRNA - 678 ( 
technical/biomed/1471-2148-3-7.txt:          the SSU rRNA gene of the distantly related stramenopile 
technical/biomed/1471-2148-3-7.txt:          fungal 674, 1057, 1514 SSU rRNA and 1093, 1098, and 1849
technical/biomed/1471-2148-3-7.txt:          LSU rRNA introns were not included in the information
technical/biomed/1471-2148-3-7.txt:          rRNA flanking regions, a number of corrections in the
technical/biomed/1471-2148-3-7.txt:          positions of the introns within the SSU rRNA (e.g., 1129
technical/biomed/1471-2148-3-7.txt:          http://www.rna.icmb.utexas.edu/ANALYSIS/FUNGINT/ [ 44 ] .
technical/biomed/1471-2148-3-7.txt:          This page includes detailed rRNA conservation and intron
technical/biomed/1471-2148-3-7.txt:          nucleotide frequency values, and the SSU and LSU rRNA
technical/biomed/1471-2148-3-7.txt:          Information Analysis of the rRNA Introns
technical/biomed/1471-2148-3-7.txt:          and downstream of the different rRNA spliceosomal intron
technical/biomed/1471-2148-3-7.txt:          frequencies over all sites for 80 Euascomycetes rRNA
technical/biomed/1471-2148-3-7.txt:          nucleotide frequencies of Euascomycetes rRNA and the
technical/biomed/1471-2148-3-7.txt:          rRNAs
technical/biomed/1471-2148-3-7.txt:          used for calculating the weights. For both the LSUrRNA
technical/biomed/1471-2148-3-7.txt:          and SSUrRNA sequence alignment data sets, we used a
technical/biomed/1471-2148-3-7.txt:          Positions of Introns Relative to Conserved rRNA
technical/biomed/1471-2148-3-7.txt:          exon sequences flanking all rRNA spliceosomal and group I
technical/biomed/1471-2148-3-7.txt:          same rRNA site were counted as separate intron
technical/biomed/1471-2148-3-7.txt:          certain rRNA sites (e.g., SSU 788, 1199, LSU 1949, 2500
technical/biomed/1471-2148-3-7.txt:          actual number of independent hits at rRNA sites is,
technical/biomed/1471-2148-3-7.txt:          and LSU rRNA sequences, respectively, from the three
technical/biomed/1471-2148-3-7.txt:          Escherichia coli rRNAs. The second
technical/biomed/1471-2148-3-7.txt:          SSU and LSU rRNA sequences, respectively, from the three
technical/biomed/1471-2148-3-7.txt:          E. coli rRNAs. These diagrams are
technical/biomed/1471-2148-3-7.txt:          LSU rRNA site using the 
technical/biomed/1471-2148-3-7.txt:          available fungal rRNAs (1434 SSU and 880 LSU sequences)
technical/biomed/1471-2148-3-7.txt:          rRNA Intron Distribution
technical/biomed/1471-2148-3-7.txt:          group II, and tRNA-like archaeal [ 50 ] introns were
technical/biomed/1471-2148-3-7.txt:          E. coli SSU and LSU rRNA. These
technical/biomed/1471-2148-3-7.txt:          hits at the same rRNA site, were then studied to
technical/biomed/1471-2148-3-7.txt:          sticks of length 1542 nt (SSU rRNA) or 2904 nt (LSU rRNA)
technical/biomed/1471-2148-3-7.txt:          introns in SSU rRNA. For the LSU rRNA, the stick was
technical/biomed/1471-2148-3-7.txt:          introns. The paucity of rRNA group II introns (3 and 8
technical/biomed/1471-2148-3-7.txt:          introns in the SSU and LSU rRNA, respectively) and
technical/biomed/1471-2148-3-7.txt:          rRNA, respectively) did not allow their individual
technical/biomed/1471-2148-3-7.txt:        database and the rRNA-intron database, generated the rRNA
technical/biomed/1471-2148-3-7.txt:        produced the 3Dom and 3Dom2O rRNA conservation data. DB
technical/biomed/1471-2156-2-12.txt:          allows detection of diurnal differences
technical/biomed/1471-2156-2-12.txt:          reported to mask diurnal variation in IOP [ 21 ] ), we
technical/biomed/1471-2156-2-12.txt:          Diurnal variation in IOP is common in humans and
technical/biomed/1471-2156-2-12.txt:          underlying the diurnal rhythm are not defined but
technical/biomed/1471-2156-2-12.txt:          humor drainage may also contribute to diurnal differences
technical/biomed/1471-2156-2-12.txt:          are needed to define the characteristics of the diurnal
technical/biomed/1471-2156-2-12.txt:          diurnal rhythms of IOP and that may be relevant to
technical/biomed/1471-2156-2-12.txt:          diurnal pattern of IOP changes. In agreement with this
technical/biomed/1471-2156-2-12.txt:          diurnal rhythms compared to pigmented mice [ 75 ] .
technical/biomed/1471-2156-2-12.txt:          diurnal rhythm of IOP or alters it in different ways
technical/biomed/1471-2156-2-12.txt:          during the dark. Diurnal rhythms are known to depend on
technical/biomed/1471-2156-2-12.txt:          diurnal fluctuation of IOP and results in constantly
technical/biomed/1471-2156-2-12.txt:          the nature of the diurnal rhythm of IOP in the albino B6
technical/biomed/1471-2156-2-12.txt:        between inbred mouse strains and a diurnal rhythm of IOP
technical/biomed/1471-2156-2-17.txt:        chemical cleavage of mismatch [ 20 ] , and RNase cleavage [
technical/biomed/1471-2156-2-17.txt:        RNA and protein analysis. Fortunately, there are other
technical/biomed/1471-2156-2-17.txt:        RNA and tissue from patients for whom all 86 fragments were
technical/biomed/1471-2156-2-17.txt:          Starting with known mRNA sequence (accession # Ml 8533),
technical/biomed/1471-2156-2-18.txt:          photoreceptor nuclei extended externally and were in
technical/biomed/1471-2156-2-18.txt:          defects. Alternatively, BMP4 may direct expression of
technical/biomed/1471-2156-2-3.txt:        bilateral ptosis and external ophthalmoplegia, with the
technical/biomed/1471-2156-2-5.txt:        encoding products involved in the metabolism of alternative
technical/biomed/1471-2156-2-5.txt:          SUC2 mRNA levels. Under repressing
technical/biomed/1471-2156-2-5.txt:          SUC2 mRNA was increased by
technical/biomed/1471-2156-2-5.txt:          SUC2 mRNA levels while a 
technical/biomed/1471-2156-2-5.txt:          SUC2 mRNA levels in double and
technical/biomed/1471-2156-2-5.txt:        MIG1 mRNA levels are unaffected by an
technical/biomed/1471-2156-2-5.txt:          GAL 1-10 mRNA of a 
technical/biomed/1471-2156-2-5.txt:          to mid-log phase (1-2 × l0 7cells/ml), and total RNA was
technical/biomed/1471-2156-2-5.txt:          prepared as previously described [ 27, 30]. RNA was
technical/biomed/1471-2156-2-8.txt:        method [ 13]. Both desmuslin mRNA and protein are expressed
technical/biomed/1471-2156-3-11.txt:        Tnfrh1 mRNA and discuss the
technical/biomed/1471-2156-3-11.txt:        allelic bias in mRNA expression in the placenta, but not in
technical/biomed/1471-2156-3-11.txt:        maternal cells, it is not known with certainty whether 
technical/biomed/1471-2156-3-11.txt:        of human tissue RNAs with the 
technical/biomed/1471-2156-3-11.txt:        Tnfrh1 mRNA transcripts in nearly all
technical/biomed/1471-2156-3-11.txt:        Tnfrh1 mRNA in whole placenta was
technical/biomed/1471-2156-3-11.txt:        spongiotrophoblast and giant cell layers) and a maternal
technical/biomed/1471-2156-3-11.txt:        component (the decidua basalis, as well as maternal blood
technical/biomed/1471-2156-3-11.txt:        half, enriched in deep fetal and superficial maternal
technical/biomed/1471-2156-3-11.txt:        components, and extracted RNA from each half. This
technical/biomed/1471-2156-3-11.txt:        blot with a probe for Ipl mRNA (Fig. 4) validated this
technical/biomed/1471-2156-3-11.txt:        signal only in RNA from the superficial halves. The same
technical/biomed/1471-2156-3-11.txt:        Tnfrh1 mRNA is restricted to layers
technical/biomed/1471-2156-3-11.txt:        component or, alternatively, in the maternal component of
technical/biomed/1471-2156-3-11.txt:        Tnfrh1 only at the fetal-maternal
technical/biomed/1471-2156-3-11.txt:        distinguish maternal from paternal alleles in interspecific
technical/biomed/1471-2156-3-11.txt:        but partial maternal bias in the fetal liver, and a nearly
technical/biomed/1471-2156-3-11.txt:        complete bias towards the maternal allele in placenta (Fig.
technical/biomed/1471-2156-3-11.txt:        from maternal cells, not imprinting.
technical/biomed/1471-2156-3-11.txt:        these crosses, and showed a maternal expression bias, but
technical/biomed/1471-2156-3-11.txt:        Tnfrh1 mRNA was superimposed on a
technical/biomed/1471-2156-3-11.txt:        alternative trivial explanation for the baseline bias,
technical/biomed/1471-2156-3-11.txt:        towards expression of the maternal allele in several fetal
technical/biomed/1471-2156-3-11.txt:        from maternal cells (Fig. 8). Direct sequencing of cDNAs
technical/biomed/1471-2156-3-11.txt:        tissues, and a strong maternal bias in the placenta (Fig.
technical/biomed/1471-2156-3-11.txt:        Obph1 , or alternatively indicate
technical/biomed/1471-2156-3-11.txt:        expression from maternal cells.
technical/biomed/1471-2156-3-11.txt:        Tnfrh1 mRNA in cells at the
technical/biomed/1471-2156-3-11.txt:        fetal-maternal boundary, highlights 
technical/biomed/1471-2156-3-11.txt:        between fetal and maternal alleles. Anecdotal examples,
technical/biomed/1471-2156-3-11.txt:        Kcnq1ot1 non-translated RNA. This
technical/biomed/1471-2156-3-11.txt:        relatively repressed on the paternal allele and active on
technical/biomed/1471-2156-3-11.txt:        the maternal allele. The simplest explanation for our
technical/biomed/1471-2156-3-11.txt:        hyper-expression from the maternal allele, is that the
technical/biomed/1471-2156-3-11.txt:          was used to prepare total RNA from fetal and adult mouse
technical/biomed/1471-2156-3-11.txt:          total RNA using the Superscript Preamplification System
technical/biomed/1471-2156-3-11.txt:          maternal and fetal portions was done as described
technical/biomed/1471-2156-3-11.txt:          previously [ 6 ] . RNA was extracted using Trizol, and
technical/biomed/1471-2156-3-11.txt:          6-10 micrograms of total RNA was electrophoresed and
technical/biomed/1471-2156-3-11.txt:          total RNA from panels of mouse tissues were purchased
technical/biomed/1471-2156-3-11.txt:          RNA in situ hybridization
technical/biomed/1471-2156-3-11.txt:          RNA Labeling Kit, Roche), followed by alkaline
technical/biomed/1471-2156-3-16.txt:          excision (Internal Eliminated Sequences or IESs [ 23 ] ).
technical/biomed/1471-2156-3-16.txt:          of alternative processing families of MAC chromosomes. We
technical/biomed/1471-2156-3-16.txt:          have studied alternative processing of the 81 MAC locus,
technical/biomed/1471-2156-3-16.txt:          oligomers that pair with telomerase template RNA at their
technical/biomed/1471-2156-3-16.txt:          telomere repeats internal to the 3' primer end [ 43 ] .
technical/biomed/1471-2156-3-16.txt:          RNA [ 46 ] . Thus, while it may serve a 3' editing
technical/biomed/1471-2156-3-16.txt:          Alternative processing of the 81-MAC locus
technical/biomed/1471-2156-3-16.txt:          advantage to such couplings, but the alternative
technical/biomed/1471-2156-3-16.txt:          alternative breakage patterns of polytene chromatids of
technical/biomed/1471-2156-3-16.txt:          chromatid, alternative breakage at the regions bounding
technical/biomed/1471-2156-3-16.txt:          and that erosion alternatively stops at the arm-distal
technical/biomed/1471-2156-3-16.txt:          Alternatively these chromosomes may be able express
technical/biomed/1471-2156-3-16.txt:          promoter element resides internal to this region: we have
technical/biomed/1471-2156-3-16.txt:        By trying to explain why alternatively- or
technical/biomed/1471-2156-3-16.txt:        consider alternative explanations. First, we assume the
technical/biomed/1471-2156-3-16.txt:        previous model for alternative processing, that the CR
technical/biomed/1471-2156-3-16.txt:        Two further, alternative, mechanisms are offered to
technical/biomed/1471-2156-3-16.txt:        internal segments that pair with the RNA template
technical/biomed/1471-2156-3-16.txt:        Oxytricha , other alternatively
technical/biomed/1471-2156-3-17.txt:          be impaired in these mutants. Alternatively, these
technical/biomed/1471-2156-3-17.txt:        Alternatively, the extensive ER proliferations that result
technical/biomed/1471-2156-3-3.txt:          inherits her unaffected paternal grandfather's 
technical/biomed/1471-2156-3-4.txt:          alteration of rDNA morphology, and reduction of rRNA
technical/biomed/1471-2156-3-4.txt:          SUP11 suppressor transfer RNA gene
technical/biomed/1471-2156-3-4.txt:          mRNA-binding protein Npl3 [ 36 37 ] . Interestingly, 
technical/biomed/1471-2156-3-4.txt:          localization of mRNA binding proteins Nab2 and Hrp1 to
technical/biomed/1471-2156-3-4.txt:          alternative possibility is that they sequester an
technical/biomed/1471-2156-4-10.txt:        require an alternative correction in order to achieve
technical/biomed/1471-2156-4-10.txt:        "internal" marker of the pair is giving signal while the
technical/biomed/1471-2156-4-10.txt:          the alternate parameterization in order to directly
technical/biomed/1471-2156-4-10.txt:          comparable in terms of power. We use the alternative
technical/biomed/1471-2156-4-5.txt:          no discernable difference in the relative mobility
technical/biomed/1471-2156-4-5.txt:        discernable phenotype [ 42 ] . Furthermore, a human
technical/biomed/1471-2156-4-5.txt:        glaucoma [ 44 ] or other discernable phenotypes. This
technical/biomed/1471-2156-4-5.txt:          Total RNA was extracted from rabbit eye and heart
technical/biomed/1471-2156-4-5.txt:          two micrograms rabbit total RNA was converted into first
technical/biomed/1471-2156-4-5.txt:          Transport, Department of Internal Medicine, University of
technical/biomed/1471-2156-4-5.txt:          with a 3' PCR primer (P237) covering the internal Bsu36I
technical/biomed/1471-2156-4-5.txt:          supernatant was determined with Coomassie Plus Protein
technical/biomed/1471-2156-4-6.txt:          Alternative explanations exist. For example, the
technical/biomed/1471-2156-4-6.txt:          checkpoint response. Alternatively, some structure that
technical/biomed/1471-2156-4-6.txt:          mounted on coverslips. Alternatively, cells were
technical/biomed/1471-2156-4-9.txt:          7D,7E,7F). No accumulation of E2F mRNA can be seen in 
technical/biomed/1471-2156-4-9.txt:        because maternal contributions of Cul1 are so large that
technical/biomed/1471-2156-4-9.txt:          e 4-1) and Bernadette
technical/biomed/1471-2156-4-9.txt:          mRNA was detected by in situ hybridisation using an
technical/biomed/1471-2164-2-1.txt:        alternatively spliced exons, and the genomic organization
technical/biomed/1471-2164-2-1.txt:          at least 33 exons, several of which are alternatively
technical/biomed/1471-2164-2-1.txt:          pseudogene in intron 7, a tRNA-derived repeat in intron
technical/biomed/1471-2164-2-1.txt:          identical. Notably, the alternatively spliced exons 14,
technical/biomed/1471-2164-2-1.txt:            exception of the second internal intron, which is in
technical/biomed/1471-2164-2-1.txt:            internally located than that of RPTPρ, close to the
technical/biomed/1471-2164-2-1.txt:            are in phase 1; the intron internal to the third repeat
technical/biomed/1471-2164-2-1.txt:            is in phase 0, and introns internal to the fourth
technical/biomed/1471-2164-2-1.txt:          Alternative splicing of mouse and human RPTPρ
technical/biomed/1471-2164-2-1.txt:          alternatively spliced. In addition, the presence of a
technical/biomed/1471-2164-2-1.txt:          possibility of an alternatively spliced exon between
technical/biomed/1471-2164-2-1.txt:          for the presence of alternatively spliced regions. PCR
technical/biomed/1471-2164-2-1.txt:          alternatively spliced region at 2177 to 2233 nt. This
technical/biomed/1471-2164-2-1.txt:          mouse brain mRNA. We have obtained similar results for
technical/biomed/1471-2164-2-1.txt:          indicates an additional 10 AA alternatively spliced
technical/biomed/1471-2164-2-1.txt:          exon 16 sequence (data not shown). A third alternatively
technical/biomed/1471-2164-2-1.txt:          alternatively spliced region 20 AA in length. In each
technical/biomed/1471-2164-2-1.txt:          fourth alternatively spliced region located 3' to exon
technical/biomed/1471-2164-2-1.txt:          RPTPρ and is unlikely to represent an alternatively
technical/biomed/1471-2164-2-1.txt:          products encoded by the alternatively spliced exons do
technical/biomed/1471-2164-2-1.txt:          likely to be present. Alternatively spliced isoforms of
technical/biomed/1471-2164-2-1.txt:          system, and there is evidence that alternatively spliced
technical/biomed/1471-2164-2-1.txt:        genomic structure and alternative splicing of the mouse and
technical/biomed/1471-2164-2-1.txt:        in type II phosphatases. At least two alternatively spliced
technical/biomed/1471-2164-2-1.txt:        An additional alternatively spliced exon precedes the
technical/biomed/1471-2164-2-1.txt:          RNA was isolated (RNAzol, Tel-Test, Friendswood, TX) from
technical/biomed/1471-2164-2-1.txt:          Alternative splicing
technical/biomed/1471-2164-2-1.txt:          First strand cDNA was made from total RNA from human
technical/biomed/1471-2164-2-1.txt:        AS, alternative splice site; BAC, bacterial artificial
technical/biomed/1471-2164-2-2.txt:        located in the C-terminus or internally. Motility assays
technical/biomed/1471-2164-2-2.txt:          11 have internal motors and five have N-terminal motors.
technical/biomed/1471-2164-2-2.txt:          The internal kinesins have a motor domain that is closer
technical/biomed/1471-2164-2-2.txt:          called internal depending on the parameters used to
technical/biomed/1471-2164-2-2.txt:          define an internal motor. Kat D, At30B22.20 and
technical/biomed/1471-2164-2-2.txt:          AtT9N14.6) having an internal motor which fall into the
technical/biomed/1471-2164-2-2.txt:          N-terminal or internal but are most closely related to
technical/biomed/1471-2164-2-2.txt:          subfamily. Two internal motor Arabidopsis kinesins group
technical/biomed/1471-2164-2-2.txt:          with the MCAK/KIF2 subfamily (also called the internal
technical/biomed/1471-2164-2-2.txt:          cell transport of macromolecules such as RNA through
technical/biomed/1471-2164-2-4.txt:          P1s have an internal DABCYL quencher. Amplifluor primers
technical/biomed/1471-2164-2-4.txt:          internal nonfluorescent quencher DABCYL.
technical/biomed/1471-2164-2-6.txt:        DAZ gene family encodes RNA binding
technical/biomed/1471-2164-2-6.txt:        suggest a role for the DAZ family in the regulation of mRNA
technical/biomed/1471-2164-2-6.txt:        Cdc25C mRNA [ 13 ] .
technical/biomed/1471-2164-2-6.txt:        testes. It encodes a protein with two RNA binding domains
technical/biomed/1471-2164-2-6.txt:        in vitro. It also bound to RNA
technical/biomed/1471-2164-2-6.txt:        not involved directly in mRNA translation.
technical/biomed/1471-2164-2-6.txt:          The DAZAP1 protein contains two RNA-binding domains
technical/biomed/1471-2164-2-6.txt:          Xenopus Prrp (for proline-rich RNA
technical/biomed/1471-2164-2-6.txt:          Prrp. These proteins may therefore have a similar RNA
technical/biomed/1471-2164-2-6.txt:          Dazap1 mRNA was already present in
technical/biomed/1471-2164-2-6.txt:          Dazl1 mRNA (Figure 3). The
technical/biomed/1471-2164-2-6.txt:        RNA-binding proteins have been found to participate in
technical/biomed/1471-2164-2-6.txt:        many cellular functions, including RNA transcription,
technical/biomed/1471-2164-2-6.txt:        pre-mRNA processing, mRNA transport, localization,
technical/biomed/1471-2164-2-6.txt:        family in the regulation of mRNA translation is supported
technical/biomed/1471-2164-2-6.txt:        different from two RNA-binding proteins, FXR1P and FXR2P,
technical/biomed/1471-2164-2-6.txt:        polysomal-associated RNA-binding protein, the fragile X
technical/biomed/1471-2164-2-6.txt:        transport of the mRNAs of the target genes of DAZL.
technical/biomed/1471-2164-2-6.txt:        Alternatively, DAZL and DAZAP1 may act antagonistically to
technical/biomed/1471-2164-2-6.txt:        RNA-binding proteins is exemplified by the neuron-specific
technical/biomed/1471-2164-2-6.txt:        nuclear RNA-binding protein, Nova-1. Nova-1 regulates the
technical/biomed/1471-2164-2-6.txt:        alternative splicing of the pre-mRNAs encoding neuronal
technical/biomed/1471-2164-2-6.txt:        antagonized by a second RNA-binding protein, brPTB
technical/biomed/1471-2164-2-6.txt:        DAZAP1 was shown to bind RNA homopolymers 
technical/biomed/1471-2164-2-6.txt:        Xenopus Vg1 mRNA. This Vg1
technical/biomed/1471-2164-2-6.txt:        Vg1 mRNA to the vegetal cortex of
technical/biomed/1471-2164-2-6.txt:        Vg1 mRNA to the vegetal cortex. The 
technical/biomed/1471-2164-2-6.txt:        Vg1 RNA encodes a member of the
technical/biomed/1471-2164-2-6.txt:        suggests that these proteins may bind to similar RNA
technical/biomed/1471-2164-2-6.txt:        RNA sequence within VLE that binds Prrp, and possibly
technical/biomed/1471-2164-2-6.txt:        DAZAP1 is an evolutionarily conserved RNA-binding
technical/biomed/1471-2164-2-6.txt:        mRNA translation.
technical/biomed/1471-2164-2-6.txt:          cDNA synthesis from mouse testis RNA, and prdap37
technical/biomed/1471-2164-2-6.txt:          2 , 0.3% NP-40, 40 U/ml of Rnasin
technical/biomed/1471-2164-2-6.txt:          supernatant were applied to 15-45% sucrose gradients in
technical/biomed/1471-2164-2-7.txt:        produces several alternatively spliced transcripts using
technical/biomed/1471-2164-2-7.txt:          this intergenic product by RT-PCR on human heart RNA.
technical/biomed/1471-2164-2-7.txt:          uses an internal consensus cryptic splice site. Using the
technical/biomed/1471-2164-2-7.txt:          searched the EST database for other alternative and
technical/biomed/1471-2164-2-7.txt:          to Genbank sequence D43642) to position 1107 (internal to
technical/biomed/1471-2164-2-7.txt:          in exon 2 at which it splices internal to exon 6 at
technical/biomed/1471-2164-2-7.txt:        RT-PCR and some by RNase protection assays. Thus, further
technical/biomed/1471-2164-2-7.txt:        play an important biological role either at the RNA or
technical/biomed/1471-2164-2-7.txt:        alternative or intergenic transcripts. The genomic
technical/biomed/1471-2164-2-7.txt:        alternative transcripts could be produced from the use of
technical/biomed/1471-2164-2-7.txt:          Exceptions were the RNA source, human heart poly (A)+
technical/biomed/1471-2164-2-7.txt:          RNA, (Clontech, 6533-1), primers were YL1-35,
technical/biomed/1471-2164-2-8.txt:        proteins with rRNA to form ribosomes, is a reaction that
technical/biomed/1471-2164-2-8.txt:        ribonuclease activity (for processing preribosomal RNA) [
technical/biomed/1471-2164-2-8.txt:          Npm3 RNA levels. Nevertheless, the
technical/biomed/1471-2164-2-8.txt:          NPM3 RNA are consistent with other
technical/biomed/1471-2164-2-8.txt:          Human tissue northern blots of poly(A) +RNA were
technical/biomed/1471-2164-2-8.txt:          rpm, Eppendorf 5415C, 4°C). The resulting supernatant was
technical/biomed/1471-2164-2-8.txt:          supernatant was the nuclear extract.
technical/biomed/1471-2164-2-9.txt:        component of the RNA polII holoenzyme [ 8 ] . yCCR4 was
technical/biomed/1471-2164-2-9.txt:        in a RNA polII complex distinct from the SRBP-containing
technical/biomed/1471-2164-2-9.txt:        association with yPOP2, of the major yeast cytoplasmic mRNA
technical/biomed/1471-2164-2-9.txt:        poly(A)-specific mRNA degradation [ 14 15 ] . yCCR4 might
technical/biomed/1471-2164-2-9.txt:          reverse-transcribed RNAs using appropriate primers
technical/biomed/1471-2164-2-9.txt:          both transcription regulation and mRNA deadenylase
technical/biomed/1471-2164-2-9.txt:          of the major yeast cytoplasmic mRNA deadenylase complex,
technical/biomed/1471-2164-2-9.txt:          and to be required for efficient poly(A)-specific mRNA
technical/biomed/1471-2164-2-9.txt:          for RNA and/or poly (A) tail). Along this line,
technical/biomed/1471-2164-2-9.txt:          RNaseD family of exonucleases [ 34 ] . The present
technical/biomed/1471-2164-2-9.txt:          (RT)-PCR reaction, using total RNAs extracted from CBA
technical/biomed/1471-2164-2-9.txt:          RNAs was reverse transcribed from random (dN)6 primers in
technical/biomed/1471-2164-2-9.txt:          RNAsin, 50 mM Tris-HCl, 75 mM KCl, 5 mM MgCl 
technical/biomed/1471-2164-2-9.txt:          internal control for transfection efficiency. The amount
technical/biomed/1471-2164-3-1.txt:        the RING finger protein topors [ 6 ] , the RNA splicing
technical/biomed/1471-2164-3-1.txt:        cycle regulatory protein ARF [ 9 ] , RNA pol II complex [
technical/biomed/1471-2164-3-1.txt:          Characterization of BTBD1 and BTBD2 mRNA
technical/biomed/1471-2164-3-1.txt:          mRNA, RT-PCR followed by nested PCR was used. Two
technical/biomed/1471-2164-3-1.txt:          predicted from the mRNA template resulted (Fig. 1B). If
technical/biomed/1471-2164-3-1.txt:          the predicted mRNA (Fig. 1A). The cDNA starting at the
technical/biomed/1471-2164-3-1.txt:          distribution and sizes of the mRNA encoding BTBD1 and
technical/biomed/1471-2164-3-1.txt:          BTBD2 (Fig. 2). Poly (A)+RNA from human tissues (2
technical/biomed/1471-2164-3-1.txt:          mRNA was detected in all the tissues tested. BTBD1 mRNA
technical/biomed/1471-2164-3-1.txt:        in the BTBD2 gene for their presence on the mRNA. RT-PCR
technical/biomed/1471-2164-3-1.txt:        BTBD2 mRNA and that it shares predicted polypeptide
technical/biomed/1471-2164-3-1.txt:        • BTBD1 and BTBD2 mRNA were detected in all human
technical/biomed/1471-2164-3-1.txt:        tissues tested. BTBD1 mRNA was highly expressed in testes,
technical/biomed/1471-2164-3-1.txt:        in skeletal muscle. Only a single mRNA species was present
technical/biomed/1471-2164-3-1.txt:          (A) + RNA (Human Multiple Tissue Northern Blot IV and
technical/biomed/1471-2164-3-1.txt:          the cofactor to enable it to use mRNA as a template. None
technical/biomed/1471-2164-3-1.txt:          To determine whether the mRNA contained the BTBD2 gene
technical/biomed/1471-2164-3-1.txt:          see below). PolyA+ RNA was reverse transcribed using 
technical/biomed/1471-2164-3-13.txt:        proteins and small nuclear RNAs (snRNAs) [ 1 2 3 ] . RNA
technical/biomed/1471-2164-3-13.txt:        phosphate at the 3' splice site, yielding a ligated mRNA
technical/biomed/1471-2164-3-13.txt:        Alternative splicing might play a role in this apparent
technical/biomed/1471-2164-3-13.txt:        discrepancy. Alternative splicing is an important mechanism
technical/biomed/1471-2164-3-13.txt:        understand the mechanism of alternative splice site
technical/biomed/1471-2164-3-13.txt:        and encodes approximately 13 kb mRNA containing 60 exons.
technical/biomed/1471-2164-3-13.txt:        alternative splicing and these isoforms were also detected
technical/biomed/1471-2164-3-13.txt:        10 ] . Four additional alternative transcripts were
technical/biomed/1471-2164-3-13.txt:        are more abundant when RNA is analysed from aged blood or
technical/biomed/1471-2164-3-13.txt:        or alternative splicing in 
technical/biomed/1471-2164-3-13.txt:          the RNA immediately after blood drawing, allowing to
technical/biomed/1471-2164-3-13.txt:          that play a role in alternative splice regulation could
technical/biomed/1471-2164-3-13.txt:          alternative exons and of all deletions and insertions
technical/biomed/1471-2164-3-13.txt:          by RNA-RNA interactions between these sequences and snRNA
technical/biomed/1471-2164-3-13.txt:          a fraction of the mRNA (bold in Table 1), including the
technical/biomed/1471-2164-3-13.txt:          alternative exons 9br, 23a and 48a, and the mean values
technical/biomed/1471-2164-3-13.txt:          full intron splicing of an alternative intron, than
technical/biomed/1471-2164-3-13.txt:          CFTR mRNA transcripts [ 23 ] . Our
technical/biomed/1471-2164-3-13.txt:          branch point in alternative splicing [ 24 25 ] . The
technical/biomed/1471-2164-3-13.txt:          and the base pairing of the branch point with the U2RNA
technical/biomed/1471-2164-3-13.txt:          free-energy structures of the pre-mRNA at the donor site
technical/biomed/1471-2164-3-13.txt:          alternative structure is too different from the lowest
technical/biomed/1471-2164-3-13.txt:          be skipped in a significant part of the mRNA in several
technical/biomed/1471-2164-3-13.txt:          RNA-protein complexes limit the prediction capacities of
technical/biomed/1471-2164-3-13.txt:          the U1snRNP is mainly directed by RNA-RNA base pairing [
technical/biomed/1471-2164-3-13.txt:        several alternative transcripts have been found previously
technical/biomed/1471-2164-3-13.txt:        alternative splice sites depends on the relative quality of
technical/biomed/1471-2164-3-13.txt:        relaxation of the RNA splicing, is currently unknown.
technical/biomed/1471-2164-3-13.txt:        Although the RNA was extracted immediately after blood
technical/biomed/1471-2164-3-13.txt:          RNA isolation and cDNA preparation
technical/biomed/1471-2164-3-13.txt:          RNA was isolated from fresh blood leukocytes from two
technical/biomed/1471-2164-3-13.txt:          according to the manufacturer's instructions. RNA
technical/biomed/1471-2164-3-13.txt:          factors. Total RNA (2 μg) was reverse transcribed using
technical/biomed/1471-2164-3-13.txt:          • Sequence changes are all described at the RNA level,
technical/biomed/1471-2164-3-13.txt:          http://bioinfo.math.rpi.edu/~mfold/rna/form1.cgiwas used
technical/biomed/1471-2164-3-13.txt:          to predict the RNA secondary structure and to calculate
technical/biomed/1471-2164-3-13.txt:          100 nucleotides after transcription where the pre-mRNA is
technical/biomed/1471-2164-3-13.txt:          nascent RNA emerges.
technical/biomed/1471-2164-3-15.txt:          external appearance [ 5 14 15 ] . This strain is
technical/biomed/1471-2164-3-15.txt:          in situ hybridization with PEVE RNA
technical/biomed/1471-2164-3-15.txt:          RNA and ss-DNA. If so, there is one polarity of the ss
technical/biomed/1471-2164-3-15.txt:          RNA and ss-DNA.
technical/biomed/1471-2164-3-15.txt:          Biophysics, Pushino). Genomic DNA and total RNA from
technical/biomed/1471-2164-3-15.txt:          DNA and RNA preparation, first-strand cDNA
technical/biomed/1471-2164-3-15.txt:          RNase A for RNA degradation. Total RNA was purified by
technical/biomed/1471-2164-3-15.txt:          performed at neutral pH. RNA was precipitated with 96%
technical/biomed/1471-2164-3-15.txt:          lithium chloride. RNA was further treated with bovine
technical/biomed/1471-2164-3-15.txt:          the supernatant into another tube, PEVE DNA was
technical/biomed/1471-2164-3-15.txt:          Total RNA from planarian (10 μg per line) were
technical/biomed/1471-2164-3-15.txt:          probes. Gel-electrophoresis and transfer of RNA to the
technical/biomed/1471-2164-3-15.txt:          negative control, the RNA sample was treated with RNase A
technical/biomed/1471-2164-3-15.txt:          templates to produce DIG-labeled RNA probes for 
technical/biomed/1471-2164-3-16.txt:        probes are deposited in an orderly manner, RNA is first
technical/biomed/1471-2164-3-16.txt:        isolated from the biological material under study. The mRNA
technical/biomed/1471-2164-3-16.txt:        (1-5% of total RNA) is reverse transcribed to cDNA, during
technical/biomed/1471-2164-3-16.txt:        require more than 50 μg of total RNA for consistent
technical/biomed/1471-2164-3-16.txt:        tumor tissues are often needed to obtain this much RNA,
technical/biomed/1471-2164-3-16.txt:        that requires less RNA. Several molecular biology
technical/biomed/1471-2164-3-16.txt:          the PCR step (1 or 3 cycles) before aRNA amplification
technical/biomed/1471-2164-3-16.txt:        total RNA.
technical/biomed/1471-2164-3-16.txt:          RNA amplification and target labeling
technical/biomed/1471-2164-3-16.txt:          (Gibco-BRL, Gaithersburg, MD). Total RNA was isolated
technical/biomed/1471-2164-3-16.txt:          containing 1 μg total RNA, 1 μg oligdT25- T7
technical/biomed/1471-2164-3-16.txt:          at 42°C for 2 hours. Then 1 u RNase H (Roche, Branchburg,
technical/biomed/1471-2164-3-16.txt:          Valencia, CA). The anti-sense RNA (aRNA) amplification by
technical/biomed/1471-2164-3-16.txt:          manufacturer's instructions. After RNA amplification, the
technical/biomed/1471-2164-3-16.txt:          with 4 units of RNase-free DNase I (Ambion) at 37°C for
technical/biomed/1471-2164-3-16.txt:          15 min. aRNA purification was achieved by Rneasy Mini Kit
technical/biomed/1471-2164-3-16.txt:          (Qiagen). The purified 5 μg aRNA was labeled with Cy3 or
technical/biomed/1471-2164-3-16.txt:          yeast tRNA (Gibco-BRL), 10 μg of human Cot I DNA
technical/biomed/1471-2164-3-16.txt:          (Amersham). For northern blotting, 20 μg of total RNA was
technical/biomed/1471-2164-3-18.txt:          alternative model for midasin structure in which the
technical/biomed/1471-2164-3-18.txt:          supernatant fraction upon centrifugation at 2,000 × g for
technical/biomed/1471-2164-3-18.txt:          supernatant fraction after centrifugation at 150,000 × g
technical/biomed/1471-2164-3-18.txt:        YML029p and HRT1p, that function principally in RNA
technical/biomed/1471-2164-3-18.txt:        family [ 53 ] . However, there are alternative
technical/biomed/1471-2164-3-18.txt:          resultant supernatant was then centrifuged for 20 min at
technical/biomed/1471-2164-3-19.txt:        in RNA isolation, purity, labeling and detection [ 6 9 10
technical/biomed/1471-2164-3-19.txt:        significant in terms of reflecting actual changes in mRNA
technical/biomed/1471-2164-3-19.txt:        Positive controls may be spiked RNAs from non-homologous
technical/biomed/1471-2164-3-19.txt:        M . (ii) Alternatively, if the positive
technical/biomed/1471-2164-3-19.txt:          tips (CMPB2) are purchased from Telechem International
technical/biomed/1471-2164-3-19.txt:          described in (14) Briefly, 2 μg mRNA spiked with 
technical/biomed/1471-2164-3-19.txt:          B. subtilis RNA cocktail (described
technical/biomed/1471-2164-3-19.txt:          below) at indicated amounts. mRNA was added to 4 μg of
technical/biomed/1471-2164-3-19.txt:          ice. A reaction mixture consisting of mRNA, first-strand
technical/biomed/1471-2164-3-19.txt:          42°C for 2 hours. The cDNA:mRNA hybrid was isolated on a
technical/biomed/1471-2164-3-19.txt:          Generation of B. subtilisRNA cocktail
technical/biomed/1471-2164-3-19.txt:          pglbs-thr, pglbs-dap). Polyadenylated control RNA was
technical/biomed/1471-2164-3-19.txt:          contained equal proportions (wt/wt) of each RNA species
technical/biomed/1471-2164-3-19.txt:          and was spiked into cDNA reactions at 125 pg/2 ug mRNA in
technical/biomed/1471-2164-3-19.txt:            j ). Alternatively, each observed
technical/biomed/1471-2164-3-24.txt:          between alternative marker orders. We merged the G3 and
technical/biomed/1471-2164-3-24.txt:          HTGS data, clone walking using RNA probes from end clones
technical/biomed/1471-2164-3-24.txt:          run-off transcription. Since RNA probes were directly
technical/biomed/1471-2164-3-24.txt:          with pools of RNA probes prepared from the ends of BAC
technical/biomed/1471-2164-3-24.txt:          RNA kit (Ambion).
technical/biomed/1471-2164-3-24.txt:          with individual RNA probes from the pools above. All
technical/biomed/1471-2164-3-24.txt:          Preparation of RNA probes from the ends of BAC
technical/biomed/1471-2164-3-24.txt:          Hin d III. RNA probes were
technical/biomed/1471-2164-3-24.txt:          transcription using the Strip-EZ RNA kit (Ambion) and
technical/biomed/1471-2164-3-24.txt:          RNase-free Sephadex G-50 (Sigma) spin columns.
technical/biomed/1471-2164-3-26.txt:        The enzymatic cleavage of double-stranded(ds) RNA
technical/biomed/1471-2164-3-26.txt:        of many eukaryotic and prokaryotic RNAs. Members of the
technical/biomed/1471-2164-3-26.txt:        the primary agents of dsRNA cleavage [ 2 ] . RNase III
technical/biomed/1471-2164-3-26.txt:        Escherichia coli RNase III [ 3 ] as
technical/biomed/1471-2164-3-26.txt:        E. coli RNase III is active as a
technical/biomed/1471-2164-3-26.txt:        E. coli RNase III cleaves rRNA and
technical/biomed/1471-2164-3-26.txt:        mRNA precursors as part of the respective maturation
technical/biomed/1471-2164-3-26.txt:        E. coli RNase III also initiates mRNA
technical/biomed/1471-2164-3-26.txt:        degradation, and participates in antisense RNA action [ 2 5
technical/biomed/1471-2164-3-26.txt:        Bacterial RNase III orthologues exhibit the simplest
technical/biomed/1471-2164-3-26.txt:        dsRNA-binding motif (dsRBM), and an N-terminal catalytic
technical/biomed/1471-2164-3-26.txt:        other proteins that bind dsRNA [ 9 10 ] and is important
technical/biomed/1471-2164-3-26.txt:        for RNase III activity in 
technical/biomed/1471-2164-3-26.txt:        feature of RNase III orthologues. The isolated 
technical/biomed/1471-2164-3-26.txt:        E. coli RNase III catalytic domain,
technical/biomed/1471-2164-3-26.txt:        which retains homodimeric behavior, can cleave dsRNA
technical/biomed/1471-2164-3-26.txt:        Aquifex aeolicus RNase III reveals an
technical/biomed/1471-2164-3-26.txt:        subunits predicted to bind dsRNA [ 12 ] . The two proposed
technical/biomed/1471-2164-3-26.txt:        E. coli RNase III [ 13 ] .
technical/biomed/1471-2164-3-26.txt:        Two mammalian RNase III orthologues have been
technical/biomed/1471-2164-3-26.txt:        apparently unique features. The RNase III orthologue
technical/biomed/1471-2164-3-26.txt:        "Dicer" (Figure 1) plays a central role in RNA interference
technical/biomed/1471-2164-3-26.txt:        (RNAi) by cleaving dsRNAs to ~21 bp fragments, termed small
technical/biomed/1471-2164-3-26.txt:        interfering(si) RNAs. The siRNAs are incorporated into a
technical/biomed/1471-2164-3-26.txt:        homologous RNA sequences [ 14 ] . Dicer action serves to
technical/biomed/1471-2164-3-26.txt:        precursors to small regulatory RNAs (reviewed in [ 14 15 ]
technical/biomed/1471-2164-3-26.txt:        addition, the N-terminal region contains a DExH/DEAH RNA
technical/biomed/1471-2164-3-26.txt:        which is also present in other proteins involved in RNAi [
technical/biomed/1471-2164-3-26.txt:        The second mammalian RNase III orthologue also exhibits
technical/biomed/1471-2164-3-26.txt:        Preliminary evidence indicates that this RNase III
technical/biomed/1471-2164-3-26.txt:        orthologue participates in rRNA maturation. Thus, a
technical/biomed/1471-2164-3-26.txt:        reduction in human RNase III levels 
technical/biomed/1471-2164-3-26.txt:        specific rRNA processing intermediates [ 18 ] . Consistent
technical/biomed/1471-2164-3-26.txt:        with this functional role, human RNase III localizes to the
technical/biomed/1471-2164-3-26.txt:        truncated form of human RNase III has been purified and
technical/biomed/1471-2164-3-26.txt:        shown to cleave dsRNA 
technical/biomed/1471-2164-3-26.txt:        polypeptide of mouse RNase III, (ii) demonstrate transcript
technical/biomed/1471-2164-3-26.txt:        locations of the mouse and human RNase III genes.
technical/biomed/1471-2164-3-26.txt:          Features of the mouse RNase III cDNA
technical/biomed/1471-2164-3-26.txt:          The mouse RNase III cDNA structure was determined by
technical/biomed/1471-2164-3-26.txt:          the mouse RNase III cDNA is 4487 nt (see Additional File
technical/biomed/1471-2164-3-26.txt:          of the mRNA. However, several independent partial cDNA
technical/biomed/1471-2164-3-26.txt:          5'-UTR with that of human RNase III (245 nt). The 3'-UTR
technical/biomed/1471-2164-3-26.txt:          (data not shown). The predicted 3'-UTR of the mouse RNase
technical/biomed/1471-2164-3-26.txt:          III mRNA and that of the rat RNase III mRNA share 85%
technical/biomed/1471-2164-3-26.txt:          Mouse RNase III cDNA and amino acid sequences. The
technical/biomed/1471-2164-3-26.txt:          provided on the right. The human RNase III amino acid
technical/biomed/1471-2164-3-26.txt:          Features of the predicted RNase III
technical/biomed/1471-2164-3-26.txt:            Conceptual translation of the mouse RNase III cDNA,
technical/biomed/1471-2164-3-26.txt:            The polypeptide contains a single dsRBM and two RNase
technical/biomed/1471-2164-3-26.txt:            The RNase III domain (i.e. the two catalytic domains
technical/biomed/1471-2164-3-26.txt:            identity. Figure 3provides an alignment of the RNase
technical/biomed/1471-2164-3-26.txt:            C. elegans RNase III orthologues.
technical/biomed/1471-2164-3-26.txt:            Drosophila RNase III has a
technical/biomed/1471-2164-3-26.txt:            RNase III orthologues not only provides residues
technical/biomed/1471-2164-3-26.txt:            RNase III is active as a homodimer. If so, the
technical/biomed/1471-2164-3-26.txt:            human RNase III. Repetitive proline sequences tend to
technical/biomed/1471-2164-3-26.txt:            The presence of a PRR in mouse RNase III suggests
technical/biomed/1471-2164-3-26.txt:            C-terminal domain of RNA polymerase II during
technical/biomed/1471-2164-3-26.txt:            The mouse RNase III polypeptide contains an RS
technical/biomed/1471-2164-3-26.txt:            in constitutive or alternative mRNA splicing [ 23 24 25
technical/biomed/1471-2164-3-26.txt:            ] . RS proteins bind RNA 
technical/biomed/1471-2164-3-26.txt:            via an RNA recognition motif
technical/biomed/1471-2164-3-26.txt:            presence of this domain in mouse RNase III suggests
technical/biomed/1471-2164-3-26.txt:            similar protein-protein interactions involved in RNA
technical/biomed/1471-2164-3-26.txt:            components of the RNA splicing and transport
technical/biomed/1471-2164-3-26.txt:            Psort analysis of the predicted mouse RNase III
technical/biomed/1471-2164-3-26.txt:            shown that human RNase III localizes to the nucleolus
technical/biomed/1471-2164-3-26.txt:          Mouse RNase III transcript expression
technical/biomed/1471-2164-3-26.txt:          show that the mouse RNase III transcript is expressed in
technical/biomed/1471-2164-3-26.txt:          may represent an alternatively processed form of the
technical/biomed/1471-2164-3-26.txt:          The mouse RNase III gene was mapped using fluorescent 
technical/biomed/1471-2164-3-26.txt:        revealed only two RNase III orthologues (Dicer and RNase
technical/biomed/1471-2164-3-26.txt:        of an additional RNase III-specific transcript in at least
technical/biomed/1471-2164-3-26.txt:        one tissue indicates the possibility of alternative forms
technical/biomed/1471-2164-3-26.txt:        of RNase III. The broad expression pattern suggests a
technical/biomed/1471-2164-3-26.txt:        conserved cellular function for mouse RNase III. In this
technical/biomed/1471-2164-3-26.txt:        the RNase III gene among many other vertebrates, including
technical/biomed/1471-2164-3-26.txt:        mammalian RNase III have yet to be fully defined. A role in
technical/biomed/1471-2164-3-26.txt:        rRNA maturation is suggested by the observation that
technical/biomed/1471-2164-3-26.txt:        RNase III levels also causes a decrease in the amount of
technical/biomed/1471-2164-3-26.txt:        5.8 S rRNA and a concomitant increase in the 12 S precursor
technical/biomed/1471-2164-3-26.txt:        [ 18 ] . A similar defect in rRNA maturation is seen upon
technical/biomed/1471-2164-3-26.txt:        U8 snoRNA depletion in 
technical/biomed/1471-2164-3-26.txt:        Xenopus oocytes [ 26 ] . As U8 snoRNA
technical/biomed/1471-2164-3-26.txt:        participates in rRNA maturation, it is possible that an
technical/biomed/1471-2164-3-26.txt:        RNase III-dependent step also involves U8 snoRNA.
technical/biomed/1471-2164-3-26.txt:        Alternatively, a role for RNase III in the maturation of U8
technical/biomed/1471-2164-3-26.txt:        snoRNA (as well as other snoRNAs) is a possibility. In this
technical/biomed/1471-2164-3-26.txt:        S. cerevisiae RNase III orthologue
technical/biomed/1471-2164-3-26.txt:        Rnt1p not only cleaves the 35 S rRNA precursor within the
technical/biomed/1471-2164-3-26.txt:        3'-ETS [ 27 28 29 ] , but also processes snoRNA and snRNA
technical/biomed/1471-2164-3-26.txt:        are required to identify the RNA targets for mammalian
technical/biomed/1471-2164-3-26.txt:        RNase III and to determine its involvement in RNA
technical/biomed/1471-2164-3-26.txt:          kidney RNA as previously described [ 34 ] . Bacterial
technical/biomed/1471-2164-3-26.txt:          cDNA sequence for mouse RNase III. One strategy was based
technical/biomed/1471-2164-3-26.txt:          RNase III orthologues by a BLAST search of the NCBI
technical/biomed/1471-2164-3-26.txt:          E. coli RNase III as query
technical/biomed/1471-2164-3-26.txt:          Drosophila and human RNase III [ 18
technical/biomed/1471-2164-3-26.txt:          Total RNA was obtained from mouse embryonic tissue or
technical/biomed/1471-2164-3-26.txt:          used as an internal standard; primer sequences were
technical/biomed/1471-2164-3-27.txt:        alternative to developing species-specific microarrays may
technical/biomed/1471-2164-3-27.txt:        hybridisation of pig skeletal muscle RNA to a human cDNA
technical/biomed/1471-2164-3-27.txt:        4, or 6 μg pig RNA, respectively. When the variable genes
technical/biomed/1471-2164-3-27.txt:        identified from human and from pig (4 μg of RNA) data were
technical/biomed/1471-2164-3-27.txt:        from the hybridisation of human and pig skeletal muscle RNA
technical/biomed/1471-2164-3-27.txt:        among human and pig 2, 4, or 6 μg RNA (Figure 6). However,
technical/biomed/1471-2164-3-27.txt:        data from the pig using 6 μg of RNA has several large
technical/biomed/1471-2164-3-27.txt:        using single pig or human RNA samples. Thus, variation
technical/biomed/1471-2164-3-27.txt:        skeletal muscle RNA with human cDNA microarrays. Together,
technical/biomed/1471-2164-3-27.txt:          Pig skeletal muscle RNA was obtained from a
technical/biomed/1471-2164-3-27.txt:          longissimus dorsi muscle sample. All pig RNA was
technical/biomed/1471-2164-3-27.txt:          RNA was purchased (Clontech). Total RNA was reverse
technical/biomed/1471-2164-3-27.txt:          reaction. Initially, 2, 4, or 6 ug of RNA was combined
technical/biomed/1471-2164-3-27.txt:          2 and 6 μg of pig, and 4 μg of human total RNA, and
technical/biomed/1471-2164-3-27.txt:          transcribed from 4 μg of pig total RNA (see Table 1).
technical/biomed/1471-2164-3-27.txt:          Comparisons of 4 μg pig RNA with human or 2 or 6 μg pig
technical/biomed/1471-2164-3-27.txt:          RNA (Tables 2through) used data generated from the third,
technical/biomed/1471-2164-3-28.txt:          processing and measuring the expression of total RNA in
technical/biomed/1471-2164-3-28.txt:          control human DRG sample was pooled from total RNA (n =
technical/biomed/1471-2164-3-28.txt:          (n=3). Total RNA was extracted from the tissue by Trizol
technical/biomed/1471-2164-3-28.txt:          (LifeTechnologies) extraction and polyA +RNA was
technical/biomed/1471-2164-3-28.txt:          recovered by Oligotex mRNA Spin Columns (Qiagen).
technical/biomed/1471-2164-3-28.txt:          Biotinylated cRNA targets were prepared and hybridized to
technical/biomed/1471-2164-3-29.txt:        of genes whose mRNA are enriched in libraries where IL-8 is
technical/biomed/1471-2164-3-30.txt:          codon encoding alanine at 1403 position of mRNA and A to
technical/biomed/1471-2164-3-30.txt:          G (Figure 1B) substitution at position 2242 of mRNA. Of
technical/biomed/1471-2164-3-30.txt:        (exon 17) of mRNA. Of these, 6 individuals were homozygous
technical/biomed/1471-2164-3-30.txt:        the untranslated region at position 2242 of mRNA. Of these,
technical/biomed/1471-2164-3-31.txt:        procedures require 2-4 μg poly(A) +RNA or 25-50 μg total
technical/biomed/1471-2164-3-31.txt:        RNA per cDNA microarray. This amount of poly(A) +RNA or
technical/biomed/1471-2164-3-31.txt:        total RNA can be obtained from samples of human tissue that
technical/biomed/1471-2164-3-31.txt:        and yield only 3-15 μg of total RNA. Small tumors
technical/biomed/1471-2164-3-31.txt:        small to excise a specimen with enough RNA for microarray
technical/biomed/1471-2164-3-31.txt:        mRNA for expression array analysis. One approach to low
technical/biomed/1471-2164-3-31.txt:        specimen RNA input has been to use indirect labelling
technical/biomed/1471-2164-3-31.txt:        such that as little as 1 μg of total RNA from cell lines
technical/biomed/1471-2164-3-31.txt:        RNA amplification techniques have been developed to
technical/biomed/1471-2164-3-31.txt:        address the need for sufficient RNA from tiny specimen for
technical/biomed/1471-2164-3-31.txt:        total RNA extracted from ~2 × 10 4microdissected cells for
technical/biomed/1471-2164-3-31.txt:        most groups perform RNA amplification for this purpose [ 16
technical/biomed/1471-2164-3-31.txt:        The most commonly used mechanism for RNA amplification
technical/biomed/1471-2164-3-31.txt:        phage T7 RNA polymerase promoter to prime synthesis of
technical/biomed/1471-2164-3-31.txt:        +RNA component of total RNA. Second strand cDNA is
technical/biomed/1471-2164-3-31.txt:        synthesized by degrading the poly(A) +RNA strand with RNase
technical/biomed/1471-2164-3-31.txt:        antisense RNA (aRNA) is obtained from in vitro
technical/biomed/1471-2164-3-31.txt:        template using T7 RNA polymerase. Several protocols based
technical/biomed/1471-2164-3-31.txt:        cDNA. The gene expression of amplified total RNA from
technical/biomed/1471-2164-3-31.txt:        compared to that of unamplified total or poly(A) +RNA using
technical/biomed/1471-2164-3-31.txt:        and compared between total RNA, mRNA, and different amounts
technical/biomed/1471-2164-3-31.txt:        of input aRNA. Hu and co-workers [ 27 ] compared amplified
technical/biomed/1471-2164-3-31.txt:        and unamplified samples using total RNA obtained from human
technical/biomed/1471-2164-3-31.txt:        placenta RNA and RNA from matched normal and tumor renal
technical/biomed/1471-2164-3-31.txt:        amounts of input poly(A) +RNA but that a 3-fold
technical/biomed/1471-2164-3-31.txt:        comparing ratios between amplified and unamplified mRNA.
technical/biomed/1471-2164-3-31.txt:        RNA necessary to achieve reasonable fidelity and
technical/biomed/1471-2164-3-31.txt:        conditions using total RNA isolated from primary human
technical/biomed/1471-2164-3-31.txt:        yield of aRNA. The effect of diminishing amounts of input
technical/biomed/1471-2164-3-31.txt:        total RNA was also tested.
technical/biomed/1471-2164-3-31.txt:          expression using unamplified poly(A) +RNA
technical/biomed/1471-2164-3-31.txt:          hybridization using standard methods, poly(A) +RNA was
technical/biomed/1471-2164-3-31.txt:          Universal Human Reference total RNA (Stratagene ®). The
technical/biomed/1471-2164-3-31.txt:          BC2 poly(A) +RNA labelled with Cy5 and the reference
technical/biomed/1471-2164-3-31.txt:          poly(A) +RNA labelled with Cy3 were hybridized on five
technical/biomed/1471-2164-3-31.txt:          +RNA isolated from BC2 total RNA three months later and a
technical/biomed/1471-2164-3-31.txt:          arrays. However, when the unamplified poly(A) +RNA arrays
technical/biomed/1471-2164-3-31.txt:          to differences in microarray printing, poly(A) +RNA
technical/biomed/1471-2164-3-31.txt:          isolation, and RNA labelling and hybridization contribute
technical/biomed/1471-2164-3-31.txt:          created a virtual poly(A) +RNA expression array that
technical/biomed/1471-2164-3-31.txt:          The idealized expression profile from the poly(A) +RNA
technical/biomed/1471-2164-3-31.txt:          coefficient between each individual poly(A) +RNA array
technical/biomed/1471-2164-3-31.txt:          expression profiles of aRNA amplified in the presence or
technical/biomed/1471-2164-3-31.txt:          unamplified poly(A) +RNA. Total RNA isolated from primary
technical/biomed/1471-2164-3-31.txt:          breast carcinoma BC91 and reference total RNA were
technical/biomed/1471-2164-3-31.txt:          protocol [ 24 ] , except that aRNA was purified using an
technical/biomed/1471-2164-3-31.txt:          +RNA array was created for BC91 using the average
technical/biomed/1471-2164-3-31.txt:          unamplified poly(A) +RNA. A "virtual correlation
technical/biomed/1471-2164-3-31.txt:          As shown in Table 1, using aRNA amplified from total
technical/biomed/1471-2164-3-31.txt:          RNA as reference, the expression profiles obtained in the
technical/biomed/1471-2164-3-31.txt:          significant. When poly(A) +RNA rather than total RNA was
technical/biomed/1471-2164-3-31.txt:          correlation coefficient using aRNA amplified from total
technical/biomed/1471-2164-3-31.txt:          RNA as reference is higher than using aRNA amplified from
technical/biomed/1471-2164-3-31.txt:          poly(A) +RNA as reference regardless of whether TS primer
technical/biomed/1471-2164-3-31.txt:          is used. This suggests that when total RNA from a tumor
technical/biomed/1471-2164-3-31.txt:          reference RNA should also be amplified from total
technical/biomed/1471-2164-3-31.txt:          RNA.
technical/biomed/1471-2164-3-31.txt:          The yield of aRNA amplified from BC91 total RNA using
technical/biomed/1471-2164-3-31.txt:          the total RNA is poly(A) +RNA, a 253 and 370-fold
technical/biomed/1471-2164-3-31.txt:          TS primer, respectively. The yield of aRNA amplified from
technical/biomed/1471-2164-3-31.txt:          total RNA which are generated from cultured cell lines
technical/biomed/1471-2164-3-31.txt:          RNA was amplified (data not shown).
technical/biomed/1471-2164-3-31.txt:          synthesis is self-primed or primed by small pieces of RNA
technical/biomed/1471-2164-3-31.txt:          generated by RNase H; and 2) adding a few base pairs to
technical/biomed/1471-2164-3-31.txt:          change the aRNA significantly enough to affect the array
technical/biomed/1471-2164-3-31.txt:          aRNA (ranging from 0.2 kb to 6 kb, data not shown) as
technical/biomed/1471-2164-3-31.txt:          the yield of aRNA amplified without DNA ligase are high
technical/biomed/1471-2164-3-31.txt:          necessary for RNA amplification in microarray analysis.
technical/biomed/1471-2164-3-31.txt:          profiles of the resulting aRNA to aRNA obtained using the
technical/biomed/1471-2164-3-31.txt:          ligase is not required for total RNA amplification in
technical/biomed/1471-2164-3-31.txt:          cDNA microarray analysis. However, the yield of aRNA is
technical/biomed/1471-2164-3-31.txt:          aRNA
technical/biomed/1471-2164-3-31.txt:          alternative column-the Sephadex™ G-50 column-to filter
technical/biomed/1471-2164-3-31.txt:          unamplified samples and the yield of aRNA using this less
technical/biomed/1471-2164-3-31.txt:          We amplified total RNA from tumor BC2, either with or
technical/biomed/1471-2164-3-31.txt:          amplification. Moreover, the yield of aRNA is
technical/biomed/1471-2164-3-31.txt:          by decreasing the yield of aRNA without improving the
technical/biomed/1471-2164-3-31.txt:          fidelity of RNA amplification
technical/biomed/1471-2164-3-31.txt:          of aRNA (Figure 1B). Since the yield of aRNA at any time
technical/biomed/1471-2164-3-31.txt:          obtained using aRNA provide a close approximation of the
technical/biomed/1471-2164-3-31.txt:          suggest the conclusion that aRNA provides a close
technical/biomed/1471-2164-3-31.txt:          that Var Z for unamplified poly(A) +RNA is larger than
technical/biomed/1471-2164-3-31.txt:          revealed by aRNA ranged between 0.71-0.89. However, gene
technical/biomed/1471-2164-3-31.txt:          +RNA from these different tumors, raising the question of
technical/biomed/1471-2164-3-31.txt:          determined either with unamplified poly(A) +RNA or aRNA
technical/biomed/1471-2164-3-31.txt:          +RNA or aRNA are the same, 0.55. Moreover, the
technical/biomed/1471-2164-3-31.txt:          Another important aspect of RNA amplification is the
technical/biomed/1471-2164-3-31.txt:          the same day for poly(A) +RNA averaged 0.97 and for aRNA
technical/biomed/1471-2164-3-31.txt:          poly(A) +RNA and 0.85-0.90 for aRNA amplified from total
technical/biomed/1471-2164-3-31.txt:          RNA on different days. The reproducibility of our
technical/biomed/1471-2164-3-31.txt:          The effect of the amount of input total RNA on
technical/biomed/1471-2164-3-31.txt:          RNA on single round amplification, we amplified different
technical/biomed/1471-2164-3-31.txt:          amounts of total RNA, 3 μg, 1 μg, 300 ng, 100 ng, 30 ng
technical/biomed/1471-2164-3-31.txt:          to the quantity of input total RNA (Table 9). When the
technical/biomed/1471-2164-3-31.txt:          input total RNA is lower than 300 ng, the yield of aRNA
technical/biomed/1471-2164-3-31.txt:          smaller quantities of template RNA, but the absolute
technical/biomed/1471-2164-3-31.txt:          yield of aRNA decreases. Therefore, within the range of
technical/biomed/1471-2164-3-31.txt:          0.3-3 μg total RNA, decreasing the input RNA does not
technical/biomed/1471-2164-3-31.txt:          RNA Amplification for Microarrays website
technical/biomed/1471-2164-3-31.txt:        high fidelity aRNA for gene expression profiling using
technical/biomed/1471-2164-3-31.txt:        poly(A) +RNA increases to 0.85 when experimental
technical/biomed/1471-2164-3-31.txt:          RNA preparation
technical/biomed/1471-2164-3-31.txt:          Total RNA was isolated from primary tumor tissue using
technical/biomed/1471-2164-3-31.txt:          +RNA was isolated from total RNA with the FastTrack 2.0
technical/biomed/1471-2164-3-31.txt:          kit (Invitrogen™). The concentration of total RNA and
technical/biomed/1471-2164-3-31.txt:          poly(A) +RNA was determined using a GeneSpec I
technical/biomed/1471-2164-3-31.txt:          RNA and poly(A) +RNA was assessed using a 2100
technical/biomed/1471-2164-3-31.txt:          RNA amplification
technical/biomed/1471-2164-3-31.txt:          The amplification of total RNA or poly(A) +RNA was
technical/biomed/1471-2164-3-31.txt:          otherwise specified) tumor total RNA, Universal Human
technical/biomed/1471-2164-3-31.txt:          Reference total RNA (Stratagene ®), or 150 ng poly(A)
technical/biomed/1471-2164-3-31.txt:          +RNA was mixed with 1 μg Eberwine primer (Operon ®) in
technical/biomed/1471-2164-3-31.txt:          RNase-free water to a total volume of 9 μl. The
technical/biomed/1471-2164-3-31.txt:          RNA/primer mixture was denatured at 70°C for 3 min and
technical/biomed/1471-2164-3-31.txt:          RNasin ®(40 U/μl, Promega™), 2 μl 10 mM dNTP, and 2 μl
technical/biomed/1471-2164-3-31.txt:          RNase-free water, 15 μl 10X Advantage™ PCR buffer
technical/biomed/1471-2164-3-31.txt:          polymerase mix (Clontech), and 1 μl RNase H (2 U/μl,
technical/biomed/1471-2164-3-31.txt:          min to digest RNA, followed by 94°C for 2 min to activate
technical/biomed/1471-2164-3-31.txt:          RNase-free water.
technical/biomed/1471-2164-3-31.txt:          reaction was then carried out at 37°C for 5 hours. aRNA
technical/biomed/1471-2164-3-31.txt:          RNA labelling and hybridization
technical/biomed/1471-2164-3-31.txt:          Three micrograms of aRNA (unless otherwise specified)
technical/biomed/1471-2164-3-31.txt:          or 2 μg poly(A) +RNA were labelled either with Cy5-dUTP
technical/biomed/1471-2164-3-31.txt:          μl reaction. RNA was first mixed with either 8 μg of
technical/biomed/1471-2164-3-31.txt:          random primer for aRNA or 5 μg of oligo(dT) primer for
technical/biomed/1471-2164-3-31.txt:          poly(A) +RNA in 16 μl of RNase-free water. RNA/primer mix
technical/biomed/1471-2164-3-31.txt:          reaction at the end of the first hour. The input RNA was
technical/biomed/1471-2164-3-31.txt:          citrate (SSC), 1 μl yeast tRNA (10 μg/μl), 2 μl poly(A)
technical/biomed/1471-2164-3-31.txt:        HZ participated in study design, isolated the RNA,
technical/biomed/1471-2164-3-32.txt:        Proteins are translated from their corresponding mRNAs.
technical/biomed/1471-2164-3-32.txt:        Cellular mRNA levels are immensely informative about cell
technical/biomed/1471-2164-3-32.txt:        in mRNA abundance are positively correlated with changes in
technical/biomed/1471-2164-3-32.txt:        10 ] . Incyte's LifeExpress RNA Database is a gene
technical/biomed/1471-2164-3-32.txt:        large-scale mRNA expression data, we can infer the
technical/biomed/1471-2164-3-32.txt:        identity. We then generated mRNA expression profiles for
technical/biomed/1471-2164-3-32.txt:        these Pfam family members using Incyte's LifeExpress RNA
technical/biomed/1471-2164-3-32.txt:        mRNA expression profiles. Analysis of the profiles may be
technical/biomed/1471-2164-3-32.txt:          of up to 10,000 array elements per chip. LifeExpress RNA
technical/biomed/1471-2164-3-32.txt:          "fluorescent-labeled total RNA sample used for microarray
technical/biomed/1471-2164-3-32.txt:          GenBank mRNA sequences for those protein records were
technical/biomed/1471-2164-3-33.txt:        DNA polymerases, reverse transcriptases, viral RNA
technical/biomed/1471-2164-3-33.txt:        dependent RNA polymerases and eukaryote-type primases [ 4
technical/biomed/1471-2164-3-33.txt:          aminoacyl tRNA synthetases, RNA polymerase and other RNA
technical/biomed/1471-2164-3-33.txt:          Alternatively, they could also function as
technical/biomed/1471-2164-3-34.txt:        IS elements or tRNAs that are
technical/biomed/1471-2164-3-35.txt:        the mRNA in the pool from which the library was derived.
technical/biomed/1471-2164-3-35.txt:        of some tissue's poly(A) +RNA mixture, there is the
technical/biomed/1471-2164-3-35.txt:        derived from mRNA from two different sources are nearly the
technical/biomed/1471-2164-3-35.txt:        results is due to the similarity of the different mRNA
technical/biomed/1471-2164-3-35.txt:        skeletal muscle mRNA from two related strains of rats. As a
technical/biomed/1471-2164-3-35.txt:        cDNA probe produced from skeletal muscle mRNA. Our
technical/biomed/1471-2164-3-35.txt:          cDNA derived from skeletal muscle mRNA. Also shown in
technical/biomed/1471-2164-3-35.txt:          hybridizations were performed using muscle mRNA from both
technical/biomed/1471-2164-3-35.txt:          AA461132 (5') = RNA polymerase II polypeptide J = spot
technical/biomed/1471-2164-3-35.txt:        produced by the reverse transcription of a poly(A) +RNA
technical/biomed/1471-2164-3-35.txt:        any poly(A) +RNA mixture will be
technical/biomed/1471-2164-3-35.txt:        using probes derived from mRNA from two different sources
technical/biomed/1471-2164-3-35.txt:        different mRNA sources, rather than to incomplete blockage
technical/biomed/1471-2164-3-35.txt:        microarray hybridizations using skeletal muscle mRNA from
technical/biomed/1471-2164-3-35.txt:        mRNA, versus the signals using only an oligo(dT) probe
technical/biomed/1471-2164-3-35.txt:        derived from muscle mRNA be denoted as H 
technical/biomed/1471-2164-3-35.txt:        probe signal, above which hybridization by an mRNA-derived
technical/biomed/1471-2164-3-35.txt:          Extraction of total and messenger RNA
technical/biomed/1471-2164-3-35.txt:          percent of the volume of the reagent used. Total RNA was
technical/biomed/1471-2164-3-35.txt:          #T9424). This was followed by selection of poly(A) mRNA
technical/biomed/1471-2164-3-35.txt:          from the total RNA by hybridizing the RNA with oligo(dT)
technical/biomed/1471-2164-3-35.txt:          magnetic microparticles, then isolating the mRNA
technical/biomed/1471-2164-3-35.txt:          magnetically (mRNA Isolation Kit, Miltenyi Biotec
technical/biomed/1471-2164-3-35.txt:          #751-02). The spectrophotometric 260/280 ratios for mRNA
technical/biomed/1471-2164-3-35.txt:          oligo(dT) primed mRNA and SuperScript II RNase H- reverse
technical/biomed/1471-2164-3-35.txt:          from skeletal muscle mRNA from lean (Fa/Fa) versus obese
technical/biomed/1471-2164-3-4.txt:        The introduction of small subunit ribosomal RNA as a
technical/biomed/1471-2164-3-4.txt:        bifurcating tree of species. A decade ago ribosomal RNA
technical/biomed/1471-2164-3-4.txt:        rRNA phylogeny, at present it remains unclear whether this
technical/biomed/1471-2164-3-4.txt:        single tree. Fig. 1gives an example of an alternative
technical/biomed/1471-2164-3-4.txt:        have explored only few alternatives to the tree-paradigm
technical/biomed/1471-2164-3-4.txt:          90% bootstrap support, whereas the alternatives are
technical/biomed/1471-2164-3-4.txt:          organisms together. The alternative topologies were
technical/biomed/1471-2164-3-4.txt:          that would be expected following 16S rRNA phylogeny (12
technical/biomed/1471-2164-3-4.txt:          several tRNA synthetases, which were previously found to
technical/biomed/1471-2164-3-4.txt:          As an alternative to posterior probability vectors,
technical/biomed/1471-2164-3-4.txt:        rRNA ribosomal ribonucleic acid
technical/biomed/1471-2164-3-6.txt:          multi tissue RNA blot from Clontech. Pre hybridization
technical/biomed/1471-2164-3-6.txt:          members, p55, to form a ternary complex that links the
technical/biomed/1471-2164-3-7.txt:        Examples for analog techniques representing mRNA
technical/biomed/1471-2164-3-7.txt:        expression of low abundant cDNAs that represent mRNA in the
technical/biomed/1471-2164-3-7.txt:        sequences are initially prepared from mRNA which are then
technical/biomed/1471-2164-3-7.txt:          transcription reaction using isolated mRNA and an
technical/biomed/1471-2164-3-7.txt:          of the corresponding mRNA. The labelled oligonucleotide
technical/biomed/1471-2164-3-7.txt:          resulting from labelling of internal restriction sites
technical/biomed/1471-2164-3-7.txt:          specially designed internal size marker (Fig. 1, step 3;
technical/biomed/1471-2164-3-7.txt:          analyzed fragments and the internal size marker, the
technical/biomed/1471-2164-3-7.txt:        time RT-PCR, RNase Protection Assays, and various
technical/biomed/1471-2164-3-7.txt:        Another improvement could result from alternative DNA
technical/biomed/1471-2164-3-7.txt:          mRNA was extracted from murine tissues (BALB/c mice:
technical/biomed/1471-2164-3-7.txt:          RNA Preparation and reverse transcription
technical/biomed/1471-2164-3-7.txt:          Total RNA was extracted from the frozen mouse skin
technical/biomed/1471-2164-3-7.txt:          Sacchi (1987) [ 32 ] . The total RNA was digested by
technical/biomed/1471-2164-3-7.txt:          RNase free DNaseI and phenol extracted in order to remove
technical/biomed/1471-2164-3-7.txt:          synthesized from 1 μg of total RNA in a 100 μl reaction
technical/biomed/1471-2164-3-7.txt:          derived from total RNA. For each cDNA sample under
technical/biomed/1471-2164-3-7.txt:        cDNA - DNA complementary to ribonucleic acid (RNA), DNA
technical/biomed/1471-2164-3-8.txt:        manner [ 3 ] . These alternative or additional mediators of
technical/biomed/1471-2164-3-8.txt:        In vitro studies on quaternary
technical/biomed/1471-2164-3-8.txt:        functional similarities, and the similar quaternary
technical/biomed/1471-2164-3-8.txt:          and similarities in biochemistry and quaternary
technical/biomed/1471-2164-3-8.txt:          in vitro ERF adopts quaternary
technical/biomed/1471-2164-3-8.txt:          recombination and also shows a quaternary organization
technical/biomed/1471-2164-3-8.txt:          alternative explanation, namely that the gene coding for
technical/biomed/1471-2164-3-9.txt:        the docking of vesicles to the Golgi cisternae [ 16 17 18 ]
technical/biomed/1471-2164-3-9.txt:        internal nuclear matrix, and not predominantly at the
technical/biomed/1471-2164-3-9.txt:          named LeFPP for tomato filament-like plant protein. RNA
technical/biomed/1471-2164-3-9.txt:          blot analysis showed a single species of mRNA of ca. 2.4
technical/biomed/1471-2164-3-9.txt:          Total RNA from young tomato leaves ( 
technical/biomed/1471-2164-3-9.txt:          mRNA was purified using the mRNA purification kit
technical/biomed/1471-2164-3-9.txt:          RNA isolation and RNA blotting
technical/biomed/1471-2164-3-9.txt:          Total RNA from tomato leaves (5-15 mm), fruits (3-8 mm
technical/biomed/1471-2164-3-9.txt:          Reagent from Gibco BRL (Gaithersburg, MD). Total RNA (20
technical/biomed/1471-2164-4-13.txt:          fashion. UBF-1 specifically binds the ribosomal RNA gene
technical/biomed/1471-2164-4-13.txt:          members are expressed at the level of mRNA, and we have
technical/biomed/1471-2164-4-13.txt:          or alternatively hinders its ability to form a functional
technical/biomed/1471-2164-4-13.txt:          Mouse sequences : Tox mRNA
technical/biomed/1471-2164-4-13.txt:          (NM_145711), TOX protein (NP_663757); LCP1 mRNA
technical/biomed/1471-2164-4-13.txt:          mRNA (XM_141525.1), LOC244579 mRNA (XM_146430), SOX-4
technical/biomed/1471-2164-4-13.txt:          Human sequences : KIAA0808 mRNA
technical/biomed/1471-2164-4-13.txt:          (C14ORF92) mRNA (NM_014828), KIAA0737 predicted protein
technical/biomed/1471-2164-4-13.txt:          (NP_055643); C20ORF100 mRNA (NM_032883), C20ORF100
technical/biomed/1471-2164-4-13.txt:          predicted protein (NP_116272); TNRC9 mRNA (XM_049037),
technical/biomed/1471-2164-4-13.txt:          hybridized to a poly(A) +RNA Northern blot of mouse
technical/biomed/1471-2164-4-13.txt:          instructions. Amounts of mRNA on this blot have been
technical/biomed/1471-2164-4-14.txt:        C-terminal end, or alternatively, that upstream splice
technical/biomed/1471-2164-4-14.txt:          was performed on RNA from 
technical/biomed/1471-2164-4-14.txt:          T RNA species (6,7,8 and 4,5,6,7,8;
technical/biomed/1471-2164-4-14.txt:          T +/+ embryo RNA (Figure 1B). In
technical/biomed/1471-2164-4-14.txt:          Wis RNA using any of the primer
technical/biomed/1471-2164-4-14.txt:          Wis embryo RNA (Figure 2). Sequence
technical/biomed/1471-2164-4-14.txt:          Wis /+ RNA (Figure 2). A shorter
technical/biomed/1471-2164-4-14.txt:          amplified from the same hypothetical RNA 6,7+60ETn,8. The
technical/biomed/1471-2164-4-14.txt:          the same hypothetical RNA 6,7+60ETn,+37ETn,8.
technical/biomed/1471-2164-4-14.txt:          Alternatively, the 6,7+ETn product might have amplified
technical/biomed/1471-2164-4-14.txt:          from an RNA 6,7+?ETn, where an unknown amount of the ETn
technical/biomed/1471-2164-4-14.txt:          T mRNA is never produced.
technical/biomed/1471-2164-4-14.txt:          producing a dominant negative effect. Alternatively, the
technical/biomed/1471-2164-4-14.txt:          posttranscriptional gene silencing by an RNA-induced
technical/biomed/1471-2164-4-14.txt:          silencing complex (RISC)-based RNAi degradation pathway
technical/biomed/1471-2164-4-14.txt:        misregulation of RNA splicing. A straightforward prediction
technical/biomed/1471-2164-4-14.txt:          Technologies, Inc.) for RNA preparation. At e9.5, mutant
technical/biomed/1471-2164-4-14.txt:          For RT-PCR, total RNA from individual e7.5 and e8.5
technical/biomed/1471-2164-4-14.txt:          Reagent manufacturer's protocols for isolation of RNA
technical/biomed/1471-2164-4-14.txt:          from small quantities of tissue. Total RNA was reverse
technical/biomed/1471-2164-4-14.txt:          transcribed using Superscript II RNase H -Reverse
technical/biomed/1471-2164-4-14.txt:          performed on one half or one third of the total RNA
technical/biomed/1471-2164-4-14.txt:          positive control reactions, RNA from one wild type embryo
technical/biomed/1471-2164-4-15.txt:        # 105830), when deletions occur on the paternally-derived
technical/biomed/1471-2164-4-15.txt:        or maternally-derived homolog, respectively (see Figure 1;
technical/biomed/1471-2164-4-15.txt:        data suggest a higher risk for autism with maternal
technical/biomed/1471-2164-4-15.txt:        compared to paternal duplications [ 5 6 7 ] . Chromosome 15
technical/biomed/1471-2164-4-15.txt:        that for idic(15) when maternally-derived [ 7 12 13 ] .
technical/biomed/1471-2164-4-15.txt:        CHRNA7 ) gene [ 24 ] . This
technical/biomed/1471-2164-4-15.txt:        CHRNA7 . The repetitive nature of
technical/biomed/1471-2164-4-15.txt:        transcript is larger than the longest available mRNA
technical/biomed/1471-2164-4-15.txt:        alternative polyadenylation sites. The presence of multiple
technical/biomed/1471-2164-4-15.txt:        alternative splicing for this gene. To our knowledge,
technical/biomed/1471-2164-4-15.txt:          Northern blots containing adult human brain polyA+ RNA
technical/biomed/1471-2164-4-15.txt:          cRNA probes were synthesized with the MAXIscript kit
technical/biomed/1471-2164-4-15.txt:          using T3, T7, or SP6 RNA polymerase (Ambion, Austin, TX)
technical/biomed/1471-2164-4-16.txt:        We developed an alternative cloning procedure based on
technical/biomed/1471-2164-4-16.txt:          at an alternative site and inactivation of 
technical/biomed/1471-2164-4-16.txt:          URA3 mRNA and resistance to 5-FOA
technical/biomed/1471-2164-4-16.txt:          [ 21 ] . Alternatively, the transformants may have
technical/biomed/1471-2164-4-16.txt:          located at DNA fragment ends, rather than by internal
technical/biomed/1471-2164-4-16.txt:        system provides an alternative approach to selectively
technical/biomed/1471-2164-4-19.txt:        commonly, mRNA expression levels are measured on a global,
technical/biomed/1471-2164-4-19.txt:        typical mRNA expression analyses where microgram quantities
technical/biomed/1471-2164-4-19.txt:        of mRNA are available for direct analysis. Furthermore,
technical/biomed/1471-2164-4-19.txt:        with expression analysis where the mRNA 3' polyA tail
technical/biomed/1471-2164-4-19.txt:        species can be highly variable. Alternative amplification
technical/biomed/1471-2164-4-19.txt:        approaches have been developed for microarray-based mRNA
technical/biomed/1471-2164-4-19.txt:        mRNA by reverse-transcription (priming off the 3' polyA
technical/biomed/1471-2164-4-19.txt:        incorporated during the cDNA synthesis, and T7 RNA
technical/biomed/1471-2164-4-19.txt:        polymerase is subsequently used to transcribe multiple RNA
technical/biomed/1471-2164-4-19.txt:        faithfully preserves the initial representation of RNA
technical/biomed/1471-2164-4-19.txt:          protocol yields between 30 and 60 μg RNA. This yield
technical/biomed/1471-2164-4-19.txt:          IVT and by R-PCR. The IVT yielded almost 80 μg RNA, while
technical/biomed/1471-2164-4-19.txt:          were able to improve yields when amplifying mRNA by
technical/biomed/1471-2164-4-19.txt:          transcribing the amplified RNA, were fluorescently
technical/biomed/1471-2164-4-19.txt:        ). Although T7-based approaches for amplification of mRNA
technical/biomed/1471-2164-4-19.txt:        like mRNA polyA tails. Efficient tailing by terminal
technical/biomed/1471-2164-4-19.txt:        fold-amplification similar to that obtained in mRNA linear
technical/biomed/1471-2164-4-19.txt:        RNA are sufficient to generate probe for a microarray
technical/biomed/1471-2164-4-19.txt:        experiment, RNA from a single IVT amplification can be used
technical/biomed/1471-2164-4-19.txt:        alternative R-PCR approach. Extensive microarray-based
technical/biomed/1471-2164-4-19.txt:          RNeasy Mini Kit (Qiagen) per manufacturer's RNA cleanup
technical/biomed/1471-2164-4-19.txt:          buffer RPE. RNA was quantified by absorbance at 260 nm,
technical/biomed/1471-2164-4-19.txt:          amplified RNA were primed with 5 μg random hexamers and 5
technical/biomed/1471-2164-4-19.txt:          with 10 μL 0.5 M EDTA, and RNA hydrolyzed by the addition
technical/biomed/1471-2164-4-2.txt:        hnRNP A2 and hnRNP B1, members of a large family of RNA
technical/biomed/1471-2164-4-2.txt:        heterogeneous nuclear RNA [ 33 ] .
technical/biomed/1471-2164-4-2.txt:          of the hnRNP A2/B1 gene, RNA from wild-type mice and mice
technical/biomed/1471-2164-4-2.txt:          migration of 18S and 28S RNAs, is consistent with fusion
technical/biomed/1471-2164-4-2.txt:          heterozygotes or wild type embryos. RNA isolated from
technical/biomed/1471-2164-4-2.txt:          3-phosphate dehydrogenase (GAPDH) message as an internal
technical/biomed/1471-2164-4-2.txt:          exon definition in which exons in pre-mRNA are first
technical/biomed/1471-2164-4-2.txt:          processed as relatively autonomous units. Alternatively,
technical/biomed/1471-2164-4-2.txt:          To distinguish between these alternatives, hnRNP
technical/biomed/1471-2164-4-2.txt:        site at the end of an alternative exon that can be utilised
technical/biomed/1471-2164-4-2.txt:        Alternatively, other hnRNP proteins compensate for reduced
technical/biomed/1471-2164-4-2.txt:        missing from alternative splice sites [ 56 ] . Both the A
technical/biomed/1471-2164-4-2.txt:        altering these nucleotides. Alternatively, the problem may
technical/biomed/1471-2164-4-2.txt:        RNA binding proteins found associated with mammalian
technical/biomed/1471-2164-4-2.txt:        heterogeneous nuclear RNA. The proteins are thought to
technical/biomed/1471-2164-4-2.txt:        participate in the processing mRNA precursors [ 33 ] , and
technical/biomed/1471-2164-4-2.txt:        fundamental role in RNA metabolism, the human and mouse
technical/biomed/1471-2164-4-2.txt:          RT-PCR was performed as described [ 62 ] . 20 μg RNA
technical/biomed/1471-2164-4-2.txt:          was treated with 1 unit of RNAse free DNase (Gibco BRL)
technical/biomed/1471-2164-4-2.txt:          containing: 5 μg RNA, 500 nM NEO A primer
technical/biomed/1471-2164-4-2.txt:          2 units of RNAse H was added and incubated for 10 min at
technical/biomed/1471-2164-4-22.txt:          RNA and vector sequences, which yielded 735 distinct
technical/biomed/1471-2164-4-22.txt:          gene regulation and RNA processing (8%) and intracellular
technical/biomed/1471-2164-4-22.txt:            band in testis RNA and weak signals in several other
technical/biomed/1471-2164-4-22.txt:            studies revealed the existence of three alternatively
technical/biomed/1471-2164-4-22.txt:            human mRNA revealed a 1401 amino acid protein that is
technical/biomed/1471-2164-4-22.txt:            RNA (figure 1). Genome analysis permitted the mapping
technical/biomed/1471-2164-4-22.txt:            the apparent size of the detected mRNA is significantly
technical/biomed/1471-2164-4-22.txt:            revealed a specific signal in hamster testis RNA
technical/biomed/1471-2164-4-22.txt:            mRNA was specifically detected in hamster testis RNA
technical/biomed/1471-2164-4-22.txt:            detected a specific signal in hamster testis RNA
technical/biomed/1471-2164-4-22.txt:          motors, which we have named KIF27. KIF27 RNA was detected
technical/biomed/1471-2164-4-22.txt:          existence of at least three mRNAs that resulted from
technical/biomed/1471-2164-4-22.txt:          alternative splicing, at least in human. Although partial
technical/biomed/1471-2164-4-22.txt:          from either alternative splicing or promoter usage [ 31
technical/biomed/1471-2164-4-22.txt:          RNA, cDNA and plasmid preparation
technical/biomed/1471-2164-4-22.txt:          Total RNA was prepared from testes of adult Syrian
technical/biomed/1471-2164-4-22.txt:          Mesocricetus auratus ). Poly A +RNA
technical/biomed/1471-2164-4-22.txt:          was isolated using the poly A Spin™ mRNA isolation kit
technical/biomed/1471-2164-4-22.txt:          (New England Biolabs, Beverly, MA). 5 μg of polyA +RNA
technical/biomed/1471-2164-4-22.txt:          Total RNA was purified from various hamster tissues
technical/biomed/1471-2164-4-22.txt:          each RNA was electrophoresed through a 1%
technical/biomed/1471-2164-4-22.txt:          membrane (Micron Separations, Westborough, MA). The RNA
technical/biomed/1471-2164-4-23.txt:          Growth conditions and RNA isolation
technical/biomed/1471-2164-4-23.txt:          2 at a rate of 300 mL min -1. RNA was
technical/biomed/1471-2164-4-23.txt:          RNA using a reverse transcriptase reaction incorporating
technical/biomed/1471-2164-4-23.txt:          was synthesized from 16 μg total RNA using 5 μg random
technical/biomed/1471-2164-4-23.txt:          II™ reverse transcriptase (Invitrogen). RNA samples
technical/biomed/1471-2164-4-23.txt:          incubated at 65°C for 20 minutes to degrade RNA. The
technical/biomed/1471-2164-4-23.txt:        with the buffer. Tests with alternatives, including mixes
technical/biomed/1471-2164-4-23.txt:        http://microbiology.okstate.edu/faculty/burnap/index.html.
technical/biomed/1471-2164-4-23.txt:        and/or drying characteristics. Alternatives such as ethanol
technical/biomed/1471-2164-4-23.txt:        after hybridization. Alternately, Clontech type II slides
technical/biomed/1471-2164-4-23.txt:        from sample RNA is outlined in Table 2.
technical/biomed/1471-2164-4-23.txt:        Several internal and external comparisons were analyzed
technical/biomed/1471-2164-4-23.txt:        to demonstrate the effective use of the arrays. Internally,
technical/biomed/1471-2164-4-23.txt:        slides by hybridization with total RNA from control and
technical/biomed/1471-2164-4-23.txt:        similar results using a direct RNA-dye coupling procedure
technical/biomed/1471-2164-4-23.txt:        can be achieved using the Micromax™ ASAP RNA Labeling Kit
technical/biomed/1471-2164-4-23.txt:        produces a final RNA product which is less stable than the
technical/biomed/1471-2164-4-24.txt:          Tmc1 and Tmc3 mRNAs were detectable in most neuronal
technical/biomed/1471-2164-4-24.txt:          We observed that mRNAs encoding Tmc5, Tmc6, Tmc4 and
technical/biomed/1471-2164-4-24.txt:          mRNA is detectable in thymus and lung; we also found
technical/biomed/1471-2164-4-24.txt:          expression of Tmc8 mRNA in spleen (not shown). We did not
technical/biomed/1471-2164-4-24.txt:          identified two mRNA sequences encoding 
technical/biomed/1471-2164-4-24.txt:          proteins. These mRNAs are transcribed from 
technical/biomed/1471-2164-4-24.txt:          mRNA expression analysis
technical/biomed/1471-2164-4-24.txt:          kindly provided by Dr. B. Kachar, NIDCD/NIH. Total RNA
technical/biomed/1471-2164-4-24.txt:          Valencia, CA). For RT-PCR, 1 μg of total RNA was
technical/biomed/1471-2164-4-25.txt:        RNA or other artifacts. The clustering of ESTs to form ORFs
technical/biomed/1471-2164-4-25.txt:        tissues as well as by qualitative RT-PCR with RNA from 20
technical/biomed/1471-2164-4-25.txt:        the NCBI accession number for the corresponding mRNA or
technical/biomed/1471-2164-4-25.txt:        the full-length mRNA sequence (AF418980).
technical/biomed/1471-2164-4-25.txt:        (RPS10) is 95% identical to the genomic and mRNA sequences
technical/biomed/1471-2164-4-25.txt:        and mRNA sequences of keratin. Vesicular membrane protein
technical/biomed/1471-2164-4-25.txt:        a carrier for RNA during export to the cytoplasm [ 33 ]
technical/biomed/1471-2164-4-25.txt:        equally represented in the mRNAs of the twenty tissues in
technical/biomed/1471-2164-4-25.txt:        KIAA0319 had strong signal from brain and cerebellum mRNA,
technical/biomed/1471-2164-4-25.txt:          to identify parental cDNA or mRNA matches, which
technical/biomed/1471-2164-4-25.txt:          final assemblies of EST and cDNA or mRNA sequences were
technical/biomed/1471-2164-4-25.txt:          A panel containing human total RNA from 20 different
technical/biomed/1471-2164-4-25.txt:          RNA was denatured with 0.5μM of random decamer primers in
technical/biomed/1471-2164-4-25.txt:          dNTP mix, 1 Unit RNase inhibitor, and 100 Units MMLV-RT
technical/biomed/1471-2164-4-25.txt:          designed to amplify the mRNA sequences of each of the 20
technical/biomed/1471-2164-4-25.txt:          contained water during the RT-PCR step to check for RNA
technical/biomed/1471-2164-4-26.txt:        as an alternative method for genomic research. Several
technical/biomed/1471-2164-4-26.txt:        patterns and low internal correlation. Sets of genes
technical/biomed/1471-2164-4-26.txt:        have greater internal correlation. Given these differences,
technical/biomed/1471-2164-4-26.txt:        low internal correlation (average pair-wise correlation). A
technical/biomed/1471-2164-4-26.txt:        effects of including nodes with low internal correlation
technical/biomed/1471-2164-4-26.txt:        applications of SVD to RNA dynamics.
technical/biomed/1471-2164-4-26.txt:        We conclude that SVD is a useful alternative method that
technical/biomed/1471-2164-4-26.txt:          http://www.blackwell-science.com/products/journals/suppmat/PBI/PBI006/PBI006sm.htm.
technical/biomed/1471-2164-4-28.txt:        working protocol, 10 μg of total RNA from control and
technical/biomed/1471-2164-4-28.txt:        for one slide hybridization. Thus, 125 ng of total RNA can
technical/biomed/1471-2164-4-28.txt:        less total RNA than regular microarray (which generally
technical/biomed/1471-2164-4-28.txt:        requires 20 μg of total RNA). It is also comparable to
technical/biomed/1471-2164-4-28.txt:        other RNA amplification methods, such as antisense RNA
technical/biomed/1471-2164-4-28.txt:        amplification where 0.25 - 3.0 μg of total RNA is required
technical/biomed/1471-2164-4-28.txt:        total RNA is required [ 15 ] . 20-30 PCR cycles are
technical/biomed/1471-2164-4-28.txt:          Total RNA was isolated from both HL60 and HL60/TLK286
technical/biomed/1471-2164-4-28.txt:          RNA from HL60 or HL60/TLK286 cells was
technical/biomed/1471-2164-4-28.txt:          tRNA, 4.5 μl of 20x SSC and 0.75 μl of 10% SDS, heated at
technical/biomed/1471-2164-4-28.txt:          μg of total RNA was reverse-transcribed into single
technical/biomed/1471-2164-4-28.txt:          total RNA samples of HL60 and HL60/TLK286 were
technical/biomed/1471-2164-4-4.txt:        of mRNAs at one time. Affymetrix GeneChips ®contain pairs
technical/biomed/1471-2164-4-4.txt:        constitute a probe set. RNA from the sample is converted to
technical/biomed/1471-2164-4-4.txt:        biotinylated nucleotides. The biotinylated cRNA is
technical/biomed/1471-2164-4-4.txt:        material 10 μg of total RNA, from which biotinylated cRNA
technical/biomed/1471-2164-4-4.txt:        biotinylated cRNA in the hybridization. Hybridization
technical/biomed/1471-2164-4-4.txt:        reactions that contained the recommended 10 μg of cRNA
technical/biomed/1471-2164-4-4.txt:        amount of cRNA in the hybridization to 5 μg reduced the
technical/biomed/1471-2164-4-4.txt:        fraction detected to 30%, and further reducing the cRNA to
technical/biomed/1471-2164-4-4.txt:        synthesizing biotinylated cRNA from very small amounts of
technical/biomed/1471-2164-4-4.txt:        starting material. Total RNA from laser capture
technical/biomed/1471-2164-4-4.txt:        in vitro ; the resulting cRNA was
technical/biomed/1471-2164-4-4.txt:        more cRNA; this cRNA was again converted into cDNA and
technical/biomed/1471-2164-4-4.txt:        biotinylated cRNA was synthesized by a third 
technical/biomed/1471-2164-4-4.txt:        procedure produced 10 μg of biotinylated cRNA from 0.1 μg
technical/biomed/1471-2164-4-4.txt:        of starting total RNA. Hybridization with 10 μg of
technical/biomed/1471-2164-4-4.txt:        biotinylated cRNA generated by this amplification protocol
technical/biomed/1471-2164-4-4.txt:        with 10 μg of biotinylated cRNA generated by the standard
technical/biomed/1471-2164-4-4.txt:        protocol from total RNA extracted from similar tissues
technical/biomed/1471-2164-4-4.txt:        handling of the models and in the RNA extraction typically
technical/biomed/1471-2164-4-4.txt:        variability during the synthesis of biotinylated cRNA. In
technical/biomed/1471-2164-4-4.txt:        measures such as the yield of cRNA or the fraction of probe
technical/biomed/1471-2164-4-4.txt:        amounts of starting material (total RNA) in a model
technical/biomed/1471-2164-4-4.txt:        RNA from individual rats exposed to two different
technical/biomed/1471-2164-4-4.txt:        nutritional regimens and used serial dilutions of the RNA
technical/biomed/1471-2164-4-4.txt:        quantities of total RNA. We used the Rat Genome RGU34A
technical/biomed/1471-2164-4-4.txt:        determine a reasonable lower bound for total RNA that could
technical/biomed/1471-2164-4-4.txt:        truncation of the labeled cRNA. We examined the variability
technical/biomed/1471-2164-4-4.txt:          Yields and quality of cRNA
technical/biomed/1471-2164-4-4.txt:          The standard protocol uses 10 μg of total RNA to
technical/biomed/1471-2164-4-4.txt:          produce biotinylated cRNA [ 8 ] . In our experiment, the
technical/biomed/1471-2164-4-4.txt:          average yield of biotinylated cRNA was 97 μg (± 41 μg;
technical/biomed/1471-2164-4-4.txt:          RNA and used one-half of the double stranded cDNA product
technical/biomed/1471-2164-4-4.txt:          Starting with 2 μg of total RNA, we obtained an average
technical/biomed/1471-2164-4-4.txt:          cRNA after using all of the double stranded cDNA product
technical/biomed/1471-2164-4-4.txt:          biotinylated cRNA (yields ranged from 2.4 μg to 7.7 μg).
technical/biomed/1471-2164-4-4.txt:          biotinylated cRNA to make a 300 μl hybridization
technical/biomed/1471-2164-4-4.txt:          hybridization. The yield of cRNA from both 10 μg and 2 μg
technical/biomed/1471-2164-4-4.txt:          of starting RNA (above) were more than sufficient for
technical/biomed/1471-2164-4-4.txt:          this. Because yields of cRNA starting from 1 μg total RNA
technical/biomed/1471-2164-4-4.txt:          amplification step for RNA samples less than 1 μg. Our
technical/biomed/1471-2164-4-4.txt:          in vitro transcribed cRNA as
technical/biomed/1471-2164-4-4.txt:          The cRNA yields from the 0.5 μg samples with our protocol
technical/biomed/1471-2164-4-4.txt:          standard hybridizations. The cRNA yields from the 0.1 μg
technical/biomed/1471-2164-4-4.txt:          hybridized to GeneChips ®using 5 μg to 7.5 μg of cRNA to
technical/biomed/1471-2164-4-4.txt:          Aliquots of the biotinylated cRNA samples were
technical/biomed/1471-2164-4-4.txt:          quality and length. The cRNA for both the 10 μg and 2 μg
technical/biomed/1471-2164-4-4.txt:          fragmentation). The cRNA from the 0.5 μg sample prepared
technical/biomed/1471-2164-4-4.txt:          groups of samples diluted from the same individual RNA
technical/biomed/1471-2164-4-4.txt:          If the decrease in starting amount of RNA or the
technical/biomed/1471-2164-4-4.txt:          signals from all of the reduced RNA sample size groups
technical/biomed/1471-2164-4-4.txt:          was used to analyze the signals from each RNA sample size
technical/biomed/1471-2164-4-4.txt:          amounts of RNA on the variability in detection of probe
technical/biomed/1471-2164-4-4.txt:          comparing the 10 μg sample to the smaller RNA samples
technical/biomed/1471-2164-4-4.txt:          GeneChips ®from the lower RNA sample size groups were
technical/biomed/1471-2164-4-4.txt:          the RNAs were dilutions from the same RNA preparations.
technical/biomed/1471-2164-4-4.txt:          RNA
technical/biomed/1471-2164-4-4.txt:          the transcript. Synthesis of cDNA from the cRNA initially
technical/biomed/1471-2164-4-4.txt:          ends of the original mRNA, due to the requirement for
technical/biomed/1471-2164-4-4.txt:          the cRNA prepared by amplification from the 0.5μg samples
technical/biomed/1471-2164-4-4.txt:          To determine if truncation of the 5' ends of the RNA
technical/biomed/1471-2164-4-4.txt:          amounts of total RNA can be used successfully, a
technical/biomed/1471-2164-4-4.txt:          RNA extractions and were labeled by the same protocol.
technical/biomed/1471-2164-4-4.txt:          effect of using 2 μg instead of 10 μg of RNA. The fold
technical/biomed/1471-2164-4-4.txt:        less than 1 μg of total RNA did not produce enough
technical/biomed/1471-2164-4-4.txt:        biotinylated cRNA for hybridization under the normal
technical/biomed/1471-2164-4-4.txt:        concentrate samples before cRNA synthesis, and mixing the
technical/biomed/1471-2164-4-4.txt:        amplification sufficed to produce cRNA from samples as low
technical/biomed/1471-2164-4-4.txt:        as 0.1 μg of total RNA. The amplification protocol uses the
technical/biomed/1471-2164-4-4.txt:        cRNA from the initial protocol as starting material for a
technical/biomed/1471-2164-4-4.txt:        possibility of priming the second strand from an internal
technical/biomed/1471-2164-4-4.txt:        site and to cleavage of the relatively labile RNA. For this
technical/biomed/1471-2164-4-4.txt:        the cRNA extended to about 850 nt, compared with about 2000
technical/biomed/1471-2164-4-4.txt:        further away from the 3' end of the RNA, as shown with the
technical/biomed/1471-2164-4-4.txt:        samples down to 1 μg of total RNA, and our simplified
technical/biomed/1471-2164-4-4.txt:        likely to be near the real 3' ends of the mRNAs The
technical/biomed/1471-2164-4-4.txt:        could increase cDNA yields from small amounts of RNA But
technical/biomed/1471-2164-4-4.txt:        the standard 10 μg of total RNA for an Affymetnx GeneChip
technical/biomed/1471-2164-4-4.txt:        that (1) small amounts of RNA can be used effectively in
technical/biomed/1471-2164-4-4.txt:        the standard protocol, (2) even very small amounts of RNA
technical/biomed/1471-2164-4-4.txt:          Total RNA was extracted from the livers of 4 rats fed
technical/biomed/1471-2164-4-4.txt:          Valencia, CA). The RNA was resuspended and re-extracted
technical/biomed/1471-2164-4-4.txt:          the 4 RNA samples. The final concentration was adjusted
technical/biomed/1471-2164-4-4.txt:          the average cRNA yield from 1 μg of total RNA and to
technical/biomed/1471-2164-4-4.txt:          Biotinylated cRNA was prepared using the standard
technical/biomed/1471-2164-4-4.txt:          Yield RNA Transcript Labeling Kit, ENZO Diagnostics,
technical/biomed/1471-2164-4-4.txt:          untreated pooled samples. The yield of cRNA was estimated
technical/biomed/1471-2164-4-4.txt:          of the experiment was the only time RNAs from different
technical/biomed/1471-2164-4-4.txt:          animals were pooled, the cRNAs from these pooled samples
technical/biomed/1471-2164-4-4.txt:          RNA (one from each rat) were treated as individual
technical/biomed/1471-2164-4-4.txt:          μg, 2 μg, 0.5 μg and 0.1 μg total RNA (32 samples). For
technical/biomed/1471-2164-4-4.txt:          the 10 μg and 2 μg samples, cRNA was prepared using the
technical/biomed/1471-2164-4-4.txt:          possible. Because the cRNA yield from the 1 μg pooled
technical/biomed/1471-2164-4-4.txt:          double-stranded cDNA was synthesized from the total RNA
technical/biomed/1471-2164-4-4.txt:          unlabeled cRNA by 
technical/biomed/1471-2164-4-4.txt:          RNA polymerase with the Enzo BioArray, High Yield RNA
technical/biomed/1471-2164-4-4.txt:          usual manner. Yields of cDNA and cRNA were measured using
technical/biomed/1471-2164-4-4.txt:          the loss of sample. After the final round of cRNA
technical/biomed/1471-2164-4-4.txt:          synthesis, aliquots of biotinylated cRNA from each sample
technical/biomed/1471-2164-4-4.txt:          cocktails of 300 μl contained 15 μg of fragmented cRNA,
technical/biomed/1471-2164-4-4.txt:          a 200 μl hybridization cocktail containing 10 μg of cRNA
technical/biomed/1471-2164-4-4.txt:          samples, the cRNA yield was less than 15 μg so 5-7 5 μg
technical/biomed/1471-2164-4-4.txt:          of cRNA was used for the hybridization cocktail. Data
technical/biomed/1471-2164-4-4.txt:          quality and similarity of data from the various RNA
technical/biomed/1471-2164-4-4.txt:          Data from each RNA sample size group were exported and
technical/biomed/1471-2164-4-4.txt:          Changes within an RNA sample size group between normal
technical/biomed/1471-2164-4-4.txt:          for each RNA sample size group.
technical/biomed/1471-2164-4-4.txt:          target sequence from the 3' end of the mRNA or EST in the
technical/biomed/1471-2164-4-4.txt:        cRNA, complementary RNA
technical/biomed/1471-2164-4-4.txt:        dietary study and provided the total RNA for this work. HJE
technical/biomed/1471-2164-4-5.txt:        domains, like DNA- or RNA-binding modules (eg. the
technical/biomed/1471-2172-1-1.txt:          adenovirus E1b TATA box and the CAT gene. RNA transcripts
technical/biomed/1471-2172-1-1.txt:          To this end we used an in vitro human RNA polymerase II
technical/biomed/1471-2172-1-1.txt:          (n)TFIIH, and (n)RNA polymerase II. Using a promoter
technical/biomed/1471-2172-1-1.txt:          remained in the supernatant. The nuclei were washed, and
technical/biomed/1471-2172-1-1.txt:          the supernatants was solubilized in SDS sample buffer,
technical/biomed/1471-2172-1-1.txt:          the supernatant and not in the pellet, while
technical/biomed/1471-2172-1-1.txt:          start site ATG and an internal Mro I restriction site was
technical/biomed/1471-2172-1-1.txt:          and 10 μg of carrier yeast RNA. SDS was added to each
technical/biomed/1471-2172-1-1.txt:          microcentrifuge, the supernatants were transferred to new
technical/biomed/1471-2172-1-1.txt:          TFIIB, TFIID, TFIIE, TFIIF, and TFIIH) and RNA polymerase
technical/biomed/1471-2172-1-1.txt:          triphosphates were added and RNA synthesis was allowed to
technical/biomed/1471-2172-1-1.txt:          stopped, RNA transcripts were processed, and where
technical/biomed/1471-2172-1-1.txt:          Supernatants were transferred to new tubes and nuclei
technical/biomed/1471-2172-1-1.txt:          A. Protein in the supernatant and pellet fractions were
technical/biomed/1471-2172-2-10.txt:        was supported by cytokine mRNA and ELISA data. We find by
technical/biomed/1471-2172-2-10.txt:          Production of IFN-γ and TNF-α mRNA determined by
technical/biomed/1471-2172-2-10.txt:          The mRNA isolated from CD8 +T cells from 12 aged, 10
technical/biomed/1471-2172-2-10.txt:          IFN-γ (or TNF-α) cDNA copies/ug total RNA. CD8 +T cells
technical/biomed/1471-2172-2-10.txt:          total RNA extraction. For IFN-γ, CD8 +T cells from both
technical/biomed/1471-2172-2-10.txt:          cytometric data, we can infer that the enhanced mRNA in
technical/biomed/1471-2172-2-10.txt:        or procedures that measure mRNA synthesis. Secondly,
technical/biomed/1471-2172-2-10.txt:        mRNA and ELISA studies support the conclusions of the flow
technical/biomed/1471-2172-2-10.txt:          As an alternative to FC analysis of activated PBMC
technical/biomed/1471-2172-2-10.txt:          mRNA and TNF-α mRNA detection kits from BioSource Corp.
technical/biomed/1471-2172-2-10.txt:          The mRNA was highly purified from purified CD8 +cells
technical/biomed/1471-2172-2-10.txt:          activated for 3 hrs, with the Ambion RNAqueous kit for
technical/biomed/1471-2172-2-10.txt:          total RNA, and the Micro Poly (A) pure kit for mRNA.
technical/biomed/1471-2172-2-10.txt:          Generally the mRNA obtained was near 2% of total RNA. The
technical/biomed/1471-2172-2-10.txt:          2 O; 5) 5 ul cDNA; 6) 5 ul Internal
technical/biomed/1471-2172-2-3.txt:        amino-terminus. Furthermore, we have found that an internal
technical/biomed/1471-2172-2-3.txt:          5% B-mercaptoethanol). Alternatively, lysates were
technical/biomed/1471-2172-2-4.txt:          mobilization was due to calcium release from internal
technical/biomed/1471-2172-2-4.txt:          Rac1 activity. Alternatively, since the combination of
technical/biomed/1471-2172-2-4.txt:          (4-HT; Research Biochemicals International).
technical/biomed/1471-2172-2-9.txt:          Using standard tubing (0.062" I.D, internal diameter)
technical/biomed/1471-2172-2-9.txt:          with 0.01" ID (see below). Narrower internal tubing
technical/biomed/1471-2172-2-9.txt:          reduced with the reduction of the internal diameter of
technical/biomed/1471-2172-2-9.txt:          configuration. Internal tubing diameter is indicated in
technical/biomed/1471-2172-3-1.txt:        on the levels of mRNA encoding the CD4 and CD8
technical/biomed/1471-2172-3-1.txt:        cannot be a concern. After 3.0 h incubation RNA was
technical/biomed/1471-2172-3-1.txt:        mRNAs, whose constitutive expression is high in developing
technical/biomed/1471-2172-3-1.txt:        mRNA levels. On the other hand, apoptosis was ruled out as
technical/biomed/1471-2172-3-1.txt:        levels of CD4 and CD8 mRNAs. As shown in Fig. 2, the
technical/biomed/1471-2172-3-1.txt:        and CD8 mRNAs. The water-soluble phorbol 12,13 dibutyrate
technical/biomed/1471-2172-3-1.txt:        up-regulation of CD3 expression and by the unaltered mRNA
technical/biomed/1471-2172-3-1.txt:        plays a role in modulating the mRNA levels of CD3, CD4, and
technical/biomed/1471-2172-3-1.txt:        transcription, RNA processing, nuclear/cytosol transport,
technical/biomed/1471-2172-3-1.txt:        translation, and RNA and Protein stability. Since the
technical/biomed/1471-2172-3-1.txt:        half-lives of mRNA and protein can be dramatically
technical/biomed/1471-2172-3-1.txt:        internalization of the molecule by endocytosis, which in
technical/biomed/1471-2172-3-1.txt:        CD8 mRNAs (α and β), suggests that PKA activation may
technical/biomed/1471-2172-3-1.txt:        differences in mRNA and protein stability. Lastly, some of
technical/biomed/1471-2172-3-1.txt:          RNA Extraction
technical/biomed/1471-2172-3-1.txt:          Total unfractionated RNA was extracted in guanidiniun
technical/biomed/1471-2172-3-1.txt:          Total RNA (10 μg) was electrophoresed in 1.0% agarose
technical/biomed/1471-2172-3-1.txt:          2.0 hr. and autoradiographed. Equal amounts of RNA
technical/biomed/1471-2172-3-1.txt:          expressed proto-oncogene c-Ha-ras was used as internal
technical/biomed/1471-2172-3-10.txt:        zinc finger pairs can be generated by alternative RNA
technical/biomed/1471-2172-3-12.txt:          the TRIzol (GIBCO BRL) at -70°C until RNA isolation.
technical/biomed/1471-2172-3-12.txt:          International) in 1.5 ml-eppendorf tubes. RNA was
technical/biomed/1471-2172-3-12.txt:          of total RNA to cDNA was done using SuperScript II
technical/biomed/1471-2172-3-12.txt:          1 min for IL-7, SCF and their internal control β-actin;
technical/biomed/1471-2172-3-12.txt:          internal control β-actin. PCR products were visualized by
technical/biomed/1471-2172-3-12.txt:          without supplemental cytokine as an internal control. In
technical/biomed/1471-2172-3-16.txt:          or mutant Syk mRNA were identified using a three-primer
technical/biomed/1471-2172-3-16.txt:          between constitutive kinase activity and mRNA expression
technical/biomed/1471-2172-3-16.txt:          (K395A/3F)Syk mRNA (e.g. clone 2.1.2) had higher levels
technical/biomed/1471-2172-3-16.txt:          levels of (K395A/3F) Syk mRNA (e.g. clones 2.1.6, 2.4.2
technical/biomed/1471-2172-3-16.txt:          or equivalent levels of human Syk mRNA as compared with
technical/biomed/1471-2172-3-16.txt:          the levels of endogenous Syk mRNA (lanes 3 and 4, upper
technical/biomed/1471-2172-3-16.txt:        Alternatively, the absence of signal transduction in the
technical/biomed/1471-2172-3-16.txt:          of a 1:2 dilution of viral supernatant in growth medium
technical/biomed/1471-2172-3-16.txt:          centrifugation at 18,000 × g at 4°C. Supernatants were
technical/biomed/1471-2172-3-2.txt:          external loops (Dr. Richard Bott, Genencor International,
technical/biomed/1471-2172-3-4.txt:          an internal control, "sham transfection" population. CD4
technical/biomed/1471-2172-3-4.txt:        negative population to serve as an internal control (Figure
technical/biomed/1471-2172-3-4.txt:          2 . Culture supernatants were then
technical/biomed/1471-2172-3-9.txt:        mRNA coding for perforin/ granzymes A and B [ 4 ] . Hence
technical/biomed/1471-2172-3-9.txt:          centrifuged & 150 μl supernatant was carefully
technical/biomed/1471-2172-4-2.txt:        However, both GAD65 and GAD67 mRNA can be detected in the
technical/biomed/1471-2172-4-2.txt:        of mRNA, NOD mice spontaneously develop autoreactivity to
technical/biomed/1471-2180-1-12.txt:        RNA molecule [ 1; for reviews see 2, 3, 4]. The replication
technical/biomed/1471-2180-1-12.txt:        viral reverse transcriptase (P) with an RNA stem-loop (∈)
technical/biomed/1471-2180-1-12.txt:        within a terminal duplication of the pregenomic RNA. P
technical/biomed/1471-2180-1-12.txt:        templated by the pregenomic RNA [ 5, 6, 7, 8, 9, 10].
technical/biomed/1471-2180-1-12.txt:        During synthesis of the minus-strand DNA the pregenomic RNA
technical/biomed/1471-2180-1-12.txt:        is degraded by the ribonuclease H (RNAseH) activity of P.
technical/biomed/1471-2180-1-12.txt:        However, the RNAseH activity does not digest the extreme 5'
technical/biomed/1471-2180-1-12.txt:        end of the template RNA, and this ∼ 18 nucleotide capped
technical/biomed/1471-2180-1-12.txt:        RNA fragment is then transferred to direct repeat 2 (DR2),
technical/biomed/1471-2180-1-12.txt:        pregenomic RNA that is encapsidated with it in the viral
technical/biomed/1471-2180-1-12.txt:        RNAseH cleaves the RNA strand in a RNA:DNA heteroduplex,
technical/biomed/1471-2180-1-12.txt:        but it does not cleave DNA or RNA that is not hybridized to
technical/biomed/1471-2180-1-12.txt:        DNA. The RNAseH activity of P is required to remove the RNA
technical/biomed/1471-2180-1-12.txt:        transcription. If there is no RNAseH activity, positive
technical/biomed/1471-2180-1-12.txt:        virions are produced. The hepadnaviral RNAseH activity has
technical/biomed/1471-2180-1-12.txt:        (i) Sequence alignment of P with known RNAseH enzymes
technical/biomed/1471-2180-1-12.txt:        Mutation of the putative RNAseH active site residues in
technical/biomed/1471-2180-1-12.txt:        results in the expected RNA:DNA heteroduplex [ 19, 21, 22,
technical/biomed/1471-2180-1-12.txt:        23]. (iii) RNAseH activity has been detected for the human
technical/biomed/1471-2180-1-12.txt:        hepatitis B virus when the RNAseH domain was expressed as a
technical/biomed/1471-2180-1-12.txt:        fusion with the maltose binding protein [ 24]. (iv) RNAseH
technical/biomed/1471-2180-1-12.txt:        the RNAseH was less than that of the native DHBV P,
technical/biomed/1471-2180-1-12.txt:        that the signal came from a cellular RNAseH [ 25].
technical/biomed/1471-2180-1-12.txt:        In this study we attempted to directly detect the RNAseH
technical/biomed/1471-2180-1-12.txt:        conditions and substrates yielded no DHBV RNAseH activity.
technical/biomed/1471-2180-1-12.txt:        possesses an intrinsic RNAseH activity, we conclude that
technical/biomed/1471-2180-1-12.txt:        the hepadnaviral RNAseH activity is likely to be "substrate
technical/biomed/1471-2180-1-12.txt:          RNAseH activity on endogenous nucleic acids
technical/biomed/1471-2180-1-12.txt:          RNAseH activity that is active on RNA:DNA heteroduplexes
technical/biomed/1471-2180-1-12.txt:          within the RNAseH domain of P and examined the effect of
technical/biomed/1471-2180-1-12.txt:          examined by Southern analysis using strand-specific RNAs
technical/biomed/1471-2180-1-12.txt:          it was in an RNA:DNA heteroduplex. This is the predicted
technical/biomed/1471-2180-1-12.txt:          phenotype for an RNAseH-deficient hepadnaviral P protein,
technical/biomed/1471-2180-1-12.txt:          and it indicates that the P protein has an RNAseH
technical/biomed/1471-2180-1-12.txt:          activity that acts on endogenously synthesized RNA:DNA
technical/biomed/1471-2180-1-12.txt:          Oligonucleotide-directed RNAseH assays
technical/biomed/1471-2180-1-12.txt:          To examine DHBV RNAseH activity on exogenous
technical/biomed/1471-2180-1-12.txt:          substrates, internally 32P-labeled RNAs were synthesized 
technical/biomed/1471-2180-1-12.txt:          complementary DNA oligonucleotides. RNAseH activity was
technical/biomed/1471-2180-1-12.txt:          detected as cleavage of the RNA at the position of the
technical/biomed/1471-2180-1-12.txt:          this oligonucleotide-directed RNAseH assay was positive
technical/biomed/1471-2180-1-12.txt:          sense RNA derived from DHBV nt 2401 to 2605 (DRF+), which
technical/biomed/1471-2180-1-12.txt:          contains DR2, DR1, and the 5' half of ∈. This RNA was
technical/biomed/1471-2180-1-12.txt:          chosen as it contains the region where the DHBV RNAseH
technical/biomed/1471-2180-1-12.txt:          Oligonucleotide D2507- was annealed to DRF+ RNA, and
technical/biomed/1471-2180-1-12.txt:          E. coli RNAseH yielded products of
technical/biomed/1471-2180-1-12.txt:          to the DRF+ RNA (D2526+) was used as a negative control,
technical/biomed/1471-2180-1-12.txt:          and no cleavage of the RNA was detected under these
technical/biomed/1471-2180-1-12.txt:          E. coli RNAseH (data not
technical/biomed/1471-2180-1-12.txt:          RNA in the oligonucleotide-directed RNAseH assay in the
technical/biomed/1471-2180-1-12.txt:          first attempt to detect DHBV RNAseH activity on exogenous
technical/biomed/1471-2180-1-12.txt:          treated with low pH prior to the RNAseH assays to allow
technical/biomed/1471-2180-1-12.txt:          RNAseH activity was detected with the viral cores in
technical/biomed/1471-2180-1-12.txt:          limit the possibility that the failure to detect RNAseH
technical/biomed/1471-2180-1-12.txt:          particles, an RNAseH assay was performed with a 10-fold
technical/biomed/1471-2180-1-12.txt:          increase in cores. Again, no DHBV RNAseH activity was
technical/biomed/1471-2180-1-12.txt:          RNAseH active site by low pH treatment, cores were
technical/biomed/1471-2180-1-12.txt:          NP-40 [ 16], again without yielding detectable RNAseH
technical/biomed/1471-2180-1-12.txt:          RNAseH substrate to access P within the viral cores was
technical/biomed/1471-2180-1-12.txt:          synthesize limited amounts of DNA from an exogenous RNA
technical/biomed/1471-2180-1-12.txt:          RNA that does not depend on the protein-primed initiation
technical/biomed/1471-2180-1-12.txt:          inactivated by addition of EGTA. DRF+ RNA and radioactive
technical/biomed/1471-2180-1-12.txt:          template, indicating that the RNA had access to P within
technical/biomed/1471-2180-1-12.txt:          did not support DNA synthesis (lane 3). The RNAseH
technical/biomed/1471-2180-1-12.txt:          substrate itself (DRF+ RNA annealed to D2507-) also
technical/biomed/1471-2180-1-12.txt:          combination of DRF+ RNA and the non-complementary
technical/biomed/1471-2180-1-12.txt:          bound to the RNA rather than extension from the
technical/biomed/1471-2180-1-12.txt:          the RNAseH template as a substrate, because it directly
technical/biomed/1471-2180-1-12.txt:          The initial RNAseH assays were performed under
technical/biomed/1471-2180-1-12.txt:          were chosen because the RNAseH and polymerase activities
technical/biomed/1471-2180-1-12.txt:          failed to detect DHBV RNAseH activity, the
technical/biomed/1471-2180-1-12.txt:          oligonucleotide-directed RNAseH assay was performed with
technical/biomed/1471-2180-1-12.txt:          virus RNAseH [ 30]. RNAseH activity was detected using 
technical/biomed/1471-2180-1-12.txt:          E. coli RNAseH and AMV reverse
technical/biomed/1471-2180-1-12.txt:          E. coli RNAseH was active at all
technical/biomed/1471-2180-1-12.txt:          results for DHBV RNAseH activity were also obtained when
technical/biomed/1471-2180-1-12.txt:          the RNAseH assay was performed at NaCl concentrations
technical/biomed/1471-2180-1-12.txt:          E. coli RNAseH was active in all
technical/biomed/1471-2180-1-12.txt:          2 , and again no RNAseH activity was
technical/biomed/1471-2180-1-12.txt:          h. DHBV RNAseH cleavage was not detected under any of
technical/biomed/1471-2180-1-12.txt:          E. coli RNAseH activity was
technical/biomed/1471-2180-1-12.txt:          temperature of Pekin ducks is about 42°C, an RNAseH assay
technical/biomed/1471-2180-1-12.txt:          was performed with DHBV cores at 42°C. Again, no RNAseH
technical/biomed/1471-2180-1-12.txt:          efficiency of RNAseH [ 31]. Therefore, 1.5 mM ATP was
technical/biomed/1471-2180-1-12.txt:          included in an RNAseH assay. DHBV RNAseH cleavage was not
technical/biomed/1471-2180-1-12.txt:          four dNTPs did not stimulate the RNAseH activity (data
technical/biomed/1471-2180-1-12.txt:          nucleotide requirement to activate the RNAseH activity,
technical/biomed/1471-2180-1-12.txt:          induce detectable RNAseH activity.
technical/biomed/1471-2180-1-12.txt:          To detect DNA polymerization on exogenous RNA
technical/biomed/1471-2180-1-12.txt:          RNAseH activity, an RNAseH assay was performed in
technical/biomed/1471-2180-1-12.txt:          showed that RNAseH activity was not detected in
technical/biomed/1471-2180-1-12.txt:          Because the ∈ RNA stem-loop induces a structural change
technical/biomed/1471-2180-1-12.txt:          the RNAseH activity in micrococcal nuclease treated
technical/biomed/1471-2180-1-12.txt:          cores. ∈ RNA was added in 
technical/biomed/1471-2180-1-12.txt:          treated cores in the RNAseH assay, and again, DHBV RNAseH
technical/biomed/1471-2180-1-12.txt:          Oligonucleotide-directed RNAseH assays with
technical/biomed/1471-2180-1-12.txt:          alternate substrates
technical/biomed/1471-2180-1-12.txt:          The above experiments suggest that the DHBV RNAseH may
technical/biomed/1471-2180-1-12.txt:          the possibility that the DHBV RNAseH simply could not
technical/biomed/1471-2180-1-12.txt:          recognize the specific heteroduplex formed by DRF+ RNA
technical/biomed/1471-2180-1-12.txt:          with DRF+ RNA in oligonucleotide-directed RNAseH assays
technical/biomed/1471-2180-1-12.txt:          DHBV RNAseH activity was observed with the viral cores
technical/biomed/1471-2180-1-12.txt:          E. coli RNAseH recognized the
technical/biomed/1471-2180-1-12.txt:          DRF+ RNA, a second RNA, DXB+ (DHBV nt 1358-1504 positive
technical/biomed/1471-2180-1-12.txt:          D1452- was employed in RNAseH assays. Again, no specific
technical/biomed/1471-2180-1-12.txt:          DHBV RNAseH cleavage was observed (data not shown),
technical/biomed/1471-2180-1-12.txt:          indicating that using different region of RNA from the
technical/biomed/1471-2180-1-12.txt:          RNAseH could not engage an exogenous substrate. Because
technical/biomed/1471-2180-1-12.txt:          best likelihood of observing RNAseH activity, a titration
technical/biomed/1471-2180-1-12.txt:          DXB+ RNA annealed to D1452- and nuclease-treated DHBV
technical/biomed/1471-2180-1-12.txt:          Alternate RNAseH assays
technical/biomed/1471-2180-1-12.txt:          Other assays to detect DHBV RNAseH activity were also
technical/biomed/1471-2180-1-12.txt:          employed. Randomly initiated RNA synthesis by 
technical/biomed/1471-2180-1-12.txt:          E. coli RNA polymerase was used to
technical/biomed/1471-2180-1-12.txt:          make [ 32P]RNA:DNA substrates using synthetic
technical/biomed/1471-2180-1-12.txt:          homopolymers or DRF DNA [ 30]. In these assays, RNAseH
technical/biomed/1471-2180-1-12.txt:          radioactivity. No viral RNAseH activity was detected in
technical/biomed/1471-2180-1-12.txt:          obtained with the oligonucleotide-directed RNAseH assay
technical/biomed/1471-2180-1-12.txt:          active DHBV P were also employed in the RNAseH assays
technical/biomed/1471-2180-1-12.txt:          retrotransposon TY-A protein [ 29]. DHBV RNAseH activity
technical/biomed/1471-2180-1-12.txt:          in either the oligonucleotide-directed RNAseH assay or
technical/biomed/1471-2180-1-12.txt:          the synthetic homopolymer assay, although RNAseH activity
technical/biomed/1471-2180-1-12.txt:          detected (data not shown). DHBV RNAseH activity also
technical/biomed/1471-2180-1-12.txt:        The aim of this study was to determine if the DHBV RNAseH
technical/biomed/1471-2180-1-12.txt:        transcription. Oligonucleotide-directed RNAseH assays were
technical/biomed/1471-2180-1-12.txt:        of ATP and dNTPs were examined. RNAseH assays were also
technical/biomed/1471-2180-1-12.txt:        and multiple RNA sequences and DNA oligonucleotide
technical/biomed/1471-2180-1-12.txt:        combinations were employed. DHBV RNAseH activity was not
technical/biomed/1471-2180-1-12.txt:        E. coli or AMV RNAseH activity could
technical/biomed/1471-2180-1-12.txt:        treatment; (ii) the RNAseH substrate could access the
technical/biomed/1471-2180-1-12.txt:        the RNAseH substrates were suitable because they were
technical/biomed/1471-2180-1-12.txt:        E. coli RNAseH and AMV reverse
technical/biomed/1471-2180-1-12.txt:        transcriptase and because the DHBV RNAseH activity can
technical/biomed/1471-2180-1-12.txt:        degrade these RNA sequences during reverse transcription
technical/biomed/1471-2180-1-12.txt:        (the target RNAs were derived from the DHBV genome).
technical/biomed/1471-2180-1-12.txt:        However, the DHBV RNAseH activity could not degrade the
technical/biomed/1471-2180-1-12.txt:        heteroduplexes. Therefore, we feel the RNAseH activity is
technical/biomed/1471-2180-1-12.txt:        detect RNAseH activity). There are at least three other
technical/biomed/1471-2180-1-12.txt:        potential causes for the failure to detect RNAseH activity
technical/biomed/1471-2180-1-12.txt:        is that the RNAseH activity in our core preparations may be
technical/biomed/1471-2180-1-12.txt:        number for the RNAseH activity that would be needed to
technical/biomed/1471-2180-1-12.txt:        possibility of detecting RNAseH cleavage products, each
technical/biomed/1471-2180-1-12.txt:        RNAseH assay was exposed to film for up to a week to "burn
technical/biomed/1471-2180-1-12.txt:        below the input RNA on the gels. Under these conditions,
technical/biomed/1471-2180-1-12.txt:        our detection limit for the RNAseH assay was measured at
technical/biomed/1471-2180-1-12.txt:        0.625 pg of internally 32P-labeled RNA, or about 7.5 × 10
technical/biomed/1471-2180-1-12.txt:        in a typical RNAseH assay would require just a single
technical/biomed/1471-2180-1-12.txt:        the reaction. Therefore, the turnover number for the RNAseH
technical/biomed/1471-2180-1-12.txt:        sensitive enough to detect RNAseH activity if it were
technical/biomed/1471-2180-1-12.txt:        The second alternative cause for our failure to detect
technical/biomed/1471-2180-1-12.txt:        RNAseH activity is that the RNAseH active site may be
technical/biomed/1471-2180-1-12.txt:        manner was still unable to degrade the exogenous RNAseH
technical/biomed/1471-2180-1-12.txt:        RNAseH substrates (Fig. 3B). The RNAseH active site must be
technical/biomed/1471-2180-1-12.txt:        third alternative explanation for our negative data is that
technical/biomed/1471-2180-1-12.txt:        the DHBV RNAseH activity may have been inactivated by the
technical/biomed/1471-2180-1-12.txt:        polymerase activity, yet we were unable to detect RNAseH
technical/biomed/1471-2180-1-12.txt:        Furthermore, DHBV RNAseH activity could not be detected
technical/biomed/1471-2180-1-12.txt:        although TY RNAseH activity could be detected from
technical/biomed/1471-2180-1-12.txt:        recombinant DHBV polymerase for RNAseH activity on
technical/biomed/1471-2180-1-12.txt:        simplest explanation of our data, e.g. that the RNAseH
technical/biomed/1471-2180-1-12.txt:        that of HIV) bind to the RNA:DNA heteroduplex as a single
technical/biomed/1471-2180-1-12.txt:        enzymatically active HBV RNAseH as a fusion protein in 
technical/biomed/1471-2180-1-12.txt:        (e.g., substrate commitment) of this recombinant HBV RNAseH
technical/biomed/1471-2180-1-12.txt:        restriction on the RNAseH activity. Understanding the
technical/biomed/1471-2180-1-12.txt:        DHBV RNAseH activity could be detected on RNA:DNA
technical/biomed/1471-2180-1-12.txt:        the process of viral reverse transcription, but no RNAseH
technical/biomed/1471-2180-1-12.txt:        activity could be detected exogenously provided RNA:DNA
technical/biomed/1471-2180-1-12.txt:        the RNAseH active site is most probably "substrate
technical/biomed/1471-2180-1-12.txt:        minimum, we have demonstrated that the DHBV RNAseH activity
technical/biomed/1471-2180-1-12.txt:          715D to V; this alteration ablates the RNAseH activity [
technical/biomed/1471-2180-1-12.txt:          D2453+/D2543M-Sal pairs were used with DRF+ RNA, and the
technical/biomed/1471-2180-1-12.txt:          D1433+/ D1452- pair was used with DXB+ RNA. The sequences
technical/biomed/1471-2180-1-12.txt:          by centrifugation at 13,000×g for 5 min. The supernatant
technical/biomed/1471-2180-1-12.txt:          In vitrotranscription and purification of RNA
technical/biomed/1471-2180-1-12.txt:          internally 32P -labeled RNA substrates by 
technical/biomed/1471-2180-1-12.txt:          and transcribed by T3 RNA polymerase; the resulting RNA
technical/biomed/1471-2180-1-12.txt:          linearized with AvaII and was transcribed with T7 RNA
technical/biomed/1471-2180-1-12.txt:          polymerase; the resulting RNA was 182 nt long with
technical/biomed/1471-2180-1-12.txt:          templates were digested with DNaseI. RNA transcripts were
technical/biomed/1471-2180-1-12.txt:          Oligonucleotide-directed RNAseH assay
technical/biomed/1471-2180-1-12.txt:          RNAseH activity in permeabilized cores was measured by
technical/biomed/1471-2180-1-12.txt:          oligonucleotide-directed cleavage of internally
technical/biomed/1471-2180-1-12.txt:          32P-labeled RNA substrates. The reaction was performed in
technical/biomed/1471-2180-1-12.txt:          oligonucleotide, 100 ng purified radiolabeled RNA
technical/biomed/1471-2180-1-12.txt:          template, and 4 U RNasin at 37°C for 65 min. The products
technical/biomed/1471-2180-1-12.txt:          E. coli RNAseH (0.5 U; Promega) was
technical/biomed/1471-2180-1-12.txt:          DNA synthesis on exogenous RNA templates
technical/biomed/1471-2180-1-12.txt:          Reverse transcriptase activity using an exogenous RNA
technical/biomed/1471-2180-1-12.txt:          by addition of EGTA, 1.5 μg RNA was added, and the
technical/biomed/1471-2180-1-12.txt:        RNAseH, ribonuclease H
technical/biomed/1471-2180-1-16.txt:        24 25 26 27 ] . Siderophores are secreted in the external
technical/biomed/1471-2180-1-16.txt:        gets internalized through the specific outer membrane
technical/biomed/1471-2180-1-16.txt:        of siderophore in the external melieu. Daniel et.al. [ 28 ]
technical/biomed/1471-2180-1-16.txt:          by testing culture supernatants in ELISA using two
technical/biomed/1471-2180-1-16.txt:          Hybridoma supernatants reacting with antigen A alone
technical/biomed/1471-2180-1-16.txt:          supernatant (undiluted) was added to it and incubated at
technical/biomed/1471-2180-1-16.txt:          supernatant for 30 min at 37°C. To this 10 6PMN in 100 μl
technical/biomed/1471-2180-1-16.txt:          supernatant was decanted. The cell pellet was fixed by
technical/biomed/1471-2180-1-16.txt:          Briefly the culture supernatant of bacteria grown in
technical/biomed/1471-2180-1-16.txt:          antibody culture supernatant for 1 h at 37°C before
technical/biomed/1471-2180-1-26.txt:        end up with an internal pH of about 6 and markers of
technical/biomed/1471-2180-1-26.txt:        experiment contains an internal standard (the wild-type
technical/biomed/1471-2180-1-26.txt:        as that of the wild-type and could be used an internal
technical/biomed/1471-2180-1-26.txt:        Rv2233-Rv2240c as well as the tRNA
technical/biomed/1471-2180-1-28.txt:        alternatives to HIV could be considered as potential "live"
technical/biomed/1471-2180-1-28.txt:        poxviruses (vaccinia and canarypox), small RNA viruses
technical/biomed/1471-2180-1-28.txt:        replicates entirely in the cytoplasm through RNA directed
technical/biomed/1471-2180-1-28.txt:        RNA polymerization and is incapable of integrating into the
technical/biomed/1471-2180-1-28.txt:        NS4A, NS4B and NS5 include an RNA-directed RNA polymerase
technical/biomed/1471-2180-1-28.txt:          RNAase-free water in preparation for transcription. The
technical/biomed/1471-2180-1-28.txt:          GTP; 0.5 mM cap analog (NEBL); 10 mM DTT; 40 U of Rnasin
technical/biomed/1471-2180-1-28.txt:          (Promega); 30 U of SP6 RNA polymerase; and 1 × SP6 RNA
technical/biomed/1471-2180-1-28.txt:          full length viral RNA, were used to transfect
technical/biomed/1471-2180-1-29.txt:        eukaryotic mRNA and is required for mRNA stability and
technical/biomed/1471-2180-1-29.txt:        reactions: the 5' triphosphate end of the nascent pre-mRNA
technical/biomed/1471-2180-1-29.txt:        is hydrolyzed to a diphosphate by RNA triphosphatase; the
technical/biomed/1471-2180-1-29.txt:        diphosphate end is capped with GMP by RNA
technical/biomed/1471-2180-1-29.txt:        guanylyltransferase; and the GpppN cap is methylated by RNA
technical/biomed/1471-2180-1-29.txt:        RNA triphosphatase component in "lower" versus "higher"
technical/biomed/1471-2180-1-29.txt:        and mammalian RNA triphosphatases are completely different
technical/biomed/1471-2180-1-29.txt:        [ 2 3 ] . Thus, it has been suggested that RNA
technical/biomed/1471-2180-1-29.txt:        of the RNA triphosphatase Cet1 that abrogate catalytic
technical/biomed/1471-2180-1-29.txt:        key question is whether RNA triphosphatase is a valid drug
technical/biomed/1471-2180-1-29.txt:        inhibitor of one fungal RNA triphosphatase could be
technical/biomed/1471-2180-1-29.txt:        To address these issues, we have characterized the RNA
technical/biomed/1471-2180-1-29.txt:        triphosphatase components of DNA virus and protozoan mRNA
technical/biomed/1471-2180-1-29.txt:        the metal-dependent RNA triphosphatases are two
technical/biomed/1471-2180-1-29.txt:        Here we address the critical question of whether RNA
technical/biomed/1471-2180-1-29.txt:        RNA triphosphatases (Cet1 and Cth1), of which only Cet1 is
technical/biomed/1471-2180-1-29.txt:        genes encoding RNA triphosphatase and RNA
technical/biomed/1471-2180-1-29.txt:        CaCET1 gene, signifying that RNA
technical/biomed/1471-2180-1-29.txt:        conclude that RNA triphosphatase is a valid target for
technical/biomed/1471-2180-1-29.txt:          RNA Triphosphatase and RNA Guanylyltransferase are
technical/biomed/1471-2180-1-29.txt:          S. pombe RNA triphosphatase Pct1 is
technical/biomed/1471-2180-1-29.txt:          quaternary structure [ 12 ] . The 
technical/biomed/1471-2180-1-29.txt:          S. pombe RNA guanylyltransferase
technical/biomed/1471-2180-1-29.txt:          that the RNA triphosphatase and RNA guanylyltransferase
technical/biomed/1471-2180-1-29.txt:          CaCET1 gene encoding RNA
technical/biomed/1471-2180-1-29.txt:          presented here that RNA triphosphatase is essential for
technical/biomed/1471-2180-1-29.txt:        Here we have shown that the RNA triphosphatases Pct1 and
technical/biomed/1471-2180-1-29.txt:        RNA triphosphatase is an attractive therapeutic target
technical/biomed/1471-2180-1-29.txt:        structure and catalytic mechanism of fungal RNA
technical/biomed/1471-2180-1-29.txt:        triphosphatase are completely different from the RNA
technical/biomed/1471-2180-1-29.txt:        fungal RNA triphosphatases. Thus, a mechanism-based
technical/biomed/1471-2180-1-29.txt:        inhibitor of fungal RNA triphosphatase should be highly
technical/biomed/1471-2180-1-29.txt:        only if RNA triphosphatase is
technical/biomed/1471-2180-1-29.txt:        The finding that the RNA triphosphatase CaCet1 is essential
technical/biomed/1471-2180-1-29.txt:        that all fungal species will have metal-dependent RNA
technical/biomed/1471-2180-1-29.txt:          S. pombeexpression vectors for RNA triphosphatase
technical/biomed/1471-2180-1-31.txt:          from a poly(A)-enriched mRNA population of Pf strain Dd2.
technical/biomed/1471-2180-1-31.txt:          by PCR using a primer corresponding to the internal
technical/biomed/1471-2180-1-31.txt:          cDNA using the Pf3D7 genomic DNA or Dd2 total RNA as
technical/biomed/1471-2180-1-31.txt:          30 min. The supernatant, called "total extract", was
technical/biomed/1471-2180-1-33.txt:        molecule, e.g. double stranded RNA, and a peptide to form
technical/biomed/1471-2180-1-33.txt:          the original mutant [ 4 ] . RNA was isolated from the
technical/biomed/1471-2180-1-33.txt:          in the RNA isolated from the 
technical/biomed/1471-2180-1-33.txt:          in the RNA isolated from the wild type isolate (Fig. 3,
technical/biomed/1471-2180-1-33.txt:          supernatants for the presence of SpeB (Fig. 4B) or SK
technical/biomed/1471-2180-1-33.txt:          RNA was prepared from wild type CS101 wt, 
technical/biomed/1471-2180-1-33.txt:          resuspended in 3 mL Trizol (Gibco, Rockville, MD). RNA
technical/biomed/1471-2180-1-33.txt:          instructions. The RNA concentration was determined
technical/biomed/1471-2180-1-33.txt:          RNA was electrophoresed in a 1% agarose gel (Molecular
technical/biomed/1471-2180-1-33.txt:          electrophoresis, RNA was transferred to a nylon membrane
technical/biomed/1471-2180-1-33.txt:          sagA/pel mRNA was determined by the
technical/biomed/1471-2180-1-33.txt:          supernatants (100 μL) were mixed with either 1 μg of
technical/biomed/1471-2180-1-33.txt:          supernatants was assayed as described [ 47 ] . Briefly,
technical/biomed/1471-2180-1-33.txt:          50 μL of culture supernatant with or without 0.1 μM
technical/biomed/1471-2180-1-34.txt:        Over the last decade, RNA interference (RNAi), mediated
technical/biomed/1471-2180-1-34.txt:        by short interfering double-stranded RNA molecules (siRNA
technical/biomed/1471-2180-1-34.txt:        or dsRNA), has been gradually recognized as a major
technical/biomed/1471-2180-1-34.txt:        21-nucleotide long dsRNA molecules corresponding to
technical/biomed/1471-2180-1-34.txt:        specific mRNA sequences, when introduced into mammalian
technical/biomed/1471-2180-1-34.txt:        degrading the cognate mRNAs and thus abrogating the
technical/biomed/1471-2180-1-34.txt:        So far, the genes targeted for siRNA-mediated PTGS have
technical/biomed/1471-2180-1-34.txt:        been cellular in origin and thus, the mRNAs were
technical/biomed/1471-2180-1-34.txt:        transcribed in the nucleus by cellular DNA-dependent RNA
technical/biomed/1471-2180-1-34.txt:        polymerase. In contrast, the vast majority of RNA genomes
technical/biomed/1471-2180-1-34.txt:        transcription of RNA viral genomes, with the exception of
technical/biomed/1471-2180-1-34.txt:        retroviral RNA, is catalyzed by a virally encoded
technical/biomed/1471-2180-1-34.txt:        RNA-dependent RNA polymerase (RdRP) [ 3 ] . It remains
technical/biomed/1471-2180-1-34.txt:        untested whether the siRNA-mediated PTGS will work on mRNAs
technical/biomed/1471-2180-1-34.txt:        of the potency of siRNA in some organisms, it has been
technical/biomed/1471-2180-1-34.txt:        Furthermore, since dsRNA is known to be a potent inducer of
technical/biomed/1471-2180-1-34.txt:        whether this also occurs in cells in which antisense dsRNA
technical/biomed/1471-2180-1-34.txt:        negative-strand RNA (NNR) virus as a test target for
technical/biomed/1471-2180-1-34.txt:        RNA-mediated inhibition. We reasoned that, if successful,
technical/biomed/1471-2180-1-34.txt:        cytoplasmic RNA viruses. Traditionally, structure-function
technical/biomed/1471-2180-1-34.txt:        analyses of RNA genomes, including those of RNA viruses,
technical/biomed/1471-2180-1-34.txt:        selected RNA genes is not an option. These obstacles have
technical/biomed/1471-2180-1-34.txt:        Despite its revolutionary effect on RNA viral reverse
technical/biomed/1471-2180-1-34.txt:        recombinant expression of the viral genomic RNA and all the
technical/biomed/1471-2180-1-34.txt:        large RNA genomes [ 8 9 ] . The 10-15 kb long RNA genomes
technical/biomed/1471-2180-1-34.txt:        alternatives to the cDNA-based approach that might allow us
technical/biomed/1471-2180-1-34.txt:        mRNAs as targets, and another NNR virus (VSV) as well as
technical/biomed/1471-2180-1-34.txt:        cellular mRNAs as controls, we show that synthetic dsRNA
technical/biomed/1471-2180-1-34.txt:        cytoplasmic RNA viral gene expression. We also provide the
technical/biomed/1471-2180-1-34.txt:        first direct evidence that the 21-nt long dsRNAs do not
technical/biomed/1471-2180-1-34.txt:        RNA-based gene expression and a quicker and simpler
technical/biomed/1471-2180-1-34.txt:        alternative to cDNA-based reverse genetics of RNA
technical/biomed/1471-2180-1-34.txt:          Ablation of viral gene expression by dsRNA against
technical/biomed/1471-2180-1-34.txt:          RSV P mRNA
technical/biomed/1471-2180-1-34.txt:          The RNA genome of RSV is about 15 kb long and contains
technical/biomed/1471-2180-1-34.txt:          negative-strand genome RNA and its full-length
technical/biomed/1471-2180-1-34.txt:          complement, the positive-strand antigenome RNA, thus
technical/biomed/1471-2180-1-34.txt:          protein is believed to encode the basic RNA
technical/biomed/1471-2180-1-34.txt:          at the 3' end of the genomic RNA to initiate
technical/biomed/1471-2180-1-34.txt:          mRNAs. Unlike the full-length genomic and antigenomic
technical/biomed/1471-2180-1-34.txt:          RNA, the mRNAs are 5'-capped, 3'-polyadenylated, and do
technical/biomed/1471-2180-1-34.txt:          not bind N protein. Translation of these mRNAs results in
technical/biomed/1471-2180-1-34.txt:          protein then allows encapsidation of nascent leader RNA
technical/biomed/1471-2180-1-34.txt:          full-length, encapsidated anti-genomic RNA, which is in
technical/biomed/1471-2180-1-34.txt:          turn replicated into more genomic RNA [ 15 ] . Thus, the
technical/biomed/1471-2180-1-34.txt:          full-length genomic and antigenomic RNA are wrapped with
technical/biomed/1471-2180-1-34.txt:          replicated genomic RNA serves as templates for secondary
technical/biomed/1471-2180-1-34.txt:          accounts for the major burst of viral protein and RNA in
technical/biomed/1471-2180-1-34.txt:          To test the effectiveness of the anti-P dsRNA, we
technical/biomed/1471-2180-1-34.txt:          transfected the dsRNA into A549 cells, and infected the
technical/biomed/1471-2180-1-34.txt:          nM dsRNA. Although we have not tested lower amounts of
technical/biomed/1471-2180-1-34.txt:          dsRNA for P, the severe loss of P protein at 10 nM dsRNA
technical/biomed/1471-2180-1-34.txt:          and only a slightly greater loss with higher dsRNA
technical/biomed/1471-2180-1-34.txt:          to cause substantial ablation of P protein at dsRNA
technical/biomed/1471-2180-1-34.txt:          nM dsRNA-treated cells was found to be reduced by 10
technical/biomed/1471-2180-1-34.txt:          nM dsRNA (data not shown). 
technical/biomed/1471-2180-1-34.txt:          diminished in the dsRNA-treated cells, as would be
technical/biomed/1471-2180-1-34.txt:          anti-P dsRNA-treated cells were morphologically
technical/biomed/1471-2180-1-34.txt:          The specificity of dsRNA activity was further tested
technical/biomed/1471-2180-1-34.txt:          by using a dsRNA against cellular lamin A/C that was
technical/biomed/1471-2180-1-34.txt:          shown in Fig. 1(lane 'La'), the anti-lamin dsRNA, while
technical/biomed/1471-2180-1-34.txt:          anti-P dsRNA in which the lowercase A-U base pair (see
technical/biomed/1471-2180-1-34.txt:          the dsRNA sequences in Materials and Methods) was altered
technical/biomed/1471-2180-1-34.txt:          needed for the dsRNA effect, hence its extreme
technical/biomed/1471-2180-1-34.txt:          with anti-F dsRNA
technical/biomed/1471-2180-1-34.txt:          dsRNA on F as a second test gene, and also to compare and
technical/biomed/1471-2180-1-34.txt:          First, to test the effectiveness of the anti-F dsRNA
technical/biomed/1471-2180-1-34.txt:          were not treated with dsRNA; the nuclei of the same cells
technical/biomed/1471-2180-1-34.txt:          cells treated with just 3 nM anti-F dsRNA showed a
technical/biomed/1471-2180-1-34.txt:          substantial loss of F stain. At 20 nM dsRNA, F protein
technical/biomed/1471-2180-1-34.txt:          revealed that anti-F dsRNA, at concentrations as low as
technical/biomed/1471-2180-1-34.txt:          out a general protein loss. The anti-F dsRNA also had no
technical/biomed/1471-2180-1-34.txt:          effect on P protein levels, suggesting that such dsRNAs
technical/biomed/1471-2180-1-34.txt:          abrogate all viral mRNA translation. This was further
technical/biomed/1471-2180-1-34.txt:          no syncytia could be discerned in anti-F dsRNA-treated
technical/biomed/1471-2180-1-34.txt:          interesting contrast with the anti-P dsRNA (Panel C),
technical/biomed/1471-2180-1-34.txt:          Direct measurement of intracellular F mRNA by
technical/biomed/1471-2180-1-34.txt:          caused by anti-F dsRNA (Fig. 5, top panel). Similar
technical/biomed/1471-2180-1-34.txt:          RT-PCR of viral genomic RNA, viral P mRNA, or cellular
technical/biomed/1471-2180-1-34.txt:          actin mRNA revealed essentially no reduction, suggesting
technical/biomed/1471-2180-1-34.txt:          that the dsRNA did not activate a general antiviral
technical/biomed/1471-2180-1-34.txt:          response, and did not directly target genomic RNA.
technical/biomed/1471-2180-1-34.txt:          dsRNAs promote ablation of the specific mRNA target,
technical/biomed/1471-2180-1-34.txt:          Anti-RSV dsRNAs do not activate an interferon
technical/biomed/1471-2180-1-34.txt:          As mentioned before, cytoplasmic dsRNA can trigger a
technical/biomed/1471-2180-1-34.txt:          dsRNA molecules activate protein kinase PKR and
technical/biomed/1471-2180-1-34.txt:          5'-oligonucleotide synthetase activates RNase L that in
technical/biomed/1471-2180-1-34.txt:          turn catalyses non-specific degradation of mRNA. Since
technical/biomed/1471-2180-1-34.txt:          requires long dsRNA [ 5 6 ] , and it has been conjectured
technical/biomed/1471-2180-1-34.txt:          dsRNA in cultured mammalian cells is probably due to
technical/biomed/1471-2180-1-34.txt:          that the dsRNAs described here did not activate a general
technical/biomed/1471-2180-1-34.txt:          IFN response. First, the inhibitory effect of each dsRNA
technical/biomed/1471-2180-1-34.txt:          dsRNAs described here (data not shown). Lastly, elevated
technical/biomed/1471-2180-1-34.txt:          following transfection with these dsRNAs. Results (Fig.
technical/biomed/1471-2180-1-34.txt:          long double-stranded siRNAs fail to trigger interferon
technical/biomed/1471-2180-1-34.txt:        double-stranded interfering RNA as a viable tool to ablate
technical/biomed/1471-2180-1-34.txt:        specific cytoplasmic RNAs, as exemplified by the mRNAs of a
technical/biomed/1471-2180-1-34.txt:        RNA virus. The major findings are: (i) The ablation is
technical/biomed/1471-2180-1-34.txt:        highly efficient: nanomolar concentrations of dsRNA can
technical/biomed/1471-2180-1-34.txt:        protein. The two RSV mRNAs that we have targeted here,
technical/biomed/1471-2180-1-34.txt:        namely P and F, are relatively abundant viral mRNAs. In
technical/biomed/1471-2180-1-34.txt:        abundant viral mRNAs in the infected cell. Thus, we predict
technical/biomed/1471-2180-1-34.txt:        that an even lower concentration of dsRNA, perhaps in the
technical/biomed/1471-2180-1-34.txt:        mRNAs that are rarer, such as those of RSV M2 and L
technical/biomed/1471-2180-1-34.txt:        concentrations, (ii) The effect is highly specific: dsRNA
technical/biomed/1471-2180-1-34.txt:        against one viral mRNA did not affect other viral mRNAs or
technical/biomed/1471-2180-1-34.txt:        the cellular genes tested here. In this regard, dsRNA
technical/biomed/1471-2180-1-34.txt:        antisense ODNs rely on the degradation of target RNA by
technical/biomed/1471-2180-1-34.txt:        RNase H [ 31 ] , which is a predominantly nuclear enzyme,
technical/biomed/1471-2180-1-34.txt:        this mechanism is not available to RNA viruses that are
technical/biomed/1471-2180-1-34.txt:        provide direct experimental evidence that the 21-nt dsRNA
technical/biomed/1471-2180-1-34.txt:        virus-infected cell with dsRNA at any time point during
technical/biomed/1471-2180-1-34.txt:        nonviable virus. In this regard, the dsRNA technique is
technical/biomed/1471-2180-1-34.txt:        dsRNA approach is relatively simple to design, and its
technical/biomed/1471-2180-1-34.txt:        or viral gene mRNAs in any combination, either
technical/biomed/1471-2180-1-34.txt:        Lastly, the lack of effect of the anti-F dsRNA on viral
technical/biomed/1471-2180-1-34.txt:        negative- and positive-strand full-length genomic RNA, each
technical/biomed/1471-2180-1-34.txt:        strand of the anti-F dsRNA. In general, genome-length RNAs
technical/biomed/1471-2180-1-34.txt:        potential targets for RNA interference, resulting in severe
technical/biomed/1471-2180-1-34.txt:        and antigenomic RNA of NNR viruses escape the onslaught of
technical/biomed/1471-2180-1-34.txt:        dsRNA because they are tightly wrapped with the
technical/biomed/1471-2180-1-34.txt:        the dsRNA and/or the RNAi silencing complex (RISC). As
technical/biomed/1471-2180-1-34.txt:        mentioned before, the N-encapsidated genome-length RNAs are
technical/biomed/1471-2180-1-34.txt:        formation of such nuclease-resistant RNA products is in
technical/biomed/1471-2180-1-34.txt:        of the viral genomic RNA to dsRNA has important
technical/biomed/1471-2180-1-34.txt:        the dsRNA approach cannot be used against 
technical/biomed/1471-2180-1-34.txt:        in the reverse genetics of RNA viruses and in the antiviral
technical/biomed/1471-2180-1-34.txt:        double-stranded RNA (dsRNA) molecules can effectively and
technical/biomed/1471-2180-1-34.txt:        specifically abrogate translation of target RNAs without
technical/biomed/1471-2180-1-34.txt:        against mRNAs of cytoplasmic RNA viruses, the dsRNAs caused
technical/biomed/1471-2180-1-34.txt:        degradation of the specific viral mRNA and resultant
technical/biomed/1471-2180-1-34.txt:        quick, simple, and can be used against wild type RNA
technical/biomed/1471-2180-1-34.txt:        such dsRNA molecules should facilitate the reverse genetics
technical/biomed/1471-2180-1-34.txt:        and functional genomics of RNA genomes.
technical/biomed/1471-2180-1-34.txt:          Double-stranded RNA
technical/biomed/1471-2180-1-34.txt:          The following dsRNA sequences with 3'-dT extensions
technical/biomed/1471-2180-1-34.txt:          A/C mRNA sequences (Accession numbers Ml1486, M22643, and
technical/biomed/1471-2180-1-34.txt:          The two T's at the 3'-end of all RNAs were
technical/biomed/1471-2180-1-34.txt:          stability against RNases [ 2 ] , since they produced a
technical/biomed/1471-2180-1-34.txt:          lower concentration, compared to RNAs that contained all
technical/biomed/1471-2180-1-34.txt:          gel-purified. Deprotection of the RNA and hybridization
technical/biomed/1471-2180-1-34.txt:          manufacturer's protocol. In the mutant dsRNA (for P), the
technical/biomed/1471-2180-1-34.txt:          Transfection with dsRNA and RSV infection
technical/biomed/1471-2180-1-34.txt:          The dsRNAs were introduced in cells essentially as
technical/biomed/1471-2180-1-34.txt:          dsRNAs was carried out with OligofectAMINE Reagent (Life
technical/biomed/1471-2180-1-34.txt:          Indicated amounts of dsRNA, formulated into liposomes,
technical/biomed/1471-2180-1-34.txt:          (see below), RNA isolation, or immunoblot, as and where
technical/biomed/1471-2180-1-34.txt:          transfected with appropriate dsRNA (at 20 nM final) as
technical/biomed/1471-2180-1-34.txt:          Quantitation of specific mRNAs by RT-PCR was done
technical/biomed/1471-2180-1-34.txt:          essentially as described [ 34 ] . Briefly, total RNA was
technical/biomed/1471-2180-1-34.txt:          Quickprep Micro™ mRNA purification kit from Pharmacia
technical/biomed/1471-2180-1-34.txt:          Biotech (Piscataway, NJ). Equal amounts of total RNA were
technical/biomed/1471-2180-1-34.txt:          hr in the presence of 5 units of RNasin (Promega),
technical/biomed/1471-2180-1-34.txt:          RSV genomic RNA: 5'AATGACCAATTATATGAATCAATTATCTG 3'and
technical/biomed/1471-2180-1-34.txt:          mRNAs. The amount of RNA was optimized for the individual
technical/biomed/1471-2180-1-7.txt:          of the mutants in vitro. Alternatively, the GTPase
technical/biomed/1471-2180-1-7.txt:          [ 34]. An alternative is that these lateral surfaces
technical/biomed/1471-2180-1-7.txt:          supernatant by discarding a precipitate at 20% saturated
technical/biomed/1471-2180-1-7.txt:          alternative protocol is important for some mutants that
technical/biomed/1471-2180-1-7.txt:          bacterial supernatants, by adding GTP to 1 mM and calcium
technical/biomed/1471-2180-1-8.txt:        mock-infected cells using mRNA differential display and
technical/biomed/1471-2180-1-8.txt:        in gene expression in host cells, experiments using mRNA
technical/biomed/1471-2180-1-8.txt:        mock-infected lanes of the mRNA differential display gel.
technical/biomed/1471-2180-1-8.txt:        To verify the expression pattern seen in the mRNA
technical/biomed/1471-2180-1-8.txt:        used to probe Northern blots of RNAs derived from
technical/biomed/1471-2180-1-8.txt:        A6I probe reacted with a 0.8-kb RNA band, but the
technical/biomed/1471-2180-1-8.txt:        intensities of the RNA bands of samples from mock- and 
technical/biomed/1471-2180-1-8.txt:        not further studied. The A8I probe reacted with an RNA band
technical/biomed/1471-2180-1-8.txt:        rat ATPase 6 mRNA [ 15]. Both 
technical/biomed/1471-2180-1-8.txt:        mock-infected RNA samples showed the 0.7-kb band. The
technical/biomed/1471-2180-1-8.txt:        intensity of the band of the RNA sample from 
technical/biomed/1471-2180-1-8.txt:        probed with a fragment of the 18S rRNA gene were used as an
technical/biomed/1471-2180-1-8.txt:        internal control for variations in the amount of RNA loaded
technical/biomed/1471-2180-1-8.txt:        and SP-B (green signal) probes that hybridized with RNAs in
technical/biomed/1471-2180-1-8.txt:        The technique of mRNA differential display has been used
technical/biomed/1471-2180-1-8.txt:        P.carinii -derived ATPase 6 mRNA is
technical/biomed/1471-2180-1-8.txt:        cultures were processed for RNA isolation. This 5-day
technical/biomed/1471-2180-1-8.txt:        period and that differentially expressed HEL RNAs were
technical/biomed/1471-2180-1-8.txt:        over-expressed by the mRNA differential display performed
technical/biomed/1471-2180-1-8.txt:        The technique of mRNA differential display was used to
technical/biomed/1471-2180-1-8.txt:        analysis of total RNA extracted from 
technical/biomed/1471-2180-1-8.txt:          supernatant in the infected lung homogenate was
technical/biomed/1471-2180-1-8.txt:          supernatant containing 7 × 10 5 
technical/biomed/1471-2180-1-8.txt:          RNA extraction
technical/biomed/1471-2180-1-8.txt:          RNA was isolated using the hot-acidic phenol
technical/biomed/1471-2180-1-8.txt:          ultracentrifugation, the supernatant was removed and the
technical/biomed/1471-2180-1-8.txt:          RNA pellets were dissolved in TE buffer [10 mM Tris-HCl
technical/biomed/1471-2180-1-8.txt:          (pH 8), 1 mM EDTA] and then treated with RNase-free DNase
technical/biomed/1471-2180-1-8.txt:          I (100 U/ml) to remove any residual DNA. To extract RNA
technical/biomed/1471-2180-1-8.txt:          gross cellular debris. The supernatant was then treated
technical/biomed/1471-2180-1-8.txt:          buffer. Eight μg of each RNA was electrophoresed in
technical/biomed/1471-2180-1-8.txt:          integrity of the RNA and to perform Northern
technical/biomed/1471-2180-1-8.txt:          mRNA differential display
technical/biomed/1471-2180-1-8.txt:          The RNAimage™ Kit (GenHunter Corporation, Nashville,
technical/biomed/1471-2180-1-8.txt:          TN) was used to detect differences between RNA samples of
technical/biomed/1471-2180-1-8.txt:          up per sample. Each reaction contained 200 ng of RNA,
technical/biomed/1471-2180-1-8.txt:          (emb|X14778|RNSPB) [ 38] was amplified from rat lung RNA
technical/biomed/1471-2180-1-8.txt:          rat lung total RNA was added to a reaction which
technical/biomed/1471-2180-1-8.txt:          5 mM dithiothreitol, 2.9 U RNasin, 20 pmoles of primer
technical/biomed/1471-2180-1-8.txt:          ng of template DNA, 40 U of T7 RNA polymerase (for
technical/biomed/1471-2180-1-8.txt:          antisense probes) or 40 U of SP6 RNA polymerase (for
technical/biomed/1471-2180-1-8.txt:          fluorescein-12-UTP), and 20 U RNasin (Promega, Madison,
technical/biomed/1471-2180-1-8.txt:          RNase-free DNase I was added to digest the DNA templates,
technical/biomed/1471-2180-1-8.txt:          μl of RNasin was added to the suspension, and the RNA
technical/biomed/1471-2180-2-1.txt:        encounter an external impediment to their twisting. In
technical/biomed/1471-2180-2-1.txt:        reported here always appear to develop internal fluid
technical/biomed/1471-2180-2-1.txt:        motions even though the external environment is held at
technical/biomed/1471-2180-2-13.txt:        presence of nitrate, a preferred alternative electron
technical/biomed/1471-2180-2-13.txt:          between the Fnr site and the RNA polymerase recognition
technical/biomed/1471-2180-2-13.txt:          dmsA gene expression by RNA
technical/biomed/1471-2180-2-13.txt:          promote open complex formation by RNA polymerase [ 13 16
technical/biomed/1471-2180-2-13.txt:          radical attack [ 28 29 30 ] . In an alternative model,
technical/biomed/1471-2180-2-13.txt:          compete with Fnr and/or RNA polymerase for occupancy on
technical/biomed/1471-2180-2-13.txt:          Fnr, NarL, ModE, and IHF in addition to RNAP). Future
technical/biomed/1471-2180-2-13.txt:          a stable DNA protein complex. Alternatively, molecules of
technical/biomed/1471-2180-2-13.txt:        spacing between the Fnr and RNA polymerase recognition
technical/biomed/1471-2180-2-16.txt:          growth at 37°C. Culture supernatants were examined for
technical/biomed/1471-2180-2-16.txt:          transferring the supernatant to a clean tube, and
technical/biomed/1471-2180-2-20.txt:          days. Supernatants were taken immediately after washing
technical/biomed/1471-2180-2-20.txt:          cells were vortexed and supernatant was collected and
technical/biomed/1471-2180-2-20.txt:          because the primers recognize mRNA.
technical/biomed/1471-2180-2-20.txt:          a control for RNA integrity. The product was analyzed by
technical/biomed/1471-2180-2-20.txt:        supernatant supports the probability that the CMV infection
technical/biomed/1471-2180-2-20.txt:        mRNAs whose level changes were by a factor of 4 or more
technical/biomed/1471-2180-2-20.txt:          MRC-5 fibroblast infection of supernatants from CMV
technical/biomed/1471-2180-2-20.txt:          days. The cultures were vortexed, supernatant was
technical/biomed/1471-2180-2-20.txt:          Supernatant fluid was collected immediately after
technical/biomed/1471-2180-2-20.txt:          RNA extraction and isolation
technical/biomed/1471-2180-2-20.txt:          subjected to DNase treatment and RNA clean up with
technical/biomed/1471-2180-2-20.txt:          RNA quantitation
technical/biomed/1471-2180-2-20.txt:          Using Ribogreen dye and RNA quantitation standards
technical/biomed/1471-2180-2-20.txt:          from Molecular Probes (Eugene, OR), the amount of RNA in
technical/biomed/1471-2180-2-20.txt:          aliquot of the RNA samples were diluted 1:100 in TE
technical/biomed/1471-2180-2-20.txt:          buffer. RNA standards were prepared (4000, 2000, 1000,
technical/biomed/1471-2180-2-20.txt:          1:200 in TE buffer and 20 μl of the diluted RNA (standard
technical/biomed/1471-2180-2-20.txt:          RNA for cDNA production was performed using Promega's
technical/biomed/1471-2180-2-20.txt:          (Madison, WI) random hexamers, RNAsin, RT buffer, and RT
technical/biomed/1471-2180-2-20.txt:          enzyme. For each sample, the RNA (2 μg) was initially
technical/biomed/1471-2180-2-20.txt:          Incubation of the RNA and random hexamers was performed
technical/biomed/1471-2180-2-20.txt:          units of AMV RT enzyme, and 20 units of RNAsin per
technical/biomed/1471-2180-2-20.txt:          the RNA samples (with the random hexamers) and then
technical/biomed/1471-2180-2-20.txt:          gene. The BZLF1 primers recognize only mRNA and the
technical/biomed/1471-2180-2-26.txt:        In comparison to the two general alternative mechanisms
technical/biomed/1471-2180-2-26.txt:        c -myc [ 18 ] . Alternatively, HIV-1
technical/biomed/1471-2180-2-26.txt:        pathways is readily discernable. Indeed, if cells depend on
technical/biomed/1471-2180-2-26.txt:          Total RNA and protein were extracted from wild-type,
technical/biomed/1471-2180-2-26.txt:          28 ] . Briefly, RNA and protein were extracted from
technical/biomed/1471-2180-2-26.txt:          gene mutant of HIV-1, total RNA was extract from infected
technical/biomed/1471-2180-2-26.txt:          described above, total RNA was extracted from wild-type
technical/biomed/1471-2180-2-26.txt:          RNA and protein samples were analyzed as follows:
technical/biomed/1471-2180-2-26.txt:          Podocyte RNA (10 μg) was analyzed by northern blot using
technical/biomed/1471-2180-2-29.txt:        Genetic heterogeneity is a hallmark of RNA viruses in
technical/biomed/1471-2180-2-29.txt:        to the lack of fidelity of viral RNA-dependent RNA
technical/biomed/1471-2180-2-29.txt:          ≥0.90 or alternatively, an A or T with a frequency of
technical/biomed/1471-2180-2-32.txt:        More recent observations support an alternative
technical/biomed/1471-2180-2-32.txt:          16,000 rpm for 10 min at 4°C. The resultant supernatant
technical/biomed/1471-2180-2-35.txt:        bacteria [ 1 2 3 ] have rekindled interest in alternative
technical/biomed/1471-2180-2-35.txt:        alternatives is phage therapy, the use of bacteriophages to
technical/biomed/1471-2180-2-35.txt:            of resistant cells (in the vernacular of population
technical/biomed/1471-2180-2-35.txt:            As an alternative to using the initial frequency of
technical/biomed/1471-2180-2-35.txt:          phage therapy as an alternative to antibiotics, it seems
technical/biomed/1471-2180-2-35.txt:          with the use of phage as an alternative to antibiotics.
technical/biomed/1471-2180-2-35.txt:          alternative methods of treating and preventing bacterial
technical/biomed/1471-2180-2-35.txt:          readily-available and promising alternatives.
technical/biomed/1471-2180-2-35.txt:          supernatant was then enriched for 
technical/biomed/1471-2180-2-38.txt:        indistinguishable using 16s rRNA [ 4 ] , restriction
technical/biomed/1471-2180-2-38.txt:          internal shifts in reading frame that interrupt otherwise
technical/biomed/1471-2180-2-7.txt:        PCR-based assays have shown the presence of bacterial mRNA,
technical/biomed/1471-2180-2-7.txt:          and debris. The supernatant was recovered and centrifuged
technical/biomed/1471-2180-3-10.txt:        RNase P (RnpA), ribosomal protein L34 (RpmH), the
technical/biomed/1471-2180-3-10.txt:          RNase P, which consists of the protein subunit RnpA and a
technical/biomed/1471-2180-3-10.txt:          catalytic RNA subunit, is essential for generating mature
technical/biomed/1471-2180-3-10.txt:          tRNAs by cleaving the 5'-terminal leader sequences of
technical/biomed/1471-2180-3-10.txt:          precursor tRNAs [ 16 ] . 
technical/biomed/1471-2180-3-10.txt:          an alignment of the 16s rRNA gene was performed. That
technical/biomed/1471-2180-3-10.txt:        oriC region, alternative hypotheses
technical/biomed/1471-2180-3-10.txt:        ribosomal RNA operons. Each respective genome possesses
technical/biomed/1471-2180-3-10.txt:        presence of multiple copies of ribosomal RNA operons within
technical/biomed/1471-2180-3-10.txt:        However, only one rRNA operon is present in each subspecies
technical/biomed/1471-2180-3-10.txt:        increase the transcriptional rate of the rRNA operon to
technical/biomed/1471-2180-3-10.txt:        overcome gene dosage limitations [ 32 ] . The rRNA operon
technical/biomed/1471-2180-3-10.txt:        M. avium had multiple functional rRNA
technical/biomed/1471-2180-3-11.txt:        RNA viruses are important pathogens in humans, animals,
technical/biomed/1471-2180-3-11.txt:        anti-viral therapies or vaccinations. RNA viruses form
technical/biomed/1471-2180-3-11.txt:        . Besides their importance as pathogens, RNA viruses have
technical/biomed/1471-2180-3-11.txt:        RNA virus evolution, but the assumptions underlying the
technical/biomed/1471-2180-3-11.txt:        model do not always reflect the biology of RNA viruses. In
technical/biomed/1471-2180-3-11.txt:        (reviewed in [ 46 ] ). FMDV belongs to the Picornaviridea
technical/biomed/1471-2180-3-11.txt:          discrete-time version of a model of maternal effects in
technical/biomed/1471-2180-3-11.txt:        many years in a variety of picornaviruses [ 56 57 58 ] .
technical/biomed/1471-2180-3-11.txt:        compound-resistant picornaviruses [ 61 ] . Thus, phenotypic
technical/biomed/1471-2180-3-13.txt:        mRNA transcripts are mRNA stability determinants [ 1 2 ] .
technical/biomed/1471-2180-3-13.txt:        annotate the small regulatory RNA gene 
technical/biomed/1471-2180-3-13.txt:        non-protein coding RNA found in 
technical/biomed/1471-2180-3-13.txt:        micF RNA. 
technical/biomed/1471-2180-3-13.txt:        micF RNA functions by interacting
technical/biomed/1471-2180-3-13.txt:        ompF mRNA 5' UTR to form an RNA/RNA
technical/biomed/1471-2180-3-13.txt:        micF RNA/ 
technical/biomed/1471-2180-3-13.txt:        ompF mRNA 5' UTR duplex models have
technical/biomed/1471-2180-3-13.txt:        conservation of the RNA/RNA duplex structure, but also
technical/biomed/1471-2180-3-13.txt:          mRNA 5' UTR transcript sequences of 
technical/biomed/1471-2180-3-13.txt:          asnS , the asparaginyl-tRNA
technical/biomed/1471-2180-3-13.txt:          ompF mRNA 5' UTR sequences were found by a BLAST
technical/biomed/1471-2180-3-13.txt:            Yersinia species mRNA transcripts
technical/biomed/1471-2180-3-13.txt:            for conserved elements. The 5' UTRs of bacterial mRNAs
technical/biomed/1471-2180-3-13.txt:            are important determinants of mRNA stability and/or
technical/biomed/1471-2180-3-13.txt:            RNA/RNA duplex pairing with 
technical/biomed/1471-2180-3-13.txt:            ompF mRNA 5' UTR contains a long
technical/biomed/1471-2180-3-13.txt:            ompC mRNA 5' UTR sequences show
technical/biomed/1471-2180-3-13.txt:            ompF mRNA 5' UTR, the S-D
technical/biomed/1471-2180-3-13.txt:            ompC mRNA 5' UTR is not
technical/biomed/1471-2180-3-13.txt:            ompF mRNA in 
technical/biomed/1471-2180-3-13.txt:            ompF mRNA 5' UTR (positions
technical/biomed/1471-2180-3-13.txt:            variation in the type of RNA/RNA base pairing occurs
technical/biomed/1471-2180-3-13.txt:            micF RNA (positions 33-70, Figure
technical/biomed/1471-2180-3-13.txt:            molecular base-pairings in RNA/RNA interactions in 
technical/biomed/1471-2180-3-13.txt:            Yersinia micF RNA genes, i.e., 15
technical/biomed/1471-2180-3-13.txt:            Yersinia RNA/RNA duplex model
technical/biomed/1471-2180-3-13.txt:            ompF mRNA 5' UTR (67.2 %
technical/biomed/1471-2180-3-13.txt:            RNA polymerase (RNAP) with these transcription
technical/biomed/1471-2180-3-13.txt:            factors interact with RNAP to activate transcription in
technical/biomed/1471-2180-3-13.txt:          OmpFmRNA 5'UTR/ micFRNA duplex structures
technical/biomed/1471-2180-3-13.txt:          micF RNA/ 
technical/biomed/1471-2180-3-13.txt:          ompF mRNA 5' UTR interaction [ 2 8
technical/biomed/1471-2180-3-13.txt:          E. coli, micF RNA binds the 
technical/biomed/1471-2180-3-13.txt:          ompF mRNA 5' UTR to form an RNA/RNA
technical/biomed/1471-2180-3-13.txt:          Yersinia ompF mRNA 5' UTR/ 
technical/biomed/1471-2180-3-13.txt:          micF RNA duplex structure modeling
technical/biomed/1471-2180-3-13.txt:          Yersinia micF RNA species differ in
technical/biomed/1471-2180-3-13.txt:          Yersinia RNA/RNA duplex structural
technical/biomed/1471-2180-3-13.txt:          Y. enterocolitica micF RNA, as well
technical/biomed/1471-2180-3-13.txt:          micF RNA sequence between 
technical/biomed/1471-2180-3-13.txt:          significantly alter the RNA/RNA duplex structure. This
technical/biomed/1471-2180-3-13.txt:          Yersinia RNA/RNA duplex models
technical/biomed/1471-2180-3-13.txt:          ompF mRNA 5'UTR / 
technical/biomed/1471-2180-3-13.txt:          micF RNA structural model, but the 
technical/biomed/1471-2180-3-13.txt:          S. marcescens RNA/RNA duplexes.
technical/biomed/1471-2180-3-13.txt:          E. coli micF RNA/ 
technical/biomed/1471-2180-3-13.txt:          ompF mRNA 5' UTR duplex do not
technical/biomed/1471-2180-3-13.txt:          E. coli , stem 1 of the RNA/RNA
technical/biomed/1471-2180-3-13.txt:          single-stranded in free (uncomplexed) RNAs [ 2 39 ] , but
technical/biomed/1471-2180-3-13.txt:          micF RNA unfold to form the RNA/RNA
technical/biomed/1471-2180-3-13.txt:          E. coli RNA/RNA duplex, structure
technical/biomed/1471-2180-3-13.txt:          micF RNA (the ρ-independent
technical/biomed/1471-2180-3-13.txt:          terminator), which are present in uncomplexed RNAs, are
technical/biomed/1471-2180-3-13.txt:          unaltered in the RNA/RNA duplex [ 2 ] . Mfold analyses of
technical/biomed/1471-2180-3-13.txt:          predict that these stem loops are maintained in RNA/RNA
technical/biomed/1471-2180-3-13.txt:          create more sites for RNA/RNA interactions. However we
technical/biomed/1471-2180-3-13.txt:          ompF mRNA inactivation, e.g.,
technical/biomed/1471-2180-3-13.txt:          micF RNA-induced 
technical/biomed/1471-2180-3-13.txt:          ompF mRNA destabilization.
technical/biomed/1471-2180-3-13.txt:        determine gene start sites (5' ends of RNA transcripts). In
technical/biomed/1471-2180-3-13.txt:        ompF mRNA 5' UTR sequence has
technical/biomed/1471-2180-3-13.txt:        Yersinia ompF mRNA 5' UTR/ 
technical/biomed/1471-2180-3-13.txt:        micF RNA duplex structures have been
technical/biomed/1471-2180-3-13.txt:        displays 74% similarity to a putative mRNA 5' UTR sequence
technical/biomed/1471-2180-3-13.txt:        ompC mRNA 5' UTR, and the upstream
technical/biomed/1471-2180-3-13.txt:        gene in adjacent sequences. mRNA signatures such as AUG
technical/biomed/1471-2180-3-13.txt:        ompC mRNA 5' UTR sequences.
technical/biomed/1471-2180-3-13.txt:        assignment of the number of alternate structures to 10 were
technical/biomed/1471-2180-3-13.txt:        use to fold RNAs into duplex structures with the
technical/biomed/1471-2180-3-13.txt:        integration host factor; HTH, helix-turn-helix; RNAP, RNA
technical/biomed/1471-2180-3-15.txt:          Alternatively, the HOOF-Print procedure was adapted for
technical/biomed/1471-2180-3-15.txt:          mass ladder labeled with an alternative fluorescent tag.
technical/biomed/1471-2180-3-15.txt:          This insertion resulted in an alternative ladder of
technical/biomed/1471-2180-3-15.txt:          the size range of the normal and the alternative alleles,
technical/biomed/1471-2180-3-15.txt:        to the development of an international 
technical/biomed/1471-2180-3-15.txt:        this technique will be used to generate an international
technical/biomed/1471-2180-3-4.txt:        An alternative hypothesis is that given the possible
technical/biomed/1471-2180-3-4.txt:        F-specific RNA-coliphage Q beta. Inactivation in phosphate
technical/biomed/1471-2180-3-4.txt:        presence of an alternative strong oxidant that does not
technical/biomed/1471-2180-3-4.txt:          Supernatant was diluted 20× in methanol for electrospray
technical/biomed/1471-2180-3-5.txt:        osteoblasts containing internalized 
technical/biomed/1471-2180-3-5.txt:        colonization. Internalization may provide a means of
technical/biomed/1471-2180-3-5.txt:        sar loci are internalized, but do not
technical/biomed/1471-2180-3-5.txt:        osteoblasts, while mRNAs encoding the
technical/biomed/1471-2180-3-5.txt:        sustained up-regulation of TRAIL mRNA and TRAIL protein
technical/biomed/1471-2180-3-5.txt:          bacterial internalization, however, could not be
technical/biomed/1471-2180-3-5.txt:        normal human and mouse osteoblasts [ 41 ] . Messenger RNA
technical/biomed/1471-2180-3-5.txt:        S. aureus . TRAIL mRNA expression is
technical/biomed/1471-2180-3-5.txt:        inducible nature of TRAIL mRNA, the messages encoding
technical/biomed/1471-2180-3-5.txt:        physical contact, and potentially internalized by the
technical/biomed/1471-2180-3-5.txt:        Alternatively, intracellular bacteria may be the only 
technical/biomed/1471-2180-3-5.txt:        in contact with and potentially internalized by the
technical/biomed/1471-2180-3-5.txt:          approximately one internalized bacterium per osteoblast
technical/biomed/1471-2180-3-9.txt:        a nonsegmented negative-stranded RNA genome of about 15 kb
technical/biomed/1471-2180-3-9.txt:        [ 5 ] . The minimal viral RNA-dependent RNA polymerase
technical/biomed/1471-2180-3-9.txt:        viral protein, M2-1 (22K), contributes RNA antitermination
technical/biomed/1471-2180-3-9.txt:          negative-strand RNA viral RdRP are the viral large
technical/biomed/1471-2180-3-9.txt:          protein is believed to possess the basic RNA polymerase
technical/biomed/1471-2180-3-9.txt:          RNA wrapped with nucleocapsid protein N. It is only the
technical/biomed/1471-2180-3-9.txt:          N-RNA complex, and not the naked RNA, that serves as the
technical/biomed/1471-2180-3-9.txt:          profilin knock-down cell by using RNA interference
technical/biomed/1471-2180-3-9.txt:          targeted against profilin mRNA as described under
technical/biomed/1471-2180-3-9.txt:          Materials and Methods. RNA interference is now an
technical/biomed/1471-2180-3-9.txt:          mRNA in mammalian cell culture [ 24 ] , and our
technical/biomed/1471-2180-3-9.txt:          nM siRNA. In our routine experiments, therefore, we have
technical/biomed/1471-2180-3-9.txt:          used 400 nM siRNA to achieve an essentially profilin-null
technical/biomed/1471-2180-3-9.txt:          are primarily involved in viral RNA synthesis.
technical/biomed/1471-2180-3-9.txt:          RSV, and virus-specific RNA and proteins were quantified
technical/biomed/1471-2180-3-9.txt:          siRNA, and tested their effects on profilin and viral P
technical/biomed/1471-2180-3-9.txt:          200-400 nM siRNA); in rat L2 cells (panel D) a somewhat
technical/biomed/1471-2180-3-9.txt:          profilin had a role in viral RNA synthesis,
technical/biomed/1471-2180-3-9.txt:          representative N and F mRNAs as well as the
technical/biomed/1471-2180-3-9.txt:          negative-stranded viral genomic RNA were quantitated by
technical/biomed/1471-2180-3-9.txt:          show that even at the highest siRNA concentration (400
technical/biomed/1471-2180-3-9.txt:          down (data not shown), 60-80% of viral RNA synthesis
technical/biomed/1471-2180-3-9.txt:          was slightly more severe, with 30-50% RNA synthesis
technical/biomed/1471-2180-3-9.txt:          profilin by siRNA as before, infected the cells with RSV,
technical/biomed/1471-2180-3-9.txt:          in all three control cells untreated with the siRNA,
technical/biomed/1471-2180-3-9.txt:          10 hr of siRNA-treatment. A representative set of results
technical/biomed/1471-2180-3-9.txt:          pre-treatment with siRNA prior to the addition of the
technical/biomed/1471-2180-3-9.txt:          suggesting that 10 hr of siRNA-treatment was sufficient
technical/biomed/1471-2180-3-9.txt:          affected in control cells treated with siRNA against
technical/biomed/1471-2180-3-9.txt:          luciferase mRNA [ 24 ] .
technical/biomed/1471-2180-3-9.txt:        agents include many RNA viruses such as HIV, measles virus,
technical/biomed/1471-2180-3-9.txt:        "0" siRNA lanes of Panel C and D in Fig. 4). The cellular
technical/biomed/1471-2180-3-9.txt:        proof-of-concept that RNA interference can be a major tool
technical/biomed/1471-2180-3-9.txt:        RNA interference using sequence-specific siRNA can be
technical/biomed/1471-2180-3-9.txt:          from Chemicon International (Temecula, CA) and the
technical/biomed/1471-2180-3-9.txt:          RNA interference and RT-PCR analysis
technical/biomed/1471-2180-3-9.txt:          The anti-profilin double-stranded RNA (siRNA) of the
technical/biomed/1471-2180-3-9.txt:          cells with the siRNA and subsequent infection of the
technical/biomed/1471-2180-3-9.txt:          [ 25 ] . Interestingly, after designing the siRNA and
technical/biomed/1471-2180-3-9.txt:          The serendipitous success of the human siRNA against rat
technical/biomed/1471-2180-3-9.txt:          tolerated in RNA interference, the details of which will
technical/biomed/1471-2180-3-9.txt:          two nucleotide mismatch in siRNA-mediated silencing of
technical/biomed/1471-2180-3-9.txt:          human coagulation trigger tissue factor mRNA has been
technical/biomed/1471-2180-3-9.txt:          reported recently [ 46 ] . When siRNA transfected cells
technical/biomed/1471-2180-3-9.txt:          RSV negative-strand genomic RNA and N and F mRNA from
technical/biomed/1471-2199-2-1.txt:        internal deletions suggest that it contains multiple
technical/biomed/1471-2199-2-1.txt:        partially redundant internal domains [ 2]. Whether it can
technical/biomed/1471-2199-2-1.txt:          alternative well-established indicator of plasmid origin
technical/biomed/1471-2199-2-1.txt:        internal redundancy within both of the ~150-bp essential
technical/biomed/1471-2199-2-1.txt:          Generation of ~50 bp internal deletions
technical/biomed/1471-2199-2-1.txt:          that the choices of internal (forward and reverse)
technical/biomed/1471-2199-2-1.txt:          primer used in constructing Δ15 were chosen as internal
technical/biomed/1471-2199-2-10.txt:        for a variety of other applications including protein-RNA
technical/biomed/1471-2199-2-10.txt:          C-terminal fusions to lexA. The GFP internal random
technical/biomed/1471-2199-2-10.txt:          codons as for the internal peptide library. Sequence
technical/biomed/1471-2199-2-10.txt:        internal GFP peptide constructs, we did not consider it
technical/biomed/1471-2199-2-10.txt:        by recruitment of preformed RNA polymerase holoenzyme to
technical/biomed/1471-2199-2-10.txt:        holoenzyme. Alternatively, these basic peptides may bind
technical/biomed/1471-2199-2-10.txt:        Alternatively, they might provide reagents for
technical/biomed/1471-2199-2-12.txt:        internal organ hyperplasia and are highly prone to
technical/biomed/1471-2199-2-12.txt:        alternative promoters leading to multiple transcription
technical/biomed/1471-2199-2-12.txt:        p27 Kip1mRNA translation have been
technical/biomed/1471-2199-2-12.txt:        p27 Kip1mRNA translation is higher in
technical/biomed/1471-2199-2-12.txt:        p27 Kip1mRNA are able to enhance
technical/biomed/1471-2199-2-12.txt:        p27 Kip1mRNA stability [ 32 ] .
technical/biomed/1471-2199-2-12.txt:        p27 Kip1mRNAs.
technical/biomed/1471-2199-2-12.txt:        capped 5'-end of mRNAs together with RNase protection
technical/biomed/1471-2199-2-12.txt:          using RNA ligase-mediated rapid amplification of 5' cDNA
technical/biomed/1471-2199-2-12.txt:          ends of mRNAs are detected. The first step in RLM-RACE is
technical/biomed/1471-2199-2-12.txt:          treatment of the RNA sample with phosphatase. This
technical/biomed/1471-2199-2-12.txt:          removes the 5' phosphate from incomplete mRNA fragments
technical/biomed/1471-2199-2-12.txt:          and from non-mRNAs eliminating their ability to
technical/biomed/1471-2199-2-12.txt:          mRNAs is removed using a pyrophosphatase that leaves a 5'
technical/biomed/1471-2199-2-12.txt:          phosphate group. These full-length decapped mRNAs are
technical/biomed/1471-2199-2-12.txt:          thus the only RNA molecules that can be ligated to an RNA
technical/biomed/1471-2199-2-12.txt:          procedure. Finally, the RNAs are reverse transcribed
technical/biomed/1471-2199-2-12.txt:          primer and a primer homologous to the RNA oligonucleotide
technical/biomed/1471-2199-2-12.txt:          This procedure was carried out using total RNA from
technical/biomed/1471-2199-2-12.txt:          p27 Kip1mRNA sequence just upstream
technical/biomed/1471-2199-2-12.txt:          preceded by a sequence corresponding to the RNA
technical/biomed/1471-2199-2-12.txt:          When the RLM-RACE procedure was performed using RNA
technical/biomed/1471-2199-2-12.txt:          that the major mRNA cap site in MRC5 cells is 472
technical/biomed/1471-2199-2-12.txt:          site usage an RNase protection assay was employed.
technical/biomed/1471-2199-2-12.txt:          Labeled antisense RNA probes were made by in vitro
technical/biomed/1471-2199-2-12.txt:          hybridized with total RNA from various sources followed
technical/biomed/1471-2199-2-12.txt:          by digestion with RNase and analysis of the protected
technical/biomed/1471-2199-2-12.txt:          RNAs on denaturing acrylamide gels.
technical/biomed/1471-2199-2-12.txt:          3B) RNA for the RNase protection assay resulted in a
technical/biomed/1471-2199-2-12.txt:          sites mapped by RLM-RACE. Using NIH 3T3 RNA, an
technical/biomed/1471-2199-2-12.txt:          at ~480 nucleotides represents ~50.6 % of p27 Kip1mRNAs
technical/biomed/1471-2199-2-12.txt:          of the remaining p27 Kip1mRNA population.
technical/biomed/1471-2199-2-12.txt:          RNase protection assays were performed using RNA from
technical/biomed/1471-2199-2-12.txt:        and RNase protection assays described here show that the
technical/biomed/1471-2199-2-12.txt:        site is 472 nucleotides upstream of the ATG. Both RNase
technical/biomed/1471-2199-2-12.txt:        derived from RNAs capped at this site. In contrast, 100% of
technical/biomed/1471-2199-2-12.txt:        not detected by RNase protection assays. Using an RLM-RACE
technical/biomed/1471-2199-2-12.txt:        position were detected by RNase protection assays
technical/biomed/1471-2199-2-12.txt:        UTR has an internal ribosome entry
technical/biomed/1471-2199-2-12.txt:        single major site, there are also alternative transcription
technical/biomed/1471-2199-2-12.txt:        p27 Kip1mRNA levels stay relatively
technical/biomed/1471-2199-2-12.txt:        p27 Kip1mRNA. Additional studies will
technical/biomed/1471-2199-2-12.txt:          Cell culture and RNA extraction
technical/biomed/1471-2199-2-12.txt:          medium with 10% fetal bovine serum. Total RNA was
technical/biomed/1471-2199-2-12.txt:          total RNA was dephosphorylated using calf intestinal
technical/biomed/1471-2199-2-12.txt:          pyrophosphatase to target full-length messenger RNAs. An
technical/biomed/1471-2199-2-12.txt:          RNA oligonucleotide was then ligated to the full-length,
technical/biomed/1471-2199-2-12.txt:          decapped mRNAs and reverse transcription was performed
technical/biomed/1471-2199-2-12.txt:          32P-CTP, and T7 RNA polymerase. DNA from the RACE nested
technical/biomed/1471-2199-2-12.txt:          using the HybSpeed RPA kit (Ambion). Total RNA was
technical/biomed/1471-2199-2-12.txt:          RNase A/T1, the protected RNAs were precipitated and run
technical/biomed/1471-2199-2-3.txt:        that only normal interactions between the mRNA and
technical/biomed/1471-2199-2-3.txt:        partners, including a specific tRNA and a particular
technical/biomed/1471-2199-2-3.txt:        sequences on the mRNA.
technical/biomed/1471-2199-2-3.txt:        interactions between the mRNA and other components of the
technical/biomed/1471-2199-2-3.txt:          nucleotide identity: mRNA secondary structure, codon
technical/biomed/1471-2199-2-3.txt:          availability of the tRNA decoding the last sense codon,
technical/biomed/1471-2199-2-3.txt:          kinetics. Since rare tRNAs generally correspond to rare
technical/biomed/1471-2199-2-3.txt:          translational events such as sliding, internal ribosome
technical/biomed/1471-2199-2-3.txt:          the presence of an amber suppressor tRNA [ 23]. The
technical/biomed/1471-2199-2-3.txt:          construct allowing expression of the suppressor tRNA was
technical/biomed/1471-2199-2-3.txt:          suppressor tRNA. This indicates that the results observed
technical/biomed/1471-2199-2-3.txt:        recognition are involved. In particular, protein-RNA and
technical/biomed/1471-2199-2-3.txt:        role in readthrough efficiency. Availability of the tRNA
technical/biomed/1471-2199-2-3.txt:        readthrough. Since rare tRNAs generally correspond to rare
technical/biomed/1471-2199-2-3.txt:        involved, possibly between the tRNA in the P site, the
technical/biomed/1471-2199-2-3.txt:        incomming potential suppressor tRNA and the message, as it
technical/biomed/1471-2199-2-3.txt:        Glutamine-isoacceptor tRNAs in mouse is not yet available
technical/biomed/1471-2199-2-3.txt:        "Compilation of tRNA sequences and sequences of tRNA
technical/biomed/1471-2199-2-3.txt:        http://www.uni-bayreuth.de/departments/biochemie/trna/),
technical/biomed/1471-2199-2-3.txt:        from our results, one possibility would be that mRNA
technical/biomed/1471-2199-2-3.txt:          ptRNAam is a gift of Olivier Jean-Jean; it carries the
technical/biomed/1471-2199-2-3.txt:          tRNA Sergene, in which the anticodon has been replaced by
technical/biomed/1471-2199-2-3.txt:          except that 5 μg of the ptRNAam vector was added just
technical/biomed/1471-2199-2-3.txt:          used as an internal control of each individual
technical/biomed/1471-2199-2-4.txt:        RNA polymerase II (pol II) transcription factor TFIID
technical/biomed/1471-2199-2-4.txt:          II 18, or the largest subunit of RNA
technical/biomed/1471-2199-2-4.txt:          II 135 or TBP mRNA levels during
technical/biomed/1471-2199-2-4.txt:          agreement with this, the RARβ2 mRNA is fully induced by
technical/biomed/1471-2199-2-4.txt:          lines A and B. In the same RNA samples, constant
technical/biomed/1471-2199-2-4.txt:          gene, induction of the collagen IVα1 and laminin B1 mRNAs
technical/biomed/1471-2199-2-4.txt:          significant changes in the corresponding mRNA levels were
technical/biomed/1471-2199-2-4.txt:          RNA polymerases during differentiation.
technical/biomed/1471-2199-2-4.txt:          protein or RNA extracts were made from one plate of cells
technical/biomed/1471-2199-2-4.txt:          supernatant containing the cytoplasmic proteins was
technical/biomed/1471-2199-2-4.txt:          Total cellular RNA was isolated using Trizol Reagent
technical/biomed/1471-2199-2-4.txt:          those used for making protein extracts. 1 μg of total RNA
technical/biomed/1471-2199-2-5.txt:        +T >> B-1a cells [ 5, 6]. The CD5 surface and mRNA
technical/biomed/1471-2199-2-5.txt:        closely resemble the mRNA and protein levels observed for
technical/biomed/1471-2199-2-5.txt:        typical RNA polymerase II transcription complex. However,
technical/biomed/1471-2199-2-5.txt:        critical in positioning RNA polymerase II complex for
technical/biomed/1471-2199-2-5.txt:        interaction with TBP or with other subunits of RNA
technical/biomed/1471-2199-2-5.txt:        by interacting with components in the RNA polymerase II
technical/biomed/1471-2199-2-5.txt:        since CD5 lacks a TATA box for establishing a typical RNA
technical/biomed/1471-2199-2-5.txt:        members) to the Ets binding site. Alternatively, these
technical/biomed/1471-2199-2-5.txt:        proteins help to alleviate the internal Ets-1 inhibition
technical/biomed/1471-2199-2-5.txt:          For internal control in transient transfections, we
technical/biomed/1471-2199-2-6.txt:        examples of RNA-protein recognition, having been studied
technical/biomed/1471-2199-2-6.txt:        1]. The primary and secondary structures of operator RNA
technical/biomed/1471-2199-2-6.txt:        are shown in Figure 1. This RNA hairpin makes contacts with
technical/biomed/1471-2199-2-6.txt:        RNA target is the insertion of two unpaired adenosines into
technical/biomed/1471-2199-2-6.txt:        contributions to RNA-binding and translational repression.
technical/biomed/1471-2199-2-6.txt:          Amino acid substitutions in the RNA-binding site of
technical/biomed/1471-2199-2-6.txt:          operator RNA and therefore compromise its ability to
technical/biomed/1471-2199-2-6.txt:          halves of the asymmetric RNA ligand. We previously
technical/biomed/1471-2199-2-6.txt:          same RNA-binding and capsid assembly properties typical
technical/biomed/1471-2199-2-6.txt:          RNA-binding sites, related to each another by a dyad
technical/biomed/1471-2199-2-6.txt:          symmetry axis. Since the RNA ligand makes contacts with
technical/biomed/1471-2199-2-6.txt:          the two equivalent, symmetry-related RNA-binding sites as
technical/biomed/1471-2199-2-6.txt:          to one complete binding site (see Figure 3). After RNA
technical/biomed/1471-2199-2-6.txt:          asymmetric nature of their contacts with RNA. We follow
technical/biomed/1471-2199-2-6.txt:          only one of the two RNA-binding sites. Because one
technical/biomed/1471-2199-2-6.txt:          other affects half-site B, one of the RNA-binding sites
technical/biomed/1471-2199-2-6.txt:          which refers to those amino acids involved in binding RNA
technical/biomed/1471-2199-2-6.txt:          of amino acids whose roles in RNA binding are known from
technical/biomed/1471-2199-2-6.txt:            A-10. In summary, we found that RNA binding activity
technical/biomed/1471-2199-2-6.txt:            in vivo and binds RNA 7.5-fold
technical/biomed/1471-2199-2-6.txt:            severely disrupt protein-RNA contacts since
technical/biomed/1471-2199-2-6.txt:            contribute to RNA-binding in both A-pockets [ 2, 3].
technical/biomed/1471-2199-2-6.txt:            apparently makes little or no contribution to RNA
technical/biomed/1471-2199-2-6.txt:            and A-10 suggests substitutions here might affect RNA
technical/biomed/1471-2199-2-6.txt:            defective T59S is for RNA binding 
technical/biomed/1471-2199-2-6.txt:            This means that Thr59 plays a role in binding RNA in
technical/biomed/1471-2199-2-6.txt:            wild-type RNA has been determined [ 11]. It showed only
technical/biomed/1471-2199-2-6.txt:            mutants may pay a higher entropic cost in binding RNA
technical/biomed/1471-2199-2-6.txt:            most significant structural change in the T59S-RNA
technical/biomed/1471-2199-2-6.txt:            subunit B. We also point out that the RNA main chain
technical/biomed/1471-2199-2-6.txt:            contributing to an RNA-binding defect by introducing an
technical/biomed/1471-2199-2-6.txt:            Lys61's may play roles in RNA binding since they cross
technical/biomed/1471-2199-2-6.txt:            its complex with wild-type RNA since its electron
technical/biomed/1471-2199-2-6.txt:            of A-4. Moreover, in complex with a variant RNA it is
technical/biomed/1471-2199-2-6.txt:        observed in the x-ray structure of the MS2 RNA-protein
technical/biomed/1471-2199-2-6.txt:          in vivo RNA binding activities of
technical/biomed/1471-2199-3-10.txt:        due to alternative splicing and utilization of different
technical/biomed/1471-2199-3-10.txt:        protein kinase is highly induced (50-fold) at the mRNA
technical/biomed/1471-2199-3-10.txt:          Madison, WI) was used as an internal marker for
technical/biomed/1471-2199-3-11.txt:        protein was due to elevated expression of its mRNA,
technical/biomed/1471-2199-3-11.txt:        cells in particular, the increase in PTEN mRNA closely
technical/biomed/1471-2199-3-11.txt:        encompassed both major mRNA species of 2.5 and 5.0 kb. In
technical/biomed/1471-2199-3-11.txt:        the mouse cells, only the shorter mRNA species appeared to
technical/biomed/1471-2199-3-11.txt:        PTEN mRNA levels, the Northern blots were stripped and
technical/biomed/1471-2199-3-11.txt:        latter a highly abundant mRNA of unknown function [ 40 ] .
technical/biomed/1471-2199-3-11.txt:        We consistently found that the amount of β-actin mRNA was
technical/biomed/1471-2199-3-11.txt:        increase in PTEN mRNA with reference to choA. Using this
technical/biomed/1471-2199-3-11.txt:        approach, we determined that PTEN mRNA was increased up to
technical/biomed/1471-2199-3-11.txt:        expression of PTEN mRNA. Although clearly induced in both
technical/biomed/1471-2199-3-11.txt:        i.e., there was a slight reduction of PTEN mRNA and protein
technical/biomed/1471-2199-3-11.txt:        anchorage-dependent growth control. As an alternative to
technical/biomed/1471-2199-3-11.txt:          phospho-peptide-containing supernatant precipitated with
technical/biomed/1471-2199-3-11.txt:          RNA analysis
technical/biomed/1471-2199-3-11.txt:          Total RNA was isolated using the guanidium thiocyanate
technical/biomed/1471-2199-3-11.txt:          dT beads [ 61 ] . Equal amounts of each RNA sample were
technical/biomed/1471-2199-3-11.txt:          specific riboprobes were generated using T7 RNA
technical/biomed/1471-2199-3-11.txt:          RNA were loaded in each lane. For this purpose, two
technical/biomed/1471-2199-3-11.txt:          which is clone A of a group of highly expressed mRNAs
technical/biomed/1471-2199-3-12.txt:        An alternative to transfection with adenoviral vector is
technical/biomed/1471-2199-3-12.txt:          supernatant was added to 100 μl of luciferase assay
technical/biomed/1471-2199-3-17.txt:        Group II introns are catalytic RNAs that are also mobile
technical/biomed/1471-2199-3-17.txt:        considerably, the intron RNAs fold into well-conserved
technical/biomed/1471-2199-3-17.txt:        similarities between nuclear pre-mRNA splicing in
technical/biomed/1471-2199-3-17.txt:        the release of lariat RNA complexed with the intron-encoded
technical/biomed/1471-2199-3-17.txt:        3 ] . After the intron RNA reverse splices into one strand
technical/biomed/1471-2199-3-17.txt:        transcription of the inserted intron RNA. Integration of
technical/biomed/1471-2199-3-17.txt:        structural features of the intron RNA are important for
technical/biomed/1471-2199-3-17.txt:          targeting DNA or RNA in reverse splicing [ 9 ] . Not
technical/biomed/1471-2199-3-17.txt:          contains one of the most internalized regions of the
technical/biomed/1471-2199-3-17.txt:          Recently, the crystal structure of a 70 nucleotide RNA
technical/biomed/1471-2199-3-17.txt:          occurrence) (Comparative RNA Web Site database:
technical/biomed/1471-2199-3-17.txt:          http://www.rna.icmb.utexas.edu/). In aI5γ, G and U at the
technical/biomed/1471-2199-3-17.txt:          that both the intron RNA and LtrA protein are
technical/biomed/1471-2199-3-3.txt:          supernatant (Figure 4A), and free Cdc14 was active as a
technical/biomed/1471-2199-3-3.txt:          bead-bound Net1 to the supernatant fraction (Figure 4C).
technical/biomed/1471-2199-3-3.txt:          Net1N remained in the supernatant (Figure 5, Lanes 2 and
technical/biomed/1471-2199-3-3.txt:          drive exit from mitosis in these cells. Alternatively, it
technical/biomed/1471-2199-3-3.txt:          the supernatant was transferred to new tubes at the end
technical/biomed/1471-2199-3-3.txt:          and the wash was pooled with the supernatant, and
technical/biomed/1471-2199-3-7.txt:          limited by the levels of lysyl tRNA synthetase
technical/biomed/1471-2199-3-7.txt:          the heat-shock inducible LysU lysyl tRNA synthetase.
technical/biomed/1471-2199-3-7.txt:          lysyl tRNA synthetase was cloned into multicopy plasmid
technical/biomed/1471-2199-3-7.txt:          address whether plasmid pM1 indeed increased lysyl tRNA
technical/biomed/1471-2199-3-7.txt:          3H lysine into yeast tRNA. As shown in Figure 2,
technical/biomed/1471-2199-3-7.txt:          tRNA-dependent lysine incorporation was increased
technical/biomed/1471-2199-3-7.txt:          whether moderate overexpression of the lysyl tRNA
technical/biomed/1471-2199-3-7.txt:          tRNA synthetase ( 
technical/biomed/1471-2199-3-7.txt:          whether a multicopy lysyl tRNA synthetase plasmid
technical/biomed/1471-2199-3-7.txt:          Lysyl tRNA synthetase activity assay
technical/biomed/1471-2199-3-7.txt:          tritiated lysine into tRNA was measured by modification
technical/biomed/1471-2199-3-7.txt:          were performed with or without 15 μg yeast tRNA (Sigma)
technical/biomed/1471-2199-4-4.txt:        Ad5 DNA and of transgene mRNA in the liver as measures of
technical/biomed/1471-2199-4-4.txt:          transcription (CMV-promoter activity), RNA stability, RNA
technical/biomed/1471-2199-4-4.txt:          the amount of the luciferase mRNA present in the liver of
technical/biomed/1471-2199-4-4.txt:          northern blot of the liver RNA shows about 10 times more
technical/biomed/1471-2199-4-4.txt:          luciferase mRNA in the liver of the Brown Norway rats
technical/biomed/1471-2199-4-4.txt:          difference in RNA stability.
technical/biomed/1471-2199-4-4.txt:        transgenic mRNA was also different in both rat strains.
technical/biomed/1471-2199-4-4.txt:        difference in RNA stability.
technical/biomed/1471-2199-4-4.txt:          supernatant was added to 100 μl of luciferase assay
technical/biomed/1471-2199-4-4.txt:          Technologies) using a blender. Total RNA was isolated
technical/biomed/1471-2199-4-4.txt:          RNA was recovered. RNA was precipitated with isopropyl
technical/biomed/1471-2199-4-4.txt:          alcohol and the pellet was resuspended in RNase free
technical/biomed/1471-2199-4-4.txt:          water. The RNA and DNA content were measured by
technical/biomed/1471-2199-4-4.txt:          The quantity of RNA loaded was 20 μg as determined by
technical/biomed/1471-2199-4-4.txt:          spectrophotometry. The RNA loaded represents a similar
technical/biomed/1471-2199-4-4.txt:          proportion of luciferase mRNA in both strains as the
technical/biomed/1471-2199-4-4.txt:          total concentrations of RNA are similar in the Wag/Rij
technical/biomed/1471-2199-4-4.txt:          1.91 μg/gr). The RNA was run on a 1% agarose gel and
technical/biomed/1471-2199-4-4.txt:          transfer. The RNA was then fixed by UV irradiation. The
technical/biomed/1471-2199-4-4.txt:        IU: International Units
technical/biomed/1471-2199-4-5.txt:        two parental DNA molecules [ 10 ] . Alternatively, RecF
technical/biomed/1471-2199-4-5.txt:        trapped in the agarose gel (see [ 24 25 ] ). An alternative
technical/biomed/1471-2199-4-5.txt:          mg/ml) and RNase A (20 mg/ml). The plugs were then washed
technical/biomed/1471-2202-1-1.txt:        several hours ( 4, 7). The internalization of
technical/biomed/1471-2202-1-1.txt:        receptors be internalized 
technical/biomed/1471-2202-1-1.txt:        2) does the internalization process have the same kinetics
technical/biomed/1471-2202-1-1.txt:        internalization of the receptor due to its affinity as well
technical/biomed/1471-2202-1-1.txt:        provoke the internalization of the δ-opioid receptor.
technical/biomed/1471-2202-1-1.txt:        internalization process is agonist-selective. In a study
technical/biomed/1471-2202-1-1.txt:        (DAMGO) which is able to trigger an internalization
technical/biomed/1471-2202-1-1.txt:        demonstrated a possible internalization process of μ-opioid
technical/biomed/1471-2202-1-1.txt:        internalization of the δ-opioid receptors in the rat spinal
technical/biomed/1471-2202-1-1.txt:        internalization of the δ-opioid receptor within 30 minutes.
technical/biomed/1471-2202-1-1.txt:        was internalized to a greater extent in the lamina I than
technical/biomed/1471-2202-1-1.txt:        of an internalization of the δ-opioid receptors in response
technical/biomed/1471-2202-1-1.txt:        the internalized receptors is still uncertain. 
technical/biomed/1471-2202-1-1.txt:        lofentanyl, a mu agonist, is internalized in axon terminals
technical/biomed/1471-2202-1-1.txt:        rat spinal cord slices found a possible internalization of
technical/biomed/1471-2202-1-1.txt:        showed internalization after the application of opioid
technical/biomed/1471-2202-1-1.txt:        The internalized receptors are then compartmentalized in
technical/biomed/1471-2202-1-1.txt:        internalization in response to an agonist stimulation, the
technical/biomed/1471-2202-1-1.txt:        membrane ( 33). It seems that the internalization/recycling
technical/biomed/1471-2202-1-1.txt:        experimental conditions, the fate of internalized receptors
technical/biomed/1471-2202-1-1.txt:        internalization of the δ-opioid receptor at the level of
technical/biomed/1471-2202-1-1.txt:        receptor internalization ( 3) are relevant to the CNS 
technical/biomed/1471-2202-1-1.txt:        (22 ± 1°C, 12 h alternate light-dark cycles, food and water
technical/biomed/1471-2202-1-1.txt:        internalization.
technical/biomed/1471-2202-1-1.txt:        the cisterna magna was opened. A catheter was inserted
technical/biomed/1471-2202-2-1.txt:          Supernatant was divided into aliquots of 20 μl and stored
technical/biomed/1471-2202-2-1.txt:          sections were washed with water. Alternatively,
technical/biomed/1471-2202-2-10.txt:        cost-efficient, ethical alternative to existing models, and
technical/biomed/1471-2202-2-12.txt:        Furthermore, BMP-5 mRNA and protein are detected in intact
technical/biomed/1471-2202-2-12.txt:          Expression of BMP-5 mRNA and protein in SCG
technical/biomed/1471-2202-2-12.txt:          sympathetic neurons. As indicated in Figure 8, BMP-5 mRNA
technical/biomed/1471-2202-2-12.txt:          growth. In contrast, BMP-5 mRNA was not detected in adult
technical/biomed/1471-2202-2-12.txt:        observations that mRNA for BMP type IA and type II
technical/biomed/1471-2202-2-12.txt:        BMP-5 mRNA was not detected in adult SCG, Western blot
technical/biomed/1471-2202-2-12.txt:        patterns of BMP-5 expression at the mRNA level, as assessed
technical/biomed/1471-2202-2-12.txt:          maximum speed for 5 min and the resultant supernatant
technical/biomed/1471-2202-2-12.txt:          RNA Isolation and Analyses
technical/biomed/1471-2202-2-12.txt:          Total RNA was extracted from freshly harvested
technical/biomed/1471-2202-2-12.txt:          Technology, Carlsbad, CA). RNA samples (5 μg) were
technical/biomed/1471-2202-2-14.txt:        chrna7 gene with sensorimotor gating
technical/biomed/1471-2202-2-15.txt:          Alternatively, Siah1a binding may alter the 'normal'
technical/biomed/1471-2202-2-15.txt:          Alternatively, the presence of Siah1a itself may
technical/biomed/1471-2202-2-15.txt:          In all recordings, the external (bath) solution
technical/biomed/1471-2202-2-15.txt:          osmolality ~320 mOsm kg -1. The internal (pipette)
technical/biomed/1471-2202-2-16.txt:        PLD2 mRNA was present in SN56 cells (Fig. 1A) while PLD1
technical/biomed/1471-2202-2-16.txt:        different concentrations and PLD2 mRNA levels were
technical/biomed/1471-2202-2-16.txt:        measured. Northern blot showed that PLD2 mRNA expression
technical/biomed/1471-2202-2-16.txt:        oligonucleotides, PLD2 mRNA, protein expression, and
technical/biomed/1471-2202-2-16.txt:        [ 21 22 ] . PLD2 mRNA is abundant in many regions of the
technical/biomed/1471-2202-2-16.txt:          Dr. Yoshinori Nozawa (Gifu International Institute of
technical/biomed/1471-2202-2-16.txt:          described previously [ 25 ] using 20 μg of total RNA per
technical/biomed/1471-2202-2-16.txt:          bromide. The RNA was size-fractionated by electrophoresis
technical/biomed/1471-2202-2-16.txt:          supernatant fluid with chloroform and water (1:2:1 v/v).
technical/biomed/1471-2202-2-17.txt:        observed that D-AKAP1 mRNA and protein expressions are high
technical/biomed/1471-2202-2-17.txt:        shown previously that one of the two alternative
technical/biomed/1471-2202-2-17.txt:          4°C; the soluble supernatant and insoluble pellet were
technical/biomed/1471-2202-2-19.txt:        hours of stimulation by a nerve terminal or by alternative
technical/biomed/1471-2202-2-19.txt:        Alternatively it may be that their culture system would
technical/biomed/1471-2202-2-19.txt:        33 34 ] . The alternative, completely consistent with all
technical/biomed/1471-2202-2-19.txt:        alternative interpretation holds that spontaneous receptor
technical/biomed/1471-2202-2-19.txt:        alternatively that laminin plays a role in aggregate
technical/biomed/1471-2202-2-20.txt:        messenger RNA in the frontal cortex, which has been shown
technical/biomed/1471-2202-2-20.txt:        than females or males fed the alternate diet. It should be
technical/biomed/1471-2202-2-20.txt:            with internal controls [ 28 ] .
technical/biomed/1471-2202-2-20.txt:            glucuronide was added as an internal standard and 700
technical/biomed/1471-2202-2-20.txt:            supernatant was decanted into another tube. The
technical/biomed/1471-2202-2-20.txt:            cold, and decanting the supernatant into the tube
technical/biomed/1471-2202-2-3.txt:          cultures by immunostaining and by mRNA analysis by
technical/biomed/1471-2202-2-3.txt:          of these cells. mRNA for estrogen receptor-α but not
technical/biomed/1471-2202-2-3.txt:          Blocking of neurotoxicity of supernatants from HIV
technical/biomed/1471-2202-2-3.txt:          Cell culture supernatants from HIV infected monocytic
technical/biomed/1471-2202-2-3.txt:          supernatants were immunoabsorbed against antisera to
technical/biomed/1471-2202-2-3.txt:          neurotoxicity of the culture supernatants was not
technical/biomed/1471-2202-2-3.txt:        important components in supernatants of HIV infected cells
technical/biomed/1471-2202-2-3.txt:        immunocytochemistry and determined their subtypes by mRNA
technical/biomed/1471-2202-2-3.txt:            mRNA level. For each gene examined, we generated
technical/biomed/1471-2202-2-3.txt:            standard curves of input RNA and cycle number to
technical/biomed/1471-2202-2-3.txt:            respect to input RNA [ 30].
technical/biomed/1471-2202-2-3.txt:          viral proteins. Culture supernatants were collected every
technical/biomed/1471-2202-2-3.txt:          viral proteins, the culture supernatants were incubated
technical/biomed/1471-2202-2-3.txt:          the supernatants were removed and immediately used for
technical/biomed/1471-2202-2-3.txt:          7.2) and neurons were incubated with culture supernatants
technical/biomed/1471-2202-2-5.txt:          57]. The BXD5 strain used as the paternal strain in this
technical/biomed/1471-2202-2-7.txt:          used as an internal reference [ 34]. In this study,
technical/biomed/1471-2202-2-7.txt:        CaMKII mRNA, protein and enzyme activity (localized in the
technical/biomed/1471-2202-2-7.txt:          were euthanized in the light period of the diurnal cycle
technical/biomed/1471-2202-2-7.txt:          10 min to produce a pellet (P1) and a supernatant (S1).
technical/biomed/1471-2202-2-7.txt:          for 10 min to obtain pellet P1' and supernatant S1'. S1
technical/biomed/1471-2202-2-7.txt:          min to produce pellet P2 and supernatant S2. P2 was
technical/biomed/1471-2202-2-7.txt:          19,000 g for 20 min to obtain pellet P3 and supernatant
technical/biomed/1471-2202-2-7.txt:          After brief centrifugation, the supernatants were mixed
technical/biomed/1471-2202-2-7.txt:          supernatants were collected and subjected to a 7.5%
technical/biomed/1471-2202-2-9.txt:        parallel neurite growth. Alternatively, biochemical cues
technical/biomed/1471-2202-2-9.txt:          Alternatively, given their tendency to fasciculate, axons
technical/biomed/1471-2202-3-1.txt:          inspecting a plot of raw data. As an alternative to
technical/biomed/1471-2202-3-1.txt:          activity can decrease slowly. Alternatively, it might
technical/biomed/1471-2202-3-1.txt:          alternatively, whether the timing of the peak of such
technical/biomed/1471-2202-3-1.txt:          rhythm. We discuss alternative methods for evaluating the
technical/biomed/1471-2202-3-1.txt:          Alternatively, the data may be transformed directly,
technical/biomed/1471-2202-3-1.txt:          coherent (phase-synchronized). Alternatively, one might
technical/biomed/1471-2202-3-1.txt:          internally as a matrix whose columns represent individual
technical/biomed/1471-2202-3-10.txt:          alternatively, regionally increased levels of components
technical/biomed/1471-2202-3-11.txt:          pair of samples. RNA was prepared from 3 such pairs of
technical/biomed/1471-2202-3-11.txt:          mRNA was found to be only marginally enriched in the
technical/biomed/1471-2202-3-11.txt:          (CAMK IV homolog) mRNA are both highly enriched in the
technical/biomed/1471-2202-3-11.txt:          and recommendations of the International Association for
technical/biomed/1471-2202-3-11.txt:          Tissue dissection and RNA preparation
technical/biomed/1471-2202-3-11.txt:          Total RNA from each sample was prepared using Trizol™
technical/biomed/1471-2202-3-11.txt:          RNEasy™ (Qiagen, Hilden Germany). RNA samples were
technical/biomed/1471-2202-3-11.txt:          total RNA quality was assessed by capillary
technical/biomed/1471-2202-3-11.txt:          to ensure that the 28S:18S rRNA ratio was >1.0 for
technical/biomed/1471-2202-3-11.txt:          T7 RNA polymerase promoter linked to oligo-dT 
technical/biomed/1471-2202-3-11.txt:          double-stranded cDNA synthesis from each total RNA sample
technical/biomed/1471-2202-3-11.txt:          42°C using Superscript II RNAseH -reverse transcriptase
technical/biomed/1471-2202-3-11.txt:          in vitro into the copy RNA (cRNA)
technical/biomed/1471-2202-3-11.txt:          High Yield RNA Transcript Labeling Kit (Enzo
technical/biomed/1471-2202-3-11.txt:          Biochemicals, New York, NY). These cRNA transcripts were
technical/biomed/1471-2202-3-11.txt:          15 μg aliquots of each cRNA sample were fragmented at
technical/biomed/1471-2202-3-11.txt:          alternative to the 'average difference' calculated by the
technical/biomed/1471-2202-3-11.txt:          Total RNA was treated with DNase I, Amplification
technical/biomed/1471-2202-3-11.txt:          t values for GAPDH RNA from the same
technical/biomed/1471-2202-3-11.txt:          t (GAPDH RNA) for dorsal sample
technical/biomed/1471-2202-3-11.txt:          sodium citrate; pH 7.0)/10 mM DTT, treated with RNase A
technical/biomed/1471-2202-3-14.txt:          alternate assay for genetic studies of attention. Our
technical/biomed/1471-2202-3-16.txt:        Measurements of mRNA and protein made in many
technical/biomed/1471-2202-3-16.txt:          Sprague-Dawley rats were pooled for each RNA population.
technical/biomed/1471-2202-3-16.txt:          Each RNA sample was labeled separately and hybridized to
technical/biomed/1471-2202-3-16.txt:          detected in arrays hybridized with naïve rat DRG cRNA and
technical/biomed/1471-2202-3-16.txt:          independent L4 and L5 DRG RNA samples extracted from
technical/biomed/1471-2202-3-16.txt:          analyzed in this way and alternate splice forms were
technical/biomed/1471-2202-3-16.txt:        array analysis to be regulated and measurements of mRNA for
technical/biomed/1471-2202-3-16.txt:        in the total RNA sample to below detection threshold [ 10 ]
technical/biomed/1471-2202-3-16.txt:        analyzed array data and the mRNA measurements. These
technical/biomed/1471-2202-3-16.txt:        array fold change and mRNA fold change.
technical/biomed/1471-2202-3-16.txt:          Tissue and RNA preparation
technical/biomed/1471-2202-3-16.txt:          removed, and stored at -80°C. Total RNA was extracted
technical/biomed/1471-2202-3-16.txt:          (TRIzol reagent, Gibco-BRL). RNA concentration was
technical/biomed/1471-2202-3-16.txt:          by electrophoresis on a 1.5% agarose gel. Each RNA sample
technical/biomed/1471-2202-3-16.txt:          the target mRNA with multiple probe pairs. Each probe
technical/biomed/1471-2202-3-16.txt:          biotin-labeled cRNA, prepared as per standard Affymetrix
technical/biomed/1471-2202-3-16.txt:          protocol. Briefly, total RNA (8 μg) from DRGs was reverse
technical/biomed/1471-2202-3-16.txt:          transcribed using an oligo-dT primer coupled to a T7 RNA
technical/biomed/1471-2202-3-16.txt:          and biotinylated-cRNA synthesized using T7 polymerase.
technical/biomed/1471-2202-3-16.txt:          The cRNA was hybridized for 16 hours to an array,
technical/biomed/1471-2202-3-16.txt:          and data analyzed using GeneChip software. External
technical/biomed/1471-2202-3-16.txt:          Hybridization levels for each species of mRNA detected
technical/biomed/1471-2202-3-16.txt:          performed on cDNA reverse transcribed from total RNA,
technical/biomed/1471-2202-3-16.txt:          Total RNA was size separated by electrophoresis on a
technical/biomed/1471-2202-3-16.txt:          1.5% agarose/formaldehyde gel (10 μg of total RNA per
technical/biomed/1471-2202-3-16.txt:          Total RNA (1.25 μg) was directly transferred to Hybond
technical/biomed/1471-2202-3-16.txt:          the mRNAs whose accession numbers were provided by
technical/biomed/1471-2202-3-17.txt:          Xenopus oocytes by mRNA injection [
technical/biomed/1471-2202-3-17.txt:          expression by reducing the amount of mRNA from 50 ng to
technical/biomed/1471-2202-3-17.txt:          injecting mRNA at room temperature [ 10 ] . Recording
technical/biomed/1471-2202-3-19.txt:        analgesia, hibernation, autonomic nervous system function,
technical/biomed/1471-2202-3-19.txt:        as hibernation, a better understanding of δ receptor
technical/biomed/1471-2202-3-20.txt:          sleep-wake distribution typical for this nocturnal
technical/biomed/1471-2202-3-20.txt:          in other tissues, mRNA levels for all three genes were
technical/biomed/1471-2202-3-20.txt:          Messenger RNA levels for 
technical/biomed/1471-2202-3-20.txt:          per2 mRNA levels were higher
technical/biomed/1471-2202-3-20.txt:          dbp mRNA decreased significantly
technical/biomed/1471-2202-3-20.txt:          of these five mRNAs were not affected by SD (data not
technical/biomed/1471-2202-3-20.txt:          per2 mRNA was confirmed by the
technical/biomed/1471-2202-3-20.txt:          per1 mRNA relative to the level of
technical/biomed/1471-2202-3-20.txt:        cry1,2 -/-mice still exhibit diurnal
technical/biomed/1471-2202-3-20.txt:        diurnal rhythm of sleep and/or by directly affecting the
technical/biomed/1471-2202-3-20.txt:        arrhythmic by lesioning of the SCN. In nocturnal rodents,
technical/biomed/1471-2202-3-20.txt:        unchanged [ 6 7 8 31 ] . Lesioning the SCN in a diurnal
technical/biomed/1471-2202-3-20.txt:        mRNA levels of CLOCK/NPAS2:BMAL1 target genes, including
technical/biomed/1471-2202-3-20.txt:        small number (~0.5%) of the ~10,000 genes screened by mRNA
technical/biomed/1471-2202-3-20.txt:        cry1,2 expression at the mRNA level
technical/biomed/1471-2202-3-20.txt:        nocturnal and diurnal species, 
technical/biomed/1471-2202-3-20.txt:        per genes was studied at the mRNA
technical/biomed/1471-2202-3-20.txt:        per mRNA and levels of the PER
technical/biomed/1471-2202-3-20.txt:        per1,2 mRNAs as transcriptional
technical/biomed/1471-2202-3-20.txt:          dry ice. Total RNA was extracted and Northern analysis
technical/biomed/1471-2202-3-20.txt:          was performed with 10 μg whole brain total RNA as
technical/biomed/1471-2202-3-20.txt:          the standard curve (range of 0.2-200 ng total RNA)
technical/biomed/1471-2202-3-3.txt:        assembly/disassembly, gene transcription, RNA processing,
technical/biomed/1471-2202-3-3.txt:          transcripts previously found by alternative technologies
technical/biomed/1471-2202-3-3.txt:          present in limiting numbers. Alternatively, there may be
technical/biomed/1471-2202-3-3.txt:          machinery [ 43 ] . The alternative is that the changes
technical/biomed/1471-2202-3-3.txt:          reported to negatively regulate double-stranded RNA
technical/biomed/1471-2202-3-3.txt:          (dsRNA)-activated protein kinase (PKR) [ 45 ] . As an
technical/biomed/1471-2202-3-3.txt:          Inc.) for the indicated times. Total cellular RNA was
technical/biomed/1471-2202-3-3.txt:          Rnase H-RT according to the manufacturer's specifications
technical/biomed/1471-2202-3-4.txt:          external divalent cations [ 24 ] , and is likely due to a
technical/biomed/1471-2202-3-4.txt:          20 24 ] . These data indicate that in our system VR1 RNA
technical/biomed/1471-2202-3-4.txt:          RNA were examined with SDS/PAGE and Western blot, three
technical/biomed/1471-2202-3-4.txt:          injected with N604S RNA. The results of these experiments
technical/biomed/1471-2202-3-4.txt:          equal amounts of VR1 and Δ2-52 RNA's were coinjected into
technical/biomed/1471-2202-3-4.txt:          Alternatively, a covalent interaction may link pairs of
technical/biomed/1471-2202-3-4.txt:          Oocytes were injected with 50 nL mRNA solution within two
technical/biomed/1471-2202-3-4.txt:          second-site mutations. mRNA was synthesized in vitro,
technical/biomed/1471-2202-3-4.txt:          centrifugation. 10 μL of supernatant was removed, mixed
technical/biomed/1471-2202-3-5.txt:        gland, and internal excretory structures [ 6 10 11 ] . But
technical/biomed/1471-2202-3-5.txt:          (dispersion) of the estimates. An alternative analysis,
technical/biomed/1471-2202-3-5.txt:          antennal clock. Alternatively, the extreme difference in
technical/biomed/1471-2202-3-5.txt:          determination of clock time or, alternatively, that it
technical/biomed/1471-2202-3-5.txt:        per mRNA cycling in photoreceptors
technical/biomed/1471-2202-3-5.txt:        significance). Alternatively, if RI is less than the
technical/biomed/1471-2202-3-7.txt:        alternative is to insert GFP into the middle of the host
technical/biomed/1471-2202-3-7.txt:        membrane [ 13 14 ] , so placing GFP within internal regions
technical/biomed/1471-2202-3-7.txt:        several insertions appear to be in internal and/or rigid
technical/biomed/1471-2202-3-7.txt:        alternative screening strategy could be particularly useful
technical/biomed/1471-2202-3-7.txt:        explanation for why GFP can be used for internal insertion
technical/biomed/1471-2202-3-7.txt:        trypsin inhibitor for internal insertions [ 21 ] . The
technical/biomed/1471-2202-3-7.txt:        membrane and supernatant fractions harvested as described
technical/biomed/1471-2202-3-7.txt:        normalized volumes of the supernatants were resolved by
technical/biomed/1471-2202-3-7.txt:        The external solution was (in mM): 150 NaCl, 3 KCl, 2 CaCl 
technical/biomed/1471-2202-3-7.txt:        solution in DMSO and diluted to 100 μM in external
technical/biomed/1471-2202-3-8.txt:        the external urethral sphincter [ 1 ] and is composed of
technical/biomed/1471-2202-3-8.txt:        external urethral sphincter [ 10 ] where there was
technical/biomed/1471-2202-4-10.txt:        of regulation by means of mRNA editing [ 39 ] . RNA editing
technical/biomed/1471-2202-4-10.txt:        occurs when double-stranded RNA deaminase converts
technical/biomed/1471-2202-4-10.txt:        the coding sequence of specific RNA transcripts. RNA
technical/biomed/1471-2202-4-10.txt:        three amino acids within the second intracellular loop. RNA
technical/biomed/1471-2202-4-10.txt:        study is also a site of mRNA editing in this receptor; i.e.
technical/biomed/1471-2202-4-10.txt:        Alternatively, additional sequence or regulatory elements,
technical/biomed/1471-2202-4-10.txt:          in vitro transcribed RNA for the
technical/biomed/1471-2202-4-10.txt:          experiments. Three days after RNA injection, oocytes were
technical/biomed/1471-2202-4-10.txt:          in vitro transcribed RNA for the
technical/biomed/1471-2202-4-11.txt:        expressed at low levels [ 1 ] . BDNF mRNA is expressed in
technical/biomed/1471-2202-4-11.txt:        detected BDNF mRNA in the muscle layer of the fin of the 4
technical/biomed/1471-2202-4-11.txt:        activity is required to maintain BDNF mRNA levels in rat
technical/biomed/1471-2202-4-11.txt:        mRNA levels above baseline [ 17 ] . Neuromuscular blockade
technical/biomed/1471-2202-4-11.txt:        in culture also decreases BDNF mRNA levels. In response to
technical/biomed/1471-2202-4-11.txt:        nerve injury BDNF mRNA is slowly but substantially
technical/biomed/1471-2202-4-11.txt:        BDNF mRNA in muscle in response to neuromuscular activity
technical/biomed/1471-2202-4-11.txt:          exons total RNA extracted from 10 days old larvae was
technical/biomed/1471-2202-4-11.txt:          transcripts in total RNA dramatically increases in the
technical/biomed/1471-2202-4-11.txt:          they represented an internal exon. Classical splice
technical/biomed/1471-2202-4-11.txt:          an internal position in a BDNF transcript. The shorter
technical/biomed/1471-2202-4-11.txt:          coding exon. Finding an internal exon was thus unexpected
technical/biomed/1471-2202-4-11.txt:          identified the insert as the 5' end of β-actin mRNA.
technical/biomed/1471-2202-4-11.txt:          an internal non-coding exon. So far internal non-coding
technical/biomed/1471-2202-4-11.txt:          cell-specifically, total RNA was extracted from the
technical/biomed/1471-2202-4-11.txt:          mRNA was readily amplified in the first round of PCR
technical/biomed/1471-2202-4-11.txt:          exon 1b, exon 1c was detected in muscle RNA after the
technical/biomed/1471-2202-4-11.txt:          second round of PCR. Total RNA from whole juvenile fish
technical/biomed/1471-2202-4-11.txt:        Unexpectedly, RT-PCR did not detect exon 1b in total RNA
technical/biomed/1471-2202-4-11.txt:        not assay RNA from these early stages of development. It is
technical/biomed/1471-2202-4-11.txt:        detected by RT-PCR in adult female muscle RNA (see figure
technical/biomed/1471-2202-4-11.txt:          preparation was total RNA extracted from 10 days old
technical/biomed/1471-2202-4-11.txt:          performed using the internal 5' GeneRacer primer and
technical/biomed/1471-2202-4-11.txt:          Total RNA was extracted from two juvenile zebrafish
technical/biomed/1471-2202-4-11.txt:          method of Chomczynski [ 39 ] . The integrity of the RNA
technical/biomed/1471-2202-4-11.txt:          1 μg of total RNA was reverse transcribed using random
technical/biomed/1471-2202-4-11.txt:          amplification. β-actin primers were used as internal
technical/biomed/1471-2202-4-12.txt:        Alternatively, the decrease in brain weight could
technical/biomed/1471-2202-4-16.txt:        An alternative proposal is that the toxicity stems from
technical/biomed/1471-2202-4-16.txt:        vacuolar membrane. Alternatively, peroxisomes might be
technical/biomed/1471-2202-4-17.txt:        11 ] . Moreover, MIF protein and mRNA were also detected by
technical/biomed/1471-2202-4-17.txt:        also shown to contain MIF protein and mRNA.
technical/biomed/1471-2202-4-17.txt:        17 ] . Alternatively, since the present study did not
technical/biomed/1471-2202-4-17.txt:        visualize MIF mRNA using in situ hybridization, it is
technical/biomed/1471-2202-4-17.txt:        total bladder MIF protein and mRNA content [ 10 ] .
technical/biomed/1471-2202-4-17.txt:        The anatomical location of MIF mRNA and protein has been
technical/biomed/1471-2202-4-17.txt:        CSF following intracisternal LPS or spinal cord injury [ 7
technical/biomed/1471-2202-4-2.txt:          profile of loss (Fig. 3). Alternatively, efferent fibers
technical/biomed/1471-2202-4-2.txt:          and probed for the presence of BDNF and NT-3 mRNA using
technical/biomed/1471-2202-4-3.txt:            tract(Fig. 2A), the internal genu of the facial nerve
technical/biomed/1471-2202-4-3.txt:          (preprotachykinin A mRNA) [ 12 ] and NKB (peptide-2;
technical/biomed/1471-2202-4-3.txt:          preprotachykinin B mRNA) [ 14 16 17 20 ] in the CNS of
technical/biomed/1471-2202-4-3.txt:          preprotachykinin mRNA in the rat brainstem than the
technical/biomed/1471-2202-4-3.txt:        - EAF : External arcuate fibers
technical/biomed/1471-2202-4-3.txt:        - Fac, G : Facial nerve, internal
technical/biomed/1471-2202-4-3.txt:        - IAF : Internal arcuate fibers
technical/biomed/1471-2202-4-5.txt:        Alternatively, spontaneous variations of nerve activity
technical/biomed/1471-2202-4-5.txt:        nerve to nerve variations or by other external factors,
technical/biomed/1471-2202-4-6.txt:        RNA splicing factors [ 5 6 7 ] . However, while
technical/biomed/1471-2202-4-6.txt:        nuclear components. Alternatively, it could be that lamins
technical/biomed/1471-2202-4-6.txt:        IF-associated structures, but rather storage sites of RNA
technical/biomed/1471-2210-1-10.txt:        uptake, RNA and protein synthesis, activation of the
technical/biomed/1471-2210-1-2.txt:        genetic factors, maternal illness and maternal drug
technical/biomed/1471-2210-1-2.txt:        antagonists and the expression of GABA receptor mRNAs are
technical/biomed/1471-2210-1-4.txt:        the external urethral sphincter must be properly
technical/biomed/1471-2210-1-4.txt:        activity of the external urethral sphincter (EUS).
technical/biomed/1471-2210-1-4.txt:        accompanying bursts in the external urethral sphincter EMG,
technical/biomed/1471-2210-1-4.txt:        variables and/or external urethral sphincter EMG.
technical/biomed/1471-2210-1-4.txt:        inhibited the activity of the external urethral sphincter.
technical/biomed/1471-2210-1-4.txt:          external urethral sphincter (Tables 2and 3)
technical/biomed/1471-2210-1-4.txt:          parameters and the external sphincter EMG
technical/biomed/1471-2210-1-4.txt:          external urethral sphincter (as reflected in the
technical/biomed/1471-2210-1-4.txt:          Blockade of the external urethral sphincter in
technical/biomed/1471-2210-1-4.txt:          the external urethral sphincter, as was the case for the
technical/biomed/1471-2210-1-4.txt:          coordinating external urethral sphincter, as may have
technical/biomed/1471-2210-1-4.txt:        external urethral sphincter in the anesthetized rat. These
technical/biomed/1471-2210-1-4.txt:        decreased activity of the external urethral sphincter.
technical/biomed/1471-2210-1-4.txt:          and after micturition. External urethral sphincter EMG
technical/biomed/1471-2210-1-4.txt:        EMG = electromyogram EUS = external urethral sphincter
technical/biomed/1471-2210-1-7.txt:        scavenger receptor mRNA [ 22 ] and tissue plasminogen
technical/biomed/1471-2210-1-7.txt:          Effect of LPS and domoic acid on TNF-α mRNA
technical/biomed/1471-2210-1-7.txt:          resulted in a time-dependent increase in TNF-α mRNA
technical/biomed/1471-2210-1-7.txt:          (control), TNF-α mRNA expression was undetectable. As
technical/biomed/1471-2210-1-7.txt:          potent yet time-dependent increase in TNF-α mRNA
technical/biomed/1471-2210-1-7.txt:          In order to determine if the increase in TNF-α mRNA
technical/biomed/1471-2210-1-7.txt:          same microglia used for TNF-α mRNA analysis were assayed
technical/biomed/1471-2210-1-7.txt:          mRNA expression shown in Fig. 5.
technical/biomed/1471-2210-1-7.txt:        neurotrophic factor (BDNF) messenger RNA " in
technical/biomed/1471-2210-1-7.txt:          termination of the experiments, cell-free supernatants
technical/biomed/1471-2210-1-7.txt:          RNA isolation and RT-PCR. For the O 
technical/biomed/1471-2210-1-7.txt:          expression: RNA isolation and semiquantitative RT-PCR
technical/biomed/1471-2210-1-7.txt:          Total rat neonatal microglia RNA was isolated with TRI
technical/biomed/1471-2210-1-7.txt:          Briefly, first strand cDNA was made using 0.25 μg of RNA,
technical/biomed/1471-2210-1-7.txt:          Immunoreactive TNF-α in cell-free media supernates was
technical/biomed/1471-2210-1-7.txt:          TNF-α purchased from Biosource International (Camarillo,
technical/biomed/1471-2210-1-8.txt:          concentrations of the resulting supernatant were measured
technical/biomed/1471-2210-1-8.txt:          Supernatant (4:1 in denaturing loading buffer, boiled
technical/biomed/1471-2210-1-8.txt:          the supernatant was discarded. The pellets were washed 2
technical/biomed/1471-2210-2-14.txt:        mRNA.
technical/biomed/1471-2210-2-14.txt:          instability of rabbit EP2 receptor mRNA in vivo.
technical/biomed/1471-2210-2-14.txt:          sequence in native cDNA was confirmed by RT-PCR on RNA
technical/biomed/1471-2210-2-14.txt:          Solution hybridization/RNase protection assays with a
technical/biomed/1471-2210-2-14.txt:          RNase-resistant fragment of the appropriate size (322 bp,
technical/biomed/1471-2210-2-14.txt:          2 receptor mRNA was detected in
technical/biomed/1471-2210-2-14.txt:          2 receptor mRNA was detected by RNase
technical/biomed/1471-2210-2-14.txt:          2 receptor mRNA in these vessels was
technical/biomed/1471-2210-2-14.txt:          2 receptor mRNA was also detected in
technical/biomed/1471-2210-2-14.txt:          from the same cDNA probe used in RNase-protection assays.
technical/biomed/1471-2210-2-14.txt:          EP2 mRNA signal was detected in the rabbit kidney (Figure
technical/biomed/1471-2210-2-14.txt:          total RNA isolated from rabbit spleen (figure 8). As
technical/biomed/1471-2210-2-14.txt:          indicating the origination of PCR products were from mRNA
technical/biomed/1471-2210-2-14.txt:          other than genomic DNA (figure 8). EP2 receptor mRNA was
technical/biomed/1471-2210-2-14.txt:          ducts (MCD). Detectable EP2 mRNA was also present in thin
technical/biomed/1471-2210-2-14.txt:          In cultured cells RNase protection assay detected EP2
technical/biomed/1471-2210-2-14.txt:          6B& 6C). EP2 mRNA was also detected in cultured
technical/biomed/1471-2210-2-14.txt:        3 receptors, no alternative splicing in
technical/biomed/1471-2210-2-14.txt:        2 mRNAs in the mouse was found in both
technical/biomed/1471-2210-2-14.txt:        significance of this mRNA splicing is not yet known, but it
technical/biomed/1471-2210-2-14.txt:        The expression level of rabbit EP2 receptor mRNA is
technical/biomed/1471-2210-2-14.txt:        skeletal muscle. This mRNA expression pattern is similar to
technical/biomed/1471-2210-2-14.txt:        29 ] . The mRNA expression results are consistent with
technical/biomed/1471-2210-2-14.txt:        2 receptor mRNA in the uterus also
technical/biomed/1471-2210-2-14.txt:        2 receptor mRNA was detected in both
technical/biomed/1471-2210-2-14.txt:        2 mRNA expression was also detected in
technical/biomed/1471-2210-2-14.txt:        2 receptor mRNA expression was detected
technical/biomed/1471-2210-2-14.txt:        2 receptor mRNA expression could be
technical/biomed/1471-2210-2-14.txt:        2 receptor mRNA expression were detected
technical/biomed/1471-2210-2-14.txt:        by RT-PCR or RNase protection assay in nephron segments
technical/biomed/1471-2210-2-14.txt:        The expression of EP2 receptor mRNA in medullary collecting
technical/biomed/1471-2210-2-14.txt:        cortical collecting duct. Alternatively the PCR detection
technical/biomed/1471-2210-2-14.txt:          Total RNA was purified from dissected nephron segments
technical/biomed/1471-2210-2-14.txt:          (GeneAmp RNA PCR kit, Perkin Elmer Cetus, Norwalk, CT).
technical/biomed/1471-2210-2-14.txt:          Solution hybridization/RNase protection
technical/biomed/1471-2210-2-14.txt:          RNase protection assays were performed as described
technical/biomed/1471-2210-2-14.txt:          synthesize cRNA probes for solution hybridization of
technical/biomed/1471-2210-2-14.txt:          total RNA from various tissues. Briefly, the fragments of
technical/biomed/1471-2210-2-14.txt:          (1 μg) transcribed in vitro with 10 U of T3 RNA
technical/biomed/1471-2210-2-14.txt:          EDTA (RPAII, Ambion). Twenty micrograms of total RNAs
technical/biomed/1471-2210-2-14.txt:          [ 35S]-labeled riboprobe used in the RNase protection
technical/biomed/1471-2210-2-14.txt:          were treated with RNase A (10 μg/ml) at 37°C for 30
technical/biomed/1471-2210-2-4.txt:        mRNA into 
technical/biomed/1471-2210-2-4.txt:        families. In addition, expression of CYP1A1 and CYP3A4 mRNA
technical/biomed/1471-2210-2-6.txt:        the external urethral sphincter. Other, newer, atypical
technical/biomed/1471-2210-2-6.txt:        external urethral sphincter during cystometry in the
technical/biomed/1471-2210-2-6.txt:          the activity of the external urethral sphincter during
technical/biomed/1471-2210-2-6.txt:        parameters, the EMG recorded from the external urethral
technical/biomed/1471-2210-2-6.txt:        recorded from the external urethral sphincter during phase
technical/biomed/1471-2210-2-6.txt:        In the anesthetized rat, the external urethral sphincter
technical/biomed/1471-2210-2-6.txt:        whereas in humans the external sphincter not active during
technical/biomed/1471-2210-2-6.txt:        voiding. Pharmacological blockade of the external urethral
technical/biomed/1471-2210-2-6.txt:        suggesting that the activity of the external urethral
technical/biomed/1471-2210-2-6.txt:        inhibit certain urodynamic parameters and the external
technical/biomed/1471-2210-2-6.txt:          introduced into the external urethral sphincter for EMG
technical/biomed/1471-2210-2-6.txt:          ml/min) while recording bladder pressure, external
technical/biomed/1471-2210-2-6.txt:          and after micturition. External urethral sphincter EMG
technical/biomed/1471-2210-2-6.txt:        EUS = external urethral sphincter
technical/biomed/1471-2210-2-9.txt:        and/or internalization of receptors from the cell surface.
technical/biomed/1471-2210-2-9.txt:        internalization pathway [ 5 ] , as well as serving as a
technical/biomed/1471-2210-2-9.txt:        levels of beta receptor mRNA [ 7 ] . Down-regulation of the
technical/biomed/1471-2210-2-9.txt:        however, does undergo arrestin-dependent internalization [
technical/biomed/1471-2210-2-9.txt:        sequestration/internalization. Site-directed mutagenesis
technical/biomed/1471-2210-2-9.txt:        agonist-induced sequestration/internalization [ 12 ] . The
technical/biomed/1471-2210-2-9.txt:          2000 × g for 5 min at 4°C, the supernatant was discarded,
technical/biomed/1471-2210-3-1.txt:        fentanyl, or in the presence of an internal pool of
technical/biomed/1471-2210-3-3.txt:            alternating current stimulus of 50 Hz and 150 mA
technical/biomed/1471-2229-1-2.txt:        would require mediation by water molecules. Alternatively,
technical/biomed/1471-2229-1-3.txt:        alternative interpretation is that mulberry has only
technical/biomed/1471-2229-2-11.txt:          internal LB-RB junction resulted in the expected product
technical/biomed/1471-2229-2-11.txt:        silencing, can be RNA mediated if suitable double stranded
technical/biomed/1471-2229-2-11.txt:        RNA versions of the promoter sequence are transcribed,
technical/biomed/1471-2229-2-3.txt:        mRNAs have been isolated from cotton ( 
technical/biomed/1471-2229-2-3.txt:        subunit A mRNAs are expressed in the unicellular alga 
technical/biomed/1471-2229-2-3.txt:        increase in both subunit A mRNA and protein in response to
technical/biomed/1471-2229-2-3.txt:        V-ATPase subunit A mRNA, however they provided no data. In
technical/biomed/1471-2229-2-3.txt:        increase only for the proteolipid mRNA, an increase of
technical/biomed/1471-2229-2-3.txt:        mRNA level in response to salt stress [ 57 ] . The effects
technical/biomed/1471-2229-2-3.txt:        finding that mRNA levels for subunit A increase two to four
technical/biomed/1471-2229-2-3.txt:        similar results with respect to induction of mRNA for
technical/biomed/1471-2229-2-3.txt:        increase in subunit A mRNA [ 50 ] . However, drought stress
technical/biomed/1471-2229-2-3.txt:        no apparent increase in mRNA levels for subunit A [ 60 ]
technical/biomed/1471-2229-2-3.txt:        exhibited an approximately two fold increase in mRNA levels
technical/biomed/1471-2229-2-3.txt:        third demonstrated an increase in mRNA levels.
technical/biomed/1471-2229-2-3.txt:        RNA blot analysis was performed to determine the organ
technical/biomed/1471-2229-2-3.txt:        Whole RNA was harvested from leaves, bolts, siliques,
technical/biomed/1471-2229-2-3.txt:        roots. RNA was denatured with glyoxal, fractionated via
technical/biomed/1471-2229-2-3.txt:        slightly higher levels of subunit A mRNA present in
technical/biomed/1471-2229-2-3.txt:        Most eukaryotic mRNAs are characterized by the presence
technical/biomed/1471-2229-2-3.txt:        translation of plant mRNAs [ 70 ] .
technical/biomed/1471-2229-2-3.txt:        common in plant mRNAs but this phenomenon is rare in animal
technical/biomed/1471-2229-2-3.txt:        Whole RNA blot analysis was used first to evaluate the
technical/biomed/1471-2229-2-3.txt:        overall response of subunit A to stress conditions. RNA was
technical/biomed/1471-2229-2-3.txt:        subunit A messenger RNA as seen with proteolipid subunit
technical/biomed/1471-2229-2-3.txt:        mRNA in 
technical/biomed/1471-2229-2-3.txt:        Equivalent loading of whole RNA was evaluated via
technical/biomed/1471-2229-2-3.txt:        the four different subunit A mRNAs. Primer pairs were
technical/biomed/1471-2229-2-3.txt:        would detect all four amplification products. Whole RNA was
technical/biomed/1471-2229-2-3.txt:        are in agreement with the whole RNA stress blot analysis.
technical/biomed/1471-2229-2-3.txt:        by whole RNA blot analysis to be transcribed in all organs
technical/biomed/1471-2229-2-3.txt:        stress. Whole RNA blot analysis performed on seedlings
technical/biomed/1471-2229-2-3.txt:          were treated with RNAse A at 37°C for 15 minutes to
technical/biomed/1471-2229-2-3.txt:          remove contaminating RNA.
technical/biomed/1471-2229-2-3.txt:          Organ specific whole RNA extraction was performed as
technical/biomed/1471-2229-2-3.txt:          nitrogen to prevent degradation of the RNA. Standard
technical/biomed/1471-2229-2-3.txt:          Whole RNA blot analysis
technical/biomed/1471-2229-2-3.txt:          RNA was fractionated via denaturing agarose gel
technical/biomed/1471-2229-2-3.txt:          the buffer recirculated by a peristaltic pump. RNA gels
technical/biomed/1471-2229-2-3.txt:          buffer for prehybridization RNA membranes were given two
technical/biomed/1471-2229-2-3.txt:          minutes each at 65°C. The probe used for whole RNA blot
technical/biomed/1471-2229-2-3.txt:          Whole RNA was diluted to a concentration of 0.67 μg/μl in
technical/biomed/1471-2229-2-3.txt:          units of a ribonuclease inhibitor (RNAsin) (Promega,
technical/biomed/1471-2229-2-3.txt:          Madison, WI) were added. Denatured, whole RNA (2 μg) was
technical/biomed/1471-2229-2-3.txt:          was used for multi organ RNA blot analysis and stress
technical/biomed/1471-2229-2-3.txt:          Probes were precipitated by adding 1 μl of tRNA (10
technical/biomed/1471-2229-2-4.txt:        alpha-amylase transcript levels [ 24 25 ] , but also mRNA
technical/biomed/1471-2229-2-4.txt:        However, alternative explanations cannot be ruled out at
technical/biomed/1471-2229-2-4.txt:        remains to be characterized in Arabidopsis, alternative
technical/biomed/1471-2229-2-9.txt:          avrB . Alternatively, if
technical/biomed/1471-2229-2-9.txt:        A potential alternative explanation for these results
technical/biomed/1471-2229-2-9.txt:        conditions [ 15 ] . The potential alternative explanation
technical/biomed/1471-2229-2-9.txt:        "or" gate with three alternative inputs. The "Fast HR"
technical/biomed/1471-2229-2-9.txt:        alternative means of capturing the rich dynamics of
technical/biomed/1471-2229-2-9.txt:          liquid nitrogen and total RNA was isolated according to
technical/biomed/1471-2229-2-9.txt:          Nawrath and Métraux [ 20 ] . RNA concentration was
technical/biomed/1471-2229-2-9.txt:          determined spectrophotometrically. 25 μg of total RNA was
technical/biomed/1471-2229-2-9.txt:          normalize for RNA loading) were PR-1 and PR-5 cDNAs [ 14
technical/biomed/1471-2229-3-3.txt:        agitation. After immobilization, the supernatant was
technical/biomed/1471-2253-1-1.txt:        Biometer International A/S, Odense, Denmark, 1999), unable
technical/biomed/1471-2253-2-4.txt:        journal publication, randomized controlled trials which
technical/biomed/1471-2261-1-6.txt:        RNA levels [ 6 ] . Efforts to enhance medicinal adherence
technical/biomed/1471-2261-2-11.txt:        dilatation changes. The internal elastic lamella of
technical/biomed/1471-2261-2-11.txt:          extraction of total tissue RNA and protein and one for
technical/biomed/1471-2261-2-11.txt:          frozen in liquid nitrogen for extraction of total RNA and
technical/biomed/1471-2261-2-11.txt:          RNA extraction. Paraffin embedded and frozen sections
technical/biomed/1471-2261-2-11.txt:          Relative mRNA levels were assessed using ribonuclease
technical/biomed/1471-2261-2-11.txt:          Non-radioactive RNA probes were transcribed from
technical/biomed/1471-2261-2-11.txt:          Diego, CA) [ 6 ] . An in vitro RNA transcription kit
technical/biomed/1471-2261-2-11.txt:          experiment. Five micrograms of total RNA from each animal
technical/biomed/1471-2261-2-11.txt:          lumen, the internal elastic lamella, and the external
technical/biomed/1471-2261-2-11.txt:          the circumference of the lumen. The external diameter was
technical/biomed/1471-2261-2-11.txt:          calculated from the circumference of the external elastic
technical/biomed/1471-2261-2-11.txt:          The relative mRNA levels of them increased with a peak at
technical/biomed/1471-2261-2-11.txt:          similar trend to mRNA levels for both TGF-β1 and β3
technical/biomed/1471-2261-2-11.txt:          relative mRNA levels of Bcl-x short isoform (Bcl-xS),
technical/biomed/1471-2261-2-11.txt:          caspase-3 and Bax mRNA levels at 4W. Other factors did
technical/biomed/1471-2261-2-11.txt:          showed a similar trend of mRNA level for Bcl-xS (Figure
technical/biomed/1471-2261-2-11.txt:        mRNA levels of Bcl-xS were initially decreased at 1 day, 3
technical/biomed/1471-2261-2-11.txt:        mRNA levels at 4 weeks. Follow up western blotting analysis
technical/biomed/1471-2261-3-4.txt:          A +mRNA from Sprague Dawley rat was used. Rat sterolin
technical/biomed/1471-2261-3-4.txt:          Total tissue RNAs were extracted from multiple tissues
technical/biomed/1471-2261-3-4.txt:          primers for reverse transcription of 2 μg of rat RNA from
technical/biomed/1471-2261-3-4.txt:          potentially contaminating genomic DNA in the total RNA
technical/biomed/1471-2261-3-4.txt:          sample (Table 3). Samples of total RNA (2 μg) from rat
technical/biomed/1471-2261-3-4.txt:          levels to compensate for variations in input RNA amounts.
technical/biomed/1471-2261-3-4.txt:          expression 2 (AverageΔΔCT). The mRNA quantity for the
technical/biomed/1471-2261-3-4.txt:          1000 g for 10 minutes at 4°C. The supernatant was saved.
technical/biomed/1471-2261-3-4.txt:          supernatants from all three steps were pooled and
technical/biomed/1471-2261-3-4.txt:          Abcg8mRNAs
technical/biomed/1471-2261-3-4.txt:          Abcg8 mRNA expression patterns were
technical/biomed/1471-2261-3-4.txt:          Abcg8 . However, the poly A +RNA
technical/biomed/1471-2261-3-4.txt:          RNA loaded may thus have less enterocyte RNA. Using a
technical/biomed/1471-2261-3-4.txt:          more sensitive RT-PCR analyses of RNA obtained from
technical/biomed/1471-2261-3-4.txt:          from an alternatively spliced mRNA, we amplified and
technical/biomed/1471-2261-3-4.txt:          total liver and intestinal RNA, using RT-PCR, from SD,
technical/biomed/1471-2261-3-4.txt:          Abcg8 genes have alternatively
technical/biomed/1471-2261-3-4.txt:          spliced mRNA, involving a CAG repeat at exon 2 and exon 8
technical/biomed/1471-2261-3-4.txt:          mRNAs showed any heterogeneity of splice-site selection
technical/biomed/1471-2261-3-4.txt:          Abcg8 mRNA could be important, if
technical/biomed/1471-2261-3-4.txt:          examined in two ways. For mRNA expression, quantitative
technical/biomed/1471-2261-3-4.txt:          assays of liver RNAs from fasted animals. Using GAPDH
technical/biomed/1471-2261-3-4.txt:          mRNA expression as a control, expression of 
technical/biomed/1471-2261-3-4.txt:          Abcg8 mRNAs appeared to be
technical/biomed/1471-2261-3-4.txt:        Our analyses of the mRNA and protein profiles would not
technical/biomed/1471-2261-3-5.txt:          As an alternative estimate of expected incidence we
technical/biomed/1471-2261-3-5.txt:        by this approach), further illustrating the internal
technical/biomed/1471-2288-1-9.txt:        An alternative and less widely known approach is the
technical/biomed/1471-2288-1-9.txt:        non-invasive interventions. Thus a validated alternative
technical/biomed/1471-2288-1-9.txt:        alternative with advantages over the usual analyses from
technical/biomed/1471-2288-2-10.txt:          Alternatively, one might attempt to model the
technical/biomed/1471-2288-2-10.txt:          journals from the major professional organizations in the
technical/biomed/1471-2288-2-10.txt:          be published, and funding source, with externally funded
technical/biomed/1471-2288-2-10.txt:          published in 'local' journals and not in the major
technical/biomed/1471-2288-2-10.txt:          international journals, therefore restricting language to
technical/biomed/1471-2288-2-10.txt:          or externally validated.
technical/biomed/1471-2288-2-10.txt:          Alternately, the investigators may generate a summary
technical/biomed/1471-2288-2-10.txt:          [ 30 ] also includes these methods as alternative methods
technical/biomed/1471-2288-2-11.txt:          p . Under the alternative
technical/biomed/1471-2288-2-11.txt:          subject under the null and alternative hypotheses
technical/biomed/1471-2288-2-11.txt:          alternative hypothesis the probability of death from all
technical/biomed/1471-2288-2-11.txt:          subject under the null and alternative hypotheses
technical/biomed/1471-2288-2-11.txt:          and alternative hypotheses. The second step is to treat
technical/biomed/1471-2288-2-11.txt:          m under the null and alternative
technical/biomed/1471-2288-2-4.txt:        Alternative approaches that do not directly optimize the
technical/biomed/1471-2288-3-4.txt:          Alternatively, a narrow window might discard too much
technical/biomed/1471-2288-3-4.txt:          As an alternative, we estimate an upper bound on the
technical/biomed/1471-2288-3-9.txt:          Kernan et al.'s [ 11 ] study of phenylpropanolamine and
technical/biomed/1471-2288-3-9.txt:          sociologic process. Furthermore, the alternative to
technical/biomed/1471-2288-3-9.txt:            Alternatively, the random sampling error could be
technical/biomed/1471-2288-3-9.txt:          (Most of these distributions have some external basis.
technical/biomed/1471-2296-3-19.txt:          identify ethnic background based on surname [ 12 ] . We
technical/biomed/1471-2296-3-3.txt:          possible alternative ways to spend their money. They also
technical/biomed/1471-2296-3-3.txt:        classes, science classes, alternative tobacco use
technical/biomed/1471-230X-1-10.txt:          tissue solubilizer (Research Products International,
technical/biomed/1471-230X-1-10.txt:          cocktail (Research Products International) were added.
technical/biomed/1471-230X-1-10.txt:          centrifuged at 3,000 × g for 15 min. The supernatant was
technical/biomed/1471-230X-1-10.txt:          suspension was centrifuged as before. The two supernatant
technical/biomed/1471-230X-1-10.txt:        transcription of IBAT mRNA and reduces IBAT protein
technical/biomed/1471-230X-1-10.txt:        CFTR mutations. An alternative mechanism for the
technical/biomed/1471-230X-1-5.txt:          Total cell RNA was extracted from SVEC cells using the
technical/biomed/1471-230X-1-5.txt:          prepared from 6 μg of total RNA using a mixture of
technical/biomed/1471-230X-1-5.txt:          normalize mRNA levels, the density of the MAdCAM-1 and
technical/biomed/1471-230X-1-5.txt:          the supernatant was removed and the monolayers were
technical/biomed/1471-230X-1-5.txt:          The 51Cr activity of the supernatant, washed fluid, and
technical/biomed/1471-230X-1-5.txt:          in lysate + cpm in supernatant and wash)] × 100. the
technical/biomed/1471-230X-1-6.txt:        persistently undetectable HCV RNA, improved liver
technical/biomed/1471-230X-1-6.txt:        HS (health state), HCV (hepatitis C virus), RNA
technical/biomed/1471-230X-2-23.txt:        ability of gallbladder epithelium to produce mRNA for
technical/biomed/1471-230X-2-23.txt:        chemokine mRNA expression profile and TNF-α protein
technical/biomed/1471-230X-2-23.txt:          RT-PCR assay of cytokine and chemokine mRNA
technical/biomed/1471-230X-2-23.txt:          trypsinization, and total RNA was extracted using TRIzol
technical/biomed/1471-230X-2-23.txt:          RNA was reverse-transcribed according to the
technical/biomed/1471-230X-2-23.txt:          prepared from 0.5 μg RNA was subjected to PCR using
technical/biomed/1471-230X-2-23.txt:          the corresponding genomic DNA. Positive RNA controls were
technical/biomed/1471-230X-2-23.txt:          internal controls.
technical/biomed/1471-230X-2-23.txt:          untreated MGBE showed distinct bands representing mRNA of
technical/biomed/1471-230X-2-23.txt:          additionally produced mRNA for interleukin-1β (IL-1β),
technical/biomed/1471-230X-2-23.txt:          or KC (murine GRO-α/CXCL1) mRNA before or after LPS
technical/biomed/1471-230X-2-23.txt:          LPS treatment caused the amount of TNF-α mRNA to slightly
technical/biomed/1471-230X-2-23.txt:          mRNA and IL-1β mRNA following LPS treatment compared to
technical/biomed/1471-230X-2-23.txt:        . Intracellular TNF-α mRNA and protein was detected in
technical/biomed/1471-230X-2-23.txt:        express mRNA for TNF-α, MIP-2, and RANTES (CCL5). After
technical/biomed/1471-230X-2-23.txt:        treating the apical surface of the cells with LPS, the mRNA
technical/biomed/1471-230X-2-23.txt:        levels for TNF-α and MIP-2 (CXCL2) increased, while mRNA
technical/biomed/1471-230X-2-23.txt:        (MIP-2/CXCL2) are all up regulated at the RNA level by
technical/biomed/1471-230X-2-23.txt:        chemokine mRNA expression clearly suggests that biliary
technical/biomed/1471-230X-2-23.txt:        chemokine production after bacterial challenge at the mRNA
technical/biomed/1471-230X-2-23.txt:        relatively high TNF-α mRNA expression levels in untreated
technical/biomed/1471-230X-2-23.txt:        along with the immunoassay results suggest that TNF-α mRNA
technical/biomed/1471-230X-2-23.txt:        mRNA of other factors, such as IL-1β, IL-6, and MCP-1
technical/biomed/1471-230X-2-23.txt:        patterns of expression of mRNA for various cytokines and
technical/biomed/1471-230X-2-23.txt:        their expression of certain cytokine and chemokine RNA and
technical/biomed/1471-230X-3-3.txt:          the incubation period, the supernatant was removed and
technical/biomed/1471-230X-3-5.txt:          epithelium to the internal limit of muscularis mucosa in
technical/biomed/1471-2318-3-2.txt:        QIOs serve as external facilitators of quality
technical/biomed/1471-2318-3-2.txt:          must comply. Such externally imposed requirements, rules,
technical/biomed/1471-2318-3-2.txt:          internal quality improvement teams to implement creative
technical/biomed/1471-2318-3-2.txt:          sake of internal corporate consistency.
technical/biomed/1471-2318-3-2.txt:        external groups such as the QIOs, State Survey Agencies,
technical/biomed/1471-2318-3-2.txt:        indicate that these external groups have had success in
technical/biomed/1471-2326-2-4.txt:          Investigators were not blinded to journal, author,
technical/biomed/1471-2326-2-4.txt:        in iron chelation therapy. Even less viable an alternative
technical/biomed/1471-2326-2-4.txt:        chelator but rather as an alternative to desferrioxamine
technical/biomed/1471-2326-2-4.txt:        that deferiprone offers a useful alternative to
technical/biomed/1471-2334-1-17.txt:          after incubation at 37°C, 100 μl of culture supernatants
technical/biomed/1471-2334-1-17.txt:          supernatants were removed and tested for p24 antigen
technical/biomed/1471-2334-1-17.txt:        interactions discernable, such interactions cannot be ruled
technical/biomed/1471-2334-1-21.txt:          supernatant was discarded. The pellet was resuspended,
technical/biomed/1471-2334-1-24.txt:          supernatants. Following virus adsorption onto the MRC-5
technical/biomed/1471-2334-1-9.txt:          The mononuclear cells were isolated from the supernatant
technical/biomed/1471-2334-1-9.txt:          mac251 viral RNA copies in plasma was
technical/biomed/1471-2334-1-9.txt:          31]. Briefly, RNA extracted from plasma was subjected to
technical/biomed/1471-2334-1-9.txt:          the SIV wild type Gag gene was used to generate internal
technical/biomed/1471-2334-1-9.txt:          route, the kinetics of viral RNA appearance in the plasma
technical/biomed/1471-2334-1-9.txt:          was assessed by NASBA. Plasma viral RNA was detected as
technical/biomed/1471-2334-1-9.txt:          1A) and at that time plasma viral RNA was 2 logs lower in
technical/biomed/1471-2334-2-1.txt:        available solutions for cleansing of external genitalia or
technical/biomed/1471-2334-2-1.txt:          Division of Endocrinology, Department of Internal
technical/biomed/1471-2334-2-24.txt:          skills component was part of (not an alternative to) the
technical/biomed/1471-2334-2-24.txt:          compared these interventions to the alternative of no
technical/biomed/1471-2334-2-26.txt:        the later changes. Bernard 
technical/biomed/1471-2334-2-26.txt:        Bernard 
technical/biomed/1471-2334-2-27.txt:          incubation at 37°C for 48 h, the culture supernatant
technical/biomed/1471-2334-2-27.txt:          centrifugation. The supernatant fluids were brought to pH
technical/biomed/1471-2334-2-29.txt:          Alternating Logistic Regression (ALR), clustering can be
technical/biomed/1471-2334-2-29.txt:        infections. Alternatively, certain household behaviors such
technical/biomed/1471-2334-2-5.txt:        enveloped single-stranded negative sense RNA viruses. RSV
technical/biomed/1471-2334-2-5.txt:          for 24 h. Supernatants were collected and spun at high
technical/biomed/1471-2334-2-5.txt:          RNase protection
technical/biomed/1471-2334-2-5.txt:          RNase protection assays (RPA) were performed using an
technical/biomed/1471-2334-2-5.txt:          RPA kit purchased from BD Pharmingen. In brief, total RNA
technical/biomed/1471-2334-2-5.txt:          hCK-5 multiprobe template set was used to synthesize RNA
technical/biomed/1471-2334-2-5.txt:          RNA polymerase. 3 × 10 5cpm of labeled probe were
technical/biomed/1471-2334-2-5.txt:          hybridized with 10 μg of total RNA for 16 h at 56°C.
technical/biomed/1471-2334-2-5.txt:          MRNA-probe hybrids were treated with RNase cocktail and
technical/biomed/1471-2334-2-5.txt:          assessed the kinetics of mRNA synthesis by chemokine
technical/biomed/1471-2334-2-5.txt:          specific RNase protection. A549 cells were infected with
technical/biomed/1471-2334-2-5.txt:          total RNA isolated at various times post-treatment over a
technical/biomed/1471-2334-2-5.txt:          induced IL-8 and MCP-1 with steady-state mRNA readily
technical/biomed/1471-2334-2-5.txt:          the 24 hr time course. In contrast, RANTES mRNA was not
technical/biomed/1471-2334-2-5.txt:          total RNA was isolated and steady state mRNA expression
technical/biomed/1471-2334-2-5.txt:          analyzed by chemokine specific RNase protection. As shown
technical/biomed/1471-2334-2-6.txt:          ndday, culture supernatants were removed from each well
technical/biomed/1471-2334-2-6.txt:          supernatants were collected and tested for p24 antigen by
technical/biomed/1471-2334-2-6.txt:          supernatants were removed and tested for p24 antigen
technical/biomed/1471-2334-2-6.txt:          pellets and supernatant fluids were assayed by an ELISA
technical/biomed/1471-2334-2-6.txt:          gp120 in the virus pellets and the supernatant fluids was
technical/biomed/1471-2334-2-7.txt:          10 minutes at 4°C and the supernatant was collected,
technical/biomed/1471-2334-2-7.txt:          treated with 100 μg/ml RNAse at 37°C for one hour.
technical/biomed/1471-2334-3-10.txt:        proportion of patients achieving HIV-1 RNA <40 copies/mL
technical/biomed/1471-2334-3-10.txt:          naïve to APV, have a plasma HIV-1 RNA >1000 copies/mL,
technical/biomed/1471-2334-3-10.txt:          patients with plasma HIV-1 RNA levels <200 copies/mL
technical/biomed/1471-2334-3-10.txt:          at week 24. Plasma HIV-1 RNA was assessed by the Roche
technical/biomed/1471-2334-3-10.txt:          week 24, plasma HIV-1 RNA levels were ≥ 200 copies/mL; or
technical/biomed/1471-2334-3-10.txt:          if the plasma HIV-1 RNA had not decreased by at least
technical/biomed/1471-2334-3-10.txt:          proportion of patients achieving HIV-1 RNA <50
technical/biomed/1471-2334-3-10.txt:          Change from baseline in plasma HIV-1 RNA levels was
technical/biomed/1471-2334-3-10.txt:          of patients achieving HIV-1 RNA <200 copies/mL at week
technical/biomed/1471-2334-3-10.txt:          achieving HIV-1 RNA <200 copies/mL and <50
technical/biomed/1471-2334-3-10.txt:          experience. Changes from baseline in plasma HIV-1 RNA
technical/biomed/1471-2334-3-10.txt:          plasma HIV-1 RNA, were tabulated by treatment arm and
technical/biomed/1471-2334-3-10.txt:          mean age of 42 years, median baseline HIV-1 RNA level of
technical/biomed/1471-2334-3-10.txt:          At week 24, the proportion of patients with HIV-1 RNA
technical/biomed/1471-2334-3-10.txt:          HIV-1 RNA <200 copies/mL with APV600/RTV minus APV1200
technical/biomed/1471-2334-3-10.txt:          antiretroviral-naïve patients who achieved HIV-1 RNA
technical/biomed/1471-2334-3-10.txt:          suppression endpoint of HIV-1 RNA <50 copies/mL
technical/biomed/1471-2334-3-10.txt:          APV600/RTV arm than the APV1200 arm achieved HIV-1 RNA
technical/biomed/1471-2334-3-10.txt:          patients who achieved HIV-1 RNA <50 copies/mL was 47%
technical/biomed/1471-2334-3-10.txt:          RNA <50 copies/mL was 34% (43/128) in the APV600/RTV
technical/biomed/1471-2334-3-10.txt:          the ITT: observed analysis, mean reduction in HIV-1 RNA
technical/biomed/1471-2334-3-10.txt:          mean AAUCMB in HIV-1 RNA in both the total population
technical/biomed/1471-2334-3-10.txt:          HIV-1 RNA for the antiretroviral-experienced subgroup
technical/biomed/1471-2334-3-10.txt:          antiretroviral-naïve patients achieving HIV-1 RNA <50
technical/biomed/1471-2334-3-10.txt:          (11 APV600/RTV, 4 APV1200) had HIV-1 RNA <200
technical/biomed/1471-2334-3-10.txt:          these 15 patients continued to have HIV-1 RNA levels
technical/biomed/1471-2334-3-10.txt:          patients who had HIV-1 RNA >200 copies/mL at week 24,
technical/biomed/1471-2334-3-10.txt:          1 discontinued when an HIV-1 RNA of 186 copies/mL was
technical/biomed/1471-2334-3-10.txt:          had an HIV-1 RNA of 878 copies/mL at week 48), and 3
technical/biomed/1471-2334-3-10.txt:          continued to have HIV-1 RNA >200 copies/mL from week
technical/biomed/1471-2334-3-10.txt:          24 to week 48. In these 3 patients, HIV-1 RNA levels
technical/biomed/1471-2334-3-10.txt:        the APV600/RTV treatment arm achieved HIV-1 RNA <50
technical/biomed/1471-2334-3-10.txt:        copies/mL. Greater reductions in plasma HIV-1 RNA levels
technical/biomed/1471-2334-3-10.txt:        achieved HIV-1 RNA <200 copies/mL in the APV600/RTV arm
technical/biomed/1471-2334-3-10.txt:        HIV-1 RNA <50 copies/mL (75%) than in the present study,
technical/biomed/1471-2334-3-10.txt:        the APV600/RTV treatment arm who achieved HIV-1 RNA <200
technical/biomed/1471-2334-3-10.txt:        who had HIV-1 RNA <200 copies/mL at week 24 maintained
technical/biomed/1471-2334-3-10.txt:        HIV-1 RNA of 4.5 log 
technical/biomed/1471-2334-3-10.txt:        200-copies/mL HIV-1 RNA endpoint. Of note, a significantly
technical/biomed/1471-2334-3-10.txt:        arm achieved HIV-1 RNA <50 copies/mL at week 24, which
technical/biomed/1471-2334-3-11.txt:        home intravenous therapy) and alternative sites for care
technical/biomed/1471-2334-3-11.txt:        the Saint Agnes foundation and the department of internal
technical/biomed/1471-2334-3-12.txt:          Hybsimulator (RNAture, Inc., Irvine, CA) was used to
technical/biomed/1471-2334-3-12.txt:        alternating current voltammogram is obtained when HPV is
technical/biomed/1471-2334-3-13.txt:          from archaea. Perna 
technical/biomed/1471-2334-3-15.txt:        by RNA polymerase. In several systems, individual sigma
technical/biomed/1471-2334-3-15.txt:          E. coli rRNA transcriptional
technical/biomed/1471-2334-3-15.txt:          E. coli rRNA transcriptional
technical/biomed/1471-2334-3-15.txt:        M. smegmatis RNA polymerase, it also
technical/biomed/1471-2334-3-15.txt:        Ewith RNA polymerase, use of the native bacterium or
technical/biomed/1471-2334-3-9.txt:          study: the Western Reserve (WR) and International Health
technical/biomed/1471-2334-3-9.txt:          Virotech International (Rockville, MD), was a gift from
technical/biomed/1471-2334-3-9.txt:          supernatant was collected and trypsin (250 μg/mL) added.
technical/biomed/1471-2334-3-9.txt:          an alternative to the liquid overlay, agar overlays were
technical/biomed/1471-2350-2-11.txt:        alternatively spliced 5' untranslated exons [ 6 ] extends
technical/biomed/1471-2350-2-11.txt:        breakpoints in introns and characterized the mutant RNA and
technical/biomed/1471-2350-2-11.txt:          Genomic DNA and total RNA were extracted from
technical/biomed/1471-2350-2-11.txt:        bp) from skin fibroblast-derived total RNA. The amplicons
technical/biomed/1471-2350-2-11.txt:        de novo. Slightly advanced paternal
technical/biomed/1471-2350-2-11.txt:        mutant mRNAs encode internally deleted proteins without a
technical/biomed/1471-2350-2-11.txt:        (13 % of normal), however, suggesting that the internally
technical/biomed/1471-2350-2-11.txt:        to conclude that the mutant mRNA is stable but that the
technical/biomed/1471-2350-2-11.txt:        the mutant mRNA level was normal as shown here in Fig. 3.
technical/biomed/1471-2350-2-11.txt:        the long RT-PCR method we used here, that requires RNA from
technical/biomed/1471-2350-2-11.txt:        strongly that studies of the mutant alleles at the RNA and
technical/biomed/1471-2350-2-2.txt:        Bernardo Study [ 5], the level of fasting insulin was
technical/biomed/1471-2350-2-2.txt:        alternative translation initiation codon, which also
technical/biomed/1471-2350-3-1.txt:        degree of stenosis of the cervical internal carotid
technical/biomed/1471-2350-3-1.txt:          infarct or failed to identify an alternative cause of the
technical/biomed/1471-2350-3-1.txt:          address, and alternative contact information. We record
technical/biomed/1471-2350-3-1.txt:          e-mail address, alternative contact information, and
technical/biomed/1471-2350-3-1.txt:          sizes to an internal standard of CEPH DNA. An ABI377 with
technical/biomed/1471-2350-3-1.txt:        An alternative design to one using affected relative
technical/biomed/1471-2350-3-1.txt:        of ischemic stroke. An alternative approach would be to
technical/biomed/1471-2350-3-12.txt:        tissues. Alternatively, while MeCP2's expression is
technical/biomed/1471-2350-3-12.txt:          further study. RNA was extracted using RNA STAT-60
technical/biomed/1471-2350-3-12.txt:          described above. RNA was extracted using RNA STAT-60
technical/biomed/1471-2350-3-12.txt:          Reverse transcription of 2 μg of total RNA was
technical/biomed/1471-2350-3-12.txt:          Indianapolis, IN) with the Superscript™ II RNase
technical/biomed/1471-2350-3-12.txt:          centrifugation at 4°C for 30 min. The supernatant was
technical/biomed/1471-2350-3-12.txt:          Messenger RNA was purified from total RNA extract
technical/biomed/1471-2350-3-12.txt:          24 -3' and 3 μg of mRNA for each
technical/biomed/1471-2350-3-12.txt:          starting RNA, the efficiency of transcription, integrity
technical/biomed/1471-2350-3-12.txt:          analysis of the starting RNA and cRNA and gel
technical/biomed/1471-2350-3-12.txt:          electrophoresis following synthesis of the cDNA, cRNA and
technical/biomed/1471-2350-3-12.txt:          fragmentation of the cRNA. A 3'/5' ratio of GAPDH less
technical/biomed/1471-2350-3-12.txt:          alternative tests.
technical/biomed/1471-2350-3-12.txt:          Total RNA from the four matched pairs of clonal
technical/biomed/1471-2350-3-12.txt:          ®data. Each RT reaction was performed with RNA from the
technical/biomed/1471-2350-3-12.txt:          Total RNA from eight additional clonal cell strains (four
technical/biomed/1471-2350-3-12.txt:          Reverse transcription of total RNA was performed after
technical/biomed/1471-2350-3-12.txt:          with the Superscript™ II Rnase H -Reverse Transcriptase
technical/biomed/1471-2350-3-12.txt:          using 2 μg of total RNA and 1 μg of random hexamers.
technical/biomed/1471-2350-3-12.txt:          analysis with Sybr Green ®. The same RNA samples used for
technical/biomed/1471-2350-3-12.txt:        [ 26 ] . The production of p44 mRNA is markedly induced in
technical/biomed/1471-2350-3-12.txt:        uterus and other internal organs, transcripts have been
technical/biomed/1471-2350-3-12.txt:        fibroblast populations, RNA samples from replicate cultures
technical/biomed/1471-2350-3-12.txt:        fibroblast clones. These authors did not study mRNA levels
technical/biomed/1471-2350-3-12.txt:        expression of small non-coding RNAs that are abundant in
technical/biomed/1471-2350-3-12.txt:        mRNA messenger ribonucleic acid
technical/biomed/1471-2350-3-12.txt:        RNA ribonucleic acid
technical/biomed/1471-2350-3-9.txt:          assignments described in the 9 thInternational
technical/biomed/1471-2350-3-9.txt:        in this geographic area [ 23 45 ] . Alternatively, we had
technical/biomed/1471-2350-4-2.txt:        and immunologists [ 1 2 ] . Zinkernagel and Doherty's Nobel
technical/biomed/1471-2350-4-2.txt:        Doherty and Zinkernagel soon after their discovery of MHC
technical/biomed/1471-2350-4-2.txt:        As an alternative to directly examining the hypothesis
technical/biomed/1471-2350-4-2.txt:        Doherty-Zinkernagel hypothesis of allele-specific
technical/biomed/1471-2350-4-2.txt:        Doherty and Zinkernagel [ 20 ] demonstrated using congenic
technical/biomed/1471-2350-4-2.txt:        Doherty and Zinkernagel [ 4 ] , simple dominance for
technical/biomed/1471-2350-4-3.txt:          in the 9 thInternational Histocompatibility Workshop [ 17
technical/biomed/1471-2350-4-3.txt:        phenotype. Alternatively, the variable immunoglobulin
technical/biomed/1471-2350-4-4.txt:        two different proteins produced by alternative splicing
technical/biomed/1471-2350-4-4.txt:          internal diameter) and mild dilation of the right
technical/biomed/1471-2350-4-4.txt:        LMNA mutations also favor alternative
technical/biomed/1471-2350-4-6.txt:        higher in middle cerebral or internal carotid arteries
technical/biomed/1471-2350-4-6.txt:        alternative selection criteria for cases and controls in
technical/biomed/1471-2369-3-1.txt:          supernatant was harvested. Total protein of each sample
technical/biomed/1471-2369-3-1.txt:        (Figure 1). A previous study used RNase protection assay
technical/biomed/1471-2369-3-10.txt:          International Classification of Diseases-9th Modification
technical/biomed/1471-2369-3-9.txt:        in international normalized ratio (INR) in 3 patients
technical/biomed/1471-2369-3-9.txt:        Physicians-American Society of Internal Medicine position
technical/biomed/1471-2369-4-5.txt:        onset of dialysis [ 12 ] . Alternatively, risk of
technical/biomed/1471-2377-1-2.txt:        International Classification of Diseases,
technical/biomed/1471-2377-1-2.txt:          two stroke studies (5% and 15%). Several international
technical/biomed/1471-2377-1-2.txt:        Our approach might have slightly reduced internal validity,
technical/biomed/1471-2377-1-2.txt:        but it should have far greater external validity, although
technical/biomed/1471-2377-1-2.txt:        this might be somewhat compromised by the reduced internal
technical/biomed/1471-2377-3-4.txt:          journals describing cross-sectional or longitudinal
technical/biomed/1471-2377-3-4.txt:            temperature), international normalized ratio, lipid
technical/biomed/1471-2377-3-4.txt:        We expect this to enhance the external validity of the
technical/biomed/1471-2407-1-13.txt:          time. There are national and international surveys that
technical/biomed/1471-2407-1-13.txt:          International Classification of Disease, Second Edition
technical/biomed/1471-2407-1-13.txt:          C559. Hysterectomy is defined as International
technical/biomed/1471-2407-1-15.txt:        genes, translation of RNA transcripts, and cellular
technical/biomed/1471-2407-1-15.txt:        characterized this protein as an RNA binding protein with
technical/biomed/1471-2407-1-15.txt:        a role for nmt55/p54 nrbin pre-mRNA splicing (unpublished
technical/biomed/1471-2407-1-15.txt:        attributed to the regulation of mRNA expression, protein
technical/biomed/1471-2407-1-15.txt:        NMT-1. In this study, we compared mRNA levels in ER+ and
technical/biomed/1471-2407-1-15.txt:          supernatant fraction (cytosol) was collected. After the
technical/biomed/1471-2407-1-15.txt:          supernatant fraction (nuclear extract) was collected and
technical/biomed/1471-2407-1-15.txt:          RNA preparation and northern blot analyses
technical/biomed/1471-2407-1-15.txt:          Total RNA from MCF-7 cells and human breast tumors was
technical/biomed/1471-2407-1-15.txt:          prepared as described [ 33 ] . Total RNA was
technical/biomed/1471-2407-1-15.txt:          homologous RNA binding proteins. A 545 bp HindIII/Xbal
technical/biomed/1471-2407-1-15.txt:          normalize for RNA loading [ 34 ] .
technical/biomed/1471-2407-1-15.txt:          specifications. RNA was isolated and prepared as
technical/biomed/1471-2407-1-15.txt:          transcribed with T7 RNA polymerase in the presence of α-[
technical/biomed/1471-2407-1-15.txt:          or SP6 RNA polymerase in the presence of non-labeled
technical/biomed/1471-2407-1-15.txt:          RNA and the antisense probe were mixed and
technical/biomed/1471-2407-1-15.txt:          an RNase A/T1 mixture. Following digestion, RNase was
technical/biomed/1471-2407-1-15.txt:          inactivated and hybridized RNA was precipitated according
technical/biomed/1471-2407-1-15.txt:          Analysis of nmt55/p54 nrbmRNA in ER+ and ER- human
technical/biomed/1471-2407-1-15.txt:          downregulated in ER- tumors, we analyzed mRNA levels from
technical/biomed/1471-2407-1-15.txt:          nrbmRNA expression in 12 human breast tumors. MCF-7 cells
technical/biomed/1471-2407-1-15.txt:          mRNA transcript for nmt55/p54 nrb. nmt55/p54
technical/biomed/1471-2407-1-15.txt:          ER+ and ER- tumors. mRNA transcript was expressed at high
technical/biomed/1471-2407-1-15.txt:          further. These different nmt55/p54 nrbmRNA levels were
technical/biomed/1471-2407-1-15.txt:          not due to differential RNA loading, as GAPDH levels were
technical/biomed/1471-2407-1-15.txt:          nmt55/p54 nrbmRNA transcripts are expressed at various
technical/biomed/1471-2407-1-15.txt:          nmt55/p54 nrbmRNA expression. Specifically, the decreased
technical/biomed/1471-2407-1-15.txt:          regulation of nmt55/p54 nrbmRNA since mRNA expression in
technical/biomed/1471-2407-1-15.txt:          samples expressed nmt55/p54 nrbmRNA transcript. nmt55/p54
technical/biomed/1471-2407-1-15.txt:          nrbmRNA was not detected in calf uterine tissue. This was
technical/biomed/1471-2407-1-15.txt:          and the mRNA allowing complete mRNA probe digestion.
technical/biomed/1471-2407-1-15.txt:          that nmt55/p54 nrbmRNA is expressed independent of tumor
technical/biomed/1471-2407-1-15.txt:          hormonal status suggesting that nmt55/p54 nrbmRNA is not
technical/biomed/1471-2407-1-15.txt:          Since there was no apparent nmt55/p54 nrbmRNA
technical/biomed/1471-2407-1-15.txt:          Since nmt55/p54 nrbbelongs to a family of RNA binding
technical/biomed/1471-2407-1-15.txt:          related RNA binding proteins. nmt55/p54 nrbprotein was
technical/biomed/1471-2407-1-15.txt:        investigated nmt55/p54 nrbmRNA expression using Northern
technical/biomed/1471-2407-1-15.txt:        mRNA transcripts for nmt55/p54 nrbshowed similar expression
technical/biomed/1471-2407-1-15.txt:        phosphorylation, in or near this epitope or an alternative
technical/biomed/1471-2407-1-15.txt:        place in other pre-mRNA splicing proteins though the role
technical/biomed/1471-2407-1-15.txt:        studies to bind RNA and interact with PSF and Topoisomerase
technical/biomed/1471-2407-1-15.txt:        suggest that nmt55/p54 nrbmay be involved in pre-mRNA
technical/biomed/1471-2407-1-15.txt:        critical cell growth factors due to lack of proper pre-mRNA
technical/biomed/1471-2407-1-15.txt:        in RNA processing and the production of aberrantly spliced
technical/biomed/1471-2407-1-15.txt:        mRNAs, which may result in non-functional gene products or
technical/biomed/1471-2407-1-15.txt:        of aberrant RNA processing [ 40 41 42 43 ] . These
technical/biomed/1471-2407-1-15.txt:        aberrantly spliced mRNAs, if translated, could lead to
technical/biomed/1471-2407-1-15.txt:        the role of RNA processing in oncogenesis [ 45 46 ] . Many
technical/biomed/1471-2407-1-15.txt:        gene, suggest that high fidelity pre-mRNA splicing is
technical/biomed/1471-2407-1-15.txt:        treatment. Although an RNA splicing protein, hnRNP A2/B1,
technical/biomed/1471-2407-1-15.txt:        pre-mRNA splicing has been implicated in breast cancer
technical/biomed/1471-2407-1-15.txt:        functional link between this RNA binding protein and hERα
technical/biomed/1471-2407-1-19.txt:          experiment comparing the RNA of NRP-152 to NRP-154 cells,
technical/biomed/1471-2407-1-19.txt:        are using alternative strategies in more experiments
technical/biomed/1471-2407-1-6.txt:          statistical tests assumed a two-sided alternative with a
technical/biomed/1471-2407-2-11.txt:          (J. L. Shepherd & Associates, San Fernando, CA). The
technical/biomed/1471-2407-2-12.txt:        achieved with chemotherapy alone. Alternatively recruitment
technical/biomed/1471-2407-2-15.txt:        oligos, or an adenovirus expressing IGF-IR antisense cRNA,
technical/biomed/1471-2407-2-15.txt:        to the IGF-IR mRNA prevents metastasis in the murine
technical/biomed/1471-2407-2-15.txt:          tropism. Cell culture supernatants and cells were
technical/biomed/1471-2407-2-15.txt:        alternative.
technical/biomed/1471-2407-2-16.txt:        in the rat, castration resulted in an increase in mRNAs for
technical/biomed/1471-2407-2-16.txt:        of mRNAs for RAR α and γ in non-tumorigenic rat epithelial
technical/biomed/1471-2407-2-16.txt:          Northern blot analysis of RAR mRNA
technical/biomed/1471-2407-2-16.txt:          To determine the effects of T on RAR mRNA expression,
technical/biomed/1471-2407-2-16.txt:          Detailed procedures for isolation of total RNA,
technical/biomed/1471-2407-2-16.txt:          enrichment of poly (A)+ RNA by oligo-dT cellulose
technical/biomed/1471-2407-2-16.txt:          of RNA have been described previously [ 13 ] . The cDNA
technical/biomed/1471-2407-2-16.txt:          cDNA for 18S ribosomal RNA. The relative abundance of
technical/biomed/1471-2407-2-16.txt:          against that of the 18S ribosomal RNA in each sample. The
technical/biomed/1471-2407-2-16.txt:          average ratio between the mRNA and the 18 S ribosomal RNA
technical/biomed/1471-2407-2-16.txt:          determine the effect of RA on the RAR mRNA responses to
technical/biomed/1471-2407-2-16.txt:          RAR α and γ mRNA
technical/biomed/1471-2407-2-16.txt:          and γ mRNA transcripts, with the maximal effect of 2-20
technical/biomed/1471-2407-2-16.txt:          mRNAs in LNCaP cells were suppressed in a dose dependent
technical/biomed/1471-2407-2-16.txt:          manner (P < 0.05, Figure 3). The 4.0 kb RAR α mRNA was
technical/biomed/1471-2407-2-16.txt:        that on RAR α and γ mRNA levels further suggests that RAR
technical/biomed/1471-2407-2-16.txt:        Stimulation of RAR α and γ mRNA in LNCaP cells by T
technical/biomed/1471-2407-2-16.txt:        cancer cells, RAR α mRNA was also up-regulated by estrogen
technical/biomed/1471-2407-2-16.txt:        [ 16 ] . Thus, T stimulation of RAR mRNAs in LNCaP cells
technical/biomed/1471-2407-2-16.txt:        its mRNA.
technical/biomed/1471-2407-2-17.txt:          supernatant of the cell culture lysate after 2 days of
technical/biomed/1471-2407-2-17.txt:          supernatant was added to 100 μl of luciferase assay
technical/biomed/1471-2407-2-17.txt:          of the supernatant. Total protein in the extracts was
technical/biomed/1471-2407-2-17.txt:          expressed in the supernatant of Ad Adapt mhAB infected
technical/biomed/1471-2407-2-18.txt:        in the internalization and degradation of IGF-II [ 10 ] .
technical/biomed/1471-2407-2-18.txt:          (either 45 bp of M6P/IGF2R mRNA or an unmatched sequence
technical/biomed/1471-2407-2-18.txt:          transcripts were generated with T7 RNA polymerase
technical/biomed/1471-2407-2-18.txt:          Cleavage reactions contained 30 nM substrate RNA,
technical/biomed/1471-2407-2-18.txt:          DTT, and 1 μl RNA inhibitor in a final volume of 10 μl.
technical/biomed/1471-2407-2-18.txt:          using the GeneAmp EZ rTt RNA PCR kit (Roche). Total RNA
technical/biomed/1471-2407-2-18.txt:          was extracted from cultured cells using an RNA isolation
technical/biomed/1471-2407-2-18.txt:          Measurement of 125I -IGF-II internalization
technical/biomed/1471-2407-2-18.txt:          determined by a γ-counter. Specific internalized
technical/biomed/1471-2407-2-18.txt:          M6P/IGF2R mRNA, and a catalytic core (Fig. 1A). To
technical/biomed/1471-2407-2-18.txt:          substrates, [α- 32P] labeled RNA transcripts containing
technical/biomed/1471-2407-2-18.txt:          45 bp of M6P/IGF2R mRNA or an unmatched sequence, were
technical/biomed/1471-2407-2-18.txt:          mRNA into the expected products. In this assay, the
technical/biomed/1471-2407-2-18.txt:          (Rz-IGF2R), total RNA was extracted from cells infected
technical/biomed/1471-2407-2-18.txt:          levels of M6P/IGF2R mRNA in MCF-7 cells, total RNA was
technical/biomed/1471-2407-2-18.txt:          a parallel reaction to serve as an internal standard.
technical/biomed/1471-2407-2-18.txt:          exhibit a significantly lower level of M6P/IGF2R mRNA
technical/biomed/1471-2407-2-18.txt:          M6P/IGF2R mRNA between Ad-GFP-infected cells and
technical/biomed/1471-2407-2-18.txt:          endogenous M6P/IGF2R mRNA level. These results
technical/biomed/1471-2407-2-18.txt:          internalization of exogenous 125I-IGF-II was measured in
technical/biomed/1471-2407-2-18.txt:          internalization when compared with control cells
technical/biomed/1471-2407-2-18.txt:          to internalize exogenous β-glucuronidase after treatment
technical/biomed/1471-2407-2-18.txt:        decrease in internalization of 125I-IGF-II, and
technical/biomed/1471-2407-2-18.txt:        not ruled out a RNAi effect in cells, the observed effects
technical/biomed/1471-2407-2-18.txt:        IGF2R mRNA by the ribozyme we used.
technical/biomed/1471-2407-2-18.txt:        decrease in IGF-II internalization, supporting the above
technical/biomed/1471-2407-2-19.txt:          supernatants collected. Supernatants were flash frozen in
technical/biomed/1471-2407-2-22.txt:        (International Classification of Diseases, 9th Revision)
technical/biomed/1471-2407-2-23.txt:        earlier. An alternative approach to large studies in
technical/biomed/1471-2407-2-3.txt:        cost-effective alternative; they have already been
technical/biomed/1471-2407-2-3.txt:          elements included: date of service, International
technical/biomed/1471-2407-2-3.txt:        Alternatively, patients and physicians in rural areas may
technical/biomed/1471-2407-2-33.txt:          the proliferating external granule cell layer of P0
technical/biomed/1471-2407-2-33.txt:        β-catenin in both internal granule layer (IGL) and
technical/biomed/1471-2407-2-33.txt:        proliferative cells of the cerebellar external granule cell
technical/biomed/1471-2407-2-33.txt:        construct. Alternatively, the contrast between the 
technical/biomed/1471-2407-2-9.txt:        and/or RNA synthesis. [ 33 ] DNA synthesis inhibition is
technical/biomed/1471-2407-2-9.txt:        cofactors. [ 34 ] Although this ternary complex is
technical/biomed/1471-2407-2-9.txt:        derived from LV not only allows optimum ternary complex
technical/biomed/1471-2407-2-9.txt:        5'-triphosphate (FUTP) into RNA has been proposed as the
technical/biomed/1471-2407-3-14.txt:          according to the International Classification of Disease
technical/biomed/1471-2407-3-15.txt:        approach is the best alternative.
technical/biomed/1471-2407-3-16.txt:        interstitial brachytherapy and external beam radiotherapy
technical/biomed/1471-2407-3-16.txt:        external beam radiotherapy, the generalized BED model
technical/biomed/1471-2407-3-16.txt:        prostate cancer treated with external beam radiotherapy at
technical/biomed/1471-2407-3-16.txt:        this period, external beam radiotherapy was delivered using
technical/biomed/1471-2407-3-16.txt:        oncologist prior to delivering the external beam treatment.
technical/biomed/1471-2407-3-16.txt:        alternative measure of merit was chosen to complement the
technical/biomed/1471-2407-3-16.txt:        of DVH's in evaluating external beam [ 5 24 25 26 27 28 29
technical/biomed/1471-2407-3-3.txt:        in an open-label, multicenter, international Phase III
technical/biomed/1471-2407-3-3.txt:        technology was applied to RNA from matched peripheral blood
technical/biomed/1471-2407-3-3.txt:          RNA lysis buffer (Clontech, Palo Alto, CA, USA) to SUGEN
technical/biomed/1471-2407-3-3.txt:          where isolation of total RNA was performed. For Trial B,
technical/biomed/1471-2407-3-3.txt:          RNA isolation.
technical/biomed/1471-2407-3-3.txt:          RNA sample processing
technical/biomed/1471-2407-3-3.txt:          Total RNA was purified from PBMC samples using
technical/biomed/1471-2407-3-3.txt:          Clontech Nucleospin RNA II kit reagents (Clontech, Palo
technical/biomed/1471-2407-3-3.txt:          RNAse-free Dnase. RNA yields were measured by UV
technical/biomed/1471-2407-3-3.txt:          absorbance and RNA quality was assessed by agarose gel
technical/biomed/1471-2407-3-3.txt:          visualization of ribosomal RNA band integrity.
technical/biomed/1471-2407-3-3.txt:          In general, the standard RNA processing and
technical/biomed/1471-2407-3-3.txt:          Analysis Technical Manual. Yields of total RNA for PBMC
technical/biomed/1471-2407-3-3.txt:          of total RNA (≥ 5 μg) as recommended in the standard
technical/biomed/1471-2407-3-3.txt:          approach [ 17 ] was used in the generation of cRNA for
technical/biomed/1471-2407-3-3.txt:          synthesized from total RNA, with Invitrogen Life
technical/biomed/1471-2407-3-3.txt:          (IVT) of cRNA. The IVT reaction was performed with
technical/biomed/1471-2407-3-3.txt:          BioArray HighYield RNA Transcript Labeling Kit
technical/biomed/1471-2407-3-3.txt:          biotinylated ribonucleotides. The cRNA product was then
technical/biomed/1471-2407-3-3.txt:          The second round of IVT of cRNA was as in the first round
technical/biomed/1471-2407-3-3.txt:          non-biotinylated ribonucleotides. Purified cRNA was
technical/biomed/1471-2407-3-3.txt:          http://www.affymetrix.com/analysis/index.affx). Total RNA
technical/biomed/1471-2407-3-3.txt:          Total RNA was isolated from PBMC prepared from
technical/biomed/1471-2407-3-3.txt:          designated as Trial A. Due to typically low RNA yields,
technical/biomed/1471-2407-3-3.txt:          1 and day 56 samples RNA yields were of 1 μg or greater
technical/biomed/1471-2407-3-3.txt:          results from the same RNA samples (n = 8 day 1-day 56
technical/biomed/1471-2407-3-3.txt:          [ 24 25 ] to standard of care plus SU5416. RNA was
technical/biomed/1471-2407-3-3.txt:        blood RNA samples from a clinical trial of the signal
technical/biomed/1471-2407-3-3.txt:        patients' blood cell RNA is utilized as a surrogate readout
technical/biomed/1471-2407-3-3.txt:        mRNA, as the gene encodes a well-characterized enzyme with
technical/biomed/1471-2407-3-3.txt:        available for storage and purification of RNA from clinical
technical/biomed/1471-2407-3-3.txt:        blood RNA stabilization reagent is an example of such
technical/biomed/1471-2407-3-4.txt:        ] ). Granzyme B internalization by the M6P/IGF2R is also
technical/biomed/1471-2407-3-4.txt:        mice with only the maternal copy of the gene being
technical/biomed/1471-2415-3-3.txt:        filament mRNA levels are greatly increased in
technical/biomed/1471-2415-3-3.txt:        arranged in any discernable pattern, in the equatorial/bow
technical/biomed/1471-2415-3-3.txt:        differentiation, mRNA for alphaB increases in conjunction
technical/biomed/1471-2415-3-3.txt:        with the induction of mRNA for myogenin, the earliest known
technical/biomed/1471-2415-3-3.txt:        proper filament assembly [ 16 ] . Beaded filament mRNA
technical/biomed/1471-2415-3-4.txt:        Administration (FDA) identified PTK as an alternative
technical/biomed/1471-2415-3-5.txt:        ] . There is a 10-fold induction of PPARγ mRNA that reaches
technical/biomed/1471-2415-3-5.txt:        segments. The levels of either PPARα mRNA or PPARβ mRNA are
technical/biomed/1471-2415-3-5.txt:          RPM for 20 min at 4°C. The supernatant from each sample
technical/biomed/1471-2415-3-5.txt:          PPARγ mRNA expression [ 24 ] in RPE, experiments were
technical/biomed/1471-2431-2-1.txt:          protocols for therapy of histiocytoses; International
technical/biomed/1471-2431-2-12.txt:          characterized as progressive external ophthalmoplegia and
technical/biomed/1471-2431-2-12.txt:          mitochondrial RNA. Further investigations are necessary
technical/biomed/1471-2431-2-4.txt:        maternal aunt, and maternal grandfather. The parents were
technical/biomed/1471-2431-2-4.txt:        encoded by a 3364 bp mRNA. The gene locus has 30 exons
technical/biomed/1471-2431-2-4.txt:        Alternatively, it is possible that both SI and lactase are
technical/biomed/1471-2431-3-4.txt:        meta-analysis by Bernard-Bonnin and colleagues [ 10 ] ,
technical/biomed/1471-2431-3-4.txt:        with infant feeding and infant and maternal health [ 18 19
technical/biomed/1471-2431-3-4.txt:          alternatives presented in a random order (very bad, bad,
technical/biomed/1471-2431-3-4.txt:          offered four alternatives in random order (negative,
technical/biomed/1471-2431-3-4.txt:          three alternatives: "before the birth of the child", "on
technical/biomed/1471-2431-3-4.txt:          Determinants of maternal attitudes towards
technical/biomed/1471-2431-3-4.txt:          When studying determinants of maternal attitudes
technical/biomed/1471-2431-3-4.txt:            to the analyses of determinants of maternal attitude,
technical/biomed/1471-2431-3-4.txt:            In all analyses of maternal attitude and feeding
technical/biomed/1471-2431-3-4.txt:            Maternal attitudes towards breastfeeding
technical/biomed/1471-2431-3-4.txt:          affected the results, since maternal feeding behavior is
technical/biomed/1471-2431-3-4.txt:          Maternal attitude has otherwise been shown to be an
technical/biomed/1471-2431-3-4.txt:          could be the measurement of maternal attitudes. A
technical/biomed/1471-2431-3-5.txt:        and maternal health have been the topic of several studies
technical/biomed/1471-2431-3-5.txt:          Diurnal breastfeeding pattern
technical/biomed/1471-2431-3-5.txt:          also presents data on the diurnal breastfeeding pattern
technical/biomed/1471-2431-3-5.txt:          30 31 ] . Alternative explanations may be the moderate
technical/biomed/1471-2431-3-6.txt:        wishing to account for infant sex, maternal race, or parity
technical/biomed/1471-2431-3-6.txt:        among fetal, maternal, and environmental factors that
technical/biomed/1471-2431-3-6.txt:        infant sex, birth order, and maternal race. Other
technical/biomed/1471-2431-3-6.txt:        factors such as maternal height and weight, [ 16 26 ] and
technical/biomed/1471-2431-3-6.txt:        as surrogates for a combination of maternal exposures such
technical/biomed/1471-244X-3-5.txt:        Thus, there has been the drive to search for alternative
technical/biomed/1471-244X-3-5.txt:        and appealing alternative treatment for postpartum mood
technical/biomed/1471-2458-1-9.txt:        ICD9CM: International classification of disease, 9
technical/biomed/1471-2458-2-16.txt:          Practice, Internal Medicine, and General Practice primary
technical/biomed/1471-2458-2-16.txt:          medicine (n = 7) and internal medicine (n = 5)
technical/biomed/1471-2458-2-18.txt:        of COX-2 mRNA and protein have been detected in pancreatic
technical/biomed/1471-2458-2-21.txt:        bronchus (3.1%), internal chest (1.5%), hands and fingers
technical/biomed/1471-2458-2-21.txt:        data on claims involving no lost work time. An alternative
technical/biomed/1471-2458-2-25.txt:        maternal substance use during pregnancy, the fear of
technical/biomed/1471-2458-2-3.txt:        internationally - contributed to morbidity and mortality
technical/biomed/1471-2458-2-3.txt:          for International Development (USAID), and CDC. This
technical/biomed/1471-2458-2-3.txt:          HIS and includes chronic diseases, maternal and child
technical/biomed/1471-2458-2-3.txt:          international comparisons on health status and care
technical/biomed/1471-2458-2-3.txt:          and disabilities; and maternal and child health,
technical/biomed/1471-2458-2-6.txt:          alternating with bradycardia).
technical/biomed/1471-2458-3-2.txt:        may be a safer alternative to drinking tap water.
technical/biomed/1471-2458-3-5.txt:        limited information regarding the effect of UVGI on RNA.
technical/biomed/1471-2458-3-5.txt:        There are conflicting studies on viruses with RNA genomes
technical/biomed/1471-2458-3-5.txt:        (single-stranded positive sense RNA genome) and rotavirus
technical/biomed/1471-2458-3-5.txt:        (double-stranded RNA genome), showed their PCR assays to be
technical/biomed/1471-2458-3-5.txt:        sense RNA genome) [ 30 ] . In this study, we present an
technical/biomed/1471-2458-3-5.txt:          AVL buffer containing carrier RNA (Qiagen QIAamp Viral
technical/biomed/1471-2458-3-5.txt:          RNA Mini Kit) and 140 μl phosphate buffered saline (PBS).
technical/biomed/1471-2458-3-5.txt:          RNA extraction
technical/biomed/1471-2458-3-5.txt:          We extracted the RNA from the filter samples with the
technical/biomed/1471-2458-3-5.txt:          Qiagen QIAamp Viral RNA Mini Kit following manufacturer's
technical/biomed/1471-2458-3-5.txt:          protocol. The use of the Qiagen QIAamp Viral RNA Mini Kit
technical/biomed/1471-2458-3-5.txt:          resulted in 80 μl of purified viral RNA.
technical/biomed/1471-2458-3-5.txt:          picornavirus RNA using primers OL26 (5'-GCA CTT CTG TTT
technical/biomed/1471-2458-3-5.txt:          Taq Mix and 10 μl of the RNA
technical/biomed/1471-2458-3-5.txt:          the picornavirus genome. The semi-nested primer pair of
technical/biomed/1471-2458-3-5.txt:        Collison nebulizer, and that the RNA from the damaged virus
technical/biomed/1471-2458-3-5.txt:        in single and double stranded RNA viruses, [ 28 29 ] while
technical/biomed/1471-2458-3-5.txt:        UV irradiation damaged other regions of the viral RNA and
technical/biomed/1471-2466-2-3.txt:        Alternatively, it is conceivable that the stronger
technical/biomed/1471-2466-3-1.txt:        HTLV-I tax/rex mRNA expression [ 6 7 ] , HTLV-I specific
technical/biomed/1471-2466-3-1.txt:        with intrapulmonary expression of tax mRNA [ 11 ] . In
technical/biomed/1471-2474-2-2.txt:        as by measurement of mRNA [ 4, 5] and 
technical/biomed/1471-2474-2-2.txt:        et al. [ 9] observed increased mRNA
technical/biomed/1471-2474-2-2.txt:        Alternatively, changes in the expression of the
technical/biomed/1471-2474-2-2.txt:          external surface was altered by the fracture repair
technical/biomed/1471-2474-2-2.txt:          NY), and RNA was extracted with TRIzol (Gibco BRL,
technical/biomed/1471-2474-2-2.txt:          Gaithersburg, MD). The RNA samples (0.8 μg) were then
technical/biomed/1471-2474-2-2.txt:          cycles of the polymerase chain reaction (PCR, GeneAmp RNA
technical/biomed/1471-2474-2-2.txt:          receptor, 18S ribosomal RNA, or G3PDH (Cat. #5507,
technical/biomed/1471-2474-2-2.txt:          mRNA level after fracture, which led to a peak in
technical/biomed/1471-2474-2-2.txt:          mRNA expression levels fell to very low levels at four
technical/biomed/1471-2474-2-2.txt:          type II collagen for cartilage. Both osteocalcin mRNA
technical/biomed/1471-2474-2-2.txt:          levels (Fig. 1, top) and type I collagen mRNA levels
technical/biomed/1471-2474-2-2.txt:          Type II collagen mRNA expression differed from that of
technical/biomed/1471-2474-2-2.txt:          decreased the mRNA expression of this gene at four and
technical/biomed/1471-2474-2-2.txt:          control process over fracture healing. BMP-2 mRNA levels
technical/biomed/1471-2474-2-2.txt:          BMP-4 mRNA levels were also undetectable in the 0-time
technical/biomed/1471-2474-2-2.txt:          In contrast, the type IA BMP receptor mRNA levels were
technical/biomed/1471-2474-2-2.txt:          one week after fracture. The mRNA levels at four and six
technical/biomed/1471-2474-2-2.txt:          expression of another gene whose mRNA levels are not
technical/biomed/1471-2474-2-2.txt:          chain reaction. In this project, 18S ribosomal RNA was
technical/biomed/1471-2474-2-2.txt:          each sample. However, the 18S rRNA amplimer varied with
technical/biomed/1471-2474-2-2.txt:        In this study we have measured mRNA gene expression in
technical/biomed/1471-2474-2-2.txt:        This decrease in the mRNA gene expression to
technical/biomed/1471-2474-2-2.txt:        extracted a similar amount of mRNA from the fracture site,
technical/biomed/1471-2474-2-2.txt:        healing process. Alternatively, these cytokines may only be
technical/biomed/1471-2474-2-2.txt:        There was a positive 18S rRNA signal in each sample.
technical/biomed/1471-2474-2-2.txt:        weeks after fracture was related to decreased mRNA
technical/biomed/1471-2474-2-2.txt:        rats were followed by increased mRNA expression for
technical/biomed/1471-2474-3-3.txt:        Stress (MPa), σ, is defined as the intensity of internal
technical/biomed/1471-2474-3-3.txt:          stress-strain curves is produced in part by internal
technical/biomed/1471-2474-3-3.txt:          equal effective bone insertion area. Alternatively the
technical/biomed/1471-2474-4-4.txt:        attractive alternative to large animal studies.
technical/biomed/1471-2474-4-8.txt:        research has been searching intensively for alternative
technical/biomed/1471-2490-3-2.txt:        accuracy, and its ability to suggest an alternative
technical/biomed/1471-2490-3-2.txt:        initial experience of diagnosing alternative or additional
technical/biomed/1471-2490-3-2.txt:        alternative or additional diseases (other than renal,
technical/biomed/1471-2490-3-2.txt:        Table 1describes in detail the alternative or additional
technical/biomed/1471-2490-3-2.txt:        (10%) with alternative or incidental diagnosis.
technical/biomed/1471-2490-3-2.txt:        should be taken to rule out alternative diagnosis for flank
technical/biomed/1471-2490-3-2.txt:        appendicitis, initiated early treatment. The alternative
technical/biomed/1471-2490-3-2.txt:        A wide variety of significant alternative or additional
technical/biomed/1472-6750-1-11.txt:        provided an alternative that may circumvent these
technical/biomed/1472-6750-1-11.txt:          plasmid, pGAL4-EGFP-SV40-neo; and the internal control
technical/biomed/1472-6750-1-11.txt:          internal control, Renilla luciferase, increase steadily
technical/biomed/1472-6750-1-11.txt:          the level of the internal control Renilla luciferase with
technical/biomed/1472-6750-1-11.txt:          luciferase was used as an internal control in addition to
technical/biomed/1472-6750-1-11.txt:        seeds prompted efforts to seek alternative inducers derived
technical/biomed/1472-6750-1-11.txt:          expressed internal control. The vector pGAL4-EGFP was
technical/biomed/1472-6750-1-12.txt:        mice contained both the mutant (paternal) and wild type
technical/biomed/1472-6750-1-12.txt:        (maternal) 
technical/biomed/1472-6750-1-12.txt:        maternal X-chromosome as expected. From this we were able
technical/biomed/1472-6750-1-12.txt:        deficiencies associated with alternative transient
technical/biomed/1472-6750-1-13.txt:        The RNA polymerase from bacteriophage T7 has a
technical/biomed/1472-6750-1-13.txt:        known to occur for T3 RNA polymerase [ 9 ] . The large
technical/biomed/1472-6750-1-13.txt:        RNA polymerase autogene construct that allows large (10 3-
technical/biomed/1472-6750-1-13.txt:        10 6) libraries of T7 RNA polymerase variants to be
technical/biomed/1472-6750-1-13.txt:        variants (Figure 1). The T7 RNA polymerase gene was linked
technical/biomed/1472-6750-1-13.txt:        to a T7 RNA polymerase promoter, creating a so-called
technical/biomed/1472-6750-1-13.txt:        production of large amounts of T7 RNA polymerase (Figure
technical/biomed/1472-6750-1-13.txt:        mutant T7 RNA polymerase promoters, little T7 RNA
technical/biomed/1472-6750-1-13.txt:        high mRNA expression levels. In consequence, mRNA extracted
technical/biomed/1472-6750-1-13.txt:        These mRNAs could be amplified en masse, re-cloned, and
technical/biomed/1472-6750-1-13.txt:        reasoned that isolating the mRNA after an hour of induction
technical/biomed/1472-6750-1-13.txt:        substitution at position 748 in T7 RNA polymerase was
technical/biomed/1472-6750-1-13.txt:        were required to amplify recovered mRNA molecules was
technical/biomed/1472-6750-1-13.txt:        assumed to follow the amount of mRNA that was produced in a
technical/biomed/1472-6750-1-13.txt:        interactions with T7 RNA polymerase [ 6 7 9 11 ] .
technical/biomed/1472-6750-1-13.txt:        adjacent to the wild-type T7 RNA polymerase promoter (GACT
technical/biomed/1472-6750-1-13.txt:        yielded substantially more T7 RNA polymerase as judged by
technical/biomed/1472-6750-1-13.txt:        previously been shown to yield an active T7 RNA polymerase
technical/biomed/1472-6750-1-13.txt:        to yield as much or more T7 RNA polymerase as did wild-type
technical/biomed/1472-6750-1-13.txt:        wild-type T7 RNA polymerase does not tolerate mutations
technical/biomed/1472-6750-1-13.txt:        On the basis of the known crystal structure of T7 RNA
technical/biomed/1472-6750-1-13.txt:        previously been hypothesized to form an alternate
technical/biomed/1472-6750-1-13.txt:        T7 RNA polymerase at all the three amino acid positions
technical/biomed/1472-6750-1-13.txt:        collecting mRNAs from intact cells, the cellular 'test
technical/biomed/1472-6750-1-13.txt:        T7 RNA polymerase autogene to select polymerase variants
technical/biomed/1472-6750-1-13.txt:        identify a mutant T7 RNA polymerase 'specialist' which
technical/biomed/1472-6750-1-13.txt:        variety of T7 promoters, and a novel RNA polymerase with an
technical/biomed/1472-6750-1-13.txt:          fragment containing the T7 RNA polymerase gene was
technical/biomed/1472-6750-1-13.txt:          which contained the wild-type T7 RNA polymerase promoter.
technical/biomed/1472-6750-1-13.txt:          region were introduced in and adjacent to the T7 RNA
technical/biomed/1472-6750-1-13.txt:          -11 in the T7 RNA polymerase promoter.
technical/biomed/1472-6750-1-13.txt:          RNA polymerase was randomized at amino acid positions
technical/biomed/1472-6750-1-13.txt:          used, T7 RNA polymerase was similarly randomized at amino
technical/biomed/1472-6750-1-13.txt:          and 748 in the wild-type RNA polymerase gene to form
technical/biomed/1472-6750-1-13.txt:          eliminated the possibility that wild-type RNA polymerases
technical/biomed/1472-6750-1-13.txt:          37°C for 7-10 hrs and T7 RNA polymerase expression was
technical/biomed/1472-6750-1-13.txt:          mM. After an hour of induction, RNA was extracted using
technical/biomed/1472-6750-1-13.txt:          the Masterpure RNA purification kit (Epicenter
technical/biomed/1472-6750-1-13.txt:          Technologies, Madison, WI). The recovered mRNA was
technical/biomed/1472-6750-1-6.txt:          Panning of mRNA targets
technical/biomed/1472-6750-1-6.txt:          regions) of four mRNAs were synthesized (Table 2). The
technical/biomed/1472-6750-1-6.txt:          re-folding. All of the mRNAs were subjected to 4 rounds
technical/biomed/1472-6750-1-6.txt:          mRNA and sequenced. Table 3shows the overall results that
technical/biomed/1472-6750-1-6.txt:          each target when compared to a control RNA (RRE). For
technical/biomed/1472-6750-1-6.txt:          each RNA target, the predicted amino acid sequences of
technical/biomed/1472-6750-1-6.txt:          RNA-binding motifs and consensus domains. Two motifs were
technical/biomed/1472-6750-1-6.txt:          observed for the APP and HCV RNAs (Figure 1and see
technical/biomed/1472-6750-1-6.txt:          below). RNA binding proteins are known to have an overall
technical/biomed/1472-6750-1-6.txt:          RNA binding proteins. Also, tryptophan, serine, and
technical/biomed/1472-6750-1-6.txt:          are known RNA-binding motifs [ 8 9 ] . The isolation of
technical/biomed/1472-6750-1-6.txt:          surrogates containing generic RNA binding motifs is not
technical/biomed/1472-6750-1-6.txt:          on RRE RNA [ 10 ] . This motif [ 
technical/biomed/1472-6750-1-6.txt:          RNA) as templates for the construction of secondary
technical/biomed/1472-6750-1-6.txt:          appropriate target RNA. Results are shown in Figure 4and
technical/biomed/1472-6750-1-6.txt:          specific RNAs, the number of target-specific clones
technical/biomed/1472-6750-1-6.txt:          In the case of the HCV RNA, we panned a sequence (AA
technical/biomed/1472-6750-1-6.txt:          structural elements on the mRNA [ 12 13 ] ).
technical/biomed/1472-6750-1-6.txt:          to the HCV mRNA (Figure 5). This motif was unique to HCV
technical/biomed/1472-6750-1-6.txt:          mRNA pans. Interestingly, the 
technical/biomed/1472-6750-1-6.txt:          peptide surrogates binding to the HCV target mRNA as well
technical/biomed/1472-6750-1-6.txt:          of p170 is necessary and critical for binding of HCV mRNA
technical/biomed/1472-6750-1-6.txt:          inability to use non-protein targets such as mRNA or
technical/biomed/1472-6750-1-6.txt:          case of the surrogates for both HCV-mRNA and TNFβ, it is
technical/biomed/1472-6750-1-6.txt:          Oligonucleotides for the mRNA pans were synthesized by
technical/biomed/1472-6750-1-6.txt:          supernatant contains the phage and is precipitated with ¼
technical/biomed/1472-6750-1-6.txt:          For the mRNA pans, all solutions and surfaces are
technical/biomed/1472-6750-1-6.txt:          pretreated with DEPC or RNaseZap (Ambion, Austin TX),
technical/biomed/1472-6750-1-6.txt:          respectively, to eliminate RNase contamination that may
technical/biomed/1472-6750-1-6.txt:          compromise the integrity of the RNA. The biotinylated -
technical/biomed/1472-6750-1-6.txt:          RNA target diluted to 1 mg/ml in binding buffer (PBS
technical/biomed/1472-6750-1-6.txt:          Re-annealed mRNAs are stored in small aliquots (10-25
technical/biomed/1472-6750-1-6.txt:          RNaseZap (Ambion) before use. One hundred microliters of
technical/biomed/1472-6750-1-6.txt:          RNA solution diluted to 2.5 ng/ μl was added to an
technical/biomed/1472-6750-1-6.txt:          supernatant is discarded, and the bacterial pellet is
technical/biomed/1472-6750-1-6.txt:          2500 × g and the supernatants used for ELISAs (see
technical/biomed/1472-6750-1-6.txt:          mRNA), plates are probed with an anti-M13 antibody
technical/biomed/1472-6750-1-6.txt:          The mRNA ELISAs are performed in a similar manner
technical/biomed/1472-6750-1-6.txt:          temperature, treated with RNaseZap, then coated with
technical/biomed/1472-6750-1-6.txt:          biotinylated RNA target (100 ng/well) by incubation for 1
technical/biomed/1472-6750-1-8.txt:        some instances, intensity ratios compared to internal
technical/biomed/1472-6750-1-8.txt:        levels of mRNA expression of interest. Rather, the relative
technical/biomed/1472-6750-1-8.txt:        examines two hybridizations that involve the same RNA
technical/biomed/1472-6750-1-8.txt:          For the Affymetrix experiments, RNA samples from 
technical/biomed/1472-6750-1-8.txt:          for Incyte experiments, human HEK293 cell line RNA (see
technical/biomed/1472-6750-1-8.txt:          Methods). Intensity measurements from the mRNA samples
technical/biomed/1472-6750-1-8.txt:          same control RNA ( 
technical/biomed/1472-6750-1-8.txt:          intensities of the control RNAs within each data type
technical/biomed/1472-6750-1-8.txt:          Each RNA sample was compared to the control RNAs (made
technical/biomed/1472-6750-1-8.txt:          of mRNA changes [ 10 ] .
technical/biomed/1472-6750-1-8.txt:        Consider a comparison of two RNA samples, A and B, and
technical/biomed/1472-6750-1-8.txt:        associated intensity values for RNAs, a 
technical/biomed/1472-6750-1-8.txt:        one RNA (b 
technical/biomed/1472-6750-1-8.txt:        using a logarithm transform of the ratio. Alternatively,
technical/biomed/1472-6750-1-8.txt:        oligonucleotides to interrogate a specific RNA. Incyte uses
technical/biomed/1472-6750-1-8.txt:          RNA samples
technical/biomed/1472-6750-1-8.txt:          RNA for the Affymetrix experiment consisted of
technical/biomed/1472-6750-1-8.txt:          poly(A)+ RNA isolated from heads from fruit flies that
technical/biomed/1472-6750-1-8.txt:          overexpressed Fos and Jun. RNA for the Incyte platform
technical/biomed/1472-6750-1-8.txt:          experiments was poly(A)+ RNA prepared from HEK293 human
technical/biomed/1472-6750-1-8.txt:          11 12 ] . Other samples (e.g., head poly(A)+ RNA from fly
technical/biomed/1472-6750-1-8.txt:          molecules; and poly(A)+ RNA from HEK293 cells that
technical/biomed/1472-6750-1-8.txt:          Excel and the companies' internal controls were removed.
technical/biomed/1472-6750-2-14.txt:        increase the thermodynamic stability of DNA:DNA and DNA:RNA
technical/biomed/1472-6750-2-14.txt:        modified bases to be effectively incorporated by RNA
technical/biomed/1472-6750-2-14.txt:        [ 21 22 ] . An alternative method to increase the
technical/biomed/1472-6750-2-14.txt:        IVT process so that the cRNA produced has the desired level
technical/biomed/1472-6750-2-14.txt:        applied these modified cRNA products to high density
technical/biomed/1472-6750-2-14.txt:        triphosphates into cRNA, yield of amplified material,
technical/biomed/1472-6750-2-14.txt:        RNA (cRNA) target samples could increase signal intensity
technical/biomed/1472-6750-2-14.txt:        in order to measure the range of effects on cRNA yield,
technical/biomed/1472-6750-2-14.txt:        into target cRNA samples may increase hybridization signal
technical/biomed/1472-6750-2-14.txt:        intensity for a wide variety of RNA:DNA hybrid duplexes. In
technical/biomed/1472-6750-2-14.txt:          Effect of modified nucleotides on cRNA yield and
technical/biomed/1472-6750-2-14.txt:          Although DAP, MeC, and MeU were tolerated by T7 RNA
technical/biomed/1472-6750-2-14.txt:          reaction cocktails reduced the yields of amplified cRNA.
technical/biomed/1472-6750-2-14.txt:          RNA tissue source and the NTP modification. However,
technical/biomed/1472-6750-2-14.txt:          system using ten micrograms of cRNA), enough cRNA was
technical/biomed/1472-6750-2-14.txt:          normalize input amounts of cRNA for each condition tested
technical/biomed/1472-6750-2-14.txt:          generated cRNA from five micrograms of total RNA and did
technical/biomed/1472-6750-2-14.txt:          amounts of input total RNA are used.
technical/biomed/1472-6750-2-14.txt:          incorporated by the T7 RNA polymerase and whether
technical/biomed/1472-6750-2-14.txt:          Briefly, the complex cRNA is digested with P1 nuclease
technical/biomed/1472-6750-2-14.txt:          incorporation of DAP into the cRNA, and this level of
technical/biomed/1472-6750-2-14.txt:          note that these analyses used the complex cRNA and
technical/biomed/1472-6750-2-14.txt:          RNA transcript. We therefore incorporated each of these
technical/biomed/1472-6750-2-14.txt:          results as seen with the complex cRNA (data not shown).
technical/biomed/1472-6750-2-14.txt:          cRNA, we also wanted to determine if adding modified NTPs
technical/biomed/1472-6750-2-14.txt:          of modified NTPs had on the length of the amplified cRNA.
technical/biomed/1472-6750-2-14.txt:          cRNA (control) to either the duplicate control
technical/biomed/1472-6750-2-14.txt:          hybridization or to intensities generated from cRNA where
technical/biomed/1472-6750-2-14.txt:          expected if DAP incorporation increased the DNA:RNA
technical/biomed/1472-6750-2-14.txt:          cRNA with no modifications or two micrograms with DAP at
technical/biomed/1472-6750-2-14.txt:          hybridized two micrograms of cRNA with no modifications
technical/biomed/1472-6750-2-14.txt:          cRNA (blue signals). The longer hybridization time
technical/biomed/1472-6750-2-14.txt:          signals. As shown before, the DAP-modified cRNA generated
technical/biomed/1472-6750-2-14.txt:          hybridized unmodified (control) cRNA for 18 hours and a
technical/biomed/1472-6750-2-14.txt:          DAP-modified cRNA for 42 hours (Figure 3B). The median
technical/biomed/1472-6750-2-14.txt:          the control situation (hybridization of unmodified cRNA),
technical/biomed/1472-6750-2-14.txt:          ATP were incorporated into the cRNA target (1:1 DAP:A),
technical/biomed/1472-6750-2-14.txt:          single mismatch with the partially modified cRNA compared
technical/biomed/1472-6750-2-14.txt:          cRNA. Full substitution of adenosine by DAP showed varied
technical/biomed/1472-6750-2-14.txt:          modified cRNA behaved similarly to the control cRNA
technical/biomed/1472-6750-2-14.txt:          specificity improved for the fully modified cRNA, as it
technical/biomed/1472-6750-2-14.txt:          did for the partially modified cRNA (Figure 4C). The
technical/biomed/1472-6750-2-14.txt:          the fully modified cRNA showed a dramatic decrease in
technical/biomed/1472-6750-2-14.txt:          modified, respectively, cRNA. A fifth test probe showed
technical/biomed/1472-6750-2-14.txt:          shown). Repeat experiments with cRNA containing modified
technical/biomed/1472-6750-2-14.txt:          The fully MeC-substituted cRNA targets were examined with
technical/biomed/1472-6750-2-14.txt:          MeC-substituted cRNA targets behaved nearly identically
technical/biomed/1472-6750-2-14.txt:          test sequence (Figure 4D), the MeC-substituted cRNA
technical/biomed/1472-6750-2-14.txt:          behaved nearly identically to the unmodified cRNA target
technical/biomed/1472-6750-2-14.txt:          DAP-substituted cRNA target with respect to the effect of
technical/biomed/1472-6750-2-14.txt:          MeC-substituted cRNA and partially DAP-substituted cRNA
technical/biomed/1472-6750-2-14.txt:          condition are attributable to specific modified cRNA
technical/biomed/1472-6750-2-14.txt:          ratio calls. Kidney and lymphoma cRNA samples containing
technical/biomed/1472-6750-2-14.txt:          cRNA are binned according to the magnitude of the CV, the
technical/biomed/1472-6750-2-14.txt:          partially modified cRNA generates more CVs in the less
technical/biomed/1472-6750-2-14.txt:          cRNA generates more ratios in the one to 1.5 fold change
technical/biomed/1472-6750-2-14.txt:          cRNA yield. Therefore, mass input of cRNA target samples
technical/biomed/1472-6750-2-14.txt:          interaction types, including DNA:DNA, DNA:RNA, and
technical/biomed/1472-6750-2-14.txt:          that DAP use could be exploited in RNA samples that are
technical/biomed/1472-6750-2-14.txt:          may prove to be a useful alternative to increase array
technical/biomed/1472-6750-2-14.txt:          purine incorporated into an RNA strand while MeC and MeU
technical/biomed/1472-6750-2-14.txt:          are pyrimidines incorporated into an RNA strand. Many
technical/biomed/1472-6750-2-14.txt:          nucleotides into cRNA. Finally, earlier studies have
technical/biomed/1472-6750-2-14.txt:          DNA-DNA and not DNA-RNA duplexes, it is possible that MeC
technical/biomed/1472-6750-2-14.txt:          adenosine and DAP in cRNA target samples did not have
technical/biomed/1472-6750-2-14.txt:          pyrimidines in DNA-RNA duplexes [ 33 ] .
technical/biomed/1472-6750-2-14.txt:          cRNA enabled an ~ 10% increase in the number of ratios
technical/biomed/1472-6750-2-14.txt:          (generation of amplified cRNA or of first strand cDNA)
technical/biomed/1472-6750-2-14.txt:          lymphoma total RNA (Ambion, Inc., Austin, TX) were added
technical/biomed/1472-6750-2-14.txt:          mix and 1 μl Superscript™ II RNaseH -reverse
technical/biomed/1472-6750-2-14.txt:          and 1 μl of RNase H (2 U/μl) for 2 hours at 16°C. The
technical/biomed/1472-6750-2-14.txt:          14 hours at 37°C and cRNA target purified using an RNeasy
technical/biomed/1472-6750-2-14.txt:          ®Kit (Qiagen). cRNA yield was quantitated by measuring
technical/biomed/1472-6750-2-14.txt:          Two μg of fragmented target cRNA was used for
technical/biomed/1472-6750-2-14.txt:          Digestion and chromatography of cRNA
technical/biomed/1472-6750-2-14.txt:          of cRNA to generate nucleotide monophosphates. The enzyme
technical/biomed/1472-6750-2-14.txt:          was incubated with the cRNA at 55°C for 6 hours, then for
technical/biomed/1472-6750-2-14.txt:        of the cRNAs. DD participated in design of the study and
technical/biomed/1472-6750-2-2.txt:        crops are not inhibited by K84. As a result, alternative
technical/biomed/1472-6750-2-21.txt:          tRNA synthetase from Neurospora mitochondria (CYT18) can
technical/biomed/1472-6750-2-21.txt:          this was in fact the case mRNA was isolated from 
technical/biomed/1472-6750-2-21.txt:          increase in spliced mRNA was observed, while most other
technical/biomed/1472-6750-2-21.txt:          the levels of spliced mRNA. An exception to this was
technical/biomed/1472-6750-2-21.txt:          mRNAs were extracted, cloned, and sequenced, and half of
technical/biomed/1472-6750-2-21.txt:          mRNA. [ 37 38 39 ]
technical/biomed/1472-6750-2-21.txt:          containing Ampliscribe T7 RNA polymerase (Epicentre),
technical/biomed/1472-6750-2-21.txt:          RNase inhibitor (GIBCO BRL, Rockville, MD; 5 units), low
technical/biomed/1472-6750-2-21.txt:          additional 30 minutes. The RNA was purified using
technical/biomed/1472-6750-2-21.txt:          The assays were performed by heating the RNA (500 nM)
technical/biomed/1472-6750-2-21.txt:          RNA was isolated from an overnight culture using a
technical/biomed/1472-6750-2-21.txt:          MasterPure RNA purification kit (Epicentre, Madison, WI)
technical/biomed/1472-6750-3-4.txt:        Such internalization events appear to contribute
technical/biomed/1472-6750-3-6.txt:        non-specific binding of labeled cRNA to surface-bound
technical/biomed/1472-6750-3-6.txt:        10 ] . We used this information to test whether the DNA:RNA
technical/biomed/1472-6750-3-6.txt:        Labeled cRNA, prepared from total RNA isolated from kidney,
technical/biomed/1472-6750-3-6.txt:        total RNA sample. In subsequent samples, two-fold serial
technical/biomed/1472-6750-3-6.txt:        dilutions of this spiked total RNA into fresh total RNA
technical/biomed/1472-6750-3-6.txt:        labeled cRNA targets from each of these samples and
technical/biomed/1472-6750-3-6.txt:        same cRNA sample to separate arrays, each array hybridized
technical/biomed/1472-6750-3-6.txt:        mismatches due to probe length or to the fact that the cRNA
technical/biomed/1472-6750-3-6.txt:        amount of cRNA used in the hybridization and compare the
technical/biomed/1472-6750-3-6.txt:        constant by varying the amount of labeled cRNA and
technical/biomed/1472-6750-3-6.txt:        supplementing the lower amount of labeled cRNA with
technical/biomed/1472-6750-3-6.txt:        unlabeled cRNA. Therefore, the only variable in these
technical/biomed/1472-6750-3-6.txt:        micrograms of labeled cRNA was compared to that obtained
technical/biomed/1472-6750-3-6.txt:        from 4 micrograms of labeled cRNA. We acknowledge that this
technical/biomed/1472-6750-3-6.txt:        changes in mRNA expression between experimental and control
technical/biomed/1472-6750-3-6.txt:          nucleotide, biotin-11-UTP, was used in the cRNA labeling
technical/biomed/1472-6750-3-6.txt:          mM. cRNA was fragmented prior to the hybridization
technical/biomed/1472-6750-3-6.txt:          of 20 ug of labeled, cRNA target. The second sample
technical/biomed/1472-6750-3-6.txt:          consisted of 4 ug of labeled cRNA target and 16 ug of
technical/biomed/1472-6750-3-6.txt:          unlabeled cRNA target for a total of 20 ug of cRNA. Each
technical/biomed/1472-6750-3-6.txt:          μM for each transcript in kidney total RNA. This 10 μM
technical/biomed/1472-6750-3-6.txt:          dilution was then diluted into kidney total RNA in a
technical/biomed/1472-6750-3-6.txt:          equal to 1 copy per cell, assuming an mRNA population
technical/biomed/1472-6750-3-6.txt:          which is 2.5% of the total RNA, 300,000 mRNAs/cells, and
technical/biomed/1472-6750-3-6.txt:          an average mRNA length of 1,000 bases [ 10 ] .
technical/biomed/1472-6750-3-6.txt:          transcript present in a complex human polyA+ RNA sample
technical/biomed/1472-6750-3-6.txt:          transcripts present in polyA+ RNA and approximately 386
technical/biomed/1472-6750-3-6.txt:          RNA. The latter scenario, in which four bacterial
technical/biomed/1472-6750-3-6.txt:          transcripts were spiked into the polyA+ RNA, was used to
technical/biomed/1472-6750-3-6.txt:          in polyA+ RNA were measured after different array
technical/biomed/1472-6750-3-6.txt:          cRNA to generate the data shown in Figure 4A. The twelve
technical/biomed/1472-6750-3-6.txt:          perfect DNA:RNA 30-mer match and 6 DNA:RNA pairs with
technical/biomed/1472-6750-3-6.txt:          m was determined for each DNA:RNA pair
technical/biomed/1472-6769-1-1.txt:          internalization of the receptor, rinsed and fixed. Under
technical/biomed/1472-6769-1-1.txt:          for 2 hrs at 4°C, to prevent internalization of the
technical/biomed/1472-6769-1-2.txt:          alternative set of torsions along the C13 side chain
technical/biomed/1472-6769-1-2.txt:          for this contention. Alternatively, the few inerrant
technical/biomed/1472-6769-1-2.txt:        attractive alternatives [ 20 ] that, in principle, can also
technical/biomed/1472-6785-2-6.txt:        such as tiger there is no alternative way of collecting
technical/biomed/1472-6785-2-6.txt:        tigers. Alternatively the infective stages may leave the
technical/biomed/1472-6785-2-6.txt:        alternative host and enter the definitive host through
technical/biomed/1472-6785-2-6.txt:        establishing territories. Alternatively transient tigers
technical/biomed/1472-6785-2-6.txt:          for 5 minutes. The supernatant was then removed and 5 ml
technical/biomed/1472-6785-2-7.txt:          humidity ranged from 30% to 72%, and the average diurnal
technical/biomed/1472-6785-2-7.txt:          number of consecutive days with maximum diurnal relative
technical/biomed/1472-6785-2-7.txt:          average number of consecutive days with a maximum diurnal
technical/biomed/1472-6785-2-7.txt:          respectively). Variables based on maximum diurnal
technical/biomed/1472-6785-2-7.txt:          consecutive days with maximum diurnal relative humidity
technical/biomed/1472-6785-2-7.txt:          maximum diurnal relative humidity less than 50% was the
technical/biomed/1472-6785-2-7.txt:          average maximum diurnal relative humidity) were highly
technical/biomed/1472-6785-2-7.txt:          diurnal relative humidity was the best predictor,
technical/biomed/1472-6785-2-7.txt:          diurnal relative humidity that was (i) greater than 90%,
technical/biomed/1472-6793-1-11.txt:        culture model to demonstrate that CaT1 mRNA is
technical/biomed/1472-6793-1-11.txt:        marked increase in CaT1 mRNA expression in the enterocyte.
technical/biomed/1472-6793-1-11.txt:          confirm the identity of the CaT1 mRNA in Caco-2 cells. As
technical/biomed/1472-6793-1-11.txt:          at PCR amplification of Caco-2 cell RNA with other PCR
technical/biomed/1472-6793-1-11.txt:          CaT1 mRNA is regulated by 1,25-dihydroxyvitamin
technical/biomed/1472-6793-1-11.txt:          1,25-dihydroxyvitamin D treatment on CaT1 mRNA
technical/biomed/1472-6793-1-11.txt:          0.001, ANOVA, n= 10 studies) in CaT1 mRNA expression. To
technical/biomed/1472-6793-1-11.txt:          steroid hormone androgen influences CaT1 mRNA expression
technical/biomed/1472-6793-1-11.txt:          h) had no effect on CaT1 mRNA expression in Caco-2 cells.
technical/biomed/1472-6793-1-11.txt:          1,25-dihydroxyvitamin D on CaT1 mRNA shown here in Caco-2
technical/biomed/1472-6793-1-11.txt:          1,25-dihydroxyvitamin D on CaT1 mRNA expression in Caco-2
technical/biomed/1472-6793-1-11.txt:          cells. As shown in Figure 3, the response of CaT1 mRNA to
technical/biomed/1472-6793-1-11.txt:          increased (~2-fold) CaT1 mRNA by 2 h, the earliest time
technical/biomed/1472-6793-1-11.txt:          1,25-dihydroxyvitamin D treatment and CaT1 mRNA response
technical/biomed/1472-6793-1-11.txt:          was a significant increase in CaT1 mRNA levels at the
technical/biomed/1472-6793-1-11.txt:          mRNA expression was observed at 10 -8mol/L
technical/biomed/1472-6793-1-11.txt:          1,25-dihydroxyvitamin D, no further effect on CaT1 mRNA
technical/biomed/1472-6793-1-11.txt:          CaT1 mRNA response to 1,25-dihydroxyvitamin D treatment
technical/biomed/1472-6793-1-11.txt:          9kmRNA expression
technical/biomed/1472-6793-1-11.txt:          D9k mRNA and CaT1 mRNA in Caco-2 cells. In Caco-2 cells,
technical/biomed/1472-6793-1-11.txt:          the mRNA for both calbindin D and CaT1 can be detected by
technical/biomed/1472-6793-1-11.txt:          D-dependent mRNA induction of the two genes clearly
technical/biomed/1472-6793-1-11.txt:          D mRNA by 1,25-dihydroxyvitamin D in Caco-2 cells up to 8
technical/biomed/1472-6793-1-11.txt:          h post treatment. In these experiments calbindin D mRNA
technical/biomed/1472-6793-1-11.txt:          CaT1 mRNA was clearly increased (>5-fold) by 4 h post
technical/biomed/1472-6793-1-11.txt:          have found a significant correlation between CaT1 mRNA
technical/biomed/1472-6793-1-11.txt:          and calbindin D mRNA expression [ 16 ] . Thus, as a
technical/biomed/1472-6793-1-11.txt:          harvested and total RNA was isolated according to
technical/biomed/1472-6793-1-11.txt:          RNA was made into a cDNA library by a reverse
technical/biomed/1472-6793-1-11.txt:          ug bovine serum albumin (BSA), 10 U RNAsin (Promega,
technical/biomed/1472-6793-1-11.txt:          containing 0.1 μg equivalent RNA was analyzed by PCR for
technical/biomed/1472-6793-1-11.txt:          9K mRNA expression were normalized
technical/biomed/1472-6793-1-11.txt:          relative to the expression of GAPDH mRNA, a
technical/biomed/1472-6793-1-12.txt:          measurements of fluorescence alternating with absorbance
technical/biomed/1472-6793-1-15.txt:        transmembrane segments in each of the four internal repeats
technical/biomed/1472-6793-1-15.txt:          1S carrying this internal deletion. A
technical/biomed/1472-6793-1-15.txt:          of external Ca 2+. Hence the signaling mechanism, like
technical/biomed/1472-6793-1-15.txt:          the absence of external Ca 2+and requiring RyR1. A
technical/biomed/1472-6793-1-15.txt:          codon nearest to the 5' end of the mRNA, and this
technical/biomed/1472-6793-1-15.txt:          initiation at internal AUGs due to leaky ribosomal
technical/biomed/1472-6793-1-15.txt:          scanning has been documented, especially for mRNAs
technical/biomed/1472-6793-1-15.txt:          5'-located leader ORF entirely, and only the "internal"
technical/biomed/1472-6793-1-15.txt:          1S mRNA in favor of a presumed ORF at
technical/biomed/1472-6793-1-15.txt:          antibodies [ 25 ] . Thus Met701 is not an internal
technical/biomed/1472-6793-1-15.txt:        four internal repeats of the voltage-gated Na +channel,
technical/biomed/1472-6793-1-15.txt:          resistance of 1-2 MΩ . The external solution was (in mM)
technical/biomed/1472-6793-1-2.txt:        Ca 2+from internal stores, but rather from activation of a
technical/biomed/1472-6793-1-2.txt:          2+from internal stores. These results are similar to
technical/biomed/1472-6793-1-2.txt:          wavelength alternated between 340 and 380 nm and
technical/biomed/1472-6793-1-2.txt:          (model 5415 C). The supernatants were removed, and placed
technical/biomed/1472-6793-1-2.txt:          supernatants was determined using the LD-L kit from
technical/biomed/1472-6793-1-8.txt:          the internal and external solutions used here (see
technical/biomed/1472-6793-1-8.txt:          of the internal recording solution and is in agreement
technical/biomed/1472-6793-1-8.txt:          measurement requires an entirely different internal
technical/biomed/1472-6793-1-8.txt:          internal and external solutions resulted in
technical/biomed/1472-6793-1-8.txt:          The external solution in all cases was (in mM) 130 TEA
technical/biomed/1472-6793-1-8.txt:          pH 7.3. For charge movements, the external solution was
technical/biomed/1472-6793-2-1.txt:          figure 5, and mean aorta external diameter at 100 mmHg
technical/biomed/1472-6793-2-1.txt:          Aortic distensibility, the increase in external
technical/biomed/1472-6793-2-1.txt:          diameter during stepwise internal pressure increases, is
technical/biomed/1472-6793-2-1.txt:            dissecting microscope (Leica MZ6). The external
technical/biomed/1472-6793-2-1.txt:            external diameter and inflation pressure as dependent
technical/biomed/1472-6793-2-1.txt:            each individual animal. The external diameter of the
technical/biomed/1472-6793-2-1.txt:            mmHg external diameter.
technical/biomed/1472-6793-2-11.txt:          taken externally on the left testis using dial calipers
technical/biomed/1472-6793-2-11.txt:          0.523). In previous studies in our lab, external testis
technical/biomed/1472-6793-2-16.txt:        parasternal intercostal muscles and increases in their
technical/biomed/1472-6793-2-17.txt:          artery that was free of internal elastic lamina (Fig. 2,
technical/biomed/1472-6793-2-17.txt:          observed adjacent to the external elastic lamina and
technical/biomed/1472-6793-2-17.txt:          external elastic lamina, occasional nerve processes and
technical/biomed/1472-6793-2-17.txt:          The 3 supernatants from each artery and from each vein
technical/biomed/1472-6793-2-17.txt:          supernatants were transferred into clean tubes and stored
technical/biomed/1472-6793-2-17.txt:          protein content of all supernatants was assayed
technical/biomed/1472-6793-2-18.txt:          Alternatively, the 1s and 0s can be interpreted as
technical/biomed/1472-6793-2-18.txt:          illustrates coordination preferences during the nocturnal
technical/biomed/1472-6793-2-19.txt:        staircase. Alternatively, this difference in
technical/biomed/1472-6793-2-2.txt:          wavelength alternated between 340 and 380 nm and
technical/biomed/1472-6793-2-2.txt:          (model 5415 C). The supernatants were removed, and placed
technical/biomed/1472-6793-2-2.txt:          supernatants was determined using the LD-L kit from
technical/biomed/1472-6793-2-2.txt:          Eppendorf 5417R centrifuge. Supernatants were collected
technical/biomed/1472-6793-2-4.txt:        binding of external blocking agents. The presence of
technical/biomed/1472-6793-2-4.txt:          evaluate the effects of TEA on ionic currents. External
technical/biomed/1472-6793-2-4.txt:          blocked by external TEA. An intriguing question remains
technical/biomed/1472-6793-2-4.txt:            in vitro synthesis of cRNA with
technical/biomed/1472-6793-2-4.txt:            T3 RNA polymerase. Prepared oocytes were injected with
technical/biomed/1472-6793-2-4.txt:            sterile water containing AQP1 cRNA (~0.2 to 0.5 ng/nl)
technical/biomed/1472-6793-2-5.txt:        into the external medium on the ~10-100 μs time scale,
technical/biomed/1472-6793-2-5.txt:          external environment.
technical/biomed/1472-6793-2-5.txt:          Alternatively, it is possible that the fast H +release
technical/biomed/1472-6793-2-5.txt:          (6000 rpm × 30 min), and the supernatants collected.
technical/biomed/1472-6793-2-5.txt:          the pooled supernatants were diluted 10× with buffer A
technical/biomed/1472-6793-2-5.txt:          supernatants, containing OG-solubilized pR (~15 mg), were
technical/biomed/1472-6793-2-8.txt:        demonstrated that VEGF mRNA is upregulated in rat
technical/biomed/1472-6793-2-8.txt:        studies show similar upregulation of VEGF mRNA in
technical/biomed/1472-6793-2-8.txt:        VEGF mRNA transcripts are produced within skeletal
technical/biomed/1472-6793-2-8.txt:        VEGF mRNA expression exist between functionally diverse
technical/biomed/1472-6793-2-8.txt:        mRNA in oxidative regions of a mixed skeletal muscle. The
technical/biomed/1472-6793-2-8.txt:        upregulate total VEGF mRNA production in rat gastrocnemius
technical/biomed/1472-6793-2-8.txt:        upregulate VEGF mRNA levels by 3-4 fold [ 10 13 14 ] . 
technical/biomed/1472-6793-2-8.txt:        mRNA transcripts. In order to observe the pattern of
technical/biomed/1472-6793-2-8.txt:          Determination of fiber types and VEGF mRNA signal
technical/biomed/1472-6793-2-8.txt:          after 1 hour of treadmill running. The VEGF mRNA signal
technical/biomed/1472-6793-2-8.txt:          VEGF mRNA levels examined in (A) resting control, (B)
technical/biomed/1472-6793-2-8.txt:          clear that VEGF mRNA levels are elevated over resting
technical/biomed/1472-6793-2-8.txt:          3which gives the quantitative densitometry for VEGF mRNA,
technical/biomed/1472-6793-2-8.txt:          normalized to 18S ribosomal RNA. A significant increase
technical/biomed/1472-6793-2-8.txt:          in VEGF mRNA over resting control is observed after 1
technical/biomed/1472-6793-2-8.txt:          mRNA levels between exercised and electrically stimulated
technical/biomed/1472-6793-2-8.txt:          Regional VEGF mRNA signal
technical/biomed/1472-6793-2-8.txt:          regions affords the possibility of comparing VEGF mRNA
technical/biomed/1472-6793-2-8.txt:          phenotype is related to VEGF mRNA signal strength. That
technical/biomed/1472-6793-2-8.txt:          fiber phenotype and VEGF mRNA signal. This was not
technical/biomed/1472-6793-2-8.txt:          mRNA signal in oxidative versus glycolytic muscle regions
technical/biomed/1472-6793-2-8.txt:          VEGF mRNA signal strength between functional regions (P =
technical/biomed/1472-6793-2-8.txt:          significantly larger regional difference in VEGF mRNA
technical/biomed/1472-6793-2-8.txt:        significantly upregulate total VEGF mRNA levels in rat and
technical/biomed/1472-6793-2-8.txt:        upregulation in VEGF mRNA in rat gastrocnemius muscle
technical/biomed/1472-6793-2-8.txt:        the fiber specific localization of VEGF mRNA transcripts on
technical/biomed/1472-6793-2-8.txt:        visualization of the intracellular location of mRNA
technical/biomed/1472-6793-2-8.txt:        a quantitative measure of mRNA signal strength. This is
technical/biomed/1472-6793-2-8.txt:        endogenous RNases, and on tissue permeability to the VEGF
technical/biomed/1472-6793-2-8.txt:        sample, and this signal was normalized to an internal
technical/biomed/1472-6793-2-8.txt:        mRNA signal is stronger in deep oxidative regions of the
technical/biomed/1472-6793-2-8.txt:        Whether the regional differences in VEGF mRNA
technical/biomed/1472-6793-2-8.txt:        VEGF mRNA upregulation after chronic electrical stimulation
technical/biomed/1472-6793-2-8.txt:        produce larger differences in VEGF mRNA signal compared to
technical/biomed/1472-6793-2-8.txt:        larger regional difference in VEGF mRNA signal after
technical/biomed/1472-6793-2-8.txt:        regional differences in the mean VEGF mRNA signal in rat
technical/biomed/1472-6793-2-8.txt:        stimulation. This regional patterning of VEGF mRNA is at
technical/biomed/1472-6793-2-8.txt:        it is not possible to conclude that the observed VEGF mRNA
technical/biomed/1472-6793-2-8.txt:          mRNA
technical/biomed/1472-6793-2-8.txt:          VEGF mRNA response in rat skeletal muscle. For the
technical/biomed/1472-6793-2-8.txt:          because hypoxia can also induce VEGF mRNA upregulation,
technical/biomed/1472-6793-2-8.txt:          detectable difference in VEGF mRNA levels by Northern
technical/biomed/1472-6793-2-8.txt:          was removed for RNA isolation, frozen in liquid nitrogen,
technical/biomed/1472-6793-2-8.txt:          Thus, the left gastrocnemius was harvested for RNA
technical/biomed/1472-6793-2-8.txt:          degraded during the RNA isolation leaving 3 rest-control,
technical/biomed/1472-6793-2-8.txt:          patterns of VEGF mRNA production in those muscles
technical/biomed/1472-6793-2-8.txt:          RNA isolation and Northern analyses
technical/biomed/1472-6793-2-8.txt:          Total cellular RNA was isolated from each
technical/biomed/1472-6793-2-8.txt:          Sacchi [ 32 ] . RNA preparations were quantified by
technical/biomed/1472-6793-2-8.txt:          absorbance at 260 nm and RNA intactness and integrity
technical/biomed/1472-6793-2-8.txt:          Fractionated RNA was transferred by Northern blot to
technical/biomed/1472-6793-2-8.txt:          transfer, RNA was cross-linked to the membrane by
technical/biomed/1472-6793-2-8.txt:          of signals and normalized to ribosomal 18S RNA
technical/biomed/1472-6793-2-8.txt:          Braissant and Wahli [ 20 ] to detect VEGF mRNA
technical/biomed/1472-6793-2-8.txt:          digoxigenin-UTP labeled complementary RNA in the
technical/biomed/1472-6793-2-8.txt:          antisense or sense orientation (using T3 or T7 RNA
technical/biomed/1472-6793-2-8.txt:          Quantification of the regional VEGF mRNA signal
technical/biomed/1472-6793-2-8.txt:          Regional VEGF mRNA signal within an individual muscle
technical/biomed/1472-6793-2-8.txt:          strength of the VEGF mRNA signal, and also on the amount
technical/biomed/1472-6793-2-8.txt:          it was necessary to normalize all VEGF mRNA optical
technical/biomed/1472-6793-2-8.txt:          density signals to an internal standard. For example, to
technical/biomed/1472-6793-2-8.txt:          densitometric measurements of the VEGF mRNA signal within
technical/biomed/1472-6793-2-8.txt:          in VEGF mRNA levels from Northern analysis between muscle
technical/biomed/1472-6793-2-8.txt:          electrical stimulation, control) on VEGF mRNA signal. 
technical/biomed/1472-6793-2-8.txt:          protocols in the regional difference of VEGF mRNA signal.
technical/biomed/1472-6793-3-3.txt:        the internal store. The response can depend on the form of
technical/biomed/1472-6793-3-4.txt:        production [ 6 ] . Hypothalamic POMC mRNA is reduced in
technical/biomed/1472-6793-3-4.txt:        with a restoration of hypothalamic POMC mRNA tone in
technical/biomed/1472-6793-3-4.txt:        mRNA is somewhat complex and may depend on the genetic
technical/biomed/1472-6793-3-4.txt:        of adrenalectomy on hypothalamic POMC mRNA may also depend
technical/biomed/1472-6793-3-4.txt:        POMC mRNA in diet-induced obesity in mice, as in
technical/biomed/1472-6793-3-4.txt:        of hypothalamic POMC mRNA tone in mice made obese on a
technical/biomed/1472-6793-3-4.txt:          mRNA
technical/biomed/1472-6793-3-4.txt:          Although diet did not influence pituitary POMC mRNA,
technical/biomed/1472-6793-3-4.txt:          POMC mRNA
technical/biomed/1472-6793-3-4.txt:          increase in hypothalamic POMC mRNA in sham-operated mice
technical/biomed/1472-6793-3-4.txt:          trend toward an increase in hypothalamic POMC mRNA in
technical/biomed/1472-6793-3-4.txt:          sham-operated mice, but a 5-fold induction of POMC mRNA
technical/biomed/1472-6793-3-4.txt:          hypothalamic AGPR mRNA levels (Fig. 5B).
technical/biomed/1472-6793-3-4.txt:        hypothalamic POMC mRNA (Fig. 5A). This elevation in
technical/biomed/1472-6793-3-4.txt:        antagonist AGRP mRNA (Fig. 5B) would be expected to lead to
technical/biomed/1472-6793-3-4.txt:        mRNA (as well as hypothalamic POMC mRNA), demonstrating
technical/biomed/1472-6793-3-4.txt:        hypothalamic POMC mRNA associated with marginal
technical/biomed/1472-6793-3-4.txt:        POMC mRNA produced significant attenuation of the
technical/biomed/1472-6793-3-4.txt:        reduced hypothalamic POMC mRNA. These data raise the
technical/biomed/1472-6793-3-4.txt:          proopiomelanocortin (POMC) mRNA levels and the reduction
technical/biomed/1472-6793-3-4.txt:          agouti-related peptide (AGRP) mRNA and pituitary POMC
technical/biomed/1472-6793-3-4.txt:          mRNA were measured by Northern blot analysis as
technical/biomed/1472-6793-3-4.txt:          previously described [ 6 ] . Briefly, total RNA was
technical/biomed/1472-6793-3-4.txt:          three micrograms of total RNA from hypothalamus,
technical/biomed/1472-6793-3-4.txt:          to measure POMC and AGRP mRNA. Three micrograms of total
technical/biomed/1472-6793-3-4.txt:          RNA from anterior pituitary was used to measure pituitary
technical/biomed/1472-6793-3-4.txt:          POMC mRNA. Total RNA was denatured in a mixture of
technical/biomed/1472-6793-3-4.txt:          phosphate agarose gel. The RNA was transferred to an
technical/biomed/1472-6793-3-4.txt:          with a single stranded internally labeled 32P probe over
technical/biomed/1472-6793-3-4.txt:          probed using single-stranded internally labeled DNA
technical/biomed/1472-6793-3-4.txt:          18S ribosomal RNA and all signals were normalized to this
technical/biomed/1472-6793-3-5.txt:        reduction in proopiomelanocortin (POMC) mRNA and elevation
technical/biomed/1472-6793-3-5.txt:        in agouti-related peptide (AGRP) mRNA, is thought to play a
technical/biomed/1472-6793-3-5.txt:        reported to block elevations in NPY mRNA in response to
technical/biomed/1472-6793-3-5.txt:        required for the induction of NPY mRNA by fasting [ 15 ] .
technical/biomed/1472-6793-3-5.txt:        mRNA depends on elevated glucocorticoid levels in fasting
technical/biomed/1472-6793-3-5.txt:        of hypothalamic AGRP and POMC mRNA.
technical/biomed/1472-6793-3-5.txt:          Fasting increased hypothalamic AGRP mRNA as expected
technical/biomed/1472-6793-3-5.txt:          mRNA in the ad-lib fed mice but this effect was not
technical/biomed/1472-6793-3-5.txt:          POMC mRNA as expected in the sham-operated fasted group,
technical/biomed/1472-6793-3-5.txt:          but fasting had no effect on POMC mRNA in the
technical/biomed/1472-6793-3-5.txt:          mRNA was also elevated after fasting, and this effect of
technical/biomed/1472-6793-3-5.txt:          fasting on NPY mRNA was also completely blocked by
technical/biomed/1472-6793-3-5.txt:          AGRP, POMC and NPY mRNAs.
technical/biomed/1472-6793-3-5.txt:          Hypothalamic AGRP mRNA was significantly elevated in
technical/biomed/1472-6793-3-5.txt:          mRNA in diabetic mice whether or not they were fasted
technical/biomed/1472-6793-3-5.txt:          (Fig. 4A). Hypothalamic POMC mRNA was reduced in diabetic
technical/biomed/1472-6793-3-5.txt:          blocked this reduction in POMC mRNA in diabetic mice
technical/biomed/1472-6793-3-5.txt:          mRNA, NPY mRNA was elevated in diabetic mice, and
technical/biomed/1472-6793-3-5.txt:          adrenalectomy blocked this induction of NPY mRNA in
technical/biomed/1472-6793-3-5.txt:          In summary, hypothalamic AGRP, POMC and NPY mRNA all
technical/biomed/1472-6793-3-5.txt:          POMC mRNA was also significantly elevated in the
technical/biomed/1472-6793-3-5.txt:          mRNA exhibited a trend toward an increase although the
technical/biomed/1472-6793-3-5.txt:          hypothalamic AGRP and POMC mRNAs were both induced by the
technical/biomed/1472-6793-3-5.txt:          glucocorticoid implant, whereas the NPY mRNA was not
technical/biomed/1472-6793-3-5.txt:        AGRP mRNA and the reduction in POMC mRNA with fasting,
technical/biomed/1472-6793-3-5.txt:        not to reduce hypothalamic POMC mRNA. Together these
technical/biomed/1472-6793-3-5.txt:        AGRP mRNA but not to reduce POMC expression.
technical/biomed/1472-6793-3-5.txt:        mRNA (Fig. 2Aand 2B), without preventing effects of fasting
technical/biomed/1472-6793-3-5.txt:        effects of fasting on hypothalamic NPY mRNA (Fig. 2C),
technical/biomed/1472-6793-3-5.txt:        and NPY mRNA, as well as the reduction of hypothalamic POMC
technical/biomed/1472-6793-3-5.txt:        mRNA. On the other hand, blocking the rise in
technical/biomed/1472-6793-3-5.txt:        hypothalamic POMC mRNA and the induction of AGRP mRNA,
technical/biomed/1472-6793-3-5.txt:        an elevation in both hypothalamic AGRP and POMC mRNA (Fig.
technical/biomed/1472-6793-3-5.txt:        6B). Since adrenalectomy blocked the elevation of AGRP mRNA
technical/biomed/1472-6793-3-5.txt:        AGRP mRNA, as was indeed observed. However, the
technical/biomed/1472-6793-3-5.txt:        elevating hypothalamic POMC mRNA, a rare if not unique
technical/biomed/1472-6793-3-5.txt:        circumstance in which hypothalamic AGRP and POMC mRNA are
technical/biomed/1472-6793-3-5.txt:        hypothalamic AGRP mRNA [ 4 ] , yet AGRP mRNA was
technical/biomed/1472-6793-3-5.txt:        AGRP mRNA while it does partially normalize plasma leptin
technical/biomed/1472-6793-3-5.txt:        and hypothalamic POMC mRNA [ 17 ] .
technical/biomed/1472-6793-3-5.txt:        POMC mRNA, and adrenalectomy blocked the effect of fasting
technical/biomed/1472-6793-3-5.txt:        on hypothalamic POMC mRNA). However, in one key respect the
technical/biomed/1472-6793-3-5.txt:        mRNA. Since we observed that adrenalectomy also blocks the
technical/biomed/1472-6793-3-5.txt:        rats and mice, since in mice hypothalamic AGRP mRNA is
technical/biomed/1472-6793-3-5.txt:        hypothalamic AGRP mRNA during fasting and diabetes but not
technical/biomed/1472-6793-3-5.txt:        the reduction in POMC mRNA. Interestingly, at least with
technical/biomed/1472-6793-3-5.txt:          RNA analysis
technical/biomed/1472-6793-3-5.txt:          Total RNA was extracted from tissue using TRIzol
technical/biomed/1472-6793-3-5.txt:          RNA from hypothalamus was subjected to Northern blot
technical/biomed/1472-6793-3-5.txt:          and NPY mRNA [ 3 4 5 9 ] . Seven micrograms of total RNA
technical/biomed/1472-6793-3-5.txt:          analysis to measure leptin mRNA. The blots were probed
technical/biomed/1472-6793-3-5.txt:          with single-stranded internally labeled DNA probes as
technical/biomed/1472-6793-3-5.txt:          described previously [ 16 ] . To monitor RNA loading,
technical/biomed/1472-6793-3-5.txt:          32P-labeled probe encoding 18S ribosomal RNA. The total
technical/biomed/1472-6793-3-5.txt:        Author 1 (HM) carried out the animal work, the mRNA
technical/biomed/1472-6793-3-6.txt:        myocardial hypertrophy or, alternatively,may up-regulate
technical/biomed/1472-6793-3-6.txt:          analysis. Diastolic left ventricular internal dimension
technical/biomed/1472-6793-3-6.txt:          (LVIDd)and systolic left ventricular internal dimension
technical/biomed/1472-6807-1-1.txt:          internal coordinate space, according to the ICM method [
technical/biomed/1472-6807-1-1.txt:          to a global energy optimization in internal coordinates [
technical/biomed/1472-6807-2-1.txt:        model were energy-minimized in the internal coordinate
technical/biomed/1472-6807-2-1.txt:        was assigned to the quaternary ammonium group of
technical/biomed/1472-6807-2-1.txt:        binding pocket and the quaternary ammonium of acetylcholine
technical/biomed/1472-6807-2-1.txt:        quaternary nitrogen of docked acetylcholine. Additionally,
technical/biomed/1472-6807-2-1.txt:        alternative, less energetically favorable conformation,
technical/biomed/1472-6807-2-1.txt:        projecting away from the ligands, alternative conformers
technical/biomed/1472-6807-2-1.txt:          energy-minimized in the internal coordinates space using
technical/biomed/1472-6807-2-3.txt:            alignments. These alternate alignments were used to
technical/biomed/1472-6807-2-3.txt:            internally developed library based on the most
technical/biomed/1472-6807-2-3.txt:          Internal testing and comparison of models to the
technical/biomed/1472-6807-2-4.txt:        Alternatively, one could use the available experimental
technical/biomed/1472-6807-2-4.txt:        alternatively, can also be defined as distance dependent [
technical/biomed/1472-6807-2-4.txt:        proteins, (iv) generation of the alternative conformations
technical/biomed/1472-6807-2-4.txt:          native and an alternate. By allowing 
technical/biomed/1472-6807-3-1.txt:        DNA replication, addition of polyA tails to mRNA, addition
technical/biomed/1472-6807-3-1.txt:        of CCA to tRNA, uridylation in RNA editing, replication of
technical/biomed/1472-6807-3-1.txt:        RNA viruses, amplification of RNA in eukaryotic
technical/biomed/1472-6807-3-1.txt:        RNA polymerases (DDRPs) involved in the transcription of
technical/biomed/1472-6807-3-1.txt:        cellular and DNA viral genes, primases, and RNA-dependent
technical/biomed/1472-6807-3-1.txt:        RNA polymerases (RDRPs) of RNA viruses and cellular PTGS
technical/biomed/1472-6807-3-1.txt:        Template-independent RNA polymerases
technical/biomed/1472-6807-3-1.txt:        Some of the RNA polymerases function as single-subunit
technical/biomed/1472-6807-3-1.txt:        Despite the basic biochemical similarity among all RNA
technical/biomed/1472-6807-3-1.txt:        unrelated folds. The RDRPs of RNA viruses define one major
technical/biomed/1472-6807-3-1.txt:        The DNA-dependent RNA polymerase of certain bacteriophages,
technical/biomed/1472-6807-3-1.txt:        RNA-recognition motif (RRM)-like fold with strategically
technical/biomed/1472-6807-3-1.txt:        any of the above template-dependent RNA polymerases [ 20 21
technical/biomed/1472-6807-3-1.txt:        affinities of two other template-dependent RNA polymerases,
technical/biomed/1472-6807-3-1.txt:        template-dependent RNA polymerases, which have several
technical/biomed/1472-6807-3-1.txt:        template-independent RNA polymerases have the same fold of
technical/biomed/1472-6807-3-1.txt:        Thus, RNA polymerase activity apparently has been
technical/biomed/1472-6807-3-1.txt:        this complex RNA synthesis machine were already present in
technical/biomed/1472-6807-3-1.txt:        RNA interference (RNAi) in animals and slime mold,
technical/biomed/1472-6807-3-1.txt:        common mechanism of RNA turnover [ 28 37 38 39 40 ] .
technical/biomed/1472-6807-3-1.txt:        Essentially, double-stranded (ds) RNA, which is formed in
technical/biomed/1472-6807-3-1.txt:        sequence-specific RNA degradation system, which targets
technical/biomed/1472-6807-3-1.txt:        homologous RNAs [ 41 42 ] . The dsRNA is broken down by the
technical/biomed/1472-6807-3-1.txt:        small interfering RNA or siRNAs [ 43 44 45 ] . The siRNAs
technical/biomed/1472-6807-3-1.txt:        RISC and target homologous RNA by serving as guides for
technical/biomed/1472-6807-3-1.txt:        multiple rounds of RNA cleavage [ 45 46 ] .
technical/biomed/1472-6807-3-1.txt:        initially described in plants as a cellular RNA polymerase
technical/biomed/1472-6807-3-1.txt:        antisense RNA in a primer-dependent or independent manner [
technical/biomed/1472-6807-3-1.txt:        of dsRNA using the target RNA as template and siRNAs as
technical/biomed/1472-6807-3-1.txt:        primers or guides and resulting in amplification of the RNA
technical/biomed/1472-6807-3-1.txt:        Evidence is presented that the ultimate ancestor of RNA
technical/biomed/1472-6807-3-1.txt:        polymerases might have been a RNA-binding DPBB domain,
technical/biomed/1472-6807-3-1.txt:          proteins, which probably also have RNA-dependent RNA
technical/biomed/1472-6807-3-1.txt:          classes of RNA polymerases.
technical/biomed/1472-6807-3-1.txt:          database included the RNA polymerase subunits in the
technical/biomed/1472-6807-3-1.txt:          latter (Fig. 2). However, the DPBB from the RNA
technical/biomed/1472-6807-3-1.txt:          show limited sequence similarity, these two RNA
technical/biomed/1472-6807-3-1.txt:          catalytic domain of RNA polymerases
technical/biomed/1472-6807-3-1.txt:          interact to form the catalytic cleft of the RNA
technical/biomed/1472-6807-3-1.txt:          comprise the ancestral conserved core of the RNA
technical/biomed/1472-6807-3-1.txt:          homodimer that bound RNA at the domain interface.
technical/biomed/1472-6807-3-1.txt:          originally catalyzed the RNA polymerization.
technical/biomed/1472-6807-3-1.txt:          modern-type RNA polymerases, the catalytic activity
technical/biomed/1472-6807-3-1.txt:          the RNA polymerase β subunit is distorted by inserts and
technical/biomed/1472-6807-3-1.txt:          shows that the DPBB domains of the RNA polymerases share
technical/biomed/1472-6807-3-1.txt:          Several versions of the DPBB, e.g., those in RNA
technical/biomed/1472-6807-3-1.txt:          with RNA or with small molecules. These generic barrel
technical/biomed/1472-6807-3-1.txt:          stage of evolution when the actual RNA polymerase
technical/biomed/1472-6807-3-1.txt:          facilitated by a non-specific, RNA-binding protein
technical/biomed/1472-6807-3-1.txt:          DNA-dependent RNA polymerases
technical/biomed/1472-6807-3-1.txt:          divergent RNA polymerases of baculoviruses and yeast
technical/biomed/1472-6807-3-1.txt:          minimal RNA polymerase seems to be represented by the
technical/biomed/1472-6807-3-1.txt:          RNA polymerases, we sought to identify additional
technical/biomed/1472-6807-3-1.txt:          ribosomal proteins, translation factors, aminoacyl-tRNA
technical/biomed/1472-6807-3-1.txt:          synthetases, RNA polymerase cofactors in archaea and
technical/biomed/1472-6807-3-1.txt:          could be traced back to ancestral RNA polymerases. Visual
technical/biomed/1472-6807-3-1.txt:          This latter form was recruited into the RNA polymerase
technical/biomed/1472-6807-3-1.txt:          that probably originally bound RNA and, subsequently,
technical/biomed/1472-6807-3-1.txt:          of the first internal repeat. This is clearly a derived
technical/biomed/1472-6807-3-1.txt:          internal repeat is additionally seen in several
technical/biomed/1472-6807-3-1.txt:          derived SBHMs of the bacterial RNA polymerase subunits
technical/biomed/1472-6807-3-1.txt:          degraded loop in the first internal repeat initially
technical/biomed/1472-6807-3-1.txt:          The RNA polymerase α subunit-core-related domain
technical/biomed/1472-6807-3-1.txt:          and other elaborations of the archaeo-eukaryotic RNA
technical/biomed/1472-6807-3-1.txt:          aspartyl-tRNA synthetases. To investigate this domain
technical/biomed/1472-6807-3-1.txt:          an RNA Recognition Motif (RRM)-like structure with a
technical/biomed/1472-6807-3-1.txt:          evolutionary diversification of the RNA polymerase
technical/biomed/1472-6807-3-1.txt:          83 ] . This suggests congruent evolution of the RNA
technical/biomed/1472-6807-3-1.txt:          beyond the DPBB domain. An alternative, perhaps more
technical/biomed/1472-6807-3-1.txt:          extant eukaryotic RDRPs are small RNAs, such as microRNAs
technical/biomed/1472-6807-3-1.txt:          and stRNAs [ 84 85 86 87 88 89 90 ] , and analogous small
technical/biomed/1472-6807-3-1.txt:          RNAs have been identified in bacteria [ 91 92 93 94 ] .
technical/biomed/1472-6807-3-1.txt:          Given that small RNAs are likely to have been abundant in
technical/biomed/1472-6807-3-1.txt:          the hypothetical ancient RNA world, RDRPs might have been
technical/biomed/1472-6807-3-1.txt:          involved in the replication of such RNAs since an early
technical/biomed/1472-6807-3-1.txt:          Hen-2/Corymbosa-like RNA methylase, AlkB-related RNA
technical/biomed/1472-6807-3-1.txt:          demethylases, and Lin28-like RNA-binding proteins [ 1 45
technical/biomed/1472-6807-3-1.txt:          proteins also have a RNA polymerase activity. Possible
technical/biomed/1472-6807-3-1.txt:          activity via amplification of antisense RNAs or perhaps a
technical/biomed/1472-6807-3-1.txt:          more conventional role as a DNA-dependent RNA polymerase
technical/biomed/1472-6807-3-1.txt:          suggests that the primordial RNA polymerase was a head to
technical/biomed/1472-6807-3-1.txt:          catalytic activity, and merely bound RNA. Originally,
technical/biomed/1472-6807-3-1.txt:          cofactors that stabilized a ribozyme RNA polymerase and
technical/biomed/1472-6807-3-1.txt:          class, the palm-domain-containing RNA and DNA
technical/biomed/1472-6807-3-1.txt:          of a RNA-binding domain of the RRM fold [ 11 ] .
technical/biomed/1472-6807-3-1.txt:          and probably functioned as generic RNA-binding and
technical/biomed/1472-6807-3-1.txt:          conferred by catalytic RNA molecules. Hence, considerable
technical/biomed/1472-6807-3-1.txt:          translation, such as aminoacyl-tRNA synthetases and
technical/biomed/1472-6807-3-1.txt:          a duplication of the DDRP β' subunit. An alternative
technical/biomed/1472-6807-3-1.txt:          likely that the ancestral protein RNA polymerase, at the
technical/biomed/1472-6807-3-1.txt:          phages and with their role in replicating microRNAs
technical/biomed/1472-6807-3-1.txt:          (potential relics of the RNA world) during PTGS in
technical/biomed/1472-6807-3-1.txt:          expunged from the cellular RNA synthesis systems and
technical/biomed/1472-6807-3-1.txt:          entities, these polymerases are encoded largely by RNA
technical/biomed/1472-6807-3-1.txt:          vestiges of the ancient RNA world that have been largely
technical/biomed/1472-6807-3-1.txt:          RNA replication in DNA-based organisms, while surviving
technical/biomed/1472-6807-3-2.txt:        alternately, the ligand, the protein, or both molecules,
technical/biomed/1472-6815-2-3.txt:          using external sounds to provide relief
technical/biomed/1472-6815-2-3.txt:          pleasant external sounds in order to decrease their
technical/biomed/1472-6815-2-3.txt:          • Patients can use external sounds to exert some
technical/biomed/1472-6815-2-3.txt:          exposure to external sounds.
technical/biomed/1472-6815-2-3.txt:          external sounds within safe limits can help patients
technical/biomed/1472-6815-2-3.txt:          • Increased exposure to external sounds (within safe
technical/biomed/1472-6815-2-3.txt:          • Increased exposure to external sounds over time
technical/biomed/1472-6823-2-2.txt:        alternatively spliced form of Ogg1 that contains a
technical/biomed/1472-6823-3-1.txt:          International Classification of Diseases-9th Modification
technical/biomed/1472-6831-2-2.txt:          alternatively divided into clusters, using the unweighted
technical/biomed/1472-6831-3-1.txt:        acceptable alternatives. That interest relates primarily to
technical/biomed/1472-6831-3-1.txt:        in this study does not enhance the internal surface
technical/biomed/1472-684X-1-5.txt:          alternate route of administration or an alternate opioid
technical/biomed/1472-684X-1-5.txt:          (rare), then pursue alternate therapies directed at
technical/biomed/1472-684X-1-5.txt:          alternative.
technical/biomed/1472-684X-1-5.txt:          effective [ 95 ] . A more sedating alternative is
technical/biomed/1472-684X-1-5.txt:          alternatives for the patient who is particularly
technical/biomed/1472-684X-2-1.txt:        We asked internal medicine residents caring for severely
technical/biomed/1472-684X-2-1.txt:            The Internal Medicine Training Program at the
technical/biomed/1472-684X-2-1.txt:            EDP rounds occur weekly and are attended by internal
technical/biomed/1472-684X-2-1.txt:            year internal medicine residents over a one-month
technical/biomed/1472-684X-2-1.txt:          contributed to a reluctance to suggest an alternative
technical/biomed/1472-684X-2-1.txt:        [ 16 ] . Alternatively, residents might be using lack of
technical/biomed/1472-684X-2-1.txt:        to propose alternative care approaches could result from
technical/biomed/1472-684X-2-1.txt:        physicians. Alternatively, the hesitation may also
technical/biomed/1472-684X-2-2.txt:        alternative, for terminally ill patients with intolerable
technical/biomed/1472-684X-2-2.txt:        internal guidelines, which were introduced after discussion
technical/biomed/1472-684X-2-2.txt:          internal guidelines. Informed consent in presence of her
technical/biomed/1472-684X-2-2.txt:        international discussion on sedation in end-of-life
technical/biomed/1472-684X-2-2.txt:        our internal guidelines by reflecting our clinical practice
technical/biomed/1472-684X-2-2.txt:        internal guidelines we grouped patients according to the
technical/biomed/1472-684X-2-2.txt:        could be an comprehensible alternative to euthanasia or
technical/biomed/1472-684X-2-2.txt:        alternatives, results and adverse effects would help to
technical/biomed/1472-6874-2-1.txt:        internal orgasm depends on the stimulation of nerve endings
technical/biomed/1472-6874-2-1.txt:        level of the internal cervical os. The cervical stump was
technical/biomed/1472-6874-2-13.txt:          2 were used as internal standards to
technical/biomed/1472-6874-2-13.txt:        in San Fernando, California and a Developmental Funds award
technical/biomed/1472-6874-2-8.txt:          paternal aunt with premature ovarian failure, and one
technical/biomed/1472-6874-2-8.txt:          patient had a paternal aunt, a grandmother, and a
technical/biomed/1472-6874-3-2.txt:          journals. The National Institute of Child Health and
technical/biomed/1472-6882-1-10.txt:          Alternatively a tincture is made with a piece of the vine
technical/biomed/1472-6882-1-10.txt:          solution to the dog. Alternatively four or five berries
technical/biomed/1472-6882-1-10.txt:          internally. Dogs with rashes are bathed with St. John's
technical/biomed/1472-6882-1-10.txt:          Vicks™ in his dog's nose as an alternative. Another used
technical/biomed/1472-6882-1-10.txt:          vinegar as an alternative to the 'scratchy' pot. Another
technical/biomed/1472-6882-1-10.txt:          responsive to even the slightest external stimulus and
technical/biomed/1472-6882-1-10.txt:          considered to have supernatural owners who require such
technical/biomed/1472-6882-1-10.txt:          nocturnal and enter water when chased [ 5 ] . They are
technical/biomed/1472-6882-1-10.txt:          are nocturnal, living in hollow fallen trees during the
technical/biomed/1472-6882-1-10.txt:          ] . Alternatively, the catecholamines released as a
technical/biomed/1472-6882-1-10.txt:          medicinal plants since supernatural emic can occasionally
technical/biomed/1472-6882-1-10.txt:          snakebites and externally for foot inflammation in
technical/biomed/1472-6882-1-10.txt:          external wounds in Perú and Indonesia [ 77 78 ] . The
technical/biomed/1472-6882-1-10.txt:          diuretic infusions and to treat external ulcers and local
technical/biomed/1472-6882-1-10.txt:          Cuna and Chocó Indians for various external ailments and
technical/biomed/1472-6882-1-10.txt:          decoction is used in Columbia in external baths for
technical/biomed/1472-6882-1-10.txt:          Piper species to remove external
technical/biomed/1472-6882-1-10.txt:          external baths of 
technical/biomed/1472-6882-1-10.txt:          leaf infusion is used externally for skin disorders [ 107
technical/biomed/1472-6882-1-10.txt:        internal and external parasites. Plant baths with species
technical/biomed/1472-6882-1-11.txt:        reduces cell death [ 11 ] , or alternatively, depletion of
technical/biomed/1472-6882-1-12.txt:        The popularity of complementary, alternative and
technical/biomed/1472-6882-1-12.txt:        alternative medical (CAM) practices. A recent commentary in
technical/biomed/1472-6882-1-12.txt:        the Archives of Internal Medicine (vol. 156, pp. 2162-2164)
technical/biomed/1472-6882-1-12.txt:        and measures simple components of internal validity. [ 15 ]
technical/biomed/1472-6882-1-12.txt:        No information about external validity, generalizability,
technical/biomed/1472-6882-1-12.txt:          homoeopathy, homoeopathy, and alternative medicine and
technical/biomed/1472-6882-1-12.txt:          are recognized journals in conventional medicine publish
technical/biomed/1472-6882-1-12.txt:          New England Journal of Medicine and
technical/biomed/1472-6882-1-12.txt:          Journal of the American Medical
technical/biomed/1472-6882-1-12.txt:          the top two journals in conventional medical research
technical/biomed/1472-6882-1-12.txt:          aspect of study design is assessed with two internal
technical/biomed/1472-6882-1-12.txt:          articles published in peer-reviewed journals. Twelve
technical/biomed/1472-6882-1-12.txt:          studies were published in 22 different journals, although
technical/biomed/1472-6882-1-12.txt:          British Homoeopathic Journal . Most
technical/biomed/1472-6882-1-12.txt:          (Figure 1) Especially high were problems with external
technical/biomed/1472-6882-1-12.txt:          conventional medicine. Surprisingly, internal validity
technical/biomed/1472-6882-1-12.txt:        alternative practice. Critical systematic review of these
technical/biomed/1472-6882-1-7.txt:        alternative therapies, indicating dissatisfaction, or
technical/biomed/1472-6882-1-7.txt:          Fiberblend) (AIM International, Nampa, ID), with
technical/biomed/1472-6882-1-7.txt:        have any financial interests in AIM, International.
technical/biomed/1472-6882-2-10.txt:          laboratory maternal tubs and assigned to one of five
technical/biomed/1472-6882-2-10.txt:        to EtOH reduces testosterone levels as well as maternal
technical/biomed/1472-6882-3-1.txt:        International Federation of Manual Medicine has stated:
technical/biomed/1472-6882-3-1.txt:        journals [ 10 11 12 ] and textbooks [ 13 14 15 16 17 18 19
technical/biomed/1472-6882-3-1.txt:          for Complementary and Alternative Medicine (University of
technical/biomed/1472-6882-3-1.txt:          a peer-reviewed journal; 4) the document could be written
technical/biomed/1472-6882-3-1.txt:          studies, publications in all languages, journal articles
technical/biomed/1472-6882-3-1.txt:          denote internal validity and quality of a study were
technical/biomed/1472-6882-3-1.txt:          the internal validity, taking into consideration biases
technical/biomed/1472-6882-3-1.txt:          of author(s) and journal were removed). The quality
technical/biomed/1472-6882-3-1.txt:          indicated its quality in terms of its internal validity
technical/biomed/1472-6882-3-1.txt:          methodological issues pertinent toward internal validity
technical/biomed/1472-6882-3-1.txt:          review, the articles were blinded to journal, title and
technical/biomed/1472-6882-3-1.txt:          different journals and the fifth study included is a
technical/biomed/1472-6882-3-1.txt:        rectify this problem. The International Federation of
technical/biomed/1472-6882-3-1.txt:        Manual Medicine (FIMM), an international organization of
technical/biomed/1472-6882-3-1.txt:        model may not have external validity when applied to human
technical/biomed/1472-6882-3-3.txt:        The increasing research in Complementary and Alternative
technical/biomed/1472-6882-3-3.txt:        Center for Complementary and Alternative Medicine (NCCAM)
technical/biomed/1472-6882-3-3.txt:        Alternative Medicine [ 8 ] .
technical/biomed/1472-6882-3-3.txt:        Alternative Medicine see 
technical/biomed/1472-6882-3-3.txt:        Alternative Medicine was implemented in
technical/biomed/1472-6882-3-3.txt:        Health Literature [ 11 ] and MANTIS - Manual, Alternative
technical/biomed/1472-6882-3-3.txt:        areas other than complementary and alternative medicine. A
technical/biomed/1472-6882-3-3.txt:          for Complementary and Alternative Medicine (University of
technical/biomed/1472-6882-3-3.txt:          study published in a peer reviewed journal in any
technical/biomed/1472-6890-1-4.txt:        membrane/external anal sphincter.
technical/biomed/1472-6890-1-4.txt:          g for 10 min at 4°C. Supernatants
technical/biomed/1472-6890-2-5.txt:          T-cell antigens relative to an internal
technical/biomed/1472-6890-3-2.txt:        as hybridization efficiency. Additionally/alternatively,
technical/biomed/1472-6890-3-2.txt:        an alternative to the use of FISH assays that require
technical/biomed/1472-6904-1-2.txt:        ether, centrifuged, and the supernatant evaporated. The
technical/biomed/1472-6904-1-2.txt:            An alternative analysis using Tamhane's procedure,
technical/biomed/1472-6904-2-4.txt:          without a breakfast) or IV on alternate days.
technical/biomed/1472-6904-2-5.txt:          i = external input to organ i
technical/biomed/1472-6904-3-1.txt:          in PKQuest, a number of alternative options are allowed
technical/biomed/1472-6920-1-3.txt:        instructional format (such as "Journal Club"), research has
technical/biomed/1472-6920-1-3.txt:            online journals, and journal clubs. The computers had a
technical/biomed/1472-6920-1-3.txt:            not use usernames and passwords to track individual
technical/biomed/1472-6920-1-3.txt:            that the Internal Medicine course focused on how to
technical/biomed/1472-6920-1-3.txt:          contributions of the Internal Medicine and Family
technical/biomed/1472-6920-1-3.txt:          sequence of rotations that placed both their Internal
technical/biomed/1472-6920-1-3.txt:        Neither of the two Internal Medicine courses nor the
technical/biomed/1472-6920-1-3.txt:        1999-2000 Internal Medicine course in conjunction with the
technical/biomed/1472-6920-1-3.txt:        negative impact of "journal clubs" [ 6 7 ] . Possibly,
technical/biomed/1472-6920-1-3.txt:        Clerkship Directors in Internal Medicine, Annual Meeting,
technical/biomed/1472-6920-2-1.txt:          measure of internal consistency is the best measure of
technical/biomed/1472-6920-2-1.txt:        internal consistency, of the overall OSCE was good at .86.
technical/biomed/1472-6920-2-3.txt:        contribution of individual countries to selected journals [
technical/biomed/1472-6920-2-3.txt:        countries contribute to the most prestigious journals in
technical/biomed/1472-6920-2-3.txt:        education journals determined by their impact factor was
technical/biomed/1472-6920-2-3.txt:          Medical education journals and their impact
technical/biomed/1472-6920-2-3.txt:          In the 1999 Journal Citation Reports-Science Edition [
technical/biomed/1472-6920-2-3.txt:          12 ] 13 journals were listed in the subject category
technical/biomed/1472-6920-2-3.txt:          Medical Education with 0.958. All the remaining journals
technical/biomed/1472-6920-2-3.txt:          also journals like the Journal of Biological Education -
technical/biomed/1472-6920-2-3.txt:          IF of 0.574. Out of these 13 journals only Academic
technical/biomed/1472-6920-2-3.txt:          Nineteen journals were listed in PubMed under the MeSH
technical/biomed/1472-6920-2-3.txt:          journals were predecessors of some of the remaining 14
technical/biomed/1472-6920-2-3.txt:          journals, e.g. the British Journal of Medical Education
technical/biomed/1472-6920-2-3.txt:          journals were listed in PubMed throughout the whole
technical/biomed/1472-6920-2-3.txt:          Journal Citation Reports-Science Edition [ 12 ] .
technical/biomed/1472-6920-2-3.txt:          Journal selection
technical/biomed/1472-6920-2-3.txt:          journals with the highest impact factor in the field of
technical/biomed/1472-6920-2-3.txt:          in a given journal [ 15 ] . The impact factor is not
technical/biomed/1472-6920-2-3.txt:          of scientific journals [ 16 ] .
technical/biomed/1472-6920-2-3.txt:          the "Journal" field. The search included the years from
technical/biomed/1472-6920-2-3.txt:          Date" field, respectively. Finally journal article was
technical/biomed/1472-6920-2-3.txt:          each entry was retrieved for each journal in each year.
technical/biomed/1472-6920-2-3.txt:          journal. If more than one country was listed in the
technical/biomed/1472-6920-2-3.txt:        From 1995 to 2000 2207 journal articles were published
technical/biomed/1472-6920-2-3.txt:        in Academic Medicine and 746 journal articles were
technical/biomed/1472-6920-2-3.txt:        articles per year increased for both journals (Fig. 1). The
technical/biomed/1472-6920-2-3.txt:        year of the investigated period of time to the journal
technical/biomed/1472-6920-2-3.txt:        publications in the two leading medical education journals
technical/biomed/1472-6920-2-3.txt:        journals were studied. Authors from all over the world
technical/biomed/1472-6920-2-3.txt:        extent in Academic Medicine, but both journals were
technical/biomed/1472-6920-2-3.txt:        leading journals of this field and found that the UK was
technical/biomed/1472-6920-2-3.txt:        the most productive country in one journal and that the USA
technical/biomed/1472-6920-2-3.txt:        both journals together. This is in accordance with our
technical/biomed/1472-6920-2-3.txt:        Academic Medicine (87.5%) and both journals together
technical/biomed/1472-6920-2-3.txt:        journals with minor fluctuations.
technical/biomed/1472-6920-2-3.txt:        some of the articles resulting from international
technical/biomed/1472-6920-2-3.txt:        this study when we consider the nature of most journal
technical/biomed/1472-6920-2-3.txt:        medical education are not only found in journals dedicated
technical/biomed/1472-6920-2-3.txt:        to this field, but also in other journals, e.g. general and
technical/biomed/1472-6920-2-3.txt:        internal medicine journals. Also contributions about the
technical/biomed/1472-6920-2-3.txt:        specialty journals, for example articles about the teaching
technical/biomed/1472-6920-2-3.txt:        of anatomy in the Journal of Anatomy. Moreover some
technical/biomed/1472-6920-2-3.txt:        countries have journals of medical education in their own
technical/biomed/1472-6920-2-3.txt:        Information. Some journals are included in other
technical/biomed/1472-6920-2-3.txt:        international databases but not in Medline. Furthermore it
technical/biomed/1472-6920-2-3.txt:        local or regional journals that are not listed in Medline.
technical/biomed/1472-6920-2-3.txt:        representation of these journals in Medline is further
technical/biomed/1472-6920-2-3.txt:        disappearance of Latin American journals from Medline [ 4 ]
technical/biomed/1472-6920-2-3.txt:        international journals [ 5 ] . For biomedical disciplines
technical/biomed/1472-6920-2-3.txt:        these "highly cited, international" journals are probably
technical/biomed/1472-6920-2-3.txt:        is the official journal of the World Federation for Medical
technical/biomed/1472-6920-2-3.txt:        Education and has therefore an important international
technical/biomed/1472-6920-2-3.txt:        journal of the Association of American Medical Colleges.
technical/biomed/1472-6920-2-3.txt:        Hence the organizations represented by both journals could
technical/biomed/1472-6920-2-3.txt:        American authors, especially when remembering that journals
technical/biomed/1472-6920-2-3.txt:        origin of the journal itself than from elsewhere [ 9 ]
technical/biomed/1472-6920-2-3.txt:        originating from the UK appeared in British journals [ 9 ]
technical/biomed/1472-6920-2-3.txt:        One could argue, that a journal is more likely to accept
technical/biomed/1472-6920-2-3.txt:        policy and the scientific rigor of these journals can't be
technical/biomed/1472-6920-2-3.txt:        medical journal showing that the acceptance rate for
technical/biomed/1472-6920-2-3.txt:        distribution in the two investigated journals. On the other
technical/biomed/1472-6920-2-3.txt:        rates of these two journals are not known to us. Further we
technical/biomed/1472-6920-2-3.txt:        European based journals [ 25 ] . They repeatedly referred
technical/biomed/1472-6920-2-3.txt:        of selecting the right journal has an influence. It was
technical/biomed/1472-6920-2-3.txt:        of journals open to them [ 25 ] . Therefore manuscripts
technical/biomed/1472-6920-2-3.txt:        internationally known general medical journals like the BMJ
technical/biomed/1472-6920-2-3.txt:        overlooking the speciality journals [ 25 ] . In the case of
technical/biomed/1472-6920-2-3.txt:        send to general medical journals while researchers are not
technical/biomed/1472-6920-2-3.txt:        aware of the speciality journals in this field like
technical/biomed/1472-6920-2-3.txt:        their work in the local journals to reach the audience in
technical/biomed/1472-6920-2-3.txt:        international journal, it could happen that their results
technical/biomed/1472-6920-2-3.txt:        and also scarce library resources. Some journals have
technical/biomed/1472-6920-2-3.txt:        discriminating advertisers, journals always have to work
technical/biomed/1472-6920-2-3.txt:        journals in such a direction [ 25 ] . This hindrance should
technical/biomed/1472-6920-2-3.txt:        be swept away by the appearance of e-journals like the
technical/biomed/1472-6920-2-3.txt:        Providing free access to journals for the poorer
technical/biomed/1472-6920-2-3.txt:        which are not aware of the variety of journals open to
technical/biomed/1472-6920-2-3.txt:        postal services. Further journals should try to remove
technical/biomed/1472-6920-2-3.txt:        leading international medical journals.
technical/biomed/1472-6920-2-3.txt:        leading medical education journals was investigated.
technical/biomed/1472-6920-2-3.txt:        contributing countries, both journals are dominated by
technical/biomed/1472-6920-2-3.txt:        these two journals.
technical/biomed/1472-6947-1-2.txt:          alternative explanation (referred to as "x out of 100")
technical/biomed/1472-6947-1-5.txt:        International Society for Telemedicine
technical/biomed/1472-6947-1-5.txt:        scope from this study) from the International Network of
technical/biomed/1472-6947-1-5.txt:        telemedicine journals, 
technical/biomed/1472-6947-1-5.txt:        Journal of Telemedicine and
technical/biomed/1472-6947-1-5.txt:        Telemedicine Journal (recently
technical/biomed/1472-6947-1-5.txt:        Telemedicine Journal and e-Health ),
technical/biomed/1472-6947-1-5.txt:        journal editors exhibit restraint when considering
technical/biomed/1472-6947-1-6.txt:        certain physical findings, or alternatively the ability to
technical/biomed/1472-6947-2-4.txt:        International Conference on Management of Engineering and
technical/biomed/1472-6947-2-4.txt:        summary presented in proceedings, Portland International
technical/biomed/1472-6947-2-4.txt:        International Conference on Management of Engineering and
technical/biomed/1472-6947-2-7.txt:        get care they need, or alternatively do get care they do
technical/biomed/1472-6947-2-7.txt:          international standards for exchange of data, medicine
technical/biomed/1472-6947-2-7.txt:          reporting. Most organizations report externally for both
technical/biomed/1472-6947-2-7.txt:          had a hysterectomy [ 17 ] . Internally, organizations
technical/biomed/1472-6947-3-5.txt:        informaticians, commercial tissue repositories, and journal
technical/biomed/1472-6947-3-5.txt:        to journal submissions. This means that researchers will
technical/biomed/1472-6947-3-5.txt:        capture method, and the schema for internal storage. The
technical/biomed/1472-6947-3-8.txt:          ICD-O (International Classification of Diseases -
technical/biomed/1472-6955-2-1.txt:        practical alternative to mercury filled thermometer
technical/biomed/1472-6955-2-1.txt:        non-mucus temperature sites may be safe alternatives to
technical/biomed/1472-6955-2-1.txt:          may be a good alternative to rectal site temperature
technical/biomed/1472-6955-2-1.txt:          extreme international need.
technical/biomed/1472-6963-1-8.txt:          diagnoses codes assigned using the International
technical/biomed/1472-6963-3-11.txt:        10 ] Alternatively, patients can be sent customized
technical/biomed/1472-6963-3-12.txt:          International Classification of Diseases 9 thRevision
technical/biomed/1472-6963-3-13.txt:          or other external information. The protocol was
technical/biomed/1472-6963-3-13.txt:          When an alternative definition of accuracy (estimates
technical/biomed/1472-6963-3-13.txt:        inaccuracy for low-risk scenarios. However, alternate
technical/biomed/1472-6963-3-13.txt:        Fernandez acted as site supervisors for data collection and
technical/biomed/1472-6963-3-14.txt:        EBM? What are the alternatives to EBM? What is the
technical/biomed/1472-6963-3-14.txt:        relationship between EBM and the alternative approaches to
technical/biomed/1472-6963-3-14.txt:        its alternatives in light of a different philosophical
technical/biomed/1472-6963-3-14.txt:        the alternatives. The Quinean metaphor helps us to
technical/biomed/1472-6963-3-14.txt:          similarly vacuous - as if any alternative to EBM means
technical/biomed/1472-6963-3-14.txt:          alternative approaches is important and can change
technical/biomed/1472-6963-3-14.txt:          alternative approaches to medical practice will also take
technical/biomed/1472-6963-3-14.txt:          about the external world face the tribunal of sense
technical/biomed/1472-6963-3-14.txt:          Application to EBM and the alternatives
technical/biomed/1472-6963-3-14.txt:            concerning alternative medicine should be weighed and
technical/biomed/1472-6963-3-14.txt:            of alternative medicinal therapies, then we evaluate
technical/biomed/1472-6963-3-14.txt:            EBM and the other alternatives
technical/biomed/1472-6963-3-14.txt:            reliable than the alternatives. We are inclined to
technical/biomed/1472-6963-3-14.txt:        its alternatives in terms of Quine's metaphor of the web of
technical/biomed/1472-6963-3-7.txt:          code (Table 1) using International Classification of
technical/biomed/1472-6963-3-7.txt:          discernable event cost for renal transplant versus the
technical/biomed/1472-6963-3-7.txt:        ICD-9 - International Classification of Diseases
technical/biomed/1475-2832-1-1.txt:            of administration. The GDS has high internal
technical/biomed/1475-2832-1-1.txt:        Alternatively, this may simply reflect the fact that in our
technical/biomed/1475-2832-1-1.txt:        depressive symptoms. Alternatively, distress responses to
technical/biomed/1475-2867-2-15.txt:        because of alternative splicing and differential promoter
technical/biomed/1475-2867-2-15.txt:          incubated with the supernatants for 1 hour at 4°C.
technical/biomed/1475-2867-2-7.txt:        suppressor genes RB and BRCA2, transcriptional factors (RNA
technical/biomed/1475-2867-2-7.txt:        factors, such as RNA helicase A and STAT1 [ 15 16 ] .
technical/biomed/1475-2867-3-12.txt:          RT-PCR of polysome and total RNA specific for
technical/biomed/1475-2867-3-12.txt:          PP1α expression and activity, we analyzed the RNA levels
technical/biomed/1475-2867-3-12.txt:          uninduced cells, only endogenous PP1α RNA can be found
technical/biomed/1475-2867-3-12.txt:          some 6His-HA-PP1α RNA can be detected in the total RNA,
technical/biomed/1475-2867-3-12.txt:          the majority PP1α RNA detected in the total preparation
technical/biomed/1475-2867-3-12.txt:          more 6His-HA-PP1α RNA associated with polysomes than
technical/biomed/1475-2867-3-12.txt:          present at the same level in the total RNA preparation
technical/biomed/1475-2867-3-12.txt:          RNA association with polysomes suggest that
technical/biomed/1475-2867-3-12.txt:        transcription or RNA processing. Using a similar approach
technical/biomed/1475-2867-3-12.txt:        of analyzing mRNA association with ribosomes as a measure
technical/biomed/1475-2867-3-12.txt:        control also appears to exist for PP1α. If mRNA association
technical/biomed/1475-2867-3-12.txt:        doxycycline-induced cells, 6His-HA-PP1α RNA is more
technical/biomed/1475-2867-3-12.txt:        transcription or RNA processing, we cannot rule out the
technical/biomed/1475-2867-3-12.txt:        exists. Indeed, the abundance of endogenous PP1α RNA found
technical/biomed/1475-2867-3-12.txt:        combined abundance of endogenous and 6His-HA-PP1α RNA
technical/biomed/1475-2867-3-12.txt:          RT-PCR analyses of PP1α mRNA
technical/biomed/1475-2867-3-12.txt:          with doxycycline. For total RNA experiments, RNA was
technical/biomed/1475-2867-3-12.txt:          Qiagen RNeasy mini-kit. Polysome RNA was recovered from
technical/biomed/1475-2867-3-12.txt:          RNA was quantitated by UV spectrometry. 1 ug total RNA
technical/biomed/1475-2867-3-12.txt:          (or 200 ng polysome RNA) was used in first strand cDNA
technical/biomed/1475-2867-3-2.txt:        Most eukaryotic mRNAs are translated through a
technical/biomed/1475-2867-3-2.txt:        expression of eIF4E by expressing antisense RNA reverses
technical/biomed/1475-2867-3-2.txt:        protein and corresponds to activation of the p27 Kip1mRNA
technical/biomed/1475-2867-3-2.txt:          enhances cyclin D1 mRNA transport from the nucleus to the
technical/biomed/1475-2867-3-2.txt:          alter p27 Kip1mRNA levels but decreases cyclin D1 mRNA
technical/biomed/1475-2867-3-2.txt:          mRNA levels were examined by Northern blotting (Fig.
technical/biomed/1475-2867-3-2.txt:          4Aand 4B) There was no difference in mRNA levels encoding
technical/biomed/1475-2867-3-2.txt:          levels of cyclin D1 mRNA (Fig. 4B). This may contribute
technical/biomed/1475-2867-3-2.txt:          cyclin D1 mRNA in cells overexpressing eIF4E [ 26 ] .
technical/biomed/1475-2867-3-2.txt:          significantly affect protein turnover or mRNA levels
technical/biomed/1475-2867-3-2.txt:          Since no changes in p27 Kip1mRNA levels or protein
technical/biomed/1475-2867-3-2.txt:          mRNA levels (see Fig. 4). Interestingly, total protein
technical/biomed/1475-2867-3-2.txt:          translation of specific classes of mRNA than on general
technical/biomed/1475-2867-3-2.txt:          translation. One possibility is that the p27 Kip1mRNA is
technical/biomed/1475-2867-3-2.txt:          of the mouse p27 Kip1mRNA is able to mediate
technical/biomed/1475-2867-3-2.txt:          acetyltransferase (CAT), is proximal to the mRNA's cap
technical/biomed/1475-2867-3-2.txt:        mRNAs. Many of these mRNAs are involved in cell cycle
technical/biomed/1475-2867-3-2.txt:        "weak" mRNAs because they are translated inefficiently when
technical/biomed/1475-2867-3-2.txt:        mRNAs can more effectively recruit eIF4E and its associated
technical/biomed/1475-2867-3-2.txt:        in cyclin D1 mRNA levels and protein synthesis, since there
technical/biomed/1475-2867-3-2.txt:        be involved in export of cyclin D1 mRNA to the cytosol [ 25
technical/biomed/1475-2867-3-2.txt:        eIF4E, one consequence being a reduction in cyclin D1 mRNA
technical/biomed/1475-2867-3-2.txt:        Kip1mRNA has a long 5'-UTR that is 65% GC and is predicted
technical/biomed/1475-2867-3-2.txt:        "weak" mRNAs that require elevated eIF4E activity for
technical/biomed/1475-2867-3-2.txt:        coding regions in a bicistronic mRNA, the 5'-UTR stimulates
technical/biomed/1475-2867-3-2.txt:          supernatants were incubated with 50 μl of
technical/biomed/1475-2867-3-2.txt:          A portion of the supernatant was precipitated with TCA to
technical/biomed/1475-2867-3-3.txt:          Table 4. Of the antioxidant enzyme mRNAs measured, the
technical/biomed/1475-2867-3-3.txt:          only mRNA that differed significantly due to diet was the
technical/biomed/1475-2867-3-3.txt:        been defined in International Units. In addition to its
technical/biomed/1475-2867-3-3.txt:          RNA extraction and quantitative reverse
technical/biomed/1475-2867-3-3.txt:          nitrogen for RNA extraction. RNA was extracted by
technical/biomed/1475-2867-3-3.txt:          genomic DNA). Standard RNA was made for all assays by the
technical/biomed/1475-2867-3-3.txt:          RNA isolated from the mouse heart. The correlation
technical/biomed/1475-2867-3-3.txt:          was linear over at least a 5-log range of RNA for all
technical/biomed/1475-2867-3-3.txt:          differences in RNA concentration. Polymerase chain
technical/biomed/1475-2867-3-4.txt:        2. Alternatively, PMA treatment could initiate a cascade
technical/biomed/1475-2867-3-4.txt:        LS1034 cells. Alternatively, ethanol can modulate the
technical/biomed/1475-2867-3-4.txt:          centrifuged at 200 g for 30 seconds, the supernatant
technical/biomed/1475-2875-1-14.txt:        good news for international public health. Most public
technical/biomed/1475-2875-1-14.txt:        afford it. More attention is needed from the international
technical/biomed/1475-2875-1-14.txt:        International, a international NGO with a country office in
technical/biomed/1475-2875-1-5.txt:        interfering RNA (siRNA) molecules has been recently used to
technical/biomed/1475-2875-1-5.txt:        ablate specific mRNAs and thus, produce phenotypic
technical/biomed/1475-2875-1-5.txt:        this technology to knockdown specific gene products in RNA
technical/biomed/1475-2875-1-5.txt:          designed on the basis of the PlasmoDB-predicted mRNA
technical/biomed/1475-2875-1-5.txt:          total mRNA as template. Based on the prediction, primers
technical/biomed/1475-2875-1-5.txt:          on the assumption that the 3'-end of the mRNA might be
technical/biomed/1475-2875-1-5.txt:          using RNAi
technical/biomed/1475-2875-1-5.txt:          RNA interference (RNAi), mediated by short interfering
technical/biomed/1475-2875-1-5.txt:          double-stranded RNA molecules (siRNA or dsRNA), is now
technical/biomed/1475-2875-1-5.txt:          21-nucleotide long synthetic dsRNA molecules
technical/biomed/1475-2875-1-5.txt:          corresponding to specific mRNA sequences effectively and
technical/biomed/1475-2875-1-5.txt:          specifically degraded the cognate mRNAs and abrogated the
technical/biomed/1475-2875-1-5.txt:          dsRNA did not produce an appreciable loss of PfPP1. We
technical/biomed/1475-2875-1-5.txt:          6clearly demonstrates loss of PfPP1 by the RNAi
technical/biomed/1475-2875-1-5.txt:          schizont) (data not shown) and that the effect of dsRNA
technical/biomed/1475-2875-1-5.txt:          Plasmodium , the mRNA of which was
technical/biomed/1475-2875-1-5.txt:          RNAi strategy to ablate dihydroorotate dehydrogenase
technical/biomed/1475-2875-1-5.txt:          DHODH mRNA was confirmed by RT-PCR. This resulted in
technical/biomed/1475-2875-1-5.txt:          double-stranded RNA by electroporation also, using
technical/biomed/1475-2875-1-5.txt:          mechanism of the RNA uptake remains to be elucidated, the
technical/biomed/1475-2875-1-5.txt:          electroporation procedure must have allowed the dsRNA to
technical/biomed/1475-2875-1-5.txt:          difficult. The dsRNA, in contrast, is known to be
technical/biomed/1475-2875-1-5.txt:          PfPP1. Moreover, RNAi will permit the ablation of
technical/biomed/1475-2875-1-5.txt:          believe that the RNAi strategy will become a powerful and
technical/biomed/1475-2875-1-5.txt:        Indeed, the successful use of RNA interference to ablate
technical/biomed/1475-2875-1-5.txt:          Total RNA was isolated from asynchronous 
technical/biomed/1475-2875-1-5.txt:          Transfection by inhibitory dsRNA
technical/biomed/1475-2875-1-5.txt:          The following 21-mer RNA molecules, corresponding to
technical/biomed/1475-2875-1-5.txt:          The negative control luciferase RNA was the same as
technical/biomed/1475-2875-1-5.txt:          the double-stranded GL3 RNA described previously [ 17 ] .
technical/biomed/1475-2875-1-5.txt:          The RNAs were annealed 
technical/biomed/1475-2875-1-5.txt:          RNA (dsRNA) [ 18 ] and electroporation was carried out
technical/biomed/1475-2875-1-5.txt:          essentially as described [ 32 ] . In brief, 3 μg dsRNA in
technical/biomed/1475-2875-1-5.txt:          electroporated without RNA. The cells were then grown in
technical/biomed/1475-2875-2-10.txt:          the outcomes of interest. To increase internal validity,
technical/biomed/1475-2875-2-10.txt:        The main alternate model for changing shopkeeper
technical/biomed/1475-2875-2-10.txt:        USAID United States Agency for International
technical/biomed/1475-2875-2-14.txt:          Sigma, St Louis, MO. Biosource International, Rockville,
technical/biomed/1475-2875-2-14.txt:          After 24 h, total RNA was extracted from the flasks using
technical/biomed/1475-2875-2-14.txt:          RNA-STAT 60 as previously described [ 7 ] . The
technical/biomed/1475-2875-2-14.txt:          fluorescently labeled cRNA, hybridization, staining, and
technical/biomed/1475-2875-2-14.txt:          clusters and genes (including controls). RNA (10 μg)
technical/biomed/1475-2875-2-14.txt:          illicit a calcium response shows that the external media
technical/biomed/1475-2875-2-14.txt:          to influx from an external source. The subsequent ability
technical/biomed/1475-2875-2-14.txt:          can only be due to entry from an external source, as it
technical/biomed/1475-2875-2-14.txt:          external calcium (Figure 4). We next investigated the
technical/biomed/1475-2875-2-14.txt:          change in the levels of λ-tubulin mRNA (Table 2, Figure
technical/biomed/1475-2875-2-14.txt:        Alternatively, some ER-active agents (e.g. ryanodine)
technical/biomed/1475-2875-2-14.txt:        from an external source. Thapsigargin blocked both the
technical/biomed/1475-2875-2-14.txt:        from an external source. Mefloquine also induced a
technical/biomed/1475-2875-2-4.txt:        recourse to alternative methods. Appropriate selection of a
technical/biomed/1475-2875-2-4.txt:          purchased from Gibco BRL (Rockville, Maryland). RNA-STAT
technical/biomed/1475-2875-2-4.txt:          and total RNA extraction
technical/biomed/1475-2875-2-4.txt:          removed and replaced with 15.0 ml RNA STAT (Tel-Test,
technical/biomed/1475-2875-2-4.txt:          Friendswood Texas). Total RNA was then extracted
technical/biomed/1475-2875-2-4.txt:          of RNA samples (eight control and eight treated samples)
technical/biomed/1475-2875-2-4.txt:          fluorescently labeled cRNA, hybridization, staining, and
technical/biomed/1475-2875-2-4.txt:          including controls). RNA (10 μg) extracted from each
technical/biomed/1475-2875-2-4.txt:            expression of RNA for tubulin (negative control) and
technical/biomed/1475-2875-2-4.txt:            RNA was transcribed in a 20 μl reaction using the
technical/biomed/1475-2875-2-4.txt:            manufacturer's instructions. cDNA was RNase-treated ( 
technical/biomed/1475-2875-2-4.txt:            E. coli RNAse H at 37°C for 20
technical/biomed/1475-2875-2-4.txt:        in vitro and large amounts of RNA can
technical/biomed/1475-2875-2-4.txt:        observed in specific mRNA transcript levels were due to the
technical/biomed/1475-2883-2-11.txt:          100 fg of internal control plasmid [ 9 ] (generously
technical/biomed/1475-2883-2-11.txt:          distilled water without internal control was used as a
technical/biomed/1475-2883-2-11.txt:          probes specific for wild type or internal control
technical/biomed/1475-2883-2-11.txt:          DNA, but with 100 fg of internal control [ 8 ] . The
technical/biomed/1475-2883-2-11.txt:          controls were run with and without 100 fg of internal
technical/biomed/1475-2883-2-11.txt:          internal control and 
technical/biomed/1475-2883-2-11.txt:          internal control and DNA extracted from a pool of 15
technical/biomed/1475-2883-2-11.txt:          probe or internal control. Positive controls exhibited a
technical/biomed/1475-2883-2-11.txt:        quality assurance methods may provide an alternative
technical/biomed/1475-2891-1-2.txt:          rac-5,7-dimethyl tocol as an internal standard. The
technical/biomed/1475-2891-1-2.txt:          rac-5,7-dimethyl tocol internal standard was found to be
technical/biomed/1475-2891-1-2.txt:          is typically used as an internal standard. After
technical/biomed/1475-4924-1-10.txt:            Ptc1 mRNA levels in 
technical/biomed/1475-4924-1-10.txt:          gain-of-function Smo mutant. Thus we introduce a ternary
technical/biomed/1475-4924-1-10.txt:          receptors [ 29 ] . The ternary complex model for Hh
technical/biomed/1475-4924-1-10.txt:          Thus, we propose a variation of the classic 'ternary
technical/biomed/1475-4924-1-10.txt:          apparent in a ternary complex model. The ideas proposed
technical/biomed/1475-4924-1-10.txt:          complex from forming. Alternatively, Ptc could more
technical/biomed/1475-4924-1-10.txt:          alternative to an expensive Hh-protein therapeutic.
technical/biomed/1475-4924-1-10.txt:          library synthesized by Oxford Asymmetry International,
technical/biomed/1475-4924-1-10.txt:          Company, Meriden, USA) or harvested for RNA isolation
technical/biomed/1475-4924-1-10.txt:          using an RNA isolation kit (Qiagen; Valencia, USA). RNA
technical/biomed/1475-4924-1-10.txt:          supernatants were incubated for 40-60 minutes with either
technical/biomed/1475-4924-1-10.txt:          minutes at 4°C. Supernatants were discarded and the
technical/biomed/1475-4924-1-5.txt:          Our dataset is derived from RNA samples taken from
technical/biomed/1475-4924-1-5.txt:          experiments contained RNA from males and from females,
technical/biomed/1475-4924-1-5.txt:          the source of the RNA used in that hybridization. In
technical/biomed/1475-925X-2-1.txt:        presents an alternative approach to this issue.
technical/biomed/1475-925X-2-10.txt:        developing and validating the International [ 1 ] and
technical/biomed/1475-925X-2-10.txt:        An alternative to color photography is scanning laser
technical/biomed/1475-925X-2-10.txt:          defined by the International Grading System) at random
technical/biomed/1475-925X-2-10.txt:          International Classification System [ 1 ] . This method
technical/biomed/1475-925X-2-10.txt:        by stereo Grader 1, who used the International
technical/biomed/1475-925X-2-10.txt:        measurements fell into the range in the International
technical/biomed/1475-925X-2-10.txt:        needed about five minutes to grade by the International
technical/biomed/1475-925X-2-10.txt:        the widely used International Classification System, with a
technical/biomed/1475-925X-2-3.txt:        Sustained muscular contractions externally associated
technical/biomed/1475-925X-2-6.txt:        assume a static magnetic field, an alternative approach is
technical/biomed/1475-9268-1-1.txt:          genomic DNA and meiotic mRNA, respectively. In each case,
technical/biomed/1475-9268-1-1.txt:          the product from mRNA was shorter than that from genomic
technical/biomed/1475-9268-1-1.txt:          alternative outcomes of a common intermediate [ 11 ] .
technical/biomed/1475-9268-1-1.txt:          As an alternative (but not mutually exclusive)
technical/biomed/1475-9268-1-1.txt:          Rec12 is available at the right time. Alternatively, some
technical/biomed/1475-9268-1-1.txt:          meiotic induction. Genomic DNA and total RNA were
technical/biomed/1475-9268-1-1.txt:          rec12 +mRNA levels were as
technical/biomed/1475-9268-1-2.txt:        only steadfast association remains maternal age [ 1 2 ] .
technical/biomed/1475-9276-1-3.txt:        population and maternal and child health. Funded primarily
technical/biomed/1475-9276-1-3.txt:        by the United States Agency for International Development
technical/biomed/1475-9276-1-3.txt:        (USAID), DHS is administered by Macro International Inc. [
technical/biomed/1475-9276-1-3.txt:        20 ] . Low-income country governments and international
technical/biomed/1475-9276-1-3.txt:        variety of child and maternal health and family planning
technical/biomed/1475-9276-1-3.txt:        internationally comparable data on the demographic and
technical/biomed/1475-9276-1-3.txt:        the population earning less than one international dollar
technical/biomed/1475-9276-1-3.txt:        should seek further external validation of these results,
technical/biomed/1475-9276-1-3.txt:        these surveys, their premature death (from maternal or
technical/biomed/1475-9276-1-3.txt:        greater in countries with higher maternal mortality and
technical/biomed/1475-9276-1-3.txt:        authorities internationally, and even ongoing changes in
technical/biomed/1475-9276-1-3.txt:        national and international public policy as a result. All
technical/biomed/1476-069X-1-3.txt:          alternately reduced or increased the outdoor air supply.
technical/biomed/1476-069X-2-2.txt:        with changes in the sex ratio we looked at both maternal
technical/biomed/1476-069X-2-2.txt:        and paternal serum PCB levels in a cohort from the Great
technical/biomed/1476-069X-2-2.txt:          data). Because of the uncertainty in changes in maternal
technical/biomed/1476-069X-2-2.txt:          of a child should not alter paternal serum PCB
technical/biomed/1476-069X-2-2.txt:          analysis both maternal and paternal PCB levels were
technical/biomed/1476-069X-2-2.txt:          analyses were run for maternal and paternal exposure, and
technical/biomed/1476-069X-2-2.txt:          parents were included in both maternal and paternal
technical/biomed/1476-069X-2-2.txt:          samples - primarily data on maternal parity, which was
technical/biomed/1476-069X-2-2.txt:        our sample, as well as a decrease in this ratio as maternal
technical/biomed/1476-069X-2-2.txt:        adjusting for the year of the child's birth, paternal and
technical/biomed/1476-069X-2-2.txt:        maternal age at the child's birth, the mother's parity, and
technical/biomed/1476-069X-2-2.txt:        CI: 0.06-0.59). When maternal serum PCB concentration was
technical/biomed/1476-069X-2-2.txt:        0.33-0.89). We saw no effect of paternal serum PCB
technical/biomed/1476-069X-2-2.txt:        pattern of effects of both maternal and paternal serum PCB
technical/biomed/1476-069X-2-2.txt:        simultaneously adjusting for maternal and paternal PCB
technical/biomed/1476-069X-2-2.txt:        between paternal PCB exposure and odds of a male child when
technical/biomed/1476-069X-2-2.txt:        aOR for a male child with increasing maternal PCB exposure
technical/biomed/1476-069X-2-2.txt:        The relation between maternal PCB exposure and odds of a
technical/biomed/1476-069X-2-2.txt:        male child was robust to revision of maternal serum PCB
technical/biomed/1476-069X-2-2.txt:        increasing maternal PCB exposure. The only case in which
technical/biomed/1476-069X-2-2.txt:        paternal serum PCB concentration based on the toxicokinetic
technical/biomed/1476-069X-2-2.txt:        model led to some categories of paternal exposure having
technical/biomed/1476-069X-2-2.txt:        paternal PCB concentration.
technical/biomed/1476-069X-2-2.txt:        Our data suggest that maternal exposure to PCBs before
technical/biomed/1476-069X-2-2.txt:        suggestion in our data that some levels of paternal
technical/biomed/1476-069X-2-2.txt:        in our analysis, the paternal PCB concentrations were
technical/biomed/1476-069X-2-2.txt:        report for maternal exposure, those mothers who did not
technical/biomed/1476-069X-2-2.txt:        been found following paternal exposure to the nematocide
technical/biomed/1476-069X-2-2.txt:        dibromochloropropane [ 23 24 ] . Paternal, but not
technical/biomed/1476-069X-2-2.txt:        maternal, exposure to dioxin following an explosion at an
technical/biomed/1476-069X-2-2.txt:        Vietnam, paternal dioxin levels greater than 10 ppt were
technical/biomed/1476-069X-2-2.txt:        48 ] . In the latter study, however, maternal dioxin levels
technical/biomed/1476-069X-2-2.txt:        be above background), and the paternal levels were likely
technical/biomed/1476-069X-2-2.txt:        dichotomous measure of maternal serum PCB concentration and
technical/biomed/1476-069X-2-2.txt:        the quintiles of maternal serum PCB concentrations (fig.
technical/biomed/1476-069X-2-2.txt:        child as a function of maternal exposure.
technical/biomed/1476-069X-2-2.txt:        reported that maternal consumption of contaminated sport
technical/biomed/1476-069X-2-2.txt:        results for maternal exposure were quite robust to changes
technical/biomed/1476-069X-2-2.txt:        considered that an association between higher maternal PCB
technical/biomed/1476-069X-2-2.txt:        rapid excretion of maternal PCBs in some way not related to
technical/biomed/1476-069X-2-2.txt:        Our data suggest that maternal exposure to PCBs may
technical/biomed/1476-069X-2-2.txt:        suggestion that paternal exposure to PCBs may increase the
technical/biomed/1476-069X-2-2.txt:        maternal and paternal exposure. Although the overall
technical/biomed/1476-069X-2-4.txt:        International Energy Conservation Code (IECC 2000) levels
technical/biomed/1476-069X-2-4.txt:          1.11). Alternatively, using pollution data from the start
technical/biomed/1476-069X-2-4.txt:          the potential magnitude of externalities avoided in
technical/biomed/1476-069X-2-4.txt:          externalities averted through increased insulation amount
technical/biomed/1476-069X-2-4.txt:          environmental externalities and cost savings.
technical/biomed/1476-069X-2-4.txt:        about the relative merits of alternative energy efficiency
technical/biomed/1476-069X-2-4.txt:        First, if the environmental externalities represent the
technical/biomed/1476-069X-2-4.txt:        benefits might therefore dominate externality estimates.
technical/biomed/1476-069X-2-4.txt:        that alternative sulfate toxicities would strongly
technical/biomed/1476-069X-2-4.txt:        CALPUFF and an alternative dispersion model were applied [
technical/biomed/1476-069X-2-4.txt:        alternative scenarios without extensive simulations. The
technical/biomed/1476-069X-2-4.txt:        IECC 2000 - International Energy Conservation Code, year
technical/biomed/1476-069X-2-7.txt:        maternal self-report or birth certificate data for the
technical/biomed/1476-069X-2-7.txt:        reliability of information on maternal pre- and gravid
technical/biomed/1476-069X-2-7.txt:          maternal fish consumption status. Health insurance and
technical/biomed/1476-069X-2-7.txt:          consistent with most hospital records: maternal and
technical/biomed/1476-069X-2-7.txt:          included duration of maternal fish consumption in four
technical/biomed/1476-069X-2-7.txt:          and birth defects) and maternal characteristics (i.e.,
technical/biomed/1476-069X-2-7.txt:          four categories) of maternal sport fish consumption was
technical/biomed/1476-069X-2-7.txt:        A description of the sample by maternal fish consumption
technical/biomed/1476-069X-2-7.txt:        maternal fish consumption (data not shown). Mothers in the
technical/biomed/1476-069X-2-7.txt:        Birth Size Measures by Duration of Maternal Fish
technical/biomed/1476-069X-2-7.txt:        measures of birth size by maternal fish consumption and
technical/biomed/1476-069X-2-7.txt:        between duration of maternal consumption of fish from Lake
technical/biomed/1476-069X-2-7.txt:        maternal report and focuses exclusively on fish consumed
technical/biomed/1476-069X-2-7.txt:        maternal consumption of marine sport fish on gestation or
technical/biomed/1476-069X-2-7.txt:        associated with a maternal diet low in marine fish [ 43 ] .
technical/biomed/1476-069X-2-7.txt:        association between maternal sport fish consumption and
technical/biomed/1476-069X-2-7.txt:        key reasons: (1) the absence of maternal serum for
technical/biomed/1476-069X-2-7.txt:        who agreed to participation. Our exposure is maternally
technical/biomed/1476-069X-2-7.txt:        the uncertainty regarding the relation between maternal
technical/biomed/1476-069X-2-9.txt:        and the International Agency for Research on Cancer. [ 12
technical/biomed/1476-069X-2-9.txt:        alternative chemicals. It is not OSHA's intention to force
technical/biomed/1476-069X-2-9.txt:        depth of information about each case and internal validity.
technical/biomed/1476-069X-2-9.txt:            cleaning might be an acceptable alternative to
technical/biomed/1476-069X-2-9.txt:            alternatives; the company president did not express
technical/biomed/1476-069X-2-9.txt:            than invest in alternative technology for the remaining
technical/biomed/1476-069X-2-9.txt:            The company began to look into alternatives out of
technical/biomed/1476-069X-2-9.txt:            Management has told workers to rest and to "alternate
technical/biomed/1476-069X-2-9.txt:          seek out an alternative to methylene chloride. Two
technical/biomed/1476-069X-2-9.txt:        with inadequate information about alternatives.
technical/biomed/1476-069X-2-9.txt:        alternatives. The Toxics Use Reduction Institute Surface
technical/biomed/1476-069X-2-9.txt:        Massachusetts firms in finding alternatives and
technical/biomed/1476-069X-2-9.txt:        information on alternatives. Efforts could be targeted to
technical/biomed/1476-0711-2-3.txt:        to originate from the internal surface or the hub of the
technical/biomed/1476-0711-2-3.txt:        take samples only from the external surfaces of catheters
technical/biomed/1476-0711-2-3.txt:        and may not retrieve organisms from the internal surfaces
technical/biomed/1476-0711-2-3.txt:        external and internal surfaces of the catheters and
technical/biomed/1476-0711-2-7.txt:        admitted to the Internal Medicine ward and prescribed
technical/biomed/1476-0711-2-7.txt:        admitted to the Internal Medicine ward who were prescribed
technical/biomed/1476-0711-2-7.txt:        most commonly prescribed antibiotics in the Internal
technical/biomed/1476-0711-2-7.txt:        the Internal Medicine ward were prescribed antibiotics
technical/biomed/1476-0711-2-7.txt:        the 10 most commonly used antibiotics in the Internal
technical/biomed/1476-0711-2-7.txt:        days, the number of beds in the Internal Medicine ward was
technical/biomed/1476-0711-2-7.txt:        Among patients admitted to the Internal Medicine ward,
technical/biomed/1476-0711-2-7.txt:        Internal Medicine ward. The isolated organisms are becoming
technical/biomed/1476-0711-2-7.txt:        use of sulfonamides in the Internal Medicine ward. Urine
technical/biomed/1476-0711-2-7.txt:        problem in the Internal Medicine ward of our hospital. We
technical/biomed/1476-0711-2-7.txt:        department of Internal Medicine. We are working to develop
technical/biomed/1476-072X-2-3.txt:          autocorrelation). The working (alternative) hypothesis is
technical/biomed/1476-4598-1-3.txt:        RNA component of telomerase (mTERC) exhibit progressive
technical/biomed/1476-4598-1-3.txt:          Microdissection, DNA and RNA isolation and LOH
technical/biomed/1476-4598-1-3.txt:          described earlier [ 26 ] . Total RNA was isolated from
technical/biomed/1476-4598-1-3.txt:          Total RNA isolated from the cell lines was reverse
technical/biomed/1476-4598-1-5.txt:          supernatants from 6 different NSCLC cell lines producing
technical/biomed/1476-4598-1-5.txt:          supernatants were assayed for IL10 by ELISA
technical/biomed/1476-4598-1-5.txt:          specific cell type was not discernable from available
technical/biomed/1476-4598-1-5.txt:          supernatant was evaluated at 24 hr for basal production
technical/biomed/1476-4598-1-5.txt:          × 24 hr. Supernatants were assayed for PGE-2 by ELISA
technical/biomed/1476-4598-1-5.txt:          supernatant of cells cultured × 24 hr in RPMI complete
technical/biomed/1476-4598-1-6.txt:        Mitochondrial DNA encodes two rRNA, 22 tRNA and 13
technical/biomed/1476-4598-1-6.txt:          supernatants were read at 532 nm. Concentrations of
technical/biomed/1476-4598-1-6.txt:          Total RNA was extracted from exponentially growing
technical/biomed/1476-4598-1-6.txt:          cells with Trizol. Precipitated RNA was resuspended in
technical/biomed/1476-4598-1-6.txt:          5 μg experimental RNAs and 1 μl alignment control RNA
technical/biomed/1476-4598-1-6.txt:          RNAs were identified by Incyte Genomics clone
technical/biomed/1476-4598-1-6.txt:          Trizol reagent (In Vitrogen) was used to isolate RNA
technical/biomed/1476-4598-1-6.txt:          instuction. One and half micrograms of total RNA was
technical/biomed/1476-4598-1-6.txt:          reverse transcribed using Superscript II Rnase H -reverse
technical/biomed/1476-4598-1-6.txt:          mRNA level between the Rho 0cell line and parental Rho
technical/biomed/1476-4598-1-6.txt:        0cell lines. TFIIH is associated with the RNA polymerase II
technical/biomed/1476-4598-1-8.txt:          levels of mRNA expression by RT-PCR but expression was
technical/biomed/1476-4598-1-8.txt:          other cell lines did not show detectable levels of mRNA.
technical/biomed/1476-4598-1-8.txt:        mRNA levels in most of the methylated tumors. Thus in these
technical/biomed/1476-4598-1-8.txt:        mRNA in GCT, we wanted to test whether hypomethylation
technical/biomed/1476-4598-1-8.txt:          or cell pellets were utilized for DNA and/or RNA
technical/biomed/1476-4598-1-8.txt:          been previously described [ 8 ] . DNA and RNA isolated
technical/biomed/1476-4598-1-8.txt:          Semi-quantitative analysis of mRNA
technical/biomed/1476-4598-1-8.txt:          To assess gene expression, total RNA isolated from
technical/biomed/1476-4598-1-8.txt:          polyA+ RNA of testis obtained from Clontech (Palo Alto,
technical/biomed/1476-4598-1-8.txt:          expression was similarly assessed on total RNA isolated
technical/biomed/1476-4598-1-8.txt:        tumors, and isolation of genomic DNA and RNA. Author 3 (MM)
technical/biomed/1476-4598-2-1.txt:          weak (1+). These results lead us to find an alternative
technical/biomed/1476-4598-2-2.txt:        taken. One was to see if the ATM mRNA is properly
technical/biomed/1476-4598-2-2.txt:        ATM mRNA based on the published cDNA sequence (Genbank
technical/biomed/1476-4598-2-2.txt:        designing strategy is shown in Fig 3. ATM mRNA is
technical/biomed/1476-4598-2-2.txt:        control cells. The mRNA was isolated from these cells and
technical/biomed/1476-4598-2-2.txt:        translated from ATM mRNA and expressed in the
technical/biomed/1476-4598-2-2.txt:          Cell culture, RNA isolation, reverse transcription
technical/biomed/1476-4598-2-2.txt:          ] . The total RNA was isolated from the cultured cells
technical/biomed/1476-4598-2-2.txt:          using Trizol RNA isolation kit (GBCOL-BRL, Besthesda,
technical/biomed/1476-4598-2-20.txt:          PAI-1 RNA levels in MDA-MB-231 cells [ 19 ] . TGFβ
technical/biomed/1476-4598-2-20.txt:          PTHrP and, to a lesser extent, PAI-1 mRNA levels (Fig.
technical/biomed/1476-4598-2-20.txt:          RNA from the same cell suspension that was used to
technical/biomed/1476-4598-2-20.txt:          upa mRNAs were induced upon TGFβ
technical/biomed/1476-4598-2-20.txt:          c-myc RNA and confirmed these
technical/biomed/1476-4598-2-20.txt:          smad7 mRNA was basically unaffected
technical/biomed/1476-4598-2-20.txt:          pai-1 mRNA was reduced to
technical/biomed/1476-4598-2-20.txt:        protein. TGFβ-induced stabilization of the mRNA may also be
technical/biomed/1476-4598-2-20.txt:        shown also to stabilize the mRNA of the 
technical/biomed/1476-4598-2-20.txt:        stabilization of RNA does not play a major role in
technical/biomed/1476-4598-2-20.txt:        inhibit Ese-1/Esx-expression. Alternatively, inhibitory
technical/biomed/1476-4598-2-20.txt:        However, TGFβ downregulated Ese-1/Esx mRNA levels faster
technical/biomed/1476-4598-2-20.txt:        in breast cancer cells, the Ese-1/Esx mRNA is downregulated
technical/biomed/1476-4598-2-20.txt:          Isolation of total RNA and synthesis of cDNA were
technical/biomed/1476-4598-2-20.txt:          guidlines. To determine the relative RNA levels of a
technical/biomed/1476-4598-2-20.txt:          T value of a reference RNA (18S rRNA).
technical/biomed/1476-4598-2-20.txt:          18S rRNA forward 5'
technical/biomed/1476-4598-2-22.txt:        +veT cells directly. An alternative explanation is that
technical/biomed/1476-4598-2-24.txt:          in CC, we assessed the levels of mRNA by
technical/biomed/1476-4598-2-24.txt:          evidence of decreased mRNA nor any effect of
technical/biomed/1476-4598-2-24.txt:          RASSF1A mRNA. Two of three cell
technical/biomed/1476-4598-2-24.txt:        RARB mRNA is down regulated in a
technical/biomed/1476-4598-2-24.txt:          cell pellets were utilized for isolating DNA and/or RNA
technical/biomed/1476-4598-2-24.txt:          24 hours or a combination of both. Total RNA isolated
technical/biomed/1476-4598-2-24.txt:          from treated and untreated cell lines, and the total RNA
technical/biomed/1476-4598-2-24.txt:          and poly A +RNA from normal cervix obtained from Ambion
technical/biomed/1476-4598-2-24.txt:          mesenchymal cell expression were used as internal
technical/biomed/1476-4598-2-25.txt:        presence or absence of human recombinant VEGF 165. RNAs
technical/biomed/1476-4598-2-25.txt:          of total RNA isolated from ECs grown in 3D collagen
technical/biomed/1476-4598-2-25.txt:          hrs (Fig. 2E). Equal loading of RNAs was confirmed by
technical/biomed/1476-4598-2-25.txt:          alternatively spliced products or related genes. Clone
technical/biomed/1476-4598-2-25.txt:          quantity and integrity of the loaded RNA, detecting a
technical/biomed/1476-4598-2-25.txt:          by GeneCalling (a mRNA profiling technique) and 
technical/biomed/1476-4598-2-25.txt:          involved in precise transcription by RNA polymerase II,
technical/biomed/1476-4598-2-25.txt:          have several isoforms, alternatively sliced products,
technical/biomed/1476-4598-2-25.txt:          (Fig. 3K) mediates binding of aminoacyl-tRNAs to 80S
technical/biomed/1476-4598-2-25.txt:          aminoacyl-tRNAs. In addition, Translational elongation
technical/biomed/1476-4598-2-25.txt:          total RNA was extracted with TRIzol ®Reagent (Invitrogen
technical/biomed/1476-4598-2-25.txt:          Corp). Integrity of the RNA was determined by 1.2%
technical/biomed/1476-4598-2-25.txt:          agarose-formaldehyde gel electrophoresis. Poly(A) +mRNA
technical/biomed/1476-4598-2-25.txt:          was isolated from ~800 μg of total RNA using the
technical/biomed/1476-4598-2-25.txt:          FastTrack ®2.0 mRNA Isolation Kit (Invitrogen Corp) and
technical/biomed/1476-4598-2-25.txt:          primers and S UPERS CRIPTII™ RNase H -Reverse
technical/biomed/1476-4598-2-25.txt:          which was generated from total RNA by RT-PCR, as
technical/biomed/1476-4598-2-28.txt:        alternative signaling pathways in addition to the SMAD
technical/biomed/1476-4598-2-28.txt:        growth inhibition. Here, we demonstrate an alternate TGFβ 
technical/biomed/1476-4598-2-28.txt:        alternate pathway, as demonstrated above. Furthermore, this
technical/biomed/1476-4598-2-28.txt:        alternate pathway may explain the TGFβ 
technical/biomed/1476-4598-2-28.txt:        We demonstrate an alternate TGFβ 
technical/biomed/1476-4598-2-28.txt:          sec. at 4°C and 15,000 G. The supernatant was used to
technical/biomed/1476-4598-2-3.txt:          Increasing oncogene mRNA expression by RU
technical/biomed/1476-4598-2-3.txt:          remarkable 2.5-fold increase in the mRNA of JunB was
technical/biomed/1476-4598-2-3.txt:          increased the hepatic mRNA levels of the oncogene mdm2 by
technical/biomed/1476-4598-2-3.txt:          Decreasing Liver mRNA Levels of c-myc and p53 by
technical/biomed/1476-4598-2-3.txt:          In contrast to its effect on JunB and mdm2 mRNA
technical/biomed/1476-4598-2-3.txt:          and p53 mRNAs to comparable degrees (Fig 3). While mRNA
technical/biomed/1476-4598-2-3.txt:          of junB mRNA (Fig 2A). The protein product of this gene
technical/biomed/1476-4598-2-3.txt:          mRNA expression of both c-myc and p53 significantly (Fig
technical/biomed/1476-4598-2-3.txt:          hepatic levels of c-myc mRNA [ 10 ] , a proto-oncogene
technical/biomed/1476-4598-2-3.txt:          apoptosis, we concluded that the increase in c-myc mRNA
technical/biomed/1476-4598-2-3.txt:          Taken collectively, diminishing liver mRNA levels of both
technical/biomed/1476-4598-2-3.txt:          In addition to its effects on mRNA of c-myc and p53,
technical/biomed/1476-4598-2-3.txt:          to a downregulation of mdm2 protein, but not mRNA [ 29 ]
technical/biomed/1476-4598-2-3.txt:          . Consequently, the RU486-induced increase in mdm2 mRNA
technical/biomed/1476-4598-2-3.txt:          alternating 12 hours periods of light and darkness. Mice
technical/biomed/1476-4598-2-3.txt:          Hepatic RNA was extracted and quantified as we
technical/biomed/1476-4598-2-3.txt:          reported previously [ 10 ] . RNA was mixed with
technical/biomed/1476-511X-1-2.txt:          and DNA/RNA-binding.
technical/biomed/1476-511X-1-2.txt:          ADD1 mRNA, the murine homologue of human SREBP-1c. The
technical/biomed/1476-511X-1-2.txt:          HNF4α transcriptional activity. Alternatively, these
technical/biomed/1476-511X-1-2.txt:          not removed the night before, and since nocturnal mice
technical/biomed/1476-511X-1-2.txt:          consisting of equal amounts (2 μg) of total RNA from each
technical/biomed/1476-511X-1-2.txt:          independently extract a second set of RNA; these three
technical/biomed/1476-511X-1-2.txt:          n = 1) of 10 μg total hepatic RNA
technical/biomed/1476-511X-1-2.txt:          Hippocampal RNA was prepared as described above for
technical/biomed/1476-511X-1-2.txt:          hepatic RNA, except only 1 pooled control RNA sample from
technical/biomed/1476-511X-1-2.txt:          samples and four hippocampal RNA samples were hybridized
technical/biomed/1476-511X-1-2.txt:          All RNA samples were quantified with the RiboGreen RNA
technical/biomed/1476-511X-1-2.txt:          18S and 28S rRNA. All study samples were judged to
technical/biomed/1476-511X-1-2.txt:          contain sufficient amounts of high-quality RNA for
technical/biomed/1476-511X-1-2.txt:            cRNA preparation
technical/biomed/1476-511X-1-2.txt:            mouse liver RNA samples ( 
technical/biomed/1476-511X-1-2.txt:            diets, 15 μg pooled total RNA was the starting material
technical/biomed/1476-511X-1-2.txt:            In all cases, total RNA was converted to
technical/biomed/1476-511X-1-2.txt:            biotinylated cRNA, hybridized in the Affymetrix probe
technical/biomed/1476-511X-1-2.txt:            but using an oligo-dT primer containing a T7 RNA
technical/biomed/1476-511X-1-2.txt:            polymerase binding site. Labeled cRNA was prepared with
technical/biomed/1476-511X-1-2.txt:            cRNA (10 μg) was fragmented at 94°C for 35 min in
technical/biomed/1476-511X-1-2.txt:            cRNA in a 6X SSPE-T hybridization buffer (6X: 1M NaCl,
technical/biomed/1476-511X-1-2.txt:            washes in 0.5X SSPE-T at 50°C. Biotinylated cRNA was
technical/biomed/1476-511X-1-2.txt:            pooled RNA samples ( 
technical/biomed/1476-511X-2-2.txt:          5-α-cholestane (internal standard). The mixture was
technical/biomed/1476-511X-2-2.txt:          instrument delivers an alternating 800 μamp current at a
technical/biomed/1476-511X-2-2.txt:        be used as an alternative approach for monitoring these
technical/biomed/1476-511X-2-3.txt:          (visual axis is horizontal when the top of external
technical/biomed/1476-9433-1-2.txt:        CD28 activation stabilizes IL-2 mRNA transcripts,
technical/biomed/1476-9433-1-2.txt:        prolonging IL-2 mRNA life span [ 24 ] . Thus, in addition
technical/biomed/1476-9433-1-2.txt:          there is a wide range in the abundance classes of RNA
technical/biomed/1476-9433-1-2.txt:          Affymetrix. Briefly, total cellular RNA was prepared with
technical/biomed/1476-9433-1-2.txt:          Choice, Invitrogen). Biotin-labeled cRNA was prepared by
technical/biomed/1476-9433-1-2.txt:          and hybridization cocktails were prepared with 20 μg cRNA
technical/biomed/1476-9433-1-3.txt:          proliferation and the mRNA expression of TGF-β, TNF-α,
technical/biomed/1476-9433-1-3.txt:          Detection of mRNA by reverse transcription and
technical/biomed/1476-9433-1-3.txt:          Total RNA was isolated from lymphocytes isolated from
technical/biomed/1476-9433-1-3.txt:          System (Life Sciences, Invitrogen) and quality of RNA was
technical/biomed/1476-9433-1-3.txt:          verified by 260/280-nm ratio. 1 μg of RNA was reverse
technical/biomed/1476-9433-1-3.txt:            i) TGF-β mRNA
technical/biomed/1476-9433-1-3.txt:            ii) p21 mRNA expression
technical/biomed/1476-9433-1-3.txt:            iii) IL-6 and IL-10 mRNA
technical/biomed/1476-9433-1-3.txt:            mRNA expression in patients treated with TAC/MMF/Aza
technical/biomed/1476-9433-1-3.txt:            mRNA in patients treated with both TAC and SRL (0.84 ±
technical/biomed/1476-9433-1-3.txt:            Though an increase in IL-6 mRNA was observed in renal
technical/biomed/1476-9433-1-3.txt:            iv) TNF-α mRNA
technical/biomed/1476-9433-1-3.txt:            v) Cyclin mRNA expression
technical/biomed/1476-9433-1-3.txt:            The results of cyclins G and E mRNA expressed as
technical/biomed/1476-9433-1-3.txt:            decrease (p < 0.01) in Cyclin G mRNA in lymphocytes
technical/biomed/1476-9433-1-3.txt:            in Cyclin E mRNA was noted with TAC and SRL (0.2 ±
technical/biomed/1476-9433-1-3.txt:            mRNA expression correlates with the decreased
technical/biomed/1476-9433-1-3.txt:          Since we observed a significant increase in TGF-β mRNA
technical/biomed/1476-9433-1-3.txt:        Therefore there is need of an alternate strategy to use
technical/biomed/1476-9433-1-3.txt:        studied the mRNA expression of TGF-β, p21, IFN-γ, TNF-α,
technical/biomed/1476-9433-1-3.txt:        significant increase in TGF-β mRNA expression (p < 0.03)
technical/biomed/1476-9433-1-3.txt:        with TAC and SRL. The expression of p21 mRNA was also
technical/biomed/1476-9433-1-3.txt:        We noted an increased expression of IL-6 and IL-10 mRNA
technical/biomed/1476-9433-1-3.txt:        IL-10 mRNA expression.
technical/biomed/1476-9433-1-3.txt:        this study, we observed an increase in mRNA expression of
technical/biomed/1476-9433-1-3.txt:        intragraft IL-6 protein and mRNA production [ 27 ] .
technical/biomed/1476-9433-1-3.txt:        TAC and SRL increases expression of IL-6 mRNA in
technical/biomed/1476-9433-1-3.txt:        response. Also, mRNA expression of proinflammatory
technical/biomed/1477-5956-1-1.txt:        targets such as disease-specific RNAs [ 38 ] . We have also
technical/biomed/1477-7525-1-12.txt:        item responses, and internal consistency coefficients
technical/biomed/1477-7525-1-12.txt:        Cognitive Functioning were internally consistent in our
technical/biomed/1477-7525-1-9.txt:            with clinical status and quality of life. Internal
technical/biomed/1477-7827-1-13.txt:        for ER-alpha mRNA) failed to demonstrate estrogen receptor
technical/biomed/1477-7827-1-13.txt:        with advanced maternal age [ 29 30 ] . We have recently
technical/biomed/1477-7827-1-13.txt:          11000 × g for 20 min at 4°C. Supernatants were stored at
technical/biomed/1477-7827-1-13.txt:          the supernatants were resolved by SDS-PAGE. Cyclin E
technical/biomed/1477-7827-1-13.txt:          trophoblast cells, the third supernatant was the first to
technical/biomed/1477-7827-1-13.txt:          and DNase [ 42 ] . The supernatant was collected and the
technical/biomed/1477-7827-1-13.txt:          International, Naperville, Illinois). The slide chambers
technical/biomed/1477-7827-1-13.txt:          regeneration and expansion without maturation - maternal
technical/biomed/1477-7827-1-13.txt:          macrosomia in maternal diabetes; PT4A), or uncompensated
technical/biomed/1477-7827-1-13.txt:        females of advanced maternal age were reported to exhibit a
technical/biomed/1477-7827-1-13.txt:        in placental senescence or maternal diabetes, they may lead
technical/biomed/1477-7827-1-17.txt:        most common of which does not express mRNA encoding the PGF
technical/biomed/1477-7827-1-17.txt:        cell death than TNFα alone. Alternatively, IFNγ may
technical/biomed/1477-7827-1-17.txt:        for another death receptor, in which Fas mRNA expression
technical/biomed/1477-7827-1-17.txt:        is associated with a dramatic decrease in the mRNAs
technical/biomed/1477-7827-1-21.txt:        nuzzle scentmarks from the androgen-dependent suprasternal
technical/biomed/1477-7827-1-21.txt:          suprasternal gland of an unrelated male. The vial was
technical/biomed/1477-7827-1-21.txt:        suprasternal gland, accelerates ovarian follicular
technical/biomed/1477-7827-1-21.txt:        or alterations in metabolism and appetite. Alternatively,
technical/biomed/1477-7827-1-23.txt:        conceptus produced maternal recognition signal, estrogen,
technical/biomed/1477-7827-1-23.txt:        number of mRNAs hypothesized to be involved with early
technical/biomed/1477-7827-1-23.txt:          RNA.
technical/biomed/1477-7827-1-23.txt:          RNA Isolation
technical/biomed/1477-7827-1-23.txt:          Total RNA was extracted from individual conceptuses
technical/biomed/1477-7827-1-23.txt:          sterile tube, and 7 μl of Rnaid binding matrix (BIO 101,
technical/biomed/1477-7827-1-23.txt:          glass beads bound to total RNA was washed three times
technical/biomed/1477-7827-1-23.txt:          using 250 μl of 50% RNA wash (BIO 101, La Jolla, CA) and
technical/biomed/1477-7827-1-23.txt:          containing the purified total RNA was transferred to a
technical/biomed/1477-7827-1-23.txt:          sterile tube and stored at -80°C. Isolated RNA
technical/biomed/1477-7827-1-23.txt:          260 nm wavelength. Purity of RNA was determined from the
technical/biomed/1477-7827-1-23.txt:          Driver and tester cDNA was produced from 10 μg total RNA
technical/biomed/1477-7827-1-23.txt:          Fifty nanograms of total RNA were assayed for each sample
technical/biomed/1477-7827-1-23.txt:          ribosomal RNA was assayed as a normalization control to
technical/biomed/1477-7827-1-23.txt:          F1Fo-ATP synthase complex mRNA. Also, numerous
technical/biomed/1477-7827-1-23.txt:          during this transition. Several ribosomal RNA transcripts
technical/biomed/1477-7827-1-23.txt:          Messenger RNA expression profiles of SAHH, HSC70 and
technical/biomed/1477-7827-1-23.txt:          Based on normalization with 18S ribosomal RNA, SAHH
technical/biomed/1477-7827-1-23.txt:          mRNA expression was greater (P < 0.01) in filamentous
technical/biomed/1477-7827-1-23.txt:        expressed in filamentous conceptuses. Messenger RNA for
technical/biomed/1477-7827-1-23.txt:        increase in mRNA expression for OSU-T1-50 in tubular
technical/biomed/1477-7827-1-23.txt:        have previously shown the increase in maternal folate
technical/biomed/1477-7827-1-23.txt:        Establishment of the maternal-fetal interface is extremely
technical/biomed/1477-7827-1-27.txt:        is a storehouse of maternal proteins and mRNA required for
technical/biomed/1477-7827-1-27.txt:        mRNA decrease following oocyte maturation and ovulation [
technical/biomed/1477-7827-1-27.txt:        In order to identify maternal proteins present in the
technical/biomed/1477-7827-1-27.txt:        may represent a maternal stockpile of such folding
technical/biomed/1477-7827-1-27.txt:        hypothesis is that alternative folding of the chaperone
technical/biomed/1477-7827-1-31.txt:          changes in the GC internal milieu appear to modulate the
technical/biomed/1477-7827-1-36.txt:        been identified at the RNA level, often denoted as "ERβ B".
technical/biomed/1477-7827-1-36.txt:          and supernatants stored at -80°C until use [ 15 ] .
technical/biomed/1477-7827-1-36.txt:          the supernatants were resolved by SDS-PAGE. In parallel,
technical/biomed/1477-7827-1-43.txt:        set, known alternatively as NNT-1/BSF3 and CLF/CLC, also
technical/biomed/1477-7827-1-43.txt:        utilizes LIFR:gp130 as an alternative receptor complex for
technical/biomed/1477-7827-1-43.txt:        as an obligatory player in concert with the maternal GC
technical/biomed/1477-7827-1-43.txt:        gestation maternal steroid profile by maternal
technical/biomed/1477-7827-1-43.txt:        maternal GC surge impacts fetal well being in the absence
technical/biomed/1477-7827-1-43.txt:          initiation of the maternal surge [ 35 ] . Adrenalectomy
technical/biomed/1477-7827-1-43.txt:          International) or glial fibrillary acid protein (rabbit
technical/biomed/1477-7827-1-43.txt:          polyclonal anti-GFAP; Chemicon International). Antibody
technical/biomed/1477-7827-1-43.txt:          effects of the maternal GC surge on the fetus. The first
technical/biomed/1477-7827-1-43.txt:          approach toward manipulating the maternal GC surge was
technical/biomed/1477-7827-1-43.txt:          maternal adrenalectomy on E16.5, without further GC
technical/biomed/1477-7827-1-43.txt:          Thus, the impact of maternal adrenalectomy on the fetuses
technical/biomed/1477-7827-1-43.txt:          delivery and maternal culling, although they apparently
technical/biomed/1477-7827-1-43.txt:          growth plate in the untreated control and maternal
technical/biomed/1477-7827-1-43.txt:        in the absence of LIFR. Maternal adrenalectomy worsens the
technical/biomed/1477-7827-1-43.txt:        osteopenia, while maternal hormone suppression through
technical/biomed/1477-7827-1-43.txt:        There is a maternal GC surge beginning on E16.5, where
technical/biomed/1477-7827-1-43.txt:        with high surface tension. In addition, the maternal GC
technical/biomed/1477-7827-1-43.txt:        The timing of this maternal surge suggests that LIFR
technical/biomed/1477-7827-1-43.txt:        disrupted at the LIFR null maternal-fetal interface [ 31 ]
technical/biomed/1477-7827-1-43.txt:        . In that study, the maternal response to disorganized
technical/biomed/1477-7827-1-43.txt:        relative transport of RU486 or maternal mediators of fetal
technical/biomed/1477-7827-1-43.txt:        hormone balance upon adrenalectomy is unknown. Maternal
technical/biomed/1477-7827-1-43.txt:        the maternal GC surge. It likely had the effect of
technical/biomed/1477-7827-1-43.txt:        increasing maternal ACTH levels [ 42 ] that would, in turn,
technical/biomed/1477-7827-1-43.txt:        likely to be a reflection of maternal levels. An accurate
technical/biomed/1477-7827-1-43.txt:        surge, while maternal progesterone levels are declining in
technical/biomed/1477-7827-1-43.txt:        impact on maternal weight in late gestation. 0.3
technical/biomed/1477-7827-1-43.txt:        using maternal RU486 administration. Osteopenia is reduced,
technical/biomed/1477-7827-1-46.txt:          Supernatants were stored at -80°C. For western blot
technical/biomed/1477-7827-1-46.txt:          supernatant was diluted to 10 ml with blocking reagent
technical/biomed/1477-7827-1-46.txt:          interna (t, Fig. 1B), and mature granulosa cells (mg,
technical/biomed/1477-7827-1-46.txt:          interna (ti) showed more distinct LHR immunoreactivity,
technical/biomed/1477-7827-1-46.txt:          immunoreactivity was also detected in theca externa cells
technical/biomed/1477-7827-1-46.txt:          staining of theca interna, lack of LHR expression in
technical/biomed/1477-7827-1-46.txt:          intrauterine growth retardation and maternal diabetes [
technical/biomed/1477-7827-1-46.txt:        trimester, and elevated maternal midtrimester hCG is
technical/biomed/1477-7827-1-46.txt:        associated with higher rates of maternal and neonatal
technical/biomed/1477-7827-1-46.txt:        the ovary and testis via activation of alternative
technical/biomed/1477-7827-1-46.txt:        alternative second messenger pathways for the transmission
technical/biomed/1477-7827-1-46.txt:        in abnormal term placentae. Yet, elevated maternal
technical/biomed/1477-7827-1-48.txt:        the epididymis, where it is internalized and degraded by
technical/biomed/1477-7827-1-48.txt:          propidium iodide and 0.1% RNase. Control cells were
technical/biomed/1477-7827-1-48.txt:        bound and internalized by germ cells and it also modified
technical/biomed/1477-7827-1-54.txt:          To analyze the mRNA expression of 
technical/biomed/1477-7827-1-54.txt:          -80°C until RNA extraction was performed.
technical/biomed/1477-7827-1-54.txt:          RNA Extraction and Reverse Transcription-Polymerase
technical/biomed/1477-7827-1-54.txt:          RNA was extracted from LM samples using the Ambion
technical/biomed/1477-7827-1-54.txt:          al. [ 11 ] . Antisense and sense RNA probes generated
technical/biomed/1477-7827-1-54.txt:          with heat denatured RNA probes which had been diluted to
technical/biomed/1477-7827-1-54.txt:          before the supernatant was carefully removed. This was
technical/biomed/1477-7827-1-54.txt:          sperm-free, by microscopic examination. Supernatant was
technical/biomed/1477-7827-1-54.txt:          for 10 min, and the supernatant containing proteins was
technical/biomed/1477-7827-1-54.txt:          (or alternatively methanol) for 30 min and blocked for 60
technical/biomed/1477-7827-1-54.txt:          SPAM1 mRNA is Present in the Epididymal Epithelium
technical/biomed/1477-7827-1-54.txt:          SPAM1 mRNA is localized to the
technical/biomed/1477-7827-1-54.txt:          SPAM1 mRNA is synthesized in the
technical/biomed/1477-7827-1-54.txt:          can be seen (Fig. 3A). The mRNA was located predominantly
technical/biomed/1477-7827-1-54.txt:          cauda sections (F and G) serves as an internal control,
technical/biomed/1477-7827-1-54.txt:        SPAM1 mRNA expression is detected by
technical/biomed/1477-7827-1-54.txt:        SPAM1 mRNA is confined to the
technical/biomed/1477-7827-1-54.txt:        expression of the mRNA that is detectable with Northern
technical/biomed/1477-7827-1-6.txt:        That maternal undernutrition can affect fetal ovarian
technical/biomed/1477-7827-1-6.txt:        maternal oocytes were assessed for p53.
technical/biomed/1477-7827-1-6.txt:          Maternal blood samples were collected by jugular
technical/biomed/1477-7827-1-6.txt:          of ewes, fetuses, maternal and fetal ovaries, and
technical/biomed/1477-7827-1-6.txt:          surface of maternal ovaries. A small portion of luteal
technical/biomed/1477-7827-1-6.txt:          Fetal ovaries, corpora lutea, and maternal
technical/biomed/1477-7827-1-6.txt:          Sections of fetal and residual maternal ovarian
technical/biomed/1477-7827-1-6.txt:          Maternal plasma were assayed for progesterone [ 20 ]
technical/biomed/1477-7827-1-6.txt:        in maternal oocytes were not altered overall (irrespective
technical/biomed/1477-7827-1-6.txt:        Additional data relative to maternal ovaries and jugular
technical/biomed/1477-7827-1-6.txt:        Table 3. Weights of maternal ovaries and (dissected)
technical/biomed/1477-7827-1-6.txt:        Moreover, maternal nutrient restriction during the middle
technical/biomed/1477-7827-1-6.txt:        therefore appears that maternal ovaries are comparatively
technical/biomed/1477-7827-1-9.txt:        corona radiata), theca (interna and externa), and luteal
technical/biomed/1477-7827-1-9.txt:        mRNAs encoding several BMP family members have been
technical/biomed/1477-7827-1-9.txt:        BMP-4 and -7 mRNA have been identified in the theca
technical/biomed/1477-7827-1-9.txt:          made by RT-PCR. Total RNA from adult rat ovaries was
technical/biomed/1477-7827-1-9.txt:          Anti-sense and sense cRNA probes were prepared by means
technical/biomed/1477-7827-1-9.txt:          T7 RNA polymerase. Hybridization was carried out with the
technical/biomed/1477-7827-1-9.txt:          35S-labeled RNA probe (4-6 × 10 6cpm/ml) in a solution
technical/biomed/1477-7827-1-9.txt:          10 mM Tris (pH 8.2), 1 mM EDTA, 0.05% yeast tRNA, 10 mM
technical/biomed/1477-7827-1-9.txt:          and antisense cRNAs and exposed for the same time (4
technical/biomed/1477-7827-1-9.txt:          Expression of BMP-2 mRNA
technical/biomed/1477-7827-1-9.txt:          In adult rat ovaries, BMP-2 mRNA is highly expressed
technical/biomed/1477-7827-1-9.txt:          corpora lutea (CL) (Table 1, Fig. 1A,1B). BMP-2 mRNA is
technical/biomed/1477-7827-1-9.txt:          1). In the SIC, BMP-2 mRNA was constitutively expressed
technical/biomed/1477-7827-1-9.txt:          In the GC, BMP-2 mRNA is expressed in a precise
technical/biomed/1477-7827-1-9.txt:          As folliculogenesis progressed, BMP-2 mRNA expression
technical/biomed/1477-7827-1-9.txt:          secondary follicles. The expression of GC BMP-2 mRNA was
technical/biomed/1477-7827-1-9.txt:          heterogeneous. In preantral follicles, BMP-2 mRNA
technical/biomed/1477-7827-1-9.txt:          high levels of BMP-2 mRNA (Fig. 1F,1G). These findings
technical/biomed/1477-7827-1-9.txt:          highest levels of BMP-2 mRNA in the ovary were seen in
technical/biomed/1477-7827-1-9.txt:          BMP-2 mRNA expression in the dominant follicle was
technical/biomed/1477-7827-1-9.txt:          there was no detectable BMP-2 mRNA in the new CL-I during
technical/biomed/1477-7827-1-9.txt:          Expression of BMP-3 and -3b mRNA
technical/biomed/1477-7827-1-9.txt:          in the ovaries examined (data not shown). BMP-3 mRNA
technical/biomed/1477-7827-1-9.txt:          A strong expression of BMP-3b mRNA was seen in some
technical/biomed/1477-7827-1-9.txt:          cells (T) of the theca interna (TI) and externa (TE) of
technical/biomed/1477-7827-1-9.txt:          dominant follicles strongly expressed BMP-3b mRNA (Fig.
technical/biomed/1477-7827-1-9.txt:          the signal was reduced. In the CL-I, BMP-3b mRNA was
technical/biomed/1477-7827-1-9.txt:          BMP-3b mRNA was evident in degenerating CL (Table 1, Fig.
technical/biomed/1477-7827-1-9.txt:          mRNA expression was undetectable (Fig. 2H,2I).
technical/biomed/1477-7827-1-9.txt:          Expression of BMP-4 mRNA
technical/biomed/1477-7827-1-9.txt:          BMP-4 mRNA was expressed in a variety of ovary cell
technical/biomed/1477-7827-1-9.txt:          Fig. 3A,3B,3C). BMP-4 mRNA was constitutively expressed
technical/biomed/1477-7827-1-9.txt:          In the theca, the levels of BMP-4 mRNA change during
technical/biomed/1477-7827-1-9.txt:          BMP-4 mRNA was present at moderate levels in an outer
technical/biomed/1477-7827-1-9.txt:          adjacent to these cells (Fig. 3E,3F,3G). BMP-4 mRNA was
technical/biomed/1477-7827-1-9.txt:          BMP-4 mRNA was very low or undetectable in atretic
technical/biomed/1477-7827-1-9.txt:          follicles. High levels of BMP-4 mRNA continue to be
technical/biomed/1477-7827-1-9.txt:          high levels of BMP-4 mRNA while little or no BMP-4 mRNA
technical/biomed/1477-7827-1-9.txt:          Expression of BMP-6 mRNA
technical/biomed/1477-7827-1-9.txt:          BMP-6 mRNA was present in the oocytes, GC, CL, blood
technical/biomed/1477-7827-1-9.txt:          vascular system, BMP-6 mRNA was continuously expressed at
technical/biomed/1477-7827-1-9.txt:          circulation. BMP-6 mRNA showed relatively high expression
technical/biomed/1477-7827-1-9.txt:          The expression of BMP-6 mRNA in oocytes was
technical/biomed/1477-7827-1-9.txt:          mRNA in primordial and primary follicles (Table 1);
technical/biomed/1477-7827-1-9.txt:          High levels of BMP-6 mRNA were present in oocytes of all
technical/biomed/1477-7827-1-9.txt:          oocyte BMP-6 mRNA expression showed no obvious cyclic
technical/biomed/1477-7827-1-9.txt:          Like oocytes, BMP-6 mRNA was first detected in the GC
technical/biomed/1477-7827-1-9.txt:          follicles, only the membrana GC expressed BMP-6 mRNA,
technical/biomed/1477-7827-1-9.txt:          BMP-6 expression (Fig. 4E,4F). BMP-6 mRNA was not
technical/biomed/1477-7827-1-9.txt:          This loss of BMP-6 mRNA became evident soon after
technical/biomed/1477-7827-1-9.txt:          dominant follicles. The finding that BMP-6 mRNA is
technical/biomed/1477-7827-1-9.txt:          consistent with this idea. It is notable that BMP-6 mRNA
technical/biomed/1477-7827-1-9.txt:          Expression of BMP-7 mRNA
technical/biomed/1477-7827-1-9.txt:          mRNA was identified in the theca, CL and SC (Table 1and
technical/biomed/1477-7827-1-9.txt:          exhibited BMP-7 mRNA when the second layer of GC
technical/biomed/1477-7827-1-9.txt:          accompanied by increased BMP-7 mRNA expression which
technical/biomed/1477-7827-1-9.txt:          (Fig. 5D,5E). An intriguing feature of theca BMP-7 mRNA
technical/biomed/1477-7827-1-9.txt:          theca BMP-7 mRNA expression is just the opposite of BMP-4
technical/biomed/1477-7827-1-9.txt:          mRNA whose expression is limited to the outer half of the
technical/biomed/1477-7827-1-9.txt:          based on the BMP mRNAs that they expressed. As atresia
technical/biomed/1477-7827-1-9.txt:          occurs, BMP-7 mRNA is rapidly decreased to low or
technical/biomed/1477-7827-1-9.txt:          Following ovulation, BMP-7 mRNA was expressed in
technical/biomed/1477-7827-1-9.txt:          mRNA becomes undetectable. Thus, BMP-7 transcripts are
technical/biomed/1477-7827-1-9.txt:          Expression of BMP-15 mRNA
technical/biomed/1477-7827-1-9.txt:          BMP-15 mRNA expression was strictly germ cell specific
technical/biomed/1477-7827-1-9.txt:          6A,6B). BMP-15 mRNA was absent in oocytes of primordial
technical/biomed/1477-7827-1-9.txt:          expression of BMP-15 mRNA increased dramatically and very
technical/biomed/1477-7827-1-9.txt:          It is notable that the BMP-15 mRNA levels appeared to
technical/biomed/1477-7827-1-9.txt:          Expression of BMPR-IA mRNA
technical/biomed/1477-7827-1-9.txt:          The BMPR-IA mRNA was ubiquitously expressed in the
technical/biomed/1477-7827-1-9.txt:          The potential importance of oocyte BMPR-IA mRNA is
technical/biomed/1477-7827-1-9.txt:          primary follicle development the levels of BMPR-IA mRNA
technical/biomed/1477-7827-1-9.txt:          of the dominant follicle, BMPR-IA mRNA was abundantly
technical/biomed/1477-7827-1-9.txt:          BMPR-IA mRNA was highly expressed (Fig. 7I,7J).
technical/biomed/1477-7827-1-9.txt:          mRNA expression during folliculogenesis was similar to
technical/biomed/1477-7827-1-9.txt:          of BMPR-IA mRNA were expressed as it underwent
technical/biomed/1477-7827-1-9.txt:          luteinization and luteolysis. In the theca, BMPR-IA mRNA
technical/biomed/1477-7827-1-9.txt:          Expression of BMPR-IB mRNA
technical/biomed/1477-7827-1-9.txt:          The expression of BMPR-IB mRNA was strong in oocytes,
technical/biomed/1477-7827-1-9.txt:          at lower levels. In blood vessels, the BMPR-IB mRNA was
technical/biomed/1477-7827-1-9.txt:          a sharp increase in oocyte BMPR-IB mRNA expression
technical/biomed/1477-7827-1-9.txt:          follicle stage-specific shifts in BMPR-IB mRNA
technical/biomed/1477-7827-1-9.txt:          expression. BMPR-IB mRNA was first detected in some
technical/biomed/1477-7827-1-9.txt:          sharp increase in BMPR-IB mRNA expression in all the GC
technical/biomed/1477-7827-1-9.txt:          follicles strongly expressed BMPR-IB mRNA (Fig.
technical/biomed/1477-7827-1-9.txt:          continued to show high expression of BMPR-IB mRNA (Fig.
technical/biomed/1477-7827-1-9.txt:          There was a marked decrease in BMPR-IB mRNA following
technical/biomed/1477-7827-1-9.txt:          at DII 1100 h, the BMPR-IB mRNA is expressed in the TE
technical/biomed/1477-7827-1-9.txt:          Expression of BMPR-II mRNA
technical/biomed/1477-7827-1-9.txt:          BMPR-II mRNA, with the CL, SC, and the vascular
technical/biomed/1477-7827-1-9.txt:          (Table 1, Fig. 9C). There was no detectable BMPR-II mRNA
technical/biomed/1477-7827-1-9.txt:          BMPR-II mRNA within the cumulus GC (Fig. 9D,9E).
technical/biomed/1477-7827-1-9.txt:          levels of BMPR-II mRNA. During the life of the CL, low to
technical/biomed/1477-7827-1-9.txt:          endothelial cells (Fig. 9H). BMPR-II mRNA was strongly
technical/biomed/1477-7827-1-9.txt:          Expression of FS mRNA
technical/biomed/1477-7827-1-9.txt:          that a striking change in FS mRNA expression occurred in
technical/biomed/1477-7827-1-9.txt:          FS mRNA was absent during most of the cycle, but at P
technical/biomed/1477-7827-1-9.txt:          folliculogenesis, FS mRNA was poorly expressed in the GC.
technical/biomed/1477-7827-1-9.txt:          By comparison FS mRNA was highly expressed in all the GC
technical/biomed/1477-7827-1-9.txt:          10A,10B). Then, during atresia, FS mRNA was low or absent
technical/biomed/1477-7827-1-9.txt:          ovulation, the CL showed high levels of FS mRNA
technical/biomed/1477-7827-1-9.txt:          10F,10G,10H,10I,10J,10K). The high expression of FS mRNA
technical/biomed/1477-7827-1-9.txt:          new CL-I. Interestingly, FS mRNA fell to non-detectable
technical/biomed/1477-7827-1-9.txt:          (Fig. 10L,10M). FS mRNA remained undetectable in the CL
technical/biomed/1477-7827-1-9.txt:        theca interna of healthy follicles is composed of two
technical/biomed/1477-7827-1-9.txt:        of cells juxtaposed to the theca externa (TE), and another,
technical/biomed/1477-7827-1-9.txt:        the theca interna near the basal lamina of the follicle.
technical/biomed/1477-7827-1-9.txt:        the dramatic loss of BMP-6 mRNA in the GC when the DF is
technical/biomed/1477-7827-1-9.txt:        mRNA in GC. Thus, the secondary rise of FSH may down
technical/biomed/1478-1336-1-2.txt:          ng of β-galactosidase (β-gal) internal control plasmid
technical/biomed/1478-1336-1-2.txt:          RNA analysis. Cells were subcultured and incubated in
technical/biomed/1478-1336-1-2.txt:          overnight. Various ligands were added and total RNA was
technical/biomed/1478-1336-1-3.txt:        The mechanism by which SHRs affect the rate of RNA
technical/biomed/1478-1336-1-4.txt:        involved in RNA processing [ 9 ] . NR corepressors include
technical/biomed/1478-1336-1-4.txt:          alternate NR corepressor SMRT 
technical/biomed/1478-1336-1-4.txt:        cofactors. Alternatively, ERα and ERβ action at AP-1 sites
technical/biomed/1478-1336-1-4.txt:          ss34 rotor for 1 hour at 12,000 rpm. The supernatant was
technical/biomed/1478-7954-1-3.txt:        FOS using alternative statistical techniques can facilitate
technical/biomed/1478-7954-1-3.txt:        diabetes and CHD outcomes [ 25 ] ; alternative approaches
technical/biomed/ar104.txt:          T-helper (Th)1-type cytokines by inducing mRNA
technical/biomed/ar104.txt:        inducing mRNA degradation and upregulating the expression
technical/biomed/ar104.txt:        IL-10 stimulates degradation of TNF and IL-1β mRNAs [ 20].
technical/biomed/ar118.txt:          consider alternative explanations for the increased
technical/biomed/ar118.txt:          autoantigen is expressed in alternatively spliced forms,
technical/biomed/ar118.txt:        Therefore, it is reasonable to consider alternative
technical/biomed/ar118.txt:        alternatively spliced forms, which exhibit tissue-specific
technical/biomed/ar120.txt:          mRNAs expressed by individual CD4 +memory T cells in the
technical/biomed/ar120.txt:          Expression of mRNAs was analyzed in 152 individual
technical/biomed/ar120.txt:          patients in which T-cell receptor (TCR) Cβ mRNA was
technical/biomed/ar120.txt:          cytokine and activation marker mRNA in RA synovium are
technical/biomed/ar120.txt:          2-20% of cells expressed the other cytokine mRNAs.
technical/biomed/ar120.txt:          marker mRNAs were observed. Notably, no cells contained
technical/biomed/ar120.txt:          both IFN-γ and LT-α mRNAs, cytokines that are thought to
technical/biomed/ar120.txt:          Expression of cytokine and activation marker mRNAs was
technical/biomed/ar120.txt:          cells expressed both IFN-γ and LT-α mRNAs, even though
technical/biomed/ar120.txt:          with IFN-γ expression. Although IFN-γ and TNF-α mRNAs
technical/biomed/ar120.txt:          cells from RA patients, LT-α mRNA was not detected,
technical/biomed/ar120.txt:          express LT-α mRNA. The present studies indicate that the
technical/biomed/ar120.txt:          trafficking is unknown. The presence of LT-α mRNA in
technical/biomed/ar120.txt:          synovium until LT-α mRNA decreases.
technical/biomed/ar120.txt:          chemokine receptor mRNAs.
technical/biomed/ar120.txt:        chemokine receptor mRNAs.
technical/biomed/ar120.txt:          [Sigma], 5 U/ml PRIME RNase Inhibitor [5 Prime ?? 3 Prime
technical/biomed/ar120.txt:          Incorporated, Boulder, CO, USA], 300 U/ml RNAguard
technical/biomed/ar120.txt:          bp of the 3' end of each mRNA. The primers used were as
technical/biomed/ar120.txt:          after sorting, TCR Vβ mRNA was analyzed by single-cell
technical/biomed/ar120.txt:          Expressions of mRNAs were analyzed in 152 individual
technical/biomed/ar120.txt:          patients in which TCR Cβ mRNA was detected. Cytokine and
technical/biomed/ar120.txt:          cytokine and activation marker mRNA in RA synovium are
technical/biomed/ar120.txt:          2-20% of cells expressed the other mRNAs.
technical/biomed/ar120.txt:          marker mRNAs were observed. Notably, no cells contained
technical/biomed/ar120.txt:          mRNAs for both IFN-γ and LT-α, cytokines that are thought
technical/biomed/ar120.txt:          expressed CCR5, 39% CCRb, and 19% CCR7 mRNAs, whereas 16%
technical/biomed/ar120.txt:          expressed CXCR3 and 76% expressed CXCR4 mRNAs. The
technical/biomed/ar120.txt:          Expressions of cytokine and activation marker mRNAs
technical/biomed/ar120.txt:          that expressed cytokine and activation marker mRNA are
technical/biomed/ar120.txt:          cells expressed chemokine receptor mRNAs. Except for
technical/biomed/ar120.txt:        analyze cytokine mRNA expressions by unstimulated RA
technical/biomed/ar120.txt:        CD4 +memory T cells produced IFN-γ mRNA. Previous studies [
technical/biomed/ar120.txt:        CD4 +memory T cells expressed both IFN-γ and LT-α mRNA,
technical/biomed/ar120.txt:        both Th1 cytokine mRNAs can be expressed.
technical/biomed/ar120.txt:        IFN-γ expression. Although IFN-γ and TNF-α mRNAs were
technical/biomed/ar120.txt:        cells from RA patients, LT-α mRNA was not detected, whereas
technical/biomed/ar120.txt:        express LT-α mRNA. Previous studies have documented the
technical/biomed/ar120.txt:        presence of IFN-γ and IL-10 mRNA in circulating T cells of
technical/biomed/ar120.txt:        trafficking is unknown. The presence of LT-α mRNA in
technical/biomed/ar120.txt:        until LT-α mRNA decreases.
technical/biomed/ar120.txt:        cytokines and certain chemokine receptor mRNAs.
technical/biomed/ar130.txt:        been unrewarding, except for a report by Fernandez 
technical/biomed/ar130.txt:          anti-IgG1. Stro-1 is a culture supernatant, monoclonal
technical/biomed/ar130.txt:          for 20 min. The supernatant was discarded and
technical/biomed/ar130.txt:          days. Supernatants were taken at 5, 10, and 15 days and
technical/biomed/ar130.txt:          supernatants was estimated using a 
technical/biomed/ar130.txt:          Cell supernatants were assayed for AP activity in 50 mmol
technical/biomed/ar130.txt:          RNA was isolated from BMPCs cultured for 7-12 days
technical/biomed/ar130.txt:          USA). RNA was then used for the first-strand cDNA
technical/biomed/ar130.txt:          conditions to normalize for the amount of RNA. Reaction
technical/biomed/ar130.txt:          supernatants was measured (Fig. 7). The lowest
technical/biomed/ar130.txt:          13]. RT-PCR analysis for SDF-1 mRNA expression in two
technical/biomed/ar130.txt:        Therefore, the failure of Fernandez 
technical/biomed/ar130.txt:        immunoglobulin-producing cells [ 41]. SDF-1 mRNA is
technical/biomed/ar130.txt:        constitutive expression of SDF-1 mRNA in cultured BMPCs
technical/biomed/ar130.txt:        (Fig. 8) and as protein in supernatants from cultured BMPCs
technical/biomed/ar140.txt:        be altered by external stimuli [ 22]. A third possibility
technical/biomed/ar149.txt:        the capacity of supernatants from RA synovial stromal cells
technical/biomed/ar149.txt:          ng/ml TNF-α. To assess chemokine mRNA expression, cell
technical/biomed/ar149.txt:          in Trizol and stored at -80°C. Supernatants were
technical/biomed/ar149.txt:          Supernatants (550 μl) of cell lines cultured in various
technical/biomed/ar149.txt:          experiments, the supernatants were cultured with blocking
technical/biomed/ar149.txt:          RNA isolation and reverse transcriptase-polymerase
technical/biomed/ar149.txt:          RNA was extracted from SCLs and fibroblasts using
technical/biomed/ar149.txt:          instructions. Two micrograms of the extracted RNA was
technical/biomed/ar149.txt:          Supernatants of cell lines attract monocytes
technical/biomed/ar149.txt:          response to culture supernatants of RA and OA SCLs and
technical/biomed/ar149.txt:          fibroblasts was examined (Fig. 2). Supernatants of all
technical/biomed/ar149.txt:          P < 0.01). Those supernatants
technical/biomed/ar149.txt:          monocytes than the supernatants of the OA SCL and skin
technical/biomed/ar149.txt:          Chemokine mRNA production by cell lines
technical/biomed/ar149.txt:          Production of proinflammatory chemokine mRNA by the
technical/biomed/ar149.txt:          mRNAs, including MCP-1, IL-8, MIP-1α, MIP-1β, RANTES, and
technical/biomed/ar149.txt:          IP-10. OA SCL also expressed these same chemokine mRNAs
technical/biomed/ar149.txt:          expressed mRNAs for IL-8, MCP-1, and IP-10, but not
technical/biomed/ar149.txt:          Chemokines secreted into the culture supernatants of
technical/biomed/ar149.txt:          production and the capacity of supernatants to influence
technical/biomed/ar149.txt:          monocyte trafficking. Supernatants from RA SCLs
technical/biomed/ar149.txt:          inhibited monocyte migration by supernatants of RA SCLs
technical/biomed/ar149.txt:        The results of this study indicate that supernatants of
technical/biomed/ar149.txt:        [ 13]. Migration assays using supernatants of RA SCLs were
technical/biomed/ar149.txt:        indicate that supernatants of RA SCLs attract more
technical/biomed/ar149.txt:        monocytes than the supernatants of OA SCL and skin
technical/biomed/ar149.txt:        fibroblasts. This result suggests that the supernatants
technical/biomed/ar149.txt:        that these cells expressed MCP-1 and IL-8 mRNAs, and also
technical/biomed/ar149.txt:        some discrepancies between mRNA expression and protein
technical/biomed/ar149.txt:        production. From the mRNA expression, we expected RA SCLs
technical/biomed/ar149.txt:        According to previous reports, mRNAs of MCP-1, IL-8, and
technical/biomed/ar149.txt:        examine the chemokines in the supernatants of SCL that
technical/biomed/ar149.txt:        IL-8 accounted for the capacity of RA SCL supernatants to
technical/biomed/ar149.txt:        produce IP-10. Moreover, supernatants of TNF-α-stimulated
technical/biomed/ar149.txt:        supernatants.
technical/biomed/ar319.txt:          Alternatively, there might be two effects in the region,
technical/biomed/ar321.txt:        often accompanied by insufficiency of internal organs, such
technical/biomed/ar321.txt:          RNA preparation and northern blot analysis
technical/biomed/ar321.txt:          from 10 -9to 10 -6mol/l for 24 h. Total RNA was extracted
technical/biomed/ar321.txt:          Sunnyvale, CA) for mRNA quantitation.
technical/biomed/ar321.txt:          Effect of CPT on expression of COL1A2 mRNA
technical/biomed/ar321.txt:          The effect of CPT on COL1A2 steady-state mRNA levels
technical/biomed/ar321.txt:          mRNA expression levels in SSc and healthy control
technical/biomed/ar321.txt:          Note that GAPDH mRNA levels were not inhibited by CPT
technical/biomed/ar321.txt:          about 60% inhibition of COL1A2 mRNA levels in both SSc
technical/biomed/ar321.txt:          expression of collagen mRNA.
technical/biomed/ar321.txt:          treatment. Consistent with the mRNA data, the maximal
technical/biomed/ar321.txt:          mRNA levels (10 -8to 10 -6mol/l). This probably reflects
technical/biomed/ar321.txt:        The drug inhibited COL1A2 steady-state mRNA levels and
technical/biomed/ar321.txt:          RNA preparation and northern blot analysis
technical/biomed/ar321.txt:          -6mol/l for 24 h. Total RNA was extracted and analyzed by
technical/biomed/ar321.txt:          for mRNA quantitation. SSc and healthy dermal fibroblast
technical/biomed/ar321.txt:          RNA samples were analyzed together.
technical/biomed/ar328.txt:        international Groupe ORIS Cedex-France) using
technical/biomed/ar328.txt:        2 ) (International CIS Sorin, Paris,
technical/biomed/ar331.txt:        cycloheximide blocks mRNA expression of both collagenases [
technical/biomed/ar331.txt:        Second, the amount of total RNA required for microarray
technical/biomed/ar331.txt:        sustained inflammation. Alternatively, this was accompanied
technical/biomed/ar331.txt:          Harvest and microarray analysis of mRNA
technical/biomed/ar331.txt:          Reagent (Gibco/BRL), and RNA was purified in accordance
technical/biomed/ar331.txt:          with the manufacturer's instructions. The RNA pellets
technical/biomed/ar331.txt:          courier. Clontech analyzed the RNA using their Atlas
technical/biomed/ar331.txt:          assay. Briefly, RNA was treated with DNAse I and then 2
technical/biomed/ar331.txt:        Human Cancer 1.2 K Array and total RNA from SW1353 cells
technical/biomed/ar331.txt:        Levels of JunB mRNA peaked within 1 hour of IL-1
technical/biomed/ar331.txt:        robust increase in egr-1 mRNA within 1 hour of IL-1
technical/biomed/ar331.txt:        1). Thus, the relatively short half-life of egr-1 mRNA
technical/biomed/ar331.txt:        array using RNA from cells treated for 1 hour with IL-1
technical/biomed/ar331.txt:        Indeed, RT-PCR confirmed that MMP-13 mRNA continues to
technical/biomed/ar331.txt:        steady-state MMP-13 mRNA levels peak 12 hours after IL-1
technical/biomed/ar407.txt:        investigated both the distribution and the levels of mRNA
technical/biomed/ar407.txt:          Cell culture, RNA quantification and western blot
technical/biomed/ar407.txt:          Cell culture, RNA purification, reverse transcription,
technical/biomed/ar407.txt:          demonstrated significantly higher Ang-1 mRNA expression
technical/biomed/ar407.txt:          compared to OA and normal tissues. Ang-1 mRNA expression
technical/biomed/ar407.txt:          The Ang-2 mRNA expression pattern was similar to Ang-2
technical/biomed/ar407.txt:          immunostaining on vascular endothelium. The Ang-2 mRNA
technical/biomed/ar407.txt:          Ang-2 mRNA was expressed at low levels compared to that
technical/biomed/ar407.txt:          staining on macrophages and fibroblasts. Tie1 mRNA
technical/biomed/ar407.txt:          staining on macrophages and fibroblasts. Tie2 mRNA levels
technical/biomed/ar407.txt:          same pattern as the mRNA expression (Fig. 4).
technical/biomed/ar407.txt:        that RA synovial tissue had significantly higher Ang-1 mRNA
technical/biomed/ar407.txt:        Ang-1 mRNA expression was detected in RA fibroblasts (Fig.
technical/biomed/ar407.txt:        revealed that VEGF mRNA and protein localized to
technical/biomed/ar407.txt:        lines mainly express Ang-2 mRNA [ 23 ] . In contrast to
technical/biomed/ar407.txt:        dominance of Ang-2 over Ang-1 mRNA and protein in OA
technical/biomed/ar407.txt:        Ang-2 mRNA expression pattern correlates with the Ang-2
technical/biomed/ar407.txt:        mRNA expression was also detected on RA fibroblasts.
technical/biomed/ar407.txt:        angiogenic mediators over inhibitors, the higher Ang-1 mRNA
technical/biomed/ar407.txt:        (Fig. 3). In accordance with the protein data, the mRNA
technical/biomed/ar407.txt:        upregulation of Tie1 mRNA and protein expression in RA is
technical/biomed/ar407.txt:        mainly on endothelial cells. Tie2 mRNA and protein
technical/biomed/ar407.txt:        exclusively higher than Ang-2 at the mRNA and protein
technical/biomed/ar407.txt:          RNA purification
technical/biomed/ar407.txt:          Total RNA was prepared from synovial tissue by an acid
technical/biomed/ar407.txt:          Chomczynski and Sacchi [ 31 ] . RNA (20 μg) was digested
technical/biomed/ar407.txt:          containing eight units of RNase inhibitor (Gibco/Life
technical/biomed/ar407.txt:          (Fisher, Itasca, IL, USA). The RNA was precipitated with
technical/biomed/ar407.txt:          Reverse transcription of RNA was performed using 5 μg
technical/biomed/ar407.txt:          of RNA in a total volume of 20 μl. The RNA was reverse
technical/biomed/ar408.txt:        an animal model of RA [ 22 23 ] . Alternatively the
technical/biomed/ar409.txt:        technique for concentration of viral supernatant. Viral
technical/biomed/ar409.txt:        to concentrated viral supernatant.
technical/biomed/ar409.txt:          Concentration of viral supernatant by superspeed
technical/biomed/ar409.txt:          Following centrifugation, the supernatant was aspirated
technical/biomed/ar409.txt:          Quantitation of viral RNA by slot blot
technical/biomed/ar409.txt:          Viral RNA was quantitated using a slot blot
technical/biomed/ar409.txt:          transduced with serial dilutions of supernatant. The
technical/biomed/ar409.txt:          cells)/ volume of supernatant (ml).
technical/biomed/ar409.txt:          5cells/well. FLS were cultured with viral supernatant
technical/biomed/ar409.txt:          Concentration of viral supernatant
technical/biomed/ar409.txt:          supernatant. Prior studies reported improved transduction
technical/biomed/ar409.txt:          concentrated viral supernatant 100-fold in as few as four
technical/biomed/ar409.txt:          concentration of viral supernatant increased FLS
technical/biomed/ar409.txt:          supernatant, compared with 41.3 ± 14.7% for 10X
technical/biomed/ar409.txt:          concentrated supernatant ( 
technical/biomed/ar409.txt:          unconcentrated supernatant), and 47.3 ± 14.8% for 100X
technical/biomed/ar409.txt:          concentrated supernatant ( 
technical/biomed/ar409.txt:          unconcentrated supernatant).
technical/biomed/ar409.txt:          supernatant (Fig. 3).
technical/biomed/ar409.txt:        ± 8.2%) of FLS with unconcentrated supernatant (titer of 10
technical/biomed/ar409.txt:        Centrifugal concentration of viral supernatant by 10- to
technical/biomed/ar409.txt:        separate donors. Concentration of supernatant to viral
technical/biomed/ar409.txt:        alternative to MoMLV-based vectors for some
technical/biomed/ar409.txt:          viral supernatants with titers in the range of 10 5to 10
technical/biomed/ar409.txt:          viral supernatants have been pursued with mixed results.
technical/biomed/ar409.txt:          USA). Retroviral supernatant was collected 48 hours after
technical/biomed/ar409.txt:          supernatant, 100% of the PA317 cells were transduced with
technical/biomed/ar409.txt:          as the source of viral supernatant for subsequent viral
technical/biomed/ar409.txt:          Quantitation of viral RNA by slot blot
technical/biomed/ar409.txt:          immediately before sample loading. Retroviral supernatant
technical/biomed/ar409.txt:          containing a defined volume of viral supernatant,
technical/biomed/ar409.txt:          exposure to viral supernatant for 24 hours, the medium
technical/biomed/ar409.txt:          viral supernatant were tested.
technical/biomed/ar409.txt:            Supernatant collected from the RET2.EGFP producer
technical/biomed/ar409.txt:            supernatant was collected and saved for quantitation of
technical/biomed/ar409.txt:            the supernatant. As measured on NIH 3T3 cells by flow
technical/biomed/ar409.txt:            supernatant. Even following concentration for as long
technical/biomed/ar409.txt:            on viral RNA in the postcentrifugation supernatant and
technical/biomed/ar409.txt:            RNA was concentrated in the viral pellet. Almost no
technical/biomed/ar409.txt:            retroviral RNA remained in the postcentrifugation
technical/biomed/ar409.txt:            supernatant after centrifugation for 12 hours.
technical/biomed/ar409.txt:            supernatant at an RCF of 20,000 
technical/biomed/ar409.txt:        titer of retroviral supernatant is one of several factors
technical/biomed/ar409.txt:        transduction. Centrifugation of retroviral supernatant is a
technical/biomed/ar409.txt:        super-speed centrifugation of retroviral supernatant, has
technical/biomed/ar409.txt:        concentrated viral supernatant produced by our protocol.
technical/biomed/ar409.txt:        titer retroviral supernatants from production lots of
technical/biomed/ar409.txt:        with retroviral supernatant 
technical/biomed/ar430.txt:        correlated with expression of hTNF-α mRNA in the joints [ 7
technical/biomed/ar430.txt:          the manufacturer's instructions (Biosource International,
technical/biomed/ar430.txt:          RNA isolation and RNase protection assay
technical/biomed/ar430.txt:          Supplementary material and analyzed in an RNase
technical/biomed/ar430.txt:          IL-6, IL-1β, and IFN-γ mRNA, which are expressed in the
technical/biomed/ar430.txt:          following anti-TNF-α treatment when total joint RNA was
technical/biomed/ar430.txt:          examined by RNase protection assays (see Supplementary
technical/biomed/ar430.txt:          mRNA were standardized to glyceraldehyde-3-phosphate
technical/biomed/ar430.txt:          mRNA was not affected by treatment with anti-TNF-α
technical/biomed/ar430.txt:        other proinflammatory cytokine mRNAs were decreased in the
technical/biomed/ar430.txt:        mAb = monoclonal antibody; mRNA = messenger ribonucleic
technical/biomed/ar430.txt:            RNA isolation and RNase protection assay
technical/biomed/ar430.txt:            nitrogen at 2-minute pulses. RNA was isolated from 50
technical/biomed/ar430.txt:            BRL, Grand Island, NY, USA). RNA was extracted with 0.2
technical/biomed/ar430.txt:            RNA from each sample was used for RNase protection
technical/biomed/ar430.txt:            cytokine messenger RNA (mRNA) to GAPDH was
technical/biomed/ar601.txt:        proinflammatory cytokine mRNA expression and protein
technical/biomed/ar601.txt:          measured from day 5 supernatant using the OptEIA mouse
technical/biomed/ar612.txt:          supernatants were harvested and reacted with 1%
technical/biomed/ar624.txt:        alternatively transferred CD4 +CD25 +-depleted spleen cells
technical/biomed/ar624.txt:          International, Inc. (Camarillo, CA, USA). For induction
technical/biomed/ar624.txt:        autoreactive T cells anergic, or alternatively by
technical/biomed/ar68.txt:          Isolation of DNA and RNA, and preparation of
technical/biomed/ar68.txt:          and total RNA was isolated using Ultraspec RNA (Biotech
technical/biomed/ar68.txt:          One microgram of RNA was reverse transcribed to
technical/biomed/ar68.txt:          Technologies, Grand Island, NY, USA), 1U RNAse inhibitor
technical/biomed/ar68.txt:          cells contain much higher levels of V gene messenger RNA
technical/biomed/ar68.txt:          RNA, these fingerprinting assays cannot readily
technical/biomed/ar774.txt:        Although it may also participate in DNA replication and RNA
technical/biomed/ar778.txt:        (CCCH) zinc fingers, which are responsible for RNA binding
technical/biomed/ar778.txt:        is associated with increased mRNA stability [ 23 ] . TTP
technical/biomed/ar778.txt:        region of TNF mRNA, which regulates TNF mRNA turnover 
technical/biomed/ar778.txt:        mRNA. TTP also regulates the stability of GM-CSF
technical/biomed/ar778.txt:        (granulocyte/macrophage-colony-stimulating factor) mRNA
technical/biomed/ar778.txt:        and both IL-3 and IL-8 via the ARE in their mRNA [ 29 30 ]
technical/biomed/ar778.txt:          Human TTP cDNA was generated by RT-PCR from THP-1 RNA
technical/biomed/ar778.txt:          The white-cell supernatant was then aspirated,
technical/biomed/ar778.txt:          for the remainder of the experiment. The supernatant was
technical/biomed/ar778.txt:          centrifuged, the supernatant was aspirated, and 3.8 μg
technical/biomed/ar778.txt:          mRNA in bone-marrow-derived murine macrophages [ 23 ]
technical/biomed/ar778.txt:          supernatant, preventing its interaction with TNF
technical/biomed/ar778.txt:        TTP mRNA expression [ 38 ] , these data are consistent with
technical/biomed/ar778.txt:        with the kinetics of their mRNA induction [ 23 ] .
technical/biomed/ar778.txt:        Alternatively, the late rise in cytoplasmic TTP may be due
technical/biomed/ar792.txt:        alternative therapies are needed [ 17 ] .
technical/biomed/ar792.txt:        An alternative approach to the prevention of cartilage
technical/biomed/ar792.txt:          further 18 hours of culture with IL-1, total RNA was
technical/biomed/ar792.txt:          those above 1 μM resulted in poor RNA harvests and low
technical/biomed/ar792.txt:        expression of MMP-13 mRNA more effectively than that of
technical/biomed/ar795.txt:          supernatant containing amphotropic retrovirus
technical/biomed/ar93.txt:        populations studied. Alternatively, it is possible that the
technical/biomed/bcr273.txt:          Alternative levels of regulation of the bioefficacy
technical/biomed/bcr284.txt:          centrifuged at 3000 rpm for 5 min and the supernatant
technical/biomed/bcr284.txt:          4°C, and the supernatant designated the cytoplasmic
technical/biomed/bcr284.txt:          supernatants were designated as nuclear extracts after
technical/biomed/bcr284.txt:        activation of histone mRNA synthesis, was related to cell
technical/biomed/bcr284.txt:        whether the effect of SAHA is at the RNA transcription
technical/biomed/bcr284.txt:        complex after SAHA treatment may have an alternative
technical/biomed/bcr285.txt:          Based on ethnic [ 1] and international [ 2]
technical/biomed/bcr285.txt:          an alternate explanation may be that the size of the
technical/biomed/bcr285.txt:          through more available sex steroids. Alternatively, the
technical/biomed/bcr285.txt:        result of its estrogenic effects [ 3]. An alternative
technical/biomed/bcr285.txt:        of Asian diets may alternatively inhibit the secretion of
technical/biomed/bcr303.txt:        intracellular drug accumulation and the expression of mRNA
technical/biomed/bcr303.txt:            RNA isolation
technical/biomed/bcr303.txt:            Total RNA was extracted from the treated cell line
technical/biomed/bcr303.txt:            concentration and purity of RNA were quantified
technical/biomed/bcr303.txt:            280 of pure RNA is approximately
technical/biomed/bcr303.txt:            The RNA sample was added to a sterile RNase-free
technical/biomed/bcr303.txt:            added to 9.5 μl. The RNA sample was heated to 70°C for
technical/biomed/bcr303.txt:            dNTP, 0.5 μl of Rnasin (1 U/μl) (Promega), 1 μl of
technical/biomed/bcr303.txt:            catalyse the formation of cDNA on the mRNA template.
technical/biomed/bcr303.txt:            Promega, 10 pmol of internal standard gene upstream and
technical/biomed/bcr303.txt:            specific genes expressed in relation to the internal
technical/biomed/bcr303.txt:          treated with 1% (v/v) Triton X-100 and 0.01% RNase for 10
technical/biomed/bcr303.txt:            MDR1 and GSTπ mRNA expression
technical/biomed/bcr303.txt:            time-dependent manner. The expression of both mRNA
technical/biomed/bcr303.txt:            MRP and TopoIIα mRNA expression
technical/biomed/bcr303.txt:            After treatment with NOM, the MRP mRNA expression
technical/biomed/bcr303.txt:            control. No significant changes in MRP and TopoIIα mRNA
technical/biomed/bcr303.txt:          protein were similar to those of NOM on mRNA expression
technical/biomed/bcr303.txt:        used to determine relative initial target mRNA levels in
technical/biomed/bcr303.txt:        of results. Most investigators use internal amplification
technical/biomed/bcr303.txt:        chose to use endogenous standards. The reference mRNA and
technical/biomed/bcr303.txt:        target mRNA are usually processed together throughout the
technical/biomed/bcr303.txt:        experiments, from RNA extraction until PCR amplification.
technical/biomed/bcr303.txt:        This tends to minimize differences in RNA yields between
technical/biomed/bcr303.txt:        mRNA in the colon carcinoma cell lines HCT15 and HCT16. Liu
technical/biomed/bcr303.txt:        MDR mRNA expression level was very low, and that of P-gp
technical/biomed/bcr303.txt:        the level of expression of GSTπ mRNA and protein with a
technical/biomed/bcr317.txt:        behave in a similar manner. Alternatively, if the tumors
technical/biomed/bcr317.txt:        duplicate labeling of the same RNA source.
technical/biomed/bcr317.txt:          RNA sample preparation
technical/biomed/bcr317.txt:          Total RNA was extracted from dissected tumor
technical/biomed/bcr317.txt:          ®(Qiagen, Valencia, CA, USA). Total RNA (20 μg) was used
technical/biomed/bcr317.txt:          used to synthesize biotin-labeled antisense cRNA
technical/biomed/bcr317.txt:          (BioArray™ High Yield RNA Transcript Labeling Kit; Enzo
technical/biomed/bcr317.txt:          Diagnostics, Farmingdale, NY, USA). Labeled cRNA was
technical/biomed/bcr317.txt:          labeled cRNA target prepared from tumors 5A and 5B were
technical/biomed/bcr317.txt:          cRNA sample, approximately 50% of the 12,500 transcripts
technical/biomed/bcr317.txt:          seen when different cRNA targets are prepared from the
technical/biomed/bcr317.txt:          same total RNA source and hybridized to separate U95A
technical/biomed/bcr317.txt:          chips, total RNA from tumor 5A was used to prepare cRNA
technical/biomed/bcr317.txt:          three weeks after the initial preparation (5AsRNA). Gene
technical/biomed/bcr317.txt:          expression patterns from 5A and 5AsRNA had a pairwise
technical/biomed/bcr317.txt:          the comparison of 5A with 5AsRNA. Thus, use of the same
technical/biomed/bcr317.txt:          RNA source resulted in the additional perturbation of
technical/biomed/bcr317.txt:          When the expression profiles of cRNA targets from all
technical/biomed/bcr317.txt:          genes observed when comparing cRNA targets prepared from
technical/biomed/bcr317.txt:          same total RNA source (165 genes). In fact, the pairwise
technical/biomed/bcr317.txt:          was higher than those observed with multiple cRNAs from
technical/biomed/bcr317.txt:          the same total RNA source (0.915). Therefore, we conclude
technical/biomed/bcr317.txt:          (5A/5AsRNA, 5A/7i and 5A/9i), the ranked correlation
technical/biomed/bcr317.txt:        Affymetrix U95A chips. When the total RNA was hybridized to
technical/biomed/bcr317.txt:        preparation variation, may be due to a small amount of RNA
technical/biomed/bcr317.txt:        baseline level. The 5AsRNA expression profile differed from
technical/biomed/bcr317.txt:        correlation coefficients of 5A and 5AsRNA more closely
technical/biomed/bcr317.txt:        the human mRNA and promoter region DNA of the PR, on the
technical/biomed/bcr45.txt:          RNA and protein levels of BRCA1 in the BG-1 human ovarian
technical/biomed/bcr45.txt:          BRCA1 RNA and protein levels were
technical/biomed/bcr45.txt:          BRCA1 mRNA and protein levels to
technical/biomed/bcr45.txt:          BRCA1 mRNA and protein can result
technical/biomed/bcr45.txt:        in yeast reporter assays [ 26, 27] and binds the RNA
technical/biomed/bcr45.txt:          ecotropic packaging cell line GPE86 [ 31]. Supernatant,
technical/biomed/bcr45.txt:          supernatant collection. Supernatants were filtered (0.20
technical/biomed/bcr45.txt:          BG-1 cells were exposed to supernatant containing either
technical/biomed/bcr45.txt:          Sample RNA (20μg total RNA) was coprecipitated with the
technical/biomed/bcr45.txt:          RNA and protein levels of BRCA1 in the BG-1 human ovarian
technical/biomed/bcr45.txt:          which were from independently made supernatants) showed
technical/biomed/bcr45.txt:          be no detectable amounts of BRCA1 RNA present after
technical/biomed/bcr45.txt:          BRCA1 RNA and protein levels were
technical/biomed/bcr45.txt:          BRCA1 mRNA and protein levels to
technical/biomed/bcr45.txt:          BRCA1 mRNA in BG-1 cells after 24 h
technical/biomed/bcr45.txt:          BRCA1 mRNA and protein can result
technical/biomed/bcr45.txt:          transgenic knockout mice [ 29, 30, 52]. Alternatively,
technical/biomed/bcr458.txt:          International Classification of
technical/biomed/bcr458.txt:          International Classification of
technical/biomed/bcr458.txt:          Sacramento, San Bernardino, San Diego, San Joaquin, San
technical/biomed/bcr571.txt:        alternatively, the observed molecular changes may be used
technical/biomed/bcr588.txt:        assess the correlations between the mRNA expression of Met
technical/biomed/bcr588.txt:          Total RNA was extracted from axillary lymphatic fluid
technical/biomed/bcr588.txt:          was performed with 1-2 μg of total RNA. The first strand
technical/biomed/bcr588.txt:          of subscripts II RNAse-H-reverse transcriptase
technical/biomed/bcr588.txt:          for Met was 1 pg of total RNA.
technical/biomed/bcr588.txt:        that both RNA preparation and cDNA synthesis were
technical/biomed/bcr602.txt:          RNA isolation and reverse transcription polymerase
technical/biomed/bcr602.txt:          Total RNA was extracted from human breast cell lines,
technical/biomed/bcr602.txt:          in accordance with the manufacturer's protocol. Total RNA
technical/biomed/bcr602.txt:          of 225 base pairs. The internal control for all samples
technical/biomed/bcr602.txt:          BP1 mRNA levels were analyzed in a series of breast
technical/biomed/bcr602.txt:          BP1 mRNA expression was examined in 46 invasive ductal
technical/biomed/bcr605.txt:        States as a whole [ 2 ] . Pronounced international and
technical/biomed/bcr605.txt:        Further studies with alternative control ascertainment
technical/biomed/bcr605.txt:        population, an alternative explanation could be that
technical/biomed/bcr618.txt:        An alternative treatment strategy can be developed in
technical/biomed/bcr618.txt:        alternatively, decreasing below acceptable ANC levels in
technical/biomed/bcr620.txt:          acetone for 30 s and washed with RNAse-free water.
technical/biomed/bcr620.txt:          RNA extraction and cDNA synthesis
technical/biomed/bcr620.txt:          Total RNA was extracted from frozen breast tissues and
technical/biomed/bcr620.txt:          laser-captured materials using the StrataPrep Total RNA
technical/biomed/bcr620.txt:          was synthesized from total RNA using MMLV reverse
technical/biomed/bcr620.txt:          commercially (OPN [1:100], Chemicon International, Inc.,
technical/biomed/bcr620.txt:          This procedure allowed OPN, TSP-1 and TYRP-1 mRNA
technical/biomed/bcr620.txt:          OPN mRNA was found to be present in all microdissected
technical/biomed/bcr620.txt:        quantitation of OPN, TSP-1 and TYRP-1 mRNA was achieved
technical/biomed/bcr620.txt:        In the present study, TYRP-1 mRNA was present, but at
technical/biomed/bcr631.txt:          total protein concentration in the supernatant (separated
technical/biomed/bcr631.txt:          Protein Assay Reagent (Cytoskeleton Inc). The supernatant
technical/biomed/bcr631.txt:          International) was performed overnight at 4°C in a humid
technical/biomed/bcr631.txt:          mRNA levels in selected breast tissues (Table 1: T1, N1,
technical/biomed/bcr631.txt:          levels were correlated with mRNA levels. We developed
technical/biomed/bcr631.txt:          PCR to establish the relative amounts of mRNA transcripts
technical/biomed/bcr631.txt:          III, IVa, IVb, V, and VI). Total RNA was extracted from 5
technical/biomed/bcr631.txt:          × 10 6cells with the Micro-to-Midi™ Total RNA
technical/biomed/bcr631.txt:          Purification System (Invitrogen). The purity of the RNA
technical/biomed/bcr631.txt:          280 ratios. Electrophoresis with RNA
technical/biomed/bcr631.txt:          to determine the integrity of ribosomal RNA. The RNA
technical/biomed/bcr631.txt:          primers for each of the isotype mRNAs and Reflectase
technical/biomed/bcr631.txt:          to quantify the mRNA levels for selected breast tissues.
technical/biomed/bcr631.txt:          The amount of β-tubulin isotype mRNA in a known amount of
technical/biomed/bcr631.txt:          total RNA was determined from standard curves.
technical/biomed/bcr631.txt:          Correlation of β-tubulin isotype protein and mRNA
technical/biomed/bcr631.txt:          could be inferred from mRNA levels, we used quantitative
technical/biomed/bcr631.txt:          real-time PCR to measure β-tubulin mRNA levels in
technical/biomed/bcr631.txt:          These data show a broad distribution of mRNA content for
technical/biomed/bcr631.txt:          (data not shown). When the fraction of mRNA for β-tubulin
technical/biomed/bcr631.txt:          there is no correlation between tubulin mRNA and protein
technical/biomed/bcr631.txt:          quantitative work was done by comparing mRNA levels.
technical/biomed/bcr631.txt:          However, mRNA and protein levels are not correlated for
technical/biomed/bcr631.txt:          occurs by autoregulation. This process alters mRNA
technical/biomed/bcr631.txt:          polysomal β-tubulin mRNA and an amino-terminal
technical/biomed/bcr631.txt:          polypeptide [ 55 56 57 ] . Furthermore, α-tubulin mRNA
technical/biomed/bcr631.txt:          tubulin depends on both mRNA stability and protein
technical/biomed/bcr631.txt:          of tubulin mRNA might be associated with low levels of
technical/biomed/bcr631.txt:          isotype protein levels and mRNA levels in
technical/biomed/bcr631.txt:          mRNA levels are currently interpreted by most
technical/biomed/bcr631.txt:          intracellular tubulin protein pool. One alternative to
technical/biomed/bcr631.txt:          mRNA quantification is immunostaining. Although
technical/biomed/bcr631.txt:          tissue samples revealed that β-tubulin mRNA and protein
technical/biomed/bcr631.txt:          sensitive and accurate assay to complement mRNA assays
technical/biomed/bcr631.txt:          paclitaxel [ 32 ] . The alternative hypothesis, derived
technical/biomed/cc103.txt:          as always, when safer or less invasive alternatives are
technical/biomed/cc103.txt:          better alternative for the patient who primarily requires
technical/biomed/cc1044.txt:        hypo/hypernatremia (<130 and >150 mmol/l), elevated
technical/biomed/cc1044.txt:        hypo/hyperpotassemia, hypernatremia, hypoalbuminemia,
technical/biomed/cc1044.txt:        Foreman [ 31] determined that hypernatremia, hypokalemia,
technical/biomed/cc1476.txt:          crossed-over to receive the alternate saline or albuterol
technical/biomed/cc1477.txt:        There is great international variability in patient mix
technical/biomed/cc1495.txt:        catheter [Arrow AH 050050-H, 7.5 F; Arrow International,
technical/biomed/cc1495.txt:        For this reason, the international literature recommends
technical/biomed/cc1529.txt:        sepsis international advisory group [ 1].
technical/biomed/cc1529.txt:          The KyberSept trial was a large, international, phase
technical/biomed/cc1538.txt:          After internal review board approval at the University
technical/biomed/cc1538.txt:          exploration of alternatives for data and alarm
technical/biomed/cc1856.txt:        esophageal capnometry could be used as an alternative to
technical/biomed/cc1856.txt:        • Esophageal capnometry could be used as an alternative
technical/biomed/cc2167.txt:          three had an elevated international normalized ratio
technical/biomed/cc2167.txt:        international normalized ratio). Risk for sepsis-related
technical/biomed/cc2167.txt:        Gordon R Bernard received grant support from Eli Lilly
technical/biomed/cc2171.txt:          following seven features, without an alternative cause,
technical/biomed/cc2190.txt:        An alternative to the use of a small intestinal feeding
technical/biomed/cc2358.txt:        Recently, Garnacho-Montero and coworkers [ 12 ] reported
technical/biomed/cc2358.txt:        pneumonia. On the other hand, Garnacho-Montero and
technical/biomed/cc2358.txt:        Garnacho-Montero and coworkers [ 12 ] , in patients with
technical/biomed/cc300.txt:            for 30 min, after which the supernatant for each was
technical/biomed/cc300.txt:        mRNA; these inhibitory mechanisms may be deregulated by
technical/biomed/cc303.txt:        International Classification of Diseases (ICD)-9 procedure
technical/biomed/cc303.txt:        The study protocol was approved by the Internal Review
technical/biomed/cc350.txt:        perfusion in the ICU and provides an objective alternative
technical/biomed/cc4.txt:          External compression of the pulmonary vessels by PEEP,
technical/biomed/cc713.txt:        GaziAntep, Adiyaman, Batman, Mardin, Siirt and Sirnak.
technical/biomed/cvm-2-4-180.txt:        international trial. To understand the role of such a
technical/biomed/cvm-2-4-180.txt:        International Steering Committee agreed on the definitions
technical/biomed/cvm-2-4-187.txt:        assessment of MIs in a large international trial. In a
technical/biomed/cvm-2-4-187.txt:          formulated by the International Steering Committee based
technical/biomed/cvm-2-6-278.txt:          through alternative mRNA splicing of a single gene [ 4,
technical/biomed/cvm-2-6-278.txt:          presents an attractive alternative to purified proteins
technical/biomed/cvm-2-6-286.txt:        age 69.1 ± 8 years) with 53 internal carotid artery
technical/biomed/cvm-2-6-286.txt:        had a surgical anastamosis between the external and
technical/biomed/cvm-2-6-286.txt:        internal carotid arteries.
technical/biomed/cvm-2-6-286.txt:          lesions (in 31 patients) of the internal carotid artery
technical/biomed/cvm-2-6-286.txt:        internal carotid artery. The external carotid is also
technical/biomed/cvm-2-6-286.txt:        occluded to avoid flow traveling from the external one back
technical/biomed/cvm-2-6-286.txt:        up the internal one. This system establishes protection
technical/biomed/gb-2000-1-1-research002.txt:          homologous to the alternative second exon of the human
technical/biomed/gb-2000-1-1-research002.txt:          in the mRNA leads to the formation of a nonfunctional
technical/biomed/gb-2000-1-1-research002.txt:        alternatively be taken to indicate a neutral effect of
technical/biomed/gb-2000-1-1-research002.txt:          collection of eight internal primers. In this manner, the
technical/biomed/gb-2000-1-2-research0003.txt:        measurements of a large proportion of the mRNA species
technical/biomed/gb-2000-1-2-research0003.txt:           , or alternatively, the percent variance
technical/biomed/gb-2000-1-2-research0003.txt:          The international prognostic index (IPI) A score was
technical/biomed/gb-2001-2-10-research0041.txt:        activated B-like DLBCL, alternative therapeutic agents must
technical/biomed/gb-2001-2-10-research0041.txt:        the carboxy-terminal domain of the RNA polymerase II
technical/biomed/gb-2001-2-10-research0041.txt:        turnover rate of mRNA on a genomic-scale. mRNA turnover is
technical/biomed/gb-2001-2-10-research0041.txt:        cis-elements in mRNA molecules. For many labile mRNAs,
technical/biomed/gb-2001-2-10-research0041.txt:        By measuring mRNA turnover rates comprehensively, we
technical/biomed/gb-2001-2-10-research0041.txt:        a gene and its mRNA stability. In addition, we found that
technical/biomed/gb-2001-2-10-research0041.txt:        labile mRNAs, thus revealing a coordinated strategy to
technical/biomed/gb-2001-2-10-research0041.txt:        rapidly modulate the mRNA levels of these genes. This
technical/biomed/gb-2001-2-10-research0041.txt:        understanding of mRNA turnover on a genomic scale provides
technical/biomed/gb-2001-2-10-research0041.txt:        mRNA levels were observed following flavopiridol treatment
technical/biomed/gb-2001-2-10-research0041.txt:        decreasing mRNA levels. Patients receiving infusions of
technical/biomed/gb-2001-2-10-research0041.txt:        global reduction in mRNA levels caused by flavopiridol is a
technical/biomed/gb-2001-2-10-research0041.txt:        mRNA levels.
technical/biomed/gb-2001-2-10-research0041.txt:        well-measured genes on the Lymphochip, the mRNA abundance
technical/biomed/gb-2001-2-10-research0041.txt:        therefore be used to measure mRNA turnover rates (see
technical/biomed/gb-2001-2-10-research0041.txt:        Materials and methods). Genes are grouped according to mRNA
technical/biomed/gb-2001-2-10-research0041.txt:        representative mRNAs were verified by northern blot
technical/biomed/gb-2001-2-10-research0041.txt:        To investigate whether the mRNA degradation rates were
technical/biomed/gb-2001-2-10-research0041.txt:        first-order kinetics model would describe the mRNA
technical/biomed/gb-2001-2-10-research0041.txt:        first-order mRNA degradation rates.
technical/biomed/gb-2001-2-10-research0041.txt:        mRNA half-lives would be most rapidly and quantitatively
technical/biomed/gb-2001-2-10-research0041.txt:        proliferation that have unstable mRNAs, as decreased
technical/biomed/gb-2001-2-10-research0041.txt:        have a short-lived mRNA, and an obviously important target
technical/biomed/gb-2001-2-10-research0041.txt:        short half-lives of these mRNAs may be important to ensure
technical/biomed/gb-2001-2-10-research0041.txt:        anti-apoptotic genes with rapid mRNA turnover (Figure 4b).
technical/biomed/gb-2001-2-10-research0041.txt:        in OCI-Ly3 cells - A1 and MCL1 - had mRNA half-lives
technical/biomed/gb-2001-2-10-research0041.txt:        mRNA half-lives and encode anti-apoptotic proteins that act
technical/biomed/gb-2001-2-10-research0041.txt:        OCI-Ly3 cells and had a very short mRNA half-life. As TNF-α
technical/biomed/gb-2001-2-10-research0041.txt:        The majority of the genes with labile mRNAs, however,
technical/biomed/gb-2001-2-10-research0041.txt:        have unstable mRNAs (Figure 4d). This observation led us to
technical/biomed/gb-2001-2-10-research0041.txt:        is enriched for genes with labile mRNAs. We used Lymphochip
technical/biomed/gb-2001-2-10-research0041.txt:        with relatively short mRNA half-lives (<2 hours and 2-4
technical/biomed/gb-2001-2-10-research0041.txt:        in OCI-Ly3 cells were in this rapid mRNA turnover category
technical/biomed/gb-2001-2-10-research0041.txt:        induced by these stimuli had mRNA half-lives of less than 4
technical/biomed/gb-2001-2-10-research0041.txt:        This analysis of mRNA turnover in OCI-Ly3 cells
technical/biomed/gb-2001-2-10-research0041.txt:        are, as a class, likely to generate labile mRNAs. To test
technical/biomed/gb-2001-2-10-research0041.txt:        this notion, we profiled mRNA turnover rates in peripheral
technical/biomed/gb-2001-2-10-research0041.txt:        flavopiridol was added and mRNA levels were subsequently
technical/biomed/gb-2001-2-10-research0041.txt:        the inducible class if their mRNA levels increased more
technical/biomed/gb-2001-2-10-research0041.txt:        mRNA half-lives shorter than 2 hours. By contrast, only 11%
technical/biomed/gb-2001-2-10-research0041.txt:        of the non-inducible class of genes had mRNA half-lives
technical/biomed/gb-2001-2-10-research0041.txt:        mRNA half-lives longer than 6 hours ( 
technical/biomed/gb-2001-2-10-research0041.txt:        preferentially encode rapidly degraded mRNAs.
technical/biomed/gb-2001-2-10-research0041.txt:        the genes assigned to each mRNA turnover class (Figure 5b).
technical/biomed/gb-2001-2-10-research0041.txt:        inducible and had mRNA half-lives of less than 2 hours. By
technical/biomed/gb-2001-2-10-research0041.txt:        transcriptional regulation with rapid mRNA turnover of key
technical/biomed/gb-2001-2-10-research0041.txt:        have labile mRNAs (Figure 5b). Several of these genes are
technical/biomed/gb-2001-2-10-research0041.txt:        transcription factors is well known to have unstable mRNAs
technical/biomed/gb-2001-2-10-research0041.txt:        mRNAs have more lymphocyte-specific functions, such as
technical/biomed/gb-2001-2-10-research0041.txt:        mRNA half-lives of less than 2 hours. As expected, many
technical/biomed/gb-2001-2-10-research0041.txt:        cytokine mRNAs were both rapidly inducible and rapidly
technical/biomed/gb-2001-2-10-research0041.txt:        much more stable mRNAs than the cytokine genes, even though
technical/biomed/gb-2001-2-10-research0041.txt:        mRNAs for the cytokine and chemokine receptors also
technical/biomed/gb-2001-2-10-research0041.txt:        receptors CCR1 and CXCR5 had labile mRNAs, whereas most of
technical/biomed/gb-2001-2-10-research0041.txt:        α chains) had relatively stable mRNAs. The differential
technical/biomed/gb-2001-2-10-research0041.txt:        mRNA stabilities of cytokines, chemokines and their
technical/biomed/gb-2001-2-10-research0041.txt:        which can be achieved given their short mRNA half-lives. On
technical/biomed/gb-2001-2-10-research0041.txt:        of the relative stability of chemokine mRNAs.
technical/biomed/gb-2001-2-10-research0041.txt:        cis -acting mRNA motifs could account
technical/biomed/gb-2001-2-10-research0041.txt:        for the mRNA turnover rates measured in the present study.
technical/biomed/gb-2001-2-10-research0041.txt:        turnover of some mRNAs. Three different classes of ARE have
technical/biomed/gb-2001-2-10-research0041.txt:        13]. A recent bioinformatics analysis of labile mRNAs with
technical/biomed/gb-2001-2-10-research0041.txt:        UAUUUAWW, and a database of mRNAs that have matches to this
technical/biomed/gb-2001-2-10-research0041.txt:        AU-rich motifs among the classes of mRNAs with different
technical/biomed/gb-2001-2-10-research0041.txt:        preferentially in the most unstable mRNAs and was observed
technical/biomed/gb-2001-2-10-research0041.txt:        with decreasing frequency in mRNAs with longer half-lives.
technical/biomed/gb-2001-2-10-research0041.txt:        the ARE motif is not completely predictive of rapid mRNA
technical/biomed/gb-2001-2-10-research0041.txt:        turnover. Furthermore, many of the RNAs with unstable mRNAs
technical/biomed/gb-2001-2-10-research0041.txt:        The systematic determination of mRNA degradation rates
technical/biomed/gb-2001-2-10-research0041.txt:        logic that relates gene function and mRNA stability. The
technical/biomed/gb-2001-2-10-research0041.txt:        largest category of genes found to have unstable mRNAs
technical/biomed/gb-2001-2-10-research0041.txt:        promoters. Thus, the rapid degradation of these mRNAs
technical/biomed/gb-2001-2-10-research0041.txt:        for unstable mRNAs. Two such classes, the cytokine genes
technical/biomed/gb-2001-2-10-research0041.txt:        previously known to have unstable mRNAs. The class of
technical/biomed/gb-2001-2-10-research0041.txt:        be enriched for labile mRNAs. However, given the need to
technical/biomed/gb-2001-2-10-research0041.txt:        M phase of the cell cycle had rapidly degraded mRNAs. In
technical/biomed/gb-2001-2-10-research0041.txt:        flavopiridol. The regulatory logic of mRNA degradation
technical/biomed/gb-2001-2-10-research0041.txt:        half-lives of mRNAs encoding M-phase proteins and other key
technical/biomed/gb-2001-2-10-research0041.txt:        with unstable mRNAs. For example, OCI-Ly3 lymphoma cells
technical/biomed/gb-2001-2-10-research0041.txt:        MCL1 mRNAs therefore may contribute to the toxicity of
technical/biomed/gb-2001-2-10-research0041.txt:          Total RNA was prepared using Trizol reagent (Gibco BRL)
technical/biomed/gb-2001-2-10-research0041.txt:          sample, 40 μg of total RNA was used for the labeling
technical/biomed/gb-2001-2-10-research0041.txt:          Ten micrograms of total RNA were used for northern
technical/biomed/gb-2001-2-10-research0041.txt:          basis of three criteria. First, the mRNA abundance at X
technical/biomed/gb-2001-2-10-research0041.txt:          ARE-mRNA database
technical/biomed/gb-2001-2-10-research0041.txt:          copies of AUUUA were downloaded from the ARE-mRNA
technical/biomed/gb-2001-2-10-research0041.txt:          Mathematical analysis of mRNA half-lives
technical/biomed/gb-2001-2-10-research0041.txt:          in their assay variability. The mRNA half-life for each
technical/biomed/gb-2001-2-10-research0042.txt:        An alternative way of approaching the analysis problem
technical/biomed/gb-2001-2-10-research0042.txt:          two groups have described alternative methods that start
technical/biomed/gb-2001-2-10-research0042.txt:          assess this type of complexity, the total number of mRNA
technical/biomed/gb-2001-2-11-research0045.txt:          supernatant was used for western blot analysis and
technical/biomed/gb-2001-2-12-research0051.txt:        computational procedures. More importantly, alternative
technical/biomed/gb-2001-2-12-research0051.txt:          MJ1477: a predicted archaeal cysteinyl-tRNA
technical/biomed/gb-2001-2-12-research0051.txt:          Aminoacyl-tRNA synthetases (aaRSs) specific for 17 of
technical/biomed/gb-2001-2-12-research0051.txt:          alternative mechanism for cysteine incorporation into
technical/biomed/gb-2001-2-12-research0051.txt:          polysaccharide hydrolysis or its reversal. Aminoacyl-tRNA
technical/biomed/gb-2001-2-12-research0051.txt:          with the cognate tRNA, producing aminoacyl-tRNA. Even if
technical/biomed/gb-2001-2-12-research0051.txt:          family contain any recognizable RNA-binding domains.
technical/biomed/gb-2001-2-12-research0051.txt:          them are involved in RNA processing [ 28]. None of these
technical/biomed/gb-2001-2-12-research0051.txt:          An alternative TS or its subunit is predicted to be
technical/biomed/gb-2001-2-12-research0051.txt:          positive-strand RNA, negative-strand RNA, single-stranded
technical/biomed/gb-2001-2-12-research0051.txt:          33]. Subsequently, Cmpp16 was shown to bind RNA, which is
technical/biomed/gb-2001-2-12-research0051.txt:          polyphosphates and other proteins, but apparently not RNA
technical/biomed/gb-2001-2-12-research0051.txt:        alternative computational solutions that we describe here
technical/biomed/gb-2001-2-12-research0051.txt:        itself. Falsification is offered by alternative,
technical/biomed/gb-2001-2-12-research0051.txt:        M. jannaschii cysteinyl-tRNA
technical/biomed/gb-2001-2-12-research0051.txt:        ATP-binding or RNA-binding domains.
technical/biomed/gb-2001-2-12-research0051.txt:        that the alternative computational predictions presented
technical/biomed/gb-2001-2-12-research0053.txt:          Messenger RNA sequences from 
technical/biomed/gb-2001-2-12-research0054.txt:        of only 564 ORFs, 32 tRNAs and a single copy of each rRNA
technical/biomed/gb-2001-2-12-research0054.txt:          rRNA (which is widely conserved and identical for 
technical/biomed/gb-2001-2-12-research0054.txt:          Loss of RNA genes
technical/biomed/gb-2001-2-12-research0054.txt:          rRNA, and the separation of these genes into two
technical/biomed/gb-2001-2-12-research0054.txt:          transcriptional units with the 16S rRNA gene ( 
technical/biomed/gb-2001-2-12-research0054.txt:          possess multiple rRNA operons, each containing all three
technical/biomed/gb-2001-2-12-research0054.txt:          rRNA genes descend from two different ancestral operons,
technical/biomed/gb-2001-2-12-research0054.txt:          with other rRNA operons lost entirely. From flanking
technical/biomed/gb-2001-2-12-research0054.txt:          within syntenic fragments. All other rRNA operons were
technical/biomed/gb-2001-2-12-research0054.txt:          arrangement of rRNA genes is the result of the loss of
technical/biomed/gb-2001-2-12-research0054.txt:          E. coli has 86 tRNAs, and most of
technical/biomed/gb-2001-2-12-research0054.txt:          criterion for presence of a tRNA in the ancestor, based
technical/biomed/gb-2001-2-12-research0054.txt:          tRNA genes). 
technical/biomed/gb-2001-2-12-research0054.txt:          Buchnera has only 32 tRNAs, with
technical/biomed/gb-2001-2-12-research0054.txt:          ancestor had the same complement of tRNAs as 
technical/biomed/gb-2001-2-12-research0054.txt:          at least one tRNA for each amino acid, as observed in
technical/biomed/gb-2001-2-12-research0054.txt:          large deletions containing some tRNAs would have created
technical/biomed/gb-2001-2-12-research0054.txt:          codons in the genome do not have corresponding tRNAs
technical/biomed/gb-2001-2-12-research0055.txt:        abundance of mRNA molecules in biological samples [ 1]. The
technical/biomed/gb-2001-2-12-research0055.txt:        investigator isolates total and/or polyadenylated RNA from
technical/biomed/gb-2001-2-12-research0055.txt:        DNA (cDNA), transcribes complementary RNA (cRNA) from the
technical/biomed/gb-2001-2-12-research0055.txt:        cDNA template, and then hybridizes the cRNA to the array [
technical/biomed/gb-2001-2-12-research0055.txt:        scanning), and between-cRNA variation (as independently
technical/biomed/gb-2001-2-12-research0055.txt:        prepared cRNAs have variable purity and/or
technical/biomed/gb-2001-2-12-research0055.txt:        absolutely quantify mRNA abundances. Readouts are
technical/biomed/gb-2001-2-12-research0055.txt:        mean expression level of all monitored mRNAs is constant.
technical/biomed/gb-2001-2-12-research0055.txt:        For smaller arrays that monitor a limited set of mRNAs,
technical/biomed/gb-2001-2-12-research0055.txt:        1:100,000 mRNAs). Measurements for such mRNAs are not only
technical/biomed/gb-2001-2-12-research0055.txt:        The primary criterion for any alternative to global
technical/biomed/gb-2001-2-12-research0055.txt:        we describe alternative procedures that seek to quantitate
technical/biomed/gb-2001-2-12-research0055.txt:        array results in terms of transcripts per unit cRNA. We
technical/biomed/gb-2001-2-12-research0055.txt:        chose cRNA quantitation because it meets the primary
technical/biomed/gb-2001-2-12-research0055.txt:        First, cRNA quantitation is easily applied to array
technical/biomed/gb-2001-2-12-research0055.txt:        experiments using small amounts of starting total RNA that
technical/biomed/gb-2001-2-12-research0055.txt:        reagents described here for cRNA quantitation can be used
technical/biomed/gb-2001-2-12-research0055.txt:        accuracy and scientific value of cRNA quantitation are at
technical/biomed/gb-2001-2-12-research0055.txt:        least as good as those of alternative techniques, such as
technical/biomed/gb-2001-2-12-research0055.txt:        per mass of input material, transcripts per total RNA or
technical/biomed/gb-2001-2-12-research0055.txt:        transcripts per polyadenylated RNA.
technical/biomed/gb-2001-2-12-research0055.txt:        We evaluated two alternatives to the standard global
technical/biomed/gb-2001-2-12-research0055.txt:        be used to estimate message abundance in cRNA, compute a
technical/biomed/gb-2001-2-12-research0055.txt:        damping spurious signals from below-sensitivity mRNAs.
technical/biomed/gb-2001-2-12-research0055.txt:          fraction of polyadenylated mRNA per total RNA is
technical/biomed/gb-2001-2-12-research0055.txt:          level of variable-sized mRNA sets across samples covering
technical/biomed/gb-2001-2-12-research0055.txt:          because very large biological modulation of many mRNAs
technical/biomed/gb-2001-2-12-research0055.txt:          C. elegans mRNAs, and the sum of
technical/biomed/gb-2001-2-12-research0055.txt:          mRNAs monitored by the arrays were selected at random.
technical/biomed/gb-2001-2-12-research0055.txt:          mean expression level is below 7% for any set of mRNAs
technical/biomed/gb-2001-2-12-research0055.txt:          Nonrandom selection of even large mRNA sets for
technical/biomed/gb-2001-2-12-research0055.txt:          first array monitors mRNAs with confirmed cDNA library
technical/biomed/gb-2001-2-12-research0055.txt:          matches, and the other array monitors mRNAs whose
technical/biomed/gb-2001-2-12-research0055.txt:          transforming AD to cRNA frequency (F) estimates quoted in
technical/biomed/gb-2001-2-12-research0055.txt:          cRNA and a corresponding amount of spike-in transcripts.
technical/biomed/gb-2001-2-12-research0055.txt:          mRNAs. Experiments using 0.1 to 10 μg cRNA per
technical/biomed/gb-2001-2-12-research0055.txt:          approximately 1 μg cRNA in each hybridization, or reduced
technical/biomed/gb-2001-2-12-research0055.txt:          transcripts can be spiked into cRNA. Specifically,
technical/biomed/gb-2001-2-12-research0055.txt:          purity of cRNA preparations, the actual ratio of the
technical/biomed/gb-2001-2-12-research0055.txt:          spiked transcripts to cDNA-template-derived cRNAs might
technical/biomed/gb-2001-2-12-research0055.txt:          source of variable impurities in cRNA preparations could
technical/biomed/gb-2001-2-12-research0055.txt:          be oligo(dT)-primer-dependent cRNA product [ 19]. Such
technical/biomed/gb-2001-2-12-research0055.txt:          cRNA impurities would result in erroneous normalization
technical/biomed/gb-2001-2-12-research0055.txt:          transcripts to cDNA-template-derived cRNAs, by averaging
technical/biomed/gb-2001-2-12-research0055.txt:          the response to spiked cRNAs over multiple
technical/biomed/gb-2001-2-12-research0055.txt:          average differences of all spiked cRNAs on all the arrays
technical/biomed/gb-2001-2-12-research0055.txt:          the spiked cRNAs, yielding ten different calibration
technical/biomed/gb-2001-2-12-research0055.txt:          cDNA-template-derived cRNAs in the ten experiments, both
technical/biomed/gb-2001-2-12-research0055.txt:          spiked transcripts to cDNA-template-derived cRNAs is
technical/biomed/gb-2001-2-12-research0055.txt:          svalues are estimates of transcript abundance in cRNA,
technical/biomed/gb-2001-2-12-research0055.txt:          based on the average response to the spiked cRNAs over
technical/biomed/gb-2001-2-12-research0055.txt:          based solely on the response to spiked cRNAs in a single
technical/biomed/gb-2001-2-12-research0055.txt:          classes of mRNAs: those called Present in at least 50% of
technical/biomed/gb-2001-2-12-research0055.txt:          mRNAs), and those Present in fewer than 50% of the
technical/biomed/gb-2001-2-12-research0055.txt:          mRNAs). All metrics showed higher (worse) MEDACVs for the
technical/biomed/gb-2001-2-12-research0055.txt:          low-abundance Absent mRNAs than for the higher-abundance
technical/biomed/gb-2001-2-12-research0055.txt:          Present mRNAs (Figure 3), as expected from the presence
technical/biomed/gb-2001-2-12-research0055.txt:          reproducibility than AD sfor Absent mRNAs, owing to
technical/biomed/gb-2001-2-12-research0055.txt:          the same mRNA on different array designs. For this
technical/biomed/gb-2001-2-12-research0055.txt:          analysis, we selected the three mRNAs that were monitored
technical/biomed/gb-2001-2-12-research0055.txt:          the 0 hour cRNA sample. The observed CV of the AD smetric
technical/biomed/gb-2001-2-12-research0055.txt:          and was greater than 0.55 for all three mRNAs, indicating
technical/biomed/gb-2001-2-12-research0055.txt:          0.13-0.29). The mRNA K11C4.5 was expressed at >
technical/biomed/gb-2001-2-12-research0055.txt:          10-fold lower levels than either of the other two mRNAs,
technical/biomed/gb-2001-2-12-research0055.txt:          other two mRNAs. Comparison of the across-array-design
technical/biomed/gb-2001-2-12-research0055.txt:          across distinct designs was that the mRNAs monitored by
technical/biomed/gb-2001-2-12-research0055.txt:          independent lines of evidence. First, the mRNAs on the A
technical/biomed/gb-2001-2-12-research0055.txt:          libraries. Second, A array mRNAs were more likely than B
technical/biomed/gb-2001-2-12-research0055.txt:          or C array mRNAs to be detected in the developmental time
technical/biomed/gb-2001-2-12-research0055.txt:          Absolute quantitation of cRNA and cellular
technical/biomed/gb-2001-2-12-research0055.txt:          RNA
technical/biomed/gb-2001-2-12-research0055.txt:          the cRNA quantitiation given by the scaled frequency
technical/biomed/gb-2001-2-12-research0055.txt:          uncertainty in the molar ratio of spike-in mRNAs to
technical/biomed/gb-2001-2-12-research0055.txt:          template-derived cRNAs in any hybridization (the
technical/biomed/gb-2001-2-12-research0055.txt:          probably arises primarily from cRNA purity variation.
technical/biomed/gb-2001-2-12-research0055.txt:          between frequency metric readouts and true cRNA
technical/biomed/gb-2001-2-12-research0055.txt:          anticipate that inaccuracies of cRNA quantitation arising
technical/biomed/gb-2001-2-12-research0055.txt:          quantitation of cRNA preparations.
technical/biomed/gb-2001-2-12-research0055.txt:          contained two probe sets for each of these mRNAs). On the
technical/biomed/gb-2001-2-12-research0055.txt:          uncertainty in cRNA quantitation due to heterogeneity in
technical/biomed/gb-2001-2-12-research0055.txt:          in cRNA quantitation, there are at least two important
technical/biomed/gb-2001-2-12-research0055.txt:          factors leading to differences between cRNA abundances
technical/biomed/gb-2001-2-12-research0055.txt:          and cellular RNA abundances in the starting biological
technical/biomed/gb-2001-2-12-research0055.txt:          First, because cRNA is generated from the
technical/biomed/gb-2001-2-12-research0055.txt:          polyadenylated fraction of total cellular RNA by a linear
technical/biomed/gb-2001-2-12-research0055.txt:          polyadenylated RNA in total cellular RNA. This may be a
technical/biomed/gb-2001-2-12-research0055.txt:          per-total-RNA abundance is less relevant than
technical/biomed/gb-2001-2-12-research0055.txt:          per-polyadenylated-RNA abundance.
technical/biomed/gb-2001-2-12-research0055.txt:          Second, any gene-specific biases in the cRNA
technical/biomed/gb-2001-2-12-research0055.txt:          differences between cRNA and per-total-RNA
technical/biomed/gb-2001-2-12-research0055.txt:          threefold differences between scaled frequency per-cRNA
technical/biomed/gb-2001-2-12-research0055.txt:          estimates and per-polyadenylated-RNA abundances in the
technical/biomed/gb-2001-2-12-research0055.txt:          improved cRNA process control and quantitation, and by
technical/biomed/gb-2001-2-12-research0055.txt:        We have shown that cRNAs spiked into hybridization
technical/biomed/gb-2001-2-12-research0055.txt:        be adversely affected by variations in the 'purity' of cRNA
technical/biomed/gb-2001-2-12-research0055.txt:        meticulous quality control during the production of cRNA
technical/biomed/gb-2001-2-12-research0055.txt:        In the presence of variation in cRNA purity, the F
technical/biomed/gb-2001-2-12-research0055.txt:        expression levels of all worm mRNAs on all three of our
technical/biomed/gb-2001-2-12-research0055.txt:        cRNA quantitation and the damping of low-amplitude signals
technical/biomed/gb-2001-2-12-research0055.txt:          the 19,099 predicted worm mRNAs in the October 1998 worm
technical/biomed/gb-2001-2-12-research0055.txt:          generated complementary RNA (cRNA) preparations from the
technical/biomed/gb-2001-2-12-research0055.txt:          same starting total RNA. Primary data for all transcripts
technical/biomed/gb-2001-2-12-research0055.txt:          UV-quantitated cRNA mass in the hybridization, so as to
technical/biomed/gb-2001-2-12-research0055.txt:          worm cRNA in a 200 μl hybridization volume, and an
technical/biomed/gb-2001-2-12-research0055.txt:          cRNAs.
technical/biomed/gb-2001-2-12-research0055.txt:          spike-in mRNAs called Absent were lower-abundance
technical/biomed/gb-2001-2-12-research0055.txt:          technical uncertainties in cRNA preparation (see Results
technical/biomed/gb-2001-2-12-research0055.txt:          i th mRNA on the 
technical/biomed/gb-2001-2-12-research0055.txt:          i th mRNA
technical/biomed/gb-2001-2-12-research0055.txt:          i th mRNA on the 
technical/biomed/gb-2001-2-12-research0055.txt:          i th mRNA on the 
technical/biomed/gb-2001-2-12-research0055.txt:          i th mRNA on the 
technical/biomed/gb-2001-2-12-research0055.txt:          mRNAs)
technical/biomed/gb-2001-2-12-research0055.txt:          mRNAs)
technical/biomed/gb-2001-2-12-research0055.txt:           was a single random factor for all spiked cRNAs on a
technical/biomed/gb-2001-2-12-research0055.txt:          spike-skew factor for the spiked cRNAs was Gaussian with
technical/biomed/gb-2001-2-2-research0004.txt:        library [ 12, 13, 14] and to detect DNA-, RNA-, and
technical/biomed/gb-2001-2-2-research0004.txt:        internal standard for each protein to be assayed. Two
technical/biomed/gb-2001-2-2-research0004.txt:          diverse set of internal control proteins in the protein
technical/biomed/gb-2001-2-2-research0004.txt:        internal calibration proteins to control for variation in
technical/biomed/gb-2001-2-2-research0004.txt:          antigens, which served as internal standards, to the
technical/biomed/gb-2001-2-3-research0007.txt:          plant RNA viruses from the caria-, tricho- and potexvirus
technical/biomed/gb-2001-2-3-research0007.txt:          that ssRNA could be the substrate for other members of
technical/biomed/gb-2001-2-3-research0007.txt:          this family. Given the presence of RNA methylases that
technical/biomed/gb-2001-2-3-research0007.txt:          could modify RNA in a similar way as the alkylating
technical/biomed/gb-2001-2-3-research0007.txt:          inactivation of viral RNAs, and the AlkB homologs
technical/biomed/gb-2001-2-3-research0007.txt:          regulation of RNA stability or DNA repair via controlled
technical/biomed/gb-2001-2-3-research0007.txt:          new, RNA-related roles by some paralogs. In the case of
technical/biomed/gb-2001-2-3-research0007.txt:        possibly in RNA modification, for the AlkB protein and its
technical/biomed/gb-2001-2-3-research0008.txt:        complexity of an mRNA population. Here, we use a modified
technical/biomed/gb-2001-2-3-research0008.txt:          evidence of RNA processing (exon/intron borders and
technical/biomed/gb-2001-2-3-research0008.txt:          to genomic DNA. Alternatively, these novel RNA molecules
technical/biomed/gb-2001-2-3-research0008.txt:        proteins or RNAs that are involved in a brain-specific
technical/biomed/gb-2001-2-3-research0008.txt:          RNA preparation
technical/biomed/gb-2001-2-3-research0008.txt:          RNA was isolated according to the Micro RNA Isolation
technical/biomed/gb-2001-2-3-research0008.txt:          increased the yield of RNA from dried tissue to
technical/biomed/gb-2001-2-3-research0008.txt:          total RNA extracted from 100 fresh heads, 15-29.3 μg
technical/biomed/gb-2001-2-3-research0008.txt:          total RNA extracted from 100 acetone-dried heads with
technical/biomed/gb-2001-2-3-research0008.txt:          rehydration step, compared to 3-6.6 μg total RNA
technical/biomed/gb-2001-2-3-research0008.txt:          rehydration step). Poly(A) RNA was isolated using the
technical/biomed/gb-2001-2-3-research0008.txt:          Poly(A) Quick mRNA Isolation Kit from Stratagene
technical/biomed/gb-2001-2-3-research0008.txt:          Approximately 5 μg poly(A) RNA was extracted from
technical/biomed/gb-2001-2-3-research0008.txt:          primed from the 3' end of the poly(A) RNA using a poly(T)
technical/biomed/gb-2001-2-3-research0008.txt:          to protect internal 
technical/biomed/gb-2001-2-3-research0008.txt:          synthesis was primed by the partially digested RNA that
technical/biomed/gb-2001-2-3-research0008.txt:          resulted from RNase H treatment of the first-strand
technical/biomed/gb-2001-2-4-research0010.txt:        tRNA abundance [ 8, 9, 10, 11, 12, 13, 14], gene expression
technical/biomed/gb-2001-2-4-research0010.txt:        gene length [ 44, 45, 46, 47], and mRNA secondary structure
technical/biomed/gb-2001-2-4-research0010.txt:        61] and tRNA copy number [ 62].
technical/biomed/gb-2001-2-4-research0010.txt:          between the GC content of noncoding, exon, intron, tRNA
technical/biomed/gb-2001-2-4-research0010.txt:          and rRNA sequences, which indicates that a common force
technical/biomed/gb-2001-2-4-research0010.txt:          on the extent to which alternative synonyms of more
technical/biomed/gb-2001-2-4-research0010.txt:        grounds that they had alternative genetic codes (for
technical/biomed/gb-2001-2-4-research0011.txt:        SLC4A9 , a novel and alternatively
technical/biomed/gb-2001-2-4-research0011.txt:          an alternatively used 5' splice site, but no correlation
technical/biomed/gb-2001-2-4-research0011.txt:          SLC4A9 mRNA isoforms is full
technical/biomed/gb-2001-2-4-research0011.txt:          the 5' end of the mRNA. Nested RACE-PCR (rapid
technical/biomed/gb-2001-2-4-research0011.txt:          primer. All gene-specific RACE primers and all internal
technical/biomed/gb-2001-2-4-research0011.txt:          on a non-Clontech sample of total RNA freshly extracted
technical/biomed/gb-2001-2-4-research0011.txt:          low levels of alternatively spliced 
technical/biomed/gb-2001-2-4-research0011.txt:          SLC4A9 mRNA variants.
technical/biomed/gb-2001-2-4-research0011.txt:          alternatively spliced. Both the RACE-verified complete
technical/biomed/gb-2001-2-4-research0011.txt:          NBC4 mRNA are completely identical
technical/biomed/gb-2001-2-4-research0011.txt:          AC073263. These ESTs correspond to alternate, extended
technical/biomed/gb-2001-2-4-research0011.txt:          the 3'-UTRs of the published full-length mRNAs.
technical/biomed/gb-2001-2-4-research0011.txt:          Alternative splicing of SLC4A9
technical/biomed/gb-2001-2-4-research0011.txt:          of alternative splicing is the most interesting feature
technical/biomed/gb-2001-2-4-research0011.txt:          SLC4A9 alternative splicing is
technical/biomed/gb-2001-2-4-research0011.txt:          these alternatively spliced portions of the gene, the use
technical/biomed/gb-2001-2-4-research0011.txt:          site sequences. Therefore, alternative splicing of 
technical/biomed/gb-2001-2-4-research0011.txt:          intron retention or alternative splicing. Instead,
technical/biomed/gb-2001-2-4-research0011.txt:          degradation of incorrectly spliced mRNAs with disrupted
technical/biomed/gb-2001-2-4-research0011.txt:          Of all alternative splicing in humans, only 20% occurs
technical/biomed/gb-2001-2-4-research0011.txt:          alternative splicing of 
technical/biomed/gb-2001-2-4-research0011.txt:          alternatively spliced exons, of which no more than two
technical/biomed/gb-2001-2-4-research0011.txt:          elements. Two alternate 3'-terminal untranslated exons of
technical/biomed/gb-2001-2-4-research0011.txt:          SLC4A9. Alternative polyadenylation
technical/biomed/gb-2001-2-4-research0011.txt:          transporters. The alternatively spliced amino-terminal
technical/biomed/gb-2001-2-4-research0011.txt:          of unknown function. It is possible that alternative
technical/biomed/gb-2001-2-4-research0011.txt:          cochlea, different transcripts produced by alternative
technical/biomed/gb-2001-2-4-research0011.txt:          proteins encoded by the alternative 
technical/biomed/gb-2001-2-4-research0011.txt:          diverged. Extensive alternative splicing in these areas
technical/biomed/gb-2001-2-4-research0011.txt:          Alternately used exon 10d contains an almost perfect
technical/biomed/gb-2001-2-4-research0011.txt:          repeat-expressing, alternatively spliced genes? Are
technical/biomed/gb-2001-2-4-research0011.txt:          confirmed the uniform loading of mRNA in each lane.
technical/biomed/gb-2001-2-4-research0012.txt:          contain other compartments representing internal
technical/biomed/gb-2001-2-4-research0012.txt:          OR1 ) and RNA polymerase (RNAP) to
technical/biomed/gb-2001-2-4-research0012.txt:          PR (RNAP- 
technical/biomed/gb-2001-2-4-research0012.txt:          OR2, RNAP- 
technical/biomed/gb-2001-2-4-research0012.txt:          PRM and CI-RNAP is represented by
technical/biomed/gb-2001-2-4-research0012.txt:          association of RNAP with 
technical/biomed/gb-2001-2-4-research0014.txt:          arrays with adult mouse testicular RNA from C57BL/6 mice
technical/biomed/gb-2001-2-4-research0014.txt:          14 days. RNA extracted from these testes and hybridized
technical/biomed/gb-2001-2-4-research0014.txt:          with different RNA populations can be identified quickly
technical/biomed/gb-2001-2-4-research0014.txt:          alternative splicing) repertoire of every cell type in
technical/biomed/gb-2001-2-4-research0014.txt:            Total RNA was extracted individually from the testes
technical/biomed/gb-2001-2-4-research0014.txt:            Reagent (Sigma). The control and heat-shocked total RNA
technical/biomed/gb-2001-2-4-research0014.txt:            Oligotex™ mRNA Purification System (Qiagen) to produce
technical/biomed/gb-2001-2-4-research0014.txt:            poly(A) RNA. One microgram each of normal and
technical/biomed/gb-2001-2-4-research0014.txt:            heat-shocked testicular poly(A) RNA was submitted to
technical/biomed/gb-2001-2-4-research0014.txt:            the mouse testis transcriptome gene list. The same RNA
technical/biomed/gb-2001-2-4-research0014.txt:            produced from 2 μg of each pooled RNA, using the
technical/biomed/gb-2001-2-4-research0014.txt:            control and heat-shock RNA pools were each hybridized
technical/biomed/gb-2001-2-4-research0014.txt:            Adult human testicular total RNA was purchased from
technical/biomed/gb-2001-2-4-research0014.txt:            Clontech. This pooled RNA originated from samples taken
technical/biomed/gb-2001-2-4-research0014.txt:            micrograms of total RNA was reverse transcribed with
technical/biomed/gb-2001-2-4-research0014.txt:            ChromaSpin (human) columns. One microgram of RNA was
technical/biomed/gb-2001-2-4-research0014.txt:          RNA
technical/biomed/gb-2001-2-4-research0014.txt:          testes harvested. Total RNA was extracted from half a
technical/biomed/gb-2001-2-4-research0014.txt:          of the total RNA from a single animal was primed with
technical/biomed/gb-2001-2-4-research0014.txt:          μl [ 33P]dCTP (ICN)) were then added to the primed RNA.
technical/biomed/gb-2001-2-4-research0014.txt:          of signal intensity. Alternatively, Phoretix Array v2.0
technical/biomed/gb-2001-2-6-research0018.txt:        mammals investigate the external chemical environment. The
technical/biomed/gb-2001-2-6-research0018.txt:        appear to be pseudogenes [ 20]. Many alternative
technical/biomed/gb-2001-2-6-research0018.txt:          potential alternative biological roles for this class of
technical/biomed/gb-2001-2-6-research0018.txt:            the OR coding region [ 53]. Extensive alternative
technical/biomed/gb-2001-2-6-research0018.txt:            splicing of 5'-UTRs of OR mRNAs have been described [
technical/biomed/gb-2001-2-6-research0018.txt:          suggest an alternative hybrid nomenclature reflecting
technical/biomed/gb-2001-2-6-research0018.txt:          alternative to the existing OR classifications.
technical/biomed/gb-2001-2-6-research0018.txt:          potential splice sites in predicted 5'-UTRs of OR mRNAs.
technical/biomed/gb-2001-2-6-research0020.txt:        [ 14], or co-localization of the mRNAs in the same region
technical/biomed/gb-2001-2-6-research0020.txt:            terms of small subunit rRNA (SSU rRNA) substitutions.
technical/biomed/gb-2001-2-6-research0020.txt:            Brinkmann and Philippe [ 23] argued that SSU rRNAs of
technical/biomed/gb-2001-2-6-research0020.txt:            genomic methods. The unequal mutation rate in SSU rRNA,
technical/biomed/gb-2001-2-6-research0020.txt:            conservation could be used as an alternative measure of
technical/biomed/gb-2001-2-6-research0020.txt:            the SSU rRNA distances between bacteria and archaea are
technical/biomed/gb-2001-2-6-research0020.txt:          phylogenetic distance (estimated by SSU rRNA
technical/biomed/gb-2001-2-6-research0020.txt:        been proposed as alternatives to classical molecular
technical/biomed/gb-2001-2-6-research0020.txt:        alternative, and integration of information on different
technical/biomed/gb-2001-2-6-research0020.txt:        SSU rRNA. The classical molecular phylogeny of SSU rRNA was
technical/biomed/gb-2001-2-6-research0020.txt:        on SSU rRNA phylogeny; averaged distances of molecular
technical/biomed/gb-2001-2-6-research0021.txt:          97 gene products (67 proteins and 30 structural RNAs) in
technical/biomed/gb-2001-2-6-research0021.txt:          2 rRNAs and 22 tRNAs) over 16,569 base pairs [ 3]. All
technical/biomed/gb-2001-2-6-research0021.txt:          involved in oxidative phosphorylation, mitochondrial tRNA
technical/biomed/gb-2001-2-6-research0021.txt:          genes and mitochondrial rRNA genes. This subclass has
technical/biomed/gb-2001-2-6-research0021.txt:          small-scale mtDNA mutations in tRNA and rRNA genes [ 8].
technical/biomed/gb-2001-2-6-research0021.txt:          mtDNA deletions [ 9] (Ia-i) and even up to 95% for tRNA
technical/biomed/gb-2001-2-6-research0021.txt:            alternatively termed NADH CoQ 
technical/biomed/gb-2001-2-6-research0021.txt:            external ophthalmoplegia, gastrointestinal dismotility,
technical/biomed/gb-2001-2-6-research0021.txt:            repeat is believed to form localized RNA secondary
technical/biomed/gb-2001-2-6-research0021.txt:        mt-tRNA, mt-rRNA and proteins that affect mitochondrial
technical/biomed/gb-2001-2-7-research0024.txt:        myosin (Dd MyoJ), which is alternatively grouped with class
technical/biomed/gb-2001-2-7-research0024.txt:        material, or alternatively as an anchor for actin along the
technical/biomed/gb-2001-2-7-research0025.txt:        completed in draft form by an international public
technical/biomed/gb-2001-2-7-research0025.txt:          sequences [ 16, 17]. These approaches emphasize internal
technical/biomed/gb-2001-2-7-research0025.txt:          transcript indices contain one or more internal
technical/biomed/gb-2001-2-7-research0025.txt:          transcripts, suggesting alternative splicing, internal
technical/biomed/gb-2001-2-7-research0025.txt:          contamination). The prevalence of alternative splicing
technical/biomed/gb-2001-2-7-research0025.txt:          indices, unless both the internal and the flanking
technical/biomed/gb-2001-2-7-research0025.txt:          apparent internal genes). In addition, we observed a
technical/biomed/gb-2001-2-7-research0025.txt:          not yet a practical alternative to experimental
technical/biomed/gb-2001-2-7-research0025.txt:          also applies to the tRNA, rRNA and other snRNAs in the
technical/biomed/gb-2001-2-7-research0025.txt:          larger sets of mRNAs or known genes, and are similar to
technical/biomed/gb-2001-2-7-research0025.txt:          function at the RNA level [ 33].
technical/biomed/gb-2001-2-7-research0025.txt:          International Gene Ontology Consortium to assign each
technical/biomed/gb-2001-2-7-research0025.txt:          Alternatively, the jumps may reflect statistical
technical/biomed/gb-2001-2-7-research0025.txt:          strong internal sequence similarity, some of which arises
technical/biomed/gb-2001-2-7-research0025.txt:          (only PRI mRNA sequences were used, version 119) [ 72];
technical/biomed/gb-2001-2-8-research0030.txt:          supernatant was collected and designated as the shocked
technical/biomed/gb-2001-2-8-research0030.txt:          supernatant fraction was collected and passed through a
technical/biomed/gb-2001-2-8-research0030.txt:          for 20 min. The resulting supernatant was dialyzed
technical/biomed/gb-2001-2-8-research0031.txt:        RNA molecules with a library of complementary strands fixed
technical/biomed/gb-2001-2-8-research0031.txt:        abundance of the corresponding mRNA. This is the Affymetrix
technical/biomed/gb-2001-2-8-research0031.txt:        DNA chip technology. Alternatively, cDNA can be spotted on
technical/biomed/gb-2001-2-8-research0031.txt:        nylon filters or glass slides. Complex mRNA probes are
technical/biomed/gb-2001-2-8-research0031.txt:        mRNA concentrations can be measured in parallel,
technical/biomed/gb-2001-2-8-research0031.txt:        exploratory and requires an external similarity measure.
technical/biomed/gb-2001-2-8-research0031.txt:            Alternatively, the generalized linear model can be
technical/biomed/gb-2001-2-8-research0032.txt:          also used half of the probe pairs (by alternatively
technical/biomed/gb-2001-2-8-research0032.txt:          at total mRNA level (the total mRNA sample is split and
technical/biomed/gb-2001-2-8-research0032.txt:          limit of expression to a lower mRNA concentration.
technical/biomed/gb-2001-2-9-research0035.txt:        reconstructions, alternative gene boundaries and verified
technical/biomed/gb-2001-2-9-research0035.txt:        system [ 10] was also applied. MAGPIE detected alternative
technical/biomed/gb-2001-2-9-research0035.txt:          and 116 to encode RNAs. Since then six Bnums have been
technical/biomed/gb-2001-2-9-research0035.txt:          RNA encoding b4408. The current number of 
technical/biomed/gb-2001-2-9-research0035.txt:          encoding proteins and 116 encoding RNAs.
technical/biomed/gb-2001-2-9-research0035.txt:          result of internal duplication (56 genes) or a
technical/biomed/gb-2001-2-9-research0035.txt:          represented by 4,401 genes encoding 116 RNAs and 4,616
technical/biomed/gb-2001-2-9-research0035.txt:          matching internal paralogs as 
technical/biomed/gb-2001-2-9-research0035.txt:        deposit. Alternative gene boundaries were produced by
technical/biomed/gb-2001-2-9-research0037.txt:        alternative to 
technical/biomed/gb-2001-2-9-research0037.txt:        for translation of a messenger RNA into an amino acid. EST
technical/biomed/gb-2001-2-9-research0037.txt:        An alternative approach to determining the origin of a
technical/biomed/gb-2001-2-9-research0037.txt:        isolated source of a sequence was an mRNA or DNA molecule,
technical/biomed/gb-2001-2-9-research0037.txt:        as indicated by the column labeled 'mRNA?'.
technical/biomed/gb-2001-2-9-research0037.txt:        single-stranded RNAs such as transfer and ribosomal RNAs [
technical/biomed/gb-2001-2-9-research0037.txt:        highly conserved across taxa than messenger RNAs. Also,
technical/biomed/gb-2001-2-9-research0037.txt:        the mRNA sequence were present in the training set. This
technical/biomed/gb-2001-2-9-research0037.txt:        be expected when sequencing reverse complements of mRNAs
technical/biomed/gb-2001-2-9-research0037.txt:        bacteria generally do not form polyadenylated mRNAs [ 35].
technical/biomed/gb-2001-2-9-research0037.txt:        As the protocols used to extract and purify mRNAs from
technical/biomed/gb-2001-2-9-research0037.txt:            RNA sequences. The results consisted of all sequences
technical/biomed/gb-2001-2-9-research0037.txt:            basidiomycetes, based on 18S ribosomal RNA sequence
technical/biomed/gb-2001-2-9-research0037.txt:            contain an internal poly(A) or poly(T) segment longer
technical/biomed/gb-2001-2-9-research0037.txt:            The decision to exclude non-coding RNA sequences from
technical/biomed/gb-2001-2-9-research0037.txt:          mitochondrial genes, and non-coding RNA transcripts
technical/biomed/gb-2001-2-9-research0037.txt:          (ribosomal and transfer RNAs). Independent BLASTN
technical/biomed/gb-2001-2-9-research0037.txt:          et al. [ 19] tested two alternative
technical/biomed/gb-2001-2-9-research0037.txt:          A . Alternatively, it might be from
technical/biomed/gb-2001-3-1-research0001.txt:        cRNA have amply confirmed that many AQPs do facilitate
technical/biomed/gb-2001-3-1-research0001.txt:          internal segment including exons 3 and 4 and parts of
technical/biomed/gb-2001-3-1-research0001.txt:          and/or diurnal rhythmicity, light-regulated expression
technical/biomed/gb-2001-3-1-research0001.txt:          fact, diurnal expression changes in root aquaporin
technical/biomed/gb-2001-3-1-research0001.txt:          R is present at the internal loop in
technical/biomed/gb-2001-3-1-research0001.txt:          reminiscent of the consensus at the putative internal
technical/biomed/gb-2001-3-1-research0001.txt:          at their carboxyl terminus. No such internal site is
technical/biomed/gb-2001-3-1-research0001.txt:          between the plasma membrane and internal vesicles, a
technical/biomed/gb-2001-3-1-research0001.txt:          for those for movement from the external medium into the
technical/biomed/gb-2001-3-1-research0004.txt:          values at many individual internal nodes, the clusters
technical/biomed/gb-2001-3-1-research0004.txt:          internalized tunnel ([ 7] and references therein). Ligand
technical/biomed/gb-2001-3-1-research0004.txt:          allosteric conformations are mediated by alternative salt
technical/biomed/gb-2001-3-1-research0004.txt:          with K167, it forms an alternative salt bridge with R141,
technical/biomed/gb-2001-3-1-research0004.txt:          K167, which participates in the alternative β-β or β-α
technical/biomed/gb-2001-3-1-research0004.txt:          rRNA tree in Figure 7. 
technical/biomed/gb-2001-3-1-research0004.txt:          Perhaps the most likely 'alternative' function of
technical/biomed/gb-2001-3-1-research0005.txt:        amplification and fractionation of cDNA and cRNA.
technical/biomed/gb-2001-3-1-research0005.txt:        cRNA. Whereas our results show that quantitative detection
technical/biomed/gb-2001-3-1-research0005.txt:        alternative metrics for further improving the power of the
technical/biomed/gb-2001-3-1-research0005.txt:        Biotinylated target cRNA from four prokaryotic genes - 
technical/biomed/gb-2001-3-1-research0005.txt:        complex cRNA background generated from human brain total
technical/biomed/gb-2001-3-1-research0005.txt:        RNA. This background concentration roughly corresponds to
technical/biomed/gb-2001-3-1-research0005.txt:        total RNA concentration. 
technical/biomed/gb-2001-3-1-research0005.txt:        target transcripts + cRNA background), a tenfold reduction
technical/biomed/gb-2001-3-1-research0005.txt:        background cRNA content. In the cRNA sample comprised
technical/biomed/gb-2001-3-1-research0005.txt:        a standard assay (brain cRNA background), the range of
technical/biomed/gb-2001-3-1-research0005.txt:        complex cRNA. Consequently, by comparing both sides of
technical/biomed/gb-2001-3-1-research0005.txt:        Addition of a complex cRNA background elicited a
technical/biomed/gb-2001-3-1-research0005.txt:        were detectable in the absence of brain cRNA background.
technical/biomed/gb-2001-3-1-research0005.txt:        However, the presence of complex cRNA essentially rendered
technical/biomed/gb-2001-3-1-research0005.txt:        them undetectable. It is evident that the complex cRNA
technical/biomed/gb-2001-3-1-research0005.txt:        the absence of complex cRNA. The increased hybridization
technical/biomed/gb-2001-3-1-research0005.txt:        or present complex cRNA background; and the use of
technical/biomed/gb-2001-3-1-research0005.txt:        previously that the ADI is proportional to cRNA level and
technical/biomed/gb-2001-3-1-research0005.txt:        predictive of absolute RNA concentration within a factor of
technical/biomed/gb-2001-3-1-research0005.txt:        sequence diversity and amount of cRNA will nonlinearly
technical/biomed/gb-2001-3-1-research0005.txt:        solely because of the presence of eukaryotic cRNA
technical/biomed/gb-2001-3-1-research0005.txt:        specific and relate to cRNA derived from the same yeast
technical/biomed/gb-2001-3-1-research0005.txt:        lieu of an ideal functional profile, the use of alternative
technical/biomed/gb-2001-3-1-research0005.txt:        background. However, after addition of cRNA background,
technical/biomed/gb-2001-3-1-research0005.txt:        be a viable alternative, as these enabled partial detection
technical/biomed/gb-2001-3-1-research0005.txt:        new methods of mRNA amplification [ 9] that robustly
technical/biomed/gb-2001-3-1-research0005.txt:        simultaneously distort the underlying RNA expression
technical/biomed/gb-2001-3-1-research0005.txt:        saturation level was not affected by cRNA background. The
technical/biomed/gb-2001-3-1-research0005.txt:        background noise. The net result of cRNA background is that
technical/biomed/gb-2001-3-1-research0005.txt:          preparing cRNA and subsequent steps leading to
technical/biomed/gb-2001-3-1-research0005.txt:          NY) using a BioArray High Yield RNA Transcript Labeling
technical/biomed/gb-2001-3-1-research0005.txt:          labeled cRNA was purified using RNeasy spin columns
technical/biomed/gb-2001-3-1-research0005.txt:          eukaryotic transcripts, 20 μg total human brain RNA
technical/biomed/gb-2001-3-1-research0005.txt:          labeled cRNA was included into a final volume of 80 μl
technical/biomed/gb-2001-3-1-research0005.txt:          Before hybridization, the cRNA samples were heated to
technical/biomed/gb-2002-3-10-research0052.txt:        or through an RNA intermediate. Retrotransposons mobilize
technical/biomed/gb-2002-3-10-research0052.txt:        through an RNA intermediate, and are classified as either
technical/biomed/gb-2002-3-10-research0052.txt:        nucleotides long and consists of a 5' UTR with an internal
technical/biomed/gb-2002-3-10-research0052.txt:        from an internal RNA polymerase II promoter [ 15, 16], and
technical/biomed/gb-2002-3-10-research0052.txt:        L1 RNA, integrating the L1 into a new genomic locus [ 12,
technical/biomed/gb-2002-3-10-research0052.txt:          Alternatively, long TSDs may be an artifact of
technical/biomed/gb-2002-3-10-research0052.txt:          presence of an intact L1 internal promoter [ 16, 43, 44].
technical/biomed/gb-2002-3-10-research0052.txt:          however, these alternative codons have been documented in
technical/biomed/gb-2002-3-10-research0052.txt:          insertions in the genome are internally rearranged [ 42].
technical/biomed/gb-2002-3-10-research0052.txt:          and end points of coding sequence (CDS) and mRNA
technical/biomed/gb-2002-3-10-research0052.txt:          genomic segment to which an mRNA and/or CDS has been
technical/biomed/gb-2002-3-10-research0052.txt:          gene's mRNA due to the L1 polyadenylation signal [ 27,
technical/biomed/gb-2002-3-10-research0052.txt:          We found that 2,864 mRNAs (approximately 9% of all
technical/biomed/gb-2002-3-10-research0052.txt:          annotated mRNA or CDS was, on average, 282 kb upstream or
technical/biomed/gb-2002-3-10-research0052.txt:        standard L1 insertions. Alternatively, it has been reported
technical/biomed/gb-2002-3-10-research0052.txt:          files at [ 55]) was collected and scanned for mRNA or CDS
technical/biomed/gb-2002-3-10-research0052.txt:          with the locations of the mRNA and CDS annotations. L1s
technical/biomed/gb-2002-3-10-research0052.txt:          annotated CDS or mRNAs. The same approach was used to
technical/biomed/gb-2002-3-10-research0052.txt:          generate the mRNA and CDS densities along the length of
technical/biomed/gb-2002-3-10-research0053.txt:        involving an RNA intermediate. The RNA genome of a
technical/biomed/gb-2002-3-10-research0053.txt:          Osr12 contains a large internal
technical/biomed/gb-2002-3-10-research0053.txt:          Osr25 are all internally deleted
technical/biomed/gb-2002-3-10-research0053.txt:          internally deleted and either completely lack or encode
technical/biomed/gb-2002-3-10-research0053.txt:          cultivar used by the International Rice Genome Sequencing
technical/biomed/gb-2002-3-10-research0055.txt:          'tryptophanyl-tRNA synthetase', 'Sky' = 'TYRO3 protein
technical/biomed/gb-2002-3-10-research0055.txt:          co-regulated ESTs is the 'Homo sapiens cig5 mRNA, partial
technical/biomed/gb-2002-3-10-research0056.txt:        responses to hormones, developmental cues and external
technical/biomed/gb-2002-3-11-research0059.txt:        evolved to survive varying internal and external
technical/biomed/gb-2002-3-11-research0059.txt:            alternative groups of genes is triggered by different
technical/biomed/gb-2002-3-11-research0059.txt:            involved in respiration and utilization of alternative
technical/biomed/gb-2002-3-11-research0059.txt:            the use of alternative carbon sources and respiration
technical/biomed/gb-2002-3-11-research0059.txt:        details reflect the alternative regulatory systems that are
technical/biomed/gb-2002-3-11-research0059.txt:        alternative system (Gcn4p) in response to a general signal
technical/biomed/gb-2002-3-11-research0059.txt:        alternative algorithms that might accomplish the same ends.
technical/biomed/gb-2002-3-11-research0060.txt:          repression sensor kinase for PhoB, an alternative sensor
technical/biomed/gb-2002-3-11-research0060.txt:          high internal osmotic pressure [ 17]. LpxD is a key
technical/biomed/gb-2002-3-11-research0061.txt:        versatile folds probably emerged in contexts related to RNA
technical/biomed/gb-2002-3-11-research0061.txt:        the external surfaces of the sheets. A few ancient and
technical/biomed/gb-2002-3-11-research0061.txt:        have had roles related to RNA metabolism [ 9, 11, 12, 13].
technical/biomed/gb-2002-3-11-research0061.txt:        RNA processing and ribosomal assembly in the course of
technical/biomed/gb-2002-3-11-research0061.txt:        evolutionary connection between RNA metabolism, translation
technical/biomed/gb-2002-3-11-research0061.txt:          for efficient translation and processing of 16S RNA [ 23,
technical/biomed/gb-2002-3-11-research0061.txt:          participates in the maturation of the 16S rRNA [ 23, 24,
technical/biomed/gb-2002-3-11-research0061.txt:          could be used to bind RNA or proteins. An acidic residue
technical/biomed/gb-2002-3-11-research0061.txt:          proteins, or, alternatively, interact with RNA. The
technical/biomed/gb-2002-3-11-research0061.txt:          RNA metabolism [ 9]. Likewise, the presence of the
technical/biomed/gb-2002-3-11-research0061.txt:          they function in RNA metabolism, perhaps as the archaeal
technical/biomed/gb-2002-3-11-research0061.txt:          involved in RNA metabolism. The extensive presence of
technical/biomed/gb-2002-3-11-research0061.txt:        is predicted to function in RNA metabolism. It seems
technical/biomed/gb-2002-3-11-research0061.txt:        in RNA metabolism. The identification of this domain may
technical/biomed/gb-2002-3-11-research0061.txt:        metabolism and RNA metabolism.
technical/biomed/gb-2002-3-11-research0062.txt:        Pooled RNA derived from cell lines is a commonly used
technical/biomed/gb-2002-3-11-research0062.txt:        variety of tissues. One example is the universal human RNA
technical/biomed/gb-2002-3-11-research0062.txt:        reference consists of equimolar quantities of RNA from ten
technical/biomed/gb-2002-3-11-research0062.txt:        protocols and including many different RNA samples will
technical/biomed/gb-2002-3-11-research0062.txt:        identifying differentially expressed genes. RNA from 19
technical/biomed/gb-2002-3-11-research0062.txt:        reference RNA, and RNA isolated from a tumor specimen were
technical/biomed/gb-2002-3-11-research0062.txt:        optimal reference pool consisting of RNA derived from cell
technical/biomed/gb-2002-3-11-research0062.txt:        representation in the final RNA pool is below the
technical/biomed/gb-2002-3-11-research0062.txt:        design of reference RNA samples.
technical/biomed/gb-2002-3-11-research0062.txt:          cDNA microarray data across a number of distinct RNA
technical/biomed/gb-2002-3-11-research0062.txt:          which aliquots of the same RNA are separately labeled
technical/biomed/gb-2002-3-11-research0062.txt:          microarray. Poly(A) +RNA was prepared from 19 human
technical/biomed/gb-2002-3-11-research0062.txt:          human reference RNA. RNA was reverse transcribed into
technical/biomed/gb-2002-3-11-research0062.txt:          the RNA sample assayed in each experiment. This is also
technical/biomed/gb-2002-3-11-research0062.txt:          array experiments, using mRNA derived from human
technical/biomed/gb-2002-3-11-research0062.txt:          In our experience, hybridization using RNA derived
technical/biomed/gb-2002-3-11-research0062.txt:          of comparable quality can be generated with tissue RNA,
technical/biomed/gb-2002-3-11-research0062.txt:          we carried out a similar expression analysis using RNA
technical/biomed/gb-2002-3-11-research0062.txt:          micrograms of total RNA that have been extracted using
technical/biomed/gb-2002-3-11-research0062.txt:          samples, such as RNA from a cell line and the same line
technical/biomed/gb-2002-3-11-research0062.txt:          triplicate hybridizations. RNA from the same isolation
technical/biomed/gb-2002-3-11-research0062.txt:          samples often consist of pools of RNA molecules derived
technical/biomed/gb-2002-3-11-research0062.txt:          source of large quantities of RNA. Each cell line
technical/biomed/gb-2002-3-11-research0062.txt:          expresses a distinct assortment of RNA species, so any
technical/biomed/gb-2002-3-11-research0062.txt:          Consequently, cell line RNA reference pools are typically
technical/biomed/gb-2002-3-11-research0062.txt:          underlying such a design is that by combining RNAs from
technical/biomed/gb-2002-3-11-research0062.txt:          quantities of RNA. TP-1 consists of colon cell lines
technical/biomed/gb-2002-3-11-research0062.txt:          This illustrates that a simple pool of RNA from diverse
technical/biomed/gb-2002-3-11-research0062.txt:        tissue RNA from tumor samples. Individual labeling
technical/biomed/gb-2002-3-11-research0062.txt:        number of RNA samples from cell lines and tissue, suggest
technical/biomed/gb-2002-3-11-research0062.txt:          (Telechem International) as described previously and
technical/biomed/gb-2002-3-11-research0062.txt:          RNA extraction
technical/biomed/gb-2002-3-11-research0062.txt:          200 μg/ml streptomycin and 200 U/ml penicillin. RNA was
technical/biomed/gb-2002-3-11-research0062.txt:          the manufacturer's protocol and stored at -80°C. mRNA
technical/biomed/gb-2002-3-11-research0062.txt:          selection from 100 μg total RNA using oligo-d(T) 
technical/biomed/gb-2002-3-11-research0062.txt:          +-enriched RNA in 20 μl 10 mM Tris-HCl, pH 7.5. Agilent
technical/biomed/gb-2002-3-11-research0062.txt:          2100 Bioanalyzer mRNA assays were carried out on 1-μl
technical/biomed/gb-2002-3-11-research0062.txt:          vary between 0 and 25%. The rest of the mRNA sample was
technical/biomed/gb-2002-3-11-research0062.txt:          RNA from a colon tumor liver metastasis was extracted
technical/biomed/gb-2002-3-11-research0062.txt:          total RNA were used.
technical/biomed/gb-2002-3-11-research0062.txt:          μl of 0.5 M EDTA and RNA template was hydrolyzed by the
technical/biomed/gb-2002-3-11-research0062.txt:          to 18S ribosomal RNA Ambion QuantumRNA 18S Internal
technical/biomed/gb-2002-3-11-research0065.txt:          of RNA expression data, in which the shape of the
technical/biomed/gb-2002-3-11-research0065.txt:        designed for expression (mRNA) studies, in which the
technical/biomed/gb-2002-3-12-research0071.txt:        alternatively, empirical evaluation of the distribution of
technical/biomed/gb-2002-3-12-research0071.txt:          amount of labeled mRNA hybridized to the microarray, the
technical/biomed/gb-2002-3-12-research0071.txt:          where is the absolute quantity of mRNA per cell, the 
technical/biomed/gb-2002-3-12-research0071.txt:           are the scaled quantities of mRNA in samples 
technical/biomed/gb-2002-3-12-research0071.txt:          terms that are consistent for both mRNA preparations,
technical/biomed/gb-2002-3-12-research0075.txt:        dataset to demonstrate its validity as an alternative to
technical/biomed/gb-2002-3-12-research0075.txt:        provides good evidence that CGMA is a practical alternative
technical/biomed/gb-2002-3-12-research0077.txt:        evolution, correlated mRNA profiles and patterns of domain
technical/biomed/gb-2002-3-12-research0077.txt:        other RNA-binding structures, support the argument that
technical/biomed/gb-2002-3-12-research0077.txt:        YlxR is an RNA-binding protein.
technical/biomed/gb-2002-3-12-research0077.txt:        correspond to distances between phosphate groups in an RNA
technical/biomed/gb-2002-3-12-research0077.txt:        implies that the predicted RNA-binding function is
technical/biomed/gb-2002-3-12-research0077.txt:        residues modulate the specificity of the predicted RNA
technical/biomed/gb-2002-3-12-research0077.txt:        of potential subtypes in the RNA-binding specificity.
technical/biomed/gb-2002-3-12-research0077.txt:        the acceptor stem of prokaryotic prolyl-tRNA synthetases (S
technical/biomed/gb-2002-3-12-research0077.txt:        have shown that RNA-binding proteins are flexible and
technical/biomed/gb-2002-3-12-research0077.txt:        evidence that the prolyl-tRNA synthetases (S 
technical/biomed/gb-2002-3-12-research0077.txt:        prediction. These findings supported an RNA-binding
technical/biomed/gb-2002-3-12-research0077.txt:          Alternatively, in the subclade trace algorithm, requiring
technical/biomed/gb-2002-3-12-research0078.txt:        and/or structure of the gene product. An alternative
technical/biomed/gb-2002-3-12-research0078.txt:        noncoding regions of mRNAs can have functional effects. For
technical/biomed/gb-2002-3-12-research0078.txt:        affect mRNA translation, and sequence in the 3' UTR can
technical/biomed/gb-2002-3-12-research0078.txt:        affect mRNA stability. The 3' UTR region can also contain
technical/biomed/gb-2002-3-12-research0078.txt:        relevance of sequence changes in noncoding parts of mRNAs
technical/biomed/gb-2002-3-12-research0078.txt:          the brains dissected. Whole-brain RNA was isolated using
technical/biomed/gb-2002-3-12-research0079.txt:          RNA-directed RNA polymerase, interspersed with 1-kb units
technical/biomed/gb-2002-3-12-research0079.txt:          side by 120-bp tandem repeats with similarity to snoRNAs
technical/biomed/gb-2002-3-12-research0079.txt:            Internal sequencing primers were synthesized for
technical/biomed/gb-2002-3-12-research0079.txt:            generate the sequence. Alternatively, random shotgun
technical/biomed/gb-2002-3-12-research0080.txt:        additional cases of RNA editing. We have confirmed the
technical/biomed/gb-2002-3-12-research0080.txt:          internal estimates of RT errors (see below), based on the
technical/biomed/gb-2002-3-12-research0080.txt:          RNAseH-deficient RT (SuperScriptII, Invitrogen, Carlsbad,
technical/biomed/gb-2002-3-12-research0080.txt:          likely the result of priming from internal poly(A)
technical/biomed/gb-2002-3-12-research0080.txt:          opposite strand from that of the mRNA encoding the
technical/biomed/gb-2002-3-12-research0080.txt:          may represent alternative transcripts (138) and clones
technical/biomed/gb-2002-3-12-research0080.txt:          represent alternative splicing forms. To identify cDNAs
technical/biomed/gb-2002-3-12-research0080.txt:          mRNA editing
technical/biomed/gb-2002-3-12-research0080.txt:          RNA editing is a well-documented mechanism of
technical/biomed/gb-2002-3-12-research0080.txt:          double-stranded regions of nuclear-encoded RNAs,
technical/biomed/gb-2002-3-12-research0080.txt:          conversion in the mRNA can alter the genetic information
technical/biomed/gb-2002-3-12-research0080.txt:          function of pre-mRNA editing is to modify adult behavior
technical/biomed/gb-2002-3-12-research0080.txt:          25, 26]. Among the mRNAs known to be edited in 
technical/biomed/gb-2002-3-12-research0080.txt:          reveal cases of RNA editing. In cases in which the
technical/biomed/gb-2002-3-12-research0080.txt:          with RNA editing; however, additional cDNA or EST data
technical/biomed/gb-2002-3-12-research0080.txt:          will be required to distinguish RNA editing from RT
technical/biomed/gb-2002-3-12-research0080.txt:          enough cDNA and EST data to indicate that RNA editing is
technical/biomed/gb-2002-3-12-research0080.txt:          human [ 30, 31]. Ten potential sites of RNA editing were
technical/biomed/gb-2002-3-12-research0080.txt:          by gene-specific RT-PCR using RNA isolated from heads of
technical/biomed/gb-2002-3-12-research0080.txt:          rigorous and thorough analysis of potential RNA-editing
technical/biomed/gb-2002-3-12-research0080.txt:          mRNA editing
technical/biomed/gb-2002-3-12-research0080.txt:          corresponding to a mRNA edited base is q90. Similarly, we
technical/biomed/gb-2002-3-12-research0080.txt:          determined the phrap estimated error rate for each mRNA
technical/biomed/gb-2002-3-12-research0080.txt:          validate the editing sites, total RNA was isolated from
technical/biomed/gb-2002-3-12-research0080.txt:          RNA isolation reagent according to the manufacturer's
technical/biomed/gb-2002-3-12-research0081.txt:          available. However, when we introduced the internal
technical/biomed/gb-2002-3-12-research0081.txt:          portion of code became an alternative means of
technical/biomed/gb-2002-3-12-research0081.txt:          possible alternative transcripts from the raw EST
technical/biomed/gb-2002-3-12-research0081.txt:          alternative donor sites. The set of possible transcripts
technical/biomed/gb-2002-3-12-research0081.txt:          External pipelines
technical/biomed/gb-2002-3-12-research0081.txt:          external groups to run their pipelines on our genomic
technical/biomed/gb-2002-3-12-research0081.txt:          available from our internal pipeline.
technical/biomed/gb-2002-3-12-research0081.txt:          network-wide NIS maps were translated to the internal
technical/biomed/gb-2002-3-12-research0081.txt:        'exon', 'transcript', 'protein-coding gene', 'tRNA gene',
technical/biomed/gb-2002-3-12-research0081.txt:        external pipeline, usually delivered as files conforming to
technical/biomed/gb-2002-3-12-research0081.txt:        literature, such as tRNA, snRNA, snoRNA, microRNA or rRNA
technical/biomed/gb-2002-3-12-research0081.txt:        transposable element, or a tRNA overlaps a protein-coding
technical/biomed/gb-2002-3-12-research0081.txt:        our original definition of 'alternative transcript'; the
technical/biomed/gb-2002-3-12-research0081.txt:        processed mRNA, requiring support for one to many
technical/biomed/gb-2002-3-12-research0082.txt:        determining alternative transcripts, understanding promoter
technical/biomed/gb-2002-3-12-research0082.txt:        useful predictive programs for tRNA genes [ 16] and
technical/biomed/gb-2002-3-12-research0082.txt:        non-coding RNA genes. Until a day arrives when we know all
technical/biomed/gb-2002-3-12-research0082.txt:          As alternatively spliced transcripts are added to a
technical/biomed/gb-2002-3-12-research0082.txt:          creates alternatively spliced transcripts for a gene
technical/biomed/gb-2002-3-12-research0082.txt:          External data adaptors: connecting Apollo to a
technical/biomed/gb-2002-3-12-research0082.txt:          Typically (for data coming from an external data source)
technical/biomed/gb-2002-3-12-research0082.txt:          structure of the external data and the internal Apollo
technical/biomed/gb-2002-3-12-research0082.txt:          feature or sequence data from an external source. The
technical/biomed/gb-2002-3-12-research0082.txt:          allow the user to select an adaptor for an external data
technical/biomed/gb-2002-3-12-research0082.txt:          software that must be provided to add a new external
technical/biomed/gb-2002-3-12-research0082.txt:          software developer must provide to add an external
technical/biomed/gb-2002-3-12-research0082.txt:          an alternate to explicitly setting load parameters using
technical/biomed/gb-2002-3-12-research0082.txt:          In summary, the mechanics of adding a new external
technical/biomed/gb-2002-3-12-research0082.txt:        between their internal data and the public human genomic
technical/biomed/gb-2002-3-12-research0082.txt:        name to query their internal data source and then display
technical/biomed/gb-2002-3-12-research0082.txt:        the data from an internal web service. The 
technical/biomed/gb-2002-3-12-research0082.txt:        from external pipelines and of the internal sequence reads
technical/biomed/gb-2002-3-12-research0082.txt:        Finally, we have developed external analysis adaptors
technical/biomed/gb-2002-3-12-research0083.txt:        non-protein-coding RNA gene. Adding such annotations to the
technical/biomed/gb-2002-3-12-research0083.txt:        alternative transcripts has increased as a direct result of
technical/biomed/gb-2002-3-12-research0083.txt:        coding regions contained on a single processed mRNA), and
technical/biomed/gb-2002-3-12-research0083.txt:        genes that, by means of alternative splicing, encode two
technical/biomed/gb-2002-3-12-research0083.txt:            compared to Release 2 (5%) show alternative transcripts
technical/biomed/gb-2002-3-12-research0083.txt:            alternative splicing (an introduced bias; see Materials
technical/biomed/gb-2002-3-12-research0083.txt:            and methods), but 13% are due to alternative promoters
technical/biomed/gb-2002-3-12-research0083.txt:            and 6% to alternative polyadenylation sites.
technical/biomed/gb-2002-3-12-research0083.txt:            Alternative splicing results in the 26% increase in the
technical/biomed/gb-2002-3-12-research0083.txt:            massive 69.7 kilobase (kb) mRNA and a 23,054 amino-acid
technical/biomed/gb-2002-3-12-research0083.txt:            Non-protein-coding RNA genes
technical/biomed/gb-2002-3-12-research0083.txt:            Small, non-protein-coding RNAs are also included in
technical/biomed/gb-2002-3-12-research0083.txt:            this re-annotation. We searched for new tRNA genes
technical/biomed/gb-2002-3-12-research0083.txt:            using the program tRNAscan-SE [ 32] and Sim4 alignments
technical/biomed/gb-2002-3-12-research0083.txt:            to known tRNAs: 290 are annotated in the euchromatin
technical/biomed/gb-2002-3-12-research0083.txt:            (Table 2). Release 1 reported 292 tRNAs [ 3]; two tRNA
technical/biomed/gb-2002-3-12-research0083.txt:            Other non-protein-coding RNAs are limited, in
technical/biomed/gb-2002-3-12-research0083.txt:            database [ 1, 2]. All 23 of the known microRNAs in 
technical/biomed/gb-2002-3-12-research0083.txt:            the 45 small nuclear RNAs (snRNAs) involved in
technical/biomed/gb-2002-3-12-research0083.txt:            splicing, with the exception of the four snRNAs, K2a,
technical/biomed/gb-2002-3-12-research0083.txt:            or cytological data available. Of the 41 snRNAs
technical/biomed/gb-2002-3-12-research0083.txt:            we precisely located by sequence alignment 28 snRNAs in
technical/biomed/gb-2002-3-12-research0083.txt:            snRNA:U4atac gene in the 83A
technical/biomed/gb-2002-3-12-research0083.txt:            All nine of the small nucleolar RNA (snoRNA) genes
technical/biomed/gb-2002-3-12-research0083.txt:            located 19 more snoRNAs. Identification of other
technical/biomed/gb-2002-3-12-research0083.txt:            snoRNAs should be possible in the future with the use
technical/biomed/gb-2002-3-12-research0083.txt:            methylation guide snoRNAs [ 35]; however, the program
technical/biomed/gb-2002-3-12-research0083.txt:            The longer non-protein-coding RNA genes αγ- 
technical/biomed/gb-2002-3-12-research0083.txt:            element, bft, RNaseP:RNA, Hsr-omega,
technical/biomed/gb-2002-3-12-research0083.txt:            7SLRNA, pgc, roX1, roX2 , and 
technical/biomed/gb-2002-3-12-research0083.txt:            genome. 27 new 'miscellaneous non-coding RNA' genes
technical/biomed/gb-2002-3-12-research0083.txt:            including non-coding RNAs, are included within the
technical/biomed/gb-2002-3-12-research0083.txt:            We analyzed the mRNAs predicted for neighboring
technical/biomed/gb-2002-3-12-research0083.txt:            annotated genes (2,054) involve the overlap of mRNAs on
technical/biomed/gb-2002-3-12-research0083.txt:            Complementary sequences between distinct RNAs from
technical/biomed/gb-2002-3-12-research0083.txt:            Alternatively transcribed genes
technical/biomed/gb-2002-3-12-research0083.txt:            alternative transcripts. Approximately 20% of Release 3
technical/biomed/gb-2002-3-12-research0083.txt:            internal alternative splicing as well as alternative
technical/biomed/gb-2002-3-12-research0083.txt:            alternative splicing will undoubtedly be identified.
technical/biomed/gb-2002-3-12-research0083.txt:            alternative splicing that was observed clearly
technical/biomed/gb-2002-3-12-research0083.txt:            illustrates that alternative splicing is an important
technical/biomed/gb-2002-3-12-research0083.txt:            Alternative splicing creates opportunities for
technical/biomed/gb-2002-3-12-research0083.txt:            Very commonly, these alternative transcripts vary in
technical/biomed/gb-2002-3-12-research0083.txt:            of alternative promoters and offering the possibility
technical/biomed/gb-2002-3-12-research0083.txt:            alternative transcripts encode two or more protein
technical/biomed/gb-2002-3-12-research0083.txt:            products, indicating that alternative splicing
technical/biomed/gb-2002-3-12-research0083.txt:            are alternatively spliced to an array of different 3'
technical/biomed/gb-2002-3-12-research0083.txt:            alternative transcripts (including four previously
technical/biomed/gb-2002-3-12-research0083.txt:            specific RNA polymerase II transcription factors that
technical/biomed/gb-2002-3-12-research0083.txt:            Alternative splicing can produce two (or more)
technical/biomed/gb-2002-3-12-research0083.txt:            pre-mRNA species; we identified 12 such cases (for
technical/biomed/gb-2002-3-12-research0083.txt:            Spec , see Figure 7). The mRNAs
technical/biomed/gb-2002-3-12-research0083.txt:            mRNAs, and thus internal translation initiation is not
technical/biomed/gb-2002-3-12-research0083.txt:            continuum of protein diversity created by alternative
technical/biomed/gb-2002-3-12-research0083.txt:            regions contained on a single processed mRNA, requiring
technical/biomed/gb-2002-3-12-research0083.txt:            internal initiation of translation of the downstream
technical/biomed/gb-2002-3-12-research0083.txt:            there is evidence supporting alternative monocistronic
technical/biomed/gb-2002-3-12-research0083.txt:            occur at an internal site. There are two proposed
technical/biomed/gb-2002-3-12-research0083.txt:            mechanisms for the initiation of internal translation.
technical/biomed/gb-2002-3-12-research0083.txt:            One mechanism is that internal initiation occurs by
technical/biomed/gb-2002-3-12-research0083.txt:            initiation utilizing an internal ribosome entry site
technical/biomed/gb-2002-3-12-research0083.txt:            UTRs might be translated via internal ribosome entry.
technical/biomed/gb-2002-3-12-research0083.txt:            alternative transcripts not currently in the DGC.
technical/biomed/gb-2002-3-12-research0083.txt:            as an alternative splice donor. Eleven instances of
technical/biomed/gb-2002-3-12-research0083.txt:            sba (CG13598) . Two alternative
technical/biomed/gb-2002-3-12-research0083.txt:            two alternative transcripts encoded by the same gene,
technical/biomed/gb-2002-3-12-research0083.txt:        genes with overlapping UTRs; genes with alternative
technical/biomed/gb-2002-3-12-research0083.txt:        show alternative splicing or are nested within neighboring
technical/biomed/gb-2002-3-12-research0083.txt:          determination of alternative transcriptional starts and
technical/biomed/gb-2002-3-12-research0083.txt:          containing each site of alternative splicing represented
technical/biomed/gb-2002-3-12-research0083.txt:          Often, sites of alternative splicing were supported by
technical/biomed/gb-2002-3-12-research0083.txt:          alternative transcripts that differ as a result of
technical/biomed/gb-2002-3-12-research0083.txt:          To annotate small, non-protein-coding RNA genes
technical/biomed/gb-2002-3-12-research0083.txt:          Sim4 alignment. MicroRNAs were aligned by BLASTN
technical/biomed/gb-2002-3-12-research0083.txt:          microRNAs listed in FlyBase.
technical/biomed/gb-2002-3-12-research0083.txt:            (chimeras), and internal priming of cDNAs during
technical/biomed/gb-2002-3-12-research0083.txt:            readily distinguishable from alternative splicing
technical/biomed/gb-2002-3-12-research0083.txt:            UTRs, alternative splicing events, detailed exon-intron
technical/biomed/gb-2002-3-12-research0083.txt:            alternatively spliced products. At the time of
technical/biomed/gb-2002-3-12-research0083.txt:            transposable elements and tRNA genes, or appeared
technical/biomed/gb-2002-3-12-research0083.txt:        distribution of alternatively spliced transcripts, and
technical/biomed/gb-2002-3-12-research0085.txt:        bobbed (ribosomal RNA), and the
technical/biomed/gb-2002-3-12-research0085.txt:          Finally, we annotated six non-protein-coding RNA
technical/biomed/gb-2002-3-12-research0085.txt:          and 28 rRNAs, a truncated 18S rRNA sequence that extends
technical/biomed/gb-2002-3-12-research0085.txt:          into a sequence gap, and a truncated 2S rRNA sequence
technical/biomed/gb-2002-3-12-research0085.txt:          (UTRs), alternative transcripts, and intron-exon
technical/biomed/gb-2002-3-12-research0085.txt:          sequences define two alternative 
technical/biomed/gb-2002-3-12-research0085.txt:          sequences using Apollo. Alternative transcripts supported
technical/biomed/gb-2002-3-12-research0085.txt:          at 60°C, pretreated in 100 μg/ml RNaseA/2x SSC, pH 7 at
technical/biomed/gb-2002-3-12-research0086.txt:        non-protein-coding RNAs, and 
technical/biomed/gb-2002-3-12-research0086.txt:          under the alternative hypotheses of functional constraint
technical/biomed/gb-2002-3-12-research0086.txt:          who proposed an alternative hypothesis for non-coding
technical/biomed/gb-2002-3-12-research0086.txt:          alternatives we studied the spatial distribution and
technical/biomed/gb-2002-3-12-research0086.txt:          EST/cDNA data exists will require alternative approaches,
technical/biomed/gb-2002-3-12-research0086.txt:          an alternative means of defining enhancer structure based
technical/biomed/gb-2002-3-12-research0086.txt:          [ 14]. For genes with alternative transcripts, the
technical/biomed/gb-2002-3-12-research0087.txt:        which comprises the multisubunit RNA polymerase II and
technical/biomed/gb-2002-3-12-research0087.txt:        methods that utilize the 5'-cap structure of mRNAs have
technical/biomed/gb-2002-3-12-research0087.txt:          examined these alignments for alternative splice forms
technical/biomed/gb-2002-3-12-research0087.txt:          but also exclude alternative start sites or start sites
technical/biomed/gb-2002-3-12-research0087.txt:          site of the mRNA [ 17, 19]; with a cluster of ESTs within
technical/biomed/gb-2002-3-12-research0087.txt:        recognition site for an alternative transcription
technical/biomed/gb-2002-3-12-research0087.txt:          showed evidence of alternative splicing. The remaining
technical/biomed/gb-2002-3-12-research0088.txt:        gene-expression patterns on a large scale - RNA 
technical/biomed/gb-2002-3-12-research0088.txt:        microarrays [ 2, 3, 4]. Whole-mount RNA 
technical/biomed/gb-2002-3-12-research0088.txt:        high-throughput fashion [ 7, 8]. Although RNA 
technical/biomed/gb-2002-3-12-research0088.txt:        attempt to isolate mRNA from every tissue at different
technical/biomed/gb-2002-3-12-research0088.txt:        We used high-throughput RNA 
technical/biomed/gb-2002-3-12-research0088.txt:          antisense RNA probe by 
technical/biomed/gb-2002-3-12-research0088.txt:          RNA probes were hybridized to fixed 
technical/biomed/gb-2002-3-12-research0088.txt:          maternally contributed but are ubiquitously expressed in
technical/biomed/gb-2002-3-12-research0088.txt:          maternally expressed; and 91 (4.2%) show both maternal
technical/biomed/gb-2002-3-12-research0088.txt:          Microarray data as independent measurements of RNA
technical/biomed/gb-2002-3-12-research0088.txt:          each time window, and hybridized total RNA from each
technical/biomed/gb-2002-3-12-research0088.txt:          Large-scale production of RNA 
technical/biomed/gb-2002-3-12-research0088.txt:          useful to identify experiments where the RNA 
technical/biomed/gb-2002-3-12-research0088.txt:          were also added to describe when and where a given mRNA
technical/biomed/gb-2002-3-12-research0088.txt:          side by side (Figure 7). Alternatively, one can explore
technical/biomed/gb-2002-3-12-research0088.txt:          Systematic RNA 
technical/biomed/gb-2002-3-12-research0088.txt:          alternative to mutagenesis screens [ 32] to uncover genes
technical/biomed/gb-2002-3-12-research0088.txt:          A major advantage of RNA 
technical/biomed/gb-2002-3-12-research0088.txt:          subcellular localization of mRNAs. Figure 9j,lshows an
technical/biomed/gb-2002-3-12-research0088.txt:          apically localized mRNA in the columnar epithelium of the
technical/biomed/gb-2002-3-12-research0088.txt:          that of a basally localized mRNA from a different gene
technical/biomed/gb-2002-3-12-research0088.txt:          the nucleus (Figure 9n,o). We also found novel mRNAs
technical/biomed/gb-2002-3-12-research0088.txt:          dataset can also be useful in identifying aspects of RNA
technical/biomed/gb-2002-3-12-research0088.txt:          a polymerase reaction cocktail consisting of 2 U T7 RNA
technical/biomed/gb-2002-3-12-research0088.txt:          polymerase, 4.6 U RNase inhibitor, 10 mM NTPs, 3.5 mM
technical/biomed/gb-2002-3-12-research0088.txt:          The digoxigenin-labeled RNA probe was quantified by
technical/biomed/gb-2002-3-12-research0088.txt:          pre-sterilized tips (Rainin). Digoxigenin-labeled RNA
technical/biomed/gb-2002-3-12-research0088.txt:          Total RNA was isolated from the 12 embryo samples
technical/biomed/gb-2002-3-12-research0088.txt:          plastic pellet pestle in Ambion RNAwiz solution, followed
technical/biomed/gb-2002-3-12-research0088.txt:          micrograms of total RNA were used to generate
technical/biomed/gb-2002-3-12-research0088.txt:          digoxigenin-labeled fragmented cRNA using a standard
technical/biomed/gb-2002-3-12-research0088.txt:          Affymetrix amplification and labeling protocol. cRNA was
technical/biomed/gb-2002-3-12-research0088.txt:          the form of external database links, protein domains and
technical/biomed/gb-2002-3-2-research0008.txt:        led to the proposal of two alternative hypotheses.
technical/biomed/gb-2002-3-2-research0008.txt:        genomes as well, in particular, aminoacyl-tRNA synthetases,
technical/biomed/gb-2002-3-2-research0008.txt:        being redundant [ 26]. The alternative hypothesis - that
technical/biomed/gb-2002-3-2-research0008.txt:        temporary mechanism to increase protein or RNA dosage, as
technical/biomed/gb-2002-3-2-research0008.txt:        in the case of rRNA genes in amphibian oocytes and ciliate
technical/biomed/gb-2002-3-2-research0009.txt:        alternative solutions to these issues is model-based
technical/biomed/gb-2002-3-2-research0009.txt:          microarrays [ 14] to the mRNA analysis of 1,176 genes in
technical/biomed/gb-2002-3-2-research0009.txt:          0 against the alternative 
technical/biomed/gb-2002-3-2-research0009.txt:          are interesting alternatives that provide a more
technical/biomed/gb-2002-3-2-research0009.txt:        were pooled and submitted for mRNA purification. Purified
technical/biomed/gb-2002-3-2-research0009.txt:        mRNAs, [α - 32P]dATP, dNTP mix and reverse transcriptase
technical/biomed/gb-2002-3-3-research0011.txt:        three independent international projects have been set up
technical/biomed/gb-2002-3-3-research0011.txt:          data points in view. In the alternative method of
technical/biomed/gb-2002-3-3-research0012.txt:          endonucleases and the amino-terminal domain of the tRNA
technical/biomed/gb-2002-3-3-research0012.txt:          domain probably functions as a RNA-binding domain rather
technical/biomed/gb-2002-3-3-research0012.txt:          the host cell. An alternative scenario, that the viral
technical/biomed/gb-2002-3-3-research0012.txt:          site-specific DNA endonucleases and tRNA endonuclease
technical/biomed/gb-2002-3-4-research0018.txt:        used in the cRNA preparation (see Materials and methods)
technical/biomed/gb-2002-3-4-research0018.txt:          collection of 12 Mu11KsubA chips hybridized to mRNA
technical/biomed/gb-2002-3-4-research0018.txt:          Materials and methods). There are 66 internal pairwise
technical/biomed/gb-2002-3-4-research0018.txt:        current incarnations of the arrays still behave fairly
technical/biomed/gb-2002-3-4-research0018.txt:        ratio scores may deviate from the real mRNA concentration
technical/biomed/gb-2002-3-4-research0018.txt:            with liquid nitrogen. Total RNA was isolated. Poly (A)
technical/biomed/gb-2002-3-4-research0018.txt:            +RNA was then isolated with magnetic oligo-dT beads.
technical/biomed/gb-2002-3-4-research0018.txt:            For each brain region, 1 μg poly(A) +RNA was converted
technical/biomed/gb-2002-3-4-research0018.txt:            to double-stranded T7 cDNA. Labeled cRNAs were produced
technical/biomed/gb-2002-3-4-research0019.txt:        expression analysis as the messenger RNA levels of
technical/biomed/gb-2002-3-4-research0019.txt:        standard microarray experiment, total RNA or mRNA is
technical/biomed/gb-2002-3-4-research0019.txt:        parallel using a common reference RNA. In such experiments,
technical/biomed/gb-2002-3-4-research0019.txt:          In this experiment, mRNAs from whole brains of mice of
technical/biomed/gb-2002-3-4-research0019.txt:          27]) were compared to mRNAs from brains of mice lacking a
technical/biomed/gb-2002-3-4-research0019.txt:          were used to measure the mRNA expression in total brain
technical/biomed/gb-2002-3-4-research0019.txt:        antidepressant treatment data (RNA from total mouse brain
technical/biomed/gb-2002-3-4-research0019.txt:        antidepressant effects on the brain's mRNA transcription
technical/biomed/gb-2002-3-4-research0019.txt:          and total brain RNA extracted, labeled and hybridized as
technical/biomed/gb-2002-3-4-research0019.txt:          end of treatment, RNA was extracted by RNeasy and TRIZOL
technical/biomed/gb-2002-3-4-research0019.txt:          procedure. Total RNA (100 μg) was fluorescence-labeled by
technical/biomed/gb-2002-3-4-research0019.txt:           reflects the relation of experiment RNA to
technical/biomed/gb-2002-3-4-research0019.txt:          normalizing RNA and is of no biological interest, it can
technical/biomed/gb-2002-3-4-research0019.txt:           reflects the global variance in RNA preparation,
technical/biomed/gb-2002-3-5-research0020.txt:        hybridized to cDNA probes derived from paired RNA samples
technical/biomed/gb-2002-3-5-research0020.txt:          levels in lung RNA from multiple, individual control and
technical/biomed/gb-2002-3-5-research0020.txt:          inhalation and lung RNA isolated 24 h later. In summary,
technical/biomed/gb-2002-3-5-research0020.txt:          compared to those of an RNA pool prepared from equivalent
technical/biomed/gb-2002-3-5-research0020.txt:          amounts of lung RNA from each of six normal control
technical/biomed/gb-2002-3-5-research0020.txt:          C3 mRNA levels and subsequent
technical/biomed/gb-2002-3-5-research0020.txt:          IP-10 mRNA, which is induced in a
technical/biomed/gb-2002-3-5-research0020.txt:          IP-10 mRNA observed here in monkeys
technical/biomed/gb-2002-3-5-research0020.txt:          p27 mRNA by IL-4, identified by
technical/biomed/gb-2002-3-5-research0020.txt:          Briefly, total RNA was isolated from lung tissue by
technical/biomed/gb-2002-3-5-research0020.txt:          gradients [ 43]. For each probe pair, poly(A) mRNA was
technical/biomed/gb-2002-3-5-research0020.txt:          isolated from approximately 200 μg of total RNA using
technical/biomed/gb-2002-3-5-research0020.txt:          quantitative detection of the target mRNAs were designed
technical/biomed/gb-2002-3-5-research0020.txt:          Total RNA was isolated from monkey lungs with a Qiagen
technical/biomed/gb-2002-3-5-research0020.txt:          RNA/DNA kit (Qiagen, Valencia, CA), followed by DNase
technical/biomed/gb-2002-3-5-research0020.txt:          contamination. The RNA was then used for the first-strand
technical/biomed/gb-2002-3-5-research0020.txt:          cDNA synthesis. Two micrograms of total RNA were primed
technical/biomed/gb-2002-3-5-research0020.txt:          60°C). The relative quantitation of the target mRNAs was
technical/biomed/gb-2002-3-5-research0020.txt:          45]. The mRNA expression levels for all samples were
technical/biomed/gb-2002-3-5-research0021.txt:        Expression of antisense RNA has long been known to be
technical/biomed/gb-2002-3-5-research0021.txt:        9, 10, 11, 12]. Double-strand RNA (dsRNA) formed by
technical/biomed/gb-2002-3-5-research0021.txt:        to initiate a pathway in which homologous RNA sequences are
technical/biomed/gb-2002-3-5-research0021.txt:        transcriptional gene silencing (PTGS) or RNA interference
technical/biomed/gb-2002-3-5-research0021.txt:        (RNAi). Expression of inverted-repeat constructs, where the
technical/biomed/gb-2002-3-5-research0021.txt:        transcript is expected to fold into a dsRNA hairpin, has
technical/biomed/gb-2002-3-5-research0021.txt:        been shown to be an efficient initiator of RNAi [ 13, 14,
technical/biomed/gb-2002-3-5-research0021.txt:        conditional system for RNAi could be created.
technical/biomed/gb-2002-3-5-research0021.txt:        conditional RNAi. For each PGM construct five independent
technical/biomed/gb-2002-3-5-research0021.txt:        Pgm RNA levels were more readily
technical/biomed/gb-2002-3-5-research0021.txt:        Pgm RNA levels. The decrease varied
technical/biomed/gb-2002-3-5-research0021.txt:        therefore appears to function as expected to induce RNAi
technical/biomed/gb-2002-3-5-research0021.txt:        The phenomenon of RNAi (or PTGS) is of great interest
technical/biomed/gb-2002-3-5-research0021.txt:        Drosophila, RNAi can be initiated by
technical/biomed/gb-2002-3-5-research0021.txt:        injection of dsRNA into embryos, and this has allowed
technical/biomed/gb-2002-3-5-research0021.txt:        application in the adult, as it is unlikely that the RNAi
technical/biomed/gb-2002-3-5-research0021.txt:        constructs have been used to cause RNAi in 
technical/biomed/gb-2002-3-5-research0021.txt:        inverted-repeat provided conditional RNAi of the 
technical/biomed/gb-2002-3-5-research0021.txt:        RNAi pathway itself and in the design of experiments where
technical/biomed/gb-2002-3-5-research0021.txt:        RNAi is used a research tool. Conditional RNAi should be
technical/biomed/gb-2002-3-5-research0021.txt:        Conditional RNAi should provide a powerful means to study
technical/biomed/gb-2002-3-5-research0021.txt:        specifically in the adult using tet-on RNAi may allow
technical/biomed/gb-2002-3-5-research0021.txt:        of a heat-shock gene promoter to drive expression of dsRNA,
technical/biomed/gb-2002-3-5-research0021.txt:        Pgm RNA levels were decreased 1.3- to
technical/biomed/gb-2002-3-5-research0021.txt:        overexpression and RNAi of genes near 
technical/biomed/gb-2002-3-5-research0021.txt:          supernatant was removed, taking care to avoid a top layer
technical/biomed/gb-2002-3-5-research0021.txt:          supernatant was used in a 3.1 ml assay mixture that
technical/biomed/gb-2002-3-5-research0021.txt:          total RNA isolated from a strain of flies homozygous for
technical/biomed/gb-2002-3-5-research0021.txt:          RNA was extracted using Trizol reagent (Gibco BRL) and
technical/biomed/gb-2002-3-5-research0021.txt:          the amount of RNA was quantitated by UV
technical/biomed/gb-2002-3-5-research0021.txt:          spectrophotometry. Approximately 5-10 μg RNA per lane was
technical/biomed/gb-2002-3-5-research0021.txt:          resolved on a 1.0% agarose gel. RNA markers (Gibco BRL)
technical/biomed/gb-2002-3-5-research0021.txt:          blotting, the RNA was fixed to Genescreen nylon membrane
technical/biomed/gb-2002-3-5-research0021.txt:          Rp49 RNA levels.
technical/biomed/gb-2002-3-5-research0022.txt:          DNA microarrays were applied to the mRNA analysis of
technical/biomed/gb-2002-3-5-research0022.txt:          i  . Note that an alternative
technical/biomed/gb-2002-3-5-research0022.txt:         in our proposal, there maybe alternative ways of
technical/biomed/gb-2002-3-5-research0022.txt:        0 , such as using an alternative
technical/biomed/gb-2002-3-5-research0022.txt:        alternative is to obtain reasonable estimates from other
technical/biomed/gb-2002-3-5-research0022.txt:        variances. Some alternative smoothing methods have also
technical/biomed/gb-2002-3-5-research0023.txt:        called cisternae [ 1, 2]. Secreted proteins, like all other
technical/biomed/gb-2002-3-5-research0023.txt:          to the membrane. Alternatively, at least some of the
technical/biomed/gb-2002-3-5-research0024.txt:        Alternatively, are independent fusions of the same gene
technical/biomed/gb-2002-3-5-research0024.txt:        tight cluster separated by a long internal branch from the
technical/biomed/gb-2002-3-5-research0024.txt:        alternatively, gene transfer from eukaryotes to
technical/biomed/gb-2002-3-5-research0024.txt:        strongly supported internal branch in each of the trees)
technical/biomed/gb-2002-3-5-research0024.txt:        internal branch by using the resampling of estimated
technical/biomed/gb-2002-3-5-research0025.txt:          using rRNA sequences. Two possible scenarios could
technical/biomed/gb-2002-3-5-research0025.txt:          transfer to the other domain. Alternatively, a GshA gene
technical/biomed/gb-2002-3-5-research0025.txt:          displacement of several aminoacyl-tRNA synthetases in
technical/biomed/gb-2002-3-5-research0025.txt:          the protein involved in that function. Alternatively, if
technical/biomed/gb-2002-3-5-research0025.txt:          RNA, proteins and polysaccharides. As the supply of a
technical/biomed/gb-2002-3-6-research0029.txt:        transcribed into messenger RNA, the positions in the mRNA
technical/biomed/gb-2002-3-6-research0029.txt:        of the gene. If alternative splice variants are present,
technical/biomed/gb-2002-3-6-research0029.txt:        genome. Sequencing the mature transcripts (spliced mRNA)
technical/biomed/gb-2002-3-6-research0029.txt:          represent RNA genes, pseudogenes or other types of
technical/biomed/gb-2002-3-6-research0029.txt:          problematic cDNA is either an RNA gene or a likely
technical/biomed/gb-2002-3-6-research0029.txt:          frequency of alternative splicing in a species.
technical/biomed/gb-2002-3-6-research0029.txt:          Alternative splicing appears to be relatively common in
technical/biomed/gb-2002-3-6-research0029.txt:          alternative splicing, or possibly another type of
technical/biomed/gb-2002-3-6-research0029.txt:          indicate an alternative 3' acceptor site for an intron;
technical/biomed/gb-2002-3-6-research0029.txt:          17 alignments indicate an alternative 5' donor site for
technical/biomed/gb-2002-3-6-research0029.txt:          cytoplasmic mRNA sequences. Six alignments indicate that
technical/biomed/gb-2002-3-6-research0029.txt:          an internal exon is missing in one isoform; presumably
technical/biomed/gb-2002-3-6-research0029.txt:          suggest possible alternative transcription initiation
technical/biomed/gb-2002-3-6-research0029.txt:          exons as a result of alternative initiation sites.
technical/biomed/gb-2002-3-6-research0029.txt:          Thirteen alignments suggest alternative 3'
technical/biomed/gb-2002-3-6-research0029.txt:          Table 5lists many of these alternatively spliced
technical/biomed/gb-2002-3-6-research0029.txt:          Figure 2a, the alternative 3' splice site on the second
technical/biomed/gb-2002-3-6-research0029.txt:          the alternative splicing events occur within the same
technical/biomed/gb-2002-3-6-research0029.txt:          examples of alternative splicing discovered in this data
technical/biomed/gb-2002-3-6-research0029.txt:          aberrant RNA products not destined to be translated [
technical/biomed/gb-2002-3-6-research0029.txt:          27]. One clear conclusion is that alternative splicing
technical/biomed/gb-2002-3-6-research0029.txt:          predicted mRNA transcript. The sequencing of the RIKEN
technical/biomed/gb-2002-3-6-research0029.txt:          Ceres data, many mRNAs appeared to have two or more
technical/biomed/gb-2002-3-6-research0029.txt:          putative alternative transcription start sites. This
technical/biomed/gb-2002-3-6-research0029.txt:          representative of alternative transcription initiation
technical/biomed/gb-2002-3-6-research0029.txt:          longer on the 5' end. If alternative transcription
technical/biomed/gb-2002-3-6-research0029.txt:          cases, both alternative cDNAs contain complete ORFs.
technical/biomed/gb-2002-3-6-research0029.txt:          alternative polyadenylation sites or stabilized ends of
technical/biomed/gb-2002-3-6-research0029.txt:          RNA that get polyadenylated, then these are quite common.
technical/biomed/gb-2002-3-6-research0029.txt:          of full-length cDNAs for finding alternative splice
technical/biomed/gb-2002-3-6-research0029.txt:          variants, short exons, UTRs, short genes and alternative
technical/biomed/gb-2002-3-6-research0029.txt:          Starting material for cDNA synthesis was polysomal RNA
technical/biomed/gb-2002-3-6-research0029.txt:          RNA from roots of Landsberg erecta was used to construct
technical/biomed/gb-2002-3-6-research0029.txt:          RNA. Nine parts inflorescence to one part root, as
technical/biomed/gb-2002-3-6-research0029.txt:          the source ecotype for any individual cDNA. Polysomal RNA
technical/biomed/gb-2002-3-6-research0029.txt:          was isolated from a detergent-generated supernatant on a
technical/biomed/gb-2002-3-6-research0029.txt:          However, they would cluster separately if alternative
technical/biomed/gb-2002-3-6-research0029.txt:          non-redundancy (eliminating alternatively spliced
technical/biomed/gb-2002-3-6-software0001.txt:        possible to measure messenger RNA levels quantitatively for
technical/biomed/gb-2002-3-6-software0001.txt:        region from multiple different mice. We used RNA from the
technical/biomed/gb-2002-3-6-software0001.txt:        mRNA transcripts or subtle changes in gene expression.
technical/biomed/gb-2002-3-6-software0001.txt:        maintaining sensitivity to rare mRNAs and small differences
technical/biomed/gb-2002-3-6-software0001.txt:        (signal) is proportional to mRNA abundance [ 15] and the
technical/biomed/gb-2002-3-6-software0001.txt:        corresponds to about 3-5 copies of the mRNA transcript per
technical/biomed/gb-2002-3-6-software0001.txt:        of expression measurements for cerebellar mRNA from two
technical/biomed/gb-2002-3-6-software0001.txt:        experiment described above, RNA samples from two
technical/biomed/gb-2002-3-7-research0032.txt:        an adult male does not change the external genitalia or
technical/biomed/gb-2002-3-7-research0032.txt:        poly(A) +RNA was extracted from the cells and analyzed
technical/biomed/gb-2002-3-7-research0032.txt:        performed. In the first, mRNA from each sample of treated
technical/biomed/gb-2002-3-7-research0032.txt:        reference' of Cy3-labeled cDNA prepared from mRNA extracted
technical/biomed/gb-2002-3-7-research0032.txt:        70 hours after addition of R1881. RNA samples from treated
technical/biomed/gb-2002-3-7-research0032.txt:        androgen-induced changes in the internal or external milieu
technical/biomed/gb-2002-3-7-research0032.txt:          0.01%. Messenger RNA was prepared from cells using the
technical/biomed/gb-2002-3-7-research0032.txt:          polyadenylated RNAs (Qiagen, Chatsworth, CA).
technical/biomed/gb-2002-3-7-research0032.txt:          polyadenylated RNA was reverse-transcribed in the
technical/biomed/gb-2002-3-7-research0035.txt:        RNA (aRNA) obtained from 
technical/biomed/gb-2002-3-7-research0035.txt:          doses. We could not confirm the aRNA-based results by
technical/biomed/gb-2002-3-7-research0035.txt:          detection of cellular markers in aRNA, total RNA and at
technical/biomed/gb-2002-3-7-research0035.txt:          alone had minimal effects on HUVEC. Supernatant from PBMC
technical/biomed/gb-2002-3-7-research0035.txt:          supernatants from PBMC conditioned for 24 hours with IL-2
technical/biomed/gb-2002-3-7-research0035.txt:          induced with supernatants conditioned for 3 hours. These
technical/biomed/gb-2002-3-7-research0035.txt:          co-hybridized with reference RNA obtained pre-IL-2 from
technical/biomed/gb-2002-3-7-research0035.txt:        and A375) to supernatant from IL-2-conditioned PBMC
technical/biomed/gb-2002-3-7-research0035.txt:          in lysis buffer for RNA isolation (RNeasy, Qiagen,
technical/biomed/gb-2002-3-7-research0035.txt:          Valencia, CA). RNA was amplified using the protocol for
technical/biomed/gb-2002-3-7-research0035.txt:          mRNA amplification and probe preparation previously
technical/biomed/gb-2002-3-7-research0035.txt:          published [ 17]. Each probe/test sample (antisense RNA
technical/biomed/gb-2002-3-7-research0035.txt:          (aRNA) obtained at each time point) was labeled with Cy5
technical/biomed/gb-2002-3-7-research0035.txt:          buffer for RNA isolation (RNeasy, Qiagen). RNA was
technical/biomed/gb-2002-3-7-research0035.txt:          amplified using the protocol for mRNA amplification and
technical/biomed/gb-2002-3-7-research0035.txt:          subsequently washed in PBS before RNA isolation.
technical/biomed/gb-2002-3-7-research0035.txt:          lysis buffer (Qiagen) for RNA isolation and probe
technical/biomed/gb-2002-3-7-research0035.txt:          lysed for RNA isolation using 2.1 ml RNeasy lysis buffer
technical/biomed/gb-2002-3-7-research0035.txt:          supernatant was carefully removed and washed in Hanks's
technical/biomed/gb-2002-3-7-research0035.txt:          blood cells by ACK lysis (Biofluids International,
technical/biomed/gb-2002-3-7-research0035.txt:          supernatant collection
technical/biomed/gb-2002-3-7-research0035.txt:          supernatants containing non-adherent cells were collected
technical/biomed/gb-2002-3-7-research0035.txt:          Exposure of HUVEC to supernatant obtained from PBMC
technical/biomed/gb-2002-3-7-research0035.txt:          Supernatants obtained from PBMC exposed to IL-2 or
technical/biomed/gb-2002-3-7-research0035.txt:          the adherent cell monolayers and isolate RNA for
technical/biomed/gb-2002-3-7-research0035.txt:          Total RNA was isolated using RNeasy minikits (Qiagen).
technical/biomed/gb-2002-3-7-research0035.txt:          aRNA was prepared from total RNA (0.5-3 μg) according the
technical/biomed/gb-2002-3-7-research0035.txt:          amplification utilized 0.5 to 1 μg aRNA as starting
technical/biomed/gb-2002-3-7-research0035.txt:          the template-switch primer. aRNA (3.5-5 μg) obtained
technical/biomed/gb-2002-3-7-research0036.txt:          mRNA samples), where 
technical/biomed/gb-2002-3-7-research0036.txt:            using internal indices as described next.
technical/biomed/gb-2002-3-7-research0036.txt:            Internal indices
technical/biomed/gb-2002-3-7-research0036.txt:            referred to as internal indices, in the sense that they
technical/biomed/gb-2002-3-7-research0036.txt:            evaluation of 30 internal indices. Other approaches
technical/biomed/gb-2002-3-7-research0036.txt:            statistic method, calibrates an internal index, such as
technical/biomed/gb-2002-3-7-research0036.txt:            alternative of 'heterogeneity'). Tibshirani 
technical/biomed/gb-2002-3-7-research0036.txt:            the internal indices that showed a better performance
technical/biomed/gb-2002-3-7-research0036.txt:            internal indices and the gap statistic are described in
technical/biomed/gb-2002-3-7-research0036.txt:            internal indices are commonly used to estimate the
technical/biomed/gb-2002-3-7-research0036.txt:            compares an observed internal index, such as the
technical/biomed/gb-2002-3-7-research0036.txt:            External indices
technical/biomed/gb-2002-3-7-research0036.txt:            partitions are referred to as external indices; several
technical/biomed/gb-2002-3-7-research0036.txt:             }. External indices of partitional agreement can
technical/biomed/gb-2002-3-7-research0036.txt:            An external index S is often standardized in such a
technical/biomed/gb-2002-3-7-research0036.txt:            This amounts to computing a standardized external
technical/biomed/gb-2002-3-7-research0036.txt:            The significance of an observed external index is
technical/biomed/gb-2002-3-7-research0036.txt:            external indices are convenient tools for comparing two
technical/biomed/gb-2002-3-7-research0036.txt:            indices as internal rather than external measures.
technical/biomed/gb-2002-3-7-research0036.txt:          using one of the external indices (or similarity
technical/biomed/gb-2002-3-7-research0036.txt:          sample. Finally, an external index is used to assess the
technical/biomed/gb-2002-3-7-research0036.txt:          (f) Compute an external index 
technical/biomed/gb-2002-3-7-research0036.txt:            External index
technical/biomed/gb-2002-3-7-research0036.txt:            All the external indices described in Background
technical/biomed/gb-2002-3-7-research0036.txt:          in Table 4. Recall that mRNA samples in the lymphoma,
technical/biomed/gb-2002-3-7-research0036.txt:        focus here on the clustering of tumor mRNA samples using
technical/biomed/gb-2002-3-7-research0036.txt:        hypothesis was used here; a natural alternative would be to
technical/biomed/gb-2002-3-7-research0036.txt:            from a tumor mRNA sample (red-fluorescent dye, Cy5) and
technical/biomed/gb-2002-3-7-research0036.txt:            a reference mRNA sample derived from a pool of nine
technical/biomed/gb-2002-3-7-research0036.txt:            n = 81 mRNA samples. The tumor
technical/biomed/gb-2002-3-7-research0036.txt:            mRNA samples consist of 29 cases of B-CLL, 9 cases of
technical/biomed/gb-2002-3-7-research0036.txt:            on the website (after pooling the 38 mRNA samples from
technical/biomed/gb-2002-3-7-research0036.txt:            the learning set and the 34 mRNA samples from the test
technical/biomed/gb-2002-3-7-research0036.txt:            intensities for a particular gene across the 72 mRNA
technical/biomed/gb-2002-3-7-research0036.txt:            j in mRNA sample 
technical/biomed/gb-2002-3-7-research0036.txt:            from a cell-line mRNA sample (red-fluorescent dye, Cy5)
technical/biomed/gb-2002-3-7-research0036.txt:            and a reference mRNA sample obtained by pooling equal
technical/biomed/gb-2002-3-7-research0036.txt:            mixtures of mRNA from 12 of the cell lines
technical/biomed/gb-2002-3-7-research0036.txt:            (cell culture, mRNA isolation, labeling, hybridization,
technical/biomed/gb-2002-3-7-research0036.txt:            or control mRNA sample (red-fluorescent dye, Cy5) and a
technical/biomed/gb-2002-3-7-research0036.txt:            common reference mRNA sample (green-fluorescent dye,
technical/biomed/gb-2002-3-7-research0036.txt:            j in mRNA sample 
technical/biomed/gb-2002-3-7-research0036.txt:          gene-expression profiles of two mRNA samples to measure
technical/biomed/gb-2002-3-7-research0036.txt:            differences in tissue sampling, as the CLL mRNA samples
technical/biomed/gb-2002-3-7-research0037.txt:          g for 3 min. The supernatant
technical/biomed/gb-2002-3-7-research0037.txt:          until RNA extraction. The Atlas Pure Total RNA protocol
technical/biomed/gb-2002-3-7-research0037.txt:          for poly(A) +mRNA extraction was used. Samples were
technical/biomed/gb-2002-3-8-research0038.txt:        alternative developmental fates. Much of our understanding
technical/biomed/gb-2002-3-8-research0038.txt:        Hybridization of mRNA pools to DNA microarrays can
technical/biomed/gb-2002-3-8-research0038.txt:        amount of RNA contained in a single 
technical/biomed/gb-2002-3-8-research0038.txt:        Approximately 4 μg poly(A) +RNA is required to make a
technical/biomed/gb-2002-3-8-research0038.txt:        resolution is relatively low when RNA preparations from
technical/biomed/gb-2002-3-8-research0038.txt:        We applied linear RNA amplification methods that were
technical/biomed/gb-2002-3-8-research0038.txt:        amplified RNA (aRNA) from different tissues of single larva
technical/biomed/gb-2002-3-8-research0038.txt:          was synthesized either from total RNA isolated from
technical/biomed/gb-2002-3-8-research0038.txt:          imaginal discs or from poly(A) +-purified embryonic RNA.
technical/biomed/gb-2002-3-8-research0038.txt:          generating an RNA product that represented an
technical/biomed/gb-2002-3-8-research0038.txt:          amplification of approximately 1,000 fold. This RNA was
technical/biomed/gb-2002-3-8-research0038.txt:          +RNA.
technical/biomed/gb-2002-3-8-research0038.txt:          yielded similar quantities of aRNA. When these aRNA
technical/biomed/gb-2002-3-8-research0038.txt:          The most important feature of RNA pools that
technical/biomed/gb-2002-3-8-research0038.txt:          RNAs. We established the quality of our amplification
technical/biomed/gb-2002-3-8-research0038.txt:          method in several ways. First, we isolated poly(A) +RNA
technical/biomed/gb-2002-3-8-research0038.txt:          distribution of the aRNA ranged from about 100
technical/biomed/gb-2002-3-8-research0038.txt:          aRNA from independent amplifications was then used to
technical/biomed/gb-2002-3-8-research0038.txt:          aliquots of 1 ng of the same embryonic poly(A) +RNA
technical/biomed/gb-2002-3-8-research0038.txt:          1 ng and 10 ng poly(A) +RNA yielded essentially the same
technical/biomed/gb-2002-3-8-research0038.txt:          reproducible and that good proportionality of RNA was
technical/biomed/gb-2002-3-8-research0038.txt:          of poly(A) +RNA differed by tenfold.
technical/biomed/gb-2002-3-8-research0038.txt:          Comparisons between amplified and unamplified RNA
technical/biomed/gb-2002-3-8-research0038.txt:          poly(A) +RNA 99% (5,514 out of 5,574) did so with both
technical/biomed/gb-2002-3-8-research0038.txt:          spots shows that the aRNA is an essentially complete
technical/biomed/gb-2002-3-8-research0038.txt:          different probes on microarrays are valid if the RNA
technical/biomed/gb-2002-3-8-research0038.txt:            poly(A) +RNA isolated from left and right wing discs of
technical/biomed/gb-2002-3-8-research0038.txt:            or to possible contamination by glial cell RNA in the
technical/biomed/gb-2002-3-8-research0038.txt:            eye-antennal RNA.
technical/biomed/gb-2002-3-8-research0038.txt:          probes from the poly(A) +RNA isolated from several larval
technical/biomed/gb-2002-3-8-research0038.txt:          diversity of cell types and states. An alternative
technical/biomed/gb-2002-3-8-research0038.txt:        We have shown that linear RNA amplification is
technical/biomed/gb-2002-3-8-research0038.txt:        pg poly(A) +RNA yields enough aRNA for one hybridization.
technical/biomed/gb-2002-3-8-research0038.txt:          Larval dissections, RNA isolation and in
technical/biomed/gb-2002-3-8-research0038.txt:          Total RNA from larval tissues was extracted using the
technical/biomed/gb-2002-3-8-research0038.txt:          Mini RNA Isolation Kit (Zymo Research, Orange, CA) and
technical/biomed/gb-2002-3-8-research0038.txt:          was eluted with RNase-free water. Total RNA from embryos
technical/biomed/gb-2002-3-8-research0038.txt:          poly(A) +RNA was purified using the Oligotex mRNA Mini
technical/biomed/gb-2002-3-8-research0038.txt:          Kit (Qiagen). Poly(A) +RNA was not purified before
technical/biomed/gb-2002-3-8-research0038.txt:          amplification of disc RNA because of the small amounts
technical/biomed/gb-2002-3-8-research0038.txt:          RNA amplification
technical/biomed/gb-2002-3-8-research0038.txt:          et al. [ 23]. Total RNA isolated
technical/biomed/gb-2002-3-8-research0038.txt:          from dissected larval tissues or poly(A) +RNA purified
technical/biomed/gb-2002-3-8-research0038.txt:          each), 0.3 μl T4gp32 (USB, 13.82 mg/ml), 0.5 μl RNasin
technical/biomed/gb-2002-3-8-research0038.txt:          45 μl RNase-free water, 15 μl 5× second-strand buffer
technical/biomed/gb-2002-3-8-research0038.txt:          E. coli RNaseH (2 U/μl)). Enzymes
technical/biomed/gb-2002-3-8-research0038.txt:          (Zymo Research), eluting twice with 8 μl RNase-free
technical/biomed/gb-2002-3-8-research0038.txt:          digestion. aRNA was purified using Mini RNA Isolation Kit
technical/biomed/gb-2002-3-8-research0038.txt:          or RNA Clean-up kit (Zymo Research), eluting in 2 × 8 μl
technical/biomed/gb-2002-3-8-research0038.txt:          RNase-free water. Random hexanucleotides (250 ng) and TS
technical/biomed/gb-2002-3-8-research0038.txt:          total aRNA was applied to the clean-up columns after the
technical/biomed/gb-2002-3-8-research0039.txt:        interactions with proteins [ 17, 18] and RNA [ 19, 20], the
technical/biomed/gb-2002-3-8-research0039.txt:          histones or transcription factors; alternatively they
technical/biomed/gb-2002-3-8-research0039.txt:        other nuclear proteins. Alternatively, they may oxidize
technical/biomed/gb-2002-3-8-research0040.txt:        particular fold, and the number of expressed mRNA
technical/biomed/gb-2002-3-8-research0040.txt:          E -value cut-off. Alternatively,
technical/biomed/gb-2002-3-8-research0040.txt:          seven alternative functions for protein-fold occurrence
technical/biomed/gb-2002-3-8-research0040.txt:          mRNA, and so their occurrences are actually related to
technical/biomed/gb-2002-3-9-research0043.txt:          (three or more internal stop codons or frameshifts
technical/biomed/gb-2002-3-9-research0043.txt:          arise when mRNA molecules are reverse transcribed and
technical/biomed/gb-2002-3-9-research0043.txt:          The presence of internal stop codons or frameshift
technical/biomed/gb-2002-3-9-research0043.txt:          tyrosine kinases [ 40]. In addition, alternative
technical/biomed/gb-2002-3-9-research0043.txt:          In general, these alternative trees are similar to the
technical/biomed/gb-2002-3-9-research0043.txt:          (RNasel) whose GenBank annotation overlooks similarity to
technical/biomed/gb-2002-3-9-research0043.txt:          kinases of interest within the collection, alternative
technical/biomed/gb-2002-3-9-research0043.txt:          corresponding genomic sequences, the presence of internal
technical/biomed/gb-2002-3-9-research0043.txt:          within the catalytic domain. The presence of internal
technical/biomed/gb-2002-3-9-research0043.txt:          Alternative names for the EPKs were retrieved from
technical/biomed/gb-2002-3-9-research0043.txt:          records, NT mRNA records, NT genomic records, and HTG
technical/biomed/gb-2002-3-9-research0044.txt:        Characterized examples of endogenous antisense RNA in
technical/biomed/gb-2002-3-9-research0044.txt:        1, 2] for extensive review). Antisense RNAs transcribed
technical/biomed/gb-2002-3-9-research0044.txt:        [ 4, 5], RNA interference [ 6], translational regulation [
technical/biomed/gb-2002-3-9-research0044.txt:        7], alternative splicing [ 8], X-inactivation [ 9], and RNA
technical/biomed/gb-2002-3-9-research0044.txt:        mRNA can each suppress protein levels (but not mRNA levels)
technical/biomed/gb-2002-3-9-research0044.txt:        pairs of RNA species with the potential to form long
technical/biomed/gb-2002-3-9-research0044.txt:        pairs of annotated human mRNAs that originate from the same
technical/biomed/gb-2002-3-9-research0044.txt:        NCBI, in which full-length mRNA and EST sequences are
technical/biomed/gb-2002-3-9-research0044.txt:        annotated mRNAs as initializing seeds), but these clusters
technical/biomed/gb-2002-3-9-research0044.txt:        their sense counterparts. As nearly all annotated mRNAs in
technical/biomed/gb-2002-3-9-research0044.txt:        to the mRNA transcript); then, focusing exclusively on ESTs
technical/biomed/gb-2002-3-9-research0044.txt:        misoriented ESTs. We then mapped the mRNA and EST sequences
technical/biomed/gb-2002-3-9-research0044.txt:        distinct RNA species, on the basis of differential
technical/biomed/gb-2002-3-9-research0044.txt:        tails of eukaryotic mRNAs do provide directional
technical/biomed/gb-2002-3-9-research0044.txt:        UniGene clusters includes at least one full-length mRNA
technical/biomed/gb-2002-3-9-research0044.txt:        mRNA-defined orientations (Figure 1). Our subsequent
technical/biomed/gb-2002-3-9-research0044.txt:        but oppositely oriented RNA species were present in a
technical/biomed/gb-2002-3-9-research0044.txt:        the relevant set of ESTs and mRNAs from candidate UniGene
technical/biomed/gb-2002-3-9-research0044.txt:        and antisense ESTs represented distinct RNA species, on the
technical/biomed/gb-2002-3-9-research0044.txt:        but oppositely oriented RNA species, co-clustered in
technical/biomed/gb-2002-3-9-research0044.txt:        reaction. Although total RNA from a series of different
technical/biomed/gb-2002-3-9-research0044.txt:        interested in whether sense and antisense RNA species in
technical/biomed/gb-2002-3-9-research0044.txt:        certain about this until the full-length RNA species are
technical/biomed/gb-2002-3-9-research0044.txt:        sense transcript (all of which are annotated mRNAs in the
technical/biomed/gb-2002-3-9-research0044.txt:        pattern of the overlap with the antisense RNA species is
technical/biomed/gb-2002-3-9-research0044.txt:        long duplex dsRNA can potentially affect gene regulation
technical/biomed/gb-2002-3-9-research0044.txt:        RNA species in cancer tissues has functional relevance with
technical/biomed/gb-2002-3-9-research0044.txt:        mRNA sequences. Many probes on orientation-sensitive
technical/biomed/gb-2002-3-9-research0044.txt:        long-duplex dsRNA has been suggested or shown to influence
technical/biomed/gb-2002-3-9-research0044.txt:          UniGene cluster contains an mRNA with a defined open
technical/biomed/gb-2002-3-9-research0044.txt:          whose BOU representative was an mRNA with an annotated
technical/biomed/gb-2002-3-9-research0044.txt:          mRNAs from candidate UniGene clusters to the mouse and
technical/biomed/gb-2002-3-9-research0044.txt:          sequence that was internal to a predicted region of
technical/biomed/gb-2002-3-9-research0044.txt:          total human RNA from placenta, kidney, brain, thymus or
technical/biomed/gb-2002-3-9-research0044.txt:          RT-PCR reactions were carried out using total human RNA
technical/biomed/gb-2002-3-9-research0044.txt:          were carried out using total human RNA from a single
technical/biomed/gb-2002-3-9-research0044.txt:          the 45,588 relevant mRNA and EST sequences that belonged
technical/biomed/gb-2002-3-9-research0045.txt:        containing 1,400 EST cDNA clones. Fernandes 
technical/biomed/gb-2002-3-9-research0045.txt:        (1-2 cm) RNA populations on separate endosperm and ear
technical/biomed/gb-2002-3-9-research0045.txt:        and cDNA clones could be devised. Thirteen RNA samples from
technical/biomed/gb-2002-3-9-research0045.txt:        37% showed a two- to fourfold difference in mRNA amounts
technical/biomed/gb-2002-3-9-research0045.txt:        compared to the reference sample - maize seedling RNA.
technical/biomed/gb-2002-3-9-research0045.txt:          Internal consistency of hybridization
technical/biomed/gb-2002-3-9-research0045.txt:          pool of mRNA from 4-day-old roots (4DR) was used to
technical/biomed/gb-2002-3-9-research0045.txt:          aliquots of mRNAs from immature ears (IME) and 4DR were
technical/biomed/gb-2002-3-9-research0045.txt:          The relative amounts of mRNA for each printed EST were
technical/biomed/gb-2002-3-9-research0045.txt:          2 ratio > 2) mRNA amount in
technical/biomed/gb-2002-3-9-research0045.txt:          together, although their internal relationships were less
technical/biomed/gb-2002-3-9-research0045.txt:          remove them during mRNA purification for cDNA library
technical/biomed/gb-2002-3-9-research0045.txt:          transcript amounts, an RNA blot hybridization was carried
technical/biomed/gb-2002-3-9-research0045.txt:          the different properties of microarray and RNA blot
technical/biomed/gb-2002-3-9-research0045.txt:          kind of tethered probe at each position, whereas an RNA
technical/biomed/gb-2002-3-9-research0045.txt:          RNA targets separated by size using gel
technical/biomed/gb-2002-3-9-research0045.txt:          a fourfold difference in RNA abundance and could indicate
technical/biomed/gb-2002-3-9-research0045.txt:          that 45-mer oligos are a good alternative to
technical/biomed/gb-2002-3-9-research0045.txt:          gene-specific RNA blot hybridization to measure
technical/biomed/gb-2002-3-9-research0045.txt:          based on PCR products based on the RNA blot hybridization
technical/biomed/gb-2002-3-9-research0045.txt:          Internal consistency of the microarray
technical/biomed/gb-2002-3-9-research0045.txt:          Internal consistency of the array hybridization
technical/biomed/gb-2002-3-9-research0045.txt:          First, a control hybridization with one type of mRNA for
technical/biomed/gb-2002-3-9-research0045.txt:          samples of mRNA hybridized on separate slides yielded
technical/biomed/gb-2002-3-9-research0045.txt:          was internally consistent.
technical/biomed/gb-2002-3-9-research0045.txt:          this microarray, most genes hybridized to RNA from
technical/biomed/gb-2002-3-9-research0045.txt:          RNA from just one sample. According to the array
technical/biomed/gb-2002-3-9-research0045.txt:          consistent with DNA-RNA reassociation kinetic studies
technical/biomed/gb-2002-3-9-research0045.txt:          of RNA complexity. The apparent low number of tissue- or
technical/biomed/gb-2002-3-9-research0045.txt:          Some genes may be expressed at similar RNA levels but
technical/biomed/gb-2002-3-9-research0045.txt:          specialization has occurred. By RNA blot hybridizations,
technical/biomed/gb-2002-3-9-research0045.txt:          probes appear to be a good alternative for analysis of
technical/biomed/gb-2002-3-9-research0045.txt:          RNA purification, labeling, and
technical/biomed/gb-2002-3-9-research0045.txt:          Total RNA was extracted from 13 samples, using the
technical/biomed/gb-2002-3-9-research0045.txt:          Trizol method (GibcoBRL). mRNA was further purified from
technical/biomed/gb-2002-3-9-research0045.txt:          total RNA with Oligotex mini-columns (Qiagen, Valencia,
technical/biomed/gb-2002-3-9-research0045.txt:          CA). mRNA quantity and quality were examined by UV
technical/biomed/gb-2002-3-9-research0045.txt:          absorption at 260 and 280 nm. RNA quality was also
technical/biomed/gb-2002-3-9-research0045.txt:          of ribosomal RNA after mRNA purification. About 2 μg of
technical/biomed/gb-2002-3-9-research0045.txt:          poly (A) +RNA was used to synthesize fluorescently
technical/biomed/gb-2002-3-9-research0045.txt:          μg poly(A) +RNA, 1x reaction buffer (50 mM Tris-HCl pH 8,
technical/biomed/gb-2002-3-9-research0045.txt:          61-65°C and an initial washing at 55°C. mRNA from
technical/biomed/gb-2002-3-9-research0045.txt:          RNA blot hybridization
technical/biomed/gb-2002-3-9-research0045.txt:          A 15 μg sample of total RNA was loaded onto a glyoxal
technical/biomed/gb-2002-3-9-research0045.txt:          gel as described in [ 54]. Hybridization probes for RNA
technical/biomed/gb-2002-3-9-research0046.txt:        gene-expression dataset is published. Some journals (for
technical/biomed/gb-2002-3-9-research0046.txt:        hoped) that in the future, journals and funding agencies
technical/biomed/gb-2002-3-9-research0046.txt:          OntologyEntries. Databases are references to external
technical/biomed/gb-2002-3-9-research0046.txt:          intergenic regions, RNA genes and protein-coding genes.
technical/biomed/gb-2002-3-9-research0046.txt:          (a MAGE-ML predecessor) as an internal data-communication
technical/biomed/gb-2002-3-9-research0046.txt:          very well for a disconnected high-throughput internal
technical/biomed/gb-2002-3-9-research0046.txt:          RNA abundance (gene expression, polysome profiling), and
technical/biomed/gb-2002-3-9-research0048.txt:          extension of existing cDNA methodologies. Alternatively,
technical/biomed/gb-2002-3-9-research0048.txt:           were the control and mutant RNA samples on array A
technical/biomed/gb-2002-3-9-research0048.txt:        1,000 mRNA copies per cell will be no more or less biased
technical/biomed/gb-2002-3-9-research0048.txt:          2 for 7 days. Messenger RNA was
technical/biomed/gb-2002-3-9-research0048.txt:          resuspended in 400 μl water and RNA was isolated from
technical/biomed/gb-2002-3-9-research0048.txt:          this by the use of four tubes from the fastRNA kit blue
technical/biomed/gb-2002-3-9-research0048.txt:          RNA preparations were run in duplicate and each sample
technical/biomed/gb-2002-3-9-research0048.txt:          control RNA was labeled with Cy5 and treatment RNA with
technical/biomed/gb-2002-3-9-research0048.txt:          mRNA (wild type). By this method, all 12 channels from
technical/biomed/gb-2002-3-9-research0051.txt:        tryptophanyl-tRNA synthetase [ 19]. Thus, the host not only
technical/biomed/gb-2002-3-9-research0051.txt:        tryptophanyl-tRNA synthetase.
technical/biomed/gb-2002-3-9-research0051.txt:          kprS (alternative name: 
technical/biomed/gb-2002-3-9-research0051.txt:          L-tryptophan requires an alternative source of
technical/biomed/gb-2002-3-9-research0051.txt:          Alternative sources of ATP, for example, utilization of
technical/biomed/gb-2002-3-9-research0051.txt:          in the HAAAP family. An alternative query, the 
technical/biomed/gb-2002-4-1-r1.txt:          MGSCv3, we used BLAT [ 3] to compare 8,434 mouse mRNA
technical/biomed/gb-2002-4-1-r1.txt:          we determined the numbers of mRNAs that have more than
technical/biomed/gb-2002-4-1-r1.txt:          assembly (Figure 1). Although most mRNAs could be matched
technical/biomed/gb-2002-4-1-r1.txt:          with both assemblies, there were some mRNAs that could be
technical/biomed/gb-2002-4-1-r1.txt:          more mRNAs had higher percentage matches in Cel2 than in
technical/biomed/gb-2002-4-1-r1.txt:          especially investigated how well long mRNAs can be
technical/biomed/gb-2002-4-1-r1.txt:          matched to each assembly. The 10 longest mRNA sequences
technical/biomed/gb-2002-4-1-r1.txt:          mRNA sequences can only be used to check the quality
technical/biomed/gb-2002-4-1-r1.txt:          cause some slight differences when comparing mRNAs or
technical/biomed/gb-2002-4-1-r1.txt:          From the above analyses of mouse mRNAs and BACs, we
technical/biomed/gb-2002-4-1-r1.txt:          the regions covered by sequenced BACs. However, the mRNA
technical/biomed/gb-2002-4-1-r1.txt:            'alternative exon'-related (that is, the location of
technical/biomed/gb-2002-4-1-r1.txt:            according to one mRNA transcript, but in an exon region
technical/biomed/gb-2002-4-1-r1.txt:            according to another mRNA transcript). Here, the
technical/biomed/gb-2002-4-1-r1.txt:            known mRNA sequences, were further examined and
technical/biomed/gb-2002-4-1-r1.txt:            CSEs may actually be alternative exons. For example, we
technical/biomed/gb-2002-4-1-r1.txt:            Some of them also shared similarity with mouse mRNAs.
technical/biomed/gb-2002-4-1-r1.txt:            region of a novel gene with mRNA accession number
technical/biomed/gb-2002-4-1-r1.txt:            CSEs in RNA genes
technical/biomed/gb-2002-4-1-r1.txt:            RNA genes (from golden path April 2001 human genome
technical/biomed/gb-2002-4-1-r1.txt:            annotation), such as ribosomal RNA, microRNA, small
technical/biomed/gb-2002-4-1-r1.txt:            nucleolar RNA (snoRNA), and the like. For example, Z30
technical/biomed/gb-2002-4-1-r1.txt:            small nucleolar RNA [ 16] (accession number: AJ007733),
technical/biomed/gb-2002-4-1-r1.txt:            methylation guide molecule for U6 snRNA. The whole
technical/biomed/gb-2002-4-1-r1.txt:            the discovery of RNA genes.
technical/biomed/gb-2002-4-1-r1.txt:          BLAT was used to match all mouse mRNA sequences and
technical/biomed/gb-2002-4-1-r1.txt:          continuous human region contained internal splice sites
technical/biomed/gb-2002-4-1-r2.txt:        internalins InlA, and InlB) to specific receptors on the
technical/biomed/gb-2002-4-1-r2.txt:        actA internal in-frame deletion
technical/biomed/gb-2002-4-1-r2.txt:        of the internalins, but cannot escape from the phagocytic
technical/biomed/gb-2002-4-1-r2.txt:          Messenger RNA was isolated from each experimental
technical/biomed/gb-2002-4-1-r2.txt:          reverse transcription [ 40]. To provide an internal
technical/biomed/gb-2002-4-1-r2.txt:          standard for each measurement, a pool of reference mRNA
technical/biomed/gb-2002-4-1-r2.txt:          mRNA from 10 different human cell lines was mixed with
technical/biomed/gb-2002-4-1-r2.txt:          pool of RNA was designed to provide some signal for as
technical/biomed/gb-2002-4-1-r2.txt:          mRNA was isolated on different days and hybridized at
technical/biomed/gb-2002-4-1-r2.txt:          time. We found that the correlations of the global mRNA
technical/biomed/gb-2002-4-1-r2.txt:          correlation of measurements for mRNA samples prepared in
technical/biomed/gb-2002-4-1-r2.txt:          0 ) mRNA from uninfected cells was
technical/biomed/gb-2002-4-1-r2.txt:          mRNA (Figure 5). The three measurements of log 
technical/biomed/gb-2002-4-1-r2.txt:          0 ), but this alternative approach did
technical/biomed/gb-2002-4-1-r2.txt:          most highly induced chemokines at the RNA level (Figures
technical/biomed/gb-2002-4-1-r2.txt:          supernatants following infections with each of the three
technical/biomed/gb-2002-4-1-r2.txt:          both mRNA amplification and detection have improved
technical/biomed/gb-2002-4-1-r2.txt:          three independent mRNA samples were prepared before
technical/biomed/gb-2002-4-1-r2.txt:          culture dishes for mRNA isolation using oligo(dT) binding
technical/biomed/gb-2002-4-1-r2.txt:          Cells used for infections and mRNA isolations were
technical/biomed/gb-2002-4-1-r2.txt:          mRNA isolation, labeling and hybridization
technical/biomed/gb-2002-4-1-r2.txt:          mRNA was isolated from monolayers of infected cells by
technical/biomed/gb-2002-4-1-r2.txt:          channel, and reference RNA is measured in the green
technical/biomed/gb-2002-4-1-r2.txt:          μl from both apical and basolateral supernatants were
technical/biomed/gb-2002-4-1-r2.txt:          Supernatants from infected cultures were harvested at
technical/biomed/gb-2003-4-1-r5.txt:        alternative splice variants and antisense RNAs.
technical/biomed/gb-2003-4-1-r5.txt:        Alternatively, microarrays can be composed of short
technical/biomed/gb-2003-4-1-r5.txt:        and alternative splice variants. As such, oligonucleotide
technical/biomed/gb-2003-4-1-r5.txt:        with complementary targets derived from synthetic RNA as
technical/biomed/gb-2003-4-1-r5.txt:        opposed to cellular RNA). A drawback to using modified
technical/biomed/gb-2003-4-1-r5.txt:        the addition of the 5'-amino linker. An alternative
technical/biomed/gb-2003-4-1-r5.txt:        composed of both cellular and synthetic RNA.
technical/biomed/gb-2003-4-1-r5.txt:          rat brain and heart RNA. Using these two methods, optimal
technical/biomed/gb-2003-4-1-r5.txt:          targets derived from rat brain and heart RNA. As seen in
technical/biomed/gb-2003-4-1-r5.txt:          for moderate and abundant mRNAs but also for rare
technical/biomed/gb-2003-4-1-r5.txt:          Each of the 10 plasmids was used to synthesize cRNA 
technical/biomed/gb-2003-4-1-r5.txt:          in vitro . cRNAs were quantitated
technical/biomed/gb-2003-4-1-r5.txt:          and differentially spiked into heart and brain RNA
technical/biomed/gb-2003-4-1-r5.txt:          assumptions: 360,000 mRNA transcripts per cell, 20 pg
technical/biomed/gb-2003-4-1-r5.txt:          total RNA per cell and 1 pg mRNA transcript per cell;
technical/biomed/gb-2003-4-1-r5.txt:          about 0.14 ng 'spike' transcript in 10 μg total RNA [
technical/biomed/gb-2003-4-1-r5.txt:          ten control cRNAs into the Cy3 and Cy5 labeling reactions
technical/biomed/gb-2003-4-1-r5.txt:          cell. The remaining five control cRNAs were spiked into
technical/biomed/gb-2003-4-1-r5.txt:          excellent negative controls when exogenous cRNA is not
technical/biomed/gb-2003-4-1-r5.txt:          added to the labeling reaction. In the absence of cRNA
technical/biomed/gb-2003-4-1-r5.txt:          Cy-labeled target derived from rat heart and brain RNA.
technical/biomed/gb-2003-4-1-r5.txt:          of RNA samples) with correlation coefficients ( 
technical/biomed/gb-2003-4-1-r5.txt:          heart RNA as before. The median Cy3 and Cy5 hybridization
technical/biomed/gb-2003-4-1-r5.txt:          Arabidopsis cRNA that were
technical/biomed/gb-2003-4-1-r5.txt:          differentially spiked into rat heart and brain RNA. Six 
technical/biomed/gb-2003-4-1-r5.txt:          synthetic cRNA concentrations ranging from 10 to 300
technical/biomed/gb-2003-4-1-r5.txt:          accurately determine twofold differences in cRNA species
technical/biomed/gb-2003-4-1-r5.txt:        mRNA populations as low as twofold (namely, 14-3-3 protein
technical/biomed/gb-2003-4-1-r5.txt:        Arabidopsis spiking control cRNAs
technical/biomed/gb-2003-4-1-r5.txt:        into a complex mix of mammalian target RNA in order to
technical/biomed/gb-2003-4-1-r5.txt:        transcript number at a level of 2-20 mRNA copies per cell.
technical/biomed/gb-2003-4-1-r5.txt:        Arabidopsis cRNAs were engineered to
technical/biomed/gb-2003-4-1-r5.txt:        contain a 3' poly(A) tail. Hence, alternative protocols
technical/biomed/gb-2003-4-1-r5.txt:        using oligo(dT) to prime mRNA for the synthesis of labeled
technical/biomed/gb-2003-4-1-r5.txt:        cellular RNA mixtures and in synthetic spiked cRNAs. In
technical/biomed/gb-2003-4-1-r5.txt:        efficiency. Alternatively, the higher spotting
technical/biomed/gb-2003-4-1-r5.txt:        International, personal communication). The T content of
technical/biomed/gb-2003-4-1-r5.txt:        region in the tumor endothelial marker 8 mRNA. It has been
technical/biomed/gb-2003-4-1-r5.txt:        Second, tumor endothelial marker 8 mRNA was identified in
technical/biomed/gb-2003-4-1-r5.txt:        mouse. The orthologous rat mRNA has not been cloned yet,
technical/biomed/gb-2003-4-1-r5.txt:        cannot discount the possibility that alternative attachment
technical/biomed/gb-2003-4-1-r5.txt:          Constructing exogenous spiking cRNA controls and a
technical/biomed/gb-2003-4-1-r5.txt:          cRNAs containing a 3' poly(A) tail, pSP64poly(A)
technical/biomed/gb-2003-4-1-r5.txt:          Arabidopsis cRNA set was designed
technical/biomed/gb-2003-4-1-r5.txt:          Arabidopsis control spiking cRNA
technical/biomed/gb-2003-4-1-r5.txt:          Arabidopsis control spiking cRNA
technical/biomed/gb-2003-4-1-r5.txt:          considerations included uniqueness, avoidance of internal
technical/biomed/gb-2003-4-1-r5.txt:          non-redundant set of expressed mRNA sequences [ 20] was
technical/biomed/gb-2003-4-1-r5.txt:          International, Sunnyvale, CA) using an Intelligent
technical/biomed/gb-2003-4-1-r5.txt:          total RNA from rat heart or brain (Clontech, Palo Alto,
technical/biomed/gb-2003-4-1-r5.txt:          transcriptase (Invitrogen/Life Technologies). RNA was
technical/biomed/gb-2003-4-1-r5.txt:          region of the mRNA molecule. In contrast, oligo(dT) 
technical/biomed/gb-2003-4-1-r5.txt:          design considerations to the 3' end of the mRNA
technical/biomed/gb-2003-4-1-r5.txt:          Arabidopsis control cRNA set spiked
technical/biomed/gb-2003-4-1-r5.txt:          into the query RNA samples at a 1:1 ratio [ 21]. After
technical/biomed/gb-2003-4-1-r7.txt:          the terms 'RNA metabolism', 'RNA processing', 'mRNA
technical/biomed/gb-2003-4-1-r7.txt:          processing', and 'mRNA splicing' appear as upregulated in
technical/biomed/gb-2003-4-1-r7.txt:          that mRNA splicing is a child term of both RNA splicing
technical/biomed/gb-2003-4-1-r7.txt:          and mRNA processing, which are in turn child terms of RNA
technical/biomed/gb-2003-4-1-r7.txt:          internally, and to the user the GO hierarchy seen in the
technical/biomed/gb-2003-4-2-r11.txt:        peptidoglycan consists of a chain of alternating 
technical/biomed/gb-2003-4-2-r11.txt:        DNA viruses, positive-strand RNA viruses and certain
technical/biomed/gb-2003-4-2-r11.txt:          animal positive-strand RNA viruses with statistically
technical/biomed/gb-2003-4-2-r11.txt:            orthologous groups. Gene loss is an alternative
technical/biomed/gb-2003-4-2-r11.txt:            such potential function. Alternatively, these proteins
technical/biomed/gb-2003-4-2-r11.txt:            picornaviruses such as human parechoviruses, Aichi
technical/biomed/gb-2003-4-2-r11.txt:            including the forms from RNA viruses, clearly form a
technical/biomed/gb-2003-4-2-r14.txt:          pointing out that alternative explanations for apparent
technical/biomed/gb-2003-4-2-r14.txt:          Woese [ 16] contends that the rRNA tree is a valid
technical/biomed/gb-2003-4-2-r14.txt:          evolutionary time. Using the aminoacyl-tRNA synthases as
technical/biomed/gb-2003-4-2-r14.txt:          evaluated the evidence for the alternative possibilities
technical/biomed/gb-2003-4-2-r14.txt:          spaced from one another on the 16S rRNA tree.
technical/biomed/gb-2003-4-2-r14.txt:          aroF . A hierarchy of internal
technical/biomed/gb-2003-4-2-r14.txt:          16S rRNA tree, although the 
technical/biomed/gb-2003-4-2-r14.txt:          Figure 9shows a segment of the 16S rRNA tree that
technical/biomed/gb-2003-4-2-r14.txt:          fusion domains. This might suggest an alternative to LGT,
technical/biomed/gb-2003-4-2-r14.txt:          trp-pathway genes in the 16S rRNA tree sector that is
technical/biomed/gb-2003-4-2-r14.txt:          16S rRNA subtrees were derived from the Ribosomal
technical/biomed/gb-2003-4-2-r16.txt:        curated only a subset of them (mostly mRNA and RefSeq
technical/biomed/gb-2003-4-2-r16.txt:        either singleton mRNA/EST sequence with no TC accession
technical/biomed/gb-2003-4-2-r16.txt:        curating associations with genomic and mRNA sequence data.
technical/biomed/gb-2003-4-2-r16.txt:        mRNA sequences and 20,908 of them have MGI associations.
technical/biomed/gb-2003-4-2-r16.txt:        The remaining 5,532 DTs with mRNA sequences might represent
technical/biomed/gb-2003-4-2-r16.txt:        alternative transcripts of MGI genes, known genes not yet
technical/biomed/gb-2003-4-2-r16.txt:          often represent alternatively spliced transcripts. For
technical/biomed/gb-2003-4-2-r16.txt:          different transcripts generated from alternative splicing
technical/biomed/gb-2003-4-2-r16.txt:          [ 19]. At least eight distinct mRNAs have been identified
technical/biomed/gb-2003-4-2-r16.txt:          caused by alternative splicing (and/or alternative
technical/biomed/gb-2003-4-2-r16.txt:          transcription from alternative promoters and/or
technical/biomed/gb-2003-4-2-r16.txt:          whole dataset based on our experience of ongoing internal
technical/biomed/gb-2003-4-2-r16.txt:          genes share similar structure and sequence. Their mRNAs
technical/biomed/gb-2003-4-2-r16.txt:          Ear10 ) and RNA guanylyltransferase
technical/biomed/gb-2003-4-2-r16.txt:          because they are mostly high-quality mRNA sequences and
technical/biomed/gb-2003-4-2-r16.txt:          and mRNA sequences. One possibility is different degrees
technical/biomed/gb-2003-4-2-r8.txt:        and smaller RNAs containing 
technical/biomed/gb-2003-4-2-r8.txt:        function at the RNA level to affect life span. There are no
technical/biomed/gb-2003-4-2-r8.txt:          RNA was isolated from adult 
technical/biomed/gb-2003-4-2-r8.txt:          Drosophila using the RNAqueous kit
technical/biomed/gb-2003-4-2-r8.txt:          size was determined by comparison with 1 kb RNA ladder
technical/biomed/gb-2003-4-2-r8.txt:          Relative RNA levels and the fold induction of
technical/biomed/gb-2003-4-2-r8.txt:          phosphoimage. The 1x and 2x northern lanes for each RNA
technical/biomed/gb-2003-4-2-r9.txt:        provides an easy alternative for the functional genomic
technical/biomed/gb-2003-4-2-r9.txt:          a highly sensitive alternative to PCR products and
technical/biomed/gb-2003-4-2-r9.txt:          P. falciparum total RNA). Ten
technical/biomed/gb-2003-4-2-r9.txt:          the presence of internal mismatches (bubbles and bulges)
technical/biomed/gb-2003-4-2-r9.txt:          hybridizations was carried out where total RNA from an
technical/biomed/gb-2003-4-2-r9.txt:          For microarray hybridization, total RNA was prepared
technical/biomed/gb-2003-4-2-r9.txt:          equal mass of total RNA from both the trophozoite and
technical/biomed/gb-2003-4-2-r9.txt:          schizont stages when equal masses of total RNA are
technical/biomed/gb-2003-4-2-r9.txt:          +RNA were used for the northern blot (Figure 7a). The
technical/biomed/gb-2003-4-2-r9.txt:          discrepancy between northern blots with total RNA and
technical/biomed/gb-2003-4-2-r9.txt:          poly(A) +mRNA are probably due to changes in the relative
technical/biomed/gb-2003-4-2-r9.txt:          amounts of mRNA and ribosomal RNA during the
technical/biomed/gb-2003-4-2-r9.txt:            aminoacyl-tRNA synthetases, and 10 initiation and seven
technical/biomed/gb-2003-4-2-r9.txt:            including Asp-tRNA synthetase, two plasmodial
technical/biomed/gb-2003-4-2-r9.txt:            among the trophozoite genes: five DEAD-box RNA
technical/biomed/gb-2003-4-2-r9.txt:            P. cynomolgi RNA helicases-1 [
technical/biomed/gb-2003-4-2-r9.txt:            that found a group of DEAD-box RNA helicases to be
technical/biomed/gb-2003-4-2-r9.txt:            genes involved in various steps of RNA synthesis and
technical/biomed/gb-2003-4-2-r9.txt:            including 16 ORFs belonging to various RNA polymerase
technical/biomed/gb-2003-4-2-r9.txt:            previously identified plasmodial RNA polymerase
technical/biomed/gb-2003-4-2-r9.txt:            P. falciparum RNA polymerase II,
technical/biomed/gb-2003-4-2-r9.txt:            PfRNApolIIA (M73770), and a homolog RNApolK (14 kD) [
technical/biomed/gb-2003-4-2-r9.txt:            phosphorylases had elevated mRNA levels during the
technical/biomed/gb-2003-4-2-r9.txt:        transcriptional phenomena, including antisense mRNA
technical/biomed/gb-2003-4-2-r9.txt:        transcription [ 48] and alternative splicing and/or
technical/biomed/gb-2003-4-2-r9.txt:          RNA preparation and microarray hybridization
technical/biomed/gb-2003-4-2-r9.txt:          Total RNA was prepared directly from the frozen
technical/biomed/gb-2003-4-2-r9.txt:          and RNA was extracted according to the manufacturer's
technical/biomed/gb-2003-4-2-r9.txt:          instructions. mRNA was isolated from total RNA
technical/biomed/gb-2003-4-2-r9.txt:          preparations using the Oligotex mRNA Mini Kit (Qiagen,
technical/biomed/gb-2003-4-2-r9.txt:          total RNA was used for first-strand cDNA synthesis as
technical/biomed/gb-2003-4-2-r9.txt:          follows: RNA was mixed with a mixture of random hexamer
technical/biomed/gb-2003-4-2-r9.txt:          at 42°C for 120 min and the residual RNA was hydrolyzed
technical/biomed/gb-2003-4-2-r9.txt:          Total RNA (10 μg) or poly(A) +RNA (0.4 μg) was
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy3 and schizont RNA labeled with Cy5;
technical/biomed/gb-2003-4-2-r9.txt:        Three hybridizations ( 4, 5, 6) with trophozoite RNA
technical/biomed/gb-2003-4-2-r9.txt:        labeled with Cy5 and schizont RNA labeled with Cy3.
technical/biomed/gb-2003-4-2-r9.txt:        10, 11, 12) with trophozoite RNA labeled with Cy3 and
technical/biomed/gb-2003-4-2-r9.txt:        schizont RNA labeled with Cy5; four hybridizations ( 14,
technical/biomed/gb-2003-4-2-r9.txt:        15, 15, 16) with trophozoite RNA labeled with Cy5 and
technical/biomed/gb-2003-4-2-r9.txt:        schizont RNA labeled with Cy3.
technical/biomed/gb-2003-4-2-r9.txt:        Figure 5: hybridization with trophozoite RNA labeled
technical/biomed/gb-2003-4-2-r9.txt:        with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        Figure 5: hybridization with trophozoite RNA labeled
technical/biomed/gb-2003-4-2-r9.txt:        with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        Figure 5: hybridization with trophozoite RNA labeled
technical/biomed/gb-2003-4-2-r9.txt:        with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        Figure 5: hybridization with trophozoite RNA labeled
technical/biomed/gb-2003-4-2-r9.txt:        with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        Figure 5: hybridization with trophozoite RNA labeled
technical/biomed/gb-2003-4-2-r9.txt:        with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        Figure 5: hybridization with trophozoite RNA labeled
technical/biomed/gb-2003-4-2-r9.txt:        with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        Figure 5: hybridization with trophozoite RNA labeled
technical/biomed/gb-2003-4-2-r9.txt:        with Cy5 and schizont RNA labeled with Cy3
technical/biomed/gb-2003-4-2-r9.txt:        Figure 5: hybridization with trophozoite RNA labeled
technical/biomed/gb-2003-4-2-r9.txt:        with Cy5 and schizont RNA labeled with Cy3
technical/biomed/gb-2003-4-2-r9.txt:        Figure 5: hybridization with trophozoite RNA labeled
technical/biomed/gb-2003-4-2-r9.txt:        with Cy5 and schizont RNA labeled with Cy3
technical/biomed/gb-2003-4-2-r9.txt:        Figure 5: hybridization with trophozoite RNA labeled
technical/biomed/gb-2003-4-2-r9.txt:        with Cy5 and schizont RNA labeled with Cy3
technical/biomed/gb-2003-4-2-r9.txt:        Figure 5: hybridization with trophozoite RNA labeled
technical/biomed/gb-2003-4-2-r9.txt:        with Cy5 and schizont RNA labeled with Cy3
technical/biomed/gb-2003-4-2-r9.txt:        Figure 5: hybridization with trophozoite RNA labeled
technical/biomed/gb-2003-4-2-r9.txt:        with Cy5 and schizont RNA labeled with Cy3
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy3 and schizont RNA labeled with Cy5
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy5 and schizont RNA labeled with Cy3
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy5 and schizont RNA labeled with Cy3
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy5 and schizont RNA labeled with Cy3
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy5 and schizont RNA labeled with Cy3
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy5 and schizont RNA labeled with Cy3
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy5 and schizont RNA labeled with Cy3
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy5 and schizont RNA labeled with Cy3
technical/biomed/gb-2003-4-2-r9.txt:        RNA labeled with Cy5 and schizont RNA labeled with Cy3
technical/biomed/gb-2003-4-3-r17.txt:        to profile mRNA levels in a variety of organisms and
technical/biomed/gb-2003-4-3-r17.txt:        RNA. These modifications include the direct binding of mRNA
technical/biomed/gb-2003-4-3-r17.txt:        libraries from the same mRNA samples to examine the
technical/biomed/gb-2003-4-3-r17.txt:        constructed from either identical mRNA samples or ditag
technical/biomed/gb-2003-4-3-r17.txt:          by measurement of mRNA reassociation kinetics, examines
technical/biomed/gb-2003-4-3-r17.txt:          the relative fraction of total mRNA made up of
technical/biomed/gb-2003-4-3-r17.txt:          brain RNA (Figure 1a,1b,1c) [ 11 ] .
technical/biomed/gb-2003-4-3-r17.txt:          accurate measure of mRNA abundance - that is, give tag
technical/biomed/gb-2003-4-3-r17.txt:          levels that match levels of mRNAs for which abundance
technical/biomed/gb-2003-4-3-r17.txt:          several such mRNAs. Although no absolute quantification
technical/biomed/gb-2003-4-3-r17.txt:          of mRNAs in mouse retina has been made, measurement of
technical/biomed/gb-2003-4-3-r17.txt:          retinol-binding protein (IRBP) mRNAs in adult rat retina
technical/biomed/gb-2003-4-3-r17.txt:          0.1-0.2% of total RNA, respectively [ 12 ] . These
technical/biomed/gb-2003-4-3-r17.txt:          figures are based on the observation that mRNA consists
technical/biomed/gb-2003-4-3-r17.txt:          of roughly 2% of total RNA in both rat and mouse retina
technical/biomed/gb-2003-4-3-r17.txt:          levels, or the failure to identify all alternative 3'
technical/biomed/gb-2003-4-3-r17.txt:          two libraries made from the same mRNA sample ( 
technical/biomed/gb-2003-4-3-r17.txt:          crx +/+mRNA samples (that is, the
technical/biomed/gb-2003-4-3-r17.txt:          RNA sample was divided into two tubes at the onset of the
technical/biomed/gb-2003-4-3-r17.txt:          (approximately 5%) when more than 1 μg total RNA is used
technical/biomed/gb-2003-4-3-r17.txt:          reliably reflect mRNA abundance profiles, despite the
technical/biomed/gb-2003-4-3-r17.txt:          fact that nearly 1,000-fold less starting mRNA was used
technical/biomed/gb-2003-4-3-r17.txt:          identical mRNA samples and ditag ligations showed very
technical/biomed/gb-2003-4-3-r17.txt:          ditag ligation than in those made from the same mRNA
technical/biomed/gb-2003-4-3-r17.txt:          mRNA stability between tissue collection and mRNA
technical/biomed/gb-2003-4-3-r17.txt:          reported a high degree of variation in RNA levels in rat
technical/biomed/gb-2003-4-3-r17.txt:          in mRNA levels as measured by northern or RT-PCR [ 23 41
technical/biomed/gb-2003-4-3-r17.txt:          SAGE. Underestimating differences in mRNA levels will
technical/biomed/gb-2003-4-3-r17.txt:          RNA instability following tissue dissection does
technical/biomed/gb-2003-4-3-r17.txt:          temperature for 4 hours and then processed for RNA
technical/biomed/gb-2003-4-3-r17.txt:          among the libraries might represent differential mRNA
technical/biomed/gb-2003-4-3-r17.txt:          have indicated a high level of RNA stability for up to 48
technical/biomed/gb-2003-4-3-r17.txt:          indicated instability of mRNA in tissue stored long term
technical/biomed/gb-2003-4-3-r17.txt:          cellular mRNA expression, while previous studies examined
technical/biomed/gb-2003-4-3-r17.txt:          of the tissue before mRNA preparation. However,
technical/biomed/gb-2003-4-3-r17.txt:          differential mRNA stability, one would expect to see a
technical/biomed/gb-2003-4-3-r17.txt:          subset of mRNAs that were much reduced in expression in
technical/biomed/gb-2003-4-3-r17.txt:          of time between enucleation and RNA extraction. One might
technical/biomed/gb-2003-4-3-r17.txt:          mRNA stability during long-term frozen storage. However,
technical/biomed/gb-2003-4-3-r17.txt:          (Figure 7), suggesting that differential mRNA stability
technical/biomed/gb-2003-4-3-r17.txt:          mRNA degradation occurs between tissue harvesting and
technical/biomed/gb-2003-4-3-r17.txt:          binding of the mRNA to the magnetic oligo(dT)-coupled
technical/biomed/gb-2003-4-3-r17.txt:        the same starting mRNA samples. However, we find that
technical/biomed/gb-2003-4-3-r17.txt:          made directly from Trizol-purified total RNA and were the
technical/biomed/gb-2003-4-3-r17.txt:          before RNA extraction; hypothalamus B, mice were housed
technical/biomed/gb-2003-4-3-r17.txt:          which 5 μg total RNA was used, and the microdissected
technical/biomed/gb-2003-4-3-r17.txt:        mRNA stage); Additional data file 4- 41-year-old peripheral
technical/biomed/gb-2003-4-3-r18.txt:        become lost from the alternative sex chromosome. 
technical/biomed/gb-2003-4-3-r18.txt:        patterns [ 22]. Alternatively, if a control gene confers
technical/biomed/gb-2003-4-3-r18.txt:        apraxia [ 26, 27] and the scavenger mRNA decapping enzyme
technical/biomed/gb-2003-4-3-r18.txt:        ASW mRNA is highly expressed in the
technical/biomed/gb-2003-4-3-r18.txt:        HINT mRNA is expressed at levels
technical/biomed/gb-2003-4-3-r18.txt:        the mRNA [ 37]. Involvement of ASF/SF2 in the regulation of
technical/biomed/gb-2003-4-3-r18.txt:        ASW mRNA is interesting because
technical/biomed/gb-2003-4-3-r18.txt:        doublesex mRNA in 
technical/biomed/gb-2003-4-3-r18.txt:        the dimer that could be a site of alternative localization
technical/biomed/gb-2003-4-3-r20.txt:          after the treatment and pooled before RNA extraction
technical/biomed/gb-2003-4-3-r20.txt:          to the abundance of the mRNA used for constructing the
technical/biomed/gb-2003-4-3-r20.txt:          the chronic ozone library. RNA was isolated as described
technical/biomed/gb-2003-4-3-r20.txt:          pooled for RNA extraction and identification of genes
technical/biomed/gb-2003-4-3-r20.txt:          RNA isolations. Four-week-old plants were sprayed with 50
technical/biomed/gb-2003-4-3-r20.txt:          for RNA isolation.
technical/biomed/gb-2003-4-3-r20.txt:          RNA isolation
technical/biomed/gb-2003-4-3-r20.txt:          Total RNA was isolated from frozen leaf tissue using
technical/biomed/gb-2003-4-3-r20.txt:          removed to a clean tube and RNA was precipitated with an
technical/biomed/gb-2003-4-3-r20.txt:          g to pellet the RNA. The pellet was
technical/biomed/gb-2003-4-3-r20.txt:          washed with 75% ethanol and resuspended in RNase-free
technical/biomed/gb-2003-4-3-r20.txt:          water. The typical yield of total RNA was 50-80 μg/100 mg
technical/biomed/gb-2003-4-3-r20.txt:          leaf tissue. Poly(A) +RNA was purified from total RNA
technical/biomed/gb-2003-4-3-r20.txt:          the amount of mRNA to 3-4 μg from the 2 μg recommended by
technical/biomed/gb-2003-4-3-r20.txt:          the manufacturer to compensate for the loss of mRNA
technical/biomed/gb-2003-4-3-r20.txt:          Total RNA was fractionated on a 1.2% agarose/0.4 M
technical/biomed/gb-2003-4-3-r20.txt:          formaldehyde RNA gel and transferred to Hybond N +nylon
technical/biomed/gb-2003-4-4-r24.txt:        severe malaria [ 1 2 3 ] . Alternatively, these 
technical/biomed/gb-2003-4-4-r26.txt:        with known RNA interference (RNAi) phenotypes. Genes
technical/biomed/gb-2003-4-4-r26.txt:          calcium binding (22 clusters), RNA recognition motif (18
technical/biomed/gb-2003-4-4-r26.txt:          As an alternative method of categorizing clusters by
technical/biomed/gb-2003-4-4-r26.txt:          M. incognita only. Alternatively,
technical/biomed/gb-2003-4-4-r26.txt:          evolution and diversification. Alternatively, since the 
technical/biomed/gb-2003-4-4-r26.txt:          Nematodes process many mRNAs by 
technical/biomed/gb-2003-4-4-r26.txt:          transcript among EST collections. As an alternative
technical/biomed/gb-2003-4-4-r26.txt:          Comparison to C. elegansgenes with known RNAi
technical/biomed/gb-2003-4-4-r26.txt:          The technique of RNAi, whereby the introduction of a
technical/biomed/gb-2003-4-4-r26.txt:          sequence-specific double-stranded RNA leads to
technical/biomed/gb-2003-4-4-r26.txt:          degradation of matching mRNAs [ 62 ] , has allowed the
technical/biomed/gb-2003-4-4-r26.txt:          where high-throughput RNAi is not yet possible. A list of
technical/biomed/gb-2003-4-4-r26.txt:          C. elegans RNAi experiments
technical/biomed/gb-2003-4-4-r26.txt:          Meloidogyne clusters and RNAi
technical/biomed/gb-2003-4-4-r26.txt:          revealed. A specific phenotype by RNAi was apparent for
technical/biomed/gb-2003-4-4-r26.txt:          C. elegans RNAi phenotypes for
technical/biomed/gb-2003-4-4-r26.txt:          comparison, RNAi surveys of all predicted genes on a 
technical/biomed/gb-2003-4-4-r26.txt:          enrichment for genes with severe phenotypes by RNAi such
technical/biomed/gb-2003-4-4-r26.txt:          phenotype by RNAi had previously been shown by comparison
technical/biomed/gb-2003-4-4-r26.txt:          nematode species. Applying RNAi techniques directly to
technical/biomed/gb-2003-4-4-r26.txt:          RNAi effects in both plant [ 66 ] and animal [ 67 ]
technical/biomed/gb-2003-4-4-r26.txt:          related species. Alternatively, genes may be special
technical/biomed/gb-2003-4-4-r26.txt:          Meloidogyne nodL mRNA and the
technical/biomed/gb-2003-4-4-r26.txt:        to result in different representation from an mRNA pool
technical/biomed/gb-2003-4-4-r26.txt:        evidence of alternative splicing, another feature which
technical/biomed/gb-2003-4-4-r26.txt:          Total RNA was isolated from collected L2 by the Trizol
technical/biomed/gb-2003-4-4-r26.txt:          +RNA was isolated from total RNA using the Promega
technical/biomed/gb-2003-4-4-r26.txt:          no more than a one non-A/T base); internal poly(A) and/or
technical/biomed/gb-2003-4-4-r26.txt:          than one non-A/T base; internal stretches of low
technical/biomed/gb-2003-4-4-r26.txt:          internal consensus position with a calculated quality
technical/biomed/gb-2003-4-4-r26.txt:          sequences, and six internally constructed databases using
technical/biomed/gb-2003-4-4-r26.txt:          As an alternative means of assigning function to
technical/biomed/gb-2003-4-4-r26.txt:          C. eleganshomologs with RNAi phenotype
technical/biomed/gb-2003-4-4-r26.txt:          using RNAi, a list of all 7,212 available 
technical/biomed/gb-2003-4-4-r26.txt:          C. elegans RNAi experiments (5 May
technical/biomed/gb-2003-4-4-r26.txt:          database. Redundant RNAi experiments were removed to
technical/biomed/gb-2003-4-4-r26.txt:        C. elegans RNAi phenotypes for genes
technical/biomed/gb-2003-4-4-r26.txt:        data file 3); classification by RNAi phenotype of 
technical/biomed/gb-2003-4-4-r26.txt:        C. elegans RNAi phenotypes for genes
technical/biomed/gb-2003-4-4-r26.txt:        C. elegans RNAi phenotypes for genes
technical/biomed/gb-2003-4-4-r26.txt:        A classification by RNAi phenotype of 
technical/biomed/gb-2003-4-4-r26.txt:        A classification by RNAi phenotype of 
technical/biomed/gb-2003-4-4-r28.txt:        gene as a query to an external data resource. The number of
technical/biomed/gb-2003-4-4-r28.txt:        external databases provide GoMiner with a rich set of
technical/biomed/gb-2003-4-4-r28.txt:        tree (Figure 1a) or, alternatively, in the form of a DAG
technical/biomed/gb-2003-4-4-r28.txt:          biological significance as well. An alternative is to
technical/biomed/gb-2003-4-4-r28.txt:          alternative pathways for performing a biological
technical/biomed/gb-2003-4-4-r28.txt:        We recently implemented an alternative command-line
technical/biomed/gb-2003-4-5-r30.txt:        target site in DNA and reverse transcribe L1 RNA,
technical/biomed/gb-2003-4-5-r30.txt:        mRNA [ 28 ] .
technical/biomed/gb-2003-4-5-r30.txt:        sequence. These sequence structures may indicate internal
technical/biomed/gb-2003-4-5-r30.txt:          long enough to include the internal promoter in the 5'
technical/biomed/gb-2003-4-5-r30.txt:          too short to have been transcribed from the internal L1
technical/biomed/gb-2003-4-5-r30.txt:          within 1,650 nucleotides of the start of an mRNA
technical/biomed/gb-2003-4-5-r30.txt:          transcripts may have been internally primed at an A-rich
technical/biomed/gb-2003-4-5-r30.txt:          different type of internal priming is also required by a
technical/biomed/gb-2003-4-5-r30.txt:          If internal priming is a mechanism by which standard
technical/biomed/gb-2003-4-5-r30.txt:          whose 3' ends coincide with internal A-rich regions of
technical/biomed/gb-2003-4-5-r30.txt:          avoid long internal tracts of As in order to prevent
technical/biomed/gb-2003-4-5-r30.txt:          internal priming of the transcript. The L1 consensus
technical/biomed/gb-2003-4-5-r30.txt:        discussion). Alternatively, Boissinot 
technical/biomed/gb-2003-4-5-r30.txt:        the position of the A-rich sequence or RNA polymerase II
technical/biomed/gb-2003-4-5-r30.txt:        been polyadenylated. Alternatively, there may be a
technical/biomed/gb-2003-4-5-r30.txt:        synthesis be primed internally on the L1 transcript [ 45 ]
technical/biomed/gb-2003-4-5-r30.txt:        3'-transducing transcript may also be primed at an internal
technical/biomed/gb-2003-4-5-r30.txt:        We did not find evidence of internal priming for
technical/biomed/gb-2003-4-5-r30.txt:        of another transposable element. Lack of internal priming
technical/biomed/gb-2003-4-5-r30.txt:        specifically to L1 RNA [ 50 ] . Moreover, it is possible
technical/biomed/gb-2003-4-5-r30.txt:        minus the 5' UTR, the length of the longest internal
technical/biomed/gb-2003-4-5-r30.txt:        multiple mechanisms to avoid internal priming on A-rich
technical/biomed/gb-2003-4-5-r30.txt:          included in the annotation of any mRNA or CDS.
technical/biomed/gb-2003-4-5-r30.txt:        internally primed at an A-rich sequence is available as a
technical/biomed/gb-2003-4-5-r30.txt:        internally primed at an A-rich sequence
technical/biomed/gb-2003-4-5-r30.txt:        internally primed at an A-rich sequence
technical/biomed/gb-2003-4-5-r32.txt:        microarrays measured mRNA transcription levels of genes
technical/biomed/gb-2003-4-5-r32.txt:          of AdoMet synthetase mRNA observed in the present study
technical/biomed/gb-2003-4-5-r32.txt:          mRNA peaks at 72 hours after CCl 
technical/biomed/gb-2003-4-5-r32.txt:          g was flash frozen in liquid nitrogen. RNA was extracted
technical/biomed/gb-2003-4-5-r32.txt:          Total RNA was quantified and assessed for quality on a
technical/biomed/gb-2003-4-5-r32.txt:          Bioanalyzer RNA chip (Agilent, Palo Alto, CA). Each chip
technical/biomed/gb-2003-4-5-r32.txt:          carry out electrophoretic separations. Ribosomal RNA
technical/biomed/gb-2003-4-5-r32.txt:          in an electropherogram. A successful total RNA sample
technical/biomed/gb-2003-4-5-r32.txt:          featured two distinct ribosomal peaks (18S and 28S rRNA).
technical/biomed/gb-2003-4-5-r32.txt:          They may contain nucleoli, or chromatin figures internal
technical/biomed/gb-2003-4-5-r32.txt:          with a clear internal structure highlighted by dark
technical/biomed/gb-2003-4-5-r32.txt:          measurements of internally visible chromatin and/or
technical/biomed/gb-2003-4-5-r34.txt:          to known external knowledge of the data); and cluster
technical/biomed/gb-2003-4-5-r34.txt:          stability. External validation compares clustering
technical/biomed/gb-2003-4-5-r34.txt:          results to known independent external knowledge of which
technical/biomed/gb-2003-4-5-r34.txt:          the external knowledge is assumed to be accurate.
technical/biomed/gb-2003-4-5-r34.txt:            An alternative idea is to cluster the repeated
technical/biomed/gb-2003-4-5-r34.txt:            Because independent external knowledge is often
technical/biomed/gb-2003-4-5-r34.txt:            our external knowledge. That is, we evaluate algorithm
technical/biomed/gb-2003-4-5-r34.txt:            that indicates the agreement between the external
technical/biomed/gb-2003-4-5-r34.txt:            is used to refer to the external knowledge, while the
technical/biomed/gb-2003-4-5-r34.txt:            cluster analysis may merge partitions that the external
technical/biomed/gb-2003-4-5-r34.txt:            remeasurements. The external knowledge is not used in
technical/biomed/gb-2003-4-5-r34.txt:          There are also some limitations with the external
technical/biomed/gb-2003-4-5-r34.txt:        measurements and external criteria available. We would
technical/biomed/gb-2003-4-5-r34.txt:            Alternatively, the adjusted Rand index can be used for
technical/biomed/gb-2003-4-5-r34.txt:        11, 12, 13, 14). Our website [ 33 ] also has external links
technical/biomed/gb-2003-4-6-r37.txt:        underlying male external genitalia development might be
technical/biomed/gb-2003-4-6-r37.txt:          individuals with female external genitalia. The AR status
technical/biomed/gb-2003-4-6-r37.txt:          gene-expression patterns, mRNA was isolated from
technical/biomed/gb-2003-4-6-r37.txt:        the programs that underlie external genital development.
technical/biomed/gb-2003-4-6-r37.txt:        traits of the external genitalia. Some genes expressed in
technical/biomed/gb-2003-4-6-r37.txt:        participate in the AR-initiated programs of external
technical/biomed/gb-2003-4-6-r37.txt:        and a potential role of BMP4 in external genital
technical/biomed/gb-2003-4-6-r37.txt:        little or no change in the external genitalia. It is
technical/biomed/gb-2003-4-6-r37.txt:          cells were scraped and mRNA harvested directly.
technical/biomed/gb-2003-4-6-r37.txt:          RNA isolation and cDNA labeling
technical/biomed/gb-2003-4-6-r37.txt:          Protocols for mRNA preparation and cDNA labeling are
technical/biomed/gb-2003-4-6-r37.txt:          available online [ 32 ] . mRNA (2 μg) from single
technical/biomed/gb-2003-4-6-r37.txt:          (pseudo-coloured red) and pooled reference mRNA was
technical/biomed/gb-2003-4-6-r37.txt:          labeled with Cy3 (pseudo-coloured green). Reference mRNA
technical/biomed/gb-2003-4-6-r37.txt:          contained equal mixtures of fibroblast mRNA (pooled from
technical/biomed/gb-2003-4-6-r37.txt:          mRNAs isolated from 11 different proliferating cultured
technical/biomed/gb-2003-4-6-r37.txt:          of 21 DNA microarray analyses of mRNA from normal and AIS
technical/biomed/gb-2003-4-6-r37.txt:        external genitalia, M = normal male external genitalia,
technical/biomed/gb-2003-4-6-r39.txt:        Alternatively, the transfer event may be more recent, such
technical/biomed/gb-2003-4-6-r39.txt:          asparaginyl-tRNA synthetase. Three of the four had best
technical/biomed/gb-2003-4-6-r41.txt:        An alternative to the statistic (1) is 
technical/biomed/gb-2003-4-7-r42.txt:        all genomes also contain a constellation of non-coding RNA
technical/biomed/gb-2003-4-7-r42.txt:        genes. With the exception of certain classes of RNAs with
technical/biomed/gb-2003-4-7-r42.txt:        ribosomal and transfer RNAs, identification of most
technical/biomed/gb-2003-4-7-r42.txt:        non-coding RNAs has historically been a relatively
technical/biomed/gb-2003-4-7-r42.txt:        RNA genes was laid bare by recent work on microRNAs
technical/biomed/gb-2003-4-7-r42.txt:        (miRNAs), an abundant family of 21-22 nucleotide non-coding
technical/biomed/gb-2003-4-7-r42.txt:        RNAs [ 2 3 ] . The founding members of this family, lin-4
technical/biomed/gb-2003-4-7-r42.txt:        ] . Both of these RNAs are post-transcriptional regulators
technical/biomed/gb-2003-4-7-r42.txt:        9 ] and miRNA genes are now recognized as a pervasive and
technical/biomed/gb-2003-4-7-r42.txt:        In general, it is thought that miRNA biogenesis proceeds
technical/biomed/gb-2003-4-7-r42.txt:        stem-loop structure (pre-miRNA), although at least some
technical/biomed/gb-2003-4-7-r42.txt:        pre-miRNAs are further derived from even longer transcripts
technical/biomed/gb-2003-4-7-r42.txt:        (primary miRNA transcripts, or pri-miRNAs). These can exist
technical/biomed/gb-2003-4-7-r42.txt:        as long individual pre-miRNA precursor transcripts, as
technical/biomed/gb-2003-4-7-r42.txt:        operon-like multiple pre-miRNA precursors, or even as part
technical/biomed/gb-2003-4-7-r42.txt:        of primary mRNA transcripts. Processing of pri-miRNA into
technical/biomed/gb-2003-4-7-r42.txt:        the pre-miRNA stem-loop occurs in the nucleus, while
technical/biomed/gb-2003-4-7-r42.txt:        subsequent processing of pre-miRNA into 21-22 mers is a
technical/biomed/gb-2003-4-7-r42.txt:        cytoplasmic event mediated by the RNAse III enzyme Dicer [
technical/biomed/gb-2003-4-7-r42.txt:        long perfectly double-stranded RNA into 21-22 nucleotide
technical/biomed/gb-2003-4-7-r42.txt:        fragments during RNA interference (RNAi) [ 2 21 ] . These
technical/biomed/gb-2003-4-7-r42.txt:        latter molecules, known as silencing RNA (siRNA), bind to
technical/biomed/gb-2003-4-7-r42.txt:        and trigger the degradation of perfectly homologous mRNA
technical/biomed/gb-2003-4-7-r42.txt:        molecules via RISC, a double-strand RNA-induced silencing
technical/biomed/gb-2003-4-7-r42.txt:        in vivo function of only a few miRNAs
technical/biomed/gb-2003-4-7-r42.txt:        regulation of complementary mRNA targets. Interestingly,
technical/biomed/gb-2003-4-7-r42.txt:        associated with mRNA degradation [ 24 25 26 ] , similar to
technical/biomed/gb-2003-4-7-r42.txt:        the effects of siRNA, whereas imperfect base-pairing is
technical/biomed/gb-2003-4-7-r42.txt:        27 ] . Recently, siRNAs with imperfect match to target mRNA
technical/biomed/gb-2003-4-7-r42.txt:        RNA-mediated regulation may be largely determined by the
technical/biomed/gb-2003-4-7-r42.txt:        The vast majority of the approximately 300 miRNAs
technical/biomed/gb-2003-4-7-r42.txt:        short RNA molecules. Although this method has been quite
technical/biomed/gb-2003-4-7-r42.txt:        necessity for a considerable amount of RNA as raw material
technical/biomed/gb-2003-4-7-r42.txt:        few highly expressed miRNAs. For example, 41% of miRNAs
technical/biomed/gb-2003-4-7-r42.txt:        brain miRNAs are variants of miR-124, and 45% of miRNAs
technical/biomed/gb-2003-4-7-r42.txt:        mammalian miRNAs will be easily identified by the direct
technical/biomed/gb-2003-4-7-r42.txt:        As a complementary approach to miRNA identification, we
technical/biomed/gb-2003-4-7-r42.txt:        intronic and intergenic sequences to an RNA folding and
technical/biomed/gb-2003-4-7-r42.txt:        miRNAs. The specificity of this computational procedure was
technical/biomed/gb-2003-4-7-r42.txt:        shown by the presence of 18 out of 24 reference miRNAs
technical/biomed/gb-2003-4-7-r42.txt:        novel miRNA candidates whose existence was strongly
technical/biomed/gb-2003-4-7-r42.txt:        vertebrate genomes. Expression of 24 novel miRNA genes was
technical/biomed/gb-2003-4-7-r42.txt:        the newly verified miRNA genes vary tremendously with
technical/biomed/gb-2003-4-7-r42.txt:        rates (based on our ability to identify known miRNAs and
technical/biomed/gb-2003-4-7-r42.txt:        presumed genuine, novel miRNAs) leads us to estimate that
technical/biomed/gb-2003-4-7-r42.txt:        drosophilid genomes contain around 110 miRNA genes, or
technical/biomed/gb-2003-4-7-r42.txt:        32 33 34 ] , it is likely that most miRNAs in completed
technical/biomed/gb-2003-4-7-r42.txt:          Evolutionarily conserved characteristics of miRNA
technical/biomed/gb-2003-4-7-r42.txt:          Drosophila pre-miRNA sequences ( 
technical/biomed/gb-2003-4-7-r42.txt:          specifically describe known miRNA genes within anonymous
technical/biomed/gb-2003-4-7-r42.txt:          viewed in VISTA plot alignments [ 35 ] , miRNA genes
technical/biomed/gb-2003-4-7-r42.txt:          for many other non-coding RNA genes, their degree of
technical/biomed/gb-2003-4-7-r42.txt:          that miRNA genes might be found by folding fixed lengths
technical/biomed/gb-2003-4-7-r42.txt:          characteristic of known pre-miRNAs. However, pilot
technical/biomed/gb-2003-4-7-r42.txt:          miRNA gene predictions.
technical/biomed/gb-2003-4-7-r42.txt:          Drosophila pre-miRNA sequences and
technical/biomed/gb-2003-4-7-r42.txt:          (Figure 2a, class 1), indicating that most pre-miRNAs
technical/biomed/gb-2003-4-7-r42.txt:          of the non-miRNA-encoding arm. This attribute is not
technical/biomed/gb-2003-4-7-r42.txt:          due to the acceptability of G-U base-pairing in RNA.
technical/biomed/gb-2003-4-7-r42.txt:          labile portion of pre-miRNA.
technical/biomed/gb-2003-4-7-r42.txt:          non-miRNA-encoding arm, and orthologous pre-miRNAs from
technical/biomed/gb-2003-4-7-r42.txt:          nucleotide mature miRNA itself. However, because of
technical/biomed/gb-2003-4-7-r42.txt:          miRNAs from species of an appropriate evolutionary
technical/biomed/gb-2003-4-7-r42.txt:          non-miRNA-encoding arm (Figure 2a, class 3). This is the
technical/biomed/gb-2003-4-7-r42.txt:          than on the non-miRNA-encoding arm and three have an
technical/biomed/gb-2003-4-7-r42.txt:          non-miRNA-encoding arm (Figure 2a, class 3); only one
technical/biomed/gb-2003-4-7-r42.txt:          number of changes on the non-miRNA arm than the loop
technical/biomed/gb-2003-4-7-r42.txt:          situation that would imply that the miRNA sequence itself
technical/biomed/gb-2003-4-7-r42.txt:          pattern of evolutionary divergence of miRNAs, and
technical/biomed/gb-2003-4-7-r42.txt:          into these classes to represent 'good' miRNA candidates.
technical/biomed/gb-2003-4-7-r42.txt:          probability of reflecting a genuine miRNA in 
technical/biomed/gb-2003-4-7-r42.txt:          Computational prediction of DrosophilamiRNA genes
technical/biomed/gb-2003-4-7-r42.txt:            snRNA, snoRNA, tRNA and rRNA genes. In total, we were
technical/biomed/gb-2003-4-7-r42.txt:            could contain miRNA genes (designated as 'regions'). We
technical/biomed/gb-2003-4-7-r42.txt:            sufficient to identify all known miRNA genes within
technical/biomed/gb-2003-4-7-r42.txt:            observation that RNA folding algorithms would not
technical/biomed/gb-2003-4-7-r42.txt:            necessarily identify characteristic pre-miRNA
technical/biomed/gb-2003-4-7-r42.txt:            longer RNAs, owing to base-pairing with non-miRNA
technical/biomed/gb-2003-4-7-r42.txt:            our windowing parameters segregated individual miRNAs
technical/biomed/gb-2003-4-7-r42.txt:            within known miRNA clusters (the 
technical/biomed/gb-2003-4-7-r42.txt:            RNA-folding algorithm [ 41 ] . As miRNA genes can be
technical/biomed/gb-2003-4-7-r42.txt:            penalize internal loops of increasing size. Since
technical/biomed/gb-2003-4-7-r42.txt:            unpaired nucleotides in known miRNAs have a tendency to
technical/biomed/gb-2003-4-7-r42.txt:            as it appears to be variable in known pre-miRNAs;
technical/biomed/gb-2003-4-7-r42.txt:            typically returns one to six alternate structures, each
technical/biomed/gb-2003-4-7-r42.txt:            probable miRNA candidate sequence. We then searched for
technical/biomed/gb-2003-4-7-r42.txt:            fraction of known fly miRNAs lack mosquito counterparts
technical/biomed/gb-2003-4-7-r42.txt:            miRNAs from among the 118,000 conserved
technical/biomed/gb-2003-4-7-r42.txt:            likelihood of representing genuine miRNAs (Figure 2a,
technical/biomed/gb-2003-4-7-r42.txt:            then defined a potential miRNA candidate sequence as
technical/biomed/gb-2003-4-7-r42.txt:            potential miRNA (Figure 2a, class 4). If both arms
technical/biomed/gb-2003-4-7-r42.txt:            passed this test, it was kept as a miRNA candidate
technical/biomed/gb-2003-4-7-r42.txt:            as either arm could potentially contain a miRNA. The
technical/biomed/gb-2003-4-7-r42.txt:            candidate miRNA arm. We defined the nonconserved arm as
technical/biomed/gb-2003-4-7-r42.txt:            the non-miRNA-encoding arm and eliminated the candidate
technical/biomed/gb-2003-4-7-r42.txt:            positions in both the loop and the non-miRNA-encoding
technical/biomed/gb-2003-4-7-r42.txt:            non-miRNA-encoding arm compared to within the loop
technical/biomed/gb-2003-4-7-r42.txt:            as potential miRNAs. Of the reference set miRNAs, only
technical/biomed/gb-2003-4-7-r42.txt:            mir-2b-1 failed these filters (as a class 6 miRNA),
technical/biomed/gb-2003-4-7-r42.txt:            genuine miRNAs (Figure 4, Table 1). A second measure of
technical/biomed/gb-2003-4-7-r42.txt:            Candidate mature miRNA sequences were defined by the
technical/biomed/gb-2003-4-7-r42.txt:            miRNAs were identifiable in non-insect species, a
technical/biomed/gb-2003-4-7-r42.txt:            A predicted miRNA produced from candidates whose only
technical/biomed/gb-2003-4-7-r42.txt:          miRNAs
technical/biomed/gb-2003-4-7-r42.txt:          We next sought to validate the predicted miRNAs by
technical/biomed/gb-2003-4-7-r42.txt:          northern blot of total RNA isolated from 0-24 hour
technical/biomed/gb-2003-4-7-r42.txt:          the mature miRNA can be derived from either arm of a
technical/biomed/gb-2003-4-7-r42.txt:          given stem-loop, and many predicted pre-miRNAs fold well
technical/biomed/gb-2003-4-7-r42.txt:          of a putative miRNA. Second, a significant fraction of
technical/biomed/gb-2003-4-7-r42.txt:          miRNAs are likely to be expressed at extremely low levels
technical/biomed/gb-2003-4-7-r42.txt:          classes of predicted miRNAs: 27 that were conserved
technical/biomed/gb-2003-4-7-r42.txt:          This analysis confirmed 24 novel miRNA genes that give
technical/biomed/gb-2003-4-7-r42.txt:          rise to processed 21-24 nucleotide RNAs (Figure 5, Table
technical/biomed/gb-2003-4-7-r42.txt:          miRNAs during development were much more heterogenous
technical/biomed/gb-2003-4-7-r42.txt:          miRNAs [ 10 ] . We identified miRNAs whose expression was
technical/biomed/gb-2003-4-7-r42.txt:          2. We also note that these experimentally verified miRNAs
technical/biomed/gb-2003-4-7-r42.txt:          three orders of magnitude less abundant than miRNAs
technical/biomed/gb-2003-4-7-r42.txt:          discovered by direct cloning. Other undetected miRNAs
technical/biomed/gb-2003-4-7-r42.txt:          sequencing miRNA cDNA libraries would have been
technical/biomed/gb-2003-4-7-r42.txt:          bona fide Drosophila miRNAs that
technical/biomed/gb-2003-4-7-r42.txt:          reference set followed by newly identified miRNAs that
technical/biomed/gb-2003-4-7-r42.txt:          fulfill accepted criteria for miRNA biogenesis (that is,
technical/biomed/gb-2003-4-7-r42.txt:          and/or are homologous to miRNAs cloned in other species);
technical/biomed/gb-2003-4-7-r42.txt:          a miRNA [ 44 ] that was identified as a high-scoring
technical/biomed/gb-2003-4-7-r42.txt:          newly identified miRNAs (miR-34, miR-79, miR-87, miR-92a,
technical/biomed/gb-2003-4-7-r42.txt:          assessing the validity of a miRNA [ 46 ] . Indeed, one
technical/biomed/gb-2003-4-7-r42.txt:          miRseeker appears to be an unannotated U2 snRNA [ 43 ] .
technical/biomed/gb-2003-4-7-r42.txt:          show alignments and RNA folds of the four insect
technical/biomed/gb-2003-4-7-r42.txt:          of genuine miRNAs (preponderance of divergence within the
technical/biomed/gb-2003-4-7-r42.txt:          and perfect conservation of a putative miRNA-encoding
technical/biomed/gb-2003-4-7-r42.txt:          miR-137, and thus accepted as a genuine miRNA. We
technical/biomed/gb-2003-4-7-r42.txt:          Drosophila miRNA genes. In the
technical/biomed/gb-2003-4-7-r42.txt:          reference set and 25 novel miRNAs that meet accepted
technical/biomed/gb-2003-4-7-r42.txt:          criteria for representing genuine miRNAs. Of the
technical/biomed/gb-2003-4-7-r42.txt:          = 29 to 50 additional miRNAs in this list of unverified
technical/biomed/gb-2003-4-7-r42.txt:          miRNAs (18 reference + 25 novel verified genes + 29-50
technical/biomed/gb-2003-4-7-r42.txt:          contain 96-124, or around 110 miRNA genes. This suggests
technical/biomed/gb-2003-4-7-r42.txt:          Drosophila genes are miRNAs, a
technical/biomed/gb-2003-4-7-r42.txt:          miRNA genes: clusters and paralogs
technical/biomed/gb-2003-4-7-r42.txt:          A subset of miRNA genes are known to reside in local
technical/biomed/gb-2003-4-7-r42.txt:          The largest cluster of miRNA genes in 
technical/biomed/gb-2003-4-7-r42.txt:          seven-miRNA cluster that is conserved in 
technical/biomed/gb-2003-4-7-r42.txt:          flux in the miRNA content of this region even within the
technical/biomed/gb-2003-4-7-r42.txt:          5' end to another experimentally verified miRNA (miR-279,
technical/biomed/gb-2003-4-7-r42.txt:          The volatility of miRNA genes is further indicated by
technical/biomed/gb-2003-4-7-r42.txt:          identified miRNAs is one containing 
technical/biomed/gb-2003-4-7-r42.txt:          nematodes. Although complementary sites for both miRNAs
technical/biomed/gb-2003-4-7-r42.txt:          targets, these miRNAs are not physically linked in the 
technical/biomed/gb-2003-4-7-r42.txt:          miRNAs has not yet been explicitly demonstrated in other
technical/biomed/gb-2003-4-7-r42.txt:          coordinate expression of all three as a single pri-miRNA
technical/biomed/gb-2003-4-7-r42.txt:          evidence for coordinate expression of these miRNAs as a
technical/biomed/gb-2003-4-7-r42.txt:          single pri-miRNA [ 45 50 ] .
technical/biomed/gb-2003-4-7-r42.txt:          Drosophila miRNA that deviates from
technical/biomed/gb-2003-4-7-r42.txt:          mismatch actually resides within the mature miRNA
technical/biomed/gb-2003-4-7-r42.txt:          linked miRNAs that are transcribed from the same strand
technical/biomed/gb-2003-4-7-r42.txt:          miRNA genes (such as 
technical/biomed/gb-2003-4-7-r42.txt:          did not find that clusters of paralogous miRNA genes were
technical/biomed/gb-2003-4-7-r42.txt:          corroborated by the identification of several miRNA
technical/biomed/gb-2003-4-7-r42.txt:          Drosophila miRNAs are members of
technical/biomed/gb-2003-4-7-r42.txt:          observations of miRNAs in vertebrates, where the majority
technical/biomed/gb-2003-4-7-r42.txt:          of known miRNAs are members of paralogous gene sets [ 31
technical/biomed/gb-2003-4-7-r42.txt:          Drosophilid genomes contain around 110 microRNA
technical/biomed/gb-2003-4-7-r42.txt:          Although the first two miRNA genes were identified
technical/biomed/gb-2003-4-7-r42.txt:          miRNAs were identified by direct cloning of mature 21-22
technical/biomed/gb-2003-4-7-r42.txt:          nucleotide RNAs, either from size-selected total RNA or
technical/biomed/gb-2003-4-7-r42.txt:          aimed at identifying the processed miRNA that is
technical/biomed/gb-2003-4-7-r42.txt:          miRNAs will not be amenable to direct cloning, including
technical/biomed/gb-2003-4-7-r42.txt:          which the isolation of sufficient amounts of RNA for
technical/biomed/gb-2003-4-7-r42.txt:          structural features of known miRNA genes might permit the
technical/biomed/gb-2003-4-7-r42.txt:          unbiased discovery of the remaining complement of miRNA
technical/biomed/gb-2003-4-7-r42.txt:          found to have the capacity to fold into plausible miRNA
technical/biomed/gb-2003-4-7-r42.txt:          computational prediction of miRNAs based on presumed
technical/biomed/gb-2003-4-7-r42.txt:          identification of several miRNAs via a structural
technical/biomed/gb-2003-4-7-r42.txt:          C. elegans miRNAs identified
technical/biomed/gb-2003-4-7-r42.txt:          miRNA precursor.
technical/biomed/gb-2003-4-7-r42.txt:          Drosophila miRNA genes that ranks
technical/biomed/gb-2003-4-7-r42.txt:          Drosophila miRNA genes, and a
technical/biomed/gb-2003-4-7-r42.txt:          newly verified miRNAs (24 of which were confirmed here by
technical/biomed/gb-2003-4-7-r42.txt:          allows us to estimate the presence of around 110 miRNA
technical/biomed/gb-2003-4-7-r42.txt:          predictions of miRNA genes by similar overall strategies
technical/biomed/gb-2003-4-7-r42.txt:          colleagues predicting 200-255 miRNA genes in vertebrates,
technical/biomed/gb-2003-4-7-r42.txt:          of nucleotide divergence within miRNA precursors. The
technical/biomed/gb-2003-4-7-r42.txt:          pre-miRNA, an observation supported by the identification
technical/biomed/gb-2003-4-7-r42.txt:          of orthologous insect miRNAs that vary quite
technical/biomed/gb-2003-4-7-r42.txt:          selective pressure on the sequence of the non-miRNA arm,
technical/biomed/gb-2003-4-7-r42.txt:          every input dsRNA ever tested in RNAi assays. It may be
technical/biomed/gb-2003-4-7-r42.txt:          characteristic of pre-miRNA, or alternatively, that the
technical/biomed/gb-2003-4-7-r42.txt:          non-miRNA-encoding product may in fact have some
technical/biomed/gb-2003-4-7-r42.txt:          non-miRNA-encoding arm is mild, and that it diverges long
technical/biomed/gb-2003-4-7-r42.txt:          before the sequence of the mature miRNA does.
technical/biomed/gb-2003-4-7-r42.txt:          It is worth noting that the fraction of miRNAs
technical/biomed/gb-2003-4-7-r42.txt:          higher than the fraction of miRNAs that are conserved
technical/biomed/gb-2003-4-7-r42.txt:          This indicates that insect miRNAs evolve much more
technical/biomed/gb-2003-4-7-r42.txt:          rapidly than do vertebrate miRNAs. This is in general
technical/biomed/gb-2003-4-7-r42.txt:          In these heady times of miRNA gene discovery, it is
technical/biomed/gb-2003-4-7-r42.txt:          resemble known miRNA genes [ 46 ] . At the same time,
technical/biomed/gb-2003-4-7-r42.txt:          miRNA prediction algorithms may further reduce the
technical/biomed/gb-2003-4-7-r42.txt:          bias at the 5' end of miRNA (including a propensity to
technical/biomed/gb-2003-4-7-r42.txt:          pre-miRNA genes and not mature miRNA sequences
technical/biomed/gb-2003-4-7-r42.txt:          (thus including a potential miRNA) was in most cases
technical/biomed/gb-2003-4-7-r42.txt:          arbitrary to select a candidate miRNA sequence just so
technical/biomed/gb-2003-4-7-r42.txt:          that different chemical strategies for capturing miRNA
technical/biomed/gb-2003-4-7-r42.txt:          molecules may differentially recover miRNAs according to
technical/biomed/gb-2003-4-7-r42.txt:          their 5' ends [ 33 ] , so reevaluation of miRNA 5' bias
technical/biomed/gb-2003-4-7-r42.txt:          miRNA genes may be transcribed by RNA polymerase II. Our
technical/biomed/gb-2003-4-7-r42.txt:          mentioned earlier, one of the 24 reference miRNAs
technical/biomed/gb-2003-4-7-r42.txt:          divergent miRNAs, including class 6 candidates.
technical/biomed/gb-2003-4-7-r42.txt:          miRNA genes evolve rapidly and although none of the
technical/biomed/gb-2003-4-7-r42.txt:          non-coding RNA genes (tncRNAs) that share some features
technical/biomed/gb-2003-4-7-r42.txt:          with miRNAs provides a precedent for exceptionally
technical/biomed/gb-2003-4-7-r42.txt:          rapidly evolving small RNA genes; tncRNAs are not even
technical/biomed/gb-2003-4-7-r42.txt:          any miRNAs that might be processed from spliced mRNA,
technical/biomed/gb-2003-4-7-r42.txt:          missed those miRNAs that proceed through precursor
technical/biomed/gb-2003-4-7-r42.txt:          pre-miRNAs in 
technical/biomed/gb-2003-4-7-r42.txt:          nucleotides in length, plant miRNA precursors are often
technical/biomed/gb-2003-4-7-r42.txt:          miRNAs may proceed through precursors of noncanonical
technical/biomed/gb-2003-4-7-r42.txt:          pre-miRNAs in metazoans is unknown at present.
technical/biomed/gb-2003-4-7-r42.txt:          ability of miRseeker to identify genuine miRNAs is
technical/biomed/gb-2003-4-7-r42.txt:          Drosophila miRNAs as very
technical/biomed/gb-2003-4-7-r42.txt:          candidate miRNA genes.
technical/biomed/gb-2003-4-7-r42.txt:          regarding miRNAs lies in determining their regulatory
technical/biomed/gb-2003-4-7-r42.txt:          targets. It is presumed that most of them will form RNA
technical/biomed/gb-2003-4-7-r42.txt:          duplexes with complementary sequences in mRNA, but direct
technical/biomed/gb-2003-4-7-r42.txt:          miRNAs. Although many miRNAs in plants were found to be
technical/biomed/gb-2003-4-7-r42.txt:          target mRNAs [ 24 52 ] , the few cases of known or
technical/biomed/gb-2003-4-7-r42.txt:          presumed animal miRNA targets involve imperfect and
technical/biomed/gb-2003-4-7-r42.txt:          miRNAs in animal genomes to date have not succeeded in
technical/biomed/gb-2003-4-7-r42.txt:          in random sequence. Thus, matching miRNAs to their
technical/biomed/gb-2003-4-7-r42.txt:          Drosophila miRNAs were recently
technical/biomed/gb-2003-4-7-r42.txt:          miRNA targets might be found by searching for complements
technical/biomed/gb-2003-4-7-r42.txt:          to the 5'-most 8-10 nucleotides of miRNAs in 3' UTRs.
technical/biomed/gb-2003-4-7-r42.txt:          hid are targets of the miRNA bantam
technical/biomed/gb-2003-4-7-r42.txt:          complementarity to miRNAs. Comparisons with 
technical/biomed/gb-2003-4-7-r42.txt:          miRNAs will be prime candidates to test as new examples
technical/biomed/gb-2003-4-7-r42.txt:          of miRNA-mediated post-transcriptional gene
technical/biomed/gb-2003-4-7-r42.txt:            transposable elements, snRNA, snoRNA, tRNA and rRNA
technical/biomed/gb-2003-4-7-r42.txt:            genes. Conserved miRNA candidate regions were extracted
technical/biomed/gb-2003-4-7-r42.txt:            RNA folding and scoring of conserved
technical/biomed/gb-2003-4-7-r42.txt:            internal loops within arms was loaded into the MySQL
technical/biomed/gb-2003-4-7-r42.txt:            kcal/mol) and miRNA-like helicity. Helicity was
technical/biomed/gb-2003-4-7-r42.txt:            these are more rarely observed in genuine miRNAs. An
technical/biomed/gb-2003-4-7-r42.txt:            miRNA.
technical/biomed/gb-2003-4-7-r42.txt:            nucleotides. Potential miRNA-encoding arms were then
technical/biomed/gb-2003-4-7-r42.txt:            contained potential miRNA sequences, the region passed
technical/biomed/gb-2003-4-7-r42.txt:            and it was considered a miRNA candidate (colored green
technical/biomed/gb-2003-4-7-r42.txt:            miRNA-encoding arm was identified, then the other arm
technical/biomed/gb-2003-4-7-r42.txt:            was defined as the non-miRNA-encoding arm. The terminus
technical/biomed/gb-2003-4-7-r42.txt:            of the potential miRNA-encoding arm was provisionally
technical/biomed/gb-2003-4-7-r42.txt:            and the non-miRNA-encoding arm was trimmed to an equal
technical/biomed/gb-2003-4-7-r42.txt:            non-miRNA-encoding arm was evaluated. Candidates with
technical/biomed/gb-2003-4-7-r42.txt:            only a single candidate miRNA-encoding arm were
technical/biomed/gb-2003-4-7-r42.txt:            number of mismatches in the non-miRNA-encoding arm was
technical/biomed/gb-2003-4-7-r42.txt:          and performs all the steps of the miRNA-finding procedure
technical/biomed/gb-2003-4-7-r42.txt:          described above, producing a list of miRNA candidates
technical/biomed/gb-2003-4-7-r42.txt:          distinguishes genuine miRNAs will differ with sequences
technical/biomed/gb-2003-4-7-r42.txt:          indiscriminately used to filter miRNA candidates derived
technical/biomed/gb-2003-4-7-r42.txt:          Northern blot validation of predicted miRNA
technical/biomed/gb-2003-4-7-r42.txt:          Total RNA was isolated from embryos (made by combining
technical/biomed/gb-2003-4-7-r42.txt:          equal amounts of 0-12-hour and 12-24-hour embryo RNA),
technical/biomed/gb-2003-4-7-r42.txt:          third instar and 0-1-day-old pupal RNA), and 0-2-day-old
technical/biomed/gb-2003-4-7-r42.txt:          mg RNA from each time point per lane on 15% acrylamide
technical/biomed/gb-2003-4-7-r43.txt:          bases. These repressed genes were enriched for rRNA
technical/biomed/gb-2003-4-7-r43.txt:        recruiting or inhibiting RNA polymerase. These differences
technical/biomed/gb-2003-4-7-r43.txt:        regions of TCRs. Alternatively, the possibility that each
technical/biomed/gb-2003-4-7-r43.txt:          c ). The alternate hypothesis
technical/biomed/gb-2003-4-7-r46.txt:          developed after 21 days. Global mRNA expression profiles
technical/biomed/gb-2003-4-7-r46.txt:          HuGeneFL chip that might be attributable to mouse RNA, a
technical/biomed/gb-2003-4-7-r46.txt:          culture profiles with equal amounts of RNA, the total
technical/biomed/gb-2003-4-7-r46.txt:          with the same amount of RNA. As the control profile was
technical/biomed/gb-2003-4-7-r46.txt:          and connective tissue. Total RNA was prepared from tumor
technical/biomed/gb-2003-4-7-r46.txt:          probe sets, each representing an mRNA transcript. To
technical/biomed/gb-2003-4-7-r46.txt:          (designed for human mRNAs) that could be attributable to
technical/biomed/gb-2003-4-7-r46.txt:          mouse mRNA in a xenograft tumor sample, a sample of mouse
technical/biomed/gb-2003-4-7-r46.txt:          lung tissue was also profiled. Preparation of mRNA,
technical/biomed/gb-2003-4-7-r46.txt:          mean gene mRNA expression levels between groups of
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 gene, characterized in detail
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 locus in 15q13.3 and is highly
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 duplication involves at least
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 duplication had, on the basis
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 within the chimpanzee genome [
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 -related sequence, yielding a
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 locus, produced a single FISH
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 (Figure 5). Upon hybridization
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 duplication was specific to
technical/biomed/gb-2003-4-8-r50.txt:        alternatively a sequence within RP11-40J8 had been
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 locus in 15q13.3 previously
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 locus is a human-specific
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 duplication appeared
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 locus in the human genome may
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 loci does not establish the
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 duplication, as gene
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 duplication which revealed
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 locus, did not produce dual
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 duplication (RP11-422F16)
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 -related sequence. Barring
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 sequence is single copy in the
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 was found either by
technical/biomed/gb-2003-4-8-r50.txt:        Alternatively, this site, which contains a recent
technical/biomed/gb-2003-4-8-r50.txt:        CHRNA7 locus, may be a preferential
technical/biomed/gb-2003-4-8-r50.txt:          CHRNA7 duplication with respect to
technical/biomed/gb-2003-4-8-r50.txt:          CHRNA7 - 
technical/biomed/gb-2003-4-8-r50.txt:          CHRNA7 -related sequence within
technical/biomed/gb-2003-4-8-r50.txt:          CHRNA7 in 
technical/biomed/gb-2003-4-8-r50.txt:          CHRNA7 - 
technical/biomed/gb-2003-4-8-r50.txt:          CHRNA7 .probe2.1 (forward,
technical/biomed/gb-2003-4-8-r50.txt:          CHRNA7 .probe2.2 (reverse,
technical/biomed/gb-2003-4-8-r50.txt:          CHRNA7 -related portion of BAC
technical/biomed/gb-2003-4-8-r51.txt:            superfamily, family, and domain level. Alternatively,
technical/biomed/gb-2003-4-8-r51.txt:            library can be browsed. Alternatively, it can be
technical/biomed/gb-2003-4-8-r51.txt:          external data are updated when a major release of NR
technical/biomed/gb-2003-4-9-r57.txt:          the internalization of A+T-rich exogenous DNA in the
technical/biomed/gb-2003-4-9-r58.txt:        Anopheles or, alternatively, gene
technical/biomed/gb-2003-4-9-r58.txt:        the internal segments of the channel, rather than what has
technical/biomed/gb-2003-4-9-r58.txt:        5' and 3' ends [ 18 19 ] . Alternative splicing at the pore
technical/biomed/gb-2003-4-9-r58.txt:        the Kv3 and Irk3 (Figure 3b) gene families. Alternatively,
technical/biomed/gb-2003-4-9-r60.txt:          experimental, RNA preparation, and GeneChip hybridization
technical/biomed/gb-2003-4-9-r60.txt:          and external resources drastically improved the discovery
technical/biomed/gb-2003-4-9-r60.txt:          link out to external data repositories including
technical/biomed/gb-2003-4-9-r60.txt:          hyperlinks to external data repositories for each gene,
technical/biomed/rr166.txt:        RNA synthesis in several cell types, including fibroblasts
technical/biomed/rr166.txt:          twice, and the supernatants were pooled and cultured in
technical/biomed/rr166.txt:          supernatant was aspirated and fresh media containing 30
technical/biomed/rr166.txt:          min of incubation the supernatant was collected and saved
technical/biomed/rr166.txt:          were used for RNA and protein extractions, respectively.
technical/biomed/rr166.txt:          described [ 23 ] . Briefly, deuterium-labeled internal
technical/biomed/rr166.txt:          1α were added to the supernatants with
technical/biomed/rr166.txt:          internal standards had been added.
technical/biomed/rr166.txt:          Cell pellets were lyzed and RNA extracted using the
technical/biomed/rr166.txt:          instructions. RNA was quantified by determining light
technical/biomed/rr166.txt:          MOPS/formaldehyde gel. The RNA was denatured prior to
technical/biomed/rr166.txt:          loading by incubating the RNA at 65°C for 10 min in a
technical/biomed/rr166.txt:          bromophenol blue, 0.025% xylene cyanol. The RNA was
technical/biomed/rr166.txt:          showed minimal COX-2 mRNA in unstimulated cells and
technical/biomed/rr166.txt:          significant upregulation of COX-2 mRNA expression when
technical/biomed/rr166.txt:        upregulates COX-2 protein and mRNA expression to a similar
technical/biomed/rr166.txt:        2 , decreases procollagen I and III mRNA
technical/biomed/rr167.txt:          g . After removing the supernatant
technical/biomed/rr167.txt:          RNase I. The slurry was passed twice through a French
technical/biomed/rr167.txt:          Press set at 20,000 lbs/in 2. DNase and RNase were again
technical/biomed/rr167.txt:          added to the supernatant and incubated at 37°C overnight
technical/biomed/rr167.txt:          the repeated DNase and RNase treatments. LPS preparations
technical/biomed/rr167.txt:        chains of lipid A might also provide alternative binding
technical/biomed/rr171.txt:          DNA extracted from the supernatants by overnight
technical/biomed/rr171.txt:          Total RNA was isolated from cells using an RNeasy
technical/biomed/rr171.txt:          the manufacturer's instructions. RNA was quantified by
technical/biomed/rr171.txt:          absorbance at 260 nm. For first strand synthesis, RNA
technical/biomed/rr171.txt:          mM random hexamers and 200 U Superscript II RNase H -RT
technical/biomed/rr171.txt:          incubation at 37°C, RNase H -(2 U) was added and the
technical/biomed/rr171.txt:          (TNF-α) mRNA was determined using mouse COX-2 and TNF-α
technical/biomed/rr171.txt:          total RNA), 10 mM Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl
technical/biomed/rr171.txt:          centrifuged (4000 × g, 5 min) and supernatants containing
technical/biomed/rr171.txt:          ice for an additional 20 min. Supernatants containing
technical/biomed/rr171.txt:          enzyme COX-2 [ 18 ] . We found that COX-2 mRNA was
technical/biomed/rr171.txt:          hours. Subsequently, COX-2 mRNA returned to control
technical/biomed/rr171.txt:          levels. Induction of COX-2 mRNA following endotoxin
technical/biomed/rr171.txt:          protein. However, in contrast to mRNA, protein levels
technical/biomed/rr171.txt:          resulted in a time dependent increase in TNF-α mRNA
technical/biomed/rr171.txt:          mRNA, TNF-α mRNA levels began to decline at 12 hours and
technical/biomed/rr171.txt:        protein-2 (MIP-2) mRNA following endotoxin administration [
technical/biomed/rr171.txt:        COX-2 mRNA and protein. The effects of endotoxin
technical/biomed/rr171.txt:        and TNF-α mRNA expression declined and by 12 hours were at
technical/biomed/rr171.txt:        neutrophil apoptosis in control animals. Alternatively,
technical/biomed/rr172.txt:          concentrations of CSC in 0.5% DMSO, and total RNA was
technical/biomed/rr172.txt:          RNA (1 μg) was converted to cDNA in a 50 μl reaction
technical/biomed/rr172.txt:          molecules. Total RNA isolated from NHBEs following
technical/biomed/rr172.txt:        expression of several cytokines at the mRNA level. IL-1β,
technical/biomed/rr191.txt:        insulin down-regulates SP-A mRNA and protein levels in
technical/biomed/rr191.txt:        and SP-B mRNA and protein [ 14 ] . The hormonal regulation
technical/biomed/rr191.txt:          Labeled, newly synthesized RNA was then isolated and
technical/biomed/rr191.txt:          45°C and then hybridized to the labeled RNAs (6 × 10 6cpm
technical/biomed/rr191.txt:          in the presence of 500 units of RNasin) in duplicate for
technical/biomed/rr191.txt:          in 2 X SSC with 10 μg/ml RNase A at 37°C for 30 min and
technical/biomed/rr191.txt:          SP-A mRNA levels. H441 cells were harvested and total RNA
technical/biomed/rr191.txt:          of total RNA from each condition were separated on
technical/biomed/rr191.txt:          estimated by densitometry and corrected for RNA loading
technical/biomed/rr191.txt:          lung explant samples, 4 μg of total RNA from each
technical/biomed/rr191.txt:          In addition, 10 μg of total RNA from each explant sample
technical/biomed/rr191.txt:          the RNA samples and to correct for RNA loading.
technical/biomed/rr191.txt:          insulin on SP-A mRNA levels
technical/biomed/rr191.txt:          effect of insulin, i.e., an ~22% inhibition of SP-A mRNA
technical/biomed/rr191.txt:          alone, did not significantly alter SP-A mRNA levels at
technical/biomed/rr191.txt:          insulin-mediated inhibition of SP-A mRNA levels at all
technical/biomed/rr191.txt:          alone, decreased SP-A mRNA levels at concentrations
technical/biomed/rr191.txt:          did not affect basal SP-A mRNA levels. In the control
technical/biomed/rr191.txt:          group, insulin significantly decreased SP-A mRNA levels
technical/biomed/rr191.txt:          μM LY294002, insulin only decreased SP-A mRNA levels to
technical/biomed/rr191.txt:          mRNA levels (Fig. 1B). However, rapamycin abolished the
technical/biomed/rr191.txt:          alone, significantly decreased SP-A mRNA levels in a
technical/biomed/rr191.txt:          the insulin inhibition of SP-A mRNA levels.
technical/biomed/rr191.txt:          the insulin inhibition of SP-A mRNA while decreasing
technical/biomed/rr191.txt:          basal SP-A mRNA levels in a dose-dependent manner when
technical/biomed/rr191.txt:        basal SP-A mRNA levels, at any concentration tested.
technical/biomed/rr191.txt:        SP-A mRNA levels in a dose-dependent manner. We hypothesize
technical/biomed/rr196.txt:        reaction (RT-PCR) assay for rat MHC mRNA [ 19 ] , we set
technical/biomed/rr196.txt:        mRNA expression in emphysematous rat diaphragm. To evaluate
technical/biomed/rr196.txt:          MHC mRNA expression was analyzed by an MHC RT-PCR
technical/biomed/rr196.txt:          mRNA of the embryonic, neonatal, I, IIa, IIx, and IIb MHC
technical/biomed/rr196.txt:          In brief, mRNA was extracted from an approximately 50
technical/biomed/rr196.txt:          with the manufacturer's protocol. The mRNA was then
technical/biomed/rr196.txt:          at a wavelength of 260 nm. mRNA (150 ng) was reverse
technical/biomed/rr196.txt:          1 pg of an internal control fragment [ 22 ] to be
technical/biomed/rr196.txt:          MHC mRNA isoforms in a given sample [ 19 ] . We performed
technical/biomed/rr196.txt:          each piece of muscle, starting with the same mRNA sample.
technical/biomed/rr196.txt:          The mean percentage compositions of mRNA representing
technical/biomed/rr196.txt:          isoforms at the mRNA level, and this shift occurred
technical/biomed/rr196.txt:          results at the mRNA level. Table 2demonstrates that, as
technical/biomed/rr196.txt:        systematically greater concentration of IIb mRNA in IIb and
technical/biomed/rr196.txt:        IIb/IIx fibers than of other isoforms' mRNAs in their
technical/biomed/rr196.txt:        between studies addressing mRNA levels and those addressing
technical/biomed/rr196.txt:        emphysematous rat diaphragm at both the protein and mRNA
technical/biomed/rr196.txt:        chronically swimming rats [ 28 ] . We found IIb mRNA
technical/biomed/rr196.txt:        IIb MHC expression at both the protein and mRNA levels in
technical/biomed/rr37.txt:          or nocturnal), use of systemic corticosteroids, use of
technical/biomed/rr37.txt:          office visits for asthma, either to regular or alternate
technical/biomed/rr37.txt:        specialist [ 10]. Low income may alternatively be a marker
technical/biomed/rr73.txt:            Supernatant media from 3D cultures were concentrated
technical/biomed/rr74.txt:        hypoxia from birth and measured NOS mRNA and protein
technical/biomed/rr74.txt:          protein and RNA measurement, and the left lung was fixed
technical/biomed/rr74.txt:          Total RNA was extracted from 100 mg of frozen lung
technical/biomed/rr74.txt:          2 O. RNA was quantified and samples
technical/biomed/rr74.txt:          Biosystems, Foster City, CA, USA). RNA quantity was
technical/biomed/rr74.txt:          determined using 18 S rRNA primers/probes (Applied
technical/biomed/rr74.txt:          RNA.
technical/biomed/rr74.txt:        The increase in eNOS protein and mRNA levels, and the
technical/biomed/rr74.txt:        both iNOS mRNA and protein levels in rat lungs following
technical/biomed/rr74.txt:        iNOS mRNA levels was not associated with detectable iNOS
technical/biomed/rr74.txt:        in vivo downregulation of eNOS mRNA
